Citrus Sinensis ID: 017341

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370---
Protein Sequence
MQEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Secondary Structure (PSIPRED)
ccccccEEEccccccEEEEEEEEEccccccccEEEEEEEEEEEEcccEEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEccEEEccccccccEEEEEEEEcccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEcccccHHHHccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccHHHcccccHHHHHHccHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccc
Coil and Loop (DISEMBL)
mqemeatvvdgngteAGHIIVTTiggkngqpkqTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffstteKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTigvchrdikpqnllvnphthqlklcdfgsakvlvkgepnisyicsryyrapelifgateyTAAIDIWSAGCVLAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifqkrmppeAVDLVSRLLQYSPNLRSTALEALIhpffdelrdpntrlpngrflpplfnfkphelkgvpvDMLVKLIPEHARKQCAFLGL
Flexible Loop (DISEMBL)
MQEMEATVvdgngteaGHIIVTtiggkngqpKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIkkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHhykmsqrmPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Low Complexity Region (SEG)
MQEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Disordered region (IsUnstruct)
*************TEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAF***
Disordered Region (DISOPRED)
******************IIVTTIGGK*GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC*****
Disordered Region (DISEMBL)
*********DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Disordered Region (DISPRO)
*****ATVVDG*GTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MQEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	373	2.2.26 [Sep-21-2011]
P43288	405	Shaggy-related protein ki	yes	no	0.997	0.918	0.919	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.994	0.902	0.922	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.994	0.902	0.908	0.0
P43289	409	Shaggy-related protein ki	no	no	0.997	0.909	0.903	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.997	0.907	0.897	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.997	0.905	0.911	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.997	0.909	0.895	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.975	0.771	0.802	0.0
Q39019	421	Shaggy-related protein ki	no	no	0.997	0.883	0.779	1e-180
Q9FVS6	420	Shaggy-related protein ki	no	no	0.997	0.885	0.782	1e-179

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  723 bits (1866), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/372 (91%), Positives = 358/372 (96%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEATVVDGNGTE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 34  KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 93

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 94  TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 153

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ K++QRMPLIYVKLY YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 154 VIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 213

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGE
Sbjct: 214 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 273

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 274 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 333

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRS AL+ L+HPFFDELRDPN RLPNGRFLPPLFNFKPHELKGVP++M+ KL+P
Sbjct: 334 LQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVP 393

Query: 362 EHARKQCAFLGL 373
           EHARKQC +LGL
Sbjct: 394 EHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  723 bits (1866), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/372 (92%), Positives = 358/372 (96%), Gaps = 1/372 (0%)

Query: 2   QEMEA-TVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG 60
           +EMEA T+VDGNGTE GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG
Sbjct: 38  KEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG 97

Query: 61  EAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVH 120
           E VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 
Sbjct: 98  ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVS 157

Query: 121 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 180
           RVI+H+ KM+QRMP+IYVKLY YQICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+C
Sbjct: 158 RVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKIC 217

Query: 181 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 240
           DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPG
Sbjct: 218 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPG 277

Query: 241 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR 300
           ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSR
Sbjct: 278 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 337

Query: 301 LLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           LLQYSPNLRSTALEAL+HPF+D++RDPNTRLPNGRFLPPLFNFK +ELKGVP +MLVKL+
Sbjct: 338 LLQYSPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLV 397

Query: 361 PEHARKQCAFLG 372
           P HARKQCA  G
Sbjct: 398 PPHARKQCALFG 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  716 bits (1848), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/371 (90%), Positives = 353/371 (95%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEA VVDGN TEAGH+IVTTIGGKNGQPKQTISYMAER VG GSFGVVFQAKCLETGE
Sbjct: 39  KEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGE 98

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVV+LKHCFFSTTEKDELYLNLVLE+VPETVHR
Sbjct: 99  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHR 158

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VI+H+ KM+QRMPLIYVKLY YQICR+LAYIHN +GV HRDIKPQNLLVNPHTHQLKLCD
Sbjct: 159 VIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCD 218

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT+AIDIWSAGCVL ELLLGQPLFPG 
Sbjct: 219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGA 278

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF+KRMPPEAVDLVSRL
Sbjct: 279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRL 338

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTALEAL+HPFFDELRDPNTRLPNGR LPPLFNFK +ELKGVP +MLVKL+P
Sbjct: 339 LQYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVP 398

Query: 362 EHARKQCAFLG 372
            HARKQC+   
Sbjct: 399 SHARKQCSLFA 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  714 bits (1844), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/372 (90%), Positives = 356/372 (95%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEAT+V+GN TE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 38  KEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 98  TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ K++QRMPL+YVKLY YQI R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 158 VIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR  AL++L+HPFFDELRDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+P
Sbjct: 338 LQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQC +L L
Sbjct: 398 EHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  712 bits (1839), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/372 (89%), Positives = 352/372 (94%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEA VVDGNGTE GHIIVTTIGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE
Sbjct: 39  KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGE 98

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+R
Sbjct: 99  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYR 158

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           V KH+ + +QRMP+IYVKLY YQICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 159 VSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCD 218

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGE
Sbjct: 219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGE 278

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRL
Sbjct: 279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRL 338

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTA+EA++HPFFDELRDPNTRLPNGR LPPLFNFKP ELKG  +++L KLIP
Sbjct: 339 LQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIP 398

Query: 362 EHARKQCAFLGL 373
           +HARKQC+FL L
Sbjct: 399 DHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  712 bits (1837), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/372 (91%), Positives = 352/372 (94%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEATVVDGNGTE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 40  REMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 99

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 100 TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 159

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ K++QRMP+IYVKLY YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 160 VIKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 219

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AID+WS GCVLAELLLGQPLFPGE
Sbjct: 220 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGE 279

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
            GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMP EAVDLVSRL
Sbjct: 280 RGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRL 339

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR  AL+ L HPFFDELRDPN RLP GRFLPPLFNFKPHELKGVPV+ L+KL+P
Sbjct: 340 LQYSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVP 399

Query: 362 EHARKQCAFLGL 373
           EHARKQC FLGL
Sbjct: 400 EHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  699 bits (1804), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/372 (89%), Positives = 350/372 (94%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +E+EA +VDGNGTE GHIIVTTIGG++GQPKQTISYMAER+VG GSFGVVFQAKCLETGE
Sbjct: 38  KEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVV LKHCFFSTTEKDE+YLNLVLEYVPETVHR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ K++QRMPLI VKLY YQI RAL+YIH+TIGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 158 VIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR TALEA+ H FFDELRDPNTRLPNGR LPPLFNFK HELKGV  + L+KL+P
Sbjct: 338 LQYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQC  LGL
Sbjct: 398 EHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  634 bits (1636), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 292/364 (80%), Positives = 324/364 (89%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           ++ME TVV+G+GTE G +I TT+GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE
Sbjct: 103 KDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGE 162

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R
Sbjct: 163 QVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYR 222

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             KH+ KM+Q MP+I+V+LY YQICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CD
Sbjct: 223 ASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICD 282

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAK+LV GEPNISYICSRYYRAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGE
Sbjct: 283 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGE 342

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 343 SGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 402

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR TALEA  HPFFD+LRDPN  LPNGR LPPLFNF   EL G   ++  +LIP
Sbjct: 403 LQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIP 462

Query: 362 EHAR 365
            H +
Sbjct: 463 AHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  631 bits (1627), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 290/372 (77%), Positives = 330/372 (88%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           ++ E  ++DG G E GH+I TT+ G+NGQ +QT+SY++E VVG GSFG+VFQAKC ETGE
Sbjct: 48  RDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGE 107

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS T+ +E+YLNLVLE+VPETV+R
Sbjct: 108 VVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNR 167

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           V + + + +Q MPLIYVKLY YQICRALAYIHN+ G+CHRDIKPQNLLVNPHTHQLK+CD
Sbjct: 168 VARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICD 227

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYT AIDIWS GCV+AELLLGQPLFPGE
Sbjct: 228 FGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGE 287

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R 
Sbjct: 288 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRF 347

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
            QYSPNLR TALEA IHP FDELRDPNTRLPNGR LPPLFNFKP EL G+P +++ +L+P
Sbjct: 348 FQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVP 407

Query: 362 EHARKQCAFLGL 373
           EHARKQ  F+ L
Sbjct: 408 EHARKQNLFMAL 419

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  628 bits (1619), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 291/372 (78%), Positives = 327/372 (87%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           ++ E  ++DG G E GH+I TT+ G+NGQ +QT+SY+AE VVG GSFG+VFQAKC ETGE
Sbjct: 47  RDSEPDIIDGVGAEPGHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGE 106

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQ M++LDHPNVV LKH F+S TE +E+YLNLVLE+VPETV+R
Sbjct: 107 VVAIKKVLQDKRYKNRELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNR 166

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             + + +M+Q MPLIYVKLY YQICR LAY+HN  G+CHRDIKPQNLLVNPHTHQLK+CD
Sbjct: 167 TARSYSRMNQLMPLIYVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICD 226

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWS GCV+AELLLGQPLFPGE
Sbjct: 227 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 286

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R 
Sbjct: 287 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRF 346

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
            QYSPNLR TA+EA IHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P + + +L+P
Sbjct: 347 FQYSPNLRCTAVEACIHPFFDELRDPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVP 406

Query: 362 EHARKQCAFLGL 373
           EHARKQ  F+ L
Sbjct: 407 EHARKQNHFMAL 418

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
224068663	409	predicted protein [Populus trichocarpa]	0.997	0.909	0.962	0.0
224128207	409	predicted protein [Populus trichocarpa]	0.997	0.909	0.962	0.0
255548323	409	Glycogen synthase kinase-3 beta, putativ	0.997	0.909	0.965	0.0
164521171	409	serine/threonine protein kinase [Adonis	0.997	0.909	0.951	0.0
225437683	409	PREDICTED: glycogen synthase kinase-3 ho	0.997	0.909	0.956	0.0
449461703	409	PREDICTED: glycogen synthase kinase-3 ho	0.994	0.907	0.948	0.0
297744035	381	unnamed protein product [Vitis vinifera]	0.997	0.976	0.956	0.0
226533162	408	glycogen synthase kinase-3 MsK-3 [Zea ma	0.997	0.911	0.908	0.0
242052465	408	hypothetical protein SORBIDRAFT_03g00958	0.997	0.911	0.905	0.0
225450484	409	PREDICTED: shaggy-related protein kinase	0.997	0.909	0.930	0.0

>gi|224068663|ref|XP_002302794.1| predicted protein [Populus trichocarpa] gi|222844520|gb|EEE82067.1| predicted protein [Populus trichocarpa]

 Score =  753 bits (1944), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/372 (96%), Positives = 365/372 (98%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEA VVDGNGTE GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE
Sbjct: 38  KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGLVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+YKMSQRMPLIYVKLYFYQICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 158 VIKHYYKMSQRMPLIYVKLYFYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTALEALIHPFFDELRDPN RLPNGR LPPLFNFKPHELKGVPV+MLVKLIP
Sbjct: 338 LQYSPNLRSTALEALIHPFFDELRDPNARLPNGRILPPLFNFKPHELKGVPVEMLVKLIP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQCAFLGL
Sbjct: 398 EHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128207|ref|XP_002320270.1| predicted protein [Populus trichocarpa] gi|222861043|gb|EEE98585.1| predicted protein [Populus trichocarpa]

 Score =  753 bits (1943), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/372 (96%), Positives = 367/372 (98%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEATVVDGNGTE GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 38  KEMEATVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ KMSQRMPLIYVKLYFY+ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 158 VIKHYSKMSQRMPLIYVKLYFYEICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT+AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVP++MLVKLIP
Sbjct: 338 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPLEMLVKLIP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQCAFLGL
Sbjct: 398 EHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255548323|ref|XP_002515218.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223545698|gb|EEF47202.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  751 bits (1940), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/372 (96%), Positives = 366/372 (98%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEATVVDGNGTE GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 38  KEMEATVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
           AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 98  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ KM QRMPLIYVKLYFYQICRALAYIHN+IGVCHRDIKP NLLVNPHTHQLKLCD
Sbjct: 158 VIKHYNKMGQRMPLIYVKLYFYQICRALAYIHNSIGVCHRDIKPHNLLVNPHTHQLKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTAL+ALIHPFFDELRDPNTRLPNGRFLPPLFNF+PHELKGVPV++LVKLIP
Sbjct: 338 LQYSPNLRSTALDALIHPFFDELRDPNTRLPNGRFLPPLFNFRPHELKGVPVEVLVKLIP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQCAFLGL
Sbjct: 398 EHARKQCAFLGL 409

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|164521171|gb|ABY60447.1| serine/threonine protein kinase [Adonis aestivalis var. palaestina]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/372 (95%), Positives = 362/372 (97%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEATVVDGNGTE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE
Sbjct: 38  KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGIVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET HR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETAHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ KM+QRMPLIYVKLY YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 158 VIKHYNKMNQRMPLIYVKLYTYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTAL+ALIHPFFDELRDP TRLPNGRFLPPLFNFKPHELKGVPV++L KLIP
Sbjct: 338 LQYSPNLRSTALDALIHPFFDELRDPTTRLPNGRFLPPLFNFKPHELKGVPVEILGKLIP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQCAFLGL
Sbjct: 398 EHARKQCAFLGL 409

Source: Adonis aestivalis var. palaestina

Species: Adonis aestivalis

Genus: Adonis

Family: Ranunculaceae

Order: Ranunculales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437683|ref|XP_002279596.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3 [Vitis vinifera] gi|147767229|emb|CAN75652.1| hypothetical protein VITISV_017659 [Vitis vinifera]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/372 (95%), Positives = 362/372 (97%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EME TVVDGNGTE GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 38  KEMEDTVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ KM+QRMP+IYVKLY YQICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 158 VIKHYNKMNQRMPMIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGE NISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGELNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTALEALIHPFFDELR+PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP
Sbjct: 338 LQYSPNLRSTALEALIHPFFDELREPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQCAFLGL
Sbjct: 398 EHARKQCAFLGL 409

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461703|ref|XP_004148581.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus] gi|449511511|ref|XP_004163975.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 352/371 (94%), Positives = 362/371 (97%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +E+EATVVDGNGTE GHIIVTTIGGKNGQPKQTISYMAER VGHGSFGVVFQAKCLETGE
Sbjct: 38  KEIEATVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERAVGHGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ KM+QRMPLIYVKLYFYQICRAL+YIHN+IGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 158 VIKHYNKMNQRMPLIYVKLYFYQICRALSYIHNSIGVCHRDIKPQNLLVNPHTHQLKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLV+GEPNI+YICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 218 FGSAKVLVRGEPNIAYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK HELKGVP +MLV+LIP
Sbjct: 338 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKAHELKGVPPEMLVRLIP 397

Query: 362 EHARKQCAFLG 372
           EHARKQC FLG
Sbjct: 398 EHARKQCNFLG 408

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297744035|emb|CBI37005.3| unnamed protein product [Vitis vinifera]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/372 (95%), Positives = 362/372 (97%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EME TVVDGNGTE GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 10  KEMEDTVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 69

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHR
Sbjct: 70  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHR 129

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ KM+QRMP+IYVKLY YQICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 130 VIKHYNKMNQRMPMIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCD 189

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGE NISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGE
Sbjct: 190 FGSAKVLVKGELNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 249

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 250 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 309

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLRSTALEALIHPFFDELR+PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP
Sbjct: 310 LQYSPNLRSTALEALIHPFFDELREPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 369

Query: 362 EHARKQCAFLGL 373
           EHARKQCAFLGL
Sbjct: 370 EHARKQCAFLGL 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|226533162|ref|NP_001148880.1| glycogen synthase kinase-3 MsK-3 [Zea mays] gi|195622888|gb|ACG33274.1| glycogen synthase kinase-3 MsK-3 [Zea mays] gi|413947048|gb|AFW79697.1| putative glycogen synthase kinase family protein [Zea mays]

 Score =  728 bits (1880), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/372 (90%), Positives = 359/372 (96%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +E+EAT+++G GTE GHIIVTT GGKNGQPKQT+SYMAER+VG GSFG+VFQAKCLETGE
Sbjct: 37  KEVEATIINGKGTETGHIIVTTTGGKNGQPKQTVSYMAERIVGQGSFGIVFQAKCLETGE 96

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVV+LKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 97  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVHR 156

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           V+KHH KM+QRMPLIYVKLY YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 157 VVKHHNKMNQRMPLIYVKLYMYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCD 216

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGE
Sbjct: 217 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGE 276

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK+F KRMPPEAVDLVSRL
Sbjct: 277 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRL 336

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR TA+EAL+HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVP D++ KLIP
Sbjct: 337 LQYSPNLRCTAMEALVHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPSDIVAKLIP 396

Query: 362 EHARKQCAFLGL 373
           EHA+KQC+++GL
Sbjct: 397 EHAKKQCSYVGL 408

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242052465|ref|XP_002455378.1| hypothetical protein SORBIDRAFT_03g009580 [Sorghum bicolor] gi|241927353|gb|EES00498.1| hypothetical protein SORBIDRAFT_03g009580 [Sorghum bicolor]

 Score =  726 bits (1873), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/372 (90%), Positives = 358/372 (96%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +E+EAT+++G GTE GHIIVTT GGKNGQPKQT+SYMAER+VG GSFG+VFQAKCLETGE
Sbjct: 37  KEVEATIINGKGTETGHIIVTTTGGKNGQPKQTVSYMAERIVGQGSFGIVFQAKCLETGE 96

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVV+LKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 97  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVHR 156

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           V+KHH KM+QRMPLIYVKLY YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 157 VVKHHNKMNQRMPLIYVKLYMYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCD 216

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGE
Sbjct: 217 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGE 276

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK+F KRMPPEAVDLVSRL
Sbjct: 277 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRL 336

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR TA+EAL+HPFFDELRDPNTRLPNGRFLPPLFNFK HELKGVP D++ KLIP
Sbjct: 337 LQYSPNLRCTAVEALVHPFFDELRDPNTRLPNGRFLPPLFNFKAHELKGVPADIVAKLIP 396

Query: 362 EHARKQCAFLGL 373
           EHA+KQC+++GL
Sbjct: 397 EHAKKQCSYVGL 408

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225450484|ref|XP_002280673.1| PREDICTED: shaggy-related protein kinase alpha [Vitis vinifera]

 Score =  725 bits (1872), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/372 (93%), Positives = 359/372 (96%)

Query: 2   QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
           +EMEATVVDGNGTE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct: 38  KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query: 62  AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
            VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           VIKH+ K++QRMPLIYVKLY YQI RAL+YIH +IGVCHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 158 VIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQLKLCD 217

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGE 277

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           LQYSPNLR TA++AL H FFDELRD +TRLPNGRFLPPLFNFKPHELKGVPV++LVKLIP
Sbjct: 338 LQYSPNLRCTAMDALTHSFFDELRDSSTRLPNGRFLPPLFNFKPHELKGVPVEILVKLIP 397

Query: 362 EHARKQCAFLGL 373
           EHARKQC FLGL
Sbjct: 398 EHARKQCPFLGL 409

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.997	0.918	0.919	1.8e-190
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.997	0.909	0.903	1e-187
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.997	0.907	0.897	8.2e-186
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.997	0.883	0.779	4.3e-164
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.975	0.771	0.802	1.5e-163
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.978	0.896	0.795	6.3e-163
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.978	0.885	0.797	1.7e-162
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.986	0.968	0.779	7.5e-160
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.978	0.833	0.731	4.3e-148
UNIPROTKB|F1NPL8	390	GSK3B "Uncharacterized protein	0.954	0.912	0.664	1.7e-128

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1846 (654.9 bits), Expect = 1.8e-190, P = 1.8e-190
 Identities = 342/372 (91%), Positives = 358/372 (96%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             +EMEATVVDGNGTE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct:    34 KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 93

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct:    94 TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 153

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             VIKH+ K++QRMPLIYVKLY YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct:   154 VIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 213

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGE
Sbjct:   214 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 273

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct:   274 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 333

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSPNLRS AL+ L+HPFFDELRDPN RLPNGRFLPPLFNFKPHELKGVP++M+ KL+P
Sbjct:   334 LQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVP 393

Query:   362 EHARKQCAFLGL 373
             EHARKQC +LGL
Sbjct:   394 EHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1820 (645.7 bits), Expect = 1.0e-187, P = 1.0e-187
 Identities = 336/372 (90%), Positives = 356/372 (95%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             +EMEAT+V+GN TE GHIIVTTIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE
Sbjct:    38 KEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR
Sbjct:    98 TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             VIKH+ K++QRMPL+YVKLY YQI R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct:   158 VIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGE
Sbjct:   218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 277

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct:   278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSPNLR  AL++L+HPFFDELRDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+P
Sbjct:   338 LQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVP 397

Query:   362 EHARKQCAFLGL 373
             EHARKQC +L L
Sbjct:   398 EHARKQCPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1802 (639.4 bits), Expect = 8.2e-186, P = 8.2e-186
 Identities = 334/372 (89%), Positives = 352/372 (94%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             +EMEA VVDGNGTE GHIIVTTIGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE
Sbjct:    39 KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGE 98

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+R
Sbjct:    99 TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYR 158

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             V KH+ + +QRMP+IYVKLY YQICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCD
Sbjct:   159 VSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCD 218

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGE
Sbjct:   219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGE 278

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRL
Sbjct:   279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRL 338

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSPNLRSTA+EA++HPFFDELRDPNTRLPNGR LPPLFNFKP ELKG  +++L KLIP
Sbjct:   339 LQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIP 398

Query:   362 EHARKQCAFLGL 373
             +HARKQC+FL L
Sbjct:   399 DHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1597 (567.2 bits), Expect = 4.3e-164, P = 4.3e-164
 Identities = 290/372 (77%), Positives = 330/372 (88%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             ++ E  ++DG G E GH+I TT+ G+NGQ +QT+SY++E VVG GSFG+VFQAKC ETGE
Sbjct:    48 RDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGE 107

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS T+ +E+YLNLVLE+VPETV+R
Sbjct:   108 VVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNR 167

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             V + + + +Q MPLIYVKLY YQICRALAYIHN+ G+CHRDIKPQNLLVNPHTHQLK+CD
Sbjct:   168 VARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICD 227

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYT AIDIWS GCV+AELLLGQPLFPGE
Sbjct:   228 FGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGE 287

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R 
Sbjct:   288 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRF 347

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
              QYSPNLR TALEA IHP FDELRDPNTRLPNGR LPPLFNFKP EL G+P +++ +L+P
Sbjct:   348 FQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVP 407

Query:   362 EHARKQCAFLGL 373
             EHARKQ  F+ L
Sbjct:   408 EHARKQNLFMAL 419

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1592 (565.5 bits), Expect = 1.5e-163, P = 1.5e-163
 Identities = 292/364 (80%), Positives = 324/364 (89%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             ++ME TVV+G+GTE G +I TT+GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE
Sbjct:   103 KDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGE 162

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R
Sbjct:   163 QVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYR 222

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
               KH+ KM+Q MP+I+V+LY YQICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CD
Sbjct:   223 ASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICD 282

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAK+LV GEPNISYICSRYYRAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGE
Sbjct:   283 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGE 342

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             SG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRL
Sbjct:   343 SGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 402

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSPNLR TALEA  HPFFD+LRDPN  LPNGR LPPLFNF   EL G   ++  +LIP
Sbjct:   403 LQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIP 462

Query:   362 EHAR 365
              H +
Sbjct:   463 AHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1586 (563.4 bits), Expect = 6.3e-163, P = 6.3e-163
 Identities = 291/366 (79%), Positives = 329/366 (89%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             +EM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLETGE
Sbjct:    35 KEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE 94

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
             +VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVPET++R
Sbjct:    95 SVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYR 154

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             V++H+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ+KLCD
Sbjct:   155 VLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 214

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQPLFPGE
Sbjct:   215 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGE 274

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRL
Sbjct:   275 NSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 334

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSP+LR TALEA  HPFF+ELR+PN RLPNGR LPPLFNFK  EL G  ++++ +LIP
Sbjct:   335 LQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLIP 393

Query:   362 EHARKQ 367
             EH R+Q
Sbjct:   394 EHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1582 (562.0 bits), Expect = 1.7e-162, P = 1.7e-162
 Identities = 292/366 (79%), Positives = 327/366 (89%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             +EM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLETGE
Sbjct:    37 KEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE 96

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
             +VAIKKVLQD+RYKNRELQ MRL+DHPNVVSLKHCFFSTT +DEL+LNLV+EYVPET++R
Sbjct:    97 SVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYR 156

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             V+KH+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ KLCD
Sbjct:   157 VLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCD 216

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWSAGCVLAELLLGQPLFPGE
Sbjct:   217 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGE 276

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRL
Sbjct:   277 NSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 336

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSP+LR TALEA  HPFF+ELR+PN RLPNGR LPPLFNFK  EL G   +++ +LIP
Sbjct:   337 LQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELSGASPELINRLIP 395

Query:   362 EHARKQ 367
             EH R+Q
Sbjct:   396 EHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1557 (553.2 bits), Expect = 7.5e-160, P = 7.5e-160
 Identities = 290/372 (77%), Positives = 327/372 (87%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             +EM A VVDG+    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLETGE
Sbjct:     5 KEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE 64

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE+++R
Sbjct:    65 TVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYR 124

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             V+KH+   +QRMPL+YVKLY YQI R LAYIHN  GVCHRD+KPQNLLV+P THQ+K+CD
Sbjct:   125 VLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICD 184

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAK LVKGE NISYICSR+YRAPELIFGATEYT +IDIWSAGCVLAELLLGQPLFPGE
Sbjct:   185 FGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             + VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIF KRMPPEA+D  SRL
Sbjct:   245 NAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRL 304

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSP+LR TALEA  HPFFDELR+PN RLPNGR  PPLFNFK  E+ G   +++ KLIP
Sbjct:   305 LQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKLIP 363

Query:   362 EHARKQCAFLGL 373
             +H ++Q   LGL
Sbjct:   364 DHIKRQ---LGL 372

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1446 (514.1 bits), Expect = 4.3e-148, P = 4.3e-148
 Identities = 267/365 (73%), Positives = 307/365 (84%)

Query:     2 QEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 61
             ++M+  ++ GNGTE+G II T   G N Q  +TISY AE V+G GSFGVVFQAKCLET E
Sbjct:    74 KDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEE 133

Query:    62 AVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 121
              VAIKKVLQDKRYKNRELQ MR+LDHPNVV LKH FFSTTEKDELYLNLVLEYVPET++R
Sbjct:   134 KVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYR 193

Query:   122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
               + + KM+Q MPLIY++LY YQICRA+ Y+H  +GVCHRDIKPQNLLVN  TH++K+CD
Sbjct:   194 ASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICD 253

Query:   182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
             FGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+AID+WS GCV+AEL LG PLFPGE
Sbjct:   254 FGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGE 313

Query:   242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             + VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIKA PWHKIF++++ PEA+DL SRL
Sbjct:   314 TSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRL 373

Query:   302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
             LQYSPNLR TALEA  HPFFD+LRDP   LPNGR LPPLF+F   EL G  V++  +LIP
Sbjct:   374 LQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIP 433

Query:   362 EHARK 366
             EHARK
Sbjct:   434 EHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|F1NPL8 GSK3B "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 240/361 (66%), Positives = 290/361 (80%)

Query:    10 DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
             D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct:     1 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 58

Query:    70 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
             QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct:    59 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 118

Query:   129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
               Q +P+IYVKLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   119 AKQTLPMIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

Query:   189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
             V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct:   178 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237

Query:   249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct:   238 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 297

Query:   309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
             R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct:   298 RLTPLEACAHSFFDELRDPNVKLPNGREKPALFNFTTQELSSNP-SLASILIPAHARNQA 356

Query:   369 A 369
             A
Sbjct:   357 A 357

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000320 "re-entry into mitotic cell cycle" evidence=IEA

GO:0001085 "RNA polymerase II transcription factor binding" evidence=IEA

GO:0001837 "epithelial to mesenchymal transition" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005977 "glycogen metabolic process" evidence=IEA

GO:0006349 "regulation of gene expression by genetic imprinting" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0006983 "ER overload response" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0007520 "myoblast fusion" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0009887 "organ morphogenesis" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0030426 "growth cone" evidence=IEA

GO:0030529 "ribonucleoprotein complex" evidence=IEA

GO:0030877 "beta-catenin destruction complex" evidence=IEA

GO:0031333 "negative regulation of protein complex assembly" evidence=IEA

GO:0031334 "positive regulation of protein complex assembly" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0032091 "negative regulation of protein binding" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0032855 "positive regulation of Rac GTPase activity" evidence=IEA

GO:0032886 "regulation of microtubule-based process" evidence=IEA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=IEA

GO:0034236 "protein kinase A catalytic subunit binding" evidence=IEA

GO:0035372 "protein localization to microtubule" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0043198 "dendritic shaft" evidence=IEA

GO:0044027 "hypermethylation of CpG island" evidence=IEA

GO:0044337 "canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process" evidence=IEA

GO:0045444 "fat cell differentiation" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0050321 "tau-protein kinase activity" evidence=IEA

GO:0051059 "NF-kappaB binding" evidence=IEA

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=IEA

GO:0071109 "superior temporal gyrus development" evidence=IEA

GO:2000738 "positive regulation of stem cell differentiation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.9032	0.9973	0.9095	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9193	0.9973	0.9185	yes	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6079	0.9142	0.8811	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7907	0.9839	0.9017	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6479	0.9008	0.9359	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7978	0.9785	0.8859	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7795	0.9865	0.9684	no	no
Q388M1	GSK3B_TRYB2	2, ., 7, ., 1, 1, ., 2, 6	0.5030	0.8552	0.9062	N/A	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7795	0.9973	0.8836	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5841	0.7774	0.7837	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6656	0.8605	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7822	0.9973	0.8857	no	no
O23145	KSG2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7315	0.9785	0.8468	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8951	0.9973	0.9095	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6648	0.9544	0.8476	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6287	0.8873	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9112	0.9973	0.9051	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9083	0.9946	0.9026	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9220	0.9946	0.9026	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7912	0.9758	0.7777	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6648	0.9544	0.8476	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8978	0.9973	0.9073	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6648	0.9544	0.8476	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6620	0.9544	0.8476	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6648	0.9544	0.8476	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	373
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-136
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-96
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-85
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-83
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-81
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-79
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-77
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-77
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-75
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-75
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-72
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-70
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-70
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-69
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-64
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-64
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-63
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-63
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-63
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-60
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-59
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-58
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-57
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-57
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-56
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-56
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-55
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-55
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-54
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-54
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-54
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-53
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-53
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-53
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-53
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-52
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-52
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-51
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-49
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-48
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-48
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-48
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-47
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-45
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-45
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-45
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-44
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-41
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-39
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-38
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-37
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-37
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-37
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-36
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-35
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-35
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-31
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-31
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-30
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-30
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-28
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-23
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-23
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-22
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-20
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-20
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-16
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-14
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-14
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-10
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.001
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.002
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.002
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.003
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  394 bits (1013), Expect = e-136
 Identities = 175/331 (52%), Positives = 245/331 (74%), Gaps = 5/331 (1%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           SY    ++G+GSFGVV++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 96  CFFSTT-EKDE--LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            +++   +K+E  ++LN+V+E++P+TVH+ +KH+ + +  +PL  VKLY YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   +CHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
           T YT  ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           KFP +K     K+F K  P +A++ +S+ L+Y P  R   +EAL  PFFD+LRDP  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 333 NG-RFLPPLFNFKPHELKGVPVDMLVKLIPE 362
                LP LFNF   E+K +      K+IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  289 bits (741), Expect = 5e-96
 Identities = 124/339 (36%), Positives = 186/339 (54%), Gaps = 28/339 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y   + +G G++GVV  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 91  VSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           + L       S  + +++Y+  V E +   +H+VIK      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRG 115

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYR 204
           L Y+H +  V HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++K 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 265 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           + +     +    P+    P  K+F     PEA+DL+ ++L + P  R TA EAL HP+ 
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 322 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
            +L DP    P      P F+F   +   +  + L +LI
Sbjct: 293 AQLHDPE-DEPVA---KPPFDFDFFDDDELTEEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  264 bits (677), Expect = 5e-87
 Identities = 112/295 (37%), Positives = 170/295 (57%), Gaps = 35/295 (11%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSLK 94
           +G G++GVV++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
               +   + +LYL  V EY    + + +    K    +    +K   YQ+ R LAY H 
Sbjct: 65  DVIHT---ERKLYL--VFEYCDMDLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
           +  + HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 116 SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
           +  Y+ A+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E      P  T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228

Query: 272 FK-----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                  FP+       K+   R+ PE +DL+S++LQY+P  R +A EAL HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  258 bits (662), Expect = 8e-85
 Identities = 111/292 (38%), Positives = 167/292 (57%), Gaps = 23/292 (7%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
             +G G+ G+VF+AK  ETGE VA+KKV   +          RE++ ++   HP VV L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             F            LV+EY+P  +  V++      + +P   VK Y   + + +AY+H 
Sbjct: 66  DVF-----PHGSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGA 212
             G+ HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 269
            +Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +  FP+ K  P  +IF     PEA+DL+  LL Y P+ R +A EAL HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  255 bits (653), Expect = 1e-83
 Identities = 114/294 (38%), Positives = 170/294 (57%), Gaps = 20/294 (6%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 90
           Y     +G G++GVV++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           + L   F     K +LYL  V E++   ++++IK   +    +P   +K Y YQ+ + LA
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 209
           + H+  G+ HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 268
            G   Y+  +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 269 -YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              +F FP+    P  K+F     P+A+DL+S++L Y P+ R TA +AL HP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  248 bits (636), Expect = 2e-81
 Identities = 104/291 (35%), Positives = 154/291 (52%), Gaps = 43/291 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 91
           Y     +G GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L   F    ++D+LYL  V+EY     +  ++K   ++S+       + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           Y+H+  G+ HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           G   Y  A+DIWS G +L ELL G+P FPG+   DQL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWD--- 222

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                              + PEA DL+ +LL   P  R TA EAL HPFF
Sbjct: 223 -------------------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  245 bits (628), Expect = 1e-79
 Identities = 113/291 (38%), Positives = 165/291 (56%), Gaps = 21/291 (7%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 95
           VVG G++GVV + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F     K  LYL  V EYV  T+  +++        +P   V+ Y +Q+ +A+AY H+ 
Sbjct: 68  AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGAT 213
             + HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 271
            Y   +D+W+ GC++AELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 272 FKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             FP+        + +  ++   A+D +   L+  P  R T  E L HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  240 bits (615), Expect = 2e-77
 Identities = 115/299 (38%), Positives = 163/299 (54%), Gaps = 29/299 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 87
           Y   + +G G++ VV++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN++ L   F     K    +NLV E++   + +VIK     S  +    +K Y     R
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SRYYR 204
            L Y+H+   + HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 265 MN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +   P+Y EFK       P  +IF      +A+DL+ RLL  +PN R TA +AL HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  237 bits (607), Expect = 7e-77
 Identities = 95/289 (32%), Positives = 142/289 (49%), Gaps = 39/289 (13%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 93
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              F    +KD LYL  V+EY           +      +     K    QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 212
           +  G+ HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 S-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y   +D+WS G +L ELL G+P F GE+ +DQL  I ++LG P   +    +      
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS----- 228

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                               EA DL+ + L   P+ R TA E L HP+F
Sbjct: 229 -----------------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  235 bits (602), Expect = 4e-75
 Identities = 113/309 (36%), Positives = 178/309 (57%), Gaps = 31/309 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRE---LQTMRLLDH 87
           Y   + +G G++G+V++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L +   +  +KD +YL  V EY+   +H VI+    + + +   Y+    YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA--NILEDVHKRYI---MYQLLK 118

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------YICSR 201
           AL YIH +  V HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           +YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 262 IKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           I+ +   +        P     P  ++   +   +A+DL+ +LL ++PN R TA EAL H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 319 PFFDELRDP 327
           P+  +  +P
Sbjct: 296 PYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  232 bits (595), Expect = 9e-75
 Identities = 112/293 (38%), Positives = 175/293 (59%), Gaps = 26/293 (8%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVS 92
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           LK  F    E DELY   V EY+   +++++K      +      ++   YQI + LA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHI 115

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H   G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPN 268
           T Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +  
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              F+FPQ      H++      PEA+DL+  +L++ P  R TA +AL HP+F
Sbjct: 233 -LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  226 bits (578), Expect = 4e-72
 Identities = 97/292 (33%), Positives = 159/292 (54%), Gaps = 24/292 (8%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 95
           +G G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIHN 154
                T K +  + +V EY+   +  ++     K ++      +K Y  Q+   L Y+H+
Sbjct: 66  I---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIKCYMKQLLEGLQYLHS 118

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGA 212
             G+ HRDIK  N+L+N     LKL DFG A+   K       + + + +YR PEL+ GA
Sbjct: 119 -NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 269
           T Y   +D+WS GC+LAEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              K  +       + F+  + P A+DL+ +LL   P  R +A +AL H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  223 bits (571), Expect = 2e-70
 Identities = 107/307 (34%), Positives = 178/307 (57%), Gaps = 26/307 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 91
           Y     +G G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 92  SLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            +       +    +++Y+  V E +   ++++IK     +Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRA 205
            YIH+   V HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++  +  YT AIDIWS GC+LAE+L  +PLFPG+  + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 266 -NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +    NY +   P     PW+K+F     P+A+DL+ ++L ++P+ R T  EAL HP+ 
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 322 DELRDPN 328
           ++  DP+
Sbjct: 296 EQYHDPS 302

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  223 bits (570), Expect = 2e-70
 Identities = 109/307 (35%), Positives = 165/307 (53%), Gaps = 24/307 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPN 89
            Y     +G G++GVV  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +++++         D   + +V++ +   +H +I       Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYR 204
            YIH+   V HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APEL+    EYT AID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 265 MNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           +       Y +   P+ +  PW KIF K   PEA+DL+S++LQ+ P  R T  +AL HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 321 FDELRDP 327
             +  DP
Sbjct: 297 LAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  220 bits (563), Expect = 2e-69
 Identities = 118/336 (35%), Positives = 187/336 (55%), Gaps = 26/336 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y+  + +G G++G+V  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 91  VSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           +++K        +  +++Y+  V E +   +H++I+     SQ +   + + + YQ+ R 
Sbjct: 67  IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRG 120

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPE 207
           L YIH+   V HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-N 266
           L+   +EYT AID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238

Query: 267 PNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                +    P      + ++F     P A+DL+ ++L + P+ R T  EAL HP+   L
Sbjct: 239 EKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Query: 325 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
            DP+         P  F+F+   L     + + +LI
Sbjct: 298 HDPSDEPVCQT--PFSFDFEEDALTE---EDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  217 bits (556), Expect = 3e-68
 Identities = 106/305 (34%), Positives = 166/305 (54%), Gaps = 26/305 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 88
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 89  NVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           NV+ L   F   +  ++   + LV   +   ++ ++K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
            L YIH+  G+ HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 268 ----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
               NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA EAL HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 324 LRDPN 328
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  211 bits (539), Expect = 2e-66
 Identities = 101/291 (34%), Positives = 163/291 (56%), Gaps = 26/291 (8%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S  +   LYL  V E++   + + +         +    +K Y YQ+ + +AY H + 
Sbjct: 67  VHSENK---LYL--VFEFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCH-SH 118

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G+ 
Sbjct: 119 RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 270
           +Y+  +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+Y 
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              FP+       K+    +  + +DL+S++L Y P  R +A  AL HP+F
Sbjct: 235 P-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  206 bits (527), Expect = 2e-64
 Identities = 109/292 (37%), Positives = 167/292 (57%), Gaps = 30/292 (10%)

Query: 46  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFFS 99
           G++GVV++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 100 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 159
           +   D++Y+  V+EYV   +  +++    M Q      VK    Q+   +A++H+   + 
Sbjct: 76  SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128

Query: 160 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYT 216
           HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185

Query: 217 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 276
            AID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +      P ++E    +
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGAK 241

Query: 277 IKAHPWHKIFQ--KRMPP-----EAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            K    +   Q  K+ P         DL++RLL Y P  R +A +AL HP+F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  206 bits (527), Expect = 6e-64
 Identities = 122/314 (38%), Positives = 178/314 (56%), Gaps = 29/314 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V +KH     + ++   + +V E +   +H+VIK +  ++      + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 206
           YIH T  V HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 207 ELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-K 263
           EL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMP---PEAVDLVSRLLQYSPNLRSTALEALIHPF 320
             N     +     K  P    F ++ P   P A+ L+ RLL + P  R TA EAL  P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 321 FDEL----RDPNTR 330
           F  L    R+P+ +
Sbjct: 293 FKGLAKVEREPSAQ 306

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  204 bits (520), Expect = 2e-63
 Identities = 104/289 (35%), Positives = 152/289 (52%), Gaps = 25/289 (8%)

Query: 44  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 95
           G G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIH 153
             F         L LV E +   ++ +IK        +R     VK Y YQ+ ++L ++H
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIKGRKRPLPEKR-----VKSYMYQLLKSLDHMH 117

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
              G+ HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +    
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEF 272
            Y   +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            FP  K     K+       E +DL+ +LL Y P+ R TA +AL HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  205 bits (523), Expect = 2e-63
 Identities = 111/304 (36%), Positives = 177/304 (58%), Gaps = 25/304 (8%)

Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDH 87
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            N++SL   F S  E  ++Y   V E +   +HR++      S+ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 206
            L Y+H+  GV HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 265
           E++    +Y   +DIWSAGC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 266 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           + N   F    P+ +  P+ + F+    P A+DL+ ++L + P  R +A EAL HP+   
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293

Query: 324 LRDP 327
             DP
Sbjct: 294 YHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  203 bits (518), Expect = 2e-63
 Identities = 114/295 (38%), Positives = 169/295 (57%), Gaps = 31/295 (10%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 95
           +VG GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALA 150
            F     K  LYL  V E+V  TV   ++ +         ++        Y +QI R + 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESRVRK--------YLFQILRGIE 114

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELI 209
           + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+
Sbjct: 115 FCHSH-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNP 267
            G T+Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 268 NYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +   + P++K   P  K F K +    +DL  + L+  P+ R ++ + L H FF
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  197 bits (502), Expect = 3e-60
 Identities = 111/304 (36%), Positives = 159/304 (52%), Gaps = 27/304 (8%)

Query: 43  VGHGSFGVVFQAKCLET--GEAVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 93
           +G G++G+V  A+  ET   E VAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 94  KHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
                      +ELYL    E +   +H++I+      Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI 121

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 207
           H+   V HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 HSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKC 264
           ++     YT AID+WS GC+LAELL  +P+F G+  VDQL +I++VLGTP  E    I  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                     P I   P+  IF     P A+DL+ +LL + P  R +  EAL HP+    
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298

Query: 325 RDPN 328
            DP+
Sbjct: 299 HDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  192 bits (489), Expect = 7e-59
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 25/291 (8%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 96
           +G GS+GVVF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 154
           F     + +  L+LV EY   TV   ++ +    + +P   +K   +Q  +A+ + H  N
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 213
            I   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T
Sbjct: 121 CI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 271
           +Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  +  
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 272 FKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              P+ +   P    F   +   A+  +   LQ  P  R +  E L HP+F
Sbjct: 237 LSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  190 bits (485), Expect = 3e-58
 Identities = 100/295 (33%), Positives = 160/295 (54%), Gaps = 23/295 (7%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 97  FFSTTEKD-ELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHN 154
                EK+ +  L LV EY+   + + +  + +   R +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
             GV HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
           +T Y+  +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 272 FK----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 322
            +    FPQ K     +     + PE +DL+ ++L+Y P  R +A  AL HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  187 bits (476), Expect = 5e-57
 Identities = 103/289 (35%), Positives = 165/289 (57%), Gaps = 22/289 (7%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 97
           +G G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
             T  K    L LV EY+ + + + +  H  +   +    VK + YQ+ + +A+ H    
Sbjct: 67  IHTENK----LMLVFEYMDKDLKKYMDTH-GVRGALDPNTVKSFTYQLLKGIAFCHEN-R 120

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 214
           V HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G+  
Sbjct: 121 VLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 272
           Y+ +IDIWS GC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y + 
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KP 236

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            FP+       ++F     P  +DL+ RLLQ +P LR +A +AL HP+F
Sbjct: 237 TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  186 bits (475), Expect = 8e-57
 Identities = 110/298 (36%), Positives = 166/298 (55%), Gaps = 40/298 (13%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL  V E++    H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 68  IHT---ENKLYL--VFEFL----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 119 H-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       + P  T 
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230

Query: 272 FK-----FPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                  FP+         F K +PP   +  DL+S++L Y PN R +A  AL HPFF
Sbjct: 231 LPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  185 bits (472), Expect = 2e-56
 Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 24/298 (8%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 90
           +Y     +G GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V+L H    T +     L LV EY+   + + +         + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLA 117

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           Y H    V HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 264
           ++ G+TEY+ ++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            NP +  + FP     P      +    P   +L  + LQY P  R +A EA+ HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  184 bits (470), Expect = 9e-56
 Identities = 105/295 (35%), Positives = 155/295 (52%), Gaps = 28/295 (9%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G+V++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                  D ++L  V+EY  + +  ++     M        VK    Q+ R L Y+H   
Sbjct: 75  VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            + HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ G T
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
            YT AID+W+ GC+LAELL  +PL PG+S ++QL  II++LGTP        +  P   +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 272 FKFPQIKAHPWHKIFQKRMP--PEA-VDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           F  P+    P++ +  K  P   EA + L++ LL Y P  R+TA EAL   +F E
Sbjct: 245 FTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  183 bits (466), Expect = 2e-55
 Identities = 105/301 (34%), Positives = 168/301 (55%), Gaps = 23/301 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y     +G G++GVV++A+   T E +A+KK+  ++  +       RE+  ++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L+    S     E  L LV EY+   + + +      ++   LI  K Y YQI R +A
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI--KTYLYQILRGIA 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           Y H+   V HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE
Sbjct: 117 YCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 266
           ++ G+  Y+  +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +  
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
            P+Y    FP+        +    + P  VDL+S++L+  P+ R TA  AL H +F +L 
Sbjct: 234 LPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291

Query: 326 D 326
           D
Sbjct: 292 D 292

Length = 294

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  181 bits (461), Expect = 6e-55
 Identities = 93/290 (32%), Positives = 133/290 (45%), Gaps = 44/290 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 94
            ++G GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             + S  ++++  LN+ LEYV       +    K   ++P   ++ Y  QI   LAY+H+
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIFG 211
             G+ HRDIK  N+LV+     +KL DFG AK L   E        R   Y+ APE+I G
Sbjct: 120 N-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
             EY  A DIWS GC + E+  G+P +         +  I   G P              
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              P+I  H         +  EA D + + L+  P  R TA E L HPF 
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  180 bits (460), Expect = 1e-54
 Identities = 98/303 (32%), Positives = 159/303 (52%), Gaps = 46/303 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 89
           +G G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 90  VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           +V L   C    T++ EL L LV E+V + +   +    K    +P   +K    Q+ R 
Sbjct: 63  IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRG 119

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           + ++H +  + HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +  ++ Y   +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE       
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE------- 229

Query: 269 YTEFKFPQIKAHPWH-------KIFQKRMP---PEAVDLVSRLLQYSPNLRSTALEALIH 318
                +P+  + P         + F+  +P    E +DL+ ++L ++P+ R +A EAL H
Sbjct: 230 -----WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 319 PFF 321
           P+F
Sbjct: 285 PYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  182 bits (463), Expect = 2e-54
 Identities = 106/304 (34%), Positives = 164/304 (53%), Gaps = 25/304 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 90
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           + L   F S    DE     LV+ Y+   + +++ H     +      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLCGL 130

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 208
            YIH+  G+ HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 266
           I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 267 --PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
              +Y +   P+     +  +F  +  P+AVDL+ ++L+   + R TA EAL HP+FD  
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Query: 325 RDPN 328
           RD +
Sbjct: 304 RDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  181 bits (462), Expect = 2e-54
 Identities = 98/315 (31%), Positives = 168/315 (53%), Gaps = 48/315 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 92
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 93  LKHCFFST-----------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           +      +           TE + +Y+  V EY+   +  V++        +   + +L+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQ-----GPLSEEHARLF 119

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---- 197
            YQ+ R L YIH+   V HRD+KP N+ +N     LK+ DFG A+++   +P+ S+    
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYL 175

Query: 198 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VEII 251
              + +++YR+P L+     YT AID+W+AGC+ AE+L G+PLF G   ++Q+   +E +
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Query: 252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFQKRMP---PEAVDLVSRLLQYSP 306
            V+    R E+  + P++       ++       +  +  +P   PEA+D + ++L ++P
Sbjct: 236 PVVREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288

Query: 307 NLRSTALEALIHPFF 321
             R TA EAL+HP+ 
Sbjct: 289 MDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  179 bits (456), Expect = 5e-54
 Identities = 105/292 (35%), Positives = 159/292 (54%), Gaps = 28/292 (9%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S  +     L LV EY  + +    K+    +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHSDKK-----LTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 214 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 270
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E    ++  P+Y 
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 271 EF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +  +P   +     +   ++     DL+  LL  +P  R +A EAL HP+F
Sbjct: 236 PYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  182 bits (461), Expect = 7e-54
 Identities = 93/321 (28%), Positives = 138/321 (42%), Gaps = 48/321 (14%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHP 88
           SY   R +G GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 89  -NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            N+V L   F     +DE  L LV+EYV       +         +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------SYICS 200
           AL Y+H + G+ HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 201 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG 255
             Y APE++ G +    +++ DIWS G  L ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
           TP                     A P      + +   A DL+ +LL   P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 316 LIHPFFDELRDPNTRLPNGRF 336
           L H     L+   + L +   
Sbjct: 273 LSHDLLAHLKLKESDLSDLLK 293

Length = 384

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  176 bits (448), Expect = 1e-53
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 97
           +G G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 98  FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                +DE +L LV+EY    ++  ++K +     ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-N 111

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 215
           G+ HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 274
           +   DIWS G +L EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 275 PQIKAHP 281
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  180 bits (457), Expect = 1e-53
 Identities = 106/297 (35%), Positives = 160/297 (53%), Gaps = 22/297 (7%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 96
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 97  FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           F      D  +   LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIHAA 137

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
            G+ HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 271
           T  +DIWS GC++AE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
            K P+ +   +  +      P AV+++ ++L      R TA EAL HP+F+E  DP 
Sbjct: 254 -KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  179 bits (455), Expect = 1e-53
 Identities = 114/317 (35%), Positives = 158/317 (49%), Gaps = 46/317 (14%)

Query: 43  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           +G G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 152
              F    +K  +YL  + +Y    + ++IK H       +P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 153 HNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNISYICSRY 202
           H+   V HRD+KP N+LV    P    +K+ D G A       K L   +P +  I   +
Sbjct: 125 HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 253
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 254 LGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQY 304
           LGTPT ++   IK M P Y     +FK     ++   K  +K      +  DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 305 SPNLRSTALEALIHPFF 321
            P  R TA EAL HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  176 bits (448), Expect = 7e-53
 Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 24/292 (8%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 95
           VVG G++GVV + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F     + +LYL  V EYV + +  +++        +P   V+ Y YQ+ +A+ + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 213
             + HRDIKP+NLL++ H   LKLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 271
            Y  A+D+WS GC+L EL  GQPLFPGES +DQL  I KVLG    E++K    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 272 FKFPQIKAHP--WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +FP +  HP    + +   +    +DL+  LL+ +P  R    + L HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  177 bits (451), Expect = 3e-52
 Identities = 111/309 (35%), Positives = 164/309 (53%), Gaps = 41/309 (13%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 92
           +R +G+G+FGVV+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 93  --------LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
                       F      +E+Y+  V E +   +H++I       Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQ 111

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-----IC 199
           I R L Y+H + G+ HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           ++YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEAL 316
           E ++                 P   +          EAV L+ R+L + P+ R +A +AL
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 317 IHPFFDELR 325
            HP+ DE R
Sbjct: 287 AHPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  174 bits (444), Expect = 3e-52
 Identities = 98/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 92
           +G G++GVV++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L+       ++  LYL  + E++   + + +       Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM---QESRLYL--IFEFLSMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFC 117

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 209
           H+   V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 267
            G+  Y+  +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +Y    FP+ K     +   K +  + +DL+ ++L Y P  R +A +AL HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  174 bits (442), Expect = 1e-51
 Identities = 99/313 (31%), Positives = 146/313 (46%), Gaps = 53/313 (16%)

Query: 44  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 96
           G G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 97  FFSTTEKDELYLNLVLEYVPETVH---------RVIKHHYKMSQRMPLIYVKLYFYQICR 147
                +K +     V    P   H          V       SQ      +K Y  Q+  
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ------IKCYMLQLLE 126

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---------- 197
            + Y+H    + HRDIK  N+L++ +   LK+ DFG A+      PN             
Sbjct: 127 GINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 198 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
             + +R+YR PEL+ G   YT A+DIW  GCV AE+   +P+  G+S +DQL  I K+ G
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244

Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-------KRMPPEAVDLVSRLLQYSPNL 308
           TPT E      P +     P  +       +         ++ PE +DL+S+LL   P  
Sbjct: 245 TPTEETW----PGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298

Query: 309 RSTALEALIHPFF 321
           R TA +AL HP+F
Sbjct: 299 RLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  167 bits (425), Expect = 7e-49
 Identities = 101/316 (31%), Positives = 154/316 (48%), Gaps = 53/316 (16%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------------RELQTMR 83
           +G G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            + H N++ L   +    E D  ++NLV++ +   + +V+    ++++      VK    
Sbjct: 76  EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLTES----QVKCILL 126

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----VLVKGEPNISYI 198
           QI   L  +H    + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 199 CSR----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
             R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+PLFPGE+ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 249 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
            I ++LGTP  +   + K + P YTEF   + K      IF      +A+DL+  LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNA-SDDAIDLLQSLLKLN 300

Query: 306 PNLRSTALEALIHPFF 321
           P  R +A EAL H +F
Sbjct: 301 PLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  167 bits (426), Expect = 8e-49
 Identities = 107/321 (33%), Positives = 165/321 (51%), Gaps = 48/321 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKR-YKNRELQTMRLLDHP 88
           Y   + +G G+ G+V  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 89  NVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYF 142
           N++ L + F    S  E  ++YL  V+E +   + +VI+    H +MS          Y 
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERMS----------YL 123

Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
            YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +R
Sbjct: 124 LYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           YYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ LGTP+ E 
Sbjct: 182 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240

Query: 262 IKCMNP---NYTEFKFPQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSP 306
           +  + P   NY E + P+   + + ++F             K    +A DL+S++L   P
Sbjct: 241 MSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299

Query: 307 NLRSTALEALIHPFFDELRDP 327
             R +  +AL HP+ +   DP
Sbjct: 300 EKRISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  167 bits (423), Expect = 1e-48
 Identities = 102/304 (33%), Positives = 161/304 (52%), Gaps = 24/304 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 91  VSLKHCFFSTT---EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           + L   F   T     +E+YL  V   +   ++ ++K      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLR 129

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
            L YIH+  G+ HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +K ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 268 NYTEFKF---PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
            +        P +      KIF +   P A+DL+ ++L    + R +A EAL HP+F + 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 325 RDPN 328
            DP 
Sbjct: 305 HDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  165 bits (419), Expect = 5e-48
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 96  CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F      +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 270
           Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  163 bits (415), Expect = 6e-48
 Identities = 105/298 (35%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 90
           SY+    +G GS+  V++      G+ VA+K +             RE   ++ L H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L H    T E     L  V EY+   + + +  H      +    V+L+ +Q+ R LA
Sbjct: 66  VLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLA 117

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           YIH    + HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPD 173

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 266
           ++ GAT+Y++A+DIW AGC+  E+L GQP FPG S V +QL +I  VLG PT +    ++
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Query: 267 --PNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             PNY    F   K      ++++   PP+A DL S++L   P  R +A +AL+HP+F
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  162 bits (412), Expect = 7e-48
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 42/285 (14%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
             +G G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           +    +KDEL+  +V+E+    ++  ++K     +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
            G+ HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
               DIWS G    EL  G+P +  E    + +  I   G P               + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LRNP 220

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                       ++   E  D + + LQ +P  R TA + L HPF
Sbjct: 221 ------------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  163 bits (414), Expect = 1e-47
 Identities = 99/308 (32%), Positives = 166/308 (53%), Gaps = 23/308 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
           +Y+    +G G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R L 
Sbjct: 67  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLN 118

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 265
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
           N  +  + +P+ +A   H     R+  +  +L+S+LLQ+    R +A EA+ HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 326 DPNTRLPN 333
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  158 bits (400), Expect = 1e-45
 Identities = 100/299 (33%), Positives = 161/299 (53%), Gaps = 23/299 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V+L H    T +     L LV EY+ + + + +         M +  VK++ YQI R LA
Sbjct: 67  VTL-HDIVHTDKS----LTLVFEYLDKDLKQYMD---DCGNIMSMHNVKIFLYQILRGLA 118

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++ G++EY+  ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 268 N--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           N  +  + FP+ K  P       R+  E ++L+++ LQY    R +A EA+ H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  157 bits (398), Expect = 2e-45
 Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 23/296 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V+L H    T    E  L LV EY+   + + + +       M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 265
           ++ G+TEY+  ID+W  GC+L E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           N  +  + FPQ +A P       R+  + +DL+S LL Y    R +A  AL H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  156 bits (396), Expect = 6e-45
 Identities = 91/307 (29%), Positives = 149/307 (48%), Gaps = 47/307 (15%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 95
            +G G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 96  CFFSTTE-----KDELYLNLVLEYVPETVHRVIKH---HYKMSQRMPLIYVKLYFYQICR 147
                 +     KD+    LV EY+   +  +++    H+          +K +  Q+  
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------IKSFMKQLLE 127

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRA 205
            L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR 
Sbjct: 128 GLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PEL+ G   Y  AID+WS GC+L EL   +P+F     + QL  I ++ G+P       +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PAV 241

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRM------------PPEAVDLVSRLLQYSPNLRSTAL 313
            P+  +  +       ++ +  K+             P  A+DL+  +L   P+ R TA 
Sbjct: 242 WPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 314 EALIHPF 320
           EAL  P+
Sbjct: 295 EALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  151 bits (385), Expect = 8e-44
 Identities = 90/292 (30%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F     + E  L LVLEY P  E +   +    + S+       + Y  +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 212
           + +G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 S-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y  A+D WS G +L E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-LI--HPFF 321
           +FP            + + PEA DL+S LLQ  P  R  +  A  I  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  151 bits (384), Expect = 1e-43
 Identities = 86/301 (28%), Positives = 131/301 (43%), Gaps = 60/301 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y   + +G GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +     F    EK    L +V+EY     + + IK   K  +  P   +  +F Q+C AL
Sbjct: 62  IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 200
            Y+H +  + HRDIKPQN+ +      +KL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            YY +PEL      Y    DIWS GCVL EL   +  F GE+ + +L    K+L    + 
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           +   +   Y                       E  +LVS LLQ  P  R +  + L  PF
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPF 257

Query: 321 F 321
            
Sbjct: 258 I 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  145 bits (367), Expect = 4e-41
 Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 54/292 (18%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHC 96
           V+G GS GVV++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           F+      E  +++VLEY+   ++  ++K   K+ + +    +     QI + L Y+H  
Sbjct: 68  FYK-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIF 210
             + HRDIKP NLL+N    ++K+ DFG +KVL     N    C+ +     Y +PE I 
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           G + Y+ A DIWS G  L E  LG+ P L PG+    +L++ I            C    
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CD--- 217

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                 P            +   PE  D +S  LQ  P  R +A E L HPF
Sbjct: 218 -----GPPPSLPA------EEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  141 bits (356), Expect = 3e-39
 Identities = 102/301 (33%), Positives = 156/301 (51%), Gaps = 24/301 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 90
           SY     +G GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L H    T E     L LV EYV   + + +  H      +    VKL+ +Q+ R L+
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLS 117

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           YIH    + HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPD 173

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 266
           ++ G+TEY+  +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    ++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 267 --PNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
             P++   +F         + + K      A DL S+LLQ  P  R +A  AL H +F +
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Query: 324 L 324
           L
Sbjct: 294 L 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  139 bits (353), Expect = 1e-38
 Identities = 91/302 (30%), Positives = 143/302 (47%), Gaps = 34/302 (11%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH- 95
           +G G+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 96  CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           C    T     K   YL  V E+    +  ++ +    + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYY 134

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 206
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 265
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 266 N-PNYTEFKFPQ-----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
               + + + PQ     +K      +      P A+DL+ +LL   P  R  A  AL H 
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYV----KDPHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 320 FF 321
           FF
Sbjct: 309 FF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  137 bits (346), Expect = 4e-38
 Identities = 88/290 (30%), Positives = 136/290 (46%), Gaps = 48/290 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 91
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
                 +  TE++E  L + LE VP  ++ ++     K     P   ++LY  QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKL----LKKYGSFPEPVIRLYTRQILLGLE 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           Y+H+     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               Y  A DIWS GC + E+  G+P +   S ++ +  + K+  +     I        
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     P H      +  EA D + + LQ  P+LR TA E L HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  137 bits (347), Expect = 2e-37
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 136

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + PQ     + ++F   + P           +A DL+S++L   P+ R +  EA
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 316 LIHPFFDELRDP 327
           L HP+     DP
Sbjct: 313 LRHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  135 bits (343), Expect = 2e-37
 Identities = 86/321 (26%), Positives = 141/321 (43%), Gaps = 79/321 (24%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 88
           +   +++G GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            ++ L + F     +DE  L  VLEY P   + + I+ +  + ++      + Y  +I  
Sbjct: 63  GIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRY- 202
           AL Y+H+  G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 203 ----------------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 246
                           Y +PEL+        + D+W+ GC++ ++L G+P F G +  + 
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EY 228

Query: 247 LV--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 304
           L   +I+K                  E+ FP               PP+A DL+ +LL  
Sbjct: 229 LTFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVL 259

Query: 305 SPNLRSTALEALI----HPFF 321
            P  R    E       HPFF
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  135 bits (342), Expect = 3e-37
 Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 16/288 (5%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 93
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                ++    E  + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
               + HRD+KP+N+LV     Q+KL DFG A++          + + +YRAPE++  +T
Sbjct: 126 -ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +       
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPRGA 241

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           F      P        +      L+  +L ++P+ R +A  AL HPFF
Sbjct: 242 FSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  134 bits (340), Expect = 3e-37
 Identities = 88/292 (30%), Positives = 142/292 (48%), Gaps = 50/292 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 96
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           +     ++++Y+   +EY    T+  +++H   + + +    +++Y  Q+   LAY+H +
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLH-S 117

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 210
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 211 GAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           G     +  A DIWS GCV+ E+  G+  +   S +D   +I+  +G          +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                 P I           ++ PE  D + R L+  P  R TA E L HPF
Sbjct: 225 ------PPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 8e-37
 Identities = 87/295 (29%), Positives = 133/295 (45%), Gaps = 62/295 (21%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 95
           ++G G+FGVV++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                  +    L ++LEY    ++ ++IK      + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 213
             GV HRDIK  N+L       +KL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
             + A DIWS GC + ELL G P +                          +NP      
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNP------ 204

Query: 274 FPQIKAHPWHKIFQKRMPP-------EAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                     +I Q   PP       E  D + +  Q  PNLR TA + L HP+ 
Sbjct: 205 -----MAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  133 bits (336), Expect = 7e-36
 Identities = 100/315 (31%), Positives = 161/315 (51%), Gaps = 37/315 (11%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 129

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 313 LEALIHPFFDELRDP 327
            EAL HP+ +   DP
Sbjct: 306 DEALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  132 bits (333), Expect = 3e-35
 Identities = 97/315 (30%), Positives = 160/315 (50%), Gaps = 37/315 (11%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312

Query: 313 LEALIHPFFDELRDP 327
            EAL HP+ +   DP
Sbjct: 313 DEALQHPYINVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  129 bits (326), Expect = 3e-35
 Identities = 94/298 (31%), Positives = 143/298 (47%), Gaps = 63/298 (21%)

Query: 46  GSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKHCFF 98
           G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 99  STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           S   K  LYL  V+EY+P   +  ++++   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHS-NG 113

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISY--------ICSRYYRAPEL 208
           + HRD+KP N+L++ + H LKL DFG +KV LV+ + N++         + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           I G   ++  +D WS GC+L E L+G P F GE                T EEI      
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI------ 209

Query: 269 YTEFKFPQIKAH--PWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF 321
                F  I      W +  +  +  EA+DL+S+LL   P  R    +  E   HPFF
Sbjct: 210 -----FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  128 bits (323), Expect = 1e-34
 Identities = 95/292 (32%), Positives = 149/292 (51%), Gaps = 23/292 (7%)

Query: 43  VGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 92
           +G G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 93  L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   C  S T++ E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDF 125

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 126 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
           ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P    
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVA 238

Query: 272 FKFPQIKAHPWHKI--FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                  +     I  F   +     DL+ + L ++P  R +A  AL HP+F
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  121 bits (306), Expect = 3e-32
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKH 95
             +G G+ GVV +     TG+ +A+K +    ++  +    REL  +   + P +V    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F++  +     +++ +EY+       I    ++  R+P   +      + + L Y+H  
Sbjct: 67  AFYNNGD-----ISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
             + HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYT 270
           +   DIWS G  L EL  G+  +P E+       + L  I+               P   
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
               P++ +  +         P+  D V+  L   P  R +  E L HPF 
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  120 bits (302), Expect = 2e-31
 Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 56/292 (19%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 98
            +G G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84

Query: 99  STTEKDELYLNLVLEY--------VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
                    L +V+EY        +      + ++  +M++   + YV     ++ + L 
Sbjct: 85  ----LVGDELWVVMEYMDGGSLTDI------ITQNFVRMNEPQ-IAYVCR---EVLQGLE 130

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELI 209
           Y+H+   V HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE+I
Sbjct: 131 YLHSQ-NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K      
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK------ 237

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                       W   F+        D +++ L   P  R +A E L HPF 
Sbjct: 238 --------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  120 bits (301), Expect = 4e-31
 Identities = 101/319 (31%), Positives = 153/319 (47%), Gaps = 50/319 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 98
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 153
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 154 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 203
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PGESGVDQLVEIIKVL 254
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 255 GTPTR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFQKRMPPEAVDLVSRLL 302
           G P     E+IK M  + T  K            IK    HK+   +   +A  L+ +LL
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLL 298

Query: 303 QYSPNLRSTALEALIHPFF 321
              P  R T+ +A+  P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  119 bits (300), Expect = 4e-31
 Identities = 82/296 (27%), Positives = 141/296 (47%), Gaps = 60/296 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 93
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              F     +D+  L LV+EYVP  E     +  H + S R P    + Y  Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 210
           +H+ + + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               Y  A+D W+ G ++ E+L G P F  ++   Q+ E I          ++       
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI----------LEG------ 213

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPFF 321
           + +FP                P+A DL+  LLQ        NL++   +   HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  117 bits (296), Expect = 7e-31
 Identities = 74/214 (34%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 89
           +  E+ +G G F VV++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V+     F    E     LN+VLE      + R+IKH  K  + +P   +  YF Q+C A
Sbjct: 64  VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 207
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
            I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  118 bits (297), Expect = 1e-30
 Identities = 99/317 (31%), Positives = 156/317 (49%), Gaps = 46/317 (14%)

Query: 43  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 98
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 153
           S +++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 154 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 203
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PGESGVDQLVEIIKVL 254
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 255 GTPTR---EEIKCMNPNY----TEFKFPQIKAHPWHKIFQK-RMPPEA--VDLVSRLLQY 304
           G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +LL  
Sbjct: 242 GFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM 300

Query: 305 SPNLRSTALEALIHPFF 321
            P  R T+ +AL  P+F
Sbjct: 301 DPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  116 bits (293), Expect = 2e-30
 Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 52/296 (17%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 96
           V+G G+  VV+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS-QRMPLIYVKLYFYQICRALAYIHN 154
            F     DEL+  LV+ Y+   ++  ++K  Y        +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELI 209
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 265
                Y    DIWS G    EL  G        P +     L+  ++    P+ E     
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQN-DPPSLETGADY 233

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                 F+                       ++S  LQ  P+ R TA E L H FF
Sbjct: 234 KKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 3e-30
 Identities = 88/291 (30%), Positives = 128/291 (43%), Gaps = 58/291 (19%)

Query: 46  GSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 98  FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +S   KD  YL LV+EY+      ++        K    +P  + K Y  ++   +  +H
Sbjct: 64  YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
              G+ HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           +     D WS GCV+ E L G P F  E+  D + + I          I     N+ E  
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEV 216

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFF 321
                             PEAVDL++RLL   P  R  A    E   HPFF
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  114 bits (287), Expect = 1e-29
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
            +G GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                + +    L +V+EY     + ++I+   K  + +   ++     Q+  AL   HN
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 155 TIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 207
                  V HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 252
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  112 bits (282), Expect = 9e-29
 Identities = 88/304 (28%), Positives = 146/304 (48%), Gaps = 55/304 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYK------NRELQTM 82
           ++   ++G G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLY 141
           + LDH N+V          E  E YL++ LEYVP  ++   ++ + +  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNISYI 198
             Q+   LAY+H+  G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 199 CSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
            S ++ APE+I   ++ Y+A +DIWS GCV+ E+  G+  +  E                
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215

Query: 258 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
             E I  M      FK   +  A P        + P A+D ++     +P+ R TA E L
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267

Query: 317 IHPF 320
            HPF
Sbjct: 268 QHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (279), Expect = 2e-28
 Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 47/237 (19%)

Query: 40  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            + +G G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYF-YQICR 147
           V L       TE++ LY  +V+EY+     +  + K+  K+S         L F  QI R
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSD-----LLSFALQIAR 113

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 114 GMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 205 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 252
                   APE +    ++T+  D+WS G +L E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (277), Expect = 3e-28
 Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 44/236 (18%)

Query: 40  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            + +G G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V L       TE++ L   +V+EY+P    +  + K+  K    + L  +  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMPGGDLLDYLRKNRPK---ELSLSDLLSFALQIARG 115

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 205 -------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 252
                  APE +    ++T+  D+WS G +L E+  LG+  +PG S   +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 5e-28
 Identities = 88/320 (27%), Positives = 136/320 (42%), Gaps = 79/320 (24%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 94
           V+G G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           +  F    +DE +L LV+EY+P  + ++ +I+         P    + Y  ++  AL  +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSV 117

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 189
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 190 KGEPNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           +   +               Y APE++ G T Y    D WS G +L E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 243 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               L E        T  +I     N+ E  +FP              + PEA+DL+ RL
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRL 268

Query: 302 LQYSPNLRSTALEALIHPFF 321
           L    +   +  E   HPFF
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  110 bits (276), Expect = 6e-28
 Identities = 89/307 (28%), Positives = 137/307 (44%), Gaps = 65/307 (21%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-------QDKRYKN------RELQTMR 83
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L H N+V            D  +LN+ LEYVP      + ++Y          V+ +  
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVR 113

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------- 195
           QI + L Y+HN  G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N         
Sbjct: 114 QILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNGA 168

Query: 196 --SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
             S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K+
Sbjct: 169 RPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224

Query: 254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
                            E   P+I ++         +  EA+D + +  +   N R TA 
Sbjct: 225 ----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTAA 259

Query: 314 EALIHPF 320
           E L HPF
Sbjct: 260 ELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  108 bits (273), Expect = 2e-27
 Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 50/292 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 93
           RV+G G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQICRALAY 151
            + F     +DE  + LV++ +     R     Y +SQ++      VK +  +I  AL Y
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLR-----YHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +H+  G+ HRDIKP N+L++   H + + DF  A  +       S   +  Y APE++  
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y+ A+D WS G    E L G+  + G S                R++I+        
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK------ 213

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALI-HPFF 321
               Q  A     ++      EA+D +++LL+  P  R    L+ L  HP+F
Sbjct: 214 ----QETADV---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (271), Expect = 2e-27
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 41/284 (14%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 99
            +G GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 100 TTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 158
            T+     L +V+EY    +V  ++K     ++ +    +    YQ  + L Y+H+    
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120

Query: 159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTA 217
            HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y  
Sbjct: 121 IHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178

Query: 218 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 277
             DIWS G    E+  G+P +     +  +  I                P  T    P  
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LSDP-- 222

Query: 278 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                     ++  PE  D V + L   P  R +A++ L HPF 
Sbjct: 223 ----------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  108 bits (272), Expect = 4e-27
 Identities = 82/298 (27%), Positives = 128/298 (42%), Gaps = 49/298 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           K C+       E    LV+EY   +   +++ H K  Q + +  +        + LAY+H
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GALQGLAYLH 132

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +     HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I    
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMD 187

Query: 214 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 228

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 329
              P + ++ W   F         + V   LQ  P  R ++ E L H F    R P  
Sbjct: 229 NDSPTLSSNDWSDYF--------RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  107 bits (269), Expect = 6e-27
 Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 50/293 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G FG V   K        A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 96  CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             F    KD+ Y+ +++EY     +  +++      +       + Y   +  A  Y+HN
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
             G+ +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I     
Sbjct: 112 -RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y  ++D WS G +L ELL G+P F GE   D +             +I   N      +F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL---EF 215

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPFFD 322
           P              +   A DL+ +LL+ +P     NL+    +   H +F+
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  106 bits (267), Expect = 9e-27
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 49/296 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 90
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +       +T E    + NL +E++       +   Y   +   +I    Y  Q+ R L+
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN---YTEQLLRGLS 117

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRA 205
           Y+H    + HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                    P I  H         + P   D+  R L+  P  R  + E L HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 93
           ++G G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +          L +++EY      R +     ++++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 212
             +GV HRDIK  N+LV  +T  +KLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 247
             Y    DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  104 bits (263), Expect = 3e-26
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 41  RVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           + +G G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALA 150
            L       T+ + LY  +V EY+P      +    +       +   L    QI + + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------ 204
           Y+ +     HRD+  +N LV      +K+ DFG ++ + + +         YYR      
Sbjct: 117 YLES-KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165

Query: 205 ------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                 APE +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  102 bits (257), Expect = 2e-25
 Identities = 88/300 (29%), Positives = 123/300 (41%), Gaps = 62/300 (20%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 90
           Y+  RV+G G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           ++  + F      D+  L + +EY    T++  I       Q      V  Y +QI  A+
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAV 114

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 200
           +YIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P       
Sbjct: 115 SYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165

Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            YY +PEL  G  +Y    DIW+ GCVL ELL  +  F         + ++         
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV--------- 210

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            +K +  NYT                      E + LV  LLQ  P  R TA E L  P 
Sbjct: 211 -VKIVQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 4e-25
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 91
           +++G G+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
               C      +D+  L++ +EY+P  +V   +K +  +++ +     + Y  QI   + 
Sbjct: 68  QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 206
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT        
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                   PQ+ +H         + P+A + + R    +   R +A E L H F 
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 87/297 (29%), Positives = 141/297 (47%), Gaps = 47/297 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GS G+V  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           + S    DEL++  V+E++       I  H +M++   +  V L    + +AL+++H   
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ-IATVCL---AVLKALSFLHAQ- 134

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 215
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              +DIWS G ++ E++ G+P +  E  +  +            + I+   P       P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP-------P 233

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           ++K    HK+      P     + R+L   P  R+TA E L HPF  +   P++ +P
Sbjct: 234 KLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 3e-24
 Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 46/284 (16%)

Query: 44  GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 97
           G GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 98  FSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                 D   L +V+EY P   + + I    K  + +P   +   F Q+ R L  +H   
Sbjct: 69  L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 157 GVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
            + HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
           +   DIWS GC+L E+    P F   S  D      KV                   K+P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG----------------KYP 219

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
            I               +  + +  +LQ  P LR    + L  P
Sbjct: 220 PIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =   99 bits (250), Expect = 3e-24
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 46/228 (20%)

Query: 41  RVVGHGSFGVVFQAKC---LETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 92
           + +G G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETV-------HRVIKHHYKMSQRMPLIYVKLYFYQI 145
           L       TE++ LY  LVLEY+            R           + L  +  +  QI
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRP-VFPSPEKSTLSLKDLLSFAIQI 114

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
            + + Y+ +     HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 115 AKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 205 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                      APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 3e-24
 Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 59/297 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 91
           +     +G GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
                F   ++     L +++EY    +   ++K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 203
           Y+H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPK 212

Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
             NP       P ++ + + K F+        D VS  L   P  R +A E L H F
Sbjct: 213 N-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 99.3 bits (247), Expect = 6e-24
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 88
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 206
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 16/213 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 90
           Y   RVVG G+FG+V   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +     F          L +V+EY P  T+   I+   + +  +    +  +F QI  AL
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H  + + HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            G   Y    DIW+ GCVL EL   +  F   +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 49/294 (16%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 95
           +GHGSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H+ 
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLHSH 140

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 214
             + HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 215 -YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            Y   +D+WS G    EL   +P     + +  L  I                    +  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
            P ++++ W   F+          V   LQ  P  R  + E L H F    R  
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 41/298 (13%)

Query: 44  GHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           G G++GVV + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           F   E D   + + +E +  ++ +  K  Y     +P   +      I +AL Y+H+ + 
Sbjct: 70  FR--EGD---VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 214
           V HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y    D+WS G  + EL  G+  FP +S             TP  +++K           
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK----------- 218

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
            Q+   P  ++  ++  PE  D V++ L+ +   R    E L HPFF+     NT + 
Sbjct: 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 91/330 (27%), Positives = 150/330 (45%), Gaps = 71/330 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 91
           +++ +G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           S+  C F T      +L +V+EYV       ++K+       +P+   ++YF +   AL 
Sbjct: 65  SM-FCSFETKR----HLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALE 115

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNI-------------- 195
           Y+HN  G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 196 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
             +C +  Y APE+I     Y   +D W+ G +L E L+G   F G++  +   ++I   
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230

Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---ST 311
                ++I    P   E                  +P +A DL+SRLL+ +P  R     
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGG 266

Query: 312 ALEALIHPFFDELRDPNTRL-PNGRFLPPL 340
           A E   H FF  L D N  L     F+P L
Sbjct: 267 AFEVKQHRFFLGL-DWNGLLRQKAEFIPQL 295

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.5 bits (242), Expect = 6e-23
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 49/289 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           K C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLH 142

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +   + HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 214 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 238

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + P ++++ W   F+        + V   LQ  P  R T+ E L H F
Sbjct: 239 NESPTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 88
           ++  E+ +G G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           NV+     F    E     LN+VLE      + ++IK+  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 206
           A+ ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 214 E--YTAAIDIWSAGCVLAELLLGQP 236
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 66/298 (22%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 98
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 99  STTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALA 150
               +D+L+  +V+EY      + +++V +      Q   + YV       CR     LA
Sbjct: 71  R---RDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV-------CRETLKGLA 115

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPEL 208
           Y+H T G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+
Sbjct: 116 YLHET-GKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172

Query: 209 IFGATE----YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK 263
              A E    Y    DIW+ G    EL   Q P+F         +  ++ L   ++    
Sbjct: 173 A--AVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS--- 219

Query: 264 CMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                   F  P++K    W  +F         D + + L   P  R TA + L HPF
Sbjct: 220 -------NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 88/320 (27%), Positives = 131/320 (40%), Gaps = 71/320 (22%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLL---DHPNVVSLKH 95
           VG G +G VF AK  +TGE VA+K     +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 96  CFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            F     +D+ YL L +EYVP            V+   +           + Y  ++  A
Sbjct: 69  AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------ARFYMAEMFEA 113

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +  +H  +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE+
Sbjct: 114 VDALHE-LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEV 169

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           + G   Y   +D WS GC+L E L G P F G                          PN
Sbjct: 170 LRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPN 204

Query: 269 YTEFKFPQIKAHPWHKIFQK--------RMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            T   +  +K   W +  Q+         +  EA DL+++L+        +  +   HPF
Sbjct: 205 ET---WENLKY--WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259

Query: 321 FDELRDPNTRLPNGRFLPPL 340
           F E+     R     F+P L
Sbjct: 260 FKEVDWNELRELKPPFVPEL 279

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 88/318 (27%), Positives = 136/318 (42%), Gaps = 57/318 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 94
           +G G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 152
           + F +   KD+L L + L    +     +K+H Y + +   P      Y  QI   L ++
Sbjct: 60  YAFET---KDDLCLVMTLMNGGD-----LKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H    + +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ G 
Sbjct: 112 HQR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y  ++D ++ GC L E++ G+  F       Q  E ++      +EE+K         
Sbjct: 170 -VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR------- 209

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDP 327
                        +  +  PEA DL   LLQ  P  R      +A E   HP F +L   
Sbjct: 210 ----TLEMAVE--YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263

Query: 328 NTRLPNGRFLPPLFNFKP 345
             RL  G   PP   F P
Sbjct: 264 --RLEAGMLEPP---FIP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 93/315 (29%), Positives = 143/315 (45%), Gaps = 55/315 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           +V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  C F T E    +L  V+EY+       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G
Sbjct: 113 H-KKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
             +Y  ++D WS G +L E+L+GQ  F GE   D+L + I         +          
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR--------- 212

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDELRDPNTR 330
                    P    F + +  EA D +S+L +  P  R     +   HPFF  +     R
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID--WER 258

Query: 331 LPNGRFLPPLFNFKP 345
           L      PP   FKP
Sbjct: 259 LEKREIPPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 54/298 (18%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           +V+G GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L H  F T  KD L+   V+EYV       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++  
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y  A+D W+ G +L E+L GQ  F G+   D+L                        
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL------------------------ 204

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-----LIHPFFDEL 324
             F  I        + + +  EA  ++   L  +P  R   L         HPFF E+
Sbjct: 205 --FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.4 bits (232), Expect = 7e-22
 Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 43/290 (14%)

Query: 40  ERVV-GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 94
           ERVV G G++G+V+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 95  HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 152
                 +E    +  + +E VP  ++  +++  +  +      I    Y  QI   L Y+
Sbjct: 72  GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-F 210
           H+   + HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 125 HDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           G   Y A  DIWS GC + E+  G+P F                       I+   P   
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAA 220

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FK    K HP      + +  EA + + R  +  P+ R++A + L  PF
Sbjct: 221 MFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 94.2 bits (234), Expect = 8e-22
 Identities = 90/314 (28%), Positives = 137/314 (43%), Gaps = 56/314 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 95
           +G GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
             FS    ++LYL L      E     + HH +   R  L   + Y  ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLH-K 111

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 214
             V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           YT A+D W+ G +L E+L G P F  E+ V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFDELRDPNTRL 331
                      F      +A DL+  LL   P  R   + A E   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 332 PNGRFLPPLFNFKP 345
                 PP   FKP
Sbjct: 259 LMKGIQPP---FKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 53/297 (17%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 95
           V+G G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 96  CFF---STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            F         D+L+  LV+E     +V  ++K   K  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 210
           +H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 211 GATE------YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
            A +      Y A  D+WS G    EL  G+P       +  L +I +            
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------------ 232

Query: 265 MNPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            NP       P +K    W K F         D +S  L  +   R    E L HPF
Sbjct: 233 -NPP------PTLKSPENWSKKFN--------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 91
           +V+G GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L H  F T +K    L  VL+YV       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTADK----LYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 210
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++ 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y   +D W  G VL E+L G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 96
           +G GSFGVVF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           F      D+  LN+V+EY     +H+++K      + +P   V  +F QI   LA++H+ 
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 211
             + HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 252
              Y    D+W+ G VL E   G+  F   +    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 49/291 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 94
           + +G GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F S  E   L++  V+EY    + + R+ +    +     ++    +F QI   L +I
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIF 210
           H+   + HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I 
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               Y    DIWS GCVL EL   +  F G + + QLV  I       +     ++PN++
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI------CQGYFAPISPNFS 227

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                                 +   L+S+L + SP  R +    L  PF 
Sbjct: 228 R---------------------DLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 82/305 (26%), Positives = 124/305 (40%), Gaps = 47/305 (15%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHC 96
            +G G+ GVV +     +G  +A K + L+ K   +N   REL+ +   + P +V     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 97  FFSTTE-------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           F+S  E        D   L+ VL               K + R+P   +      + R L
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVL---------------KKAGRIPENILGKISIAVLRGL 112

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 170

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G T YT   DIWS G  L E+ +G+   P         E+  + G P  E     +   
Sbjct: 171 QG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRP 225

Query: 270 TEFKFPQ-------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
                P              I   P  K+       E  D V + L+ +P  R+   E  
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Query: 317 IHPFF 321
            HPF 
Sbjct: 286 KHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 87/307 (28%), Positives = 138/307 (44%), Gaps = 63/307 (20%)

Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRLLDH---------- 87
           RV+G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 88  ----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
               P +V+L H  F T  K    L+L+L+YV      +  H Y+  +      V++Y  
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIA 112

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSR 201
           +I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E     S+  + 
Sbjct: 113 EIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTI 170

Query: 202 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y APE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R 
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRR 223

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALI 317
            +K   P                  F K M  EA D + +LL+  P  R   + A E   
Sbjct: 224 ILKSKPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265

Query: 318 HPFFDEL 324
           HPFF  +
Sbjct: 266 HPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 87/297 (29%), Positives = 138/297 (46%), Gaps = 47/297 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 86  YLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLKALSVLHAQ- 135

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 215
           GV HRDIK  ++L+  H  ++KL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P+  +P
Sbjct: 235 KLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 91/315 (28%), Positives = 150/315 (47%), Gaps = 55/315 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           +V+G GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L +C F T  K+ L+   V+E++       +  H +   R  L     Y  +I   L ++
Sbjct: 61  L-YCTFQT--KEHLFF--VMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H+  G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G
Sbjct: 113 HSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
             +YT ++D WS G +L E+L+GQ  F G+   D+L E I+V  TP              
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP-------------- 213

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFDELRDPNTR 330
             +P+     W       +  E+ D++ +L +  P  R   +  +  HPFF  +    T 
Sbjct: 214 -HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN--WTA 258

Query: 331 LPNGRFLPPLFNFKP 345
           L      PP   FKP
Sbjct: 259 LEKRELDPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 41  RVVGHGSFGVVFQAKCLE-----TGEAVAIKK-----VLQDKRYKNRELQTMRLLDHPNV 90
           + +G G FG V      +     TGE VA+K        Q +    RE++ +R LDH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRA 148
           V  K        +    L L++EY+P    R     Y  +   ++ L  + L+  QIC+ 
Sbjct: 69  VKYKGVCEKPGGRS---LRLIMEYLPSGSLR----DYLQRHRDQINLKRLLLFSSQICKG 121

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSR 201
           + Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        EP  S I   
Sbjct: 122 MDYLGSQ-RYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--F 177

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
           +Y APE +  +   +A+ D+WS G  L EL 
Sbjct: 178 WY-APECLRTSKFSSAS-DVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 85/331 (25%), Positives = 134/331 (40%), Gaps = 88/331 (26%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 93
           +V+G G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F     +DE YL L++EY+P  + +  ++K     ++     Y+     +   A+  
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIA----ETILAIDS 116

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 199
           IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+     
Sbjct: 117 IH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 200 SR--------------------Y-------YRAPELIFGATEYTAAIDIWSAGCVLAELL 232
                                 Y       Y APE +F  T Y    D WS G ++ E+L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Query: 233 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 292
           +G P F  +               P     K +N   T  +FP           +  + P
Sbjct: 234 VGYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSP 268

Query: 293 EAVDLVSRLLQYSPNL--RSTALEALIHPFF 321
           EA DL+ RL   +      +   E   HPFF
Sbjct: 269 EAKDLIKRLCCEAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 87/316 (27%), Positives = 142/316 (44%), Gaps = 57/316 (18%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           +++G GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L +C F T E     L  V+EY+       +  H +   +  L     Y  +I   L ++
Sbjct: 61  L-YCTFQTKE----NLFFVMEYLNGGD---LMFHIQSCHKFDLPRATFYAAEIICGLQFL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G
Sbjct: 113 HSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
             +Y  ++D WS G +L E+L+GQ  F G    +              + I+  NP Y  
Sbjct: 171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPR 217

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDELRDPNT 329
           +                 +  EA D++ +L    P  R   ++  I  HPFF E+    +
Sbjct: 218 W-----------------LTREAKDILVKLFVREPE-RRLGVKGDIRQHPFFREID--WS 257

Query: 330 RLPNGRFLPPLFNFKP 345
            L      PP   FKP
Sbjct: 258 ALEEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           + S    +EL++  ++E++       I    ++++      +      + +AL Y+H+  
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHSQ- 136

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 215
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              +DIWS G ++ E++ G+P +  +S V  +  +        R+              P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
             K    HKI      P   D + R+L   P  R+TA E L HPF  +   P   +P
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 85.7 bits (212), Expect = 6e-19
 Identities = 73/299 (24%), Positives = 127/299 (42%), Gaps = 48/299 (16%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 97
           +G G++G V++     TG  +A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           F      E  + + +EY+       +      ++ +P   ++   Y + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 212
           + HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNY 269
             YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           +                      +A D V++ L   PN R T  + L HP+  + ++ +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 54/291 (18%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 95
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F    +++ +Y   +LE+V   V   +  H + + R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
             + +RD+KP+NLL++   H +K+ DFG AK +   +   +   +  Y APE+I  +  +
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKGH 192

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
             A+D W+ G +L E + G P F  +              TP R   K +       KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-----HPFF 321
                 W   F  R    A DLV  LLQ     R   L+  +     HP+F
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.6 bits (209), Expect = 9e-19
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 71/304 (23%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 91
           V+G G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
                 +  T  D+  +++ +E+VP  ++  ++         +P      Y  QI   +A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVA 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI-------CSRYY 203
           Y+HN   V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            APE+I   + Y    DIWS GC + E+  G+P     + +D+L  +             
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF------------ 218

Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLVSRLLQYSPNLRSTALEAL 316
                        I AH      +  MP         A+D V+  L    + R +AL+ L
Sbjct: 219 ------------YIGAH------RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Query: 317 IHPF 320
            H F
Sbjct: 261 RHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 91/318 (28%), Positives = 137/318 (43%), Gaps = 51/318 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 91
           +V+G GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L H  F TTEK    L  VL++V       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 210
           +H +I + +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I 
Sbjct: 112 LH-SINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------R 259
               Y   +D W  G VL E+L G P F      +    I+ K L    G          
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228

Query: 260 EEIKCMNPNYTEFK--FPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           E ++         K  F +I+ HP      W  + QK++PP           ++PN+   
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP----------FNPNVEGP 278

Query: 312 ALEALIHPFFDELRDPNT 329
              +     F E   P +
Sbjct: 279 DDISNFDAVFTEETVPYS 296

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           Y   RVVG GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           + K  F     + + +L +V+EY    + + ++     K+    P   +  +F Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPEL 208
            +IH    V HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 209 IFGATEYTAAIDIWSAGCVLAEL 231
           I+    Y    DIWS GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 88/321 (27%), Positives = 133/321 (41%), Gaps = 59/321 (18%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 92
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 150
           L + +     KD L L L L    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
            +H    + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV- 173

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               YT + D W  GC++ E++ G+  F          E +K      REE++       
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQ 221

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 325
           E              + ++    A  +  +LL   P  R       A E   HPFF   R
Sbjct: 222 E-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF---R 265

Query: 326 DPN-TRLPNGRFLPPLFNFKP 345
             N  RL  G   PP   F P
Sbjct: 266 TANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 90/311 (28%), Positives = 146/311 (46%), Gaps = 49/311 (15%)

Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTM 82
           G P++ +    +  +G GS G+V  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           R   H NVV +   + S    DEL++  V+E++       I  H +M++      +    
Sbjct: 74  RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 124

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 201
             + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P   S + + 
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E  +  +  I        R+ 
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDN 233

Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +            P++K    HK+    +    +DL   +L   P+ R+TA E L HPF 
Sbjct: 234 LP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275

Query: 322 DELRDPNTRLP 332
                P+  +P
Sbjct: 276 KLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 34/214 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                TE D+ +L +++EYVP   +   +++  + S    L Y      +I  AL Y+H 
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS----EIVCALEYLH- 118

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRAPEL 208
           +  + +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE+
Sbjct: 119 SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPEV 169

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 170 I-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 34/208 (16%)

Query: 43  VGHGSFGVVFQAKCL------ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 92
           +G G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            K   +S   ++   L LV+EY+P    R  + KH  ++  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYY 203
           Y+ +   V HRD+  +N+LV      +K+ DFG  KVL          EP  S I   ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAEL 231
            APE +   ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.4 bits (206), Expect = 6e-18
 Identities = 96/339 (28%), Positives = 153/339 (45%), Gaps = 69/339 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           RV+G GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L +C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 61  L-YCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I  
Sbjct: 113 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQ 169

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y  ++D W+ G +L E+L G   F  E+  D L E I        +E+         
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV--------- 213

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR--STAL---EALI-HPFFDELR 325
                        ++   +  +AVD++   +  +P +R  S  L   EA++ HPFF EL 
Sbjct: 214 -------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL- 259

Query: 326 DPNTRLPNGRFLPPLF-----------NFKPHELKGVPV 353
             +    N R + P F           NF P  +K  PV
Sbjct: 260 --DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPV 296

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 8e-18
 Identities = 104/403 (25%), Positives = 163/403 (40%), Gaps = 110/403 (27%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 93
           +V+G G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F     +D  YL L++E++P  + +  +IK+    S+ +     + Y  +   A+  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDV----TRFYMAECVLAIEA 116

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 199
           +H  +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I 
Sbjct: 117 VHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 200 SRY------------------------------------YRAPELIFGATEYTAAIDIWS 223
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 224 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPW 282
            G ++ E L+G P F  E+  +   +II                N+ E   FP       
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD------ 271

Query: 283 HKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPNTRLPNGRFLPPL 340
                  +  EA DL+ RL+  + N   R  A E   HPFF  +     R     F+P L
Sbjct: 272 ----DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327

Query: 341 FN------FKPHELKGVPVDMLVKL-----IPEHARKQCAFLG 372
            +      F   EL+ VP    +K        E      AF+G
Sbjct: 328 KSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIG 370

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 93/307 (30%), Positives = 143/307 (46%), Gaps = 62/307 (20%)

Query: 41  RVVGHGSFGVVF---QAKCLETGEAVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 87
           +V+G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPET---VHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           P +V+L H  F T  K    L+L+L+YV       H   + ++   +      V+ Y  +
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE------VRFYSGE 113

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY- 202
           I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    
Sbjct: 114 IILALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRIL 224

Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 317
           KC  P                  F   + PEA DL+ +LL+  P  R       A E   
Sbjct: 225 KCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266

Query: 318 HPFFDEL 324
           HPFF  L
Sbjct: 267 HPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 36/286 (12%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 97
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 98  FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
            +     E  + + +E++   ++ R+    YK    +P+  +      +   L Y++N  
Sbjct: 73  LN-----ENNICMCMEFMDCGSLDRI----YKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
            + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 217 AAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           QI   P  ++     P +  D V   L   P  R T  +    P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 53/302 (17%)

Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             HPN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      E + P+            ++     D ++R L+     R +A E L HP
Sbjct: 234 -----------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270

Query: 320 FF 321
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 77/300 (25%), Positives = 136/300 (45%), Gaps = 52/300 (17%)

Query: 35  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLL 85
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
            H  +V    C     EK    L + +EY+P  +V   +K +  +++ +   Y +    Q
Sbjct: 62  QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR----Q 114

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICS 200
           I   ++Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y+ +PE+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN- 227

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                         PQ+ +H         +   A D +  +   + + R +A E L HPF
Sbjct: 228 --------------PQLPSH---------ISEHARDFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 81/296 (27%), Positives = 136/296 (45%), Gaps = 46/296 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           ++  +V GH S G ++  K L+    V   K  +  R + + L+ +R    P +V+L + 
Sbjct: 17  FLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYA 73

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  AL ++H  +
Sbjct: 74  FQTDTK-----LHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-L 124

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELIFGA-T 213
           G+ +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y AP+++ G   
Sbjct: 125 GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K   P      
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSEPP------ 230

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDEL 324
           +PQ             M   A D++ RLL   P  R     S A E   HPFF ++
Sbjct: 231 YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 81/325 (24%), Positives = 147/325 (45%), Gaps = 63/325 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 91
           RV+G GS+  V   +  +T    A+ KV++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAM-KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L  CF + +      L  V+E+V       +  H +  +++P  + + Y  +I  AL +
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIF 210
           +H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 260
           G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 261 EIKC-------MNPNYTE-------FKFPQIKAHP------WHKIFQKRMPPEAVDLVSR 300
            +K        +N +  E         F  IK+HP      W  + QK++ P        
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP------- 281

Query: 301 LLQYSPNLRST-ALEALIHPFFDEL 324
              Y PN+ S   L+     F DE 
Sbjct: 282 ---YKPNIESDRDLDNFDPQFTDEP 303

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 70/305 (22%)

Query: 44  GHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 97  FFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           +F    +++L+  +++E+      +++   ++      Q   +        Q+  AL ++
Sbjct: 71  YFY---ENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVC------RQMLEALNFL 119

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI-- 209
           H+   V HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++  
Sbjct: 120 HSHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 210 --FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
             F    Y    DIWS G  L EL   +P                    P  E    +NP
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNP 213

Query: 268 NYTEFKFPQ------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                K  +       +   W   F         D +   L   P+ R TA E L HPF 
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFV 265

Query: 322 DELRD 326
            +  D
Sbjct: 266 SDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 47/296 (15%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 96
           ++GHG+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 97  FFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           FF      E  +++  E++      V+R I  H  +  R+ +  VK         L Y+ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYRKIPEH--VLGRIAVAVVK--------GLTYLW 112

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
            ++ + HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  
Sbjct: 113 -SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-E 168

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           +Y    D+WS G    EL LG+  +P        +  +++L     E+            
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP----------- 217

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 329
            P +    + + F        V  +++ ++  P  R      + HPF  +  D N 
Sbjct: 218 -PVLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 94/320 (29%), Positives = 141/320 (44%), Gaps = 57/320 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 92
           RV+G G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 150
           L + +     KD L L L L    +     +K H Y M +          Y  +IC  L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
            +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++ 
Sbjct: 117 DLHQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV- 173

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               YT + D W+ GC+L E++ GQ  F       Q  + IK      REE++ +     
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQ 221

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 325
           E              + ++  P+A  L   LL   P  R       A E   HP F ++ 
Sbjct: 222 E-------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Query: 326 DPNTRLPNGRFLPPLFNFKP 345
               RL  G   PP   FKP
Sbjct: 269 --FKRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 84/301 (27%), Positives = 130/301 (43%), Gaps = 63/301 (20%)

Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHP 88
           +V+G G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            +V L    F T  K    L L+LEY+   E    + +    M           Y  +I 
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEIS 110

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 205
            AL ++H   G+ +RD+KP+N+L++   H +KL DFG  K  +         C    Y A
Sbjct: 111 LALEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE I   + +  A+D WS G ++ ++L G P F  E+    + +I+K          K  
Sbjct: 169 PE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLN 218

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 320
            P Y                    + PEA DL+ +LL+ +P+ R       A E   HPF
Sbjct: 219 LPPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Query: 321 F 321
           F
Sbjct: 259 F 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 27/236 (11%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 91
           +++G G+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
               C     E+    L++ +E++P  ++   +K +  +++ +     + Y  QI   ++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 206
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           E+I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 90
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 148
           V + + F  T +K    L+L+              HY +SQ       ++ FY  +I   
Sbjct: 60  VCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQ----------------------PLFPGESGVDQ 246
           +     Y ++ D +S GC+L +LL G                          P     + 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226

Query: 247 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 292
              +  +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 61/236 (25%), Positives = 117/236 (49%), Gaps = 27/236 (11%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 91
           +++G G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
               C     EK    L++ +EY+P  ++   +K +  +++ +     + Y  QI + ++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNISYICSRYYRAP 206
           Y+H+ + + HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           E+I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.6 bits (196), Expect = 8e-17
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 41/214 (19%)

Query: 41  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           RV+G G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 149
             K C    +E+    L L++EYVP    R  + KH   ++Q +      L+  QIC  +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 207
           AY+H+   + HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 208 ---LIFGATE------YTAAIDIWSAGCVLAELL 232
              + + A E      ++ A D+WS G  L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           +V+G G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            H  F    +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL  IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFYTAEVVLALDAIH 159

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 208
           + +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE+
Sbjct: 160 S-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPEV 214

Query: 209 IF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           +    G   Y    D WS G  L E+L+G   F  +S V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 50/283 (17%)

Query: 44  GHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFF 98
           G G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 99  STTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              ++    + + +EY     +     +V K   ++ ++   +  K+    + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK---VLGKIAE-SVLKGLSYLH 122

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELI 209
            +  + HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 -SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 258
            G   Y+   D+WS G  L E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 259 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFQKRMP 291
                EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 66/224 (29%), Positives = 116/224 (51%), Gaps = 28/224 (12%)

Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R LAY+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 215 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 257
           Y+   DIWS G  L EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 42/289 (14%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 96
           +G G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 97  FFSTTEKD-----ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            F   E D     EL +++ L+   + V+ V+K        +P   +        +AL Y
Sbjct: 72  LF--REGDCWICMEL-MDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNY 122

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-- 209
           +   + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I  
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR---EEIKCM 265
                Y    D+WS G  L E+  G+  +P   S  DQL +++K  G P      E +  
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPILSNSEEREF 239

Query: 266 NPNYTEF-------------KFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           +P++  F             K+ ++  HP+ K +++R    A  +   L
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRIL 288

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 80/328 (24%), Positives = 136/328 (41%), Gaps = 58/328 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 92
           +G G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           LK   FS     +LYL  V +Y+       +  H +   R      K Y  ++  AL ++
Sbjct: 61  LK---FSFQTDSDLYL--VTDYMSGGE---LFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 211
           H    + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++  
Sbjct: 113 HKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII---------KVLGTPTREEI 262
              YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+ +
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQFV 229

Query: 263 KCM---NPNY---TEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRS 310
           K +   NP +         ++K HP      W  + +K++ P           + P + S
Sbjct: 230 KGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP----------FKPIVDS 279

Query: 311 TALEALIHPFFDELRDPNTRLPNGRFLP 338
               +   P F      N+ L N   +P
Sbjct: 280 DEDVSNFDPEFT-----NSSLLNAGIVP 302

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 90
           Y+  + +G GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR---MPLIYVKLYFYQIC 146
           V  +  F    E   LY+  V++Y     +++ I      +QR    P   +  +F QIC
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEGGDLYKKIN-----AQRGVLFPEDQILDWFVQIC 111

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 205
            AL ++H+   + HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I     Y    DIW+ GCVL E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 45/284 (15%)

Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 90
           +V+G GSFG VF  + +   + G+  A+ KVL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAM-KVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L H  F T  K  LYL L      +   R+ K      +      VK Y  ++  AL 
Sbjct: 61  VKL-HYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALD 112

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELI 209
           ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 113 HLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPT---------- 258
                +T + D WS G ++ E+L G   F G+   + +  I+K  LG P           
Sbjct: 171 -NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229

Query: 259 REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFQKRMPP 292
           R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 230 RALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 83/302 (27%), Positives = 134/302 (44%), Gaps = 53/302 (17%)

Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRL 84
           G PK+   Y     +G G+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           L +PN+V+    F      DEL+  +V+EY+       +     M +             
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDEAQ--------IAA 119

Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H    V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
              +  NP                    +++ P   D ++R L+     R +A E L HP
Sbjct: 234 ---ELQNP--------------------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270

Query: 320 FF 321
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 99/381 (25%), Positives = 155/381 (40%), Gaps = 106/381 (27%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 92
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L   ++S  +KD LY   V++Y+P  + +  +I+      +  P +  + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIE 115

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG--------EP 193
            +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG        EP
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 194 NI-------------------------------SYICSRYYRAPELIFGATEYTAAIDIW 222
           +                                S + +  Y APE++     YT   D W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWW 232

Query: 223 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 282
           S G +L E+L+GQP F              +  TPT  ++K +N   T    PQ+K    
Sbjct: 233 SVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK---- 274

Query: 283 HKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDEL-------RDPNTRLPN 333
                  + PEAVDL+++L   +     R+ A +   HPFF E+         P   +P 
Sbjct: 275 -------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327

Query: 334 GRFLPPLFNFKPHELKGVPVD 354
                   NF P E +    D
Sbjct: 328 ISHPMDTSNFDPVEEESPWND 348

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 82/324 (25%), Positives = 133/324 (41%), Gaps = 79/324 (24%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 93
           +++G G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F + T     YL LV++Y P   + R+++      + +     + Y  ++  AL Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYL 119

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEP 193
           H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V   P
Sbjct: 120 HL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 194 NISYICS-----------RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           + ++                Y APE+I G   + +A+D W+ G +L E+L G   F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 243 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 302
             +    I+K                  E  FP              +   A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269

Query: 303 QYSPNLR----STALEALIHPFFD 322
              P+ R      A E   HPFF 
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 4e-16
 Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 89
           +Y   RVVG GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +V+ +  +    E   LY+ +      +  H++ +   K+   +P   V  +F QI  AL
Sbjct: 61  IVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMAL 115

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 208
            Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
            F    Y    D+W+ GC + E+   +  F  +     +  II                 
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----------------- 215

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
             E K P +          K   PE  +L++ +L   P  R +    L  P+
Sbjct: 216 --EGKLPPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 82/323 (25%), Positives = 137/323 (42%), Gaps = 68/323 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F      D   L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 207
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R       A E + H FF 
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255

Query: 323 ELRDPNTRLPNGRFLPPLFNFKP 345
            +      +   +  PP   FKP
Sbjct: 256 SIN--WQDVVQKKLEPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 54/292 (18%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   +HP +V L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIH 153
           +   +     L +++E+ P      I          P I V      ICR    AL Y+H
Sbjct: 79  YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------ICRQMLEALQYLH 127

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 212
            ++ + HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   
Sbjct: 128 -SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 213 T----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           T     Y    DIWS G  L E+   +P                    P  E    +NP 
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP--------------------PHHE----LNPM 221

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
               K    K+ P       +   E  D +   L   P  R +A + L HPF
Sbjct: 222 RVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 91
           +V+G GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L H  F T EK    L  VL+YV       +  H +  +       + Y  ++  A+ Y
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGY 111

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 210
           +H ++ + +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE + 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y   +D W  G VL E+L G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 66/229 (28%), Positives = 119/229 (51%), Gaps = 23/229 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K   ++ +++ L  V +    + + L Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI-LGKVSI---AVIKGLTYLRE 121

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 215 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y+   DIWS G  L E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.8 bits (189), Expect = 9e-16
 Identities = 69/222 (31%), Positives = 115/222 (51%), Gaps = 25/222 (11%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           +V+G GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L HC F T ++    L  V+EYV   + + ++ +     S++      + Y  ++  AL 
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALM 110

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 209
           ++H   GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               EY  ++D W+ G ++ E++ GQP F  ++  D L E I
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 58/295 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 92
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 251
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 252 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 292
                     L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 230 VKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 38/315 (12%)

Query: 49  GVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHCFFSTTE 102
            +V  AK   T   VA+KK+  D   K        E+ T R L HPN++     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 161
             ELY+  V   +   +   ++K H+   + +P + +      +  AL YIH+  G  HR
Sbjct: 71  DSELYV--VSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK-GFIHR 125

Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNISYICSRYYRAPELIFGAT 213
            +K  ++L++     + L     +  ++K         +   S + +  + +PE++    
Sbjct: 126 SVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 214 E-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--------EEIKC 264
           + Y    DI+S G    EL  G   F        L+E  KV GT                
Sbjct: 185 QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDKSTYPLYEDS 242

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           M+ + +  + P  +       + +         V   LQ  P  R +A + L H FF + 
Sbjct: 243 MSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Query: 325 RDPNTRLPNGRFLPP 339
           +  NT L +   L P
Sbjct: 302 KRRNTSLLD--LLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 94
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           H  F T   D LY   V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 67  HSCFQTV--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 213
             G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I    
Sbjct: 120 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AYQ 176

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 47/242 (19%)

Query: 43  VGHGSFGVVFQAKCLETGE---AVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 94
           +GHG+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 95  HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                  + + L   LV+E  P   + + +K      + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE 112

Query: 154 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 204
           +   V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 205 ----APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 257
               APE I     +++  D+WS G  L E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 258 TR 259
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 53/302 (17%)

Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
              +  NP                    +R+     D ++R L+   + R +A E L HP
Sbjct: 234 ---ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270

Query: 320 FF 321
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 69/302 (22%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 91
           V+G G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           +L  CF     +D +    V+EY         +H                    Y   + 
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACVV 111

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 205
             L Y+H    + +RD+K  NLL++     +K+ DFG  K  +      S  C +  + A
Sbjct: 112 LGLQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++   T YT A+D W  G ++ E+L+G+  FPG+                  EE+   
Sbjct: 170 PEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV--- 209

Query: 266 NPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHP 319
                   F  I      +  F   +  EA+ ++ RLL+ +P  R       A +    P
Sbjct: 210 --------FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258

Query: 320 FF 321
           FF
Sbjct: 259 FF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 64/234 (27%), Positives = 115/234 (49%), Gaps = 28/234 (11%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 92
           RV+G GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  CF +T+      L LV+EYV       +  H +  +++P  + + Y  +IC AL ++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +KL D+G  K  +      S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 259
             EY  ++D W+ G ++ E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 39/235 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 89
           Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  AL
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLAL 155

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 199
             IH ++G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+     
Sbjct: 156 DAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD----- 208

Query: 200 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 90
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 148
           V + + F +    D+L   L L    +        HY +SQ       ++ FY  +I   
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDL-------HYHLSQHGVFSEKEMRFYATEIILG 109

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           +   T Y ++ D +S GC+L +LL G   F
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 49/289 (16%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 98
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 158
           S   +D+L++   +E+      + I H         + YV     +  + L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVS---RETLQGLYYLHSK-GK 127

Query: 159 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 214
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 215 -YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            Y    DIW+ G    EL  L  P+F         +  ++ L   T+          + F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNF 226

Query: 273 KFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           + P++K    W   F           V   L  +P  R TA + L HPF
Sbjct: 227 QPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 85/325 (26%), Positives = 136/325 (41%), Gaps = 73/325 (22%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 94
           +VG G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           + F    +KD LYL  V+EY P  + +  + ++  +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-------KVLVK---GEPNISYICSRY 202
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 H-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 203 YRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           Y APE++      G   Y    D WS G +  E++ G+  F   +       I+      
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222

Query: 258 TREEIKCMNPNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
                     N+  F KFP+            ++  + +DL+  LL      R    E L
Sbjct: 223 ----------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKER-LGYEGL 260

Query: 317 -IHPFFDELRDPNTRLPNGRFLPPL 340
             HPFF ++   N R     F+P L
Sbjct: 261 CCHPFFSKIDWNNIRNSLPPFVPTL 285

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 89
           Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLAL 155

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 199
             IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+     
Sbjct: 156 DAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD----- 208

Query: 200 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 38/279 (13%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 94
           V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           H  F T   D LY   V+EYV       + +H +   +    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 213
             G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AYQ 176

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCM- 265
            Y  ++D W+ G +L E+L GQP F GE       S ++  V   K L        K + 
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLL 236

Query: 266 --NPNY----TEFKFPQIKAHP------WHKIFQKRMPP 292
             +P             I+ H       W K+ ++ + P
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 30/240 (12%)

Query: 43  VGHGSFGVVFQAKCLETGEA-VAIKKVL-------QDKRYKNRELQTM--------RLLD 86
           +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +          L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVL-EYVPETVHRVI---KHHYKMSQRMPLIYVKLYF 142
           HPN+V     F    E D LY+ + L E  P   H      K      +R+  I+V    
Sbjct: 68  HPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV---- 120

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 202
            Q+  AL Y+H    + HRD+ P N+++     ++ + DFG AK         S + +  
Sbjct: 121 -QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y  PE++     Y    D+W+ GC+L ++   QP F   + +    +I++ +  P  E +
Sbjct: 179 YSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 26/210 (12%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 91
           +V+G GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L H  F T +K    L  VL+Y+   E  + + +    +  R      + Y  +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 208
            Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           +     Y   +D W  G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 86/319 (26%), Positives = 137/319 (42%), Gaps = 60/319 (18%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 93
           +V+G G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 94  KHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            + F     +DE  L LV++Y V   +  ++    K   R+P    + Y  ++  A+  +
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYICSRY 202
           H  +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI    
Sbjct: 119 HQ-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEI 174

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
            +A E   G   Y    D WS G  + E+L G+  F  ES V+   +I+           
Sbjct: 175 LQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------- 221

Query: 263 KCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHP 319
                N+ E F+FP              +  EA DL+ RL+        R+   +   HP
Sbjct: 222 -----NHKEHFQFPPD---------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267

Query: 320 FFDELRDPNTRLPNGRFLP 338
           FF+ +   N R     ++P
Sbjct: 268 FFEGIDWDNIRNSTAPYVP 286

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 87/316 (27%), Positives = 134/316 (42%), Gaps = 56/316 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 92
           RV+G G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 150
           L + +     KD L L L +    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
            +H      +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL- 173

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               YT + D W  GC++ E++ GQ  F G        E +K      REE+        
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV-------- 213

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 325
                  +     +++  +   EA  +   LL   P  R       A E   HPFF   R
Sbjct: 214 -----DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF---R 265

Query: 326 DPN-TRLPNGRFLPPL 340
           + N  RL  G   PP 
Sbjct: 266 NMNFKRLEAGMLDPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 62/299 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 207
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
                             F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 45/277 (16%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 93
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFYQICRALAYI 152
              F + ++     + + +E +   + +++K   ++   +P  I  K+    I +AL Y+
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMT-VAIVKALHYL 130

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFG 211
               GV HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I  
Sbjct: 131 KEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDP 188

Query: 212 AT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-----PTREE-- 261
                +Y    D+WS G  L EL  GQ  FP ++   +   + K+L       P  E   
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 262 -------IKCMNPNYTEF-KFPQIKAHPWHKIFQKRM 290
                    C+  ++ +  K+ ++  HP+ + ++   
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 73.2 bits (179), Expect = 6e-14
 Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 37/248 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G+G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V     F +   + +LY+  ++E+     + R I+  YKM  ++    +     Q+  AL
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 150 AYIHNTIG------VCHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKV 187
           AY HN         V HRD+KPQN+ ++     +                K+ DFG +K 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 188 LVKGEPNISYIC--SRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +  
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 245 DQLVEIIK 252
            QL+  +K
Sbjct: 250 SQLISELK 257

Length = 1021

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 88/335 (26%), Positives = 135/335 (40%), Gaps = 66/335 (19%)

Query: 26  GKNGQPKQTISYMA-ERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNR 77
                P    S    ERV  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRM 133
           E++ +R ++HPNVV     F    E     + ++LE++     E  H  I     ++   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMDGGSLEGTH--IADEQFLAD-- 172

Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-E 192
                     QI   +AY+H    + HRDIKP NLL+N     +K+ DFG +++L +  +
Sbjct: 173 -------VARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223

Query: 193 PNISYICSRYYRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQ 246
           P  S + +  Y +PE I      GA +  A  DIWS G  + E  LG+ P   G  G D 
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGRFPFGVGRQG-DW 281

Query: 247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 306
              +  +          CM+        P+  A             E    +S  LQ  P
Sbjct: 282 ASLMCAI----------CMSQP------PEAPAT---------ASREFRHFISCCLQREP 316

Query: 307 NLRSTALEALIHPFFDELRDPNTRLPNGR--FLPP 339
             R +A++ L HPF    +    +        LPP
Sbjct: 317 AKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351

Length = 353

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 41  RVVGHGSFGVVFQAK-CLETGE--AVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 92
           R +G G FG V+Q        E  AVA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++  V+E  P    R      K    + L  + LY YQ+  ALAY+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYL 123

Query: 153 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
            +   V HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 ESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 207 ELIFGATEYTAAIDIWSAG-CVLAELLLG-QPLF 238
           E I     +T+A D+W  G C+   L+LG +P  
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 87/311 (27%), Positives = 137/311 (44%), Gaps = 44/311 (14%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 100
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 101 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           T     +DE YL LV++Y       ++    K   R+P    + Y  ++  A+  IH   
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 210
            V HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 224

Query: 271 E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDP 327
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ +   
Sbjct: 225 ERFQFP---SH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275

Query: 328 NTRLPNGRFLP 338
           N R     ++P
Sbjct: 276 NIRNLEAPYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 85/324 (26%), Positives = 140/324 (43%), Gaps = 68/324 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 213

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255

Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 256 SINWQD--VVQKKLLPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 41  RVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 92
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L   F     KDE YL LVLE+V   +        + ++R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
             ++ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 Q-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF 238
                AA D W+ G  + E+L+G P F
Sbjct: 203 VGHGKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 3e-13
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 28/253 (11%)

Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 120

Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236

Query: 260 EEIKCMNPNYTEF 272
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 25/239 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 94
           +G G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 152
           + F S T     +L LV+  +       +K+H Y + +R + +  V  Y  QI   + ++
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGD---LKYHIYNVGERGLEMERVIHYSAQITCGILHL 111

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H ++ + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I   
Sbjct: 112 H-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
             Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  + N+TE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.3 bits (168), Expect = 4e-13
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 64/271 (23%)

Query: 65  IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----- 116
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++Y+      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 117 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 176
           + +        K   ++    VK    Q+  AL  +H    + H DIK +N+L +    +
Sbjct: 98  DLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHNII-HNDIKLENVLYDRAKDR 148

Query: 177 LKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAEL 231
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+ G +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 232 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP 291
           L G+   P +   D   E +         +++ +     + K P          F K + 
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234

Query: 292 PEAVDLVSRLLQYSPNLRSTALEALI-HPFF 321
             A D V  +L+Y+ N R T    +I HPF 
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 92
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKM------SQRMPLIYVKLYFYQI 145
           L + +     KD L L L +    +     +K H Y M       QR        Y  ++
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFDEQR-----AIFYAAEL 111

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
           C  L  +     + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y A
Sbjct: 112 CCGLEDLQRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMA 169

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           PE+I    +YT + D W  GC++ E++ GQ  F
Sbjct: 170 PEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 87/376 (23%), Positives = 131/376 (34%), Gaps = 118/376 (31%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 92
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L   ++S  +KD LY   V++Y+P  + +  +I+              + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIE 115

Query: 151 YIHNTIGVCHRDIKPQNLLVNPH----------------THQLKL--------------- 179
            +H  +G  HRDIKP N+L++                  TH  K                
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 180 --------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTAAI 219
                   C     +   K            G PN        Y APE++   T YT   
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLC 225

Query: 220 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 279
           D WS G +L E+L+GQP F  +              TP   ++K +N   T    P    
Sbjct: 226 DWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP---- 266

Query: 280 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF-------DELRDPNT 329
                  Q ++  EA DL+ RL       R   + A E   HPFF          R    
Sbjct: 267 ------SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319

Query: 330 RLPNGRFLPPLFNFKP 345
            +P         NF P
Sbjct: 320 YIPKITHPTDTSNFDP 335

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 77/288 (26%), Positives = 119/288 (41%), Gaps = 46/288 (15%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +      E  L +++E+        +    +     P I  ++   Q   AL Y+H    
Sbjct: 72  YY-----ENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTLEALNYLHEN-K 123

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 214
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 215 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y    D+WS G  L E+   +P                    P  E    +NP     
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 218

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           K    K+ P       R   E  D + + L+ + + R T  + L HPF
Sbjct: 219 KIA--KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 46/303 (15%)

Query: 46  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE--- 102
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134

Query: 103 -----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
                  +LY  L                   S+ +P+    +   QI   L Y+H    
Sbjct: 135 VLPHYSSDLYTYLTKR----------------SRPLPIDQALIIEKQILEGLRYLHAQ-R 177

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 217
           + HRD+K +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +
Sbjct: 178 IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235

Query: 218 AIDIWSAGCVLAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEI 262
             DIWSAG VL E+L             P    +S    L++II  L       P     
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295

Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           + +   + E+   + + +  +  FQ+  +P +   LV ++L +   +R +A E L +P F
Sbjct: 296 R-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354

Query: 322 DEL 324
            +L
Sbjct: 355 AQL 357

Length = 357

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 83/343 (24%), Positives = 145/343 (42%), Gaps = 60/343 (17%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTM---RLLDHPNVVSLKH 95
           ++G G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 96  C--FFSTTEKDELYLNLVL-EYVPETVHRVIKH----HYKMSQRMPLIYVKLYFYQICRA 148
              +F   + +  ++ +V+ +Y P  +  ++KH    H  ++Q           +Q   A
Sbjct: 196 IQRYF---QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ---------IIFQTGVA 243

Query: 149 LAYIHNTIGVCHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEP 193
           L Y H  + + H D+KP+N+L       V+P T++        +++CD G      +   
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHS 301

Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
             + + +R+YR+PE++ G   +  + D+WS GC++ EL  G+ L+     ++ L  + K 
Sbjct: 302 RTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 254 LGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFQKRMPPEAV------DLVSR 300
           LG  P+    +C        Y      +    P H  +I + R   E +      DL+  
Sbjct: 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420

Query: 301 LLQYSPNLRSTALEALIHP----FFDELRDPNTRLPNGRFLPP 339
           LL Y    R  A +   HP    ++ E R       N   L P
Sbjct: 421 LLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRP 463

Length = 467

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 34/206 (16%)

Query: 58  ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 109
            TG  VAIK +  D         R++ RE      L HPN+V+L      + E     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 169
            V EYVP    R ++        +P         Q+  ALA  HN  G+ HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 170 VN-----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRYYRAPELIFGATEYT 216
           V+     PH    K+ DFG   +L                 + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 217 AAIDIWSAGCVLAELLLGQPLFPGES 242
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 49/302 (16%)

Query: 52  FQAKCLE--TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 109
           F   C++  T E V IK     +     E   +R ++HP+++ LK  F         Y  
Sbjct: 107 FAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--------TYNK 156

Query: 110 LVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 168
                +P   ++   + Y  ++R + +  +      + RA+ Y+H    + HRDIK +N+
Sbjct: 157 FTCLILPR--YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENI 213

Query: 169 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYTAAID 220
            +N H   + L DFG+A   V    N      +YY         APEL+     Y  A+D
Sbjct: 214 FIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVD 265

Query: 221 IWSAGCVLAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           IWSAG VL E+         + G+D       Q+  II+  GT   E       N  E  
Sbjct: 266 IWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY 325

Query: 274 FPQIK-------AHP-WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               K       + P W  +++  +P +   L+ ++L +  + R +A   L    F ++ 
Sbjct: 326 IGLAKKSSRKPGSRPLWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383

Query: 326 DP 327
           DP
Sbjct: 384 DP 385

Length = 391

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 98
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHN 154
           S   +++L+  + +EY      + I H       + + YV       CR     LAY+H 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYV-------CRETLQGLAYLH- 123

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           + G  HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A 
Sbjct: 124 SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAV 180

Query: 214 E----YTAAIDIWSAGCVLAELLLGQP 236
           E    Y    DIW+ G    EL   QP
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 19/218 (8%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 94
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           H  F T   D LY   V+EYV       + +  +   R    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 213
             G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQ 176

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 21/217 (9%)

Query: 37  YMAERVVGHGSFGVVFQA-KCLETGEAVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 91
           Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 92  SLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRA 148
             KH  F   + D+  L L++EY     +++ IK   ++ + +P     V L FYQI  A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 205
           L  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY A
Sbjct: 182 LDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL +    Y+   D+WS G +L ELL     F G S
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 16/219 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y   RV+G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 91  VSLKHCFFSTTEKDE---LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           V     F     ++    L + LVL+Y     + + IK   K ++        L F Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYY 203
            A+ ++H+   + HRDIK  N+L+  +   +KL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            APE I+    Y+   D++S G +L ELL  +  F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 42/302 (13%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLL 85
           P  + ++     +G G++G VF+    + G   A+K +L      + E++        L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           DHPNVV     ++    K+   L LVLE     +V  ++K   K  +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 203
               L ++H    + HRD+K  N+L+      +KL DFG SA++        + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 204 RAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
            APE+I       + Y A  D+WS G    EL  G P                    P  
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP--------------------PLA 230

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALEALIH 318
           +    ++P    FK P+   +P   + Q  +   E  D + + L      R T  + L H
Sbjct: 231 D----LHPMRALFKIPR---NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Query: 319 PF 320
            F
Sbjct: 284 VF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 82/315 (26%), Positives = 138/315 (43%), Gaps = 52/315 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 93
           +V+G G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            + F     +DE  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 210
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 211 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
              G  +Y    D WS G  + E+L G+  F  ES V+   +I+                
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------------- 221

Query: 268 NYTE-FKFP-QIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDE 323
           N+ E F+FP Q+            +  +A DL+ RL+      L    +E    HPFF  
Sbjct: 222 NHKERFQFPAQV----------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271

Query: 324 LRDPNTRLPNGRFLP 338
           +   N R     ++P
Sbjct: 272 IDWDNIRNCEAPYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 48/295 (16%)

Query: 37  YMAERVVGHGSFGVVF--QAKCLETGEAVAIKKVL-------QDKRYKNRELQTMRLLDH 87
           Y+ ++ +G GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           P +V     F    E+D   +  + EY     +   ++      + +    V  +F Q+ 
Sbjct: 62  PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 205
             + Y+H    + HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE +     Y +  DIWS GC+L E+      F G+   + L  +++++  PT       
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT------- 222

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            P+  E                     +   ++  +L   P+LR +A E L +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 41  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
             K      TE     + L++E++P     E + R  K+   + Q++       Y  QIC
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLK------YAVQIC 119

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----- 201
           + + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +     
Sbjct: 120 KGMDYLGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDS 174

Query: 202 --YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
             ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 175 PVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 84/326 (25%), Positives = 133/326 (40%), Gaps = 79/326 (24%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 96
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 97  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------------------------- 183
            +G  HRDIKP NLL++   H +KL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 184 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 239 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLV 298
             E              TP     K MN   T   FP     P   I +K     A DL+
Sbjct: 237 CSE--------------TPQETYRKVMNWKET-LVFP-----PEVPISEK-----AKDLI 271

Query: 299 SRLLQYSPN-LRSTALEALI-HPFFD 322
            R    S N + S  +E +  HPFF+
Sbjct: 272 LRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 96
            VVG+G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 97  FFSTT---EKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           F   +     D+L+  LV+E+     V + V     +  K        ++     +I R 
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAP 206
           LA++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ AP
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 190

Query: 207 ELIF----GATEYTAAIDIWSAGCVLAELLLGQP 236
           E+I         Y    DIWS G    E+  G P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 97
           +G G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 98  FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           +   +     L LVLE     +V  ++K      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
            + HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 216 T----AAIDIWSAGCVLAELLLGQP 236
                A  D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 50/301 (16%)

Query: 46  GSFGVVFQAKCLETGEAV---AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           GS G VF   C + G+      I K +   +   RE+  ++ + H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 162
               + + V   +P+    +  +  +    +PL        ++  ALAY+H   G+ HRD
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGR-GIIHRD 210

Query: 163 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTA 217
           +K +N+ ++   + + L DFG+A  L       +  C  +       +PEL+     Y A
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 218 AIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---- 272
             DIWSAG VL E+ +    LF  +         +K   +  R  I+CM  +  EF    
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVHPLEFPQNG 317

Query: 273 ---------KFPQIKAHPWH--KIFQKRMPPEAVD-LVSRLLQYSPNLRSTALEALIHPF 320
                    ++  +   P+    + +K      V+ L++++L +    R +A + L  P 
Sbjct: 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377

Query: 321 F 321
           F
Sbjct: 378 F 378

Length = 392

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 50/286 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
              T+     L +++EY+             + +  P     +     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 214
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y +  DIWS G    EL  G+P                    P  +    M+P    F  
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PNSD----MHPMRVLFLI 213

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           P+         F K       + +   L   P+ R TA E L H F
Sbjct: 214 PKNNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
             +G G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-- 153
                 +K  +Y+  V+E VP     ++    K   R+ +  +          + Y+   
Sbjct: 58  -IGVCVQKQPIYI--VMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------AP 206
           N I   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 207 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 242
           E L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 52/244 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 96
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 97  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------------------- 194
            +G  HRDIKP NLL++   H +KL DFG    L K                        
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 195 ----------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
                            S + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 239 PGES 242
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 48/293 (16%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 97
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 98  FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 128

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 210
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 211 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
                  Y    D+WS G    E+  G P       +  L  I +             NP
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------NP 232

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                  P++K+  W K FQ          +   L  + + R T  + + HPF
Sbjct: 233 A------PRLKSKKWSKKFQS--------FIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 50/286 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLGG------GSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 214
             + HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y +  DIWS G    EL  G+P                    P  E    ++P    F  
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PHSE----LHPMKVLFLI 213

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           P+         + K +     + V   L   P+ R TA E L H F
Sbjct: 214 PKNNPPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 57/248 (22%)

Query: 43  VGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKN-----RELQTMRLL-DHPNVV 91
           +G G+FG V +A+ +          VA+K +  D   K+      E++ M+++  H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYF-- 142
           +L       T++  LY+  V+EY             R    +       P     L    
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-TLTQKD 133

Query: 143 -----YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
                YQ+ R + ++ +   + HRD+  +N+LV    H +K+ DFG A+       +I +
Sbjct: 134 LVSFAYQVARGMEFLASKKCI-HRDLAARNVLVT-EDHVMKIADFGLAR-------DIHH 184

Query: 198 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 244
           I   YYR            APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 240

Query: 245 DQLVEIIK 252
           ++L +++K
Sbjct: 241 EELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 65/297 (21%)

Query: 40  ERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 89
            R +G GSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR---------MPLIYVKL 140
           VV L      +T +  L   +V+E + +   +     Y  S+R          P    K 
Sbjct: 71  VVRLLG--VVSTGQPTL---VVMELMAKGDLK----SYLRSRRPEAENNPGLGPPTLQKF 121

Query: 141 YFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
                +I   +AY+       HRD+  +N +V      +K+ DFG  +       +I   
Sbjct: 122 IQMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE- 171

Query: 199 CSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
            + YYR            APE +     +T   D+WS G VL E+  L +  + G S  +
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E 228

Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 302
           ++++ +   G     E  C +      +        W   +  +M P  +++VS L 
Sbjct: 229 EVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)

Query: 41  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     S+       + L+ + +P    +  V  H   +  +  L +      QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV----QIAKGM 122

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
           +Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
           E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.2 bits (141), Expect = 9e-10
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 37/228 (16%)

Query: 43  VGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 94
           +G GSFGVV + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 95  HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
               +        L +V E  P     + + +    H+       +  +  Y  QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGHF------LISTLCDYAVQIANGM 110

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 204
            Y+ +   + HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +     
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166

Query: 205 -APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 250
            APE +   T ++ A D+W  G  L E+   G+  + G SG   L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.4 bits (141), Expect = 9e-10
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 91
           E+V+G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     T  K  +   +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMK 120

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 67/221 (30%)

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             QI  AL  +H+T G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   
Sbjct: 261 MRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKE 316

Query: 202 Y-----YRAPELIFGATEYTAA---------------------IDIWSAGCVLAELLLGQ 235
           +     Y APE    +T+  +A                      DI+SAG     L+  Q
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQ 371

Query: 236 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP--- 292
             FP       L++           ++K  + +             W K+ + R  P   
Sbjct: 372 MAFPNLRSDSNLIQF--------NRQLKRNDYDLVA----------WRKLVEPRASPDLR 413

Query: 293 ---EAVD--------LVSRLLQYSPNLRSTALEALIHPFFD 322
              E +D        L+  ++++    R +A  AL HP+FD
Sbjct: 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 66/242 (27%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIK--------KVLQDKRYKNR 77
           P   + ++ E  +G G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ----- 131
           E + M  L HPN+V    C      K++    L  EY+    +H  +  +   S      
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 132 -----RMPLIYVKLY--FYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 182
                +  L          QI   + Y+  H+     HRD+  +N LV      +K+ DF
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISDF 168

Query: 183 GSAKVLVKGEPNISYICSRYYR------------APELI-FGATEYTAAIDIWSAGCVLA 229
           G ++ +   +         YYR             PE I +G  ++T   DIWS G VL 
Sbjct: 169 GLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLW 217

Query: 230 EL 231
           E+
Sbjct: 218 EI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 72/296 (24%), Positives = 113/296 (38%), Gaps = 70/296 (23%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG V++     T E VAIK + L++   +     +E+  +   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
              T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 214
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y    DIWS G    EL  G+P                                      
Sbjct: 178 YDFKADIWSLGITAIELAKGEP-------------------------------------- 199

Query: 275 PQIKAHPWHKIF--QKRMPPEA--------VDLVSRLLQYSPNLRSTALEALIHPF 320
           P    HP   +F   K  PP           + V   L   P  R TA E L H F
Sbjct: 200 PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 44/229 (19%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 87
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYV-----------PETVHRVIKHHYKMSQRMPLI 136
             +V L   +   +E++ +Y+  V EY+            E     +     M+      
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA----- 110

Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
                  QI   +AY+ +     HRD+  +N+LV  +    K+ DFG A+++   E   +
Sbjct: 111 -------QIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTA 160

Query: 197 YICSRY---YRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
              +++   + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 19/161 (11%)

Query: 46  GSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKHCFF 98
           G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L   ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71

Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           S    + +YL  V+EY+     + + H Y    + M + Y+     ++  AL Y+H   G
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-G 124

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 32/229 (13%)

Query: 35  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 91
           +++M E  +G G FGVV   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L   +   T++  LY+  V E++     ++ + +   K+S+ M L   +     +C  +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YY 203
            Y+       HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 251
             PE +F  ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 42  VVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 91
            +G G FG VF AK      E GE + + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYV-KLYF-YQI 145
            L        E +  Y  ++LEY      +   R  K   +  +  PL    K+    QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
              + ++ N   V HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 205 ----------APELIFGATEYTAAIDIWSAGCVLAEL 231
                     APE +    +++   D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 60/235 (25%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRL---LDHPNVVSL 93
           R++G G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK-----------HHYKMSQRMPLIYVKLY 141
              +   ++ D +Y    + Y+   T+  ++K              K S       V  +
Sbjct: 68  ---YSICSDGDPVYYT--MPYIEGYTLKSLLKSVWQKESLSKELAEKTS-------VGAF 115

Query: 142 ---FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV----------L 188
              F++IC  + Y+H+  GV HRD+KP N+L+      + L D+G+A            +
Sbjct: 116 LSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDI 173

Query: 189 VKGEPNISY---------ICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELL 232
              E NI Y         + +  Y APE + G  A+E T   DI++ G +L ++L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 256
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             +E  +   P+YT  +  Q     WH    +R  P   +LV  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 16/95 (16%)

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 203
           Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 204 --------RAPELIFGATEYTAAIDIWSAGCVLAE 230
                    APE++ G   YT ++DIWSAG V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 15/168 (8%)

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 256
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQ 303
             ++  +   P     +  +I    W    ++R      V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 56/244 (22%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKC--LETGEA---VAIKKVLQD------KRYKNREL 79
            + TI     R +G G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 80  QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-------YKMSQ 131
           + +    H N+V         TE D     +V EY+    +++ ++ H            
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 132 RM-PLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
            M  L   +L     QI   + Y+ +   V HRD+  +N LV  +   +K+ DFG ++ +
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV 172

Query: 189 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELLL--G 234
                   Y    YYR             PE I     +T   D+WS G VL E+     
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222

Query: 235 QPLF 238
           QP +
Sbjct: 223 QPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++V+G G FG VF+      G    AVAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     T  K  +   ++ EY+    + + ++ H        L+ +      I   + 
Sbjct: 70  RLEGVV--TKFKPAM---IITEYMENGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMK 121

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 122 YLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTA 178

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G V+ E++
Sbjct: 179 PEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 38/227 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 97
           R +G G FG V++     T   VA+K +            E Q M+ L HP ++ L   +
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67

Query: 98  FSTTEKDELYL-------NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
              T ++ +Y+         +LEY+     R +    K+ Q   LI +     Q+   +A
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQ---LIDMAA---QVASGMA 117

Query: 151 YI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           Y+   N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 249
           PE       ++   D+WS G +L E++  G+  +PG +   V Q V+
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 95
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHY------KMSQRMPLIYVKLYFYQICRAL 149
            F   +  + +Y+      + E + +     +      ++     LI +     Q+   +
Sbjct: 68  -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMA---CQVAEGM 117

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSRYYR 204
           AY+       HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + 
Sbjct: 118 AYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWT 171

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 240
           APE       ++   D+WS G +L E+   GQ  +PG
Sbjct: 172 APEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 29/208 (13%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 91
           E+V+G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + ++ EY+   ++ + ++ +    +      V +    I   + 
Sbjct: 69  RLEGVVTKSRP-----VMIITEYMENGSLDKFLREN--DGKFTVGQLVGM-LRGIASGMK 120

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 204
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+  
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-T 175

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE I    ++T+A D+WS G V+ E++
Sbjct: 176 APEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 55/241 (22%)

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L     S   +D ++L  VL++        +  H      +P   VK +  ++  
Sbjct: 45  PNMVCLHKYIVS---EDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAP 206
           AL  +H    VC RD+ P N+L++   H ++L  F       + E +         Y AP
Sbjct: 97  ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYCAP 151

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCM 265
           E + G +E T A D WS G +L ELL G+ L     SG++                    
Sbjct: 152 E-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------------------- 191

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-----HPF 320
              +T    P+             +  EA  L+ +LLQ++P  R  A  A +     HPF
Sbjct: 192 ---HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Query: 321 F 321
           F
Sbjct: 237 F 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 54/242 (22%)

Query: 41  RVVGHGSFGVVFQAKCLE-----TGEA-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 89
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 90  VVS-LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF---Y 143
           +V  L  C       +  Y  +++E +   + +   ++         PL+ +K       
Sbjct: 61  IVKLLGVCL----LNEPQY--IIMELMEGGDLLS-YLRDARVERFGPPLLTLKELLDICL 113

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYIC 199
            + +   Y+     + HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 114 DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 200 SRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
           S YYR            APE L+ G   +T   D+WS G ++ E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 246 QL 247
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 23/202 (11%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 94
           +G G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFY--QICRALAY 151
           + F + T+     L LV+  +     R   H Y + +  P     +  FY  QI   L +
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 210
           +H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ 
Sbjct: 113 LHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 211 GATEYTAAIDIWSAGCVLAELL 232
           G  EY  ++D ++ G  L E++
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 30/201 (14%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G FGVV   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 100 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            T++  ++  +V EY+         R  K        + +         +C A+ Y+ + 
Sbjct: 68  CTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SDVCEAMEYLESN 119

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 210
            G  HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 211 GATEYTAAIDIWSAGCVLAEL 231
             + +++  D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 41  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E    +   +           +  +  QI + 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----------LLNWCVQIAKG 121

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+     V HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 122 MNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 180 LESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 41/281 (14%)

Query: 41  RVVGHGSFGVVFQAKCLETGEA---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 92
           RV+G G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 151
           L           E    +VL Y+    H  +++  +     P +   + F  Q+ + + Y
Sbjct: 61  L----LGICLPSEGSPLVVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--I 209
           + +   V HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L   
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167

Query: 210 FGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           + A E      +T   D+WS G +L EL+  G P +P     D  V +++  G    +  
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225

Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 303
            C +P Y      ++    WH   +  M P   +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWHP--KPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 41  RVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 89
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 148
           +V+L     + T    + +  + EY       ++    +  +    +   L F YQ+ + 
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           +A++ +   + HRD+  +N+L+  H   +K+CDFG A+ ++     +    +R    + A
Sbjct: 154 MAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           PE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 212 PESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 73/300 (24%), Positives = 132/300 (44%), Gaps = 55/300 (18%)

Query: 43  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 89
           +G G FG V  A+ L       +    VA+K +  D   K+      E++ M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---------IKHHYKMSQ--RMPLIYV 138
           +++L     + T+   LY+  ++EY  +   R          +++ Y +++     + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 139 KLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
            L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNID 191

Query: 197 YICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 249

Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPN 307
           +++K  G    +   C N  Y   +        WH I   R    + V+ + R+L  + N
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 96
           ++G G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 97  FFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
               T++  +Y  +V+E VP     +  R  K   K  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAP 206
            +     HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + AP
Sbjct: 110 ESK-NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAP 163

Query: 207 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           E L +G   Y++  D+WS G +L E   LG   +PG
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 19/108 (17%)

Query: 143 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 193
            Q+ + + ++   N I   HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 219 SQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 50/237 (21%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 80
           P+  I Y   R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 81  TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 128
            M   DHPN+V L          C    + +  + +E   +          H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 129 MSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 186
               +PL   +      Q+   +AY+     V HRD+  +N LV  +   +K+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 187 VLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVLAEL 231
                  NI    + YY+A            PE IF    YT   D+W+ G VL E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 54/290 (18%)

Query: 41  RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 91
           R++G G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ------RMPLIYVKLYFYQI 145
            L      +  K  L + +V+  +P   H  +     MS+       +PL  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYY 203
              + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YY
Sbjct: 123 ASGMEYLSSK-NFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YY 169

Query: 204 R---APELIFG--ATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEII 251
           R   A +L     A E      YT   D+W+ G  + E++  GQ  + G    +    +I
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229

Query: 252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           K  G   ++   C+   Y      ++    W    + R  P    L  +L
Sbjct: 230 K--GNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 26/199 (13%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 100 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            T++  +Y  +V EY+         R     ++ SQ + +         +C  +AY+ + 
Sbjct: 68  CTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEMC------KDVCEGMAYLESK 119

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 212
               HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   
Sbjct: 120 -QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175

Query: 213 TEYTAAIDIWSAGCVLAEL 231
           +++++  D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            L     S T      + LV + +P     + VH   +H   +  ++ L +      QI 
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWC----VQIA 119

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---Y 203
           + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    +
Sbjct: 120 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 236
            A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 178 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 49/238 (20%)

Query: 41  RVVGHGSFGVVFQAKCLE-TGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNV 90
           + +G G FG V +A      G A    VA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL---------- 140
           + L   + + ++   L L  ++EY     +  ++   + S+++   Y+            
Sbjct: 66  IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 141 --------------YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 186
                         + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 187 VLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
            + + +  +     R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 99
           +G G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 100 TTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             + + LY  +V EY+      + +    +    ++Q++       +   +C  + Y+  
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQL------GFALDVCEGMEYLEE 120

Query: 155 TIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 209
                HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +
Sbjct: 121 K-NFVHRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171

Query: 210 FGATEYTAAIDIWSAGCVLAEL 231
               +++   D+WS G +L E+
Sbjct: 172 -REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 22/168 (13%)

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K +P+  Y+  
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK-DPD--YVRK 232

Query: 201 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 253
              R      APE IF    YT   D+WS G +L E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                +E  +   P Y   +   I    WH   + R  P   +LV  L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 81/348 (23%), Positives = 135/348 (38%), Gaps = 87/348 (25%)

Query: 42  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 93
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           +  F +  E     L +V  ++     + +I  H+     M  + +      + +AL YI
Sbjct: 65  RATFIADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYI 117

Query: 153 HNTIGVCHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGE 192
           H+ +G  HR +K  ++L++                  H  +L++  DF   S KVL    
Sbjct: 118 HH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL---- 172

Query: 193 PNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
           P +S         PE++    + Y A  DI+S G    EL  G   F        L+E  
Sbjct: 173 PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-- 221

Query: 252 KVLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHKI 285
           K+ GT                  P+R        E      P  +     +  +HP+++ 
Sbjct: 222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRT 278

Query: 286 FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL-RDPNTRLP 332
           F     P     V + LQ +P+ R +A   L H FF ++ R  +  LP
Sbjct: 279 FS----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 143 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 193
           YQ+ + ++++   N I   HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 221 YQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 42  VVGHGSFGVVFQAKCLETG----EAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 92
           ++  G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 93  LKHCFFSTTEKDELYL------NLVL-----EYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           + H      E   +        NL L             + +      S +  L+++ + 
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL------STQQ-LVHMAI- 124

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 199
             QI   ++Y+H   GV H+DI  +N +++    Q+K+ D   ++ L   +    Y C  
Sbjct: 125 --QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLG 176

Query: 200 ---SRYYR--APELIFGATEYTAAIDIWSAGCVLAELL-LGQ 235
              +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 7/116 (6%)

Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
            S+ +  + +  + YQ+ R + ++ +   V HRD+  +N+L+      +K+CDFG A+ +
Sbjct: 230 GSEGLTTLDLLSFTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDI 287

Query: 189 VKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           +     +S         + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 21/152 (13%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 93
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              ++S  +KD LY   V++Y+P  + +  +I+         P    + Y  ++  A+  
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGI-----FPEDLARFYIAELTCAVES 116

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 183
           +H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 93
           +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F+  TE    Y NL L+Y+ E             Q +  + +     QI  A+ Y+ 
Sbjct: 74  EPPFYIITEF-MTYGNL-LDYLREC----------NRQEVNAVVLLYMATQISSAMEYLE 121

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 210
                 HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 122 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL- 177

Query: 211 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 240
              +++   D+W+ G +L E+   G   +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 92
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 93  --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
             L  C  ST +       LV + +P     ++ +  +   R+    +  +  QI + ++
Sbjct: 73  RLLGICLTSTVQ-------LVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 207
           Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 124 YLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            I     +T   D+WS G  + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           E V+G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALA 150
            L+     T  +  + +   +E      +  +    + +  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 204
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + 
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE I    ++T+A D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 35/224 (15%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 87
           P++T+     + +G G FG V+          VAIK + Q          E   M+ L H
Sbjct: 4   PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQI 145
           P +V L    ++   ++ +Y+  + EY+    +  +    K  + + L   KL     QI
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 146 CRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 201
              +A+I   N I   HRD++  N+LV+  T   K+ DFG A+++   E    Y      
Sbjct: 112 AEGMAFIERKNYI---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGA 163

Query: 202 ----YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                + APE I   T +T   D+WS G +L E++  G+  +PG
Sbjct: 164 KFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 41  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 92
           + +G G FG V + +  +       AV   K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-------MPLIYVKLYFYQI 145
           L      T E +     +V+  +P   H  + H + +  R       +P   +  +   I
Sbjct: 65  LIGVCLQTVESEGYPSPVVI--LPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
              + Y+ ++    HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + 
Sbjct: 122 ASGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKM 176

Query: 206 PELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPG 240
           P + + A E      YT   D+WS G  + E+   GQ  +PG
Sbjct: 177 P-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 43  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 89
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP----------LIYVK 139
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P          L   +
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLR----EYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 140 LYF-------YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           L F       YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +  
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDV 184

Query: 193 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 244
            NI Y            + APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 242

Query: 245 DQLVEIIK 252
           ++L +++K
Sbjct: 243 EELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 73/309 (23%)

Query: 43  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 89
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------L 135
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P               
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLR----EYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 136 IYVKLYF---YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           +  K      YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG A+      
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR------ 188

Query: 193 PNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 239
            +I +I   YY+            APE +F    YT   D+WS G +L E+  LG   +P
Sbjct: 189 -DIHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 240 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLV 298
           G   V++L +++K  G    +   C N  Y   +        WH +  +R    + V+ +
Sbjct: 245 GVP-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 296

Query: 299 SRLLQYSPN 307
            R+L  + N
Sbjct: 297 DRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 78/331 (23%), Positives = 137/331 (41%), Gaps = 85/331 (25%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQ 80
            ++ I+ + E  +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLI 136
            M+     +VV L         K +  L +V+E +     ++  R ++   + +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 137 YVKLYFY---QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 194 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLGQPLFP 239
                   YYR            APE +     +T + D+WS G VL E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 240 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 299
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 300 RLLQYSPNLRSTALEAL------IHPFFDEL 324
              Q++P +R T LE +      +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 135 LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           L Y+ L  + YQ+   + ++ +   V HRD+  +N+L+      +K+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 193 PNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             IS         + APE IF    YT   D+WS G +L E+  LG   +P     +Q  
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLL 302
             IK          +   P +   +  +I    W + F+ R    + V LV  LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 46/192 (23%)

Query: 64  AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 114
           A     +D     +E++ +  L  PN+  L               E  E   LN  L ++
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113

Query: 115 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNP 172
           V ET    +  + K      L+Y+     QI   + Y+   N +   HRD+  +N LV  
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK 165

Query: 173 HTHQLKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTAAID 220
             + +K+ DFG ++ L        Y    YY    RAP        E +    ++T   D
Sbjct: 166 -NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSD 214

Query: 221 IWSAGCVLAELL 232
           +W+ G  L E+L
Sbjct: 215 VWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 48/231 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 90
           +++G G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM-------PLIYVKLYFY 143
           + L    F  +   ++   +V+  +P   H  + H + +  R+       PL  +  +  
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVI--LPFMKHGDL-HSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSR 201
            I   + Y+ N     HRD+  +N ++      + +C  DFG +K +  G+         
Sbjct: 121 DIALGMEYLSNR-NFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD--------- 167

Query: 202 YYRAPELI-----FGATE------YTAAIDIWSAGCVLAELL-LGQPLFPG 240
           YYR   +      + A E      YT+  D+W+ G  + E+   GQ  +PG
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 11/186 (5%)

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSR 201
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPT 258
              +PE++ G   Y    DIWS G +L ++L       G+ G     QL++II  L    
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391

Query: 259 RE--EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL-VSRLLQYSPNLRSTALEA 315
            E  +  C   +Y +        H    + +    P   +  + ++L +  +LR  A E 
Sbjct: 392 EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451

Query: 316 LIHPFF 321
           L  P F
Sbjct: 452 LALPLF 457

Length = 501

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 43  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLLD-HPN 89
           +G G FG V +A+         +    VA+K +  +   K+      E++ M+L+  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------- 134
           +++L       T++  LY+  ++EY  +   R     +  ++R P               
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLR----EFLRARRPPGPDYTFDITKVPEEQ 130

Query: 135 LIYVKLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           L +  L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +G 
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGV 184

Query: 193 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 244
            +I Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-V 242

Query: 245 DQLVEIIK 252
           ++L ++++
Sbjct: 243 EELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 43/196 (21%)

Query: 63  VAIKKVLQD--KRYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 117
           VA+K +  D  K  +N   +E++ M  L +PN++ L     S        L ++ EY+  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101

Query: 118 ------TVHRVIKHHYKMSQRMPLIYVKLYFY---QICRALAYIHNTIGVCHRDIKPQNL 168
                    R I+  +  +  +P + +    Y   QI   + Y+  ++   HRD+  +N 
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNC 160

Query: 169 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------------APELIFGATEYT 216
           LV  H + +K+ DFG ++ L  G+         YYR            A E I    ++T
Sbjct: 161 LVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKFT 209

Query: 217 AAIDIWSAGCVLAELL 232
            A D+W+ G  L E+ 
Sbjct: 210 TASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 128 KMSQRMP-----LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 182
           K+   MP     +  +K    Q+   L  +H  IG+ HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 183 GSAKVLVKG---EPNISYICSRYYRAPELI 209
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 99
           ++G G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 100 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 159
                   L +V+E + +  + V     +    + +I +  +   +   + Y+ +   + 
Sbjct: 71  NG------LYIVMELMSKG-NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122

Query: 160 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 219
           HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +    ++++  
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178

Query: 220 DIWSAGCVLAELL-LGQPLFP 239
           D+WS G +L E+   G+  +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 91
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 92  SLKH-CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ++       L LV +  P    +  V +H   +  +  L +      QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC----VQIAKG 121

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYR 204
           + Y+     + HR++  +N+L+   +  +++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
              ++FG   YT   D+WS G  + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 61/291 (20%), Positives = 102/291 (35%), Gaps = 57/291 (19%)

Query: 41  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           R +GHG+FG V++              VA+K + +    ++      E   M   +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V        + E+   +  ++LE +     +      +     P            R +A
Sbjct: 72  V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 151 ----YIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYR 204
               Y+       HRDI  +N L+         K+ DFG A+ + +         + YYR
Sbjct: 127 KGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASYYR 176

Query: 205 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVEI 250
                       P   F    +T+  D+WS G +L E+  LG   +PG +   V + V  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236

Query: 251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
              L  P      C  P Y      +I    W    + R  P    ++ R+
Sbjct: 237 GGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 43  VGHGSFGVVFQAKCL-------ETGEAV-AIKKVLQDKRYK-NRELQTMRLLDHPNVVSL 93
           +G G+FG VF A+C        +   AV A+K+  +  R    RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH---------YKMSQRMPLIYVKLYFY 143
              F+    +    L +V EY+    ++R ++ H          +      L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 144 --QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             QI   + Y+  ++   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 202 YYRA------------PELIFGATEYTAAIDIWSAGCVLAELL 232
           YYR             PE I    ++T   DIWS G VL E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 34/207 (16%)

Query: 43  VGHGSFGVVFQA--KCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 95  HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                  E + L   LV+E      +++ +         + +  V    +Q+   + Y+ 
Sbjct: 61  ---IGVCEAEALM--LVMEMASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLE 112

Query: 154 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-------YRA 205
               V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + A
Sbjct: 113 GKNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYA 166

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++++  D+WS G  + E  
Sbjct: 167 PECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 28/201 (13%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59

Query: 98  FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              T+K  +Y  +V+E V      T  R      K+ + + ++            + Y+ 
Sbjct: 60  GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQMV------ENAAAGMEYLE 111

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LI 209
           +   + HRD+  +N LV    + LK+ DFG ++    G    +    +    + APE L 
Sbjct: 112 SKHCI-HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 210 FGATEYTAAIDIWSAGCVLAE 230
           +G   Y++  D+WS G +L E
Sbjct: 170 YG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 203
           QI   + Y+ +++   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 204 R------------APELIFGATEYTAAIDIWSAGCVLAELLL---GQPLFPGESGVDQLV 248
           R            A E I    ++T A D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 249 E 249
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 91
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHH------YKMSQRMPLIYV 138
           +L        E    YL L +EY P           RV++           +  +    +
Sbjct: 72  NL----LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 195
             +   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 127 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 182

Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 183 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 51/225 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 91
           E V+G G+FG V +A   + G  +  AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 92  SL-KHCFFSTTEKDELYLNLVLEYVP--------------ETVHRVIKHH---YKMSQRM 133
           +L   C      ++  YL + +EY P              ET     K H     ++ + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
            L +       +   + Y+     + HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LLQFAS----DVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 194 NISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL 232
              Y+     R P + + A E      YT   D+WS G +L E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVS 92
           S    + +G+G FG V+        + VA+K +            E Q M+ L H  +V 
Sbjct: 7   SLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L    ++   ++ +Y+  V EY+ + ++   +K     + ++P + V +   Q+   +AY
Sbjct: 66  L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMA-AQVAAGMAY 117

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 208
           I   +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE 
Sbjct: 118 IER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 174

Query: 209 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 240
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 37/214 (17%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 100 TTEKDELYLNLVLEYVPE-TVHRVIKH----HYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              ++ +Y+  V E++ + ++   +K     + K+ Q + +        QI   +AYI  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA------QIADGMAYIER 120

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL 208
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE 
Sbjct: 121 -MNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174

Query: 209 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 240
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 44/249 (17%)

Query: 34  TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMR 83
           T+ +M E  +G   FG V++         E  +AVAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 84  L-LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHR--VIKHHYK----------- 128
             L HPN+V    C      K++  L+++  Y   + +H   V++  +            
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
            S   P  +V +   QI   + ++ ++  V H+D+  +N+LV    + +K+ D G  + +
Sbjct: 118 KSTLEPADFVHI-VTQIAAGMEFL-SSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREV 174

Query: 189 VKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 243
              +       S +  R+     +++G  +++   DIWS G VL E+   G   + G S 
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Query: 244 VDQLVEIIK 252
            D ++E+I+
Sbjct: 233 QD-VIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	373
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.82
smart00090	237	RIO RIO-like kinase.	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
COG4248	637	Uncharacterized protein with protein kinase and he	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.99
PRK09902	216	hypothetical protein; Provisional	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.79
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.18
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.03
PLN02876	822	acyl-CoA dehydrogenase	97.99
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.92
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.86
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.86
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.84
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.81
KOG2270	520	consensus Serine/threonine protein kinase involved	97.76
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.75
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.63
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.61
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.61
PRK10593	297	hypothetical protein; Provisional	97.58
PRK05231	319	homoserine kinase; Provisional	97.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.47
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.4
PLN02236	344	choline kinase	97.3
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.24
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.11
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.98
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.89
PRK12396	409	5-methylribose kinase; Reviewed	96.86
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.57
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.55
PLN02756	418	S-methyl-5-thioribose kinase	96.53
PTZ00384	383	choline kinase; Provisional	96.43
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.18
PRK11768	325	serine/threonine protein kinase; Provisional	95.37
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.29
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.17
PRK10271	188	thiK thiamine kinase; Provisional	93.98
PTZ00296	442	choline kinase; Provisional	93.87
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.62
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	93.36

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-70  Score=477.93  Aligned_cols=351  Identities=73%  Similarity=1.175  Sum_probs=329.8

Q ss_pred             CCceEEecccCCCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecce
Q 017341           16 AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH   95 (373)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   95 (373)
                      .+.+..+...|..+.......|.-.+++|+|+||.||++....+++.||||++..+.+...+|+++|+.++|||||++..
T Consensus         5 ~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~   84 (364)
T KOG0658|consen    5 SGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLY   84 (364)
T ss_pred             ceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEE
Confidence            34555666677777777888999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC
Q 017341           96 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  175 (373)
Q Consensus        96 ~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  175 (373)
                      +|+...+.+..++.+||||++.+|.+.+++....+..++.-.++-+..||++||+|||+. |||||||||.|+|+|.+.+
T Consensus        85 ~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg  163 (364)
T KOG0658|consen   85 FFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTG  163 (364)
T ss_pred             EEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCC
Confidence            988777666788999999999999999998777778899999999999999999999997 9999999999999999988


Q ss_pred             ceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      .+||||||.|+....+++..++.+|.+|+|||.+.+...|+.+.||||.||+++||+.|++.|+|.+..+++.+|++.+|
T Consensus       164 ~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  164 VLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             eEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR  335 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~  335 (373)
                      .|+.+++.++++++.+..+|++...+|...+....++++.+|+.++|+++|.+|.++.|++.||||+++++++.+++++.
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~  323 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR  323 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence            99999999999999999999999999999888999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhcCCCCHHHHhhhchHHHHhhh
Q 017341          336 FLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC  368 (373)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (373)
                      ..|++++|+.. ..+...+....+.+++.+.+.
T Consensus       324 ~lp~lf~f~~~-e~~~~~~~~~~l~p~~~~~~~  355 (364)
T KOG0658|consen  324 PLPPLFNFKRA-ELGISPELVNVLIPEHLREQE  355 (364)
T ss_pred             cCCCccCchHH-HhccchHHHHhhccHhhhhhc
Confidence            99999999988 456778999999998887664

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.3e-61  Score=407.41  Aligned_cols=279  Identities=37%  Similarity=0.688  Sum_probs=250.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +.|+...++|+|+||+||+|++++||+.||||++..+..      ...||+++|++++|+|+|.++++|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            468899999999999999999999999999999965443      234899999999999999999999     666678


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++|+|||+.++++.+.++   ....+...++.++.|++.|+.|+|++ +++||||||+|||++.+| .+||||||+|+..
T Consensus        77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~g-vvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNG-VVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCC-cEEeccchhhHhh
Confidence            999999999988888876   36789999999999999999999999 999999999999999999 8999999999988


Q ss_pred             c-CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH--hhc
Q 017341          189 V-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCM  265 (373)
Q Consensus       189 ~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~  265 (373)
                      . .++....++.|.+|+|||.+.+...|+..+||||+||++.||++|.+.|+|.++.+++..|...+|...+...  -..
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            7 5566678899999999999999889999999999999999999999999999999999999999999888754  455


Q ss_pred             CcCcccccCCCcCCC-CccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      ++-|...++|..... ++...+ ++++..+.||+++||..||.+|++.+|+|.||||+++
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            778888888887664 444444 5788999999999999999999999999999999764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-60  Score=425.54  Aligned_cols=283  Identities=37%  Similarity=0.672  Sum_probs=253.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++|.+.++||.|.||.||+|+.+.+|+.||||++++.-.     ...||+..|++|+ ||||+++.+++.+    .+.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCc
Confidence            35699999999999999999999999999999999865432     2348999999998 9999999999843    222


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+|||||+.+|.++|+.+   +..+++..++.|+.||+.||+|+|.+ |+.|||+||+|||+..+. .|||+|||+|+
T Consensus        84 ~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~-~iKiaDFGLAR  158 (538)
T KOG0661|consen   84 ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGND-VIKIADFGLAR  158 (538)
T ss_pred             eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccc-eeEeccccccc
Confidence            79999999999999999987   58899999999999999999999998 999999999999999766 79999999999


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc-
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-  265 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-  265 (373)
                      ...+..+...++.|.+|+|||++.+...|+.+.|+||+|||++|+.+-++.|+|.++.+++.+|++.+|.|....+... 
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            9988888889999999999999998889999999999999999999999999999999999999999999998766542 


Q ss_pred             -CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 -NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                       ......+++|.....++...++. .++++.++|.+||.|||.+||||+++|+||||+...
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence             12334567777777777777754 999999999999999999999999999999998643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-59  Score=404.52  Aligned_cols=318  Identities=39%  Similarity=0.658  Sum_probs=269.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecc------cccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ...|...+.||.|+||.|+.+.++.||+.||||++..      ..+...+|+++|+.++|+||+.+.+++.......-.-
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            4467778999999999999999999999999999862      2344568999999999999999999986633333445


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+|+|+|+.+|.+.++..    +.+++..+..++.||++||.|+|+. +|+||||||+|++++.+. .+||+|||+|+.
T Consensus       101 vYiV~elMetDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c-~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELMETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADC-DLKICDFGLARY  174 (359)
T ss_pred             eEEehhHHhhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCC-CEEeccccceee
Confidence            8999999999999998863    5599999999999999999999998 999999999999999999 799999999998


Q ss_pred             ccC---CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          188 LVK---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       188 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ...   ......++.|.+|+|||++.....|+.+.||||+|||++||++|++.|+|.+...++..|...+|.|.++.+..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            754   23335678899999999998888899999999999999999999999999999999999999999999998877


Q ss_pred             cCcCc-c--cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCC
Q 017341          265 MNPNY-T--EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLF  341 (373)
Q Consensus       265 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~  341 (373)
                      +.... .  -.++|..+..++...|+ +.++.+.+|+.+||.+||.+|+|++|+|.|||+..+.+++.......   ...
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~---~~~  330 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP---IFD  330 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC---CCc
Confidence            65221 1  12678888889999995 89999999999999999999999999999999999998865432221   111


Q ss_pred             CCChhhcCCCCHHHHhhhchHHHH
Q 017341          342 NFKPHELKGVPVDMLVKLIPEHAR  365 (373)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~  365 (373)
                      .   .+.. .+.+.++++++.+..
T Consensus       331 ~---~~~~-~~~~~~r~~i~~e~~  350 (359)
T KOG0660|consen  331 S---FEHE-LTEEELRELIYKEIL  350 (359)
T ss_pred             c---cccc-ccHHHHHHHHHHHHH
Confidence            1   3333 678888888887754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.7e-59  Score=387.17  Aligned_cols=280  Identities=39%  Similarity=0.722  Sum_probs=246.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+|...+.||+|.||.||+|++..||+.||||++....      ....||++.|+.++|+||+.++++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            57999999999999999999999999999999996542      2235899999999999999999999     555558


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      -+|+||++.+|...++..   ...++...++.|+.++++||+|||++ .|.||||||+|+|++++| .+||+|||+|+..
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            899999999999999875   46689999999999999999999998 999999999999999999 8999999999987


Q ss_pred             cCCCCccc-ccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 017341          189 VKGEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  266 (373)
Q Consensus       189 ~~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  266 (373)
                      .......+ .+.|.+|+|||.+++...|+..+|+||.|||+.||+.|.+.|+|.++.+++..|++.+|+|.++.|+.+. 
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            65544333 3789999999999999999999999999999999999999999999999999999999999999988663 


Q ss_pred             -cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                       ++|..++  ..+..+....| +..++++.||+.+||.+||.+|+|+.|+|+|+||+....+
T Consensus       232 lpdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  232 LPDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             cccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence             5665554  33334444455 4688899999999999999999999999999999985443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-58  Score=424.08  Aligned_cols=250  Identities=32%  Similarity=0.547  Sum_probs=225.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.       .....+|+++.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            4799999999999999999999999999999998653       23345899999999999999999999     88888


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|||+|+|. ++|..+++++    ++++|.+++.+++||+.||.|||++ +|+|||||..|+|++++. +|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcC-cEEecccceee
Confidence            999999999 6888777743    7899999999999999999999998 999999999999999998 79999999999


Q ss_pred             eccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..... +...+.+|||.|+|||++.. ..++..+||||+||+||.|+.|+|||...+-.+++.+|...            
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------  233 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------  233 (592)
T ss_pred             eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------
Confidence            88644 67789999999999999974 45899999999999999999999999999999999988763            


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                           ++.+|            ..+|.++++||.+||+.||.+|||++++|.|+||+.--
T Consensus       234 -----~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  234 -----EYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             -----Ccccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence                 33333            57899999999999999999999999999999995533

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-59  Score=412.52  Aligned_cols=258  Identities=34%  Similarity=0.516  Sum_probs=216.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----------cchHHHHHHHHhCCCCCeeecceeeeec
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      ...+.|.+.+.||+|+||.|-+|..+.||+.||||.+.+..           ....+|+++|+.|+|||||+++++|   
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---  245 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---  245 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee---
Confidence            34558999999999999999999999999999999986432           1124899999999999999999998   


Q ss_pred             CCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC---CCc
Q 017341          101 TEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH---THQ  176 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~---~~~  176 (373)
                        +...+.||||||++| .|.+.+-.+    +.+.+..-+.++.|++.|+.|||+. ||+||||||+|||+..+   . .
T Consensus       246 --~~~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~-l  317 (475)
T KOG0615|consen  246 --EVPDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDC-L  317 (475)
T ss_pred             --ecCCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcce-E
Confidence              455557999999995 777776654    6677888899999999999999998 99999999999999766   4 6


Q ss_pred             eeEeeccceeeccCCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHH
Q 017341          177 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKV  253 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~-~~~~i~~~  253 (373)
                      +||+|||+|+.........+.+|||.|.|||++.+.  ..+..++|+|||||++|-+++|.+||.+..... ...+|.+.
T Consensus       318 lKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G  397 (475)
T KOG0615|consen  318 LKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG  397 (475)
T ss_pred             EEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence            999999999998777777899999999999999643  334558899999999999999999999876554 45555442


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      -                 +        .+....+.++|.++++||++||..||++|||++++|+||||+...
T Consensus       398 ~-----------------y--------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 R-----------------Y--------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             c-----------------c--------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            1                 1        111123367999999999999999999999999999999999754

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-58  Score=392.34  Aligned_cols=291  Identities=33%  Similarity=0.554  Sum_probs=254.2

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc------hHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      +.......|+....|++|.||.||+|+++.|++.||+|+++-+...      ..||+.+|..++|||||.+.++.+-.. 
T Consensus        70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-  148 (419)
T KOG0663|consen   70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-  148 (419)
T ss_pred             cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc-
Confidence            3344566899999999999999999999999999999998755422      248999999999999999999875432 


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                        -..+|||||||+.+|..++....   +++...+++.++.|++.|++|||.+ .|+||||||+|+|++..| .+||+||
T Consensus       149 --~d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G-~lKiaDF  221 (419)
T KOG0663|consen  149 --MDKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKG-ILKIADF  221 (419)
T ss_pred             --cceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCC-cEEeccc
Confidence              22378999999999998888763   7899999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+|+.+.+... ....+.|.+|+|||++.+...|+++.|+||+|||+.||+++++.|+|....+++.+|++.+|.|++..
T Consensus       222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            99998765533 44567899999999999999999999999999999999999999999999999999999999999988


Q ss_pred             HhhcC--cCcccccCCCcCCCCccccccCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          262 IKCMN--PNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       262 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ++...  +.+..+.++..+...+...|... ++....+|++.+|.+||.+|.||+|+|+|+||.+...+
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence            77653  44445677777777777777655 67999999999999999999999999999999985443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-56  Score=427.25  Aligned_cols=332  Identities=52%  Similarity=0.967  Sum_probs=285.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecC---CCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT---EKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~l  110 (373)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++..+.....+|+.+++.++||||++++++++...   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            45799999999999999999999999999999998777666778999999999999999998875432   233457889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+++++.+.+.........+++..++.++.||+.||+|||++ ||+||||||+||+++.+++.+||+|||+|+....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            999999998888876655567899999999999999999999998 9999999999999997765799999999987655


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++.+.++.+..+.+..+.+.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55555678899999999987766689999999999999999999999999999999999999999999999888888888


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCC-CCCCCCCCCChhhcC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG-RFLPPLFNFKPHELK  349 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  349 (373)
                      ...++......+...++...++++.+||.+||++||.+|||+.|+|+||||+.++++....+.. ...|.+++|...+..
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            8888877767777777778899999999999999999999999999999999988765544432 345777888888887


Q ss_pred             CCCHHHHhhhchHHHHh
Q 017341          350 GVPVDMLVKLIPEHARK  366 (373)
Q Consensus       350 ~~~~~~~~~~~~~~~~~  366 (373)
                      .+..+....+.+....+
T Consensus       384 ~~~~~~~~~~~~~~~~~  400 (440)
T PTZ00036        384 EMSDACRRKIIPKCTYE  400 (440)
T ss_pred             hCCHHHHHHHhhHHHHH
Confidence            77777777766654443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-57  Score=396.24  Aligned_cols=256  Identities=32%  Similarity=0.518  Sum_probs=224.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .....|++.++||+|+||+||+|+.++|++.||+|++.+..       +....|..+|..++||+||+++..|     ++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence            44568999999999999999999999999999999986543       2334799999999999999999888     67


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+|+||+.| .|...|.+    .+.+++..++.++++|+.||.|||++ ||+||||||+|||+|.+| .++|+|||
T Consensus        97 ~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~G-Hi~LtDFg  170 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQG-HIKLTDFG  170 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCC-cEEEeccc
Confidence            7779999999996 77777765    47899999999999999999999998 999999999999999999 59999999


Q ss_pred             ceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +|+.... +....+.+||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+......+|.+.-.       
T Consensus       171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-------  242 (357)
T KOG0598|consen  171 LCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-------  242 (357)
T ss_pred             cchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-------
Confidence            9985544 3556678999999999999876 599999999999999999999999999999998888876310       


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCccccCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TALEALIHPFFDELRDP  327 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~~ll~hp~~~~~~~~  327 (373)
                                           ...+.-++.+++++|+++|+.||++|.    +++++.+||||++++|.
T Consensus       243 ---------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  243 ---------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence                                 011234899999999999999999996    68999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-57  Score=408.69  Aligned_cols=285  Identities=37%  Similarity=0.631  Sum_probs=243.9

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      +.....|+..++||+|.||.||+|++..||+.||+|++..+.      ....||+.+|++|+||||+++.+.....   .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~  189 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L  189 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence            355678999999999999999999999999999999997554      2335999999999999999999987653   3


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+|||+|||+.+|..++...   .-.|++.++++++.||+.||.|||++ ||.|||||.+|||||.+| .+||+|||+
T Consensus       190 ~~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G-~LKiaDFGL  264 (560)
T KOG0600|consen  190 SGSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNG-VLKIADFGL  264 (560)
T ss_pred             CceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCC-CEEeccccc
Confidence            4568999999999988888753   35699999999999999999999998 999999999999999998 899999999


Q ss_pred             eeeccCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          185 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       185 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      |+++....  .....+.|.+|+|||++.+...|+.++|+||+||||.||++|++.|++.++.+++..|.+..|.|++..|
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            99765443  3556788999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             hhcC-cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          263 KCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       263 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      .... |.+..+.-...-.+.+.+.| ..+++.+.+|+..||+.||.+|.||+++|+|+||..-
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            6221 22222222222233444444 5789999999999999999999999999999999543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-57  Score=395.50  Aligned_cols=257  Identities=31%  Similarity=0.549  Sum_probs=215.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +.+..+.||+|..|+||+|+|+.|++.+|+|++...     .+.+.+|+++++..+|||||+++++|+...   . -++|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~---~-~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG---E-EISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---c-eEEe
Confidence            788899999999999999999999999999999433     234468999999999999999999997633   2 3789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +||||+ |+|..+++..    ++++|..+..++.+|++||.|||+..+|+||||||+|||+++.| .|||||||.++...
T Consensus       156 ~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv  230 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV  230 (364)
T ss_pred             ehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence            999999 5888777764    77999999999999999999999634999999999999999998 89999999998876


Q ss_pred             CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE--SGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       190 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ++ ...+++||..|||||.+.+. .|+.++||||||+.+.||.+|+.||...  +....+..+......+++.       
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~-------  301 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR-------  301 (364)
T ss_pred             hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-------
Confidence            66 55688999999999999776 5999999999999999999999999875  1222233322222222211       


Q ss_pred             CcccccCCCcCCCCccccccC-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                        ++. .+|+++++||..||++||.+|+|+.|+++|||++....++
T Consensus       302 ------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  302 ------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             ------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                              123 3899999999999999999999999999999999876543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-56  Score=375.27  Aligned_cols=253  Identities=29%  Similarity=0.474  Sum_probs=225.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|++.+.||.|+||+|.+++++.+|..||+|.+.+..       ....+|..+|+.+.||++++++..+     .+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence            45579999999999999999999999999999999886543       2234799999999999999999888     77


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..++||||||++| .|..++++    .+++++..++.+++||+.||+|||+. +|++|||||+|||+|++| .+||+|||
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G-~iKitDFG  189 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNG-HIKITDFG  189 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCC-cEEEEecc
Confidence            7789999999995 77777775    47899999999999999999999988 999999999999999999 69999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .|+...  ....+.||||.|+|||+++.. .|+.++|+|||||++|||+.|.+||.+.+...++.+|++.          
T Consensus       190 FAK~v~--~rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~----------  256 (355)
T KOG0616|consen  190 FAKRVS--GRTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG----------  256 (355)
T ss_pred             ceEEec--CcEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC----------
Confidence            998763  337789999999999999765 5999999999999999999999999999999999999874          


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                             .+.            |++.+++++++||+++|+.|-.+|.     ...++.+||||+++.|.
T Consensus       257 -------~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  257 -------KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             -------ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence                   222            4467899999999999999999993     67899999999998874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-55  Score=400.38  Aligned_cols=255  Identities=32%  Similarity=0.581  Sum_probs=226.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhC-CCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|..++.||.|+|++|++|+++.+++.||||++.+.       ..+..+|-.+|.+| .||.|++++..|     +|.
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD~  146 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QDE  146 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ecc
Confidence            45899999999999999999999999999999987543       23445788999999 899999998888     667


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+|+|+||++ |+|+++|.+.    +.+++.-++.++.||+.||+|||++ |||||||||+|||+|.|+ .++|+|||.
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dm-hikITDFGs  220 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDG-HIKITDFGS  220 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCC-cEEEeeccc
Confidence            77999999999 7999999876    7799999999999999999999998 999999999999999999 699999999


Q ss_pred             eeeccCCCCc--------------ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 017341          185 AKVLVKGEPN--------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  250 (373)
Q Consensus       185 a~~~~~~~~~--------------~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i  250 (373)
                      |+.+......              .+++||..|.+||++.. ...+.++|+|+||||+|+|+.|.+||.+.++.-++++|
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            9876432111              45899999999999954 45899999999999999999999999999999999999


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      +..                 ++.            |++.+++.+++||+++|..||.+|+|+++|.+||||.+++|.+.
T Consensus       300 ~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  300 QAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             HHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            884                 222            34678999999999999999999999999999999999998763

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.1e-55  Score=396.68  Aligned_cols=271  Identities=33%  Similarity=0.529  Sum_probs=227.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|.+++.||+|+||.||+|+-+.||+.+|+|++.+..-       ....|..+|...++|+||+++..|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            45789999999999999999999999999999999876542       223588899999999999999988     788


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .++||||||++| ++..+|.+.    ..+++..++.++.+++.|+..+|+. |++||||||+|+|||..| .+||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~G-HiKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKG-HIKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCC-CEeeccccc
Confidence            889999999995 777777653    7899999999999999999999988 999999999999999999 599999999


Q ss_pred             eeeccC----------------------C-CC-----c--------------------ccccccccccccccccCCCCCC
Q 017341          185 AKVLVK----------------------G-EP-----N--------------------ISYICSRYYRAPELIFGATEYT  216 (373)
Q Consensus       185 a~~~~~----------------------~-~~-----~--------------------~~~~gt~~y~aPE~l~~~~~~~  216 (373)
                      |.....                      . ..     .                    .+.+|||.|||||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            853211                      0 00     0                    1357999999999998765 99


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHH
Q 017341          217 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD  296 (373)
Q Consensus       217 ~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ..+|+||||||||||+.|.+||.+.++.++..+|...-..               ..+|..          ..++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~----------~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEE----------VDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCc----------CcccHHHHH
Confidence            9999999999999999999999999999999999874211               122211          356799999


Q ss_pred             HHHhhcCcCCCCCCC---HHHHhcCCCccccCCCCCCCCCCCCCCCCC
Q 017341          297 LVSRLLQYSPNLRST---ALEALIHPFFDELRDPNTRLPNGRFLPPLF  341 (373)
Q Consensus       297 li~~~L~~dP~~R~t---~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~  341 (373)
                      ||.+||+ ||.+|..   ++|+.+||||++++|...+.....++|.+.
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~  468 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN  468 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence            9999999 9999985   899999999999999776655555655553

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.3e-54  Score=374.32  Aligned_cols=292  Identities=35%  Similarity=0.685  Sum_probs=247.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCC-eeecceeeeecC-CCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTT-EKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~-~~~~  105 (373)
                      ...|...++||+|.||+||+|+++.+|+.||+|++..+..      ...+|+.+++.++|+| |+.+++++.... .+..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4568888999999999999999999999999999975533      2358999999999999 999999986544 1334


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+++||||++.+|..++.........++...++.+++||+.||+|||++ +|+||||||+||+++++| .+||+|||+|
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G-~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSG-VLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCC-cEeeeccchH
Confidence            56899999999999999998754435677789999999999999999999 999999999999999988 8999999999


Q ss_pred             eecc-CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +... ........++|.+|+|||++.+...|+...||||+|||++||+++++.|++.++.+++..|.+.+|.|..+.|+.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            8654 333456678899999999999998899999999999999999999999999999999999999999999988765


Q ss_pred             cC--cCcccccCCCcC-CCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          265 MN--PNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       265 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      ..  +.|.. .++... ...+.... ++.+++..+++.+||+.+|.+|.|++.+|.||||.....+..
T Consensus       248 v~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  248 VSSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             ccccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence            43  34432 344444 23333333 456689999999999999999999999999999999866543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-54  Score=397.54  Aligned_cols=254  Identities=33%  Similarity=0.528  Sum_probs=230.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .+-|++++.||.|+.|.|.+|++..||+.+|||.+.+.       ...+++|+-+|+.+.|||+++++++|     ++..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence            45699999999999999999999999999999999766       35567999999999999999999999     6677


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|+|.||++ |.|.+++...    +++++..++++++||+.|+.|||.. +||||||||+|+|+|..+ +|||+|||.|
T Consensus        86 ~lylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~-nIKIADFGMA  159 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKN-NIKIADFGMA  159 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhccc-CEeeecccee
Confidence            7999999999 5888888765    7899999999999999999999987 999999999999999988 6999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .....+.-..+.||+|.|.|||++++.++.+.++||||.|||||.|+||+.||++.+-...+.++.+.            
T Consensus       160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G------------  227 (786)
T KOG0588|consen  160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG------------  227 (786)
T ss_pred             ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC------------
Confidence            87777777778999999999999999998899999999999999999999999988877777777663            


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                           .|.+|            .++|+++++||.+||..||++|+|.+|+++|||+......
T Consensus       228 -----~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  228 -----VFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             -----cccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence                 34444            5799999999999999999999999999999999987654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-53  Score=372.58  Aligned_cols=256  Identities=31%  Similarity=0.543  Sum_probs=221.8

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....++|.+.+.||+|+||+||+|+++.++..||||.+.+..      .....|+.+|+.++|||||.++++.     +.
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~   80 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----ED   80 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ec
Confidence            345678999999999999999999999999999999997653      2235799999999999999999998     55


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-C----Ccee
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-T----HQLK  178 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-~----~~ik  178 (373)
                      ..++|+|||||. |+|..++.++    +.+++..++.++.||+.||++||++ +|+||||||+|||++.. +    ..+|
T Consensus        81 ~~~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   81 DDFIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             CCeEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEE
Confidence            667999999999 6999999876    5799999999999999999999998 99999999999999764 2    2699


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |+|||+|+....+....+.+|+|.|||||++.. ..|+.++|+||+|+|+|+|++|++||...+..+.+..+.+..... 
T Consensus       156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~-  233 (429)
T KOG0595|consen  156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV-  233 (429)
T ss_pred             ecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc-
Confidence            999999999887777788999999999999964 459999999999999999999999999998888777555421111 


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                               ..++...++...+++...|+.+|..|.+..+-+.|+++..
T Consensus       234 -------------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  234 -------------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             -------------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                     1122456778889999999999999999999999999865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-53  Score=392.56  Aligned_cols=255  Identities=29%  Similarity=0.481  Sum_probs=220.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch-------HHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|+..++||+|+||+|+++..+.+++.||||.++++....       ..|.+++... +||+++.++.+|     +
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence            34568999999999999999999999999999999987764332       2466777666 599999999999     6


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...++|+||||+.|+.   |.. ......+++..++.|++.|+.||.|||++ ||+|||||.+|||+|.+| .+||+|||
T Consensus       440 T~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eG-h~kiADFG  513 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEG-HVKIADFG  513 (694)
T ss_pred             cCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccC-cEEecccc
Confidence            6777999999999764   222 22357899999999999999999999999 999999999999999999 69999999


Q ss_pred             ceeecc-CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +++... .+....+++|||.|||||++.+. .|+.++|+|||||+||||+.|..||.++++.+....|+.-         
T Consensus       514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------  583 (694)
T KOG0694|consen  514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------  583 (694)
T ss_pred             cccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Confidence            998776 55667889999999999999765 5999999999999999999999999999999999988762         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                              +..            ++..+|.++.++++++|..+|++|+.     ++++.+||||+.++|.
T Consensus       584 --------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  584 --------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             --------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence                    122            33568999999999999999999986     5899999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-52  Score=383.17  Aligned_cols=252  Identities=35%  Similarity=0.528  Sum_probs=219.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHhCC-CCCeeecceeeeecC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTT  101 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  101 (373)
                      ...++|.+++.||+|+||.|+.+.+..+|+.||+|.+.+.         .....+|+.+++.+. ||||+++++++.   
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence            4567899999999999999999999999999999966543         123347999999999 999999999983   


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-CCceeE
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKL  179 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~ikl  179 (373)
                        ....+|+|||||.| +|.+.+.+.    +++.|..++.+++|++.|++|||++ ||+||||||+||+++.+ + ++||
T Consensus        91 --t~~~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~-~~Kl  162 (370)
T KOG0583|consen   91 --TPTKIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEG-NLKL  162 (370)
T ss_pred             --cCCeEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCC-CEEE
Confidence              34448999999995 888888863    7789999999999999999999998 99999999999999998 6 8999


Q ss_pred             eeccceeec-cCCCCcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          180 CDFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       180 ~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      +|||++... .......+.+||+.|+|||++.+.. .-+.++||||+|+++|.|++|+.||...+....+..|.+.    
T Consensus       163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----  238 (370)
T KOG0583|consen  163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----  238 (370)
T ss_pred             eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC----
Confidence            999999877 3556667889999999999998766 4468999999999999999999999998877777776542    


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCC-ChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                   .+.+|            ..+ |+++.+||.+||..||.+|+|+.+++.||||+.
T Consensus       239 -------------~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 -------------EFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------------CccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                         22222            345 999999999999999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=364.71  Aligned_cols=253  Identities=31%  Similarity=0.523  Sum_probs=212.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..|.+.++||.|.||+||++.+..+|..+|.|.+.-+      ....-.|+.+|++|+|||||++++.-+.   ++...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            4799999999999999999999999999999988522      2233479999999999999999873322   344458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc--cCC--ceeecCCCCcEEEcCCCCceeEeecc
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--TIG--VCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~--~~~--ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      +|+||||+ |+|.+.+++..+..+.++|..+|.++.|++.||..||+  . .  |.||||||.||+++.+| .+||+|||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCC-ceeeccch
Confidence            89999999 79999999998888899999999999999999999998  3 4  89999999999999988 89999999


Q ss_pred             ceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +++...+... ..+.+|||+||+||.+.+. .|+.+|||||+||++|||+.-++||.+.+-.+...+|.++--.|.+   
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---  249 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---  249 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---
Confidence            9998755433 3467999999999999765 4999999999999999999999999999777777766654111111   


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                              +..+|.++..+|..|+..||..||+.     +|+++++.
T Consensus       250 ------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  250 ------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             ------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                                    13478899999999999999999986     55555543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.1e-52  Score=386.63  Aligned_cols=280  Identities=35%  Similarity=0.587  Sum_probs=231.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchH---HHHHHHHhCC-C-----CCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|.|.+.||+|.||.|.+|.+..|++.||||+++.......   .|+.+|..|+ |     -|+|+++++|+     ...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----ccc
Confidence            89999999999999999999999999999999987766554   5888888886 3     48999999994     445


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-CCceeEeeccce
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~ikl~Dfg~a  185 (373)
                      ++|||+|.++.+|.++++.+.-  ..++...++.++.||+.||.+||+. ||||+||||+|||+... ...|||+|||+|
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccc
Confidence            5999999999999999998753  5599999999999999999999988 99999999999999543 337999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +..  .....+++.+..|+|||++.+.+ |+.+.||||||||++||++|.+.|+|.++.++++.|++.+|.|+...+...
T Consensus       339 c~~--~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFE--SQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccc--CCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            865  33344888999999999999876 999999999999999999999999999999999999999999998766543


Q ss_pred             CcCcccccC------------------------------CC---c-CCCCccccccCCCChhHHHHHHhhcCcCCCCCCC
Q 017341          266 NPNYTEFKF------------------------------PQ---I-KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  311 (373)
Q Consensus       266 ~~~~~~~~~------------------------------~~---~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  311 (373)
                      ......+.-                              ..   . ....+.......-...+.|||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            221111100                              00   0 1122222232234467899999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 017341          312 ALEALIHPFFDELRD  326 (373)
Q Consensus       312 ~~~ll~hp~~~~~~~  326 (373)
                      +.++|+||||.....
T Consensus       496 p~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  496 PAQALNHPFLTGTSL  510 (586)
T ss_pred             HHHHhcCcccccccc
Confidence            999999999996544

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-54  Score=355.23  Aligned_cols=257  Identities=32%  Similarity=0.466  Sum_probs=220.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecc------cccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|.+.+.||+|.|+.|+++.+..||+.+|+|.+..      +.+..++|+.+-+.|+||||+++.+.+     ...
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~   82 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE   82 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence            345689999999999999999999999999999997743      234456899999999999999999987     677


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC--CCceeEeec
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDF  182 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~ikl~Df  182 (373)
                      .+.|+|+|+|.| +|...+-.+    .-++|..+.++++||++||.|+|.+ ||||||+||+|+++-+.  +.-+||+||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeeccc
Confidence            789999999997 554444433    3478999999999999999999999 99999999999999543  346999999


Q ss_pred             cceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      |+|.....+.......|||.|||||++... .|+..+|||+.|+|+|-|+.|.+||.+.+....+++|.+..        
T Consensus       158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~--------  228 (355)
T KOG0033|consen  158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA--------  228 (355)
T ss_pred             ceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc--------
Confidence            999988766667788999999999999655 49999999999999999999999999999888898888742        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                               +.++.        ..++++++++++|+++||..||.+|+|+.|+|+|||+.+-
T Consensus       229 ---------yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  229 ---------YDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ---------cCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                     22221        1236799999999999999999999999999999999763

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-50  Score=367.37  Aligned_cols=278  Identities=33%  Similarity=0.637  Sum_probs=229.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     ....+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~   77 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERC   77 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence            3567999999999999999999999999999999885432     2334799999999999999999987     44456


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++||||++++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+++.
T Consensus        78 ~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~  152 (288)
T cd07871          78 LTLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA  152 (288)
T ss_pred             EEEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEECcCcceee
Confidence            8899999999988887653   34578899999999999999999998 999999999999999888 899999999875


Q ss_pred             ccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..... ......+++.|+|||++.+...++.++|+||+||++|+|++|++||.+.+..+.+..+.+..+.+..+.++...
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             ccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            43222 22345679999999998765668999999999999999999999999999999999999999988887765543


Q ss_pred             --cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 --PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        ..+..+.++.....++... ...++.++.+||++||++||.+|||++|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              2233333343332332222 24678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-51  Score=362.35  Aligned_cols=276  Identities=28%  Similarity=0.437  Sum_probs=231.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .....|++.+.||+|.-|+||+|+...++..+|+|++.+..       ...+.|.+||..++||.++.++..|     +.
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et  148 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ET  148 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ec
Confidence            34458999999999999999999999999999999996543       2234589999999999999999999     77


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      +.+.|++||||.| +|..++.++  .++.+++..++.++.+|+.||+|||-. |||+|||||+||||.++| .|.|+||.
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredG-HIMLsDFD  224 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDG-HIMLSDFD  224 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCC-cEEeeecc
Confidence            7889999999996 555554433  467899999999999999999999976 999999999999999999 59999999


Q ss_pred             ceeeccC---------------------------------C-C-----------------------Cccccccccccccc
Q 017341          184 SAKVLVK---------------------------------G-E-----------------------PNISYICSRYYRAP  206 (373)
Q Consensus       184 ~a~~~~~---------------------------------~-~-----------------------~~~~~~gt~~y~aP  206 (373)
                      ++.....                                 . .                       ...+++||-+|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            8643210                                 0 0                       01245789999999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccc
Q 017341          207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF  286 (373)
Q Consensus       207 E~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (373)
                      |++.+.. .+.++|||+||+.+|||+.|..||.|.+..+++.+|+..                 +..+|..         
T Consensus       305 EvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~---------  357 (459)
T KOG0610|consen  305 EVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE---------  357 (459)
T ss_pred             eeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC---------
Confidence            9998765 799999999999999999999999999999999998863                 2233322         


Q ss_pred             cCCCChhHHHHHHhhcCcCCCCCCC----HHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 017341          287 QKRMPPEAVDLVSRLLQYSPNLRST----ALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  344 (373)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dP~~R~t----~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~  344 (373)
                       +.++..++|||+++|.+||++|..    |+|+.+||||++++|.-.+...++++|...+..
T Consensus       358 -~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  358 -PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             -CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence             367899999999999999999998    999999999999999866666666666665543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-51  Score=362.40  Aligned_cols=257  Identities=33%  Similarity=0.536  Sum_probs=210.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..+|...+.||+|.||.||++.+.++|+..|+|.+...    .....+|+.+|+.++|||||++++......  + ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence            45799999999999999999999999999999998765    344689999999999999999988642211  1 4688


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC-CCCceeEeeccceee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~-~~~~ikl~Dfg~a~~  187 (373)
                      +.|||++ |+|.+.+.+..   ..+++..++.+.+||++||.|||++ ||+||||||+|||++. ++ .+||+|||+++.
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNG-DVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCC-eEEeccCccccc
Confidence            9999999 58998888763   2799999999999999999999998 9999999999999998 56 899999999886


Q ss_pred             ccC----CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHH
Q 017341          188 LVK----GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       188 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ...    ........||+.|||||++........++|||||||++.||+||++||... ...+.+..+...-        
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------  239 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------  239 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--------
Confidence            653    122346789999999999974322345999999999999999999999873 3333222222210        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                ..|         .++..+|.++++||.+||..||++||||+++|+|||.+.-.
T Consensus       240 ----------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  240 ----------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ----------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                      111         24467999999999999999999999999999999997744

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-49  Score=367.43  Aligned_cols=286  Identities=40%  Similarity=0.698  Sum_probs=226.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5999999999999999999999999999999875321      2245799999999999999999987654444445688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||||+++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            99999999988877643    5689999999999999999999998 999999999999999988 89999999987543


Q ss_pred             CCCC----cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          190 KGEP----NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       190 ~~~~----~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ....    .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211    1245789999999998542 4588999999999999999999999999988888888877777777665433


Q ss_pred             cCcCcc-cc--cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          265 MNPNYT-EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       265 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ....-. .+  .+......+....+ +.+++++.++|.+||+.||++|||++++++||||+.+....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            221100 00  00011111111222 35788999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-49  Score=361.53  Aligned_cols=282  Identities=33%  Similarity=0.568  Sum_probs=219.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++     .+..+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            468999999999999999999999999999999885432     2335799999999999999999988     344568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+||||+.+++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            999999999988887654   35688999999999999999999998 999999999999999888 7999999998754


Q ss_pred             cCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ... .......+|+.|+|||++.+...++.++|+|||||++|+|++|..||.+..+ .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            322 2223456899999999987666689999999999999999999999988644 45566666666666554332211


Q ss_pred             --cCcccccCCCcCCCCcccccc-CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          267 --PNYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       267 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                        +.+....+.......+...+. ...++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence              111111111111111111111 13567899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-51  Score=344.42  Aligned_cols=285  Identities=28%  Similarity=0.454  Sum_probs=234.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  101 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  101 (373)
                      ..|.-.+.||.|..++|.+|.++.+|..+|+|++....            ....+|+.+|+++ .||+|+++.++|    
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----   92 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----   92 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence            36888999999999999999999999999999884221            1123689999988 699999999998    


Q ss_pred             CCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                       +.+.++++|+|.|+ |.|.+++...    -.+++...+.+++|+++++.|||.+ +||||||||+|||+|.+. ++||+
T Consensus        93 -es~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~-~i~is  165 (411)
T KOG0599|consen   93 -ESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNM-NIKIS  165 (411)
T ss_pred             -cCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeecccc-ceEEe
Confidence             77888999999999 7899998764    6689999999999999999999988 999999999999999888 89999


Q ss_pred             eccceeeccCCCCccccccccccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          181 DFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       181 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      |||.++....+......+|||.|+|||.+.     +.+.|+..+|+|++|+|||.|+.|.+||-.....-.+..|++..-
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            999999998888888999999999999984     345689999999999999999999999977665566666665321


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR  335 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~  335 (373)
                      ...               .|.          +.++|.+.++||.+||+.||.+|.|++++|.||||..+.....+    .
T Consensus       246 qF~---------------spe----------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r----~  296 (411)
T KOG0599|consen  246 QFR---------------SPE----------WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR----Q  296 (411)
T ss_pred             ccC---------------Ccc----------hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc----c
Confidence            111               111          25789999999999999999999999999999999876443222    1


Q ss_pred             CCCCCCCCChhhcCCCCHHHHhhhchHHHHhhhhh
Q 017341          336 FLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAF  370 (373)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (373)
                      ..|           ....++++..+.+.++|...+
T Consensus       297 msP-----------~~~~~~~k~qt~~~aRkrFk~  320 (411)
T KOG0599|consen  297 MSP-----------VVEVELVKDQTSERARKRFKV  320 (411)
T ss_pred             cCC-----------CcchhhhhhhhhHHhhhheee
Confidence            111           234566666667777766543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=370.01  Aligned_cols=251  Identities=30%  Similarity=0.500  Sum_probs=218.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..|....+||+|..|.||.++...+++.||+|.+....    +.+.+|+.+|+..+|+|||.+++.|....+     +|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence            47999999999999999999999999999999996543    345689999999999999999999866532     899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||++| +|.+.+..     ..++|.+++.++++++.||+|||.+ ||+|||||.+|||++.+| .+||+|||+|..+.
T Consensus       348 VMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDG-SVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCC-cEEEeeeeeeeccc
Confidence            9999995 77777764     4489999999999999999999998 999999999999999999 89999999998776


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ... ...+.+|||+|||||++.. ..|++++||||||+++.||+-|.+||-..++...++.|... +.|.          
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~----------  488 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK----------  488 (550)
T ss_pred             cccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC----------
Confidence            554 4567899999999999955 45999999999999999999999999998888888877653 1111          


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                     ...+..+|+++++|+.+||+.|+.+|++|.+||.||||+..
T Consensus       489 ---------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  489 ---------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             ---------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                           11235799999999999999999999999999999999554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-50  Score=317.27  Aligned_cols=278  Identities=36%  Similarity=0.636  Sum_probs=239.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .|.-.++||+|.||+||++++.++++.||+|++..+..      ...+|+-+++.++|.|||+++++..+     +..+-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            57778899999999999999999999999999975432      23589999999999999999998743     33478


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|+|||...|..++...   ++.++.+.++.++.|++++|.++|++ ++.||||||.|++++.+| .+||.|||+++...
T Consensus        78 lvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            99999999888887754   67899999999999999999999999 999999999999999999 89999999998653


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  266 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  266 (373)
                      -.- -....+.|.+|++|.++++..-|++..|+||.|||+.|+.. |++.|++.+..+++.+|...+|.|+.+.++.+- 
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            332 23345679999999999999999999999999999999996 999999999999999999999999999888764 


Q ss_pred             -cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                       +.|.  .+|.++....++.+-++++...+++++++|.-+|.+|++++++++||||.+..
T Consensus       233 lpdyk--~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  233 LPDYK--PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCCc--ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence             3333  34555444444444567889999999999999999999999999999998753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-49  Score=364.88  Aligned_cols=251  Identities=29%  Similarity=0.433  Sum_probs=210.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+.
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   90 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE   90 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence            3568999999999999999999999999999999885432       2245799999999999999999988     444


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .++|+||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~Dfg~  164 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKG-HVKVTDFGF  164 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCC-CEEEeeccC
Confidence            568999999985 777777653    5688999999999999999999998 999999999999999988 899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....          
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------  231 (329)
T PTZ00263        165 AKKVPD--RTFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR----------  231 (329)
T ss_pred             ceEcCC--CcceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------
Confidence            976532  23346789999999999654 47999999999999999999999998877666555544310          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                             ..            ++..++..+.+||.+||+.||.+|++     ++++++||||++..+
T Consensus       232 -------~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        232 -------LK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             -------cC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence                   00            12347889999999999999999997     799999999988654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=360.17  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=213.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------------cchHHHHHHHHhCCCCCeeec
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVVSL   93 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~~iv~~   93 (373)
                      ....+|++.+.||+|.||.|.+|++..+++.||||++.+..                  ....+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            55679999999999999999999999999999999985432                  122479999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC
Q 017341           94 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  172 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~  172 (373)
                      +++.   ++.....+|||+|||..+-   +.... ...+ +++.+++.+++.++.||.|||.+ ||+||||||+|+|+++
T Consensus       174 iEvL---DDP~s~~~YlVley~s~G~---v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVL---DDPESDKLYLVLEYCSKGE---VKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEee---cCcccCceEEEEEeccCCc---cccCC-CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcC
Confidence            9987   3355666999999999431   11111 2334 89999999999999999999999 9999999999999999


Q ss_pred             CCCceeEeeccceeeccCCC------CcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 017341          173 HTHQLKLCDFGSAKVLVKGE------PNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESG  243 (373)
Q Consensus       173 ~~~~ikl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~  243 (373)
                      +| .+||+|||.+.....+.      ......|||.|+|||.+.+.   ...+.+.||||+||+||.|+.|+.||-+...
T Consensus       246 ~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  246 DG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            98 89999999987653221      12346899999999999762   3357799999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      .+...+|.+.                 ...+|..          +.+.++++|||.+||++||..|+++.++..|||...
T Consensus       325 ~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 LELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            9998888762                 2222221          357889999999999999999999999999999876


Q ss_pred             c
Q 017341          324 L  324 (373)
Q Consensus       324 ~  324 (373)
                      -
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            4

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-49  Score=350.54  Aligned_cols=274  Identities=27%  Similarity=0.456  Sum_probs=224.3

Q ss_pred             CCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           27 KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        27 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      ....+...+.|++...||.|..++||+|++..+++.||||++..+.     ..+.+|+..++.++||||++++-+|... 
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-   96 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-   96 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-
Confidence            4455566679999999999999999999999999999999996543     3456899999999999999999999543 


Q ss_pred             CCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                          ..+|+||+||. |++.++++....  ..++|..++.+++++++||.|||.+ |.+|||||+.||||+.+| .|||+
T Consensus        97 ----~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG-~VkLa  168 (516)
T KOG0582|consen   97 ----SELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDG-TVKLA  168 (516)
T ss_pred             ----ceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCC-cEEEc
Confidence                34999999999 699999998764  4499999999999999999999998 999999999999999999 89999


Q ss_pred             eccceeeccCCCCc-----ccccccccccccccc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017341          181 DFGSAKVLVKGEPN-----ISYICSRYYRAPELI-FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  254 (373)
Q Consensus       181 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~l-~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~  254 (373)
                      |||.+..+......     .++.||++|||||++ .....|+.++||||||++..||.+|..||....+.+.+-.-++. 
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn-  247 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN-  247 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-
Confidence            99986554433211     456899999999995 44456999999999999999999999999988877766554442 


Q ss_pred             CCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                       .|+......         .+        .--.+.++..++.+|..||+.||.+||||+++|+|+||+.....+
T Consensus       248 -~pp~~~t~~---------~~--------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  248 -DPPTLLTSG---------LD--------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             -CCCCccccc---------CC--------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence             222111000         00        001145677999999999999999999999999999999876643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.4e-50  Score=367.12  Aligned_cols=249  Identities=33%  Similarity=0.527  Sum_probs=216.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc------hHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+|-+.+.||+|.||.||+++.+.|.+.||+|.+.+..+.      ..+|+++++.++||||+.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            4788999999999999999999999999999998655433      45899999999999999999999     666679


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+|+|||.|+|..++..    ++.++|+.++.++.+++.||.|||+. +|.|||+||.||+++..+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999999988875    47899999999999999999999998 999999999999999888 7999999999877


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..+.. ....-|||.|||||+..+. .|+..+|+||||||+|||.+|++||....-.+....|.+.   +.         
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v---------  217 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV---------  217 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC---------
Confidence            55432 2355799999999999754 5999999999999999999999999877666555555441   10         


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                       ..+..++..+.+|++.+|.+||.+|.|-.+++.|||.++-
T Consensus       218 -----------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 -----------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -----------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                             1224789999999999999999999999999999999863

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-48  Score=356.81  Aligned_cols=283  Identities=33%  Similarity=0.639  Sum_probs=230.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ...+|.+.+.||+|+||.||+|++..+++.+|+|.+....     ....+|+.+++.++||||+++++++.     ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   78 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKS   78 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCe
Confidence            3568999999999999999999999999999999885432     23347999999999999999999873     3445


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++||||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        79 ~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  153 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA  153 (309)
T ss_pred             EEEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcccccee
Confidence            8899999999888877653   34578899999999999999999998 999999999999999888 899999999875


Q ss_pred             ccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..... ......+|+.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            43222 22345678999999998766668999999999999999999999999999889999999988888877655432


Q ss_pred             c--CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 P--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .  .+....++.....++.... ..+++++.+||.+||+.||.+|||++|+++||||+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            2  1222233333222222222 468899999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-48  Score=353.78  Aligned_cols=280  Identities=34%  Similarity=0.580  Sum_probs=221.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECC-CCcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceeeeecCCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~  104 (373)
                      .+|++.+.||+|+||.||+|++.. ++..+|+|.+....      ....+|+.+++.+   +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            379999999999999999999854 46889999875432      1234577776665   6999999999875443344


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~-~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCC-CEEEccccc
Confidence            55688999999999888886542  34588999999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............||+.|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+..+.+..+....+.+....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9766444444456789999999998654 489999999999999999999999999999999999988877776654432


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ... .....+......+... +.+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            110 1111111111112222 224688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-48  Score=352.55  Aligned_cols=276  Identities=39%  Similarity=0.707  Sum_probs=220.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|+++.+++.+|+|++....      ....+|+.+++.++||||+++++++     ....++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            36999999999999999999999999999999886432      2235799999999999999999887     445568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+||||+++++...+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~  150 (287)
T cd07848          76 YLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHND-VLKLCDFGFARNL  150 (287)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccCcccc
Confidence            999999998776666543   35689999999999999999999988 999999999999999888 8999999998765


Q ss_pred             cCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc-
Q 017341          189 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-  265 (373)
Q Consensus       189 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-  265 (373)
                      ....  ......||+.|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+..+....+....+......+... 
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            3322  122456899999999996654 899999999999999999999999998888888777777666665544322 


Q ss_pred             -CcCcccccCCCcCC-CCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          266 -NPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       266 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                       ++.+.....+.... ..+...+...+|.++.+||++||+.||++|||++++|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             12221122221111 111222334578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-50  Score=330.46  Aligned_cols=252  Identities=30%  Similarity=0.460  Sum_probs=221.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      -..++|++++.||.|.||.||+|+.+.++..+|+|++.++.       ....+|+++-..|+||||++++.+|     -+
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd   93 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HD   93 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ec
Confidence            44578999999999999999999999999999999986543       3345799999999999999999999     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ....|+++||.. |++...+....  ..++++..++.++.|++.||.|+|.+ +++||||||+|+|++.++ .+||+|||
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~-~lkiAdfG  169 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAG-ELKIADFG  169 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCC-CeeccCCC
Confidence            555899999998 68888887443  46799999999999999999999988 999999999999999999 89999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .+.... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||...+..+++++|.+.          
T Consensus       170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------  237 (281)
T KOG0580|consen  170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------  237 (281)
T ss_pred             ceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------
Confidence            987544 4556788999999999999665 4899999999999999999999999999988999888874          


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                             .+            .++..++.++.|+|.+||..+|.+|.+..|++.|||+..
T Consensus       238 -------~~------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  238 -------DL------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -------cc------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                   11            233679999999999999999999999999999999875

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.6e-48  Score=361.65  Aligned_cols=286  Identities=32%  Similarity=0.552  Sum_probs=224.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999999999999999885431      223479999999999999999998743321 122


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|+||||+++++...+.      ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEecCCCc
Confidence            3578999999998777664      3478888999999999999999998 999999999999999988 8999999998


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.+..+.+..+.....
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            765444334456789999999999654 4899999999999999999999999999888888888888887776533221


Q ss_pred             C----------cCcccccC----CCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          266 N----------PNYTEFKF----PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       266 ~----------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      .          +.+....+    +.... +.........++++++||.+||+.||++|||+.|+|+||||..+.++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIF-PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhcccccc-ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence            1          11111110    00000 000111234578899999999999999999999999999998765553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-49  Score=360.95  Aligned_cols=258  Identities=33%  Similarity=0.520  Sum_probs=221.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCC-CCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLD-HPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  103 (373)
                      .....|.+.+.||.|.||.||+|+++.||+.+|+|.+.+...       ...+|+.+|+.++ ||||+.++++|     +
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e  106 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----E  106 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence            344589999999999999999999999999999999865432       4568999999998 99999999999     5


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC---CceeE
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKL  179 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~---~~ikl  179 (373)
                      +...+++|||+|.| .|.+.+...     .+++..+..++.||+.++.|||+. ||+||||||+|+|+....   +.+|+
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEE
Confidence            55568999999995 777777765     399999999999999999999987 999999999999996542   27999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +|||++.....+......+||+.|+|||++.. ..|+..+|+||+|+++|.|++|.+||.+.+.......|.+..-    
T Consensus       181 ~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~----  255 (382)
T KOG0032|consen  181 IDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF----  255 (382)
T ss_pred             eeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC----
Confidence            99999998876556678899999999999954 4599999999999999999999999999998888887765311    


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                   .+   ...     ..+.++..+++||.+||..||.+|+|+.++|+|||++....
T Consensus       256 -------------~f---~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  256 -------------DF---TSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             -------------CC---CCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                         11   111     22578999999999999999999999999999999988633

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.9e-48  Score=360.42  Aligned_cols=289  Identities=31%  Similarity=0.547  Sum_probs=228.4

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~  104 (373)
                      ...++|.+.+.||+|+||.||++.+..+++.+|+|++....      ....+|+.+++.++||||+++++++..... ..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34578999999999999999999999999999999886432      223478999999999999999987743221 23


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+|+||||+++++...+.      ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~  172 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGL  172 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCC-cEEEEeCCC
Confidence            34578999999998877764      2478888999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ++............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....+.+..+....
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9765444334456789999999999654 489999999999999999999999999999999999988888877654443


Q ss_pred             cCcC----------cccccCCCc---CCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          265 MNPN----------YTEFKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       265 ~~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      ..+.          +..+.+...   ...++........+..+++||.+||+.||.+|||+.++|+||||..+.++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  329 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  329 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence            3211          111111000   0011111122335678999999999999999999999999999988766544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.6e-48  Score=349.03  Aligned_cols=279  Identities=30%  Similarity=0.539  Sum_probs=221.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999886432      1234577776655   799999999987654444456


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .++++|||+.+++...+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999998888776542  24589999999999999999999998 999999999999999888 89999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            65444334456789999999999654 48999999999999999999999999998888888888877776655433211


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                       ......+......++.. ..+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 -TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             -cccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             00001111111112222 224678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.3e-48  Score=351.56  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++.+++     .+..++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            4889999999999999999999999999999875432       1234699999999999999998887     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+.+ +|...+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            999999985 7766665432  34689999999999999999999998 999999999999999888 799999999987


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------  220 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence            5444434456789999999999654 58999999999999999999999998876544333333221110          


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                                     ...++..++.++.+||.+||+.||.+||+     ++++++||||+++++.
T Consensus       221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                           01123468899999999999999999997     8999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-48  Score=353.90  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=210.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++     .+..+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            36999999999999999999999999999999885422       2345799999999999999998877     45567


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+. ++|.+.+.+.    ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~  149 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEG-HIKLTDFGFAK  149 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEEecCcch
Confidence            899999998 4788877653    5688999999999999999999998 999999999999999888 89999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....            
T Consensus       150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------  214 (291)
T cd05612         150 KLRD--RTWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------  214 (291)
T ss_pred             hccC--CcccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence            6532  22345789999999998654 48999999999999999999999999887766666554420            


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                           .            .++..+++.+++||++||+.||.+|++     ++++++||||+.+++.
T Consensus       215 -----~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         215 -----L------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             -----c------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                 0            122457889999999999999999995     9999999999987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-47  Score=349.14  Aligned_cols=286  Identities=32%  Similarity=0.613  Sum_probs=229.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++     ....+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~   78 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKS   78 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCe
Confidence            4568999999999999999999999999999999885432     1234799999999999999999988     34456


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +++||||++++|...+...   ...+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .++|+|||++..
T Consensus        79 ~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~  153 (301)
T cd07873          79 LTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA  153 (301)
T ss_pred             EEEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCC-cEEECcCcchhc
Confidence            8899999999888877653   35688999999999999999999998 999999999999999888 899999999865


Q ss_pred             ccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            43222 22234678999999998766668899999999999999999999999998888888888887777765544321


Q ss_pred             c--CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          267 P--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       267 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .  .+.....+........ .....+++++.+||.+||+.||.+|||++++++||||+.+.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~  297 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH  297 (301)
T ss_pred             ccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence            1  1222222222111111 122468899999999999999999999999999999988765433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.8e-48  Score=362.45  Aligned_cols=284  Identities=36%  Similarity=0.596  Sum_probs=225.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|.+.+.||+|+||.||++.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..........+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999999999999999875421      2345799999999999999999988543322223688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +||||+.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999888777754    35689999999999999999999998 999999999999999888 89999999997643


Q ss_pred             CCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          190 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       190 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...  ......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            222  122346789999999997766689999999999999999999999999999999999999888888765543221


Q ss_pred             CcccccC--CCc-CCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          268 NYTEFKF--PQI-KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       268 ~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .......  +.. +.......+....++++.+||.+||+.||.+|||++++|+||||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            1100000  000 000000012245688999999999999999999999999999998854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-47  Score=357.05  Aligned_cols=286  Identities=33%  Similarity=0.559  Sum_probs=226.3

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++..... ...
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999999999999999886432      223468999999999999999998754321 223


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|+||||+++++...+.      ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~-~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCC-CEEEeeCccc
Confidence            4578999999998877664      3478888999999999999999998 999999999999999888 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+...++.+..+.....
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            765444444456789999999999654 4899999999999999999999999999988888888888887776544333


Q ss_pred             Cc----------CcccccCCCcCC---CCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 NP----------NYTEFKFPQIKA---HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~----------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      .+          .+....++....   .+.........+.++.+||.+||..||++|||+.|+|+||||....++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            22          111111111100   011111223456789999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=352.58  Aligned_cols=259  Identities=30%  Similarity=0.451  Sum_probs=230.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+-|.+.+.||+|.|+.|-+++|.-||+.||||++.+.+      ....+|++.|+.++|||||++|++.     ...
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence            34456999999999999999999999999999999986543      3345899999999999999999987     455


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+|+|+|.-++ +|.+++..+   ...+.|..++.+++||+.|+.|||+. .+|||||||+|+.+-+.-+-|||+|||+
T Consensus        90 TKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccc
Confidence            568999999884 899998876   47799999999999999999999976 9999999999998876666899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +..+..+....+.+|+..|.|||++.+..+..+++||||||||+|.|++|++||+..++.+++-.|+.+.          
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK----------  235 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK----------  235 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc----------
Confidence            9998888888899999999999999998877889999999999999999999999999999998887641          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                             |.            .+..++.++++||.+||..||.+|.|.+++..|+|++.++.+.
T Consensus       236 -------Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  236 -------YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             -------cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence                   22            2357899999999999999999999999999999999987654

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-47  Score=356.30  Aligned_cols=285  Identities=35%  Similarity=0.627  Sum_probs=227.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      .++|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            458999999999999999999999999999999886432      223479999999999999999988743221 2224


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+++++++++|...+.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~  166 (343)
T cd07878          94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLAR  166 (343)
T ss_pred             cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCC-CEEEcCCccce
Confidence            478999999888877664     25689999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+....
T Consensus       167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            6532  23455789999999999765668999999999999999999999999988888888888877777665443322


Q ss_pred             cCcccc---cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          267 PNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       267 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ......   ..+......+...+ ...++.+.+||.+||..||.+|||+.++|+||||....++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            111000   11111111111222 34678899999999999999999999999999999876654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.6e-48  Score=355.13  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=203.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999886432       1234688999999999999999887     44556899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC-
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  191 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-  191 (373)
                      |+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+++..... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 77666654    35789999999999999999999998 999999999999999888 7999999998753222 


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            223456799999999999654 4899999999999999999999999887665554444321                 0


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                      .            .++..+++++.+||.+||+.||++||     ++.++++||||+.+.+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            0            12346889999999999999999999     8999999999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-47  Score=360.05  Aligned_cols=277  Identities=24%  Similarity=0.330  Sum_probs=212.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEec
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|...  .....+|+++++.++||||++++++|.     ...+.+++||+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEec
Confidence            47999999999999999999999999999999653  334568999999999999999999883     34458899999


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC--C
Q 017341          115 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--E  192 (373)
Q Consensus       115 ~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~--~  192 (373)
                      +.++|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.....  .
T Consensus       165 ~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YKTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCC-CEEEEeCCccccccccccc
Confidence            999888777653    5688999999999999999999998 999999999999999888 7999999998653222  2


Q ss_pred             CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          193 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       193 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...       +....+..+....+.++.+.....
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            22345799999999999654 5899999999999999999999877543       234556666666555432210000


Q ss_pred             C----cCc----ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 N----PNY----TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      .    ..+    ............|...  ..++.++.+||.+||++||.+|||++|+|+||||+.+..+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            0    000    0000000000111111  2367789999999999999999999999999999986544

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-48  Score=358.52  Aligned_cols=255  Identities=32%  Similarity=0.521  Sum_probs=211.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|.+....       ....+|+.++..++||||+++++++     .+..+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            37999999999999999999999999999999986432       2234789999999999999999887     45556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~  149 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADG-HIKLADFGLCK  149 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEeecCCCCc
Confidence            8999999984 888877653    5789999999999999999999998 999999999999999988 79999999987


Q ss_pred             eccCCC------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 017341          187 VLVKGE------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  236 (373)
Q Consensus       187 ~~~~~~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~  236 (373)
                      ......                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence            654332                              12345689999999999665 58999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-HHHH
Q 017341          237 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEA  315 (373)
Q Consensus       237 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~~l  315 (373)
                      ||.+.+......++......               ...+.          ...+++++.+||.+||. ||.+|++ ++++
T Consensus       229 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~l  282 (350)
T cd05573         229 PFYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEI  282 (350)
T ss_pred             CCCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence            99988866665555431100               01111          12368999999999998 9999999 9999


Q ss_pred             hcCCCccccCCC
Q 017341          316 LIHPFFDELRDP  327 (373)
Q Consensus       316 l~hp~~~~~~~~  327 (373)
                      ++||||+.+++.
T Consensus       283 l~hp~~~~~~~~  294 (350)
T cd05573         283 KSHPFFKGIDWE  294 (350)
T ss_pred             hcCCCcCCCCHH
Confidence            999999987664

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-47  Score=356.41  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=206.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+..       ....+|+.+++.++|+||+++++.+     .+..+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            36999999999999999999999999999999886432       2234689999999999999999888     45556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+|||||+| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~-~vkL~DFGla~  149 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKG-HVKLSDFGLCT  149 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-CEEEeeccCcc
Confidence            8999999985 77777764    36789999999999999999999998 999999999999999888 79999999986


Q ss_pred             eccCCC------------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHH
Q 017341          187 VLVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  230 (373)
Q Consensus       187 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~  230 (373)
                      ......                                    .....+||+.|+|||++.+. .++.++|||||||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e  228 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHH
Confidence            532110                                    01234789999999999654 48999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--
Q 017341          231 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--  308 (373)
Q Consensus       231 lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--  308 (373)
                      |++|+.||.+.+..+...++......               ..+|.          ...++++++++|.+|+. +|.+  
T Consensus       229 ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~  282 (363)
T cd05628         229 MLIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRI  282 (363)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcC
Confidence            99999999988877766666542100               01111          02478899999999876 4544  


Q ss_pred             -CCCHHHHhcCCCccccCCC
Q 017341          309 -RSTALEALIHPFFDELRDP  327 (373)
Q Consensus       309 -R~t~~~ll~hp~~~~~~~~  327 (373)
                       ||+++|+++||||+++++.
T Consensus       283 ~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         283 GAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCCHHHHhCCCCCCCCCHH
Confidence             5899999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-48  Score=342.37  Aligned_cols=248  Identities=26%  Similarity=0.443  Sum_probs=221.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+|++.+.||+|.||.|-+++....|+.||||.+.++..       .+.+|+++|..|+||||++++++|     ++..
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence            3489999999999999999999999999999998876542       245899999999999999999999     5566


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+.|||||.. |.|.+++..+    +.+++..++++++||..|+.|||.+ +++|||||.+|||+|.++ ++||+|||++
T Consensus       127 KIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~-NiKIADFGLS  200 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNN-NIKIADFGLS  200 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCC-Ceeeeccchh
Confidence            6889999998 5899999875    6799999999999999999999988 999999999999999998 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..+.......+++|+|-|.+||++.+.+.-++.+|.||||+++|.|+.|..||+|.+-.....+|....           
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga-----------  269 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA-----------  269 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-----------
Confidence            988777778899999999999999888877899999999999999999999999998877777765531           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                         .+.+..+.++.-||+.||..+|.+|.|++|+..|=|..
T Consensus       270 -------------------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  270 -------------------YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -------------------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                               12245788999999999999999999999999997763

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-47  Score=352.25  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=210.4

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCC-cEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....+|.+.+.||+|+||.||+|.+..++ ..||+|.+....       ....+|+.+++.++||||+++++++     .
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~  101 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K  101 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence            34568999999999999999999976655 689999885431       2234699999999999999999988     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +..++|+||||+. |+|.+.+...    ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~ikL~DF  175 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDG-FIKMTDF  175 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEecC
Confidence            4456899999997 5787777653    5689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      |++.....  ......||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+.......+....        
T Consensus       176 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------  244 (340)
T PTZ00426        176 GFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------  244 (340)
T ss_pred             CCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------
Confidence            99976532  23456799999999999654 47999999999999999999999999887766666554321        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                               .            .++..+++.+.++|++||+.||.+|+     |++++++||||+++.+
T Consensus       245 ---------~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        245 ---------I------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             ---------C------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                     0            12245788999999999999999995     8999999999998765

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-46  Score=340.59  Aligned_cols=276  Identities=35%  Similarity=0.562  Sum_probs=217.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||+|++..+|+.+|+|.+....      ....+|+.+++.++||||+++++++     .+..+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            5899999999999999999999999999999885432      2345799999999999999999988     4445689


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +++||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            99999999888877653   35689999999999999999999988 999999999999999888 89999999987543


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            222 122346788999999987666679999999999999999998877 566666777777777777766554433221


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      .-.....+............+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            100011111111111112224688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.4e-47  Score=346.25  Aligned_cols=277  Identities=31%  Similarity=0.550  Sum_probs=208.7

Q ss_pred             eeeeeecCceEEEEEEEC--CCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           40 ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      .++||+|+||.||+|+++  .+++.+|+|.+....  ....+|+.+++.++||||+++++++..   .....+|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence            458999999999999975  467899999886543  234589999999999999999988754   2344688999999


Q ss_pred             cccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc----CCCCceeEeecccee
Q 017341          116 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAK  186 (373)
Q Consensus       116 ~g~l~~~l~~~~~-----~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~----~~~~~ikl~Dfg~a~  186 (373)
                      ++++...+.....     ....+++..++.++.||+.||.|||++ ||+||||||+|||++    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence            9998887764321     123588999999999999999999998 999999999999994    334 79999999997


Q ss_pred             eccCCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 017341          187 VLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV  253 (373)
Q Consensus       187 ~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---------~~~~~~i~~~  253 (373)
                      ......    ......+|+.|+|||++.+...++.++|+||+||++|+|++|++||.+...         ...+.++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    123457899999999997766689999999999999999999999976442         3566777777


Q ss_pred             hCCCCHHHHhhcCc--C-------cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          254 LGTPTREEIKCMNP--N-------YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       254 ~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      .+.+....+.....  .       +............+........+.++.+||.+||++||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            77776654433210  0       00000000000000011112346789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-47  Score=350.68  Aligned_cols=257  Identities=30%  Similarity=0.464  Sum_probs=211.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+..+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            36999999999999999999999999999999986432       2234689999999999999999887     44556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~  149 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASG-HIKLTDFGLSK  149 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEEEeCcCCc
Confidence            8999999985 888777643    5688999999999999999999998 999999999999999988 89999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......         
T Consensus       150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  217 (333)
T cd05600         150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------  217 (333)
T ss_pred             cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---------
Confidence            5433  33456789999999999765 58999999999999999999999999887766665554321100         


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                            ..+...      .....++.++.+||.+||..+|.+||+++++++||||+.+.+
T Consensus       218 ------~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         218 ------QRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ------cCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                  000000      000257899999999999999999999999999999998754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-47  Score=348.84  Aligned_cols=242  Identities=31%  Similarity=0.515  Sum_probs=200.7

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+..++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999885421       1234689999999999999998887     4445688999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC-CC
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  193 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-~~  193 (373)
                      .+ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 77777764    35689999999999999999999998 999999999999999888 8999999998754322 22


Q ss_pred             cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017341          194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  273 (373)
Q Consensus       194 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 .. 
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~-  210 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PL-  210 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CC-
Confidence            3345789999999999654 5899999999999999999999999987766655544331                 00 


Q ss_pred             CCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCccccC
Q 017341          274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELR  325 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~~ll~hp~~~~~~  325 (373)
                                 .++..+++++.+||.+||+.||.+||   ++.++++||||....
T Consensus       211 -----------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         211 -----------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             -----------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                       12346889999999999999999997   589999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-47  Score=355.97  Aligned_cols=253  Identities=31%  Similarity=0.506  Sum_probs=207.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+....       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999986432       1234699999999999999999988     445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+|||||.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999985 777777643    5689999999999999999999998 999999999999999988 899999999865


Q ss_pred             ccCCCC---------------------------------------cccccccccccccccccCCCCCCCchhHHHHHHHH
Q 017341          188 LVKGEP---------------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  228 (373)
Q Consensus       188 ~~~~~~---------------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il  228 (373)
                      ......                                       ....+||+.|+|||++.+. .++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence            422110                                       0124689999999998654 589999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC
Q 017341          229 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  308 (373)
Q Consensus       229 ~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  308 (373)
                      |+|++|.+||.+.+..+....+.....               ...++.          ...+++++++||.+||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            999999999998877666555543100               001111          12468999999999997 9999


Q ss_pred             CCC---HHHHhcCCCccccCC
Q 017341          309 RST---ALEALIHPFFDELRD  326 (373)
Q Consensus       309 R~t---~~~ll~hp~~~~~~~  326 (373)
                      |++   ++++++||||+..++
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999998765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-46  Score=360.49  Aligned_cols=280  Identities=24%  Similarity=0.377  Sum_probs=213.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCC------CCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDH------PNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~  104 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   .....|+.+++.+.|      .+++++++++.    ..
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----NE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----cC
Confidence            468999999999999999999999999999999885432   223457777777754      45788877663    22


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---------
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---------  175 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---------  175 (373)
                      ..++|+||++++++|.+.+...    ..+++..++.++.||+.||.|||++.||+||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            3468899999998888887653    568999999999999999999997349999999999999987652         


Q ss_pred             ------ceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 017341          176 ------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  249 (373)
Q Consensus       176 ------~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~  249 (373)
                            .+||+|||.+...  ........||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  3999999987542  2233456899999999999765 489999999999999999999999999998888888


Q ss_pred             HHHHhCCCCHHHHhhcC-----------cCcccccCCC----c-CCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH
Q 017341          250 IIKVLGTPTREEIKCMN-----------PNYTEFKFPQ----I-KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  313 (373)
Q Consensus       250 i~~~~~~~~~~~~~~~~-----------~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  313 (373)
                      +.+.++.++........           ........+.    . ....+..   ...++.+.+||.+||++||.+|||++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVRE---VIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhh---hhchHHHHHHHHHhCCcChhhCCCHH
Confidence            88887776544321100           0000000000    0 0000000   01246788999999999999999999


Q ss_pred             HHhcCCCccccCCC
Q 017341          314 EALIHPFFDELRDP  327 (373)
Q Consensus       314 ~ll~hp~~~~~~~~  327 (373)
                      |+|+||||......
T Consensus       434 e~L~Hp~~~~~~~~  447 (467)
T PTZ00284        434 QMTTHPYVLKYYPE  447 (467)
T ss_pred             HHhcCccccccCCc
Confidence            99999999986553

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-47  Score=357.41  Aligned_cols=254  Identities=30%  Similarity=0.487  Sum_probs=205.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||.|+||.||++.+..+++.||+|.+.+..       ....+|+++++.++||||+++++++     .+..+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            36999999999999999999999999999999885432       2234689999999999999999988     45556


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+. |+|.+.+...    ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~-~~kl~DfGla~  149 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGG-HIKLSDFGLST  149 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEEeeccccc
Confidence            899999998 5887777643    5689999999999999999999988 999999999999999888 89999999985


Q ss_pred             eccCCCC------------------------------------------------cccccccccccccccccCCCCCCCc
Q 017341          187 VLVKGEP------------------------------------------------NISYICSRYYRAPELIFGATEYTAA  218 (373)
Q Consensus       187 ~~~~~~~------------------------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~  218 (373)
                      .......                                                .....||+.|+|||++.+. .++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  228 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQE  228 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCc
Confidence            3211000                                                0124689999999999654 48999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHH
Q 017341          219 IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLV  298 (373)
Q Consensus       219 ~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  298 (373)
                      +|||||||++|+|++|.+||.+.+..+.+..+.....               ...++.          ...++.++.+||
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli  283 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLI  283 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHH
Confidence            9999999999999999999988877666655543100               001111          024788999999


Q ss_pred             HhhcCcCCCCC---CCHHHHhcCCCccccCC
Q 017341          299 SRLLQYSPNLR---STALEALIHPFFDELRD  326 (373)
Q Consensus       299 ~~~L~~dP~~R---~t~~~ll~hp~~~~~~~  326 (373)
                      .+||. +|.+|   +|+.+++.||||++.++
T Consensus       284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99998 67765   59999999999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.4e-47  Score=347.34  Aligned_cols=245  Identities=29%  Similarity=0.485  Sum_probs=201.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+++.||+|.+.++.       ....+|..+++.+ +||||+++++++     .+..++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999886432       1223677788777 699999999987     3444689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+.+ +|...+..    ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||+++.....
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 77666654    35689999999999999999999988 999999999999999988 8999999998653222


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223345789999999999654 4899999999999999999999999887765555444321                 


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~ll~hp~~~~~~~  326 (373)
                      .            ..++..++.++.+||.+||..||.+|||+     .+++.||||+...+
T Consensus       212 ~------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 E------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             C------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            0            01224578999999999999999999999     99999999988754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7e-47  Score=347.31  Aligned_cols=245  Identities=30%  Similarity=0.512  Sum_probs=201.5

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|+++.+++.||+|.+.++.       .....|..++..+ +||||+++++++     .+..++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999886432       1223577777765 799999999988     4445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC-
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  190 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-  190 (373)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 77666654    35689999999999999999999988 999999999999999988 899999999875322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2223355789999999999654 58999999999999999999999999888776666554310                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~ll~hp~~~~~~~  326 (373)
                       .            .++..++.++.++|.+||+.||.+|+++      +++++||||+.+.+
T Consensus       213 -~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         213 -V------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             -C------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence             0            1123578899999999999999999998      99999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-48  Score=349.80  Aligned_cols=254  Identities=30%  Similarity=0.479  Sum_probs=224.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+.|.+++++|.|+||.+++++++..+..+++|++....      +...+|+.+++++.|||||.+++.|+    ++..+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~   78 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL   78 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence            458999999999999999999999999999999985432      34468999999999999999999984    44555


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++|+|+||+| ++.+.+....  +..+++..+..|+.|++.|+.|||++ +|+|||||+.|||++.++ .|+|+|||+|+
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~-~VkLgDfGlaK  154 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDK-KVKLGDFGLAK  154 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccC-ceeecchhhhh
Confidence            9999999995 7888887664  56799999999999999999999987 999999999999999999 68999999999


Q ss_pred             eccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...... ...+..|||.|++||++.+. .|+.++|||||||++|||++-+++|.+.+......+|.+....|.       
T Consensus       155 ~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl-------  226 (426)
T KOG0589|consen  155 ILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL-------  226 (426)
T ss_pred             hcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence            887665 56688999999999999765 499999999999999999999999999999998888887653332       


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                           +...+.+++.+|+.||..+|..||++.++|.+|.+...
T Consensus       227 ---------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  227 ---------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             ---------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                                 24678999999999999999999999999999998743

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-46  Score=352.60  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=211.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|++.+.||+|+||.||+|++..+++.||+|.+.+..       ....+|+.+++.++||||+++++++     .+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~  114 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QD  114 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence            34568999999999999999999999999999999885421       2234789999999999999999887     45


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..++|+||||++| +|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~~kL~DfG  187 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFG  187 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCC-CEEEEecc
Confidence            5568999999984 78777653     4588999999999999999999998 999999999999999988 89999999


Q ss_pred             ceeeccCCC--CcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGE--PNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ++.......  ......||+.|+|||++.+.   ..++.++|+|||||++|+|++|++||.+.+....+.++......  
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--  265 (370)
T cd05596         188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS--  265 (370)
T ss_pred             ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc--
Confidence            997654322  12345799999999998643   23788999999999999999999999988876666665432100  


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~  326 (373)
                                   ..++.          ...+|.++.+||.+||+.+|.+  |+|++++++||||+...+
T Consensus       266 -------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         266 -------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             -------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                         01111          1257899999999999999988  999999999999987544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-46  Score=342.40  Aligned_cols=288  Identities=36%  Similarity=0.675  Sum_probs=227.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|.+.+.||+|++|.||+|.+..+|+.||+|.+....     ....+|+.+++.++|+||+++++++...........
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999999999999885321     123468999999999999999987654433444567


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+++||+++++.+.+..     ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNC-DLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEECcccceeec
Confidence            89999999988776653     5689999999999999999999998 999999999999999888 8999999998765


Q ss_pred             cCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          189 VKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       189 ~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ......    ....+|+.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+.......+....+.+..+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            332211    2346789999999876655689999999999999999999999999888888888888888777665543


Q ss_pred             cCcCccc-c--cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          265 MNPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       265 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      ....... +  ..+.....++... .+..++++.++|.+||+.||++|||+.++++||||+.+.++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~  303 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD  303 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence            2211100 0  0111111122111 1356889999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.6e-47  Score=350.28  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=211.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|.+....       ....+|+.+++.++||||+++++++     .+..+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            36999999999999999999999999999999986432       2345788999999999999998887     44456


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||++ ++|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~  150 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTG-HIKLADFGSAA  150 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCC-CEEeccCCCCe
Confidence            899999997 5888887654   35689999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCCCc--ccccccccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          187 VLVKGEPN--ISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       187 ~~~~~~~~--~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      ........  ....||+.|+|||++..     ...++.++|||||||++|+|++|+.||...+....+.++......   
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---  227 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---  227 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---
Confidence            65433222  23468999999999853     334788999999999999999999999988777666655542100   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                                  ..++.          ...+++++.+||.+||+ +|.+|||++++++||||+.+++.
T Consensus       228 ------------~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         228 ------------LKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             ------------cCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                        01111          13578999999999998 99999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-46  Score=353.56  Aligned_cols=254  Identities=29%  Similarity=0.481  Sum_probs=203.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5899999999999999999999999999999986432       1234789999999999999999988     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||||+++ +|.+.+...    ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            999999985 787777653    5689999999999999999999988 999999999999999888 899999998753


Q ss_pred             ccCCC------------------------------------------------CcccccccccccccccccCCCCCCCch
Q 017341          188 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTAAI  219 (373)
Q Consensus       188 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~  219 (373)
                      .....                                                ......||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence            21000                                                01234689999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHH
Q 017341          220 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  299 (373)
Q Consensus       220 DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  299 (373)
                      |||||||++|+|++|++||...+..+....+......               ...+.          ...+++++.+||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence            9999999999999999999887766555544421000               00110          1257899999999


Q ss_pred             hhcCcCC--CCCCCHHHHhcCCCccccCC
Q 017341          300 RLLQYSP--NLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       300 ~~L~~dP--~~R~t~~~ll~hp~~~~~~~  326 (373)
                      +|+..++  ..|++++++++||||+++++
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9765544  45999999999999998755

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.9e-46  Score=336.18  Aligned_cols=276  Identities=34%  Similarity=0.648  Sum_probs=217.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||+|++|.||+|++..+++.||+|.+....      ....+|+.+++.++||||+++++++.     +..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4899999999999999999999999999999885432      23457999999999999999999883     344588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +||||+.+++.+.+.... ....+++..++.++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988887776532 235689999999999999999999988 999999999999999888 89999999987543


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  266 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  266 (373)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+.+..+.+....+....  
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 12234568899999998766567899999999999999999999999988877777777776665544332111  


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      +.+.. ..+......... ....+++++.++|.+||+.||.+|||+.+++.||||
T Consensus       233 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYKN-TFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHh-hccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00000 011111111111 124588999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-46  Score=351.24  Aligned_cols=259  Identities=28%  Similarity=0.454  Sum_probs=210.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|++.+.||+|+||.||++++..+++.+|+|.+.+.       .....+|+.+++.++||||+++++++     .+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence            3456899999999999999999999999999999988532       12244789999999999999999988     45


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..++|+|||||+ |+|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~-~~kL~DFG  187 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHG-HLKLADFG  187 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEEecc
Confidence            556899999998 488877753     3588999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCCC--cccccccccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ++........  .....||+.|+|||++.+..   .++.++|+|||||++|+|++|++||.+.+......++......  
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~--  265 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--  265 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc--
Confidence            9976533221  23557999999999986432   3788999999999999999999999988877666665542110  


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDP  327 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~~  327 (373)
                                   ..++.          ...++..++++|.+||..++.+  |+|++++++||||+...+.
T Consensus       266 -------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~  313 (370)
T cd05621         266 -------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN  313 (370)
T ss_pred             -------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence                         01110          1247899999999999866544  8999999999999885443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.5e-47  Score=355.63  Aligned_cols=254  Identities=29%  Similarity=0.476  Sum_probs=205.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .|++.+.||+|+||.||+|++..+++.||+|.+.+..       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5999999999999999999999999999999886432       2344799999999999999999988     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+|||||++ +|.+.+.+.    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999985 787777643    5688999999999999999999988 999999999999999988 799999998742


Q ss_pred             ccCC------------------------------------------------CCcccccccccccccccccCCCCCCCch
Q 017341          188 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAI  219 (373)
Q Consensus       188 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~  219 (373)
                      ....                                                .......||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001134689999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHH
Q 017341          220 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  299 (373)
Q Consensus       220 DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  299 (373)
                      |||||||++|+|++|++||.+.+..+....+......               ...+          ....+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence            9999999999999999999988776655554431100               0111          01357899999999


Q ss_pred             hhcCcCCCCCCC---HHHHhcCCCccccCCC
Q 017341          300 RLLQYSPNLRST---ALEALIHPFFDELRDP  327 (373)
Q Consensus       300 ~~L~~dP~~R~t---~~~ll~hp~~~~~~~~  327 (373)
                      +|+ .+|.+|++   ++++++||||+.+.+.
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            986 59999997   9999999999987553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-45  Score=336.80  Aligned_cols=287  Identities=35%  Similarity=0.585  Sum_probs=227.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ....+|++.+.||.|+||.||+|.+..+|+.||+|.+.....      ...+|+.+++.++|+||+++++++..   ...
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHL   80 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCC
Confidence            345689999999999999999999999999999998853321      23479999999999999999988743   222


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+++||||+.++|.+.+...   ...+++..++.++.||+.||+|||+. |++||||||+||+++.++ .++|+|||.+
T Consensus        81 ~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~kL~dfg~~  155 (309)
T cd07845          81 DSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKG-CLKIADFGLA  155 (309)
T ss_pred             CeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcccee
Confidence            357899999999888887654   25689999999999999999999998 999999999999999888 8999999998


Q ss_pred             eeccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ....... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..+....+.+....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            7654332 122334578899999987666689999999999999999999999999999999999988887776554332


Q ss_pred             cC--cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          265 MN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       265 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ..  +....+..+......+...+ ...++.+.+||++||++||++|||+++++.||||+...-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             hhcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            21  11111122111111111111 2368899999999999999999999999999999875544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-46  Score=345.55  Aligned_cols=245  Identities=27%  Similarity=0.426  Sum_probs=202.4

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||++++..+|+.||+|.+....       ....+|+.+++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            47999999999999999999999999886432       1223689999999999999999887     34456899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC-
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  191 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-  191 (373)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 67666554    35689999999999999999999998 999999999999999888 8999999998753222 


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      .......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345789999999999654 4899999999999999999999999887766555544321                 0


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                      .            .++..+++++.++|.+||+.||.+|+     ++.++++||||.+..+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            0            12246889999999999999999998     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=328.90  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=219.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch-------HHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|...++||+|.||.|-+|+.+.+|+.||+|.++++-...       ..|-++|+..+||++..+...|     +.
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt  239 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QT  239 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----cc
Confidence            34568999999999999999999999999999999876654322       2578899999999999998877     44


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||..| .|...+.+    ...+++..++.+-..|+.||.|||++ +||+||||.+|+|+|.+| .|||+|||
T Consensus       240 ~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDG-HIKitDFG  313 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDG-HIKITDFG  313 (516)
T ss_pred             CceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCC-ceEeeecc
Confidence            5569999999995 66655554    36799999999999999999999998 999999999999999999 69999999


Q ss_pred             ceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +|+.... +....+++|||.|+|||++. ...|+.++|+|.+||+||||++|+.||...+.......|+-.         
T Consensus       314 LCKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---------  383 (516)
T KOG0690|consen  314 LCKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---------  383 (516)
T ss_pred             cchhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---------
Confidence            9986544 34456889999999999995 456999999999999999999999999998887777776642         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDPN  328 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~~  328 (373)
                              +.            .|+..++++++.|+..+|..||.+|..     +.++.+|+||..++|..
T Consensus       384 --------d~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 --------DL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             --------hc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                    22            245689999999999999999999974     79999999999998753

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-46  Score=346.55  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=201.4

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||++.+..+|+.||+|.+....       ....+|+.+++.++||||+++..++     .+...+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999886432       1234688999999999999998887     44456889999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC-
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  191 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-  191 (373)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 77666654    35689999999999999999999998 999999999999999888 8999999998753222 


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            222345789999999999654 4899999999999999999999999887665544433221                 0


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                      .            .++..+++++.+||.+||+.||.+|+     ++.++++||||...++
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            0            12346889999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-46  Score=344.45  Aligned_cols=251  Identities=28%  Similarity=0.416  Sum_probs=206.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhC-CCCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+.+...       ....|..++..+ .|++|+++++++     .+..+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            48999999999999999999999999999998864321       123466666666 588999998887     44456


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||++ |+|...+...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            889999998 5777776543    5688999999999999999999998 999999999999999988 79999999987


Q ss_pred             eccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .... ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 2223356789999999999654 48999999999999999999999999888776666655420           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~ll~hp~~~~~~~~  327 (373)
                            .            .++..++.++.+++.+||+.||.+|++.     .++++||||+.+++.
T Consensus       218 ------~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         218 ------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             ------C------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                  0            1224688999999999999999999984     899999999987653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-46  Score=336.00  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     ....++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            5899999999999999999999999999999885432       1234699999999999999998887     344468


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+.+ +|...+...  ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            999999985 777666543  235689999999999999999999998 999999999999999887 799999999876


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........|++.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+.......+...+....         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            5444333455789999999999654 489999999999999999999999988765544444433211100         


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                                      ..++..++..+.+||.+||..||.+||     +++++++||||...++.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                            012245788999999999999999999     99999999999986553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=324.62  Aligned_cols=262  Identities=29%  Similarity=0.459  Sum_probs=213.5

Q ss_pred             cccceEee-eeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEE
Q 017341           33 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        33 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .+++|.+. ++||-|-.|.|..|.++.||+.+|+|++ .+.....+|+++--.. .|||||.++++|.... .+..++-+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL-~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL-LDSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHH-hcCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEe
Confidence            35577775 4899999999999999999999999965 4555667888876554 6999999999985544 45677889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccceee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~a~~  187 (373)
                      |||.|+| .|...+..+.  ...++|.++..+++||..|+.|||+. +|.||||||+|+|....+  -.+||+|||+|+.
T Consensus       137 VmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccc
Confidence            9999995 6777776653  46699999999999999999999987 999999999999996543  2699999999987


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHh
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV----DQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~  263 (373)
                      -.......+.+.||+|.|||++ +...|+...|+||+||++|.|++|.+||.+....    ....+|....         
T Consensus       214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq---------  283 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ---------  283 (400)
T ss_pred             cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC---------
Confidence            6555556678899999999999 4556999999999999999999999999876532    3334443322         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                              +.||..   .|     +.+|++++++|+++|..+|.+|.|++++++|||+.+..
T Consensus       284 --------y~FP~p---EW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  284 --------YEFPEP---EW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             --------ccCCCh---hH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence                    222221   11     46899999999999999999999999999999998753

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-46  Score=353.82  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=204.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .|++.+.||+|+||.||+|++..+++.||+|.+.+..       ....+|+.+++.++||||+++++.+     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999885421       2244799999999999999999887     445568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+|||||+ |+|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            99999998 5788877653    5688999999999999999999998 999999999999999888 899999998742


Q ss_pred             ccCC--------------------------------------------CCcccccccccccccccccCCCCCCCchhHHH
Q 017341          188 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWS  223 (373)
Q Consensus       188 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diws  223 (373)
                      ....                                            .......||+.|+|||++.+. .++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence            2100                                            000134689999999999654 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcC
Q 017341          224 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  303 (373)
Q Consensus       224 lG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  303 (373)
                      |||++|+|++|+.||.+.+..+....+.....               ....+          ....+++++.++|.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCC----------CCCCCCHHHHHHHHHHh-
Confidence            99999999999999998876665544432100               00000          11357899999999977 


Q ss_pred             cCCCCCC---CHHHHhcCCCccccCC
Q 017341          304 YSPNLRS---TALEALIHPFFDELRD  326 (373)
Q Consensus       304 ~dP~~R~---t~~~ll~hp~~~~~~~  326 (373)
                      .+|.+|+   |+.++++||||+.++.
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            4999999   9999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.7e-46  Score=335.64  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||+|+||+||++.+..+++.+|+|.+....       .....|+.+++.++|+||+++.+++     .....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            689999999999999999999999886432       1224689999999999999998887     4445688999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC-
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  193 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~-  193 (373)
                      ++ +|...+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 77766654433456789999999999999999999998 999999999999999887 799999999876543322 


Q ss_pred             cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017341          194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  273 (373)
Q Consensus       194 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      .....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+.......                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            2345789999999999654 58999999999999999999999998765432222222211000                


Q ss_pred             CCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                               ...++..++.++.+++.+||+.||++||     +++++++||||++..+.
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                     0012346889999999999999999999     88999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-45  Score=341.12  Aligned_cols=319  Identities=35%  Similarity=0.633  Sum_probs=242.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..+|.+.+.||.|++|.||++.+..+++.||+|.+...      .....+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35799999999999999999999999999999987542      122346999999999999999999775443333345


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+++||++++|.+.+..    ..++++..+..++.||+.||.|||++ +++|+||||+||+++.++ .+||+|||++..
T Consensus        84 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcCccccc
Confidence            889999999988877764    35689999999999999999999988 999999999999999888 899999999876


Q ss_pred             ccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .... .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+....+.+..+.+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            5333 222345678899999998654458999999999999999999999999988888888888877777766543221


Q ss_pred             c-Ccccc--cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCC
Q 017341          267 P-NYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNF  343 (373)
Q Consensus       267 ~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~  343 (373)
                      . ....+  ..+......... ..+.+++++.++|.+||+.+|++|||++++++||||..+.++......    +..+.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~----~~~~~~  312 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC----QTPFSF  312 (337)
T ss_pred             chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC----CCccch
Confidence            1 10000  011111111111 124688999999999999999999999999999999998776532221    223334


Q ss_pred             ChhhcCCCCHHHHhhhchHHH
Q 017341          344 KPHELKGVPVDMLVKLIPEHA  364 (373)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~  364 (373)
                      + .+..++..+.+++++..+.
T Consensus       313 ~-~~~~~~~~~~~~~~~~~~~  332 (337)
T cd07858         313 D-FEEDALTEEDIKELIYNEM  332 (337)
T ss_pred             h-hhhhhcCHHHHHHHHHHHH
Confidence            3 2233366777777766543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.7e-46  Score=342.00  Aligned_cols=250  Identities=28%  Similarity=0.435  Sum_probs=204.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCC-CeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~  107 (373)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..+.       .....|..++..++|+ +|+++++++     .+..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            5899999999999999999999999999999886432       1234678888888765 577887777     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+++ +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999984 777776543    5688999999999999999999998 999999999999999888 89999999986


Q ss_pred             eccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .... ........||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            4322 2223355789999999999654 48999999999999999999999999887766665554310           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRD  326 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~ll~hp~~~~~~~  326 (373)
                                        ..++..+++++.++|.+||..||.+|++.     +++++||||+.+++
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              01224578999999999999999999986     89999999998755

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-46  Score=343.07  Aligned_cols=248  Identities=27%  Similarity=0.449  Sum_probs=202.8

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHH---HhCCCCCeeecceeeeecCCCCce
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      |++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|..++   +.++||||+++++++     .+..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            788999999999999999999999999999986432       1222454444   566899999999988     4445


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|+||||+.+ +|...+.     ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            68999999996 6655543     25689999999999999999999998 999999999999999988 8999999998


Q ss_pred             eeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ...... .......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            653222 223356789999999999654 58999999999999999999999999887766665554310          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                             .            .++..++.++.++|.+||+.||.+||     ++.++++||||+.+.+
T Consensus       218 -------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         218 -------V------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                   0            12245789999999999999999999     7999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.4e-46  Score=344.72  Aligned_cols=255  Identities=30%  Similarity=0.456  Sum_probs=203.0

Q ss_pred             ceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      +|++.+.||+|+||.||+|++.   .+++.||+|.+.+..        ....+|+.+++.+ +||+|+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   578999999885421        1234688999999 599999998887     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ....+++||||+.+ +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCC-CEEEeeC
Confidence            45568899999985 777777643    5689999999999999999999988 999999999999999988 8999999


Q ss_pred             cceeeccCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          183 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       183 g~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      |+++......  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...........+...+..    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9987543322  2234578999999999976555789999999999999999999999754332222222211100    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                          .                 ...++..+++.+.++|.+||+.||++||     +++++++||||+...+
T Consensus       226 ----~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 ----C-----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ----C-----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                0                 0012246789999999999999999999     8899999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=339.62  Aligned_cols=273  Identities=28%  Similarity=0.410  Sum_probs=226.0

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      .|.....|+.-++||+||||.||-|....||+.||+|++.+..       ....+|..+|..++.++||.+-.+|.+   
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT---  256 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET---  256 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC---
Confidence            4556678999999999999999999999999999999875432       122368999999999999999888844   


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                        ...+|+||..|+| +|.-.+.+..  +..+++..+..++++|+.||.+||+. +||+|||||+|||+|..| .++|+|
T Consensus       257 --kd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~G-hvRISD  330 (591)
T KOG0986|consen  257 --KDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHG-HVRISD  330 (591)
T ss_pred             --CCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCC-CeEeec
Confidence              3349999999995 7766666653  35799999999999999999999988 999999999999999999 699999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      +|+|..+..+.+....+||..|||||++.+.. |+...|+|||||++|+|+.|+.||..........++-+..-..+   
T Consensus       331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~---  406 (591)
T KOG0986|consen  331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP---  406 (591)
T ss_pred             cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch---
Confidence            99999998888888889999999999997665 99999999999999999999999987655444434433321111   


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCCCCCCCCCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDPNTRLPNGRF  336 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~~~~~~~~~~  336 (373)
                                            ..++..+|++++++...+|+.||++|.     +++++.+||||+.+++.  ++..+.+
T Consensus       407 ----------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~--rleagml  462 (591)
T KOG0986|consen  407 ----------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR--RLEAGML  462 (591)
T ss_pred             ----------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh--HHhccCC
Confidence                                  123467999999999999999999997     57899999999998864  4444444


Q ss_pred             CCC
Q 017341          337 LPP  339 (373)
Q Consensus       337 ~~~  339 (373)
                      .||
T Consensus       463 ~PP  465 (591)
T KOG0986|consen  463 EPP  465 (591)
T ss_pred             CCC
Confidence            444

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.5e-46  Score=340.29  Aligned_cols=245  Identities=28%  Similarity=0.469  Sum_probs=199.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHh-CCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.++.+|+.||+|.+....       .....|..++.. ++||||+++++++     .+..++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999886432       122356666664 4899999999988     4455689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC-
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  190 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-  190 (373)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 77766654    35689999999999999999999998 999999999999999888 899999999864322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....            +   
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~------------~---  213 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------------P---  213 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------C---
Confidence            2223456789999999999654 48999999999999999999999998877655544433210            0   


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~~ll~hp~~~~~~~  326 (373)
                                    .++..++.++.+||.+||+.||++|+++ +++++||||+.+.+
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                          1123478899999999999999999998 58889999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-45  Score=339.87  Aligned_cols=280  Identities=25%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||++++..+|..+|+|.+....     ....+|+++++.++||||+++++++.     +...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            468999999999999999999999999999999886432     23457999999999999999999884     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+++ +|.+.+...    ..+++..+..++.|++.||.|||++.+|+||||||+||+++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccc
Confidence            899999995 888777653    56889999999999999999999853699999999999999888 799999999875


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+....+-...............+
T Consensus       154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence            5332 23345789999999999654 489999999999999999999999987765443222111000000000000000


Q ss_pred             Cc----cc---ccCCC------------cCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          268 NY----TE---FKFPQ------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       268 ~~----~~---~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      ..    ..   .....            .............+++++++||.+||++||++|||++++++||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            00    00   00000            0000000001124788999999999999999999999999999998743

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=373.72  Aligned_cols=271  Identities=28%  Similarity=0.451  Sum_probs=231.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+|.++++||.|+||.|.+++++.|++.||+|++++..       ..+..|..+|..-+.+-|+.++.+|     +|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            3458999999999999999999999999999999886532       3345788999988999999999888     889


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .|+|+||||++| +|..+|.++    .++++..+++|+..|+.||.-+|+- |+|||||||+|||+|..| .|||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~G-HikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSG-HIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccC-cEeeccchh
Confidence            999999999995 888888875    4799999999999999999999976 999999999999999999 599999999


Q ss_pred             eeeccCCCC--cccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          185 AKVLVKGEP--NISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       185 a~~~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |-.+..+..  ....+|||.|++||++..    ...|+..+|+||+||++|||+.|..||...+-.+++.+|+.--    
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence            876653322  346689999999999952    2468999999999999999999999999999999999998641    


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCCCCCCCCCCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDPNTRLPNGR  335 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~ll~hp~~~~~~~~~~~~~~~~  335 (373)
                                 ..+.||..          ..+|.++++||.++++ +|+.|..   ++++.+||||.+++|.+.|...++
T Consensus       298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence                       12233321          3589999999999998 7889988   999999999999999777766666


Q ss_pred             CCCCC
Q 017341          336 FLPPL  340 (373)
Q Consensus       336 ~~~~~  340 (373)
                      ++|.+
T Consensus       356 ~vPev  360 (1317)
T KOG0612|consen  356 VVPEV  360 (1317)
T ss_pred             CCCcC
Confidence            66655

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.6e-45  Score=336.67  Aligned_cols=277  Identities=32%  Similarity=0.570  Sum_probs=205.7

Q ss_pred             eeeeeecCceEEEEEEECC--CCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           40 ERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ..+||+|+||.||+|++..  ++..+|+|.+....  ....+|+.+++.++||||+++++++..   .....++++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence            3579999999999999754  56889999886543  234589999999999999999998754   2344578999999


Q ss_pred             cccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc----CCCCceeEeecccee
Q 017341          116 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAK  186 (373)
Q Consensus       116 ~g~l~~~l~~~~~-----~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~----~~~~~ikl~Dfg~a~  186 (373)
                      ++++...+.....     ....+++..++.++.||+.||.|||++ ||+||||||+||++.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9998888764321     123588899999999999999999998 999999999999993    344 79999999997


Q ss_pred             eccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 017341          187 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV  253 (373)
Q Consensus       187 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---------~~~~~~i~~~  253 (373)
                      .......    .....+|+.|+|||++.+...++.++|||||||++|+|+||++||.....         .....++...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543321    22456799999999997666689999999999999999999999976432         2445566666


Q ss_pred             hCCCCHHHHhhcC--cCcccc-------cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          254 LGTPTREEIKCMN--PNYTEF-------KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       254 ~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      .+.+....+....  +.+...       ..................+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            6665554433211  111000       0000000000111112356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.7e-45  Score=331.44  Aligned_cols=276  Identities=41%  Similarity=0.771  Sum_probs=226.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||+|.+..+|+.+|+|.+....      ....+|+.+++.++||||+++++++     .+..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            5899999999999999999999999999999886443      2345799999999999999999988     3455689


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +||||++++|.+.+...   ...+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977888887654   26689999999999999999999998 999999999999999887 89999999987654


Q ss_pred             CCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 017341          190 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  266 (373)
Q Consensus       190 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  266 (373)
                      ....  .....++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+....+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            3321  2345689999999998766667899999999999999999999999988888888888888887765554322 


Q ss_pred             -cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                       ..+....++.....++...+ ++.+.++.++|.+||..+|++|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             12222333333222332222 45779999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.1e-46  Score=346.25  Aligned_cols=259  Identities=28%  Similarity=0.437  Sum_probs=209.5

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .....+|++.+.||+|+||.||+|++..+++.+|+|.+....       ....+|..+++.++||||+++++++     .
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~  113 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----Q  113 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----E
Confidence            344579999999999999999999999999999999885321       2234788999999999999999887     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +..++|+||||++ |+|.+.+..     ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~-~ikL~Df  186 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADF  186 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCC-CEEEEeC
Confidence            4566899999998 478777653     4588999999999999999999998 999999999999999888 7999999


Q ss_pred             cceeeccCCC--CcccccccccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |++.......  ......||+.|+|||++.+..   .++.++|||||||++|+|++|++||.+.+......++...... 
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-  265 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-  265 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc-
Confidence            9997654322  123567999999999986432   3788999999999999999999999988876666666542111 


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  326 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~  326 (373)
                                    ..++          ....++..++++|.+||..++.+  |++++++++||||++..+
T Consensus       266 --------------~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         266 --------------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             --------------ccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                          0111          01358999999999999844443  789999999999988544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6e-46  Score=342.44  Aligned_cols=246  Identities=25%  Similarity=0.473  Sum_probs=196.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+++.||+|.+.+..       ....+|..+++.+ +||||+++++++     .+..++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986432       1234688888888 799999999988     4445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC-
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  190 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-  190 (373)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 77666654    36799999999999999999999988 999999999999999888 899999999864322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  262 (373)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .+...+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            2233456789999999999654 489999999999999999999999964211        1111111110         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------ALEALIHPFFDELRD  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~ll~hp~~~~~~~  326 (373)
                             ..            ..++..++.++.++|++||+.||.+|+|      ++++++||||..+.+
T Consensus       220 -------~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 -------KQ------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             -------CC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   00            0123467899999999999999999987      789999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-45  Score=344.30  Aligned_cols=278  Identities=24%  Similarity=0.368  Sum_probs=206.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|....  .....|+.+++.++||||+++++++.     ...+.++|||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--cccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEE
Confidence            3479999999999999999999999999999997433  33457999999999999999999884     3345789999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC
Q 017341          114 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  193 (373)
Q Consensus       114 ~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~  193 (373)
                      ++.++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++........
T Consensus       138 ~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        138 HYSSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             ccCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEecCccccccccCcc
Confidence            9999988887654   36689999999999999999999998 999999999999999888 799999999875443333


Q ss_pred             cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHh
Q 017341          194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       194 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .....||+.|+|||++.+. .++.++|+|||||++|+|+++. ++|.....         ...+..+....+........
T Consensus       213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4456789999999999654 4899999999999999999854 55544321         12333334433322211000


Q ss_pred             hcCcCc-c-cccCCCcCCCCc---cccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          264 CMNPNY-T-EFKFPQIKAHPW---HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       264 ~~~~~~-~-~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      ...... . ..........++   ...-..+++.++.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            000000 0 000000000010   001113578889999999999999999999999999999863

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.4e-46  Score=339.26  Aligned_cols=245  Identities=31%  Similarity=0.489  Sum_probs=198.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHh-CCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+++.||+|.+..+.       .....|..++.. .+||||+++++++     ....++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999886432       112245555554 4899999999887     4445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||++| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99985 77766654    35689999999999999999999998 999999999999999888 8999999998754332


Q ss_pred             C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      . ......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------  212 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------  212 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            2 23355789999999999654 48999999999999999999999999887766555543210                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~~ll~hp~~~~~~~  326 (373)
                                   ..++..++.++.+||.+||+.||.+|+++ .++++||||+.+.+
T Consensus       213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                         01224578899999999999999999986 58889999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.3e-46  Score=341.77  Aligned_cols=245  Identities=29%  Similarity=0.481  Sum_probs=202.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|++..+++.||+|.+..+.       .....|.+++..+ +||||+++++++     .+...+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999999999999999886432       1123577777755 799999999988     4445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 77766654    35688999999999999999999998 999999999999999988 8999999998754322


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345789999999998654 48999999999999999999999999888777666654310                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-------CHHHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-------TALEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-------t~~~ll~hp~~~~~~~  326 (373)
                       .            .++..++.++.++|.+||+.||++|+       +++++++||||..+++
T Consensus       213 -~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         213 -V------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             -C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence             0            12234788999999999999999999       9999999999988755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-48  Score=342.69  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=211.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .....|+..+.||.|.||.||+|.+..+++.||+|++..+..     .+.+|+.++..++++||.++++.|+.     ..
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-----g~   84 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-----GT   84 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-----cc
Confidence            344579999999999999999999999999999999865543     33589999999999999999999854     33


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .++++||||.| ++.+.++.    +..+.+..+..++++++.||.|||.+ +.+|||||+.||++..+| .+||+|||.+
T Consensus        85 ~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g-~vkl~DfgVa  158 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESG-DVKLADFGVA  158 (467)
T ss_pred             cHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccC-cEEEEeccee
Confidence            48999999995 77777764    34458888999999999999999998 999999999999999997 8999999999


Q ss_pred             eeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ........ ..+++|||.|||||++.+ ..|+.++||||||++.+||++|.+|+....+...+..|-+            
T Consensus       159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk------------  225 (467)
T KOG0201|consen  159 GQLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK------------  225 (467)
T ss_pred             eeeechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC------------
Confidence            77655433 368899999999999974 4599999999999999999999999988765333222221            


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                  ..    ...+...+|+.+++|+..||.+||+.||||.+||+|+|++..
T Consensus       226 ------------~~----PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  226 ------------SA----PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             ------------CC----CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                        11    011224688999999999999999999999999999999874

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.3e-47  Score=323.30  Aligned_cols=288  Identities=37%  Similarity=0.628  Sum_probs=230.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCc----EEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      .....|++.+.||+|.||.||+|..+.++.    .+|+|++..++.      ..-+|+.+++.++|||++.+..+|... 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence            345689999999999999999997655433    689999865532      223899999999999999999998642 


Q ss_pred             CCCceeEEEEEecccccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC----CCc
Q 017341          102 EKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQ  176 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g~l~~~l~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~----~~~  176 (373)
                         +..+++++||.+.+|+..++.+.. ....++...++.++.||+.|++|||++ =|+||||||.|||+..+    | .
T Consensus       100 ---d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG-~  174 (438)
T KOG0666|consen  100 ---DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERG-R  174 (438)
T ss_pred             ---CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccC-e
Confidence               556899999999999999987653 345689999999999999999999988 89999999999999877    5 8


Q ss_pred             eeEeeccceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------c
Q 017341          177 LKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------G  243 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~---------~  243 (373)
                      |||+|||+++.+.+.-..    ...+.|.+|+|||.+.+...|+.+.|+|++|||+.||+|-.+.|.+..         -
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            999999999877554322    245679999999999999999999999999999999999999997742         3


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcC--cCcccc--cCC--CcCCCCcccccc--CCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMN--PNYTEF--KFP--QIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~--~~~--~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                      .+++.+|++.+|.|+...++.+.  |.+...  .++  ......+...+.  +.-++.+.+|+.+||.+||.+|.|++++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            47789999999999998776553  222100  111  111111111111  2345669999999999999999999999


Q ss_pred             hcCCCccccC
Q 017341          316 LIHPFFDELR  325 (373)
Q Consensus       316 l~hp~~~~~~  325 (373)
                      |+|+||..-.
T Consensus       335 leh~yF~~d~  344 (438)
T KOG0666|consen  335 LEHPYFTEDP  344 (438)
T ss_pred             hcccccccCC
Confidence            9999998743

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.9e-46  Score=344.16  Aligned_cols=246  Identities=28%  Similarity=0.426  Sum_probs=201.4

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||++.+..+|+.||+|.+....       ....+|+++++.++||||+++.+++     ....++|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999886432       1224688899999999999998887     44456899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+ . ||+||||||+||+++.++ .+||+|||+++.....
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCC-CEEEecCCCCeecCCC
Confidence            9985 66666543    3568999999999999999999997 6 999999999999999888 8999999998754322


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------  211 (325)
T cd05594         150 GATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------  211 (325)
T ss_pred             CcccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------
Confidence             222345789999999999654 4899999999999999999999999887765554443321                 


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                      ..            .++..+++++.+||.+||+.||.+|+     ++.++++||||.++.+.
T Consensus       212 ~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         212 EI------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            00            12246789999999999999999997     99999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.9e-45  Score=331.36  Aligned_cols=286  Identities=34%  Similarity=0.592  Sum_probs=221.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. ||||+++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36999999999999999999999999999999875432      23457999999995 699999998875544334455


Q ss_pred             EEEEEecccccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .|++|||+++++.+.+...... ...+++..++.++.||+.||.|||++ ||+||||+|+||+++.+++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7899999999988888755432 35689999999999999999999998 999999999999999834489999999987


Q ss_pred             eccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...... ......+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+....+..+.+..+.+....+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            543221 1223356888999999866556799999999999999999999999998888888888877766665433211


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                      ........++........ ...+.++.++.+||.+||..||.+|||+.+++.||||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            110000011111111111 11245789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4e-46  Score=347.90  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=206.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|..++..++||+|+++++.+     .+..+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            36999999999999999999999999999999885421       2234688999999999999999887     45556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||++| +|.+.+.+.    ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~-~vkL~DfG~~~  149 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKG-HVKLSDFGLCT  149 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEeeccCCc
Confidence            8999999985 787777643    5689999999999999999999988 999999999999999888 89999999986


Q ss_pred             eccCCC------------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHH
Q 017341          187 VLVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  230 (373)
Q Consensus       187 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~  230 (373)
                      ......                                    .....+||+.|+|||++.+. .++.++|+|||||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilye  228 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeee
Confidence            432110                                    01134689999999999654 48999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC
Q 017341          231 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  310 (373)
Q Consensus       231 lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  310 (373)
                      |++|++||.+.+.......+.....               ...++.          ...+++++++||.+|+. ||.+|+
T Consensus       229 l~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~  282 (360)
T cd05627         229 MLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRI  282 (360)
T ss_pred             cccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcC
Confidence            9999999998887766665543100               001110          02368899999999874 999998


Q ss_pred             ---CHHHHhcCCCccccCCC
Q 017341          311 ---TALEALIHPFFDELRDP  327 (373)
Q Consensus       311 ---t~~~ll~hp~~~~~~~~  327 (373)
                         +++++++||||+++++.
T Consensus       283 ~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         283 GSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCCHHHHhcCCCCCCCCHH
Confidence               48999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7e-45  Score=330.87  Aligned_cols=282  Identities=37%  Similarity=0.650  Sum_probs=223.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc---------hHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+......         ...|+++++.++|+||+++++++     .+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            588999999999999999999999999999998654322         24689999999999999999988     3345


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++++||||+.++|...+....   ..+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            688999999778888876531   3689999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            654432 2223456888999999866556889999999999999999999999998888888888777776665544322


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ...-...........+... .....+..+.++|.+||..||++|||+.+++.||||++...++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            1110011111111111111 1245688999999999999999999999999999999976554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=339.65  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=207.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||+|+||.||++++..+++.||+|.+.+..       ....+|..+++.++|+||+++++++     .+..+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            37999999999999999999999999999999986421       2234688899999999999999888     44556


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+. ++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~  150 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNG-HIRLADFGSCL  150 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCC-CEEEEECCcee
Confidence            899999997 5888887643   35689999999999999999999998 999999999999999888 89999999987


Q ss_pred             eccCCCCc--ccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          187 VLVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       187 ~~~~~~~~--~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ........  ....||+.|+|||++..    ...++.++|+|||||++|+|++|+.||.+.+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH----  226 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            65433222  23468999999999853    234788999999999999999999999887766665555431100    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  326 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~  326 (373)
                                 +.++.         ....++.++++||++||+.++.+  |++++++++||||.+.++
T Consensus       227 -----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         227 -----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             -----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                       01110         11347899999999999765554  789999999999988765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.1e-45  Score=339.63  Aligned_cols=286  Identities=33%  Similarity=0.585  Sum_probs=224.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..... .+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3468999999999999999999999999999999875421      123469999999999999999998753321 223


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+.|+||||+.+++.+.+..      .+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCccc
Confidence            45789999999988877653      278889999999999999999988 999999999999999988 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .............+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+......++...++.+..+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            876444333445688999999999654 5899999999999999999999999999888888888888888876543332


Q ss_pred             CcCcccc--cCCCcCCCCccccc------------cCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 NPNYTEF--KFPQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~~~~~~--~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ......+  ..+.....++...+            ....+..+.++|.+||+.||++|||+.++|.||||+.+-++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            2111100  00000011111111            12356789999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-45  Score=338.94  Aligned_cols=245  Identities=29%  Similarity=0.492  Sum_probs=201.1

Q ss_pred             eeeeecCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           41 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +.||+|+||.||+|++.   .+++.||+|.+....        ....+|+.+++.++||||+++++++     .....+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            67999999999999864   578999999885421        1234689999999999999999887     3445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999995 77766654    35688899999999999999999998 999999999999999888 8999999998754


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            3222 22345789999999999654 47899999999999999999999999887666555554310             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                          .            .++..+++++.+||.+||+.||++||     +++++++||||+...+
T Consensus       217 ----~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         217 ----L------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ----C------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                0            12245788999999999999999999     8999999999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-45  Score=336.48  Aligned_cols=314  Identities=38%  Similarity=0.656  Sum_probs=242.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||+|++..+++.+|+|.+....      ....+|+.+++.++|+||+++.+++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999999999999999886432      2345799999999999999999987554323334688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ++|||++++|.+.+...    ..+++..++.++.||+.||++||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        81 lv~e~~~~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            99999998887777642    4789999999999999999999998 999999999999999987 89999999998764


Q ss_pred             CCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          190 KGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       190 ~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...    ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            442    1234567899999999976646899999999999999999999999999999999999888888777655421


Q ss_pred             CcC-cccc--cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCC
Q 017341          266 NPN-YTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN  342 (373)
Q Consensus       266 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~  342 (373)
                      ... ...+  ..+.....++... .+.++.++.++|.+||+++|.+|||+++++.||||+++..+....+.    ...++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~----~~~~~  309 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA----KPPFD  309 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC----CCccc
Confidence            111 0000  0111112222222 24578999999999999999999999999999999998776433222    22234


Q ss_pred             CChhhcCCCCHHHHhhhc
Q 017341          343 FKPHELKGVPVDMLVKLI  360 (373)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~  360 (373)
                      +.+.+-+.+..+.+.+++
T Consensus       310 ~~~~~~~~~~~~~~~~~~  327 (330)
T cd07834         310 FDFFDDDELTEEELKELI  327 (330)
T ss_pred             ccccchhhcCHHHHhHHh
Confidence            444444445555555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.8e-46  Score=340.29  Aligned_cols=245  Identities=28%  Similarity=0.444  Sum_probs=199.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHH-HHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+|+.||+|.+.....       ...+|. .+++.++||||+++++++     .+...+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            479999999999999999999999999864321       112233 356788999999999887     3445688999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 77766654    35789999999999999999999998 999999999999999988 8999999998653222


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345789999999998654 48999999999999999999999999887666555554310                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~ll~hp~~~~~~~  326 (373)
                       .            .+...++..+.++|.+||+.||.+||++    .++++||||..+.+
T Consensus       213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 -L------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             -C------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence             0            0124578999999999999999999998    69999999988654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-45  Score=329.73  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||+|+||.||++.++.+|+.||+|.+..+.       .....|+++++.++||||+++.+++     .+..++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            689999999999999999999999885321       1223589999999999999998887     4455689999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  194 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~  194 (373)
                      .| +|...+....  ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            85 7776665432  34578888999999999999999998 999999999999999888 8999999998766544333


Q ss_pred             ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 017341          195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  274 (373)
Q Consensus       195 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  274 (373)
                      ....|++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.........+.......             ....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------EVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------cccc
Confidence            4457899999999996654 8999999999999999999999998754332222222210000             0000


Q ss_pred             CCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCCC
Q 017341          275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRDP  327 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~ll~hp~~~~~~~~  327 (373)
                                 ....++.++.++|++||+.||.+||++    ++++.||||+.++++
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence                       113578899999999999999999999    778899999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.2e-45  Score=330.45  Aligned_cols=280  Identities=37%  Similarity=0.632  Sum_probs=224.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+.....      ...+|+.+++.++||||+++++++...   +..+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence            4589999999999999999999999999999998854321      224799999999999999999887442   2256


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .|+||||++++|.+.+....   ..+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .++|+|||++..
T Consensus        81 ~~lv~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~~l~d~g~~~~  155 (293)
T cd07843          81 IYMVMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRG-ILKICDFGLARE  155 (293)
T ss_pred             EEEEehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-cEEEeecCceee
Confidence            88999999998888876542   4689999999999999999999988 999999999999999888 899999999876


Q ss_pred             ccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .... .......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+...++....+.+....+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            5443 222345678899999998765557899999999999999999999999998888888888888877776554321


Q ss_pred             --cCcccccCCCcCCCCccccccCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 --PNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        +..............+...++.. +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              11111111111222223334333 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.5e-45  Score=335.37  Aligned_cols=245  Identities=29%  Similarity=0.512  Sum_probs=199.2

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHh-CCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+++.||+|.+....       .....|..++.. ++||||+++++++     .+..++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999886432       122356667765 5899999999887     3344588999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||++ |+|...+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            9998 4787777642    5688999999999999999999998 999999999999999988 7999999998754222


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+..+....+...            .+   
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------~~---  213 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------------NP---  213 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CC---
Confidence             223456789999999999654 4899999999999999999999999887765555443321            00   


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-~ll~hp~~~~~~~  326 (373)
                                    .++..++.++.++|.+||+.||++|+++. ++++||||+.+.+
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence                          01234788999999999999999999996 8999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-46  Score=342.20  Aligned_cols=244  Identities=27%  Similarity=0.478  Sum_probs=196.7

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccccc-------hHHHHHHHHhC---CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      ||+|+||.||+|++..+++.||+|.+......       ...|..++..+   +||||++++.++     .....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            69999999999999999999999998543211       12355555544   699999999887     4445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 77766654    36689999999999999999999998 999999999999999888 8999999998654322


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22335678999999999976556899999999999999999999999887766555544321                 


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCccccC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TALEALIHPFFDELR  325 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~~ll~hp~~~~~~  325 (373)
                      ...++.           ..+++++.+||++||+.||.+||    +++++++||||....
T Consensus       213 ~~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 KVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCCC-----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            011111           24788999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.6e-45  Score=350.57  Aligned_cols=261  Identities=26%  Similarity=0.373  Sum_probs=214.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC---CC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  104 (373)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|.+....      ....+|+.++..++|+|++++++.+.....   ..
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            458999999999999999999999999999999885432      223468889999999999999877643321   22


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||+. |+|.+.+.........+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~-~vkL~DFG  188 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFG  188 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCC-CEEEEecc
Confidence            335789999998 589988887665567799999999999999999999998 999999999999999888 79999999


Q ss_pred             ceeeccCC---CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          184 SAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       184 ~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +++.....   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....     
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-----  262 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-----  262 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence            98765322   122346789999999999654 489999999999999999999999988776655554433110     


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                             ..++..+++++.+++.+||+.||.+||++.++++|||++...
T Consensus       263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                   012246889999999999999999999999999999987643

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=326.63  Aligned_cols=277  Identities=34%  Similarity=0.643  Sum_probs=216.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||.|++|.||++.+..+++.||+|.+....     ....+|+++++.++|+||+++++++     .+..+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            468999999999999999999999899999999885432     2234799999999999999999987     444568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||||+.++|.+.+...   ...+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++...
T Consensus        79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  153 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCC-CEEECcccccccc
Confidence            899999999888877654   24688999999999999999999988 999999999999999988 8999999998653


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .... ......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.. ..+....+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            2211 12233568889999998765568899999999999999999999998766 456666676777776665543322


Q ss_pred             c--CcccccCCCcCCCCccccccCCCC--hhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 P--NYTEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 ~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      .  .+.....+.....+....+ ..++  .++.++|.+||+.+|.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1  1111111111111111111 1344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9e-45  Score=335.49  Aligned_cols=288  Identities=36%  Similarity=0.668  Sum_probs=229.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..+|.+.+.||.|++|.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.... ....+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            368999999999999999999999999999999886532      12346899999999999999998774433 34456


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +++||||+.++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||.+..
T Consensus        83 ~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~  156 (334)
T cd07855          83 VYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDC-ELRIGDFGMARG  156 (334)
T ss_pred             EEEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEeccccccee
Confidence            889999999888777654    35589999999999999999999988 999999999999999988 899999999876


Q ss_pred             ccCCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          188 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       188 ~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ......     .....++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+....+.+....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            533221     123467889999999866556899999999999999999999999999988888888888888776654


Q ss_pred             hhcCcCccc---ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          263 KCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       263 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .........   ..++.....++.. ..+..+.++.++|++||+.+|.+|||+++++.||||+....+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence            322111000   0112222222222 12457899999999999999999999999999999998876654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-44  Score=324.59  Aligned_cols=276  Identities=36%  Similarity=0.666  Sum_probs=214.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|++|.||++.+..+|+.||+|.+....      +...+|+.+++.++|+|++++++++     ....++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            47999999999999999999999999999999875432      1234799999999999999999988     344568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||||+++++...+...   ...+++..++.++.||+.+|.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQG-QIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCC-cEEECccccceec
Confidence            899999998655554432   35689999999999999999999998 999999999999999888 8999999999765


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+.+..+............
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            4433 223446788999999987655688999999999999999999999998887777777666555443322111110


Q ss_pred             --CcccccCCCcCC-CCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 --NYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        -+.....+.... .+... ....++..+.+||.+||+.+|++|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              001111111111 11111 124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-44  Score=327.47  Aligned_cols=275  Identities=37%  Similarity=0.683  Sum_probs=218.1

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||+|++..+|+.+|+|.+..+.      ....+|+++++.++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4899999999999999999999999999999885432      2345799999999999999999987     3445688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +||||+.++|...+....  ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            999999988877776432  35689999999999999999999988 999999999999999888 89999999986543


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  266 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  266 (373)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|+||+.||.+.+..+...++.+..+.+....++...  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            222 12234568899999998765557889999999999999999999999988888888888877776654322110  


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      +.+. ..++.......... .+.++++++++|.+||+.||++|||++++++||||
T Consensus       232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0000 01111111111111 23578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-45  Score=328.37  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=205.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....       ....+|+.+++.++|++++.+.+.+     .+..++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            4888999999999999999999999999999885432       1234689999999999999998877     344468


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            999999985 7877775432  34589999999999999999999988 999999999999999888 799999999876


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........|++.|+|||.+.+. .++.++|+||+||++|+|++|+.||...................          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------  220 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----------
Confidence            5443333445789999999999654 48999999999999999999999998754322111111100000          


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                                     ...+...+++++.+||.+||+.||++|||     ++++++||||+++...
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         221 ---------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             ---------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                           00122457889999999999999999999     9999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-44  Score=325.27  Aligned_cols=275  Identities=37%  Similarity=0.653  Sum_probs=216.7

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |++.+.||+|++|.||++.+..+++.+|+|.+.....     ...+|+.+++.+. |+|++++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            7889999999999999999999999999998864321     1235888888885 99999999987432   2245789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+++++.+.+...   ...+++..++.++.||+.||.|||+. |++||||+|+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999999888887653   25689999999999999999999998 9999999999999998 6 899999999976654


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-c
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  269 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  269 (373)
                      ........+++.|+|||.+.....++.++|+|||||++|+|++|.+||.+.+..+....+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444444567899999998755555789999999999999999999999999888888888777776665432221111 1


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ..+.++......... ....++.++.++|.+||..+|++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            111222111111111 123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.9e-44  Score=327.48  Aligned_cols=282  Identities=35%  Similarity=0.644  Sum_probs=221.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||.|++|.||++.+..+|+.||+|.+....      ....+|+++++.++||||+++++++     .+..+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            47999999999999999999999999999999875432      2345799999999999999999988     344568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+||||+++++.+.+....  ...+++..++.++.||+.||+|||++ +++|+||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            8999999988887776432  23467888999999999999999998 99999999999999866557999999998754


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  266 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  266 (373)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+...++....+.+....+.... 
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3221 12234678899999998665568899999999999999999999999988888888887777766655433111 


Q ss_pred             -cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                       +.+. ...+...... .....+.+++++.+++.+||+.+|++||++.+++.||||++++.
T Consensus       234 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDYK-SAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhhh-hhcccCCCCC-HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence             1110 0011111111 11122467899999999999999999999999999999998753

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.8e-45  Score=336.96  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=207.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||+|+||.||+++++.+++.+|+|.+.+..       ....+|..++..++|++|+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            36999999999999999999999999999999885421       1234688889999999999999887     44456


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+. |+|.+.+.+.   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~-~~kL~DfG~a~  150 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSCL  150 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEeecchhe
Confidence            899999998 5888888653   35689999999999999999999988 999999999999999888 79999999987


Q ss_pred             eccCCCC--cccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          187 VLVKGEP--NISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       187 ~~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      .......  .....||+.|+|||++.+    ...++.++|+|||||++|+|++|+.||.+.+..+....+.....     
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----  225 (332)
T cd05623         151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----  225 (332)
T ss_pred             ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----
Confidence            5433222  123578999999999852    34578899999999999999999999998877666665543110     


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  326 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~  326 (373)
                                ...++.         ....++.++++||.+||+.++.+  |++++++++||||.++++
T Consensus       226 ----------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         226 ----------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ----------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                      001111         11357899999999999776555  689999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.8e-45  Score=333.53  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=204.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +|+..+.||+|+||.||+|.++.+|+.||+|.+.++.       .....|..+++.+. |++|+++.+++     .+...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            4788999999999999999999999999999886432       12335777887776 56778888877     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999984 77776654    35689999999999999999999998 999999999999999988 79999999987


Q ss_pred             eccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+.......+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            54222 223345689999999999654 48999999999999999999999999887766666555410           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                            .            .++..++.++.+++.+||+.+|.+|++     .+++++||||+.+++
T Consensus       218 ------~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         218 ------V------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ------C------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                  0            122457889999999999999999997     579999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.3e-45  Score=323.87  Aligned_cols=252  Identities=35%  Similarity=0.586  Sum_probs=204.9

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch------HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK------NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |++.+.||+|+||.||++++..+++.+|+|.+.......      .+|+.+++.++||||+++++++..     ..++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            899999999999999999999999999999987654222      248899999999999999998843     555789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec-
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  188 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~-  188 (373)
                      +|||+.+ +|.+.+..    ...+++..+..++.||+.||.+||++ ||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             cccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccccc
Confidence            9999997 88888873    36789999999999999999999998 999999999999999887 8999999998763 


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ..........+++.|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223333456789999999998634558999999999999999999999999874444444443322111111000     


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                       .....+.++.++|.+||+.||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001124799999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-44  Score=343.86  Aligned_cols=275  Identities=25%  Similarity=0.338  Sum_probs=206.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      ..+|.+.+.||.|+||.||++.+..+++.||+|...  .....+|+++++.++|+||+++++++.     .....++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEEEEE
Confidence            447999999999999999999999999999999643  234568999999999999999998873     3345789999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC
Q 017341          114 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  193 (373)
Q Consensus       114 ~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~  193 (373)
                      ++.++|...+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            9999988887653   24689999999999999999999988 999999999999999888 799999999876533221


Q ss_pred             ---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCC------cHHHHHHHHHHhCCCCHHH--
Q 017341          194 ---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGES------GVDQLVEIIKVLGTPTREE--  261 (373)
Q Consensus       194 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf-~~~~------~~~~~~~i~~~~~~~~~~~--  261 (373)
                         .....||+.|+|||++.+. .++.++|||||||++|||++|..|+ ....      ....+.++++.......+.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               1235689999999999665 4899999999999999999987554 3221      1234445554433221110  


Q ss_pred             ------HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          262 ------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       262 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                            .............+......|...  ..++.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  000000000001111112222221  246789999999999999999999999999999974

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.6e-45  Score=335.93  Aligned_cols=246  Identities=26%  Similarity=0.484  Sum_probs=194.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+++.||+|.+.+..       ....+|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986532       1233577777665 899999999988     3445688999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC-
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  190 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-  190 (373)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99995 67666553    35789999999999999999999998 999999999999999988 799999999875322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  262 (373)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .....+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            2223456789999999999654 489999999999999999999999953211        1111111100         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------ALEALIHPFFDELRD  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~ll~hp~~~~~~~  326 (373)
                             .            ...++..++..+.++|++||..||.+|+|      ++++++||||+.+.+
T Consensus       220 -------~------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         220 -------K------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   0            00133567899999999999999999998      589999999988754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-44  Score=359.83  Aligned_cols=265  Identities=29%  Similarity=0.417  Sum_probs=213.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ....+|++.+.||.|+||.||+|.+..++..+|+|.+....      .....|+.+++.|+||||++++++|..   ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence            44568999999999999999999999999999999885432      223479999999999999999998754   333


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc------CCceeecCCCCcEEEcCCC----
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT------IGVCHRDIKPQNLLVNPHT----  174 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~------~~ivH~Dlkp~NIll~~~~----  174 (373)
                      ..+||||||+. ++|...+.........+++..++.|+.||+.||.|||+.      .+|+||||||+||||+.+.    
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            45889999998 589888887655556799999999999999999999974      1499999999999996421    


Q ss_pred             ------------CceeEeeccceeeccCCCCcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 017341          175 ------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGE  241 (373)
Q Consensus       175 ------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~  241 (373)
                                  ..+||+|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                        24899999999765433333456789999999998543 34789999999999999999999999877


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       242 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      +....+...+...  +          .     .           .....+.++.+||..||..+|.+||++.|+|.|||+
T Consensus       247 ~~~~qli~~lk~~--p----------~-----l-----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLISELKRG--P----------D-----L-----------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHHHHHhcC--C----------C-----C-----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6555443333210  0          0     0           002467899999999999999999999999999999


Q ss_pred             cccCCC
Q 017341          322 DELRDP  327 (373)
Q Consensus       322 ~~~~~~  327 (373)
                      +.+..+
T Consensus       299 k~i~~p  304 (1021)
T PTZ00266        299 KNVGPP  304 (1021)
T ss_pred             hhcCCC
Confidence            877554

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-45  Score=337.72  Aligned_cols=245  Identities=28%  Similarity=0.466  Sum_probs=201.9

Q ss_pred             eeeeecCceEEEEEEE---CCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           41 RVVGHGSFGVVFQAKC---LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      +.||+|+||.||++++   ..+|+.+|+|.+....      ....+|+++++.++||||+++++++     .+...+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            5799999999999986   3578999999886432      2234689999999999999999887     444568899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            99998 577777654    35689999999999999999999998 999999999999999888 799999999876543


Q ss_pred             C-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 G-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      . .......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.+..               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 223356789999999999654 47899999999999999999999999887666655544310               


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                        ..            ++..+++++.++|.+||+.||.+||+     +++++.||||+.+.+
T Consensus       215 --~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         215 --LG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             --CC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence              00            22457899999999999999999999     788999999987654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-44  Score=348.02  Aligned_cols=254  Identities=29%  Similarity=0.396  Sum_probs=210.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCC-CcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..|.+.+.||.|++|.||+|.+..+ ++.+|+|.+..+.    ....+|+.+++.++||||+++++++     ....++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence            3599999999999999999998877 7889999764432    2234699999999999999999988     3344688


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+. |+|.+.+........++++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999998 588888876555556789999999999999999999998 999999999999999888 8999999999865


Q ss_pred             cCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .....   ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            43321   2345689999999998654 5899999999999999999999999887766655555432100         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                         .++..++.++.++|.+||..||++||++++++.|||++..
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               0123578899999999999999999999999999998643

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-44  Score=329.35  Aligned_cols=281  Identities=38%  Similarity=0.643  Sum_probs=214.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECC--CCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|.+.+.||+|++|.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            58999999999999999999988  89999999887632       233579999999999999999998843   2235


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC----CCCceeEee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----HTHQLKLCD  181 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~-~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~----~~~~ikl~D  181 (373)
                      .+++||||+++++.+.+........ .+++..++.++.||+.||.|||+. +|+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            6899999999988887765543333 789999999999999999999988 9999999999999998    77 899999


Q ss_pred             ccceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 017341          182 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---------DQLV  248 (373)
Q Consensus       182 fg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~---------~~~~  248 (373)
                      ||++........    .....+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533221    123467889999998876666889999999999999999999999876543         2455


Q ss_pred             HHHHHhCCCCHHHHhhcC--cCccc----ccCCCcCCCCccccccC--CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          249 EIIKVLGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFQK--RMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                      +++..++.+.........  +.+..    ..............+..  ..+.++.++|.+||+.||++|||+.+++.|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            566666655544332111  11111    00011110111111112  57789999999999999999999999999999


Q ss_pred             c
Q 017341          321 F  321 (373)
Q Consensus       321 ~  321 (373)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-44  Score=340.61  Aligned_cols=279  Identities=23%  Similarity=0.338  Sum_probs=211.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC--CCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ..+|.+.+.||.|+||.||+|...  .++..+|+|.+... ....+|+++++.++||||+++++++     .....+|++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            347999999999999999999754  45688999987543 4456899999999999999999887     444568899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          112 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       112 ~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||++.+++...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            99999988888743    36789999999999999999999998 999999999999999888 7999999998765433


Q ss_pred             CC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhhc
Q 017341          192 EP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       192 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..   ....+..+.+.++....+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   2245789999999999654 48999999999999999999999997754   34556666665544322110000


Q ss_pred             C----cCcccccCCCcCCCCcccc-ccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 N----PNYTEFKFPQIKAHPWHKI-FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .    ..+..+....-........ ....++.++.+||.+||..||.+|||+.++|.||||+...
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            0    0000000000000000000 1124678899999999999999999999999999998743

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.3e-45  Score=334.81  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=207.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|.+.+.||+|+||.||++++..+++.||+|.+.+..       ....+|..++..++|++|+++++++     .+..+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            37999999999999999999999999999999885421       1234678889999999999999887     44556


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||+. |+|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~-~~kl~DfG~a~  150 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNG-HIRLADFGSCL  150 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCC-CEEEEecccee
Confidence            899999998 5888887653   35689999999999999999999988 999999999999999888 79999999987


Q ss_pred             eccCCCCc--ccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          187 VLVKGEPN--ISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       187 ~~~~~~~~--~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ........  ....||+.|+|||++.+.    ..++.++|+|||||++|+|++|+.||.+.+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER----  226 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence            65433221  235689999999998542    34788999999999999999999999887766655555431000    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDP  327 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~~  327 (373)
                                 ..++.         ....++.++.++|.+||+.++.+  |++++++++||||+.+++.
T Consensus       227 -----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         227 -----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             -----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                       01110         01357899999999999976655  5689999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=329.52  Aligned_cols=247  Identities=30%  Similarity=0.450  Sum_probs=202.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcE-EEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEA-VAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ....+.+.||.|+||+||++.+.  |+. ||+|.+....      ..+.+|+.+|..++|||||+++++.....    ..
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~  114 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GS  114 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cc
Confidence            35667777999999999999984  555 9999886532      25668999999999999999999873322    15


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC-ceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~-ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      +++||||++ |+|.+++...  ....++...+..++.||++|+.|||++ + ||||||||+|||++.+...+||+|||++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            889999999 5888888764  347799999999999999999999998 9 9999999999999988547999999999


Q ss_pred             eeccCC-CCcccccccccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          186 KVLVKG-EPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       186 ~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      +..... .......||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+....+....+......+.     
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-----  266 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-----  266 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence            876554 23334789999999999974 34699999999999999999999999999988555555543221111     


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                            ++...++.+..++.+|+..||..||+..+++.
T Consensus       267 ----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 ----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                  22458899999999999999999999988853

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5e-44  Score=331.51  Aligned_cols=288  Identities=31%  Similarity=0.539  Sum_probs=218.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCC------
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK------  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------  103 (373)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|.+....    ....+|+++++.++||||+++++++......      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999999999999999885433    2245799999999999999998876432211      


Q ss_pred             ---CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          104 ---DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       104 ---~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                         ...++|++|||++++|.+.+..     ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++..++|+
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEEC
Confidence               1235789999999887776642     4688999999999999999999988 999999999999998666579999


Q ss_pred             eccceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          181 DFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       181 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |||.+........    .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+....+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999875432211    122357889999998765556889999999999999999999999988887777776665444


Q ss_pred             CCHHHHhhcCcCccccc--CCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          257 PTREEIKCMNPNYTEFK--FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      .................  .......+... +...++.++.+||.+||+.||.+|||+++++.||||+.+..|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  310 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF  310 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence            43322221111100000  00111111111 1245788999999999999999999999999999999775543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-44  Score=333.31  Aligned_cols=280  Identities=25%  Similarity=0.411  Sum_probs=205.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||.|+||.||++.+..++..+|+|.+....     ....+|+++++.++||||+++++++.     +..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            468999999999999999999999999999999876432     23457999999999999999999884     34468


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+.+ +|.+.+...    ..+++..+..++.|++.||.|||+..+|+|+||||+||+++.++ .+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchh
Confidence            899999985 888887653    56889999999999999999999753799999999999999888 799999999865


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHHhh-c
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKC-M  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~-~  265 (373)
                      .... ......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||......+....+.... +.+....... .
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence            4322 22345789999999999654 48999999999999999999999998765433221111000 0000000000 0


Q ss_pred             C------cCcccccCCCc---------CCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 N------PNYTEFKFPQI---------KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~------~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .      ..+.....+..         ........-...++.++.+||.+||+.||++|||++|++.||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            0      00000000000         000000000123678899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-43  Score=321.07  Aligned_cols=278  Identities=36%  Similarity=0.630  Sum_probs=212.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +.+|++.+.||+|+||.||+|.+..+|+.+|+|.+.....     ...+|+.+++.++|+||+++.+++     .+..+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence            4689999999999999999999999999999998854321     235799999999999999999987     334468


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+||||+.+++...+...   ...+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  153 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCC-cEEEecccccccc
Confidence            899999998887776543   24577888999999999999999988 999999999999999888 8999999998654


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+. .+.+.++....+.+.........
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            2221 223345789999999986655578899999999999999999999987653 35555566666666554332211


Q ss_pred             --cCcccccCCCcCCCCcccccc-CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 --PNYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        +.+.....+............ -..+.++.+++.+||..||++|||+.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              111111111111111111110 1236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.8e-45  Score=335.98  Aligned_cols=245  Identities=28%  Similarity=0.457  Sum_probs=198.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHH-HHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|++..+|+.+|+|.+....       ....+|. .+++.++||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46999999999999999999999999885431       1112333 356778999999999887     3444688999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC-
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  190 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-  190 (373)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99985 67666553    36789999999999999999999998 999999999999999988 799999999875322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            2223456789999999999654 48999999999999999999999999887666555544310                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~ll~hp~~~~~~~  326 (373)
                                   ..+.+..+..+.++|.+||+.+|.+||++    .++++||||+...+
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                         01124578899999999999999999987    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-44  Score=336.19  Aligned_cols=253  Identities=27%  Similarity=0.370  Sum_probs=198.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..+|+..+.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++     .+...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            458999999999999999999999999999999885432     2345799999999999999999987     445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+.+ +|..        ....++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       148 ~lv~e~~~~~~L~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~  217 (353)
T PLN00034        148 QVLLEFMDGGSLEG--------THIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAK-NVKIADFGVSRI  217 (353)
T ss_pred             EEEEecCCCCcccc--------cccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccccccee
Confidence            899999996 4432        13356778889999999999999998 999999999999999888 899999999876


Q ss_pred             ccCCC-CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ..... ......||..|+|||.+...    ...+.++|||||||++|+|++|+.||......+....+.......     
T Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (353)
T PLN00034        218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-----  292 (353)
T ss_pred             cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence            54322 22345789999999987421    234568999999999999999999997443222211111110000     


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                          .......++.++.+||.+||+.||++|||+.|+++||||.....
T Consensus       293 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        293 --------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                                00012457889999999999999999999999999999988543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-44  Score=322.78  Aligned_cols=276  Identities=36%  Similarity=0.663  Sum_probs=221.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +|++.+.||.|++|.||+|++..+|+.||+|.+....     ....+|+.+++.++|+||+++++++.     +....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            5899999999999999999999999999999886432     23347899999999999999999883     3345789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+++++.+.+..... ...+++..+..++.||+.||.|||+. |++|+||+|+||++++++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999998888765432 34689999999999999999999988 999999999999999888 899999999865432


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--c
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P  267 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  267 (373)
                      .. ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+...++......+....+....  +
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            21 12234578899999998766567899999999999999999999999999888888888887777765543322  1


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      .+. ..++......... +.+..+.++.++|.+||+.||.+||++.++++||||
T Consensus       233 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYK-PTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhc-ccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            111 1111111111111 223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.8e-44  Score=322.79  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+....       ....+|+++++.++|+||+++.+++     ......
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            4888999999999999999999999999999885432       1234699999999999999998887     334468


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |++|||+.+ +|...+....  ..++++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            899999995 6766665432  34689999999999999999999988 999999999999999887 799999999876


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+........         
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------  221 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence            5433333455789999999999654 489999999999999999999999988765544444433211100         


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                                      ..+...++.++.+|+.+||+.||++||+     +.+++.||||+.....
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                            0122467889999999999999999999     8999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-44  Score=333.79  Aligned_cols=245  Identities=26%  Similarity=0.413  Sum_probs=198.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHH-HHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|++..+++.||+|.+.....       ...+| ..+++.++||||+++++++     .....+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            469999999999999999999999998864321       11123 3356788999999999887     3445588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.....
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99995 77766654    35688899999999999999999998 999999999999999888 8999999998754322


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence             223456799999999999654 58999999999999999999999999887766665554310                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH----HHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL----EALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----~ll~hp~~~~~~~  326 (373)
                                   ..+.+.++..+.++|.+||+.||.+|+++.    ++++|+||...++
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                         002246889999999999999999999876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-44  Score=331.16  Aligned_cols=246  Identities=26%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..+++.+|+|.+....       ....+|..++..+ +||+|+++++++     .+...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986532       1234678888777 699999999988     4445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC-
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  190 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-  190 (373)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 77666654    35699999999999999999999998 999999999999999888 799999999875322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCCHHHHhh
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....      .+...+....  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            2233456789999999999654 589999999999999999999999964321      1222221110  0        


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------ALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~ll~hp~~~~~~~  326 (373)
                            .            ..++..++..+.++|.+||..||.+|++      .+++++||||+.+.+
T Consensus       219 ------~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         219 ------P------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             ------C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                  0            0123467899999999999999999998      579999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-43  Score=328.51  Aligned_cols=280  Identities=35%  Similarity=0.566  Sum_probs=220.7

Q ss_pred             ccccceEe-eeeeeecCceEEEEEEECCCCcEEEEEEeccccc------------------chHHHHHHHHhCCCCCeee
Q 017341           32 KQTISYMA-ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVS   92 (373)
Q Consensus        32 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~   92 (373)
                      ...++|.. .+.||.|+||.||+|.+..+++.||+|.+.....                  ...+|+++++.++|+||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            34567864 5789999999999999999999999998854321                  2347999999999999999


Q ss_pred             cceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC
Q 017341           93 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  172 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~  172 (373)
                      +++++     ....+.+++|||+.++|.+.+...    ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.
T Consensus        85 ~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~  154 (335)
T PTZ00024         85 LVDVY-----VEGDFINLVMDIMASDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINS  154 (335)
T ss_pred             eeEEE-----ecCCcEEEEEeccccCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECC
Confidence            99987     334468899999999988887643    5689999999999999999999988 9999999999999998


Q ss_pred             CCCceeEeeccceeeccCC---------------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017341          173 HTHQLKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  237 (373)
Q Consensus       173 ~~~~ikl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p  237 (373)
                      ++ .++|+|||.+......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+|
T Consensus       155 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        155 KG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             CC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            88 8999999998755311               1112234678899999987665679999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcC--cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          238 FPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       238 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                      |.+.+..+.+..+....+.+....+....  +.+..+  .......... .....+.++.++|.+||+.+|++|||++++
T Consensus       234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             CCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            99999888888888887777655333211  111111  0000111111 123568899999999999999999999999


Q ss_pred             hcCCCccccC
Q 017341          316 LIHPFFDELR  325 (373)
Q Consensus       316 l~hp~~~~~~  325 (373)
                      |.||||+...
T Consensus       311 l~~~~~~~~~  320 (335)
T PTZ00024        311 LKHEYFKSDP  320 (335)
T ss_pred             hcCcccCCCC
Confidence            9999998753

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-44  Score=326.54  Aligned_cols=259  Identities=29%  Similarity=0.487  Sum_probs=211.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+.....       ...+|+++++.++|+||+++++.+     .+..+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            69999999999999999999999999999998865432       234689999999999999999887     445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||||+.+ +|.+.+...  ....+++..++.++.||+.||.|||+. |++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            999999985 887777643  235689999999999999999999988 999999999999999888 799999998765


Q ss_pred             ccCCCC------------------------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017341          188 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  237 (373)
Q Consensus       188 ~~~~~~------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p  237 (373)
                      ......                              .....||..|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            422111                              1123578899999999654 478999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC----HH
Q 017341          238 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST----AL  313 (373)
Q Consensus       238 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~  313 (373)
                      |.+.+....+.++....                 ...+.          ...++.++.++|.+||+.||++|||    ++
T Consensus       232 f~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKKE-----------------VTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcCC-----------------ccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            98887766655544210                 00000          0236899999999999999999999    99


Q ss_pred             HHhcCCCccccCCCCCCC
Q 017341          314 EALIHPFFDELRDPNTRL  331 (373)
Q Consensus       314 ~ll~hp~~~~~~~~~~~~  331 (373)
                      ++++||||+..+++..++
T Consensus       285 ~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         285 EIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHcCchhhcCChhhccc
Confidence            999999999988765554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-43  Score=323.57  Aligned_cols=286  Identities=30%  Similarity=0.511  Sum_probs=217.7

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC--
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTE--  102 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  102 (373)
                      ....++|++.+.||.|++|.||+|.+..+++.||+|.+.....      ...+|+.+++.++||||+++++++.....  
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            3456689999999999999999999999999999998854321      22469999999999999999987754321  


Q ss_pred             -CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 -KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 -~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                       ......++||||+++++.+.+...   ...+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~d  162 (310)
T cd07865          88 NRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLAD  162 (310)
T ss_pred             cCCCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCC-cEEECc
Confidence             233457899999999888777643   24689999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCCCc-----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          182 FGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       182 fg~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      ||++.........     ....++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+.......+.+..+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9998755332211     23456788999999866555788999999999999999999999998877777766666555


Q ss_pred             CCHHHHhhcC--cCcccccCCCcCCCCccccc-cCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          257 PTREEIKCMN--PNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       257 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ...+.++...  ..+....++........... ....+..+.+||.+||..||.+|||++++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            4444322110  00111112211111111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-44  Score=332.31  Aligned_cols=245  Identities=29%  Similarity=0.426  Sum_probs=197.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHH-HHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||.|+||.||+|++..+++.||+|.+.+...       ...+|. .+++.++||||+++++++     .+...+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            479999999999999999999999998854321       112333 457889999999999887     4445688999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.....
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99985 77666543    35688999999999999999999988 999999999999999988 8999999998753222


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence             223345789999999998654 4899999999999999999999999988766555544321   0             


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~ll~hp~~~~~~~  326 (373)
                                   ..++...+.++.++|.+||+.||.+|+++    .++++||||..+++
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                         01224578899999999999999999976    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=316.57  Aligned_cols=248  Identities=27%  Similarity=0.480  Sum_probs=203.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|.+.+.||+|++|.||++.+..+++.+|+|.+....         ....+|+.+++.++||||+++++++     .+.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            46999999999999999999999999999999875331         2245689999999999999999988     334


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++++||+++ +|.+.+...    ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~-~~~l~dfg~  150 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  150 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccc
Confidence            468999999985 777777653    5688999999999999999999988 999999999999999888 899999999


Q ss_pred             eeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +.........    ....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+......++....      
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------  223 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------  223 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence            8754322111    2345788999999997654 8999999999999999999999998765554443332210      


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                           ....++..++.++.++|.+||..+|.+|||+.++++||||
T Consensus       224 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ---------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                 0011234678999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-43  Score=322.89  Aligned_cols=281  Identities=34%  Similarity=0.620  Sum_probs=219.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC---CC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  104 (373)
                      .++|++.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            679999999999999999999999999999999875322      123579999999999999999987754332   23


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+++||||+.+++...+...   ...+++..++.++.||+.||.|||++ ||+|+||||+||++++++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            4567899999998877766543   35699999999999999999999998 999999999999999988 899999999


Q ss_pred             eeeccCCCC------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017341          185 AKVLVKGEP------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       185 a~~~~~~~~------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~  252 (373)
                      +........            .....+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            875432211            11235688899999986655688999999999999999999999999998888888888


Q ss_pred             HhCCCCHHHHhhcC--cCccc-ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          253 VLGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       253 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ..+.+.+..+....  +.... ...... .......+ ...++++.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCC-CccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77766654432211  11100 000000 01111111 3456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.9e-44  Score=321.44  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHH-HHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+|++.+.||+|+||.||++.+..+|+.||+|.+.....     ....|.. .++.++||||+++++++.     ....+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            369999999999999999999999999999998865421     1223444 366779999999999873     33448


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |++|||++++|.+.+.........+++..++.++.||+.||+|||++.+++||||||+||+++.++ .+||+|||.+...
T Consensus        76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (283)
T cd06617          76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL  154 (283)
T ss_pred             EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence            899999999988888765544567999999999999999999999755899999999999999988 8999999998765


Q ss_pred             cCCCCcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhh
Q 017341          189 VKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ..........++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||.... ..+.+..+.....         
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  225 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---------  225 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---------
Confidence            433333335678899999988542   346889999999999999999999996532 2233333222100         


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                        +     ..           ....+|.++.++|.+||..+|.+||++.+++.||||+...
T Consensus       226 --~-----~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 --P-----QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             --C-----CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence              0     00           0134788999999999999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-43  Score=319.84  Aligned_cols=277  Identities=36%  Similarity=0.662  Sum_probs=214.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+++++.++||||+++++++     .+..+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            36999999999999999999999899999999875432      1234789999999999999999988     455568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+||||+.+++...+...   ...+++..+..++.||+.||+|||+. |++|+||+|+||++++++ .++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFARTL  150 (286)
T ss_pred             EEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-cEEEEeeeeeeec
Confidence            999999997654444332   34588999999999999999999998 999999999999999888 8999999998765


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  266 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  266 (373)
                      ..... .....++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+....+........... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            33322 2234678899999998765567889999999999999999999999888777777777665554332211111 


Q ss_pred             -cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                       +.......+............+.++..+.+|+.+||..+|++||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             1011111111111111111124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=319.23  Aligned_cols=274  Identities=36%  Similarity=0.668  Sum_probs=217.0

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |++.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+++++.++|||++++++++     .+..+.|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            678899999999999999999999999999886432      2345799999999999999999987     34456889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      +|||++++|.+.+....  ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999888888876542  24689999999999999999999988 999999999999999877 899999999865432


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--c
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P  267 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  267 (373)
                      .. ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+......++.+..+.+....+....  +
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            21 12233568899999988665557899999999999999999999999988888888888777766655432211  1


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ++.. .++......... ....++..+.++|.+||+.||.+|||+++++.||||
T Consensus       232 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKP-TFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhh-hcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            1100 111111111111 124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-43  Score=327.29  Aligned_cols=285  Identities=36%  Similarity=0.654  Sum_probs=224.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      .++|++.+.||+|++|.||+|++..+++.||+|.+....      ....+|+.+++.++|||++++.+++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            458999999999999999999999999999999875421      223469999999999999999887743222 2234


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|+||++++|.+.+..     .++++..++.++.||+.||.|||+. ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            5789999998888887763     5689999999999999999999988 999999999999999888 89999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .....  .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.+.+..+....
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65322  3345678899999998655567899999999999999999999999988888888888877766654333221


Q ss_pred             cCccc-c--cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          267 PNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       267 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ..... +  ..+......+...+ ...+..+.++|.+||..||.+|||+.++++||||+.+..+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence            11000 0  01111111111112 34688999999999999999999999999999999876654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.8e-43  Score=318.41  Aligned_cols=262  Identities=25%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..++|.+.+.||+|+||.||++.+..+++.+|+|.+....   ....+|+.+++.+ +|||++++++++..........+
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            3568999999999999999999999999999999885432   2334688889888 89999999998865443334568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+++ +|.+.+.........+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++..
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~-~~kl~dfg~~~~  177 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEeecccchh
Confidence            899999985 88777765444456789999999999999999999988 999999999999999888 799999999875


Q ss_pred             ccCCC-CcccccccccccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ..... ......++..|+|||.+....    .++.++|+|||||++|+|++|++||...+....+..+.+..   .    
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~----  250 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---P----  250 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---C----
Confidence            43322 122346788999999985332    26789999999999999999999998776555444432210   0    


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                  +       ....+...+..+.++|.+||+.+|++||++.++++||||+
T Consensus       251 ------------~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 ------------P-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ------------C-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                        0       0001134677899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=319.18  Aligned_cols=274  Identities=41%  Similarity=0.744  Sum_probs=221.1

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+.....      ...+|+.+++.++|+||+++++++     .+...+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            6788999999999999999999999999998864432      234789999999999999999987     33455889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+++++...+...   ...+++..+..++.||+.||.|||++ +|+|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999999888877764   25789999999999999999999998 999999999999999888 799999999876644


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  267 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  267 (373)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+....+.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 222345788899999987664689999999999999999999999999988888888888777776654443322  


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ......++......... ..+.++.++.++|.+||..||.+||+++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11111222221111111 224678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=317.77  Aligned_cols=277  Identities=39%  Similarity=0.694  Sum_probs=218.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....      ....+|+++++.++|+||+++.+++..     ....
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence            37999999999999999999999999999999875321      234579999999999999999998843     4458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +++|||+++++...+...   ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~  150 (288)
T cd07833          76 YLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARAL  150 (288)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEEeeeccccc
Confidence            899999998766655433   35589999999999999999999998 999999999999999888 8999999998765


Q ss_pred             cCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......++..|+|||++.+...++.++|+||||+++|+|++|++||.+.+..+.+..+....+...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            4433  23345678999999999766468999999999999999999999999888777777776666555543322211


Q ss_pred             --cCcccccCCCcC-CCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          267 --PNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       267 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        +.+....++... ...+...++..++.++.+||++||..+|++|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              111111111111 1112223344568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-43  Score=317.89  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +...++|++.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.+ +||||+++++++......+..
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            345679999999999999999999999999999999875432   2345788999998 699999999987654444556


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++++||||+++ +|.+.+.........+++..++.++.|++.||.|||++ +++||||||+||+++.++ .++|+|||++
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~  171 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEG-GVKLVDFGVS  171 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCC-CEEEccCCce
Confidence            78999999985 78877765544456789999999999999999999988 999999999999999988 7999999998


Q ss_pred             eeccCCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          186 KVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       186 ~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ....... ......|++.|+|||++..    ...++.++|+||+||++|+|++|+.||...+.......+...   .   
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~---  245 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P---  245 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C---
Confidence            7654322 2234568999999999842    234788999999999999999999999876543332221110   0   


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                          ......+...+..+.++|.+||+.||++|||+.++++||||
T Consensus       246 --------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 --------------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --------------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                00000113457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.7e-43  Score=323.74  Aligned_cols=286  Identities=37%  Similarity=0.627  Sum_probs=224.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCC--CcEEEEEEecccc------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+....      ....+|+.+++.+ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            589999999999999999999888  8999999875421      2234689999988 5999999988654322 2334


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .++++++|++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||.+.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            5789999999988887764    35689999999999999999999988 999999999999999888 79999999987


Q ss_pred             eccCCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      .......     .....||+.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+....+..+....+.+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6533211     12346899999999886655689999999999999999999999999988888999998888877654


Q ss_pred             HhhcCcCc-cc--ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          262 IKCMNPNY-TE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       262 ~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      +....... ..  ......+..++... ....+..+.+|+.+||+.||.+|||+.+++.||||+.++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~  303 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD  303 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence            43321110 00  01111111111111 2356889999999999999999999999999999999877643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-43  Score=315.47  Aligned_cols=263  Identities=29%  Similarity=0.425  Sum_probs=210.9

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCC-CCc
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      +..+++|++.+.||.|++|.||+|.+..+++.+++|.+....   ....+|+.+++.+ +|+||+++++++..... ...
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            455689999999999999999999999999999999886543   2345799999998 79999999998865443 345


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+++++|||+++ +|.+.+.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~-~~~l~d~~~  159 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNA-EVKLVDFGV  159 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCC-eEEECCCcc
Confidence            668899999995 77777766544456789999999999999999999998 999999999999999888 799999999


Q ss_pred             eeeccCCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +....... ......+++.|+|||.+..    ...++.++|+|||||++|+|++|++||..........++....   . 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-  235 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---P-  235 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---C-
Confidence            87653322 2234568899999998743    2346788999999999999999999998765544444433210   0 


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                     +.       .......+.++.+||.+||..||++|||++++++|||+
T Consensus       236 ---------------~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 ---------------PT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ---------------CC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                           00       00112467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-43  Score=319.41  Aligned_cols=249  Identities=29%  Similarity=0.484  Sum_probs=208.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+....       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence            6999999999999999999999999999999885422       2234689999999999999999988     444568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||||++ ++|.+.+...    ..+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999996 6888777653    6789999999999999999999998 999999999999999888 899999999876


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|+.||...+......++...  .           
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  214 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------  214 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence            5433  3345689999999998654 4788999999999999999999999887754444444321  0           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                          .            .++...+..+.++|.+||..||.+|+     +++++++||||+.+.+.
T Consensus       215 ----~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 ----V------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             ----c------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                0            12245688999999999999999999     99999999999987753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=335.43  Aligned_cols=251  Identities=31%  Similarity=0.481  Sum_probs=217.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .|.-.+.||.|+||.||-+++..|.+.||||+++-..       ..+.+|+..|+.++|||++.+.+||..     +...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence            6888999999999999999999999999999996443       234589999999999999999999954     3347


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+|||||-|+-.+++.-+.   +++-+-.++.|+.+.+.||+|||++ +.||||||..|||++..| .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            8999999999888888764   6788889999999999999999998 999999999999999988 8999999998764


Q ss_pred             cCCCCccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                         .+..+++|||+|||||++.  ....|+-++||||||++..||.-.++|+-.++....++-|.+.- .|+..      
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLq------  246 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQ------  246 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCC------
Confidence               3556789999999999984  45679999999999999999999999999999888888877631 11110      


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                          ....|..+..|+..||++-|.+|||.+++|+|+|...-+.
T Consensus       247 --------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  247 --------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             --------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence                                1356789999999999999999999999999999876543

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-43  Score=326.51  Aligned_cols=286  Identities=37%  Similarity=0.704  Sum_probs=225.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.+.||.|++|.||+|.+..+|+.+|+|++....      ....+|+.+++.+ +||||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            3568999999999999999999999899999999875321      2234699999999 99999999987633   334


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|+||||+.++|...+..     ..+++..+..++.||+.||.|||+. ||+|+||||+||+++.++ .+||+|||.+
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~-~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDC-RVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccch
Confidence            45789999999988777653     2678888899999999999999988 999999999999999988 8999999998


Q ss_pred             eeccCCC------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          186 KVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       186 ~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      .......      ......+|+.|+|||.+.+...++.++|+|||||++|+|++|++||.+....+...++....+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            7553322      1223467899999998866566889999999999999999999999998888888888887777766


Q ss_pred             HHHhhcCcCcccc---cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          260 EEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       260 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      ..+..+.......   ..+.....+..... +.++.++.++|.+||+.||++|||+.++++||||+....++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~  306 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD  306 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence            5443322111110   01111111122222 347899999999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-43  Score=323.21  Aligned_cols=283  Identities=36%  Similarity=0.625  Sum_probs=220.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      ..+|.+.+.||+|++|.||+|.+..+|+.+|+|.+....      ....+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            358999999999999999999999999999999885421      123479999999999999999998754321 1223


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|+||+..++...+      ...+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~-~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCCCCc
Confidence            46899999987665443      24688999999999999999999998 999999999999999988 89999999986


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  .......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+.+.......
T Consensus       166 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HAD--AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCC--CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            542  222345678899999998665558899999999999999999999999988778888888777666655433221


Q ss_pred             cCc-c--cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          267 PNY-T--EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       267 ~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ... .  ....+......+...+ +..+.++.+||.+||+.||.+||++++++.||||+..++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            110 0  0011111122222212 3578899999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-43  Score=317.25  Aligned_cols=277  Identities=34%  Similarity=0.622  Sum_probs=217.6

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+++++.++|+|++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            788999999999999999999999999999987542      1234799999999999999999887432   1256889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+++++...+...   ...+++..++.++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998887777643   25689999999999999999999988 999999999999999988 899999999876644


Q ss_pred             CCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          191 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       191 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ...  .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            331  223456888999998866556889999999999999999999999999888888888877766665543321110


Q ss_pred             --cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          269 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       269 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        +................+....+.++.++|.+||+.+|.+||++++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000000111122222348899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=322.83  Aligned_cols=286  Identities=34%  Similarity=0.594  Sum_probs=223.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++....      ....+|+.+++.++||||+++.+++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            468999999999999999999999999999999886432      223469999999999999999987743221 2233


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ..|+++++++++|.+.+..     ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        96 ~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~dfg~~~  168 (345)
T cd07877          96 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLAR  168 (345)
T ss_pred             cEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCC-CEEEecccccc
Confidence            4788999998888776653     4588999999999999999999988 999999999999999988 79999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  .......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+....+.+.........
T Consensus       169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            542  222345678999999998665568899999999999999999999999888888888887777666655443322


Q ss_pred             cCcccc---cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          267 PNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       267 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      ......   ..+..+...+.... ...++++.++|.+||+.||.+|+|+.+++.||||+++..+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence            111000   01111111111111 246889999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=316.53  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=214.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch-------HHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      -+|..+.+||+|+||.|.++..+.|.+.||||++.++....       ..|-++|... +-|.+++++.+|     +.-.
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTmD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTMD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhhh
Confidence            37889999999999999999999999999999887654322       2466677665 468899999998     3333


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+|+||||+.| +|-..+.+    -+.+.+..+..++..|+-||-+||++ ||++||||.+|||+|.+| .|||+|||.+
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eG-HiKi~DFGmc  497 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMC  497 (683)
T ss_pred             heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCC-ceEeeecccc
Confidence            48899999996 65555544    37789999999999999999999998 999999999999999999 6999999999


Q ss_pred             eeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +...-+ ....+++|||.|+|||++. ...|+.++|+||+||++|||+.|.+||.+.++.+..+.|....          
T Consensus       498 KEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------  566 (683)
T KOG0696|consen  498 KENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------  566 (683)
T ss_pred             cccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence            865433 3455789999999999995 4459999999999999999999999999999999999887631          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRDPN  328 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~ll~hp~~~~~~~~~  328 (373)
                                         ..+++.+|.++.++++.+|...|.+|...     .++-.||||+.++|..
T Consensus       567 -------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  567 -------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             -------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                               12456799999999999999999999754     7889999999998753

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.2e-43  Score=315.63  Aligned_cols=258  Identities=25%  Similarity=0.396  Sum_probs=204.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCC-Ccee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK-DELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~  107 (373)
                      ..+.|++.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.+ +|+|++++.+++...... ...+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            3467999999999999999999999999999999886443   2345788888888 699999999988654322 2356


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|++|||+.+ +|.+.+....  ...+++..+..++.|++.||+|||++ +|+|+||+|+||+++.++ .++|+|||++.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~-~~~l~Dfg~~~  159 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCC-CEEEccCCCce
Confidence            8899999985 7877776532  35688999999999999999999998 999999999999999888 89999999987


Q ss_pred             eccCCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ...... ......|++.|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...        
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~--------  231 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--------  231 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC--------
Confidence            643222 2234568999999999853    234788999999999999999999999765543333222110        


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                         .........++.++.+||.+||..+|.+|||+.+++.||||
T Consensus       232 -------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 -------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                               00001123578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-42  Score=309.62  Aligned_cols=249  Identities=28%  Similarity=0.464  Sum_probs=203.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||++.+..+++.+|+|.+..+.      ....+|+++++.++|+|++++.+.+.    ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            5999999999999999999999999999999885432      22356889999999999999987652    2344578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++|||+++ +|.+.+....  ...+++..+..++.|++.+|++||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999984 7877776532  35689999999999999999999988 999999999999999888 8999999998765


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+....             
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-------------  218 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            3322 22345678999999998654 47899999999999999999999998776555444433310             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                            .+         ..+..+++.+.++|.+||+.+|.+|||+.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ------LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00         0124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-42  Score=321.45  Aligned_cols=285  Identities=35%  Similarity=0.644  Sum_probs=220.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      .++|.+.+.||+|++|.||++.+..++..||+|.+....      ....+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            568999999999999999999999999999999875422      123479999999999999999998743221 1123


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++||||+++++...+..     ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||.+.
T Consensus        94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            4689999998888777653     5689999999999999999999988 999999999999999888 79999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+.+..+.+..+......
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            5432  22344678999999998654558899999999999999999999999888777777777765555443222111


Q ss_pred             cCc-cc--ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          267 PNY-TE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       267 ~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ... ..  ...+....... ......+++.+.++|.+||+.||.+|||+.+++.||||+..+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            100 00  00111111111 112256888999999999999999999999999999999986653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7e-43  Score=316.88  Aligned_cols=257  Identities=27%  Similarity=0.414  Sum_probs=205.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +.|++.+.||.|+||.||++.+..+++.+++|.+.....    ...+|+.+++.++||||+++.+++.     ....+|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence            579999999999999999999999999999998865432    2346889999999999999999873     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+++ ++...+.+.   ...+++..+..++.|++.+|.|||++ |++||||||+||+++.++ .++|+|||.+....
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            9999996 555555432   35689999999999999999999988 999999999999999877 89999999886543


Q ss_pred             CCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          190 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ... ......+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||...+......++.+.   ..      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~------  232 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP------  232 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CC------
Confidence            221 2234567889999999852    234678999999999999999999999876654443333221   00      


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                                +       ....+..++.++.++|.+||..+|++||+++++++||||..+...
T Consensus       233 ----------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         233 ----------P-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ----------c-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                      0       000123578899999999999999999999999999999887654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=318.59  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=212.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      .-|.++.+||+|+||.||++.|+.+|+.+|||.+..+.  ..+-+|+.++++.+.|++|++|+.|+-..+     +||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeeh
Confidence            35899999999999999999999999999999987554  445589999999999999999998865443     89999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      |||+ |+..+.++.+   ++++++..+..+++.-+.||+|||.- .=+|||||..|||++.+| ..||+|||.|..+.+.
T Consensus       108 EYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccc-hhhhhhccccchhhhh
Confidence            9999 7999998876   48899999999999999999999986 889999999999999999 7999999999766443


Q ss_pred             -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       ....+..|||.|||||++..- .|..++||||||++..||.-|++||.+..+...+.-      .|+..     .|.| 
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------IPT~P-----PPTF-  249 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------IPTKP-----PPTF-  249 (502)
T ss_pred             HHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------ccCCC-----CCCC-
Confidence             234577899999999999654 499999999999999999999999987654322111      11100     0011 


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                        +            -+...|.++.||+++||.+.|++|.||.++++|||++....
T Consensus       250 --~------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  250 --K------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             --C------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence              0            12356889999999999999999999999999999987543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-46  Score=307.56  Aligned_cols=286  Identities=31%  Similarity=0.544  Sum_probs=234.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC---C
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  103 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  103 (373)
                      ....|+-..++|+|.||.||+|+++.+|+.||+|++.-+.      ....+|+++|..|+|+|++.++++.-+...   .
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3457899999999999999999999999999999764321      123489999999999999999887644332   4


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      +...+|+||.+|+.+|..++.+.   ..+++...+..++.+++.||.|+|+. .|+|||+||.|++++.+| .+||+|||
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dg-ilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDG-ILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCc-eEEeeccc
Confidence            55668999999999998888765   36789999999999999999999987 999999999999999999 89999999


Q ss_pred             ceeeccCCC-----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      +++......     .....+.|.+|++||.+.+...|+++.|+|..|||+.+|++|.+.+++.+...++..|....|..+
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            997654332     223456699999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhcC--cCcccccCCCcCCCCcccc---cc-CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          259 REEIKCMN--PNYTEFKFPQIKAHPWHKI---FQ-KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       259 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      .+.|+.+.  +-|...+.+..+......+   .. -.-++++.+|+.++|..||.+|+++.++++|.||..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            88776543  2333332222222111111   10 123568999999999999999999999999999976

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-44  Score=330.47  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=222.0

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      +.+...+.|.+.+.||+|.|+.|.++++..|+..||||.+.+..      ....+|+++++.|+|||||+++.+..+   
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t---  126 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET---  126 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee---
Confidence            34455678999999999999999999999999999999886543      223589999999999999999999844   


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                        ...+|+||||+. |.+.+++.++    .+..+..++.++.|+..|++|||++ +|||||||++||+++.+. ++||+|
T Consensus       127 --~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~m-nikIaD  198 (596)
T KOG0586|consen  127 --EATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENM-NIKIAD  198 (596)
T ss_pred             --cceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhccccccc-ceeeec
Confidence              344999999998 5788888775    5677788999999999999999998 999999999999999998 799999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ||++..+..+....+.+|++.|.|||++.+....++.+|+||+|+++|.|+.|..||++.+-.+...+.+..        
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--------  270 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--------  270 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--------
Confidence            999999887777889999999999999999888899999999999999999999999988754433333221        


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                               .++            ++--++.++.++|+++|..+|.+|++.++++.|.|.......
T Consensus       271 ---------k~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  271 ---------KYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ---------eec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                     111            113478899999999999999999999999999999775543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=331.23  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=226.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+..++..||-|+||.|-++........+|+|.+++..       .....|.++|.....|+||++|..|     .+.
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~  492 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDS  492 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccc
Confidence            3457888899999999999999876555568999775432       2234689999999999999999998     888


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .|+|++||-|- |.++..++.+    +.+.+..++.++..+++|+.|||++ ||++|||||+|.+++.+| .+||.|||+
T Consensus       493 kyvYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~G-y~KLVDFGF  566 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRG-YLKLVDFGF  566 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCC-ceEEeehhh
Confidence            99999999986 5899998875    6788999999999999999999998 999999999999999999 899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      |+....+....+++|||.|.|||++.+.. .+.++|.||||+++|||++|++||++.++..++..|++.+...       
T Consensus       567 AKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------  638 (732)
T KOG0614|consen  567 AKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------  638 (732)
T ss_pred             HHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------
Confidence            99999999999999999999999998665 7999999999999999999999999999999999999865321       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                              .            +++.++..+.+||+++...+|.+|..     +.|+.+|.||.+.+|.
T Consensus       639 --------~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  639 --------E------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             --------h------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                    1            34678999999999999999999986     8999999999998764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=300.35  Aligned_cols=262  Identities=25%  Similarity=0.400  Sum_probs=215.9

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch-----HHHHHHH-HhCCCCCeeecceeeeecCC
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTM-RLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~E~~~l-~~l~h~~iv~~~~~~~~~~~  102 (373)
                      -.+....+...+..||+|.-|.|++++...+|..+|||.+.+.....     ...++++ +..+.|+||+.+++|....+
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            34455667888899999999999999999999999999996543221     1223322 23357999999999965333


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                           +++.||.|...+..++++.   .++++|..+..+...++.||.||.++.||+|||+||+|||+|..| +||||||
T Consensus       166 -----V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDF  236 (391)
T KOG0983|consen  166 -----VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDF  236 (391)
T ss_pred             -----HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecc
Confidence                 6789999987777777765   377999999999999999999999888999999999999999988 8999999


Q ss_pred             cceeeccCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~-~~~~~~~~i~~~~~~~~~  259 (373)
                      |.+.++.++.......|-+.|||||.+.-  ...|+..+||||||+.++||+||..||.+. ++.+.+..+.+... |..
T Consensus       237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L  315 (391)
T KOG0983|consen  237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLL  315 (391)
T ss_pred             cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCC
Confidence            99999988888888899999999999942  345899999999999999999999999984 56677777766211 100


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                     +          ....+|+++.+|+..||..|+.+||...+||+|||+....
T Consensus       316 ---------------~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  316 ---------------P----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ---------------C----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                           0          1134899999999999999999999999999999998764

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=297.12  Aligned_cols=258  Identities=28%  Similarity=0.394  Sum_probs=206.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..+|++.+.||+|||+-||++++..++..||+|++....    ....+|++..+.++|||+++++++.+..........|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            459999999999999999999999999999999997554    3335799999999999999999877655545667789


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++++|.. |+|.+.+......+..+++.++..|+.+|++||.+||+. .  ++||||||.||++...+ .++|.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG-LPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC-ceEEEeccCcc
Confidence            9999988 789999999888788899999999999999999999987 7  99999999999999877 89999999986


Q ss_pred             eccCCCC----------cccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017341          187 VLVKGEP----------NISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  254 (373)
Q Consensus       187 ~~~~~~~----------~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~  254 (373)
                      ...-.-.          .....+|..|+|||.+.-.  ...+.++|||||||++|.|+.|..||...         .+.-
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~G  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQG  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcC
Confidence            5421111          1134578999999998422  23688999999999999999999999532         1100


Q ss_pred             CCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +.....      -.-..+++|+.          ..+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       249 gSlaLA------v~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLALA------VQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEEe------eeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000000      00012233322          3488999999999999999999999999865

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-43  Score=314.30  Aligned_cols=275  Identities=39%  Similarity=0.713  Sum_probs=220.2

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+.....     ...+|+..++.++ |+|++++++++.     +....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence            7889999999999999999998999999998764422     2246888999998 999999999873     3455889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+.+++.+.+....  ...+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999889888877542  24689999999999999999999998 999999999999999888 899999999986654


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--C
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--N  268 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~  268 (373)
                      ........++..|+|||.+.+...++.++|+||||+++++|++|++||.+.+..+...++....+.+....+.....  .
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            44444567889999999986656689999999999999999999999999998888888888887776654322110  0


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ......+..........+ ...+.++.++|.+||+.+|++|||++|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            011111111111111112 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-43  Score=324.47  Aligned_cols=278  Identities=22%  Similarity=0.360  Sum_probs=200.1

Q ss_pred             eeeeeeec--CceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           39 AERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        39 ~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +.++||+|  ++++||++.+..+|+.||+|.+..+.      ....+|+.+++.++||||+++++++.     .+...++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            46789999  67899999999999999999986432      23447899999999999999999884     3345889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||++ +++.+++..+.  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            999998 57887776542  24588999999999999999999988 999999999999999888 89999998654322


Q ss_pred             CCCC--------cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 017341          190 KGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT----  256 (373)
Q Consensus       190 ~~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~----  256 (373)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||..................    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1110        1123467789999998653 35889999999999999999999999876554433332221000    


Q ss_pred             ---CCHHHHhhcC------cCcccc-c---CCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          257 ---PTREEIKCMN------PNYTEF-K---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       257 ---~~~~~~~~~~------~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                         ...+.+....      ..+... .   ............+...+++.+.+||.+||+.||++|||++++++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence               0000000000      000000 0   00000000111122456789999999999999999999999999999987


Q ss_pred             cC
Q 017341          324 LR  325 (373)
Q Consensus       324 ~~  325 (373)
                      +.
T Consensus       313 ~~  314 (327)
T cd08227         313 IK  314 (327)
T ss_pred             cc
Confidence            64

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=315.60  Aligned_cols=250  Identities=27%  Similarity=0.429  Sum_probs=205.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ++|.+.+.||.|++|.||++.+..+++.+|+|.+..+.     ....+|+++++.++|+|++++.+++.     +..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            36899999999999999999999999999999886443     22457899999999999999998873     335689


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|+||+.+ +|.+.+..     .++++..++.++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~  148 (274)
T cd06609          76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQL  148 (274)
T ss_pred             EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEcccccceee
Confidence            99999985 77777653     3789999999999999999999988 999999999999999988 8999999998776


Q ss_pred             cCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ... .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+.....            
T Consensus       149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------  215 (274)
T cd06609         149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------------  215 (274)
T ss_pred             cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC------------
Confidence            443 2233456788999999996554 89999999999999999999999987665443333322100            


Q ss_pred             CcccccCCCcCCCCccccccC-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                             +         .... .++.++.+++.+||..+|++|||++++++||||+...
T Consensus       216 -------~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         216 -------P---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -------C---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                   0         0111 2788999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-43  Score=317.04  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+.+++.++||||+++++++     ....+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            36899999999999999999999999999999875432     2344799999999999999999987     3445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|..++... .....+++..+..++.||+.||.|||++.+|+|+||||+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccc
Confidence            99999996 676666542 12346899999999999999999999644999999999999999877 8999999998654


Q ss_pred             cCCCCcccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          189 VKGEPNISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ... ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||...+.......+........     
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  227 (286)
T cd06622         154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-----  227 (286)
T ss_pred             cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence            322 223346788999999985332     257899999999999999999999977654443333222111000     


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                                          ..++..++.++.+||.+||..+|++||+++++++||||...+..
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                                01224578999999999999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=314.40  Aligned_cols=281  Identities=29%  Similarity=0.504  Sum_probs=219.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc---hHHHHHHHHhCCC--C----CeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---KNRELQTMRLLDH--P----NVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~  104 (373)
                      ..+|.+.+.+|+|.||.|..|.+..++..||+|++..-.++   ..-|+++|+.+.+  |    .++++.++|     +-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            56899999999999999999999999999999987543333   2358899998832  2    378887877     66


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-----------
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-----------  173 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-----------  173 (373)
                      .++.|||+|.++-++.+++.++.  ..+++...++.+.+|+++++++||+. +++|.||||+||++-+.           
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCc
Confidence            67799999999989999998754  46789999999999999999999998 99999999999998321           


Q ss_pred             --------CCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017341          174 --------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  245 (373)
Q Consensus       174 --------~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~  245 (373)
                              .-.|+++|||.|+..  .+...+.+.|..|+|||++.+-+ ++.++||||+||||+|+.||...|+..++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    115899999999865  33346778899999999998765 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhc---------CcCcccccCCCc------CCCCcccccc--CCCChhHHHHHHhhcCcCCCC
Q 017341          246 QLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQI------KAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNL  308 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~---------~~~~~~~~~~~~------~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~  308 (373)
                      .++.+...+|..+...+...         .-.|.+......      ...+......  +.--..+.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            99888888886655443332         111111111110      0111111110  011235889999999999999


Q ss_pred             CCCHHHHhcCCCccccC
Q 017341          309 RSTALEALIHPFFDELR  325 (373)
Q Consensus       309 R~t~~~ll~hp~~~~~~  325 (373)
                      |+|+.|+|.||||+.+.
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=313.39  Aligned_cols=274  Identities=39%  Similarity=0.700  Sum_probs=224.5

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |++.+.||.|++|.||+|++..+++.+|+|.+....      ....+|+.+++.++|+|++++++++.     +..+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            677889999999999999999999999999886542      12346899999999999999999873     3456889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||++++|.+.+.+..   ..+++..+..++.|++.||.+||++ ||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999999988887642   4689999999999999999999998 999999999999999887 899999999876533


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  268 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  268 (373)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+.++....+.+....+...... 
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 2223456788999999876656899999999999999999999999999988889999888888887765543222 


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      +....++..........+ +..+..+.++|.+||..||++||++++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            122233333333333333 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=339.09  Aligned_cols=262  Identities=26%  Similarity=0.437  Sum_probs=206.1

Q ss_pred             ecccCCCCCCcccc--ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCC-CCCeeecc
Q 017341           22 TTIGGKNGQPKQTI--SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLD-HPNVVSLK   94 (373)
Q Consensus        22 ~~~~~~~~~~~~~~--~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~-h~~iv~~~   94 (373)
                      ....+..|.....+  +++|.+.|.+|||+.||+|.+...|..||+|++.....    ...+|+++|+.|+ |+|||.++
T Consensus        22 ~~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yi  101 (738)
T KOG1989|consen   22 QSENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYI  101 (738)
T ss_pred             ccccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence            33444444443333  79999999999999999999988889999999865432    3358999999997 99999999


Q ss_pred             ee-eeecCCCC-ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEE
Q 017341           95 HC-FFSTTEKD-ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLL  169 (373)
Q Consensus        95 ~~-~~~~~~~~-~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIl  169 (373)
                      +. ........ ..-+.|+||||. |+|.++|..+..  ..|++.+++.|+.|+++|+++||.. .  |+|||||-+|||
T Consensus       102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvL  178 (738)
T KOG1989|consen  102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVL  178 (738)
T ss_pred             ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheE
Confidence            93 33322233 344779999999 699999998764  4499999999999999999999976 6  999999999999


Q ss_pred             EcCCCCceeEeeccceeeccCCCCc----------cccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017341          170 VNPHTHQLKLCDFGSAKVLVKGEPN----------ISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPL  237 (373)
Q Consensus       170 l~~~~~~ikl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~p  237 (373)
                      |+.++ ..||||||.++-.......          .....|+.|+|||++.  +....+.|+|||+|||+||-|+....|
T Consensus       179 ls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~P  257 (738)
T KOG1989|consen  179 LSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTP  257 (738)
T ss_pred             EcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCC
Confidence            99998 7999999998644332211          1234699999999983  334589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          238 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       238 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      |.+.....+    +.                 ..|.+|..          ++++..+++||..||+.||.+||++.+++.
T Consensus       258 Fe~sg~laI----ln-----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  258 FEESGKLAI----LN-----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             cCcCcceeE----Ee-----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence            987633221    11                 12333331          468899999999999999999999988865


Q ss_pred             C
Q 017341          318 H  318 (373)
Q Consensus       318 h  318 (373)
                      +
T Consensus       307 ~  307 (738)
T KOG1989|consen  307 E  307 (738)
T ss_pred             H
Confidence            4

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=333.33  Aligned_cols=248  Identities=28%  Similarity=0.480  Sum_probs=206.4

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc
Q 017341           42 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  117 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g  117 (373)
                      +||+|.||+||-++|..|...+|||.+....    ....+|+.+-+.|+|.|||++.+++     ..++++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            6999999999999999999999999885433    3345899999999999999999987     566688899999995


Q ss_pred             -cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC-C
Q 017341          118 -TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P  193 (373)
Q Consensus       118 -~l~~~l~~~~~~~~~~--~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~-~  193 (373)
                       +|..+++..   -+++  ++..+..+..||++||.|||++ .|||||||-+|++++...+.+||+|||.+++...-. -
T Consensus       657 GSLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             888888765   3566  8899999999999999999999 999999999999999887899999999998775433 3


Q ss_pred             ccccccccccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 017341          194 NISYICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  272 (373)
Q Consensus       194 ~~~~~gt~~y~aPE~l~-~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ..++.||..|||||++. +.+.|+.++|||||||++.||.||++||......+.  .+++.                   
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkV-------------------  791 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKV-------------------  791 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhh-------------------
Confidence            45778999999999994 456699999999999999999999999976543322  11111                   


Q ss_pred             cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                        +   ....+..++..+|.+++.||.+|+..||..||+|.++|.+||++.-
T Consensus       792 --G---myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  792 --G---MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --c---ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence              0   0011112346788999999999999999999999999999999875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8e-43  Score=314.83  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=204.3

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCC-CCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~  107 (373)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|.+....   .....|+.+++.+ +|+||+++++++..... ....+
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            4468999999999999999999999999999999875543   2334688888887 69999999998754322 23557


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|++|||+++ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~-~~~l~dfg~~~  169 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSA  169 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCcchh
Confidence            8899999985 7877776543  35588888999999999999999998 999999999999999888 79999999986


Q ss_pred             eccCC-CCcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ..... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+...   .    
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~----  242 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----  242 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C----
Confidence            54322 12234568999999999852    234788999999999999999999999766543333222110   0    


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                          ........++.++.+||.+||..||.+|||+.++++||||
T Consensus       243 --------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 --------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                0001113578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-42  Score=314.73  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=205.9

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .....+|++.+.||.|++|.||++.+..+++.+++|.+....    ....+|+.+++.++|+|++++++.+.     ...
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~   90 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGD   90 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCC
Confidence            334568999999999999999999999999999999886433    23447899999999999999999874     334


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      +.|+||||+.+ +|.+.+..     ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~-~~kl~dfg~~  163 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFC  163 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEECccccc
Confidence            58899999985 77777643     4578889999999999999999988 999999999999999888 8999999988


Q ss_pred             eeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ........ .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+... ..+       
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~-------  234 (296)
T cd06654         164 AQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP-------  234 (296)
T ss_pred             hhccccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC-------
Confidence            65432221 2234688999999998654 4789999999999999999999999877654433222110 000       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                        ....+..++..+.++|.+||..||.+|||+.++++||||...+
T Consensus       235 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         235 ------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             ------------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                              0001245788999999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=333.75  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=211.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +-|.|+..||.|+||.||++.++.++-..|.|++.....    ...-|++||..++||+||++++.||..+.     ++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            469999999999999999999999999889998743322    22358999999999999999999876443     899


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      +.|+|+|+-.+.+.-.  .+..+.+.++..+++|++.||.|||++ +|+|||||..|||++.+| .|+|+|||.+.....
T Consensus       107 liEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecC-cEeeecccccccchh
Confidence            9999997644443322  368899999999999999999999999 999999999999999999 799999998754322


Q ss_pred             C-CCccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          191 G-EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       191 ~-~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      . ....+++|||+|||||+..    ....|++++||||||+++.+|.-+.+|-..-++...+-+|.+.- .|+       
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPT-------  254 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPT-------  254 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCc-------
Confidence            2 3345789999999999974    34569999999999999999999999998888777666665421 111       


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                        ...+...+..+.||+++||..||..||+++++|+|||++.+.
T Consensus       255 ------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  255 ------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             ------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                              112356788999999999999999999999999999998654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-42  Score=314.09  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=206.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...+|++.+.||.|++|.||++.+..+++.|++|.+....    ....+|+.+++.++|||++++++.+.     ....+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   91 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDEL   91 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceE
Confidence            3457999999999999999999999999999999885432    22346899999999999999999873     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+|+||+.+ +|...+..     ..+++..+..++.|++.||+|||++ |++|+||+|+||+++.++ .++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~  164 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQ  164 (296)
T ss_pred             EEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccchh
Confidence            899999985 66666542     4588999999999999999999998 999999999999999888 899999998875


Q ss_pred             ccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+.......+... ..+.        
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------  234 (296)
T cd06655         165 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------  234 (296)
T ss_pred             cccccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc--------
Confidence            433322 2234678899999998654 4789999999999999999999999887765544333221 0000        


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                       ...+..+++.+.++|.+||..||.+|||+.+++.||||+...+
T Consensus       235 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 -----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             -----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                             0012457889999999999999999999999999999987553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.1e-42  Score=315.15  Aligned_cols=283  Identities=32%  Similarity=0.529  Sum_probs=219.2

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC----
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE----  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  102 (373)
                      ...+|++.+.||.|++|.||+|.++.+|+.||+|.+....      ....+|+++++.++|||++++++++....+    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3468999999999999999999999999999999885432      123469999999999999999988754321    


Q ss_pred             -CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 -KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 -~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                       .+..++++++||+++++...+...   ...+++..+..++.||+.||+|||+. ||+|+||+|+||+++.++ .+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKG-QIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-cEEeCc
Confidence             123368999999999887776643   34689999999999999999999988 999999999999999888 899999


Q ss_pred             ccceeeccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          182 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       182 fg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      ||.+........  .....++..|+|||.+.+...++.++|+|||||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999876543321  122345788999998865555788999999999999999999999998888888888877766655


Q ss_pred             HHHhhcC--cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          260 EEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       260 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      ..+....  +.+............+...+ ..++..+.++|.+||..||++|||+++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4332211  01100000000001111111 3478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-42  Score=311.25  Aligned_cols=252  Identities=26%  Similarity=0.496  Sum_probs=202.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      +|+..+.||+|++|.||++.+..+++.+|+|.+....          ....+|+.+++.++|+||+++++++     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4888999999999999999999999999999886432          2334799999999999999999987     444


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++||||+.+ +|.+.+...    .++++..+..++.||+.||.|||++ |++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            568899999995 777777643    5688999999999999999999998 9999999999999988775799999999


Q ss_pred             eeeccCCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +........     .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--  227 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence            876543211     1234678899999998654 47899999999999999999999997655433333222210000  


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                            ....++..+++++.+++.+||..+|++|||+.++++||||+
T Consensus       228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                  00112245788999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-42  Score=311.21  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=205.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|++|.||+|.+..++..+++|.+..+.     ....+|+.+++.++|+|++++++.+     ......+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            37999999999999999999998899999999885432     2345789999999999999998877     3344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||++.+ +|.+.+..... ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccchHHHh
Confidence            99999985 77777765421 24688999999999999999999988 999999999999999887 7999999998655


Q ss_pred             cCCCCc-----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          189 VKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       189 ~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ......     ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+......++.+..   .     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~-----  224 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---P-----  224 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---C-----
Confidence            433221     234678999999998665468999999999999999999999998776655444433310   0     


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                         +.+     +.   .    .....+++.+.+++.+||..||++|||+++++.||||
T Consensus       225 ---~~~-----~~---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 ---PSL-----ET---G----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---CCc-----CC---c----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               000     00   0    0013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-42  Score=307.24  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=206.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||++.+..+++.+|+|.+....      ....+|+.+++.++|||++++++.+     .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            5899999999999999999999999999999885432      2345789999999999999999877     3445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 8888886542  34588999999999999999999998 99999999999999876657899999999876


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ..........+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+.......+......            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------  219 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence            544444456788999999998654 4788999999999999999999999887665554444321000            


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                      .++..++.++.+++.+||..+|++|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                            0123578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-43  Score=323.39  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=193.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|.+....     ....+|+.+++.+ +||||+++++++..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK---   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence            35899999999999999999975     2456789999886432     2345799999999 89999999987632   


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhc----------------------------------------------------
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKM----------------------------------------------------  129 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~----------------------------------------------------  129 (373)
                       ....++++|||++ |+|.+.+......                                                    
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             2234789999999 5888887653210                                                    


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC---ccccccc
Q 017341          130 ------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICS  200 (373)
Q Consensus       130 ------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt  200 (373)
                            ..++++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+++.......   .....++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                  13477788899999999999999998 999999999999999888 899999999975432221   1233456


Q ss_pred             ccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCC
Q 017341          201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  279 (373)
Q Consensus       201 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (373)
                      +.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+........-.                  .     
T Consensus       240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------------------~-----  295 (338)
T cd05102         240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT------------------R-----  295 (338)
T ss_pred             ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC------------------C-----
Confidence            789999998654 48999999999999999997 9999988654433333222100                  0     


Q ss_pred             CCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          280 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                          ...+...++++.+++.+||+.||.+|||+.++++
T Consensus       296 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 ----MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                0012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=310.92  Aligned_cols=278  Identities=34%  Similarity=0.608  Sum_probs=216.5

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhC---CCCCeeecceeeeecCCCCcee
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      |++.+.||.|++|.||++.+..+++.+|+|.+.....      ...+|+.+++.+   +|||++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7889999999999999999988899999999863321      233577766655   6999999999986654444456


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++++|||+.+++.+.+....  ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999998888776542  23589999999999999999999998 999999999999999987 899999999877


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........++..|+|||.+.+. .++.++|+||+||++|+|++|++||.+.+..+...++.+....+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            6444433445678899999999654 488999999999999999999999999998888888887665544332211100


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                       .....++.....+... ..+.++..+.++|.+||+.||.+||++++++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 -LPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             -cchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             0000111111111111 113567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.9e-42  Score=316.22  Aligned_cols=283  Identities=38%  Similarity=0.730  Sum_probs=221.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||.|+||.||++.+..+++.+|+|++...      .....+|+.+++.++||||+++.+++..    ...
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~   83 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----PLE   83 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----CCC
Confidence            456899999999999999999999999999999987532      1234479999999999999999988743    123


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|++|||++++|...+..     .++++..+..++.||+.||.|||+. +|+|+||+|+||+++.++ .++|+|||.+.
T Consensus        84 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~-~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCC-CEEeCcccccc
Confidence            4789999998888777652     4578888999999999999999988 999999999999999887 89999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  .......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+.+..+.++.+......
T Consensus       157 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         157 IQD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             ccC--CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            542  222345678899999998654568999999999999999999999999888777777777777776655433211


Q ss_pred             cC-cccc--cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          267 PN-YTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       267 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .. -..+  ..+.....+..... +.++..+.++|.+||+.+|++|||+++++.||||...+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~  299 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD  299 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence            00 0000  01111111111212 357889999999999999999999999999999998877643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.5e-43  Score=314.26  Aligned_cols=253  Identities=26%  Similarity=0.453  Sum_probs=198.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+..+.     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            6889999999999999999999999999999886442     223469999999999999999998843     345789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||++++.+...       ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999996433221       3478888999999999999999998 999999999999999988 899999999876533


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      . ......+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.||........   ............         
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  216 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------  216 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence            2 23345789999999999654 489999999999999999999999975332111   001111100000         


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                            .+.        ......++++.++|.+||+.+|.+||+++++++||||+..+..
T Consensus       217 ------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         217 ------PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             ------CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence                  000        0113467899999999999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-43  Score=314.61  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=206.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|++.+.||.|++|.||++.+..+++.+|+|.+.....    ...+|+++++.++||||+++++.+.     ....+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            3579999999999999999999988999999998854332    2346899999999999999999873     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+...   ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDG-DVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCC-CEEEccCccchhh
Confidence            99999996 777776653   35689999999999999999999998 999999999999999888 8999999987654


Q ss_pred             cCCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          189 VKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .... ......+++.|+|||.+..    ...++.++|+|||||++|+|++|++||.+.+......++....  +      
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~------  225 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--P------  225 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--C------
Confidence            3222 2234568999999999742    2346789999999999999999999998776554443332210  0      


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                 +.       ...+..++.++.++|.+||+.+|.+||+++++++||||....
T Consensus       226 -----------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 -----------PT-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             -----------CC-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                       00       001235788999999999999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-42  Score=316.89  Aligned_cols=277  Identities=25%  Similarity=0.392  Sum_probs=204.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +|++.+.||+|+||.||++.+..++..+|+|.+..+.     ....+|+++++.++||||+++++++.     +..++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence            6999999999999999999999999999999876432     12347999999999999999999883     3446889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+++ +|.+.+...    ..+++..+..++.||+.||.|||+..+++|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 888787653    56899999999999999999999744899999999999999888 79999999986543


Q ss_pred             CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       190 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+... ...+...................
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            22 22345789999999998654 48899999999999999999999997765332 22222111000000000000000


Q ss_pred             ccccCCC----------cCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          270 TEFKFPQ----------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       270 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .....+.          .........-...++.++.+||.+||..+|++|||+.++++||||....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            0000000          0000000000123678999999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=323.29  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      .+++++.||+|.||.||.+.+.. ...||+|.+...   .....+|+++|+.|+|+|||+++++...     +.-+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence            56778899999999999999853 347999987643   2345589999999999999999998733     22388999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      |||. |+|.++++..  ....+...+...++.||++|++||+++ ++|||||...||||+.+. .+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9999 8999999973  246788999999999999999999998 999999999999999988 8999999999954433


Q ss_pred             CCcccccc--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          192 EPNISYIC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       192 ~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .......+  ...|.|||.+.. ..++.+||||||||+|+||+| |+.||.+.+..+.+..+.+..              
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--------------  421 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--------------  421 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--------------
Confidence            33222222  556999999954 459999999999999999999 999999999999988887753              


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  316 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll  316 (373)
                          ++|.          +..+|+++.+++..|+..+|++|||.+.+.
T Consensus       422 ----Rlp~----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  422 ----RLPR----------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ----cCCC----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                3332          257999999999999999999999999775

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-42  Score=314.27  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=204.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..+|++.+.||.|++|.||++.+..+++.||+|.+....    ....+|+.+++.++|+||+++++++     ....++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence            468999999999999999999999999999999886433    2234688999999999999999988     3445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+.+     ..+++..+..++.|++.+|.|||+. |++||||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence            99999985 77776643     4578889999999999999999988 999999999999999888 8999999998754


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... +.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~----------  233 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP----------  233 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCC----------
Confidence            33322 223467899999999865 44789999999999999999999999776543322211110 000          


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                     ....+..++..+.+||.+||..+|.+||+++++++||||+..+.
T Consensus       234 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         234 ---------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                           00112457889999999999999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-42  Score=312.39  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=203.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      -|++.+.||.|+||.||++.+..++..+++|.+....    ....+|+++++.++|||++++++++.     ...+.++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence            4788999999999999999999999999999885432    22346899999999999999999874     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+++ ++...+...   ..++++..+..++.||+.||.|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            999996 555555432   35689999999999999999999998 999999999999999888 899999999865432


Q ss_pred             CC-Cccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          191 GE-PNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .. ......+++.|+|||++.    ....++.++|+||+||++|+|++|++||...+..+....+......         
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP---------  226 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC---------
Confidence            21 223456889999999984    2234678999999999999999999999887765554444331100         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                       ....+..++.++.+||.+||+.||.+||+++++++||||+..
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 -----------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             -----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                             001123578899999999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.6e-44  Score=294.19  Aligned_cols=283  Identities=31%  Similarity=0.592  Sum_probs=233.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecc-cccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .++|++.+++|.|.|+.||.|.+..+++.++||.++. ..+.+.+|+.+|+.|. ||||+++.++..+   +......+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhH
Confidence            4689999999999999999999999999999998754 3455679999999997 9999999998744   444456789


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          112 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       112 ~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      +||+...-...+      -+.++...++.++.+++.||.|||+. ||.|||+||.|+|+|.....++|+|+|+|.+...+
T Consensus       114 FE~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999986422222      25577788999999999999999998 99999999999999988778999999999998888


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHh-----hc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CM  265 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~  265 (373)
                      ......+.+.+|.-||.+.....|+.+-|+|||||+++.|+..+.| |.|.+..+++.+|.+.+|........     .+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            8778888999999999998888899999999999999999997755 57888999999999998875443211     12


Q ss_pred             CcCcccccCCCcCCCCccccccC----CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ++.|.. .+....+.+|....++    -+++++.||+.++|.+|..+|+||.|++.||||..+...
T Consensus       267 dp~~~~-i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  267 DPQFED-ILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             ChhHhh-HhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            344432 2334455666655543    257999999999999999999999999999999887654

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.9e-42  Score=306.92  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=206.7

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||++.+..++..+|+|.+....      .....|+++++.++||||+++++.+..   .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            5899999999999999999999999999999875432      123468899999999999999887643   3344578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH-----ccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-----~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ++|||+++ +|.+.+.........+++..++.++.||+.||.|||     +. +++|+||+|+||+++.++ .++|+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999984 888888776555677899999999999999999999     87 999999999999999887 89999999


Q ss_pred             ceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+...         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------  225 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---------  225 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence            9876544332 2345689999999998654 4889999999999999999999999887644433332221         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                ..+         .++...+..+.+++.+||+.+|.+|||+.++++|||+
T Consensus       226 ----------~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ----------KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ----------CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                      000         1224678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.6e-42  Score=305.24  Aligned_cols=248  Identities=27%  Similarity=0.436  Sum_probs=203.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+....      ....+|+++++.++|||++++++++     .+....|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            4889999999999999999999999999999875321      2234688999999999999999887     3445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+.+ +|.+.+....  ...++...++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            99999984 8888777542  35688999999999999999999988 999999999999999888 7999999998765


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....+++.|+|||++.+. .++.++|+|||||++++|++|+.||...+.......+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------  217 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            43322 2234678999999998654 47899999999999999999999998877555444433210             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                            ++         .++..++.++.++|.+||+.+|++||++.+++.|||+
T Consensus       218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  00         0113578899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.6e-42  Score=307.68  Aligned_cols=247  Identities=28%  Similarity=0.475  Sum_probs=199.1

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      +|++.+.||.|+||.||++.+ .+++.+|+|.+..+.          ....+|+++++.++|+||+++.+++     .+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            588999999999999999986 578999999875432          2245799999999999999999987     344


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+++++|||+.+ +|.+.+.+.    .++++..+..++.|++.||+|||+. +|+|+||+|+||+++.++ .++|+|||.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568999999985 787777643    4678999999999999999999988 999999999999999888 899999998


Q ss_pred             eeeccCC-------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          185 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       185 a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      +......       .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...... 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8654211       111234678899999998654 4789999999999999999999999876554433332221000 


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                      .         ..++..++.++.++|.+||..+|.+||++.++++||||
T Consensus       227 ----------------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ----------------M---------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ----------------C---------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                            0         01224578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-42  Score=308.90  Aligned_cols=246  Identities=32%  Similarity=0.534  Sum_probs=199.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+....             ....+|+.+++.++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            4788999999999999999999899999999875432             1234789999999999999999887     


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      .+..+.+++|||+++ +|.+.+...    ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+|
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCC-CEEecc
Confidence            334467899999985 787777653    5688889999999999999999988 999999999999999888 899999


Q ss_pred             ccceeeccCCC-------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017341          182 FGSAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  254 (373)
Q Consensus       182 fg~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~  254 (373)
                      ||.++......       ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+......++... 
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  227 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-  227 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-
Confidence            99987653211       11134578899999998654 4788999999999999999999999876554433332220 


Q ss_pred             CCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                        ..         ..++..++..+.++|.+||+.||.+||++.++++||||
T Consensus       228 ------------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ------------------AS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------CC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              00         01224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-43  Score=320.97  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=195.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ...|++.++||+||.+.||++..-+ .+.||+|++....      ....+|+..|..|+ |.+|++++++-     -.+.
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDG  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCc
Confidence            3479999999999999999999643 4567777664322      22348999999985 99999999865     4477


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++||||||-+-+|...|.+..   ..++...++.+..||+.|+.+.|++ ||||.||||.|+++-. | .+||+|||.|.
T Consensus       434 ~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVk-G-~LKLIDFGIA~  507 (677)
T KOG0596|consen  434 YLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVK-G-RLKLIDFGIAN  507 (677)
T ss_pred             eEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEe-e-eEEeeeechhc
Confidence            899999998889999988753   3344458999999999999999999 9999999999999874 5 79999999998


Q ss_pred             eccCCCCc---ccccccccccccccccCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017341          187 VLVKGEPN---ISYICSRYYRAPELIFGAT----------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  253 (373)
Q Consensus       187 ~~~~~~~~---~~~~gt~~y~aPE~l~~~~----------~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~  253 (373)
                      .+......   .+.+||+.||+||.+....          ..++++||||||||+|+|+-|++||....  ...++ +..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aK-l~a  584 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAK-LHA  584 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHH-HHh
Confidence            77544332   3678999999999984221          15789999999999999999999996432  11222 222


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      +..|..           ++.||..+           -..++.++++.||++||.+|||+.+||+|||++..
T Consensus       585 I~~P~~-----------~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  585 ITDPNH-----------EIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hcCCCc-----------cccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            222211           12222211           11249999999999999999999999999999874

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-42  Score=308.94  Aligned_cols=250  Identities=28%  Similarity=0.482  Sum_probs=198.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|++.+.||+|+||.||++.+..++..+++|.+....         ....+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            36999999999999999999999999999999875321         224568999999999999999987643   223


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..++++|||+++ +|.+.+...    ..+++..++.++.|++.||+|||+. +|+|+||+|+||+++.++ .++|+|||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~-~~~l~dfg~  152 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  152 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCCC
Confidence            457899999985 787777643    4578899999999999999999988 999999999999999888 799999999


Q ss_pred             eeeccCCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +.......    ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+.......+..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~--  226 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--  226 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC--
Confidence            87543211    11234578899999998654 488999999999999999999999987654443332221   100  


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                            ...++..+++.+.++| +||..+|++||+++|+++||||+
T Consensus       227 ----------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ----------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ----------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                  0012235678899999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-42  Score=314.25  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=202.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|...+.||+|+||.||++.+..+++.+|+|.+....     ....+|+.++..+. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            5677889999999999999999999999999886432     12346888888885 9999999998743     33477


Q ss_pred             EEEecccccHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~-~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++|||+.+++.++..... .....+++..+..++.|++.||+|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            999999987665543221 22467999999999999999999999744999999999999999888 8999999998765


Q ss_pred             cCCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..........+++.|+|||.+.+.  ..++.++|+||+||++|+|++|++||....  .....+.+......        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~--------  228 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDP--------  228 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCC--------
Confidence            444333445688999999998655  358899999999999999999999997654  12222222111000        


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                              +..     .......++.++.+||.+||+.+|++|||++++++||||+....
T Consensus       229 --------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         229 --------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             --------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                    000     00011357889999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-42  Score=305.80  Aligned_cols=248  Identities=34%  Similarity=0.550  Sum_probs=202.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|+..+.||.|++|.||+|.+..+++.|++|.+....         ....+|+.+++.++|+||+++++++     .+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            5888899999999999999998899999999875432         2345799999999999999999877     3445


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+++++||+++ +|.+.+.+.    ..+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .+||+|||.+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            68899999985 787777643    4588999999999999999999988 999999999999999888 8999999998


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .............+++.|+|||.+.....++.++|+|||||++|+|++|+.||......+....+....           
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------  218 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-----------  218 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----------
Confidence            765444333456688999999998544347899999999999999999999997766433333322100           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                             ..         ..++..+++++.+++.+||+.+|.+||++.+++.|||+
T Consensus       219 -------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -------EL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------cC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                   00         01224578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-42  Score=308.16  Aligned_cols=248  Identities=28%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+....       ....+|+++++.++||||+++++++     .+..++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            5899999999999999999999999999999886432       2335789999999999999999887     455568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++|+||+.+ +|...+...    .++++..+..++.||+.||.|||++ |++|+||+|+||++++++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            999999985 777777643    5788999999999999999999988 999999999999999988 899999999876


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.. ....+.+....           
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-----------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-----------
Confidence            54443334566888999999986544 899999999999999999999999877642 11111111100           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH--HHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--LEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~~ll~hp~~  321 (373)
                                    ....++...+.++.++|.+||..||.+||++  .|+++||||
T Consensus       217 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 --------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             --------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                          0011234578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-42  Score=306.93  Aligned_cols=250  Identities=29%  Similarity=0.458  Sum_probs=203.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+....  ....+|+++++.++||||+++++++.     ...++|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence            57999999999999999999999889999999886543  34557999999999999999999883     345688999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+++ +|.+.+...   ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99995 777776543   35689999999999999999999988 999999999999999988 8999999998765433


Q ss_pred             C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      . ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.......+...                 
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  214 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-----------------  214 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-----------------
Confidence            2 22334578899999998654 5889999999999999999999999876544332221110                 


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                        ..+       ....+..++.++.++|.+||+.||.+|||+++++.||||
T Consensus       215 --~~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 --PPP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             --CCC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence              000       000123577899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=301.73  Aligned_cols=265  Identities=26%  Similarity=0.477  Sum_probs=203.5

Q ss_pred             eEe-eeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMA-ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |.+ .+.||+|+|+.|--|....||..||||++.+..    ....+|++++...+ |+||++++++|     +++..+|+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            444 358999999999999999999999999886653    33458999999985 99999999999     77777999


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--ceeEeeccceee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ikl~Dfg~a~~  187 (373)
                      |||-|.| +|+..+.++    ..+++..+..++.+|+.||.+||.+ ||.||||||+|||.....+  -||||||.++..
T Consensus       154 VfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999995 777777654    6699999999999999999999998 9999999999999865432  599999988653


Q ss_pred             ccCC--------CCccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHH
Q 017341          188 LVKG--------EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD------QLVE  249 (373)
Q Consensus       188 ~~~~--------~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~------~~~~  249 (373)
                      ....        ....+.+|+..|||||+..    ....|+.+.|+||||+|+|.|++|.+||.|.-..+      ...+
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            3211        1223567888999999862    23458899999999999999999999998853211      0000


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       250 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      .++.      ..+..+..  ..|.||.   ..|     ..+|.+++++|+.+|..|+.+|.++.++++|||++.....
T Consensus       309 ~CQ~------~LFesIQE--GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  309 VCQN------KLFESIQE--GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHH------HHHHHHhc--cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            0000      00000001  1223332   122     4689999999999999999999999999999999987654

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-42  Score=310.25  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=200.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|.+.....    ...+|+.+++.++||||+++++++.     ...+++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEE
Confidence            3589999999999999999999999999999998864432    2346899999999999999999873     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++|||+++ +|.+.+..    ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~  156 (267)
T cd06645          83 ICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNG-HVKLADFGVSAQI  156 (267)
T ss_pred             EEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcceeeeEc
Confidence            99999985 78777654    35689999999999999999999988 999999999999999888 7999999998765


Q ss_pred             cCCC-Cccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGE-PNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .... ......|++.|+|||.+.  ....++.++|+|||||++|+|++|..||...........+....           
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-----------  225 (267)
T cd06645         157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-----------  225 (267)
T ss_pred             cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-----------
Confidence            3322 123457899999999974  23347889999999999999999999997655433332221110           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                            ...+.     +.  ....++..+.++|.+||+.+|++|||++++++|||
T Consensus       226 ------~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         226 ------FQPPK-----LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ------CCCCc-----cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                  00000     00  01246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-42  Score=309.19  Aligned_cols=251  Identities=27%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .+|++.+.||+|+||.||+|++..+++.+|+|++....    ....+|+.+++.++||||+++++++.     ....+++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence            47999999999999999999999999999999886432    23457999999999999999998873     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999995 77776654    35688999999999999999999988 999999999999999888 79999999987653


Q ss_pred             CCC-CcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGE-PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|+.||...+.......+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 2234568899999998742  334678999999999999999999999655433222111110             


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                       .   +..+..       .....++..+.+||++||+.+|++|||++++++|+|
T Consensus       225 -~---~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 -N---FQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -C---CCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence             0   000000       011346889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-44  Score=322.79  Aligned_cols=250  Identities=30%  Similarity=0.531  Sum_probs=209.9

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      -.++||+|.||+||-+++..+|+.||||++.+-      .....+|+.+|+.+.||.||.+.-.|     +....+++||
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVM  642 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVM  642 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEe
Confidence            357999999999999999999999999988543      23456899999999999999997776     3333478999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccceeeccC
Q 017341          113 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVK  190 (373)
Q Consensus       113 e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~a~~~~~  190 (373)
                      |-+.|+++..+....  .+++++...+.++.||+.||.|||-+ +|+|+||||+|||+.+..  ..+||||||.|+.+.+
T Consensus       643 EKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            999998887777543  47899999999999999999999988 999999999999997543  3799999999999877


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      .....+.+|||.|+|||+++.. .|...-|+||+|+|+|--++|..||....+  +-.+|.+.                 
T Consensus       720 ksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNA-----------------  779 (888)
T KOG4236|consen  720 KSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNA-----------------  779 (888)
T ss_pred             hhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccc--hhHHhhcc-----------------
Confidence            7777789999999999999755 599999999999999999999999976543  22233221                 


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      .|-+|   ..||     +.+++++.|||+.+|+..-++|.|++..|.|||+++.
T Consensus       780 aFMyP---p~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 AFMYP---PNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccccC---CCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            12222   2334     5689999999999999999999999999999999875

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-42  Score=305.35  Aligned_cols=252  Identities=29%  Similarity=0.431  Sum_probs=203.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+....    ....+|+.+++.++||||+++++++     .+...+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            57999999999999999999999999999999886542    2345799999999999999999887     33445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+++ +|...+...   ...+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||.+....
T Consensus        78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999996 676666543   25689999999999999999999988 999999999999999888 79999999987553


Q ss_pred             CCC-CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGE-PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ... ......++..|+|||.+.+.  ..++.++|+|||||++|+|++|++||.+.+.......+....-.+         
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~---------  223 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP---------  223 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------
Confidence            322 22345678899999998543  247889999999999999999999998877555444333210000         


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                              +       ........+.++.++|.+||..+|.+|||+++++.|||
T Consensus       224 --------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         224 --------P-------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------c-------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                    0       00011346788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-41  Score=302.27  Aligned_cols=248  Identities=33%  Similarity=0.512  Sum_probs=205.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....      ....+|+.+++.++|+||+++++++.     +...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            5999999999999999999999999999999875432      22447999999999999999999883     345688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++|||+++ +|.+.+....  ...+++..+..++.|++.+|.|||+. |++|+||+|+||+++.++ .+||+|||.+...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999984 8888776542  35688999999999999999999988 999999999999999888 7999999998765


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-------------  217 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            3333 22345689999999998654 37889999999999999999999998877666555554310             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                       +.              .....++.++.++|.+||..+|.+||+++++++|||+
T Consensus       218 -~~--------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 -YT--------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -CC--------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence             00              0113578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-41  Score=306.46  Aligned_cols=265  Identities=26%  Similarity=0.418  Sum_probs=204.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....     ...+|+++++.++||||+++++++..   .....+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            469999999999999999999999999999998864322     34579999999999999999988743   3344578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+.........+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~  155 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFGVSGEL  155 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCC-eEEEeeccccccc
Confidence            99999985 88777765544456789999999999999999999998 999999999999999888 7999999998654


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.....  .... +....+.......     
T Consensus       156 ~~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~-----  227 (287)
T cd06621         156 VNSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPE-----  227 (287)
T ss_pred             cccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCchh-----
Confidence            3222 2234578889999998554 589999999999999999999999986632  0111 1111110000000     


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                             .+.   .+   ......++.+.+||.+||..+|++|||+.|++.||||+...
T Consensus       228 -------~~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         228 -------LKD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -------hcc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                   000   00   00013467899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.1e-42  Score=309.46  Aligned_cols=250  Identities=27%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||+|+||.||+|.+..+|+.+|+|.+....       ....+|+++++.++||||+++++++     .....+|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999999999999999885421       1224689999999999999998887     3445688999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  194 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~  194 (373)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 7877776542  24689999999999999999999988 999999999999999888 8999999998765433333


Q ss_pred             ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 017341          195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  274 (373)
Q Consensus       195 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  274 (373)
                      ....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4456788999999986554 889999999999999999999999776542222222211000                  


Q ss_pred             CCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                             ....++..+++.+.++|.+||+.||.+||     ++.++++||||..+++.
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                   00012245789999999999999999999     89999999999987753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.1e-42  Score=306.22  Aligned_cols=245  Identities=29%  Similarity=0.491  Sum_probs=199.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||.|++|.||+|.+..+++.+|+|.+....       ....+|+.+++.++||||+++++.+     .+..+++++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            689999999999999999999999885432       2345789999999999999999987     3445588999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc
Q 017341          116 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  194 (373)
Q Consensus       116 ~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~  194 (373)
                      . ++|.+.+...    ..+++..+..++.||+.||.|||++ +++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            8 5888777653    4588999999999999999999998 999999999999999988 8999999998766544333


Q ss_pred             ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 017341          195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  272 (373)
Q Consensus       195 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||....  ..+....+.....                 
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----------------  211 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence            445788999999998544 48899999999999999999999998776  3333333221000                 


Q ss_pred             cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                                ...++...++++.++|.+||+.+|++|++     ++|+++||||++.++
T Consensus       212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence                      00122345889999999999999999999     999999999998654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=299.92  Aligned_cols=282  Identities=33%  Similarity=0.571  Sum_probs=228.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ...+|.-.+.+|.|.. .|..+.|.-++++||+|++...      .+...+|+.++..++|+||++++.+|..... ...
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3458999999999998 8889999999999999988543      3455689999999999999999998743322 122


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .-+|+|||+|..++...+..      .++-..+..++.|++.|+.|||+. ||+||||||+||++..+. .+||.|||+|
T Consensus        94 ~e~y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~-~lKi~dfg~a  165 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDC-TLKILDFGLA  165 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchh-heeeccchhh
Confidence            33789999999998888762      367788999999999999999988 999999999999999998 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +.....-....++.|..|.|||++.+.. |...+||||+||++.||++|+..|.|.+..++..++.+.+|.|.+.....+
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            8654444456778899999999998766 999999999999999999999999999999999999999999999866655


Q ss_pred             CcCcccc--cCCCcCCCCcccccc-----------CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEF--KFPQIKAHPWHKIFQ-----------KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      .+.-..+  ..+++....+.+.|+           +.-+..+++++.+||..||++|.|++++|+|||++-+
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence            4321111  112211111111111           1234568999999999999999999999999999943

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-42  Score=308.63  Aligned_cols=256  Identities=29%  Similarity=0.491  Sum_probs=202.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|++|.||++.+..+++.+|+|.+....     ....+|+++++.++||||+++++.+.     ....++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence            36888999999999999999999999999999886542     22347899999999999999998873     345688


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +++||++ ++|.+.+....   ..+++..+..++.|++.||+|||+ . |++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~  150 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRG-QIKLCDFGVSGQ  150 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCC-CEEEeecccchh
Confidence            9999999 58888776542   678999999999999999999998 7 999999999999999987 799999999865


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...... ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+. ........+......        
T Consensus       151 ~~~~~~-~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  220 (265)
T cd06605         151 LVNSLA-KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--------  220 (265)
T ss_pred             hHHHHh-hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--------
Confidence            432221 226788899999998654 589999999999999999999999976521 111111111110000        


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                             .+.        .....++.++.++|.+||..||.+|||+.+++.||||+...
T Consensus       221 -------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         221 -------PPR--------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             -------CCC--------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                   000        00012788999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-41  Score=302.62  Aligned_cols=248  Identities=29%  Similarity=0.468  Sum_probs=204.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|+||.||++.+..+|+.+|+|.+....      ....+|+.+++.++||||+++.+++     .+..+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            5999999999999999999999999999999885321      2345789999999999999999987     4455688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+.+ +|.+.+....  ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999985 7877776432  24578899999999999999999998 999999999999999888 8999999998765


Q ss_pred             cCCCCc-ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...... ....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+....+.....            
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC------------
Confidence            332221 234578899999998654 478899999999999999999999987766665555443110            


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                             +         ..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus       219 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 -------P---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------C---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                   0         0124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-41  Score=309.41  Aligned_cols=254  Identities=30%  Similarity=0.501  Sum_probs=204.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +|.+.+.||+|+||.||++.+..+++.|++|.+....       ....+|+++++.++||||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            6999999999999999999999999999999886432       1233688999999999999999887     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||++| +|.+.+.+.    ..+++..+..++.|++.||.|||+. +++||||||+||+++.++ .++|+|||.++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            999999985 787777653    5689999999999999999999988 999999999999999888 899999998863


Q ss_pred             ccCCC----------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 017341          188 LVKGE----------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  251 (373)
Q Consensus       188 ~~~~~----------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~  251 (373)
                      .....                ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21100                00123567889999998654 48999999999999999999999998876655554443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCCC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDP  327 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~ll~hp~~~~~~~~  327 (373)
                      ....                 ..+.         ....++.++.++|.+||+.||++||+   +.++++||||...++.
T Consensus       230 ~~~~-----------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         230 SDDI-----------------EWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             hccc-----------------CCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            3100                 0000         01247889999999999999999998   7999999999876553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-41  Score=307.23  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=191.6

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHH---hCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           42 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMR---LLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .||+|+||.||++.+..+++.+|+|.+.....       ...+|..+++   ...||||+.+++.+.     ....+++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence            48999999999999999999999998854321       1123333333   347999999988873     33357899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+.+ +|...+...    ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999995 776666543    5689999999999999999999998 999999999999999888 899999999865432


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      . ......||+.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....            .  
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~------------~--  213 (279)
T cd05633         150 K-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL------------T--  213 (279)
T ss_pred             c-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh------------c--
Confidence            2 2234568999999999864455889999999999999999999999765432211 1111000            0  


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                                 ....++..++.++.++|.+||..||++|+     |++++++||||++++..
T Consensus       214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence                       00112346789999999999999999999     69999999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-41  Score=310.79  Aligned_cols=251  Identities=29%  Similarity=0.461  Sum_probs=204.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..|.+.+.||.|++|.||++.+..+++.||+|.+....       ....+|+.+++.++||||+++.+++..     ...
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            46999999999999999999999999999999885322       123478999999999999999998843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++||||+.|++.+.+...   ...+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCC-CEEEeecCccee
Confidence            7899999999887777643   25689999999999999999999988 999999999999999888 899999999865


Q ss_pred             ccCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...   .....+++.|+|||++.+  ...++.++|+||||+++|+|++|++||.+.+.......+....  +        
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~--------  231 (307)
T cd06607         165 VSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--S--------  231 (307)
T ss_pred             cCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--C--------
Confidence            422   234567889999998742  3457889999999999999999999998776555443332110  0        


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                               +.        ......+..+.++|.+||..+|.+||++.+++.||||..-.
T Consensus       232 ---------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 ---------PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             ---------CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                     00        00123678899999999999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.6e-41  Score=303.50  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=198.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|++.+.||+|+||.||++.+..++..||+|.+..+.         ....+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            36999999999999999999999999999999875321         123469999999999999999887632   223


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..++++|||+++ +|.+.+.+.    ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~Dfg~  152 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVG-NVKLGDFGA  152 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCC-CEEECcCcc
Confidence            467899999985 787777643    4578888999999999999999988 999999999999999888 899999999


Q ss_pred             eeeccCC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +......    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+......++..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--  226 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence            8754321    112234578899999998654 488999999999999999999999987654444333221   110  


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                            ....+...+..+.++|.+|+. +|++||+++++++|||+.
T Consensus       227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                  001224567889999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=299.25  Aligned_cols=302  Identities=25%  Similarity=0.435  Sum_probs=226.0

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-------hHHHHHHHHhC-CCCCeeecceeeeecC
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLL-DHPNVVSLKHCFFSTT  101 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l-~h~~iv~~~~~~~~~~  101 (373)
                      .......|.+.++||.|+|+.|.+++.++|.+.||+|+++++--.       ...|..+..+- +||++|.++.+|    
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----  320 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----  320 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh----
Confidence            334456899999999999999999999999999999988654222       12455555544 699999999999    


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                       +.+..+++|.||++| +|--.+.+    ...++++.++.+...|+.||.|||++ ||++||||.+|+++|..| .+||+
T Consensus       321 -qtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeg-hiklt  393 (593)
T KOG0695|consen  321 -QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLT  393 (593)
T ss_pred             -cccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCC-ceeec
Confidence             666678999999996 54333332    36799999999999999999999998 999999999999999999 69999


Q ss_pred             eccceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CCcHHHHHHHHH
Q 017341          181 DFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-------ESGVDQLVEIIK  252 (373)
Q Consensus       181 Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~-------~~~~~~~~~i~~  252 (373)
                      |+|.++.... +....+++|||.|+|||++++. .|+..+|+|+||++|+||+.|+.||.-       .+..+.+.+++-
T Consensus       394 dygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil  472 (593)
T KOG0695|consen  394 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL  472 (593)
T ss_pred             ccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence            9999976543 4556788999999999999776 499999999999999999999999942       233344444332


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC------CHHHHhcCCCccccCC
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS------TALEALIHPFFDELRD  326 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~~ll~hp~~~~~~~  326 (373)
                      .                ..+            .++..+|-.+..+++..|.+||.+|.      ...++..||||+.++|
T Consensus       473 e----------------kqi------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  473 E----------------KQI------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             h----------------hcc------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence            1                011            23356788889999999999999996      4689999999999876


Q ss_pred             CCCCCCCCCCCCCCC----C-CChhhcCCCCHHHHhhhchHHHH-----hhhhhcCC
Q 017341          327 PNTRLPNGRFLPPLF----N-FKPHELKGVPVDMLVKLIPEHAR-----KQCAFLGL  373 (373)
Q Consensus       327 ~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  373 (373)
                      .  .+.....+||..    . +.-..+..+-.+.+..+.|+...     .|..|.||
T Consensus       525 d--~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~ridqsefegf  579 (593)
T KOG0695|consen  525 D--LLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGF  579 (593)
T ss_pred             H--HHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHHhcchhhcCcc
Confidence            4  222223333321    0 11111122223344455555443     68889887

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.1e-42  Score=311.13  Aligned_cols=255  Identities=30%  Similarity=0.447  Sum_probs=204.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..|.....||.|+||.||++.+..++..+|+|.+....    ....+|+.+++.++|+|++++++.+.     ...+.++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence            46777788999999999999999999999999875432    23447899999999999999999873     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+++ +|.+.+..     ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (292)
T cd06658          97 VMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVS  169 (292)
T ss_pred             EEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccCcchhhcc
Confidence            9999986 56655532     4588999999999999999999998 999999999999999887 89999999986543


Q ss_pred             CCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+.......+........          
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  238 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----------  238 (292)
T ss_pred             cccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------
Confidence            2221 2345688999999998544 488999999999999999999999988766555444332110000          


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                      ......+..+.++|.+||..||.+|||++++++||||+....+.
T Consensus       239 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         239 ----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                            01124688999999999999999999999999999999876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-42  Score=335.79  Aligned_cols=283  Identities=22%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCC-cEEEEE------------------Eeccc---ccchHHHHHHHHhCCCCCee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETG-EAVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV   91 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~~iv   91 (373)
                      ..+|++.+.||+|+||.||+|..+... ...+.|                  .+...   .....+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            358999999999999999998764332 222222                  11111   12235799999999999999


Q ss_pred             ecceeeeecCCCCceeEEEEEecccccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341           92 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      ++++++.     +..+.|++++++.+++...+..... .........++.++.||+.||.|||++ ||+||||||+|||+
T Consensus       227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEE
Confidence            9999883     3345789999999888777654321 122344667888999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCC--CcHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGE--SGVD  245 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~--~~~~  245 (373)
                      +.++ .+||+|||+++.......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |...  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9888 799999999986643322  2345789999999999654 489999999999999999998754 4332  3344


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcC---c-ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPN---Y-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                      .+.+++..+.....+ +......   + ....+...............++.++.++|.+||++||.+|||+.|+|.||||
T Consensus       379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            555555544332221 1000000   0 0000000000000001112467889999999999999999999999999999


Q ss_pred             cccC
Q 017341          322 DELR  325 (373)
Q Consensus       322 ~~~~  325 (373)
                      ....
T Consensus       458 ~~~~  461 (501)
T PHA03210        458 SAEE  461 (501)
T ss_pred             hcCC
Confidence            8753

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=302.86  Aligned_cols=246  Identities=34%  Similarity=0.527  Sum_probs=195.3

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHH-HHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||.|++|.||+|.+..+|+.||+|.+.....       ....|..+ ....+|+|++++++++     .....+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            568999999999999999999999998854321       11233333 3455899999999888     3344688999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+++ +|.+++...    ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99985 787777643    5688999999999999999999998 999999999999999888 899999999875432 


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                        .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.....            .   
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~---  211 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI------------N---  211 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc------------C---
Confidence              23446788999999986654 89999999999999999999999988776555544432100            0   


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCC
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRD  326 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~ll~hp~~~~~~~  326 (373)
                                +.......+++++.++|.+||+.+|++||+   ++|++.||||+.+++
T Consensus       212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                      001111357899999999999999999995   589999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-41  Score=301.70  Aligned_cols=250  Identities=34%  Similarity=0.519  Sum_probs=205.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+....     ....+|+..+..++|+|++++++++     .....+++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence            6899999999999999999999999999999886543     2345789999999999999999987     33456889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|||++ ++|.+.+...    ..+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 5888887654    668999999999999999999998 7 999999999999999988 8999999998765


Q ss_pred             cCCCCcc-cccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHHhh
Q 017341          189 VKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       189 ~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.....   .+....+...   ..      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~------  220 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP------  220 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC------
Confidence            4433322 45678999999998654 588999999999999999999999987742   2222222110   00      


Q ss_pred             cCcCcccccCCCcCCCCccccccCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                         ...+.. ++..+.++|.+||..+|++|||++++++||||+..+
T Consensus       221 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 -------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                               001133 788999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-41  Score=302.99  Aligned_cols=252  Identities=32%  Similarity=0.544  Sum_probs=199.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--------------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+....              ....+|+.+++.++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            6899999999999999999999999999999874311              1234688999999999999999877    


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                       .....+++||||+.+ +|.+.+...    ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++ .++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCC-eEEEe
Confidence             334457899999985 787777653    5688899999999999999999998 999999999999999888 89999


Q ss_pred             eccceeeccCCC---CcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          181 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       181 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|+|++|..||...+......++....  
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--  228 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--  228 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--
Confidence            999987543221   122345788999999986543 47889999999999999999999997655443332221100  


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                       .                    ...........++.++.++|.+||..+|.+|||++++++||||
T Consensus       229 -~--------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 -S--------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -c--------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence             0                    0000011224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-41  Score=305.57  Aligned_cols=240  Identities=18%  Similarity=0.244  Sum_probs=194.2

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      ..+|+|++|.||++..  +|+.||+|.+....       ....+|+.+++.++||||+++++++.... ++..++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5789999999999997  78999999886532       22348999999999999999999875422 23345789999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  192 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~  192 (373)
                      |+.+ +|.+.+...    ..+++.....++.|++.||.|||+..+++||||||+||+++.++ .+||+|||+++....  
T Consensus       103 y~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--  175 (283)
T PHA02988        103 YCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--  175 (283)
T ss_pred             eCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence            9995 788887653    56888889999999999999999744899999999999999988 899999999875432  


Q ss_pred             CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          193 PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       193 ~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......+              
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence            22345688999999998642 458999999999999999999999999887666555544321000              


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                   .++...++++.++|.+||+.||++|||+++++.
T Consensus       242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                         012357889999999999999999999999985

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-41  Score=302.24  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=193.9

Q ss_pred             cceEeeeee--eecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVV--GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      +.|.+.+.+  |.|+||.||++.++.++..+|+|.+..... ...|......+ +|||++++++++.     ....+|+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEE
Confidence            466776766  999999999999999999999998764322 12233333323 7999999999883     33468999


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||++ ++|.+.+...    ..+++..++.++.||+.||.|||+. |++||||+|+||+++.++..++|+|||.+.....
T Consensus        88 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99998 5888887653    4789999999999999999999988 9999999999999998875799999999875432


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .   ....++..|+|||++.+. .++.++|+||+||++|+|++|+.||......... ..+......             
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  225 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------  225 (267)
T ss_pred             C---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------------
Confidence            2   234688999999999654 4889999999999999999999999865443221 111111000             


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCccc
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEALIHPFFDE  323 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~~ll~hp~~~~  323 (373)
                                   .....+..++.+.+||.+||+.+|.+|++ ++++|+||||+.
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                         00112358899999999999999999996 599999999963

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=321.66  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=205.0

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEecc-----c-c--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----D-K--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----~-~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +...+||+|.|-+||+|.|..+|-.||.-.+..     . .  .....|+.+|+.|+||||++++++|.+..   ..++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence            345589999999999999999999998764421     1 1  44557999999999999999999987643   35678


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC-CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+|.+. |+|..+++++    +..+...++.|++||++||.|||++- .|+|||||.+||||+.+.+.|||+|+|+|..
T Consensus       120 ~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            9999998 7999998887    56778899999999999999999863 6999999999999999888999999999987


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...+.. ...+|||.|||||++.  ..|+..+||||||.+|.||+|+..||..-+ ..+++.++...+...         
T Consensus       196 ~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~---------  263 (632)
T KOG0584|consen  196 LRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA---------  263 (632)
T ss_pred             hhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH---------
Confidence            644433 3479999999999984  569999999999999999999999997754 444455554432111         


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                        .|.+--.+++++||.+||.. .++|+|+.|||+||||..-
T Consensus       264 ------------------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  264 ------------------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ------------------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                              12234578999999999999 9999999999999999873

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-41  Score=300.26  Aligned_cols=249  Identities=29%  Similarity=0.458  Sum_probs=202.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|.+.+.||.|++|.||++.++.+|..+|+|.+...      .....+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            589999999999999999999999999999988543      22345799999999999999999887     4445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|+||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999985 8887776532  24578999999999999999999988 99999999999999988656799999988765


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....|++.|+|||.+.+. .++.++|+||||+++++|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            43322 1234578899999998554 48899999999999999999999998776555444332210             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                            .+         .....++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  00         0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.9e-41  Score=298.48  Aligned_cols=250  Identities=32%  Similarity=0.527  Sum_probs=206.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|.+.+.||.|++|.||++.+..+++.+++|.+.....      ...+|+++++.++|||++++.+.+.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence            58999999999999999999999999999999865422      2447899999999999999998873     335688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +++||+++ +|...+.........+++..+..++.|++.||.+||++ |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 88888877544457799999999999999999999998 999999999999999877 8999999998765


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4332 22345688999999998654 48899999999999999999999998776544444332210             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                            .+         ..+..++..+.+++.+||..+|++|||+.++|+||||
T Consensus       220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                  00         0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=319.23  Aligned_cols=244  Identities=32%  Similarity=0.468  Sum_probs=201.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ....|.+...+|.|+|+.|-.+.+..+++.+++|.+.+......+|..++... +||||+++.+++     .+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            45689999999999999999999999999999999988766667788666554 799999999988     777789999


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE-cCCCCceeEeeccceeecc
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll-~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||.+.| .+.+.+..     .+.....+..|++||+.|+.|||++ |++||||||+|||+ ++.+ .++|+|||.++...
T Consensus       395 ~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCC-cEEEEEechhhhCc
Confidence            999996 34444332     2333367888999999999999998 99999999999999 4666 79999999997653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       190 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      ..  ..+.+.|..|.|||++. ...|+.++||||||+++|+|++|+.||......   .++...++.+.           
T Consensus       468 ~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~-----------  530 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK-----------  530 (612)
T ss_pred             hh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-----------
Confidence            33  33456788999999996 456999999999999999999999999887655   22333222221           


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                      +...+|.++++||++||+.||.+|+++.+++.||||
T Consensus       531 ----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                            225689999999999999999999999999999999

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.2e-41  Score=303.03  Aligned_cols=247  Identities=27%  Similarity=0.386  Sum_probs=192.4

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEecccccc-------hHHHH---HHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           42 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .||+|+||.||++.+..+++.||+|.+......       ...|.   ..++...||+|+++.+++     .+...+++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            489999999999999999999999988643211       12232   344456899999998887     444568899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+.| +|...+..    ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999985 67666643    35689999999999999999999998 999999999999999888 899999999875432


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      . ......|+..|+|||.+.+...++.++|+||+||++|+|++|+.||.+........ +......              
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~--------------  213 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--------------  213 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc--------------
Confidence            2 22345789999999998655458899999999999999999999998763322111 1110000              


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                                 ....++...+.++.++|.+||..+|.+|+     ++.++++||||+...+
T Consensus       214 -----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         214 -----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             -----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence                       00012245689999999999999999999     9999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-41  Score=317.23  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=193.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      .++|.+.+.||+|+||.||+|.+..+     +..||+|.+.....     ...+|+.+++.+ +|+||+++++++     
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence            34899999999999999999986543     45799998865332     234799999999 899999999987     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  128 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~-----------------------------------------------------  128 (373)
                      .....+++|||||. |+|.+.+.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            33445889999998 588888764321                                                     


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc-
Q 017341          129 -------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-  194 (373)
Q Consensus       129 -------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~-  194 (373)
                                   ...++++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++........ 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         013477888999999999999999998 999999999999999877 8999999998765333211 


Q ss_pred             --ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          195 --ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       195 --~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                        ....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+......               
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~---------------  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ---------------  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC---------------
Confidence              122345679999998654 48999999999999999997 99999876554443333321000               


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                  ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       334 ------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 ------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        0011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4e-41  Score=299.20  Aligned_cols=245  Identities=28%  Similarity=0.474  Sum_probs=200.1

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....     ....+|+.+++.++|+||+++.+.+     .+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            5899999999999999999999999999999875322     2334688999999999999999988     44556899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+++ ++.+.+...  ....+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999984 777776543  235688999999999999999999998 999999999999999888 89999999987653


Q ss_pred             CCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+......            
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  218 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------------  218 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC------------
Confidence            3222 2345688999999998654 4899999999999999999999999887655554444321000            


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                      ..+..++..+.++|.+||+.||++|||+.+++.-
T Consensus       219 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ----------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                            0123577899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-41  Score=304.50  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=203.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..|+..+.||.|+||.||+|.+..+++.+|+|.+....     ....+|+.+++.++||||+++++++     .+..+.+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence            36889999999999999999999999999999876432     2244789999999999999999988     3445689


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+..     .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~  151 (277)
T cd06640          79 IIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQG-DVKLADFGVAGQL  151 (277)
T ss_pred             EEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCC-CEEEcccccceec
Confidence            99999985 77776653     4588889999999999999999988 999999999999999888 8999999998765


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...              
T Consensus       152 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  216 (277)
T cd06640         152 TDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--------------  216 (277)
T ss_pred             cCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--------------
Confidence            43322 2234578899999998654 4799999999999999999999999876654433222110              


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                           ..         ..+...++..+.++|.+||+.+|++||+++++++||||....
T Consensus       217 -----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         217 -----NP---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             -----CC---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                 00         011234678999999999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=303.95  Aligned_cols=251  Identities=28%  Similarity=0.489  Sum_probs=201.1

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCC---CCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .|++.+.||.|+||.||+|.+..+++.+|+|.+..+.     ....+|+.+++.++   |||++++++++.     +..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            4788899999999999999999999999999875432     22446888888886   999999998873     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .|++|||+.+ +|.+.+..     ..+++..++.++.|++.+|.|||+. ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            8899999985 77766643     3688999999999999999999988 999999999999999877 89999999987


Q ss_pred             eccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....... .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            6644332 234568899999999866555789999999999999999999999876543322111000            


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                             ..+.        ......+.++.+++.+||..||++||++.+++.||||++..
T Consensus       218 -------~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 -------KPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -------CCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                   0000        00123678999999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.7e-41  Score=306.42  Aligned_cols=250  Identities=29%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +.|...+.||.|++|.||+|++..+++.+++|.+....       ....+|+++++.++|||++++++++.     +...
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence            35777888999999999999999999999999885432       12347899999999999999999883     3445


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .|+||||+.+++...+...   ..++++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~-~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCC-CEEEeecCCCcc
Confidence            7899999999888777653   35688999999999999999999988 999999999999999888 799999998854


Q ss_pred             ccCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .   .......++..|+|||.+..  ...++.++|+|||||++|+|++|.+||.+.+.......+.... .         
T Consensus       171 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~---------  237 (313)
T cd06633         171 S---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S---------  237 (313)
T ss_pred             c---CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C---------
Confidence            2   22234578899999999842  2447889999999999999999999998877655555443210 0         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                               +.        .....++..+.+|+.+||+.+|.+||++.+++.||||+..
T Consensus       238 ---------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         238 ---------PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ---------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                     00        0113467789999999999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=319.19  Aligned_cols=238  Identities=24%  Similarity=0.414  Sum_probs=201.5

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEeccc
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP  116 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~  116 (373)
                      ..-.+.||+|+.|.||+++.  .++.||||++.   ...+.+++-|+.|+||||+.+.++.     ....++|||||||.
T Consensus       126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~---elkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVR---ELKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhhhhccCcccceeeeec--cCceehhHHHh---hhhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccc
Confidence            34467899999999999986  57899999874   3345678899999999999999988     56667999999999


Q ss_pred             -ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCcc
Q 017341          117 -ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI  195 (373)
Q Consensus       117 -g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~  195 (373)
                       |.|...|+.    ..++.......|..+|+.|++|||.+ .|||||||.-||||.-+. .|||+|||.++.........
T Consensus       196 ~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkM  269 (904)
T KOG4721|consen  196 QGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKM  269 (904)
T ss_pred             cccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhh
Confidence             788888876    46788889999999999999999998 999999999999999888 89999999998876666667


Q ss_pred             cccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017341          196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  275 (373)
Q Consensus       196 ~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      +++||..|||||++... ..+.++|||||||+||||+||..||.+-+...++..+                         
T Consensus       270 SFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-------------------------  323 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-------------------------  323 (904)
T ss_pred             hhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEec-------------------------
Confidence            89999999999999655 4899999999999999999999999876543322211                         


Q ss_pred             CcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                        ....+....+..++.-++-||+.||+..|..||+..++|.|
T Consensus       324 --GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  324 --GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             --cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence              11112222446788999999999999999999999999999

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.7e-41  Score=300.64  Aligned_cols=245  Identities=33%  Similarity=0.560  Sum_probs=199.0

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||.|++|.||++.+..+|+.+++|.+..+..       ...+|+++++.++||||+++++.+     ......|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6889999999999999999999998864432       344688999999999999998877     4455688999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC--
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  192 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~--  192 (373)
                      .+ +|...+.+.    ..+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            85 887777653    4689999999999999999999988 999999999999999988 89999999987543321  


Q ss_pred             -------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          193 -------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       193 -------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                             ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  217 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-----------  217 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence                   122345788999999986544 7899999999999999999999998877655544433210           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCccccCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFFDELRD  326 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~~ll~hp~~~~~~~  326 (373)
                            ...+.          ...++..+.+++.+||+.+|.+|||+   .++|+||||+++.+
T Consensus       218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                  00000          01258899999999999999999999   99999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-40  Score=297.89  Aligned_cols=248  Identities=27%  Similarity=0.490  Sum_probs=194.0

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEec
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      ....||+|+||.||++.+..++..+++|.+....    ....+|+.+++.++|+||+++++++     ....+.++++||
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~   86 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFMEQ   86 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEec
Confidence            3457999999999999999999999999876443    2345799999999999999999887     344568899999


Q ss_pred             ccc-cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          115 VPE-TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       115 ~~g-~l~~~l~~~~~~~~~~--~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      +.+ +|.+.+....   ..+  ++..+..++.||+.||+|||+. ||+||||||+||+++.+.+.++|+|||.+......
T Consensus        87 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          87 VPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             CCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            984 8888776542   334  7788889999999999999988 99999999999999874448999999998755332


Q ss_pred             CC-cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          192 EP-NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       192 ~~-~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .. .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|+.||................               
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  227 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---------------  227 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------
Confidence            22 2234578999999998543 347889999999999999999999997644322111000000               


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                 .....++..+++++.+++.+||+.+|.+|||+++++.||||
T Consensus       228 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 -----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                       00011234678899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-40  Score=301.16  Aligned_cols=253  Identities=30%  Similarity=0.480  Sum_probs=204.1

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .|...+.||.|++|.||++.+..+++.+++|.+....    ....+|+.+++.++|||++++++++.     ...+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence            5666789999999999999999999999999875332    22357889999999999999999873     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      +||+.+ +|.+.+..     .++++..+..++.|++.||+|||++ |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999985 77777654     4588899999999999999999998 999999999999999888 899999998765432


Q ss_pred             CCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      ... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+.......+.... .+            
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------  233 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------  233 (285)
T ss_pred             CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC------------
Confidence            221 2234688999999998654 48899999999999999999999998776655554433210 00            


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                            .       ......++..+.++|.+||..+|++|||+.++++||||+..+++
T Consensus       234 ------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         234 ------K-------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             ------C-------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                  0       00112477899999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-41  Score=306.00  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=203.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .|.....||.|+||.||++.+..+++.||+|.+....    ....+|+.+++.++|||++++++++.     .....|++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEE
Confidence            4666778999999999999999899999999875322    23347889999999999999999873     34458899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+++ +|...+..     ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCC-cEEEeechhHhhccc
Confidence            999995 66655432     4588999999999999999999988 999999999999999888 899999999865432


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+....+.... .+            
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~------------  235 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP------------  235 (297)
T ss_pred             ccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CC------------
Confidence            22 22345689999999999654 48999999999999999999999998776655544332210 00            


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                                  . ......++.++.++|.+||+.+|.+||+++++++||||.....+
T Consensus       236 ------------~-~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         236 ------------K-LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             ------------C-ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence                        0 00113578899999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.4e-41  Score=305.78  Aligned_cols=253  Identities=19%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECC----------------CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeec
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL   93 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~   93 (373)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999998532                34579999876432     124479999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhHccCC
Q 017341           94 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM---------------SQRMPLIYVKLYFYQICRALAYIHNTIG  157 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~---------------~~~~~~~~~~~i~~qil~~L~~LH~~~~  157 (373)
                      ++++..     ....++||||+. ++|.+.+......               ...++...+..++.||+.||.|||+. |
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~  158 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-N  158 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-C
Confidence            998733     334789999998 5888887653211               12367778899999999999999998 9


Q ss_pred             ceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-
Q 017341          158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  233 (373)
Q Consensus       158 ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-  233 (373)
                      |+||||||+||+++.++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence            99999999999999888 899999999876533321   1223457789999998654 48999999999999999986 


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH
Q 017341          234 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  312 (373)
Q Consensus       234 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  312 (373)
                       +..||.+.+..+....+..........                     .....++.++..+.++|.+||+.||.+|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             668888776655554443321110000                     0001124578899999999999999999999


Q ss_pred             HHHh
Q 017341          313 LEAL  316 (373)
Q Consensus       313 ~~ll  316 (373)
                      +++.
T Consensus       296 ~~i~  299 (304)
T cd05096         296 SDIH  299 (304)
T ss_pred             HHHH
Confidence            9994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9e-42  Score=307.19  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=202.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..|...+.||+|++|.||+|.+..+++.+|+|.+....     ....+|+.+++.++||||+++++++     .+..+.|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence            35888899999999999999999999999999876432     2345799999999999999999987     3445588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+.     ...+++..++.++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~  151 (277)
T cd06642          79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQG-DVKLADFGVAGQL  151 (277)
T ss_pred             EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCC-CEEEccccccccc
Confidence            99999995 6766654     25688999999999999999999988 999999999999999888 8999999998765


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+...              
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  216 (277)
T cd06642         152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------  216 (277)
T ss_pred             cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence            43221 2234578899999998654 4889999999999999999999999766544333221110              


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                           .         ........+.++.++|.+||+.+|.+|||+.++++||||.....
T Consensus       217 -----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         217 -----S---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             -----C---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence                 0         00112356789999999999999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=297.58  Aligned_cols=291  Identities=35%  Similarity=0.567  Sum_probs=231.2

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .|..-.+.+-.+.||.|+||.||.+.|..+|+.+|+|++..-      .+...+|+++|..++|.|++...++.-...-.
T Consensus        48 ~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   48 PPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             CccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            344445678889999999999999999999999999998532      34456899999999999999998876322211


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      --.-+|+++|.+..+|...+-.    .+.++..-++.++.||++||.|||+. +|.||||||.|++++++. .+||||||
T Consensus       128 fFqEiYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNC-vLKICDFG  201 (449)
T KOG0664|consen  128 FFQELYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNC-ILKICDFG  201 (449)
T ss_pred             HHHHHHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCc-eEEecccc
Confidence            1111567888888877766654    46788889999999999999999998 999999999999999999 89999999


Q ss_pred             ceeeccCCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          184 SAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       184 ~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      +++.....+..  ...+.|.+|+|||++++.+.|+.+.||||+|||+.||+-.+..|+..++.+++..|...+|.|+.+.
T Consensus       202 LARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  202 LARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             cccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            99875443322  2346799999999999999999999999999999999999999999999999999999999999998


Q ss_pred             HhhcCcCcccccCCCcCCCCccccc-----cCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIF-----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      +.....+...--.+...+.+....+     +.....+...++.++|.+||.+|.+.++++.|++..+.+-
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            7655433222111111111111111     1234467889999999999999999999999999987653

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.1e-41  Score=303.59  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|++|.||+|.+..+++.+|+|.+.....     ...+|+.++... .||||+++++++     .+.
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~   86 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD   86 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence            345689999999999999999999998999999999864321     123455555555 599999999988     344


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|++|||+++++.+++...   ...+++..+..++.||+.||+|||+..||+||||+|+||+++.++ .++|+|||.+
T Consensus        87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~  162 (296)
T cd06618          87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGIS  162 (296)
T ss_pred             CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccc
Confidence            458999999998877776653   357899999999999999999999733999999999999999887 8999999998


Q ss_pred             eeccCCCCcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHH
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~  261 (373)
                      .............+++.|+|||.+.+.   ..++.++|+||||+++|+|++|+.||..... .+.+..+....       
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  235 (296)
T cd06618         163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-------  235 (296)
T ss_pred             hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-------
Confidence            765444333444678899999998543   2378899999999999999999999976432 22222222210       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                  .+..   +    ....++.++.+||.+||..||.+||++++++.||||+....
T Consensus       236 ------------~~~~---~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         236 ------------PPSL---P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             ------------CCCC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                        0000   0    01246789999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-41  Score=303.56  Aligned_cols=260  Identities=28%  Similarity=0.420  Sum_probs=201.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..+|++.+.||+|++|.||++.+..+|+.||+|.+....     ....+|+++++.++||||+++++++.     +..++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence            457999999999999999999999999999999875432     23347999999999999999999873     34568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+++ +|...+..    .+.+++..+..++.|++.+|.|||+..+++|+||+|+||+++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~  153 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGE  153 (284)
T ss_pred             EEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccc
Confidence            899999995 67666654    256899999999999999999999744899999999999999888 899999998865


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCCHHHHh
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIK  263 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~  263 (373)
                      .... ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||......+.    ...+......    .+.
T Consensus       154 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~  227 (284)
T cd06620         154 LINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ----IVQ  227 (284)
T ss_pred             hhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH----Hhh
Confidence            4222 22345789999999998654 588999999999999999999999987654211    1111110000    000


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .        ..+.        .....++.++.+||.+||+.||.+|||++++++||||....
T Consensus       228 ~--------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         228 E--------PPPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             c--------cCCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0        0000        00023678999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-40  Score=296.66  Aligned_cols=250  Identities=32%  Similarity=0.547  Sum_probs=198.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|.+.+.||+|++|.||++.+..+++.+++|.+.....      ...+|+.+++.++|+||+++++..     .+...++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            58999999999999999999988999999998865433      234799999999999999998876     3444588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|+||+.+ +|.+.+...    ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 777776642    4578889999999999999999988 999999999999999877 8999999998765


Q ss_pred             cCCCCcc-----cccccccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          189 VKGEPNI-----SYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       189 ~~~~~~~-----~~~gt~~y~aPE~l~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      .......     ...+++.|+|||.+.+..  .++.++|+||||+++|+|++|+.||...+........... +..    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----  224 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK----  224 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----
Confidence            4332211     245788999999986432  2788999999999999999999999766433222211111 000    


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                           +     ..+.          ...+++.+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       225 -----~-----~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         225 -----P-----PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----C-----CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                 0     0000          02458899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.9e-41  Score=299.32  Aligned_cols=245  Identities=20%  Similarity=0.247  Sum_probs=194.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|++.+.||+|+||.||++.++   ..+..+|+|.+....     ....+|+.+++.++||||+++++++.     ..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence            457999999999999999999765   456789999876542     12347999999999999999998873     33


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+.++||||+++ +|.+.+...   ...+++..+..++.||+.||+|||++ |++||||||+||+++.++ .++++|||.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~-~~~l~dfg~  153 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDL-VCKISGFRR  153 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCC-cEEECCCcc
Confidence            458899999995 677676643   24688999999999999999999988 999999999999999888 899999998


Q ss_pred             eeeccCCCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          185 AKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       185 a~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      +..........  ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-----  227 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-----  227 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-----
Confidence            75432221111  22346789999998654 58999999999999999875 99999888766555544321000     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                             ..+..++..+.+++.+||+.+|.+|||++++++
T Consensus       228 -----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 -----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                   012457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-40  Score=300.81  Aligned_cols=258  Identities=23%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|.++.     .+..+|+|.+.....     ...+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            35689999999999999999997642     355899998754332     234688899999999999999887     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  175 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  175 (373)
                      .+....|+||||+. |+|.+.+......      ....+...+..++.||+.||.|||++ +|+||||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~-  156 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDF-  156 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCC-
Confidence            33345789999998 5888888754321      12345677888999999999999988 999999999999999888 


Q ss_pred             ceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 017341          176 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  251 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~  251 (373)
                      .++|+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999875433221   1122446789999998654 48999999999999999998 789998776655444332


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCccccC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI------HPFFDELR  325 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~------hp~~~~~~  325 (373)
                      ..              ..     +         ..+...++.+.+++.+||+.||++|||+.++++      ||||.++.
T Consensus       236 ~~--------------~~-----~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         236 DG--------------GY-----L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             cC--------------CC-----C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            21              00     0         011346789999999999999999999999986      99998875


Q ss_pred             C
Q 017341          326 D  326 (373)
Q Consensus       326 ~  326 (373)
                      +
T Consensus       288 ~  288 (288)
T cd05061         288 F  288 (288)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-40  Score=295.04  Aligned_cols=249  Identities=29%  Similarity=0.471  Sum_probs=205.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....      ....+|+.+++.++|+||+++.+++.     +....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            5899999999999999999999999999999886432      12346889999999999999998883     335588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|...+.+.......+++..++.++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999985 88888877655556789999999999999999999988 999999999999999877 8999999998765


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...               
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------  216 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------  216 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence            443 23345678899999998654 4788999999999999999999999887755443333221               


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                          .++.         .....+.++.++|.+||..+|.+|||+.++++||++
T Consensus       217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                0000         113467899999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-40  Score=297.02  Aligned_cols=245  Identities=21%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ..|.+.+.||.|++|.||+|.+..+++.+|+|.+..+..   ...+|+++++.++|+||+++++++     .....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence            469999999999999999999999999999998865432   235799999999999999999877     334457899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||++ ++|.+.+....  ...+++..+..++.|++.+|+|||++ |++||||||+||+++.++ .+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99998 58888776532  34588889999999999999999988 999999999999999888 899999999876533


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.....            
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  223 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------  223 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            2211  122335679999998654 48899999999999999998 9999988765554443322100            


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                      ...+..++.++.++|.+||+.+|++|||+.++++
T Consensus       224 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ----------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                            0112457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.5e-41  Score=311.70  Aligned_cols=278  Identities=21%  Similarity=0.327  Sum_probs=197.5

Q ss_pred             eeeeec--CceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      ..||.|  +||+||++.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++     ....++++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            345666  99999999999999999999876432      2335688888999999999999988     3444588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+.+ ++...+.+..  ...+++..+..++.||+.||+|||++ |++||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99995 8877777643  34588999999999999999999988 999999999999999888 8999999864322111


Q ss_pred             CCc--------ccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH--
Q 017341          192 EPN--------ISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  260 (373)
Q Consensus       192 ~~~--------~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~--  260 (373)
                      ...        ....++..|+|||++.+. ..++.++|+||+||++|+|++|++||.+.........+..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            110        112345679999998653 347899999999999999999999998876555444433211100000  


Q ss_pred             -------HHhhcCcCcc----cccCC-----CcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          261 -------EIKCMNPNYT----EFKFP-----QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       261 -------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                             ........+.    +....     ......+........++.+.+||.+||+.||++|||++++|+||||+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    00000     0000001111123467889999999999999999999999999999887


Q ss_pred             CCC
Q 017341          325 RDP  327 (373)
Q Consensus       325 ~~~  327 (373)
                      ...
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=295.62  Aligned_cols=249  Identities=27%  Similarity=0.475  Sum_probs=199.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|++.+.||+|++|.||++.+..+++.+|+|.+..+.         ....+|+.+++.++|+||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            36999999999999999999999999999999874321         123468999999999999999987643   223


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..++++|||+.+ +|.+.+...    ..+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcccc
Confidence            457799999985 787777643    4578899999999999999999988 999999999999999888 799999999


Q ss_pred             eeeccCC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ++.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.   ..+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~--  226 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT--  226 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC--
Confidence            8754321    111234678999999998654 47899999999999999999999998765444333222   1111  


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                            ...++..++..+.++|.+||. +|..||++.+++.|||.
T Consensus       227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                  011335688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-40  Score=302.45  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=202.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|.+.+.||+|+||.||++.+..++..+++|.+....    ....+|+.+++.++|||++++++.+.     .....|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence            468999999999999999999998899999999875432    22346889999999999999999873     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|+||+.+ +|.+.+..     ..+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 77777653     3578888999999999999999988 999999999999999887 8999999987654


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+... +.           
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~-----------  232 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-----------  232 (293)
T ss_pred             cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CC-----------
Confidence            33222 2234678899999998654 4789999999999999999999999876544332221110 00           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                             +     .  ...+..++..+.++|.+||..+|++||++.+++.||||+..+
T Consensus       233 -------~-----~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         233 -------P-----E--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             -------C-----C--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                   0     0  001134678999999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.1e-41  Score=313.06  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=193.4

Q ss_pred             cceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      .+|++.+.||+|+||.||+|.+     ..++..||+|.+....     ....+|+.+++.+ +||||+++++++     .
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----~  109 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----T  109 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----c
Confidence            3799999999999999999974     3567789999885432     2234799999999 899999999987     3


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh------------------------------------------------------
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK------------------------------------------------------  128 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------------------------------------------------  128 (373)
                      +....++|||||+ |+|.+.+.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            3445789999999 588888764321                                                      


Q ss_pred             -----------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          129 -----------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       129 -----------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                                       ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCC-cEEEecCccceeccCc
Confidence                             012467888999999999999999998 999999999999999877 8999999998765332


Q ss_pred             CCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          192 EPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       192 ~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...   ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+........+.....             
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-------------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-------------
Confidence            211   123345679999999654 48999999999999999998 899998765544433333210             


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                       +   ..          ..+...+.++.++|.+||+.||++|||+.++++.
T Consensus       334 -~---~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 -Y---RM----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -c---cC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence             0   00          0113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-40  Score=299.17  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=201.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      -|++.+.||.|+||.||++.+..+++.+|+|.+....     ....+|+.+++.++||||+++++++     .+..++++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            4888999999999999999999999999999875332     2344789999999999999999988     34456889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+++ +|...+..     ..++...+..++.|++.++.+||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999985 67666642     4588999999999999999999988 999999999999999888 79999999987553


Q ss_pred             CCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .... .....++..|+|||.+.+. ..+.++|+||+||++|+|++|..||...+.......+...  .            
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~------------  217 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--N------------  217 (277)
T ss_pred             cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--C------------
Confidence            3221 2234678899999998644 4788999999999999999999999876654433332210  0            


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                    ...+...++.++.++|.+||+.+|.+||++.++++||||....
T Consensus       218 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         218 --------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                          0012245788999999999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-40  Score=303.79  Aligned_cols=249  Identities=30%  Similarity=0.468  Sum_probs=203.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .|...+.||+|+||.||++++..++..+|+|.+.....       ...+|+++++.++|||++++++++.     +....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence            48999999999999999999999999999998864321       2346899999999999999999874     33447


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||||+.|++.+.+...   ..++++..+..++.||+.||.|||++ |++||||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            899999999888777643   35688999999999999999999988 999999999999999888 7999999988643


Q ss_pred             cCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .   ......+++.|+|||.+..  ...++.++|+|||||++|+|++|+.||...+.......+......+         
T Consensus       176 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             C---CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            2   2234568889999999742  2347889999999999999999999998776655555544321000         


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                        ......++.+.++|.+||+.+|.+||++.++++|||+...
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                              0113467889999999999999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-40  Score=296.96  Aligned_cols=250  Identities=30%  Similarity=0.454  Sum_probs=197.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||.|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++..     ...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            57999999999999999999999999999999774321       123469999999999999999998743     345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|||+++ +|.+.+.........+++..+..++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||.+.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 88877766544445688999999999999999999998 999999999999999888 79999999987


Q ss_pred             eccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhh
Q 017341          187 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       187 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...... ............        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  225 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--------  225 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--------
Confidence            6533221 1234678899999998654 4789999999999999999999999655321 111111111000        


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                +.        ......+..+.++|.+||..+|++||++.++++.
T Consensus       226 ----------~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         226 ----------PP--------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             ----------CC--------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                      00        0113467889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-40  Score=300.51  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=202.1

Q ss_pred             ceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|.+....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4899999999999999999874   478999999885421        2234689999999 599999998887     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ....+|+||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCC-CEEEeeC
Confidence            45568899999995 787777643    5688999999999999999999988 999999999999999888 8999999


Q ss_pred             cceeeccCCC--CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          183 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       183 g~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      |++.......  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+........ 
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-  228 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-  228 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-
Confidence            9987653322  12245688999999998643 2467899999999999999999999975443322233222110000 


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                                              ..++..+++.+.+++.+||..||++|+     ++++++.||||+...+.
T Consensus       229 ------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         229 ------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                                    002245788999999999999999997     89999999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-40  Score=300.74  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=199.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCC-----cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|++.+.||+|++|.||+|.+...+     ..+|+|.+.....     ...+|+.+++.++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~   78 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----T   78 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----c
Confidence            357999999999999999999976555     6799998854322     235799999999999999999887     3


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      +....|++|||++ ++|.+.+......            ...+++..+..++.||+.||+|||++ |++|+||||+||++
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~  157 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLV  157 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEE
Confidence            3445789999998 5888888754221            14578889999999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  246 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~  246 (373)
                      +.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus       158 ~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05048         158 GEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV  235 (283)
T ss_pred             cCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9887 799999999876533221   2234567889999998654 48999999999999999998 9999988776655


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...+......                            ..+..++.++.+|+.+||+.||.+||++.+++++
T Consensus       236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         236 IEMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5444331000                            0124688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-40  Score=304.05  Aligned_cols=251  Identities=28%  Similarity=0.449  Sum_probs=203.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..|...+.||.|++|.||++++..+++.+|+|.+....       ....+|+++++.++|+|++++.+++..     ...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence            36888999999999999999999999999999875321       123468999999999999999998743     345


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++||||+.+++.+.+...   ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  164 (308)
T cd06634          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (308)
T ss_pred             eEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCC-cEEECCccccee
Confidence            7899999999887776543   35588999999999999999999988 999999999999999887 899999999875


Q ss_pred             ccCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+.....          
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------  231 (308)
T cd06634         165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------  231 (308)
T ss_pred             ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC----------
Confidence            432   234567889999999742  23478899999999999999999999977655444443332100          


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                               +.        ......+..+.++|.+||..+|.+||+++++++|||+...+
T Consensus       232 ---------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         232 ---------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ---------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                     00        01135778999999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-40  Score=304.38  Aligned_cols=278  Identities=21%  Similarity=0.334  Sum_probs=196.3

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+.+.+|.  +|.||++++..+++.||+|++....      ....+|+.+++.++|+||+++++++.     +....+++
T Consensus         5 ~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~   77 (314)
T cd08216           5 LIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVV   77 (314)
T ss_pred             hhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEE
Confidence            34444444  4556666777799999999986541      23457999999999999999999883     34457899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||++ +++.+++....  ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~  153 (314)
T cd08216          78 SPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK  153 (314)
T ss_pred             EeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence            99999 57877777543  34588999999999999999999998 999999999999999888 899999998865432


Q ss_pred             CCC--------cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC-HH
Q 017341          191 GEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT-RE  260 (373)
Q Consensus       191 ~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~-~~  260 (373)
                      ...        .....++..|+|||++.+. ..++.++|+||+||++|+|++|+.||..........+......... ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            211        1233467789999998643 3478899999999999999999999987665443332221110000 00


Q ss_pred             -HHhhcCcCccc----ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          261 -EIKCMNPNYTE----FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       261 -~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                       ...........    ...+ .............++.++.+|+.+||.+||++|||++++|+||||+.++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             CchhhhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence             00000000000    0000 000111111223456789999999999999999999999999999987644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-40  Score=329.76  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=194.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..+.       ....+|+++++.++||||+++++++     .+...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            68999999999999999999999999999999986432       1234799999999999999999887     34445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~-------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      .|++|||++| +|.+.+......       ....+...+..++.||+.||+|||++ ||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCC-CEEE
Confidence            8899999985 888877653211       23355667888999999999999998 999999999999999888 7999


Q ss_pred             eeccceeeccCCC-------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017341          180 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  240 (373)
Q Consensus       180 ~Dfg~a~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~  240 (373)
                      +|||++.......                   ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999987651110                   01124689999999998655 489999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          241 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+.......  .....+.              ..     .     -...+++.+.+++.+||+.||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~--------------~~-----~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPI--------------EV-----A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChh--------------hc-----c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            554332211  0000000              00     0     013578899999999999999999887666543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-40  Score=298.42  Aligned_cols=245  Identities=33%  Similarity=0.592  Sum_probs=202.7

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +|.+.+.||.|++|.||++.+..+++.+|+|.+..+.       ....+|..+++.++ ||||+++++++     .+...
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            6999999999999999999999999999999875421       22346889999998 99999999887     44556


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++++||++. ++|.+.+...    ..+++..++.++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 6888887653    4689999999999999999999988 999999999999999888 79999999987


Q ss_pred             eccCCCC---------------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017341          187 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  245 (373)
Q Consensus       187 ~~~~~~~---------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~  245 (373)
                      .......                     .....++..|+|||.+.+. .++.++|+||||+++++|++|+.||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            5533221                     1233568899999998654 47889999999999999999999998877555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCc
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFF  321 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~ll~hp~~  321 (373)
                      .+..+...                             ...++..+++.+.+||.+||..+|++|||+    +++++||||
T Consensus       230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44443321                             001224578899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.7e-40  Score=290.51  Aligned_cols=250  Identities=34%  Similarity=0.527  Sum_probs=202.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+....      ....+|+.+++.++||||+++++.+...   ....++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence            4889999999999999999999899999999886543      2345799999999999999999887432   125688


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +++||++ ++|.+.+...    ..+++..++.++.|++.+|+|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 5787777653    3789999999999999999999998 999999999999999877 8999999998876


Q ss_pred             cCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+...  ..+.....          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc----------
Confidence            55443   34456889999999986543 8999999999999999999999998766211  11111100          


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                    ......++...+..+.++|.+||+.+|.+||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000011224568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.6e-40  Score=289.70  Aligned_cols=248  Identities=29%  Similarity=0.498  Sum_probs=202.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .|.+.+.||.|++|.||++.+..+++.+++|.+....    ....+|+.+++.++|+|++++.+++.     .....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence            4889999999999999999998899999999886544    34557999999999999999999873     33457899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      +||++ ++|.+.+....   ..+++..+..++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 58877776532   5689999999999999999999987 999999999999999887 899999999876644


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+... ..              
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~--------------  214 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GP--------------  214 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CC--------------
Confidence            43234567889999999986544 789999999999999999999999877544443332220 00              


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                          +..       .....++..+.++|.+||+.||++|||+.+++.|||
T Consensus       215 ----~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         215 ----PGL-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ----CCc-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                000       001224789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-41  Score=312.10  Aligned_cols=267  Identities=28%  Similarity=0.467  Sum_probs=211.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-------hHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .-|..++.||-|+||.|.++...+|...||+|.+.+..-.       ...|.+||..-+++-||+++..|     ++...
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence            3689999999999999999999999999999988654322       23588999999999999998887     66666


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||+|++| ++-.+|.+.    +-|+|..++.+++.+.+|+++.|.- |+|||||||+|||||.+| .|||+|||+|+
T Consensus       704 LYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdG-HIKLTDFGLCT  777 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCT  777 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCC-ceeeeeccccc
Confidence            9999999995 666666654    6689999999999999999999965 999999999999999999 69999999986


Q ss_pred             ecc---------CCC--------C--------------------------cccccccccccccccccCCCCCCCchhHHH
Q 017341          187 VLV---------KGE--------P--------------------------NISYICSRYYRAPELIFGATEYTAAIDIWS  223 (373)
Q Consensus       187 ~~~---------~~~--------~--------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~Diws  223 (373)
                      -+.         ++.        .                          .-..+||+.|+|||++.. ..|+..+|+||
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws  856 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWS  856 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhH
Confidence            331         000        0                          013468999999999965 45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcC
Q 017341          224 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  303 (373)
Q Consensus       224 lG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  303 (373)
                      .|||||||+.|++||-..+..++..++++.                ..         .++..+..++|.++.++|.++.+
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw----------------~~---------~l~~~~~~~ls~e~~~li~kLc~  911 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKVINW----------------RN---------FLHIPYQGNLSKEALDLIQKLCC  911 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeeeeeh----------------hh---------ccccccccccCHHHHHHHHHHhc
Confidence            999999999999999988877766555432                10         01111225789999999998765


Q ss_pred             cCCCCCCC---HHHHhcCCCccccCCCCCCCCCCCCCCC
Q 017341          304 YSPNLRST---ALEALIHPFFDELRDPNTRLPNGRFLPP  339 (373)
Q Consensus       304 ~dP~~R~t---~~~ll~hp~~~~~~~~~~~~~~~~~~~~  339 (373)
                       +++.|+.   ++|+..||||+.+++.+.|-....++|.
T Consensus       912 -sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~  949 (1034)
T KOG0608|consen  912 -SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPR  949 (1034)
T ss_pred             -ChhhhhcccchhhhhcCccccccchHhhhhccCCcCcc
Confidence             7788874   6789999999999886544333334433

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2e-40  Score=300.69  Aligned_cols=254  Identities=29%  Similarity=0.435  Sum_probs=202.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .|.....||.|++|.||++.+..+++.+|+|++....    ....+|+.+++.++|+|++++++.+.     ...+.+++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   95 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVV   95 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEE
Confidence            4455578999999999999999999999999875322    22346899999999999999999883     34458899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+++ +|.+.+.     ...+++..+..++.|++.+|+|||+. |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~  168 (292)
T cd06657          96 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSK  168 (292)
T ss_pred             EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEcccccceeccc
Confidence            999986 6655543     24578899999999999999999998 999999999999999888 799999998865533


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .. ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+......           .+
T Consensus       169 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~  236 (292)
T cd06657         169 EVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----------KL  236 (292)
T ss_pred             ccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-----------cc
Confidence            22 1233567899999998854 34789999999999999999999999887665544433321100           00


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                     .....++..+.+++.+||+.+|.+||++.+++.||||.....++
T Consensus       237 ---------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         237 ---------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             ---------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence                           01134788999999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-40  Score=290.39  Aligned_cols=246  Identities=35%  Similarity=0.584  Sum_probs=203.4

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....      ...+|+++++.++|+|++++.+++.     +..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            58999999999999999999999999999999865432      2357899999999999999988873     345688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++|||+++ +|.+.+...    ..+++..++.++.|++.+|.+||+. ||+|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 777776643    5689999999999999999999988 999999999999999877 8999999998766


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+...              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            44332 23456788999999986544 789999999999999999999999876644433332210              


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                           ..         ..++..++..+.++|.+||..+|++|||+.+++.||||
T Consensus       215 -----~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 -----DH---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -----CC---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                 00         01234678999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-40  Score=296.45  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=194.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||.|++|.||++.+.     .++..+|+|.+.....     ...+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            4568999999999999999999864     2457799998754321     234789999999999999999887     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  175 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  175 (373)
                      ......++||||++ ++|.+.+......      ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~-  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCC-
Confidence            34445789999998 5888887653221      12356778889999999999999998 999999999999999888 


Q ss_pred             ceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 017341          176 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  251 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~  251 (373)
                      .++|+|||++........   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            899999999875433221   1123457789999998654 48999999999999999999 789998876655444333


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...                   .+         ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EGG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCC-------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            210                   00         0123567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.6e-40  Score=292.77  Aligned_cols=250  Identities=33%  Similarity=0.529  Sum_probs=197.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.+.||.|++|.||+|.+..+|+.+|+|.+...       .....+|+++++.++|+|++++++++.     +...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            5799999999999999999999989999999987531       123457999999999999999999883     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|||+++ +|...+.+.......+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 88888876544456689999999999999999999998 999999999999999888 79999999987


Q ss_pred             eccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||......  ..........         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~---------  222 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEK---------  222 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhc---------
Confidence            553322 12345688899999998654 4889999999999999999999999655321  1111111000         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                            ...+.        .....++..+.++|.+||..+|++|||+.++++
T Consensus       223 ------~~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         223 ------CDYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------CCCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                  00000        011256789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.2e-40  Score=298.53  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|.+.+.||+|+||.||+|.+..     ++..+|+|.+.....     ...+|+++++.++|+||+++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence            3579999999999999999998743     467899998865432     34579999999999999999998743    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh----------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  172 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~----------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~  172 (373)
                       ....+++|||+. ++|.+.+.....          ....+++..+..++.||+.||.+||++ |++||||||+||+++.
T Consensus        80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~  157 (280)
T cd05049          80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGY  157 (280)
T ss_pred             -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcC
Confidence             345889999998 488888875421          224578889999999999999999998 9999999999999998


Q ss_pred             CCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 017341          173 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  248 (373)
Q Consensus       173 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~  248 (373)
                      ++ .++|+|||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       158 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 DL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CC-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            88 899999999875432221   1233457889999998654 48999999999999999998 999998877655544


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+.....                            ...+..++..+.+++.+||+.||.+||++.|+++
T Consensus       236 ~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         236 CITQGRL----------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4432100                            0012357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-40  Score=300.35  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=193.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCc--EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||.|+||.||+|.+..++.  .+++|.+....     ....+|+.++.++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            479999999999999999999877765  46888765321     2345689999888 799999999887     3344


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  173 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~  173 (373)
                      .++++|||++ ++|.+.+.....            ....+++..++.++.||+.||+|||++ ||+||||||+||+++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCC
Confidence            5889999998 588888865321            113588889999999999999999998 99999999999999988


Q ss_pred             CCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017341          174 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       174 ~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~  252 (373)
                      + .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 8999999998643211111122335579999998654 48999999999999999997 9999988776655544332


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ....                            ..+..++.++.+||.+||+.+|.+|||++++++.
T Consensus       234 ~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYRM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1100                            0123578899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.7e-40  Score=297.74  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=195.8

Q ss_pred             cceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|.+.+.||.|+||.||++.+.     .++..+|+|.+.....    ...+|+.+++.++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            47999999999999999999862     3456799998764332    245799999999999999999887     334


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhh---------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYK---------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  175 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~---------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  175 (373)
                      .+++++|||+. ++|.+++.....         ....+++..+..++.||+.||+|||++ |++||||||+||+++.++ 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~-  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL-  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCC-
Confidence            45889999998 588888865431         123489999999999999999999988 999999999999999888 


Q ss_pred             ceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 017341          176 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  251 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~  251 (373)
                      .++|+|||++........   .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999875432221   112335678999999865 458999999999999999998 999998877665554443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      +...                   +         ..+...+.++.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRV-------------------L---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCc-------------------C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3100                   0         011357889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-40  Score=298.34  Aligned_cols=257  Identities=30%  Similarity=0.460  Sum_probs=209.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ....|++.+.||.|++|.||++.+..++..+++|.+.....   ...+|+++++.++|+|++++++++..     ....|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEE
Confidence            45579999999999999999999998999999999865432   34579999999999999999998843     34588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +++||++ ++|.+.+....   ..++...+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDG-SVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCC-CEEECccchhhhh
Confidence            9999999 58888887642   3789999999999999999999988 999999999999999888 7999999987654


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.... .+          
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------  234 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IP----------  234 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CC----------
Confidence            3221 11234578899999998654 48999999999999999999999998776655444333210 00          


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                              .       ......++.++.++|.+||+.+|.+|||+.+++.||||+...+
T Consensus       235 --------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         235 --------P-------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             --------C-------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence                    0       0011247889999999999999999999999999999998544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-40  Score=302.56  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=193.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcE--EEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|.+.+.||+|+||.||+|.+..++..  +++|.+....     ....+|+.++..+ +||||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            45899999999999999999998877754  5777664321     2234689999999 899999999987     444


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  172 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~  172 (373)
                      .++|++|||++ ++|.+.+......            ...+++..++.++.||+.||+|||++ |++||||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  159 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecC
Confidence            56889999998 5888888754321            23578999999999999999999988 9999999999999998


Q ss_pred             CCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 017341          173 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  251 (373)
Q Consensus       173 ~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~  251 (373)
                      ++ .+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|+| |.+||.+.+..+....+.
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            88 8999999998632211111122345679999988544 48899999999999999998 999998776554433321


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...                  ..          ..+..+++++.++|.+||+.+|++||++++++.+
T Consensus       238 ~~~------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGY------------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCC------------------cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                  00          0113467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.2e-40  Score=294.25  Aligned_cols=249  Identities=25%  Similarity=0.459  Sum_probs=198.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|.+.+.||+|++|.||++.+..++..+++|.+....         .....|..+++.++||||+++++++.     +..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            5899999999999999999998877777776653211         12336888999999999999998873     334


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+++|||+.+ +|...+.........+++..++.++.|++.||.|||+. |++|+||+|+||+++. + .++|+|||.+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-C-CEeecccCce
Confidence            57899999985 88877776555567799999999999999999999988 9999999999999985 4 6999999998


Q ss_pred             eeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+...   .       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~-------  221 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---P-------  221 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---C-------
Confidence            76543322 234567889999998854 34788999999999999999999999776554443333221   0       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                               .         ..++..++.++.++|.+||..+|++||++.++++||||
T Consensus       222 ---------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ---------T---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------C---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     0         01124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-40  Score=306.25  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=193.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ++|++.+.||.|+||.||+|.+..     +++.||+|++.....     ...+|+.+++.+ +|+||+++++++..    
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~----   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK----   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence            489999999999999999997543     457899998764321     234689999999 79999999987642    


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYK------------------------------------------------------  128 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~------------------------------------------------------  128 (373)
                      ....++++|||+.+ +|.+.+.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            23357899999995 78777754321                                                      


Q ss_pred             ---cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC---ccccccccc
Q 017341          129 ---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRY  202 (373)
Q Consensus       129 ---~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~  202 (373)
                         ....++...+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++........   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence               013678889999999999999999988 999999999999999888 899999999976533221   123345678


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCC
Q 017341          203 YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  281 (373)
Q Consensus       203 y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (373)
                      |+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+....+....                         
T Consensus       241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------------  294 (337)
T cd05054         241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-------------------------  294 (337)
T ss_pred             ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-------------------------
Confidence            9999998664 48999999999999999998 99999876544433333221000                         


Q ss_pred             ccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          282 WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                        ...+...++++.+++.+||+.+|++||+++++++|
T Consensus       295 --~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 --MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              00123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.4e-40  Score=326.15  Aligned_cols=142  Identities=25%  Similarity=0.436  Sum_probs=123.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||++++.++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            468999999999999999999999999999999986532       3345788999999999999998877     3445


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|+||||+. ++|..++...    ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g-~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEG-HIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCC-CEEEEeCCCC
Confidence            6899999997 5888777643    5688899999999999999999998 999999999999999888 7999999987


Q ss_pred             e
Q 017341          186 K  186 (373)
Q Consensus       186 ~  186 (373)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.7e-40  Score=291.16  Aligned_cols=243  Identities=21%  Similarity=0.311  Sum_probs=194.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||+|+||.||++..+ ++..+|+|.+....   ....+|+.+++.++||||+++++++     .....++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence            47999999999999999999875 45679999875432   2345799999999999999999887     334458899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99998 5787776643   24588899999999999999999988 999999999999999888 899999999875433


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  220 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------  220 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence            2221  122345679999998644 58999999999999999999 99999888766666555431100           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       ..+...+..+.+++.+||+.+|.+|||++++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             011235778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-40  Score=291.65  Aligned_cols=238  Identities=21%  Similarity=0.313  Sum_probs=187.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      +.||+|+||.||+|.+..+++.+|+|.+....     ....+|+++++.++||||+++++++     .....+++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence            36899999999999999999999999875432     2345799999999999999999987     3344588999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  194 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~  194 (373)
                      .+ +|.+.+...   ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++ .+||+|||.+.........
T Consensus        76 ~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            85 787777543   34588999999999999999999988 999999999999999888 7999999998654322111


Q ss_pred             c---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          195 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       195 ~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      .   ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+.......+.....               
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence            1   11224569999998654 48999999999999999998 9999977665443333322100               


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                   ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0012356889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=290.48  Aligned_cols=244  Identities=19%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||+|++|.||.+.+.. +..+|+|.+.....   ...+|+.+++.++||||+++++++     .....++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence            579999999999999999998754 45699998764332   245799999999999999999887     333347899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+.+ +|.+.+...   ...+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999984 787777653   23689999999999999999999988 999999999999999888 899999999876533


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            3211  122345679999998654 48899999999999999998 99999877765555544332100           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                       ..+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             0113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.1e-40  Score=291.50  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.++||.|++|.||+|.+. ++..+|+|.+....   ....+|+.+++.++|+||+++++++     .+....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            358999999999999999999964 56779999876433   2334799999999999999998877     34445789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+. ++|.+.+....  ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 58888876542  35678888999999999999999988 999999999999999888 89999999997654


Q ss_pred             CCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.....           
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-----------  222 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            32211  123356789999998554 47889999999999999998 9999988766555544432110           


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                             .+          ....++.++.+++.+||..+|++|||++++.+
T Consensus       223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                   00          11357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.2e-40  Score=295.37  Aligned_cols=250  Identities=31%  Similarity=0.488  Sum_probs=196.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+|.+.+.||.|++|.||++.+..+++.+|+|.+....       ....+|+.+++.++||||+++++++.     ...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            47999999999999999999999999999999875321       12346899999999999999999873     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|||+.+ +|.+.+.........+++..++.++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            7899999985 88888776544456789999999999999999999988 999999999999999888 89999999887


Q ss_pred             eccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.....  ....+.+..         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~---------  222 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQ---------  222 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhc---------
Confidence            5533222 2234688999999998654 47889999999999999999999997654321  111111000         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                            ...+.        .....++..+.++|.+||..||.+|||+.++++
T Consensus       223 ------~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         223 ------CDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------CCCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                  00000        011347889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-40  Score=292.02  Aligned_cols=244  Identities=21%  Similarity=0.314  Sum_probs=194.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||+|++|.||++.+. ++..+|+|.+....   ....+|+++++.++||||+++++++     ....+.|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            46899999999999999999875 56789999876432   2345799999999999999998877     344468899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+++ +|.+.+....   ..+++..+..++.||+.||+|||++ |++||||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999975 7888776542   4688999999999999999999998 999999999999999888 899999999876533


Q ss_pred             CCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .....  ...++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-----------  220 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-----------
Confidence            22111  11234579999998654 48999999999999999999 89999877665554443321000           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                       ..+...+.++.+++.+||..+|++|||+.++++.
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 -----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                             0123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-40  Score=294.38  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=196.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|++.+.||+|+||.||++.+...     +..+|+|.+.....     ...+|+.+++.++||||+++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            35899999999999999999998644     37899998754432     234789999999999999999987     3


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                      ...+.++||||++ ++|.+.+......      ...+++..+..++.||+.||.|||+. +++||||||+||+++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCC-C
Confidence            3455889999998 5888888754321      23467888999999999999999988 999999999999999988 8


Q ss_pred             eeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017341          177 LKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~  252 (373)
                      +||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999999875433221   1233467889999998544 48999999999999999998 9999987766554443321


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      . ..                           ..++...+.++.++|.+||+.+|++|||+.++++
T Consensus       237 ~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 G-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0 00                           0012356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=338.64  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=206.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .+-+|.-...||.|.||.||.|.+..||+..|+|.+.-.      -....+|..++..++|||+|+++++=+..   +. 
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR---ek- 1308 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR---EK- 1308 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH---HH-
Confidence            345888899999999999999999999999999987432      23345899999999999999998864332   22 


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                       ++|.||||.| +|.+.+.+    +.-.++...+.+..|++.|++|||++ |||||||||.||+++.+| .+|++|||.|
T Consensus      1309 -v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1309 -VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNG-LIKYGDFGSA 1381 (1509)
T ss_pred             -HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCC-cEEeecccce
Confidence             6789999995 77777765    35577888888999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCC-----cccccccccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCC
Q 017341          186 KVLVKGEP-----NISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTP  257 (373)
Q Consensus       186 ~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~  257 (373)
                      ........     .....||+.|||||++.+..  ....+.|||||||++.||+||+.||...+. ..+...+-..    
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g---- 1457 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG---- 1457 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc----
Confidence            87755421     13568999999999997543  357799999999999999999999987643 3444433221    


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                     .-|+         ++.++|++.++||..||..||.+|.++.|++.|.|=+.-.+
T Consensus      1458 ---------------h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1458 ---------------HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             ---------------CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence                           1111         33568999999999999999999999999999998665444

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=292.80  Aligned_cols=251  Identities=21%  Similarity=0.295  Sum_probs=195.5

Q ss_pred             eEeeeeeeecCceEEEEEEECC---CCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           37 YMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      |.+.+.||+|+||.||+|.+..   ++..+|+|.+..+..      ...+|+..++.++||||+++++++..... .+..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998754   347899998865422      23468999999999999999987654332 3344


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~--~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      +.+++|||+. ++|...+.....  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCC-eEEECCcc
Confidence            5789999998 578777754432  224688999999999999999999988 999999999999999887 89999999


Q ss_pred             ceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR----  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            99765433221   12234678999999854 458999999999999999999 9999988766554443322100    


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                              ...+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-39  Score=306.80  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=193.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.....     ...+|+++++.+. ||||+++++++     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            34899999999999999999987433     35799998864322     2347999999996 99999999988     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  128 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~-----------------------------------------------------  128 (373)
                      .+...+|+|||||. |+|.+.+.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            34455889999998 588887765321                                                     


Q ss_pred             ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEE
Q 017341          129 ---------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  169 (373)
Q Consensus       129 ---------------------------------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIl  169 (373)
                                                             ....+++..+..++.||+.||.|||+. +|+||||||+||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEE
Confidence                                                   013477788899999999999999988 9999999999999


Q ss_pred             EcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017341          170 VNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  245 (373)
Q Consensus       170 l~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~  245 (373)
                      ++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99887 899999999876533221   1234567889999998654 48999999999999999997 999998765433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .........                 ...          ..+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 ~~~~~~~~~-----------------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSG-----------------YRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcC-----------------CCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333322210                 000          012457889999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1e-39  Score=293.81  Aligned_cols=250  Identities=20%  Similarity=0.278  Sum_probs=196.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++|.+.+.||+|++|.||+|.+..     ++..+|+|.+....     ....+|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE----   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            4579999999999999999999977     77899999875432     123468899999999999999987733    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--Cce
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQL  177 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~i  177 (373)
                       ....+++|||+. ++|.+++......   ...+++..+..++.||+.||+|||++ +++|+||||+||+++.++  ..+
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcce
Confidence             334679999997 5888888765321   13588899999999999999999998 999999999999998654  259


Q ss_pred             eEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 017341          178 KLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  253 (373)
Q Consensus       178 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~  253 (373)
                      ||+|||+++........   .....+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998765322111   122335679999999654 48999999999999999997 99999887665543332221


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      . .                           ..++..++..+.+++.+||+.+|++|||+.++++|
T Consensus       238 ~-~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 G-R---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             C-c---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0 0                           00124578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-39  Score=292.61  Aligned_cols=251  Identities=20%  Similarity=0.272  Sum_probs=192.8

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCc--EEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCcee
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  107 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  107 (373)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.+....      ....+|+.+++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4577899999999999999877765  68999875431      223468899999999999999886643221 12234


Q ss_pred             EEEEEeccc-ccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~--~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+++|||+. ++|.+.+.....  ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 588777653321  224478999999999999999999998 999999999999999888 799999999


Q ss_pred             eeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ++.......   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+....+....+.+...     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            876543321   1122456789999998654 58999999999999999999 8999988765544443322100     


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                             ...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   00124577899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=288.67  Aligned_cols=238  Identities=35%  Similarity=0.568  Sum_probs=196.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ||.|++|.||++.+..+++.+|+|.+.....       ....|+.+++.++|+|++++++.+     .+..+.|++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            6899999999999998999999998764322       345789999999999999999887     4556689999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC-CC
Q 017341          116 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  193 (373)
Q Consensus       116 ~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-~~  193 (373)
                      . ++|.+.+...    ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 6888777653    4689999999999999999999998 999999999999999888 8999999998765433 22


Q ss_pred             cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017341          194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  273 (373)
Q Consensus       194 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      .....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...                 .. 
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~-  210 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----------------PL-  210 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----------------CC-
Confidence            3345678899999998654 3788999999999999999999999877654433333220                 00 


Q ss_pred             CCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCc
Q 017341          274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFF  321 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~~ll~hp~~  321 (373)
                                 .++...+..+.++|++||..||++||++   +++++||||
T Consensus       211 -----------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         211 -----------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                       1224568899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.5e-40  Score=299.97  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=192.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcE----EEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||.||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++..     
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----   80 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   80 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----
Confidence            34799999999999999999998766664    8999875432     223468899999999999999987742     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      . ..+++++|+. |+|.+.+...   ...++...+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~-~~kl~DfG  154 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQ-HVKITDFG  154 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCC-cEEEcccc
Confidence            1 2568999988 5888887754   24578888999999999999999998 999999999999999888 79999999


Q ss_pred             ceeeccCCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +++.........   ...++..|+|||.+.+. .++.++|||||||++|+|++ |+.||.+....+. ..+.....    
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~----  228 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGE----  228 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCC----
Confidence            998654332221   12346689999998654 58999999999999999998 9999987654433 23322100    


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                   ..+          .+...+.++.+++.+||..+|.+|||+.+++.+
T Consensus       229 -------------~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 -------------RLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -------------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                         000          113467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=289.26  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|++.+.||.|++|.||+|.+. +++.||+|.+....   ....+|+.+++.++||||+++++++     .....+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence            357999999999999999999974 45789999886543   2345799999999999999999877     33345789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+. ++|.+.+....  ...++...+..++.|++.||.+||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENN-ICKVADFGLARVIK  154 (261)
T ss_pred             eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCC-CEEECCcceEEEcc
Confidence            999995 68888876542  35688999999999999999999988 999999999999999888 79999999998764


Q ss_pred             CCCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ......  ....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+.......+.+....          
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------  223 (261)
T ss_pred             CCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            322111  11224579999998654 48999999999999999999 99999887765555544321100          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                              011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-39  Score=289.91  Aligned_cols=243  Identities=25%  Similarity=0.331  Sum_probs=193.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....   ...+|+++++.++||||+++++.+     .. .+.++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-----CC-CCcEEE
Confidence            5799999999999999999998665 4599998865332   345799999999999999998765     21 236799


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+++ +|.+.+....  ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999984 8888886532  34578899999999999999999998 999999999999999888 899999999976543


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....++..|+|||...+. .++.++|+|||||++|+|++ |..||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  222 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence            3221  123456789999988544 48999999999999999999 89999887765555443321000           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       .....++..+.++|.+||+.||++||++.++++
T Consensus       223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             011357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=290.01  Aligned_cols=242  Identities=26%  Similarity=0.381  Sum_probs=197.2

Q ss_pred             eeeeecCceEEEEEEECCC---CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+...   +..+++|.+.....     ...+|++.++.++|+|++++++++.     +...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            4689999999999999865   89999998865432     3347899999999999999998873     355588999


Q ss_pred             eccc-ccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          113 EYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~-----~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ||+. ++|.+.+......     ...+++..++.++.|++.||+|||++ |++|+||+|+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCC-cEEEccccccc
Confidence            9996 6888888765221     36789999999999999999999998 999999999999999988 89999999997


Q ss_pred             eccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          187 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       187 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ......   ......+++.|+|||.+... .++.++|+|||||++|+|++ |..||...+..+....+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            664432   12344568899999998654 58999999999999999999 699999887665555443310        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                          ....+..+++++.+++.+||+.+|++|||+++++++
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                001124578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5e-40  Score=293.10  Aligned_cols=245  Identities=22%  Similarity=0.314  Sum_probs=198.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..+|++.+.||.|++|.||+|.+.. +..+++|.+.....    ...+|+.+++.++||||+++++++     .+...++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence            3579999999999999999999877 88999998865432    345789999999999999998877     3344578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+....  ...++...+..++.||+.||.|||++ |++|+||+|+||+++.++ .+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 8888887542  35688999999999999999999998 999999999999999888 8999999998765


Q ss_pred             cCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+..+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------  223 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence            32211 1123456789999998654 58899999999999999998 89999887766665554431100          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        ..+...++.+.+++.+||+.||.+|||+.++++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                              012457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.7e-39  Score=293.30  Aligned_cols=249  Identities=20%  Similarity=0.299  Sum_probs=195.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||.||+|.+.    .++..+++|.+....     ....+|+.+++.++||||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~   78 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----Q   78 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----c
Confidence            357999999999999999999853    456789999886422     23457999999999999999998873     3


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYK-------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~-------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      ....|++|||+. ++|.+.+.....             ....+++..+..++.|++.||.|||++ |++|+||||+||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili  157 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILI  157 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEE
Confidence            344789999998 488887753321             123478888999999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  246 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~  246 (373)
                      +.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+....
T Consensus       158 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05090         158 GEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV  235 (283)
T ss_pred             cCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9887 799999999976533221   2233456779999998654 48999999999999999998 9999988765444


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...+.... .                  +         ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~~-~------------------~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         236 IEMVRKRQ-L------------------L---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHcCC-c------------------C---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44332210 0                  0         0124578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=286.00  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHH-HHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +.+-...||.|+||+|++..++.+|+..|||++.....     ....|.+. ++.-+.||||+++++.+...+     .|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cW  139 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CW  139 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----ee
Confidence            34455689999999999999999999999999965443     22234443 344468999999998865333     88


Q ss_pred             EEEecccccHHHHHHH-hhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPETVHRVIKH-HYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~-~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |.||.|+-++..+-+. +..+...++|..+..+....+.||.||-...+|+|||+||+|||++..| .+||||||.+...
T Consensus       140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhH
Confidence            9999999877655543 3334577999999999999999999999888999999999999999998 8999999999877


Q ss_pred             cCCCCcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .++-....-.|-..|||||.+.... .|+.+||+||||+++||+.||+.||.+-+.  .+.++.+.....++...     
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~-----  291 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILL-----  291 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeec-----
Confidence            6665556667889999999996443 389999999999999999999999987653  44444443222111100     


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                            .+.         -.-+++..+..||..||.+|-+.||...+|+++||++....
T Consensus       292 ------~~~---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  292 ------FDK---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             ------Ccc---------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                  000         00247889999999999999999999999999999987654

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-39  Score=295.39  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=196.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTT  101 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  101 (373)
                      ...+|++.+.||+|+||.||++.+...     ...+|+|.+.....     ...+|+.+++.+ +|+||+++++++    
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            345899999999999999999997644     37899998764321     234689999999 899999999877    


Q ss_pred             CCCceeEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcE
Q 017341          102 EKDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  168 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NI  168 (373)
                       .....++++|||+. ++|...+....            .....+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus        86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Ni  163 (293)
T cd05053          86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNV  163 (293)
T ss_pred             -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeE
Confidence             33445889999998 58888876532            2245688899999999999999999988 999999999999


Q ss_pred             EEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 017341          169 LVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  244 (373)
Q Consensus       169 ll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~  244 (373)
                      +++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....
T Consensus       164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            999888 899999999876543221   1122345679999998544 48999999999999999997 99999887665


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          245 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +....+.....                            ...+...+.++.+|+.+||..||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         242 ELFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            54443322100                            00123568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-39  Score=294.08  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=198.9

Q ss_pred             ceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      +|++.+.||+|++|.||++.+.   .+++.+|+|.+....        ....+|+.++..+ +||||+++.+++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4899999999999999999864   467899999875321        2234789999999 599999999887     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ....+|+||||+.+ +|...+..    ...+++..++.++.|++.+|.|||+. +++|+||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEEEC
Confidence            44568899999985 77777654    25688999999999999999999988 999999999999999888 7999999


Q ss_pred             cceeeccCCCC--cccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          183 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       183 g~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence            99876533322  12346789999999985432 36789999999999999999999996543322222222211000  


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDP  327 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~ll~hp~~~~~~~~  327 (373)
                                    .         ...+..++..+.++|.+||+.||++|||   +.++|+||||+.+.++
T Consensus       228 --------------~---------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 --------------K---------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             --------------C---------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                          0         0012357889999999999999999998   5778999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.7e-41  Score=301.63  Aligned_cols=280  Identities=31%  Similarity=0.518  Sum_probs=222.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCC------CCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD------HPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|.+....|+|-||+|.+|.+..-|+.||||++....   +...+|+++|+.|+      .-|+++++..|     ...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence            48999999999999999999999999999999887654   23358999999995      35789998888     455


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .++|||+|.+.-+|..+++.+.. +-.+....++.|+.|++.||..|-.. ||+|.||||+|||+++....+||||||.|
T Consensus       507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccc
Confidence            56999999999999999988753 45577888999999999999999976 99999999999999988878999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .....+ ....+..+..|.|||++.+.+ |+...|+||+||+||||.||+..|+|.+..+++...+..-|..+...+...
T Consensus       585 ~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            765433 334566788899999998876 999999999999999999999999999999999998888887776543311


Q ss_pred             -------C--cCcccccCCCcCC-------------CCccccc------cC---CCChhHHHHHHhhcCcCCCCCCCHHH
Q 017341          266 -------N--PNYTEFKFPQIKA-------------HPWHKIF------QK---RMPPEAVDLVSRLLQYSPNLRSTALE  314 (373)
Q Consensus       266 -------~--~~~~~~~~~~~~~-------------~~~~~~~------~~---~~~~~~~~li~~~L~~dP~~R~t~~~  314 (373)
                             +  .+|..........             ..+.+.+      +.   .+-..+.+|+.+||..||++|.|+.+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence                   1  1111111111100             0011100      00   12235889999999999999999999


Q ss_pred             HhcCCCccc
Q 017341          315 ALIHPFFDE  323 (373)
Q Consensus       315 ll~hp~~~~  323 (373)
                      +|+||||+.
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999975

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=289.56  Aligned_cols=245  Identities=23%  Similarity=0.323  Sum_probs=194.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCC---CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .+|++.+.||+|+||.||+|.+..+   ...+|+|.+.....     ...+|+.+++.++||||+++++.+     ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence            5799999999999999999998654   45799998754322     234689999999999999999877     3344


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+++|||+.+ +|.+.+...   ...++...+..++.|++.||+|||++ +|+|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-CEEECccchh
Confidence            57899999985 888777653   24688999999999999999999988 999999999999999888 7999999999


Q ss_pred             eeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          186 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       186 ~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      .........   ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+.+....+    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----  228 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----  228 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence            866422111   122345789999998654 48999999999999999998 999998776555444443211000    


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                              .+...+..+.+++.+||+.+|++||++++++++
T Consensus       229 ------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 ------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    113578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-39  Score=287.30  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=193.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      .+|.+.+.||+|++|.||++..  .|..+|+|.+..+..  ...+|+.+++.++|+|++++++++..    .....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence            4799999999999999999986  478899998865432  34579999999999999999886542    233478999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||++ ++|.+.+.+..  ...+++..+..++.||+.||+|||++ |++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            9998 48888876542  23578899999999999999999988 999999999999999888 8999999998754322


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      .  ....++..|+|||++.+. .++.++|+|||||++|+|++ |+.||...+..+....+.+..                
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  216 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  216 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2  233446689999998544 58899999999999999997 999998766544444332210                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                  .......+++.+.++|.+||+.+|++|||+.++++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        00112457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=290.95  Aligned_cols=288  Identities=27%  Similarity=0.441  Sum_probs=214.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHhCC--------CCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD--------HPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~--------h~~iv~~~~~~~~~~~  102 (373)
                      .++|.+.++||=|.|++||+|.|..+.+.||+|+++...-+.   ..|+++|+.++        ..+||++++.|.. .+
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh-sG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH-SG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee-cC
Confidence            468999999999999999999999999999999887654433   36899998873        2469999998754 34


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC-------
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-------  175 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-------  175 (373)
                      .+..++|||+|+++.+|+.++....  .+.++...++.|++||+.||.|||..+||+|.||||+|||+..+..       
T Consensus       156 pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence            6788899999999999999998754  4668999999999999999999999999999999999999831100       


Q ss_pred             --------------------------------------------------------------------------------
Q 017341          176 --------------------------------------------------------------------------------  175 (373)
Q Consensus       176 --------------------------------------------------------------------------------  175 (373)
                                                                                                      
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------------------------ce
Q 017341          176 ------------------------------------------------------------------------------QL  177 (373)
Q Consensus       176 ------------------------------------------------------------------------------~i  177 (373)
                                                                                                    .+
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                                                                          02


Q ss_pred             eEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------CcHHHHHHHH
Q 017341          178 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE------SGVDQLVEII  251 (373)
Q Consensus       178 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~------~~~~~~~~i~  251 (373)
                      ||.|||.|+-.  ......-+.|..|+|||++.+.. |++.+||||++|++|||+||...|...      .+.+.++.|+
T Consensus       394 KIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  394 KIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             EEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            23333332211  00111223577899999998875 999999999999999999999999653      4778999999


Q ss_pred             HHhCCCCHHHHhhcCcCcccc----cCCCcCCCCcccc---------ccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          252 KVLGTPTREEIKCMNPNYTEF----KFPQIKAHPWHKI---------FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ..+|..+......-.-.-..|    .+..+..-..+..         ++..-..++.+||.-||+++|++|+||.++|+|
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence            999988876443211110111    1111111111111         112233567899999999999999999999999


Q ss_pred             CCccccCCC
Q 017341          319 PFFDELRDP  327 (373)
Q Consensus       319 p~~~~~~~~  327 (373)
                      ||+..+..+
T Consensus       551 PwLn~~~~~  559 (590)
T KOG1290|consen  551 PWLNPVAGP  559 (590)
T ss_pred             ccccCCCCC
Confidence            999986554

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.8e-40  Score=295.13  Aligned_cols=249  Identities=21%  Similarity=0.273  Sum_probs=195.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|++.+.||+|+||.||+|.+..+     +..+|+|.+.....     ...+|..++..++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~   78 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----T   78 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----c
Confidence            34689999999999999999987543     57899998864432     234688899999999999999887     3


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      .....++++||+. ++|...+....            .....+++..+..++.|++.||.|||++ ||+||||||+||++
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~  157 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLV  157 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEe
Confidence            3344789999998 47777765321            1123578888999999999999999988 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  246 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~  246 (373)
                      +.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+.
T Consensus       158 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  235 (283)
T cd05091         158 FDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  235 (283)
T ss_pred             cCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9887 799999999875533221   1233457789999998654 48999999999999999998 8899988776665


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...+......                            ..+..++.++.+++.+||+.+|.+||++.+++..
T Consensus       236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         236 IEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            5554432100                            1124688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.5e-39  Score=293.37  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|.+.+.||.|+||.||+|.+.     .++..+++|.+....    ....+|+.+++.++|+||+++++++     .+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----cc
Confidence            347999999999999999999864     345678999875443    2345799999999999999999987     33


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  171 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~  171 (373)
                      ....++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||++ ||+||||||+||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~  157 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVG  157 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEc
Confidence            445789999998 588888875431            123478899999999999999999998 999999999999999


Q ss_pred             CCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 017341          172 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  247 (373)
Q Consensus       172 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~  247 (373)
                      .++ .++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+..
T Consensus       158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            888 899999999875433221   1234567889999998654 48899999999999999999 99999877665544


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          248 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ..+...              .     .+         ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~--------------~-----~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         236 ECITQG--------------R-----VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHhCC--------------C-----CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            332211              0     00         011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-39  Score=295.20  Aligned_cols=249  Identities=21%  Similarity=0.325  Sum_probs=193.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-------CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFST  100 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~  100 (373)
                      .++|.+.+.||+|+||.||++.+..       +...+|+|.+..+..     ...+|+.+++.+ +||||+++++++   
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~---   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            3689999999999999999998643       235799998865421     234688999998 799999999887   


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                        ......|+||||+. ++|.+++.....            ....++...+..++.||+.||+|||+. |++||||||+|
T Consensus        94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~N  170 (307)
T cd05098          94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARN  170 (307)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHh
Confidence              33345789999998 588888876432            123478888999999999999999988 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      |+++.++ .++|+|||.++........   ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus       171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999888 8999999998755322111   112345689999998654 48999999999999999998 8899977654


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+....+....                            ....+...+.++.++|.+||..+|.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 EELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44333322110                            000124578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.5e-39  Score=290.30  Aligned_cols=254  Identities=19%  Similarity=0.238  Sum_probs=186.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCC---CcEEEEEEecccccchH---------------HHHHHHHhCCCCCeeeccee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC   96 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~~~~~   96 (373)
                      .+|.+.+.||+|+||.||+|.+..+   +..+|+|..........               .+...+..++|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4899999999999999999998877   66778876433222211               12234456689999999887


Q ss_pred             eeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341           97 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus        97 ~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                      ..... ....+.+++++++..++...+...    ...++..++.++.|++.||+|||++ +|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-c
Confidence            64332 223456789998887776666542    3457888999999999999999988 999999999999999887 7


Q ss_pred             eeEeeccceeeccCCC--------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017341          177 LKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  248 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~  248 (373)
                      ++|+|||+|+......        ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999987653221        11234689999999998654 48999999999999999999999998874322221


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .....      ..+......               ....+..+..+.++++.|+..+|++||+.+++++
T Consensus       244 ~~~~~------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKC------DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHH------HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11110      000000000               0001356789999999999999999999999874

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-39  Score=290.10  Aligned_cols=258  Identities=26%  Similarity=0.364  Sum_probs=190.3

Q ss_pred             cce-EeeeeeeecCceEEEEEE----ECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           35 ISY-MAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        35 ~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ++| .+.+.||.|+||+||++.    ...++..+|+|.+....     ....+|+++++.++||||+++++++..   ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence            355 999999999999998865    34578899999886432     233479999999999999999887643   23


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..+++++|||+.+ +|.+.+..     ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg  152 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDR-LVKIGDFG  152 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCC-cEEEeecc
Confidence            4457899999995 77777653     4589999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCC
Q 017341          184 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~-~~~~  258 (373)
                      ++.........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||......  ........ +...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~  229 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT  229 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence            98765432211    122356679999998654 4899999999999999999999998654321  11111100 0000


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ...+...            .........+...+..+.+++.+||+.+|++|||+++++.
T Consensus       230 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 VVRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000000            0000001123467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8e-39  Score=285.31  Aligned_cols=243  Identities=24%  Similarity=0.321  Sum_probs=193.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ++|++...||+|++|.||++.+..+ ..+|+|.+.....   ...+|+.+++.++|+|++++++++     .. ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-----SE-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-----cC-CCcEEE
Confidence            5799999999999999999997655 4699998764332   335799999999999999998765     22 236799


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 8888886532  34578889999999999999999988 999999999999999888 899999999976533


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-----------  222 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2211  123456789999988544 48999999999999999999 99999887766555444321000           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       ..+...+..+.+++.+||..||.+||+++++++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             012457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.6e-39  Score=312.92  Aligned_cols=281  Identities=23%  Similarity=0.304  Sum_probs=183.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCC----CcEEEEEEecccccchHHHHHHH---HhCCCCCeeecceeeeecCC-CC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLET----GEAVAIKKVLQDKRYKNRELQTM---RLLDHPNVVSLKHCFFSTTE-KD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~-~~  104 (373)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|++.....   .|..+.   +...+.++..+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456899999999999999999999988    99999998754322   222222   22233333333333222111 34


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKM----------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~----------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                      ...+++|+||+++ +|.+++......                ........+..++.||+.||.|||++ +|+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHH
Confidence            4457899999985 787777643100                01122345678999999999999998 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCC--CcccccccccccccccccCCC---------------------CCCCchhHHHH
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTAAIDIWSA  224 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~Diwsl  224 (373)
                      ||++.+.+.+||+|||+|+......  ......+|+.|+|||.+....                     .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9999754489999999997543322  223567899999999763221                     13446699999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCc
Q 017341          225 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  304 (373)
Q Consensus       225 G~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  304 (373)
                      ||++|+|+++..++  .+....+.+++...+...........+...    +..  ......+ ...+..+.+||.+||+.
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~-d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRAS----PDL--RRGFEVL-DLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhccccc----hhh--hhhhhhc-cccchHHHHHHHHHccC
Confidence            99999999976554  333444444444333222111111111000    000  0000001 12345677999999999


Q ss_pred             CCCCCCCHHHHhcCCCccccCC
Q 017341          305 SPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       305 dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ||++|||+.++|+||||++...
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999988544

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.7e-39  Score=287.63  Aligned_cols=249  Identities=21%  Similarity=0.383  Sum_probs=197.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECC-CCcEEEEEEecccc--------------cchHHHHHHHH-hCCCCCeeecceeeee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK--------------RYKNRELQTMR-LLDHPNVVSLKHCFFS   99 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~-~l~h~~iv~~~~~~~~   99 (373)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+....              ....+|+.++. .++||||+++++++  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            48899999999999999999987 68899999874321              11224666665 47999999999987  


Q ss_pred             cCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          100 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                         ....+.+++|||+.+ +|.+.+.........+++..++.++.|++.+|.|||+..+++|+||+|+||+++.++ .++
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence               344568899999985 787777654444567999999999999999999999633899999999999999888 899


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |+|||.+.............++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.......+......+ 
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  232 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-  232 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence            9999999765444333455688999999999654 48999999999999999999999998766554444333211000 


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                ......++.+.++|.+||+.||++||++.++..+
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      0112467899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-39  Score=286.55  Aligned_cols=228  Identities=27%  Similarity=0.327  Sum_probs=181.9

Q ss_pred             cCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc-cHHHHHH
Q 017341           46 GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIK  124 (373)
Q Consensus        46 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~  124 (373)
                      |.+|.||+|.++.+++.||+|.+..... ..+|...+....||||+++++++     .+....+++|||+.+ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence            7899999999999999999999866442 33555566666799999999987     334558899999995 8888776


Q ss_pred             HhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCccccccccccc
Q 017341          125 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR  204 (373)
Q Consensus       125 ~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~  204 (373)
                      ..    ..+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            53    4589999999999999999999988 999999999999999988 7999999987654322  22345577899


Q ss_pred             ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccc
Q 017341          205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  284 (373)
Q Consensus       205 aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (373)
                      |||.+.+. .++.++|+||+||++|+|++|+.||.......     .                .....            
T Consensus       150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~----------------~~~~~------------  195 (237)
T cd05576         150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGI-----N----------------THTTL------------  195 (237)
T ss_pred             CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----c----------------ccccc------------
Confidence            99988543 47899999999999999999998875332100     0                00000            


Q ss_pred             cccCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCc
Q 017341          285 IFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFF  321 (373)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~ll~hp~~  321 (373)
                      .++..+++.+.++|.+||+.||++|+++     +++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1224578899999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.4e-39  Score=286.36  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=193.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|++|.||+|.+. .+..+|+|.+....   ....+|+.+++.++|+|++++++++     .. ...++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-----SE-EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-----CC-CCcEE
Confidence            357999999999999999999875 56679999886532   2345799999999999999998765     11 22679


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+.+ +|.+.+....  ...+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGL-VCKIADFGLARLIE  153 (260)
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCc-eEEeCCceeeeecc
Confidence            9999985 8888776432  34588999999999999999999998 999999999999999887 89999999997653


Q ss_pred             CCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----------  222 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32211  122345679999998544 48899999999999999999 99999887766555544321000          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  316 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll  316 (373)
                                        ..+...+..+.+++.+||..+|++|||+.++.
T Consensus       223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         223 ------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                              01235788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.7e-39  Score=285.41  Aligned_cols=243  Identities=23%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.++||+|+||.||+|... +++.+|+|.+.....   ...+|+.+++.++|+||+++++++.     + ...+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEEE
Confidence            57999999999999999999864 578899998865442   3457999999999999999987651     1 237899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+. ++|.+.+....  ...++...+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            99998 58887776432  35688899999999999999999988 999999999999999888 899999999876542


Q ss_pred             CCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...  .....++..|+|||.+... .++.++|+||||+++|+|++ |++||.+.+..+....+......+          
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  223 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------  223 (260)
T ss_pred             CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----------
Confidence            221  1123456789999998544 47899999999999999999 999998877655544443211000          


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        .+...+.++.++|.+||..+|++|||+++++.
T Consensus       224 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 ------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              11356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.1e-39  Score=292.35  Aligned_cols=249  Identities=23%  Similarity=0.357  Sum_probs=195.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFST  100 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~  100 (373)
                      ....+|.+.+.||+|+||.||++.+     ..++..+|+|.+.....     ...+|+.+++.+ +||||+++++++   
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---  108 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC---  108 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE---
Confidence            3445899999999999999999975     33566899998764322     245799999999 799999999887   


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                        ......+++|||+. ++|...+....  ...+++..+..++.||+.||.|||++ +|+|+||||+||+++.++ .++|
T Consensus       109 --~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l  182 (302)
T cd05055         109 --TIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGK-IVKI  182 (302)
T ss_pred             --ecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCC-eEEE
Confidence              33345889999998 58888776432  23378999999999999999999998 999999999999999877 8999


Q ss_pred             eeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017341          180 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      +|||++........   .....++..|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+...+..... 
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-  260 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-  260 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-
Confidence            99999875533221   1123457789999998654 48999999999999999998 999998876554444333210 


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                      ..          ...+...++++.+++.+||..+|++|||+.++++
T Consensus       261 ----------------~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ----------------YR----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ----------------Cc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                            00          0011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5e-39  Score=292.05  Aligned_cols=255  Identities=19%  Similarity=0.248  Sum_probs=196.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCC----------------cEEEEEEecccc-----cchHHHHHHHHhCCCCCeee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETG----------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVS   92 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~   92 (373)
                      ..+|++.+.||+|+||.||+|.+..++                ..+|+|.+....     ....+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999876544                568999886543     22346899999999999999


Q ss_pred             cceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCC
Q 017341           93 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  164 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~-------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlk  164 (373)
                      +++++     ....+.+++|||+. ++|.+.+......       ...+++..++.++.|++.||+|||++ |++|+|||
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlk  157 (296)
T cd05051          84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLA  157 (296)
T ss_pred             EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccc
Confidence            99887     33345789999998 5888887764311       12589999999999999999999988 99999999


Q ss_pred             CCcEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q 017341          165 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFP  239 (373)
Q Consensus       165 p~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--G~~pf~  239 (373)
                      |+||+++.++ .++|+|||.++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++  |..||.
T Consensus       158 p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         158 TRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             hhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999887 899999999876533221   2233457789999998654 48999999999999999998  778998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          240 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       240 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ..+..+.+............               +      .....+..++.++.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~---------------~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGR---------------Q------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CcChHHHHHHHHhccccccc---------------c------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            77665555444332111000               0      000012356789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-39  Score=285.40  Aligned_cols=245  Identities=25%  Similarity=0.333  Sum_probs=196.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|++|.||++.+. ++..+|+|.+..+.   ....+|+.+++.++|+||+++++++     ......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEE
Confidence            468999999999999999999975 45779999886543   2345799999999999999998876     33345789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||+++ +|.+.+....  +..++...+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||.+....
T Consensus        79 v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999985 8888876532  34688999999999999999999988 999999999999999888 89999999987653


Q ss_pred             CCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .....  .....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+.......+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32111  122345679999998654 48999999999999999998 99999887766666555432110          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        ..+...+.++.+++.+||+.+|++||++++++.
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                              011346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8e-39  Score=288.30  Aligned_cols=244  Identities=21%  Similarity=0.296  Sum_probs=191.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||.||+|.+..+++    .||+|.+....     ....+|..+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            4589999999999999999999877776    48999875432     223468889999999999999887632     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                       ...+++++|++ |+|.+.+...   ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~-~~kL~dfG  154 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPN-HVKITDFG  154 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC-cEEECCCC
Confidence             12568999998 5888877653   24689999999999999999999998 999999999999999877 79999999


Q ss_pred             ceeeccCCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +++.........   ...+++.|+|||.+.+. .++.++|||||||++|+|++ |..||........... ......+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~--  230 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEKGERL--  230 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcC--
Confidence            997654332211   12346789999998654 48999999999999999998 9999977654443322 2210000  


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                               ..+...+.++.++|.+||..||++||++.+++.
T Consensus       231 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 -------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     011356889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-39  Score=284.32  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=194.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|++.+.||.|++|.||++.+  .|+.+|+|.+.....   ...+|+.+++.++|+||+++++++..     ....++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence            35799999999999999999987  488999999876544   34579999999999999999998733     344789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||++ ++|.+.+....  ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||.++...
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~  153 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDL-VAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCC-CEEEcccccccccc
Confidence            999999 58888876542  23689999999999999999999998 999999999999999888 89999999987653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ...  .....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+...               
T Consensus       154 ~~~--~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------  215 (256)
T cd05039         154 QGQ--DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------  215 (256)
T ss_pred             ccc--ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence            221  233345679999998644 48889999999999999997 99999877654433322211               


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      +             ....+...++.+.++|.+||..+|++|||++++++
T Consensus       216 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 Y-------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             C-------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            0             00012357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5e-39  Score=289.84  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             cceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+....    ....+|+++++.++|+||+++++++     .+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence            47899999999999999999743     356789999875432    2345789999999999999998877     333


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  173 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~-----------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~  173 (373)
                      ...+++|||+. ++|.+++.....           ....+++..+..++.||+.||+|||+. |++|+||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCC
Confidence            45789999998 588888775421           113478899999999999999999988 99999999999999988


Q ss_pred             CCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 017341          174 THQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  249 (373)
Q Consensus       174 ~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~  249 (373)
                      + .++|+|||++........   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |.+||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 899999999875533221   1223456789999998654 48999999999999999998 9999987766554444


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       250 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      +.....                            ...+..+++.+.++|.+||+.||.+||++.+++.
T Consensus       237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            332100                            0011357889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.4e-39  Score=287.55  Aligned_cols=245  Identities=26%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|++.+.||+|+||.||+|.+..++.   .+|+|.+....     ....+|+.+++.++||||+++++++     ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            3579999999999999999999865543   79999875432     2345789999999999999999887     334


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+.|+||||+++ +|.+.+...   ...++...+..++.|++.||.+||+. |++||||||+||+++.++ .++|+|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~-~~~l~dfg~  152 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNL-VCKVSDFGL  152 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCC-eEEeCCCCc
Confidence            458899999985 788777653   34688899999999999999999988 999999999999999888 899999999


Q ss_pred             eeeccCCCCcc----cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +..........    ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+.+..+....+.+...    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----  227 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----  227 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----
Confidence            87654322111    11235679999999654 48999999999999999887 9999988766555444432110    


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                    .+          ....+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 --------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 --------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                          00          11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=303.83  Aligned_cols=244  Identities=19%  Similarity=0.281  Sum_probs=194.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...+...||+|.||+||+|++-.   .||||++..+.      +.+.+|+.+++.-+|.||+-+.+++     ....+ .
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~-A  463 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL-A  463 (678)
T ss_pred             Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-e
Confidence            66788999999999999999843   49999986543      3456899999999999999999987     33333 7


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ||+.+|+| +|...+...   ...+.......|++||+.|+.|||.+ +|+|||||..|||+.+++ .|||+|||++..-
T Consensus       464 IiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDL-KVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCC-cEEEecccceeee
Confidence            99999998 677776644   36688889999999999999999998 999999999999999887 8999999998542


Q ss_pred             ---cCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          189 ---VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       189 ---~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                         ..........|...|||||+++.  ...|+.++|||||||++|||++|..||......+++..+-+....+.     
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd-----  613 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD-----  613 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-----
Confidence               12223334567888999999963  34589999999999999999999999995554443333222211111     


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                         ......+.+.++++|+..|+.+++++||...+||.
T Consensus       614 -------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  614 -------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                               11223578889999999999999999999999886

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.7e-39  Score=291.46  Aligned_cols=246  Identities=21%  Similarity=0.352  Sum_probs=191.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+.....     ...+|+.+++.++||||+++++.+     ...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence            47889999999999999998753     235688887754332     244799999999999999999877     333


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCC
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  164 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlk  164 (373)
                      ...+++|||+. ++|.+++.....                    ....+++..+..++.|++.||.|||+. +++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-Ceehhhhh
Confidence            44789999999 588887764321                    123478889999999999999999988 99999999


Q ss_pred             CCcEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 017341          165 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  240 (373)
Q Consensus       165 p~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~  240 (373)
                      |+||+++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999887 899999999875433221   1223456789999988554 48999999999999999998 9999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          241 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ....+....+....                  ..          ..+..++.++.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGY------------------RM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCC------------------CC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            76554333222110                  00          012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.1e-39  Score=285.15  Aligned_cols=235  Identities=24%  Similarity=0.337  Sum_probs=185.2

Q ss_pred             eeeecCceEEEEEEE--CCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           42 VVGHGSFGVVFQAKC--LETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      .||+|+||.||+|.+  ..++..+|+|.+.....      ...+|+.+++.++||||+++++++     .+. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence            589999999999964  46788999998754321      234688999999999999998865     222 3579999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  192 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~  192 (373)
                      |+++ +|.+.+..    ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||.+.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9994 78777754    25688999999999999999999998 999999999999999887 89999999987654332


Q ss_pred             Cc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          193 PN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       193 ~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..    ....+++.|+|||.+.. ..++.++|+|||||++|+|++ |.+||.+.+..+....+.+...            
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            21    12233578999999854 458889999999999999998 9999988766555444332100            


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                             +         ..+..+++++.++|.+||+.||++||+++++..
T Consensus       217 -------~---------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 -------M---------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -------C---------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                   0         012457899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.1e-39  Score=291.92  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC-------CCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS   99 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~   99 (373)
                      ..++|.+.+.||+|+||.||+|++.       .++..+|+|.+....     ....+|+.+++.+ +||||+++++++  
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence            3468999999999999999999752       234579999875432     2345799999999 899999999987  


Q ss_pred             cCCCCceeEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCC
Q 017341          100 TTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  166 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~  166 (373)
                         ......|++|||+. ++|.+++......            ...++...+..++.||+.||.|||++ |++||||||+
T Consensus        91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~  166 (304)
T cd05101          91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAAR  166 (304)
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeecccccc
Confidence               33445789999998 5888888764321            23577788999999999999999998 9999999999


Q ss_pred             cEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017341          167 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  242 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~  242 (373)
                      ||+++.++ .+||+|||.++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999887 899999999876533221   1223456789999998654 48999999999999999998 889998776


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          243 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       243 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ..+....+.....                            ...+..++.++.++|.+||..+|.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            5554444322100                            00123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-38  Score=292.32  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=193.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-------CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFST  100 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~  100 (373)
                      .++|.+.+.||+|+||.||+|.+..       ....+|+|.+.....     ...+|+.+++.+ +||||+++++++   
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC---   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE---
Confidence            4589999999999999999998632       345799998764322     234688999988 699999999987   


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                        .+..+++++|||+. ++|.+++.....            ....++...+..++.||+.||.|||++ |++||||||+|
T Consensus        88 --~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~N  164 (314)
T cd05099          88 --TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARN  164 (314)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeecccccee
Confidence              33445889999998 588888876431            124578888999999999999999988 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      |+++.++ .+||+|||.++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999888 899999999975432211   1122345679999998654 58999999999999999999 8999987765


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+....+.....                            ...+..++.++.++|.+||..+|.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 EELFKLLREGHR----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            554443322100                            0012457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-38  Score=283.50  Aligned_cols=243  Identities=27%  Similarity=0.393  Sum_probs=195.5

Q ss_pred             eEeeeeeeecCceEEEEEEECCCC----cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +++.+.||.|+||.||++.+..++    ..+|+|.+.....     ....|+.+++.++|+||+++++++.     +...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence            357789999999999999998766    8999998865432     3447899999999999999998873     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|||+.+ +|.+.+....  ...+++..+..++.|++.||++||+. +++|+||+|+||+++.++ .++|+|||.+.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~-~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENL-VVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCC-eEEEcccCCce
Confidence            8899999985 8887776542  12289999999999999999999988 999999999999999888 89999999987


Q ss_pred             eccCCCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          187 VLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       187 ~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .........  ...+++.|+|||.+. ...++.++|+|||||++|+|++ |.+||...+.......+......       
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------  223 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-------  223 (258)
T ss_pred             ecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------
Confidence            664432221  123678899999984 4458999999999999999998 89999887665555544331100       


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                           ..+...+.++.+++.+||..||++|||+.++++
T Consensus       224 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      224 ---------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                 011347889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=288.06  Aligned_cols=241  Identities=23%  Similarity=0.342  Sum_probs=186.1

Q ss_pred             eeeeecCceEEEEEEECCCCc--EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||++.+..++.  .+++|.+....     ....+|+++++.+ +||||+++++++     ....+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence            368999999999999988776  46888775322     2334689999999 799999999987     3344578999


Q ss_pred             eccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          113 EYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      ||+. ++|.+.+.....            ....+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .+||
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~-~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY-VAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCC-eEEE
Confidence            9998 588888875431            123478899999999999999999988 999999999999999888 8999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      +|||++..............+..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+....    
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----  228 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----  228 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----
Confidence            99999853221111112233567999999854 458999999999999999997 999998766554443332110    


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                    ..          ..+..++.++.+++.+|+..+|.+|||+.++++
T Consensus       229 --------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 --------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                          00          011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-38  Score=285.13  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=193.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .+|+..+.||+|++|.||+|.+..++.   .+|+|.+....     ....+|+++++.++|||++++.+++     .+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence            479999999999999999999876654   79999875432     2234689999999999999999887     3334


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..++||||+++ +|.+.+...   ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCC-cEEECCCccc
Confidence            57899999995 777777543   35688999999999999999999988 999999999999999887 8999999998


Q ss_pred             eeccCCCCcc----cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          186 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       186 ~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ..........    ....+..|+|||.+... .++.++|+|||||++|+|++ |+.||...+..+....+......+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7654322111    11224579999998654 47999999999999999997 999998777655554443211000   


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                               .....+.++.+++.+||+.+|++||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                     01346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-38  Score=286.68  Aligned_cols=245  Identities=20%  Similarity=0.298  Sum_probs=189.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||.|+||.||+|.+..+++    .+++|.+....     .....|+.+++.++||||+++++++     .+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-----~~   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-----PG   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-----CC
Confidence            3579999999999999999999987776    47777764322     1223566678899999999998875     22


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      . ..++++||+. |+|.+.+...   ...+++..+..++.||+.||.|||++ +++||||||+||+++.++ .+||+|||
T Consensus        81 ~-~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~-~~kl~Dfg  154 (279)
T cd05111          81 A-SLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFG  154 (279)
T ss_pred             C-ccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEEcCCc
Confidence            2 2568999998 6888888653   35688999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+......... ......+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~--  230 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGERL--  230 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcC--
Confidence            9976533322   1223456789999998654 48999999999999999998 9999988765443222 2210000  


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                   .            .+...+.++.+++.+|+..||++|||+.++++.
T Consensus       231 -------------~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         231 -------------A------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             -------------C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                         0            112356789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-39  Score=290.46  Aligned_cols=254  Identities=20%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCC--------------cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETG--------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH   95 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~   95 (373)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.+....     ....+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            48999999999999999999875432              358999886532     12346999999999999999999


Q ss_pred             eeeecCCCCceeEEEEEecccc-cHHHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCC
Q 017341           96 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM--------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  166 (373)
Q Consensus        96 ~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~--------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~  166 (373)
                      ++.     .....++||||+.+ +|.+.+......        ...+++..+..++.|++.||.|||++ |++|+||||+
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~  158 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATR  158 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChh
Confidence            873     34457899999985 888877543211        12367888999999999999999998 9999999999


Q ss_pred             cEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 017341          167 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGE  241 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--G~~pf~~~  241 (373)
                      ||+++.++ .+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999887 799999999875433221   1123446789999998654 48999999999999999998  67888877


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       242 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      +..+....+.+.......       ..     .         ...++..++.+.+|+.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-------~~-----~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQGR-------QI-----Y---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhccc-------cc-----c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            766555544332100000       00     0         0012357889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-38  Score=285.11  Aligned_cols=244  Identities=24%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..|.+.+.||+|+||.||+|.+..+++   .||+|.+....     .....|+.+++.++||||+++.+++     .+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            469999999999999999999877665   59999876432     2334689999999999999999887     3444


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+++||||+++ +|.+.+...   ...++...++.++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCC-cEEECCCccc
Confidence            57899999985 777777643   35688999999999999999999998 999999999999999887 8999999998


Q ss_pred             eeccCCCCccc---cc---ccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          186 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       186 ~~~~~~~~~~~---~~---gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ...........   ..   .+..|+|||.+.+. .++.++|+||+||++|+|++ |..||...+..+....+....    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~----  228 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY----  228 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----
Confidence            65433221111   11   14579999998654 48999999999999999886 999998877655544443210    


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                    ..+          .+..++..+.+++.+||+.+|.+||++.+++.
T Consensus       229 --------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 --------------RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             --------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          000          11356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-39  Score=296.55  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=191.2

Q ss_pred             cceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ++|++.+.||.|+||.||+|.+     ..+++.||+|.+..+.     ....+|+.++..+ +||||+++++++..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            4899999999999999999985     3467899999886432     1234799999999 68999999987642    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh------------------------------------------------------
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK------------------------------------------------------  128 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------------------------------------------------  128 (373)
                      ....++++||||+ |+|.+.+.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            2334789999999 588888764321                                                      


Q ss_pred             ---------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC---ccc
Q 017341          129 ---------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NIS  196 (373)
Q Consensus       129 ---------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~  196 (373)
                               ....++...+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++........   ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                     012367778889999999999999998 999999999999999888 899999999876432211   112


Q ss_pred             ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017341          197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  275 (373)
Q Consensus       197 ~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      ..+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+...............                 . .
T Consensus       241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------~-~  301 (343)
T cd05103         241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-----------------R-M  301 (343)
T ss_pred             CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-----------------C-C
Confidence            3346779999998654 48999999999999999997 9999987654333222221100                 0 0


Q ss_pred             CcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                               ..+...++++.+++.+||+.||.+|||+.++++|
T Consensus       302 ---------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     0112367889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-38  Score=282.99  Aligned_cols=239  Identities=25%  Similarity=0.331  Sum_probs=190.8

Q ss_pred             eeeeecCceEEEEEEECC-CC--cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLE-TG--EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|++|.||++.+.. ++  ..+|+|.+..+..     ...+|+.+++.++||||+++++.+.     + ..++++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            468999999999999865 33  3699998865543     3457999999999999999998873     2 4578999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||++ ++|.+.+.+...  ..+++..++.++.|++.||+|||++ |++|+||+|+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 588888876432  4688999999999999999999998 999999999999999988 8999999998765432


Q ss_pred             CCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          192 EPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       192 ~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...    ....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+......          
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  219 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER----------  219 (257)
T ss_pred             ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------
Confidence            211    123467789999998544 48999999999999999998 99999877766655554331000          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                             0011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=282.56  Aligned_cols=236  Identities=27%  Similarity=0.385  Sum_probs=186.5

Q ss_pred             eeeeecCceEEEEEEECCCC---cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      ++||+|+||.||+|.+..++   ..+|+|.+..+..     ...+|+.+++.++||||+++++++     ... ..+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KGE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----cCC-ceEEEE
Confidence            47999999999999876554   7899998865443     234789999999999999998865     222 367999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+. ++|.+.+...    ..+++..+..++.|++.+|.|||++ +++|+||||+||+++.++ .++|+|||.++.....
T Consensus        75 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            9998 5888887653    4688999999999999999999988 999999999999999888 8999999998765333


Q ss_pred             CCcc----cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          192 EPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       192 ~~~~----~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....    ...++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||...+..+....+....            
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------------
Confidence            2211    11234679999998554 48999999999999999998 999998776654443332210            


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                            .          ...+..++..+.++|.+||..+|.+||++.++++
T Consensus       216 ------~----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 ------R----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------c----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  0          0012357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-38  Score=284.79  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=195.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .+|++.+.||.|+||.||+|+.+.     +.+.+++|.+.....     ...+|+++++.++|+||+++++++     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            579999999999999999999754     346799998754332     245799999999999999999877     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMS-----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~-----~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                      ..+.++||||++ ++|.+.+.......     ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCC-cEE
Confidence            456789999998 58888877543111     2589999999999999999999988 999999999999999888 799


Q ss_pred             EeeccceeeccCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017341          179 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       179 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      |+|||++.......  ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+.......+.... 
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-  235 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-  235 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-
Confidence            99999986442221  12233567789999998654 47889999999999999998 889997766554444332110 


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                      ..          ......++..+.+++.+||+.+|.+|||+.+++++
T Consensus       236 ----------------~~----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 ----------------LE----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ----------------cC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                            00          00123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-38  Score=288.33  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=194.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|++.+.||.|+||.||+|.+..     ++..+|+|.+....     ....+|+.+++.++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            3579999999999999999998753     67889999876432     2345789999999999999999877     3


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh------------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCC
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  164 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlk  164 (373)
                      +...++++|||++ ++|.+.+.....                  ....+++..+..++.||+.||.|||++ +++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-Ceeccccc
Confidence            3345789999999 488888875321                  112467888999999999999999998 99999999


Q ss_pred             CCcEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 017341          165 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  240 (373)
Q Consensus       165 p~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~  240 (373)
                      |+||+++.++ .++|+|||.+........   ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999888 899999999875432211   1122346679999998654 48999999999999999997 8889987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          241 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+..+....+....                   ..         ..+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         236 MAHEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCHHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            76655444332210                   00         011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-38  Score=293.56  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=194.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC-------CcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  100 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  100 (373)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.+....     ....+|+.+++.+ +||||+++++++   
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC---   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence            34799999999999999999986432       2368999776432     2334789999999 799999999987   


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                        .....++++|||++ ++|.+.+.....            ....++...+..++.||+.||.|||++ |++||||||+|
T Consensus        88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~N  164 (334)
T cd05100          88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARN  164 (334)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccccccce
Confidence              33445789999998 488888875421            123467788889999999999999998 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      |+++.++ .+||+|||+++........   ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999888 8999999998765332211   122335679999998654 48899999999999999998 8999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+....+......                            ..+...+.++.++|.+||..+|.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHRM----------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5544443321000                            0113567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=306.53  Aligned_cols=266  Identities=27%  Similarity=0.424  Sum_probs=221.9

Q ss_pred             CCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           28 NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        28 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ...|..++.|++...+|.|.+|.||+++++.+++..|+|+...+.   ..++.|.++++.. .|||++.++++|.-....
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            345667788999999999999999999999999999999875443   3445678888877 599999999999877666


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ....+|||||||+ |+..++++...  +.++.|+.++.+++.++.||.+||.+ .++|||+|-.|||++.++ .|||+||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~-~VKLvDF  167 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENA-EVKLVDF  167 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccC-cEEEeee
Confidence            6777999999999 57788877665  78899999999999999999999988 999999999999999999 7999999


Q ss_pred             cceeeccCCC-CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |.+....... ...+.+|||+|||||++...    ..|+..+|+||||++..||.-|.+|+-++.+...+..|..   .|
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NP  244 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP  244 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CC
Confidence            9987765443 34578999999999999533    3477799999999999999999999988876655544322   11


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      ++                       ...-++..+..+.+||..||.+|-.+||+..++|.|||+++
T Consensus       245 PP-----------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  245 PP-----------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             Cc-----------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            11                       11112467889999999999999999999999999999974

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.2e-38  Score=282.02  Aligned_cols=236  Identities=22%  Similarity=0.294  Sum_probs=184.8

Q ss_pred             eeeecCceEEEEEEEC--CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEec
Q 017341           42 VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      .||+|+||.||+|.+.  ..+..+|+|.+.....     ...+|+.+++.++||||+++++++     +. ..+++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence            3899999999999764  4456799998754422     234789999999999999998875     22 246899999


Q ss_pred             ccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC
Q 017341          115 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  193 (373)
Q Consensus       115 ~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~  193 (373)
                      +++ +|.+.+...   ...+++..++.++.||+.||.|||++ |++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            984 777776543   35689999999999999999999988 999999999999999887 899999999875433221


Q ss_pred             c----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          194 N----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       194 ~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .    ....+++.|+|||.+... .++.++|+|||||++|+|++ |..||.+....+....+.+...             
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------------
Confidence            1    111235789999998544 48899999999999999996 9999988776554443332100             


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                     ...+...++++.++|.+||..+|++||++.++.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0022457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-38  Score=280.68  Aligned_cols=244  Identities=20%  Similarity=0.337  Sum_probs=193.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||.|+||.||++.+. ++..+|+|.+....   ....+|+++++.++|||++++++++     ......+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence            47999999999999999999875 47789999876432   2345799999999999999998887     344457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+.+ +|.+.+...   ...+++..++.++.|++.+|++||++ +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 777666543   24578899999999999999999988 999999999999999877 899999999875533


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.....            
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------  219 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence            2211  122345689999998654 48899999999999999998 9999987765554444322100            


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                      ...+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                            00113367899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-38  Score=285.78  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=190.6

Q ss_pred             cceEeeeeeeecCceEEEEEE----ECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .+|++.+.||+|+||.||++.    +..+++.||+|.+.....    ...+|+++++.++||||+++.+++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            479999999999999999997    445788999998864432    34579999999999999999887643   2334


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+++||||++ ++|.+.+...   ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCC-eEEECCCccc
Confidence            5789999997 5888887643   24588899999999999999999998 999999999999999888 7999999998


Q ss_pred             eeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHH
Q 017341          186 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTRE  260 (373)
Q Consensus       186 ~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~  260 (373)
                      .........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..++...... ....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence            765333221    111234569999998654 4899999999999999999998776443211 1100000000 00000


Q ss_pred             HHh-hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          261 EIK-CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       261 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+. .....   ...          ..+..++.++.+||.+||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKNN---GRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhcC---CcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            000 00000   000          012457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.7e-39  Score=284.62  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=188.8

Q ss_pred             EeeeeeeecCceEEEEEEEC----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           38 MAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+.+.||.|.||.||+|...    ..+..|+||.+....     ....+|++.++.++||||+++++++....     .+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PL   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cc
Confidence            56789999999999999987    456789999985432     23457999999999999999999886221     27


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+. |+|.+.+...  ....++...+..++.||+.||.|||++ +++|++|+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccc
Confidence            89999998 6899998875  235688999999999999999999998 999999999999999988 899999999876


Q ss_pred             ccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          188 LVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       188 ~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .......   ........|+|||.+.... ++.++||||||+++|||++ |+.||.+.+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            5322221   2334677899999986544 8999999999999999999 7899988877666655533110        


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                          ...+..++..+.++|.+||..||.+|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                0122467899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-38  Score=284.97  Aligned_cols=249  Identities=19%  Similarity=0.259  Sum_probs=194.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|.+.+.||+|+||.||+|.+..    ++..+++|.+.....     ...+|+.+++.++||||++++++....    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            4689999999999999999999875    357899998764322     234789999999999999998876432    


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~----~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      ....+++++|++ ++|...+.......    ..+++..+..++.||+.||+|||++ +++|+||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCC-cEEE
Confidence            234678999998 58888876543221    4588999999999999999999988 999999999999999887 8999


Q ss_pred             eeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017341          180 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      +|||+++........   ....++..|+|||.+.+. .++.++|||||||++|++++ |++||...+..+....+...  
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--  235 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG--  235 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--
Confidence            999998755332211   123456779999998654 48999999999999999999 99999877654433322211  


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                      ...          .....+++++.+++.+||..||++|||+.++++
T Consensus       236 ----------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ----------------YRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------CCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            000          011346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=308.45  Aligned_cols=208  Identities=28%  Similarity=0.420  Sum_probs=171.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC-CCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  107 (373)
                      ...|...+.||+|+||.||+++++.||+.||+|.+....     ...-+|++++++++|+|||++.++=.... .--...
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            457999999999999999999999999999999886532     22337999999999999999977532111 000222


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC--C-CceeEeecc
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--T-HQLKLCDFG  183 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~--~-~~ikl~Dfg  183 (373)
                      -.++||||.| +|...|.+- .....+++..+..++..+..||.|||++ ||+||||||.||++-..  | ...||+|||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            4689999995 787777643 2345699999999999999999999998 99999999999998422  2 257999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  243 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~  243 (373)
                      .|+...++....+.+||+.|.+||++.....|+..+|.||+||++|+++||..||.....
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            999988888888999999999999996556799999999999999999999999966543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.1e-39  Score=318.35  Aligned_cols=256  Identities=30%  Similarity=0.443  Sum_probs=194.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC-------
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-------  102 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------  102 (373)
                      .+|+....||+||||.||+|+++-+|..||||++....     ..+.+|+..+.+|+|||||+++..|+....       
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            36788999999999999999999999999999996542     335589999999999999998876632100       


Q ss_pred             ------------------------------------------------------------------C-------------
Q 017341          103 ------------------------------------------------------------------K-------------  103 (373)
Q Consensus       103 ------------------------------------------------------------------~-------------  103 (373)
                                                                                        +             
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                              0             


Q ss_pred             ----------------------------CceeEEEEEecccccHHHHHHHhhhcCCCC-CHHHHHHHHHHHHHHHHHhHc
Q 017341          104 ----------------------------DELYLNLVLEYVPETVHRVIKHHYKMSQRM-PLIYVKLYFYQICRALAYIHN  154 (373)
Q Consensus       104 ----------------------------~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~-~~~~~~~i~~qil~~L~~LH~  154 (373)
                                                  ...++||=||||+.++++.+.+..   ... ....+|.+++||++||.|+|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                        005689999999987666666542   222 367799999999999999999


Q ss_pred             cCCceeecCCCCcEEEcCCCCceeEeeccceeecc-------------------CCCCcccccccccccccccccCCC--
Q 017341          155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT--  213 (373)
Q Consensus       155 ~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~~--  213 (373)
                      . |||||||||.|||+++++ .|||+|||+|+...                   +.......+||.-|+|||++.+..  
T Consensus       716 ~-giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  716 Q-GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             C-ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            8 999999999999999888 79999999998621                   001223568999999999997655  


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChh
Q 017341          214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPE  293 (373)
Q Consensus       214 ~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      .|+.++|+||||+|++||+.   ||....+   ...++..+..+.               +|.   .   .-|..+-=+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME---Ra~iL~~LR~g~---------------iP~---~---~~f~~~~~~~  846 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSME---RASILTNLRKGS---------------IPE---P---ADFFDPEHPE  846 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHH---HHHHHHhcccCC---------------CCC---C---cccccccchH
Confidence            59999999999999999984   5654322   222333222111               110   0   1111223346


Q ss_pred             HHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          294 AVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       294 ~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                      -..+|..||+.||++||||.|||++.||-
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            67899999999999999999999999886

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=284.71  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=194.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc----EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||.||+|.++.+|+    .+|+|.......     ...+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            4589999999999999999999877665    589997754432     23478999999999999999987743     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                       ...+++|||+. ++|.+.+...   ...+++..+..++.||+.||+|||++ +++|+||||+||+++.++ .+||+|||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kL~dfg  154 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQ-HVKITDFG  154 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCC-eEEECCCc
Confidence             34789999998 5888887654   24589999999999999999999998 999999999999999888 79999999


Q ss_pred             ceeeccCCCCccc---ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      .++..........   ..++..|+|||.+.. ..++.++|+|||||++|+|++ |+.||.+.+..+....+......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---  230 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL---  230 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC---
Confidence            9876543322111   123567999998854 358899999999999999998 99999887665544433321000   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                               ..+...+.++.+++.+||..+|.+|||+.++++
T Consensus       231 -------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 -------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                     011346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-38  Score=288.42  Aligned_cols=254  Identities=20%  Similarity=0.273  Sum_probs=191.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECC----------------CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeec
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL   93 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~   93 (373)
                      .+|++.+.||+|+||.||++.+..                ++..+|+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999986432                34579999886432     224579999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCC
Q 017341           94 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  165 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~-------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp  165 (373)
                      ++++.     .....+++|||+. ++|.+++......       ...+++..+..++.||+.||+|||+. |++|+||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            99873     3334789999998 5888888764321       12367788999999999999999988 999999999


Q ss_pred             CcEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 017341          166 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPG  240 (373)
Q Consensus       166 ~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--G~~pf~~  240 (373)
                      +||+++.++ .++|+|||++........   .....+++.|+|||...+. .++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999887 899999999875533221   1122346789999987654 48999999999999999998  7799987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          241 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+..+............           ......+          .+..+++.+.+|+.+||+.||.+|||+.++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFRDQ-----------GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHhhc-----------cccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            76655443332211000           0000000          11346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-38  Score=297.10  Aligned_cols=250  Identities=22%  Similarity=0.349  Sum_probs=194.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeccccc-----chHHHHHHHHhCC-CCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  102 (373)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||+|++.....     ...+|+.++..+. ||||+++++++.    
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~----  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT----  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence            347999999999999999999853     3567899999865422     2347999999997 999999998873    


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  128 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~-----------------------------------------------------  128 (373)
                       ....+++|||||. |+|.+.+.....                                                     
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             3345889999999 588888865321                                                     


Q ss_pred             -----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          129 -----------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       129 -----------------------------------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                                                               ....++...+..++.||+.||.|||+. +++||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~N  269 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARN  269 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcce
Confidence                                                     012356677888999999999999988 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      |+++.++ .++|+|||+++.......   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.....
T Consensus       270 iLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            9999877 899999999876432221   1234567889999999654 48999999999999999998 8999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+........-                 ..          ...+..++.++.+++.+||..+|.+||++.++++.
T Consensus       348 ~~~~~~~~~~~-----------------~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         348 NEQFYNAIKRG-----------------YR----------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             hHHHHHHHHcC-----------------CC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55443333210                 00          00124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.6e-38  Score=280.40  Aligned_cols=244  Identities=25%  Similarity=0.349  Sum_probs=193.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|.+.+.||+|+||.||++.+. .+..+|+|.+.....   ...+|+.+++.++|+||+++++++.     . ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEE
Confidence            358999999999999999999864 456799998765432   3457999999999999999988763     2 34689


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||++ ++|.+.+....  ...++...+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence            999998 58888876532  34578888999999999999999988 999999999999999888 89999999987653


Q ss_pred             CCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .....  ....++..|+|||.+.. ..++.++|+|||||++|+|++ |+.||.+.+.......+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-----------  221 (260)
T ss_pred             CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence            32211  12234567999999864 348889999999999999999 9999988766554444332100           


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                             .+          .....+.++.+++.+||..+|++||++.+++.
T Consensus       222 -------~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 -------MP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -------CC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                   00          11357889999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=292.13  Aligned_cols=266  Identities=26%  Similarity=0.381  Sum_probs=209.4

Q ss_pred             CCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecc--ccc---------chHHHHHHHHhCCCCCeeecce
Q 017341           27 KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKR---------YKNRELQTMRLLDHPNVVSLKH   95 (373)
Q Consensus        27 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~---------~~~~E~~~l~~l~h~~iv~~~~   95 (373)
                      ...+|...++|.+..+||.|||+.||++.|....+.||+|+-..  +.+         ..-+|.++-+.|+||.||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            45677888899999999999999999999999999999996432  211         1127999999999999999999


Q ss_pred             eeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC-CceeecCCCCcEEEcCC
Q 017341           96 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPH  173 (373)
Q Consensus        96 ~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-~ivH~Dlkp~NIll~~~  173 (373)
                      +|..    +...+|-|+|||+| +|.-+++.+    ..+++..++.|+.||+.||.||.+.. .|+|-||||.|||+-..
T Consensus       535 yfsl----DtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G  606 (775)
T KOG1151|consen  535 YFSL----DTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG  606 (775)
T ss_pred             eeee----ccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence            8843    23347889999998 666666654    56899999999999999999999642 69999999999998532


Q ss_pred             --CCceeEeeccceeeccCCCCc--------ccccccccccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017341          174 --THQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPG  240 (373)
Q Consensus       174 --~~~ikl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~l~~---~~~~~~~~DiwslG~il~~lltG~~pf~~  240 (373)
                        .+.|||+|||+++.+......        ....||.+|++||.+.-   -+..+.++||||+|||+|.++.|+.||..
T Consensus       607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence              237999999999987554332        24578999999999853   24578899999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          241 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                      ......   |++....          .+..+..||.-          +.+++++++||++||++--++|..+.+|..||+
T Consensus       687 nqsQQd---ILqeNTI----------lkAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy  743 (775)
T KOG1151|consen  687 NQSQQD---ILQENTI----------LKATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY  743 (775)
T ss_pred             chhHHH---HHhhhch----------hcceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence            643322   2221100          01122333321          468999999999999999999999999999999


Q ss_pred             ccc
Q 017341          321 FDE  323 (373)
Q Consensus       321 ~~~  323 (373)
                      |..
T Consensus       744 llP  746 (775)
T KOG1151|consen  744 LLP  746 (775)
T ss_pred             ccc
Confidence            964

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=279.67  Aligned_cols=237  Identities=24%  Similarity=0.340  Sum_probs=187.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ++||.|++|.||++.+.. ++.||+|.+.....     ...+|+++++.++|+||+++++++     .+..+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            468999999999999877 99999998764332     345799999999999999999887     3344578999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc
Q 017341          116 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  194 (373)
Q Consensus       116 ~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~  194 (373)
                      .+ +|.+.+...   ...++...+..++.|++.+|.|||++ +++||||+|+||+++.++ .++|+|||.+.........
T Consensus        75 ~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            74 777777543   24578889999999999999999988 999999999999999888 8999999998754322111


Q ss_pred             ---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          195 ---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       195 ---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                         .....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.........+.....               
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~---------------  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR---------------  213 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence               112235679999998654 48999999999999999999 8999987765444433322100               


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                   ...+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         0012457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5e-39  Score=286.31  Aligned_cols=236  Identities=19%  Similarity=0.274  Sum_probs=181.7

Q ss_pred             eeeeecCceEEEEEEECCCCcE-------EEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~-------vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +.||.|+||.||+|.+..++..       +++|.+.....    ...+|..+++.++|||++++++++..     ....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            3689999999999998665443       88887654322    23568889999999999999998743     23467


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc-------eeEee
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-------LKLCD  181 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~-------ikl~D  181 (373)
                      +||||+++ +|...+....   ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 7777776532   3578889999999999999999988 99999999999999877632       79999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ||.+.....   .....+++.|+|||.+.+...++.++|+|||||++|+|++| .+||...+...... +...       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            998864322   23356788999999997655578999999999999999998 46666554433221 1110       


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                .            ..++...+.++.++|.+||+.||++|||++++++.
T Consensus       221 ----------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                      0            00123456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-38  Score=278.68  Aligned_cols=238  Identities=23%  Similarity=0.361  Sum_probs=187.3

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ++||.|+||.||++.. .++..+|+|.+.....     ...+|+++++.++||||+++++++.     .....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            3689999999999986 4688999998754322     2447899999999999999998873     334578999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc
Q 017341          116 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  194 (373)
Q Consensus       116 ~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~  194 (373)
                      + ++|.+.+...   ...+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            8 4777776543   24578899999999999999999988 999999999999999888 8999999998754322211


Q ss_pred             --ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          195 --ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       195 --~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                        ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+.......+.....                
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------  212 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence              12233567999999854 448899999999999999998 9999988766554443322100                


Q ss_pred             ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                  ...+..++..+.+++.+||..+|++||++.++++.
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         213 ------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                        01124578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.3e-38  Score=280.35  Aligned_cols=241  Identities=22%  Similarity=0.338  Sum_probs=192.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ..+|++.+.||+|+||.||++..  +++.+|+|.+..+.  ....+|+.+++.++|||++++++++..     . ..+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v   76 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIV   76 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEE
Confidence            35799999999999999999874  78899999886432  234579999999999999999887632     1 15799


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+. ++|.+.+....  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||.+.....
T Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~  152 (254)
T cd05083          77 MELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDG-VAKVSDFGLARVGSM  152 (254)
T ss_pred             EECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-cEEECCCccceeccc
Confidence            99998 58888887542  34578889999999999999999988 999999999999999888 899999999875432


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .  ......+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...+..+....+.+..               
T Consensus       153 ~--~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  214 (254)
T cd05083         153 G--VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------  214 (254)
T ss_pred             c--CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence            2  1223345679999998544 48899999999999999997 999998876655443332210               


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                         ..          .....++..+.+++.+||+.+|.+||++.+++.
T Consensus       215 ---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ---RM----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ---CC----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               00          011357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.6e-38  Score=281.42  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=193.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|.+.+.||.|++|.||+|.+...   ...+++|......     ....+|+.+++.++||||+++++++.     +.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC
Confidence            34799999999999999999987544   3468999875433     13447999999999999999998762     22


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                       ..++||||++ ++|.+.+...   ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~  153 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPD-CVKLGDFGL  153 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCC-CeEEccCce
Confidence             2579999998 5888887653   24588999999999999999999988 999999999999999888 899999999


Q ss_pred             eeeccCCCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          185 AKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       185 a~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      +..........  ...++..|+|||.+... .++.++|+|||||++|+|++ |..||.+.+..+....+.+....     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----  227 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-----  227 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-----
Confidence            87654332111  22335679999998544 58999999999999999996 99999887765554443321000     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                             ..+..++..+.++|.+|+..+|.+|||+.+++..
T Consensus       228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   0124578899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-38  Score=285.86  Aligned_cols=260  Identities=23%  Similarity=0.360  Sum_probs=190.3

Q ss_pred             cceEeeeeeeecCceEEEEEEE----CCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..|++.+.||+|+||.||+++.    ..++..+|+|.+....     ....+|+.+++.++|||++++.+++..   .+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            3589999999999999999984    4578899999875332     234579999999999999999887643   223


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+++|||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ |++||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~-~~~l~dfg~  155 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGL  155 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCC-CEEECCCcc
Confidence            45789999997 4788777543   24588999999999999999999998 999999999999999887 799999999


Q ss_pred             eeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCH
Q 017341          185 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~-~~~~~~  259 (373)
                      +.........    ....++..|+|||.+.+. .++.++|+|||||++|+|++++.|+.....  ........ .+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~  232 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTV  232 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccH
Confidence            8765432211    234456789999998654 488999999999999999998876533211  00000000 000000


Q ss_pred             H-HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 E-EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      . ........             .....+..++..+.+||.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         233 TRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            0 00000000             0001124578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.8e-38  Score=281.68  Aligned_cols=246  Identities=21%  Similarity=0.301  Sum_probs=184.8

Q ss_pred             eeeeecCceEEEEEEECC--CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||+|....  ....+++|.+.....     ...+|+.+++.++||||+++++.+     .....+++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence            368999999999996533  345788887653321     234688999999999999999887     33445889999


Q ss_pred             ccc-ccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          114 YVP-ETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       114 ~~~-g~l~~~l~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      |++ |+|.+.+...... ....++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCC-cEEEeccccccccccc
Confidence            998 5888888765322 23356778889999999999999998 999999999999999988 8999999998643222


Q ss_pred             CC---cccccccccccccccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          192 EP---NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       192 ~~---~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ..   .....+++.|+|||++..      ...++.++|||||||++|+|++ |..||......+.+..+.......    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----  229 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK----  229 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence            11   122345677999998742      2346889999999999999999 889998877666555544321110    


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                  .+       ....+..++..+.+++..|+ .||++|||++++++
T Consensus       230 ------------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 ------------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                        00       00122467889999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-38  Score=281.82  Aligned_cols=236  Identities=18%  Similarity=0.221  Sum_probs=178.1

Q ss_pred             eeeeecCceEEEEEEECC------------CCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           41 RVVGHGSFGVVFQAKCLE------------TGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~------------~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      +.||+|+||.||+++...            ....+++|.+.....    ...+|+.+++.++||||+++++++.     +
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            368999999999998532            223588887654332    2346788999999999999999873     3


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC------ce
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QL  177 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~------~i  177 (373)
                      ....+++|||+++ +|..++...   ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.      .+
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCcee
Confidence            3346799999995 555554432   35689999999999999999999998 9999999999999986552      28


Q ss_pred             eEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          178 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       178 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll-tG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      +++|||.+.....   .....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            9999998864422   223457888999998865556899999999999999998 588988765433221 11110   


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                 .+   .            .....+.++.+||.+||+.||.+||+..+++.+
T Consensus       225 -----------~~---~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -----------QC---M------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----------Cc---c------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                       00   0            012245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.5e-38  Score=280.46  Aligned_cols=246  Identities=20%  Similarity=0.253  Sum_probs=183.3

Q ss_pred             eeeeecCceEEEEEEEC--CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||+|...  .++..+|+|.+.....     ...+|+.+++.++||||+++++++     .+...+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence            36899999999999864  3567899998754332     344689999999999999999877     33445789999


Q ss_pred             ccc-ccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          114 YVP-ETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       114 ~~~-g~l~~~l~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      |++ ++|.+.+...... ....+...+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            999 5888888654321 23456677888999999999999988 999999999999999887 8999999998654322


Q ss_pred             CC---cccccccccccccccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          192 EP---NISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       192 ~~---~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ..   .....+++.|+|||++.+.      ..++.++|+|||||++|+|++ |+.||...+..+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            21   1223567889999998532      135789999999999999996 99999876655443322211000     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                 ..+.       .......+..+.+++.+|+ .+|++|||+++++.
T Consensus       229 -----------~~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -----------KLPK-------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----------CCCC-------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                       0000       0011246778999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.2e-38  Score=282.30  Aligned_cols=235  Identities=18%  Similarity=0.245  Sum_probs=178.7

Q ss_pred             eeeecCceEEEEEEECCC------------------------CcEEEEEEeccccc----chHHHHHHHHhCCCCCeeec
Q 017341           42 VVGHGSFGVVFQAKCLET------------------------GEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSL   93 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~------------------------~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~   93 (373)
                      .||+|+||.||++....+                        ...+++|.+.....    ...+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999975321                        23588887754322    23467889999999999999


Q ss_pred             ceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC
Q 017341           94 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  172 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~  172 (373)
                      ++++..     ..+.++||||+++ +|...+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEec
Confidence            998743     3357899999995 666665432   35688999999999999999999988 9999999999999975


Q ss_pred             CC------CceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 017341          173 HT------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD  245 (373)
Q Consensus       173 ~~------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll-tG~~pf~~~~~~~  245 (373)
                      .+      ..++++|||.+......   ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||.+....+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43      13899999987543221   23457788999999866556899999999999999995 6999998765443


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ... .....                 ..            ++...++++.++|.+||+.+|++|||+.+++++
T Consensus       230 ~~~-~~~~~-----------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KER-FYEKK-----------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHhc-----------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            322 11100                 00            112345689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.8e-38  Score=279.89  Aligned_cols=242  Identities=20%  Similarity=0.306  Sum_probs=187.7

Q ss_pred             eeeeecCceEEEEEEECCCC------cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           41 RVVGHGSFGVVFQAKCLETG------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +.||+|+||.||++.+....      +.+|+|.+....     ....+|+.+++.++||||+++++++.     +....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            36899999999999986544      689999875432     23347899999999999999998873     334578


Q ss_pred             EEEeccc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC----CceeEee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  181 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~----~~ikl~D  181 (373)
                      ++|||++ ++|.+.+......   ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999998 5888888754321   23478888999999999999999988 999999999999998754    2699999


Q ss_pred             ccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          182 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       182 fg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+....   
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---
Confidence            999875433221   1223456789999998654 48999999999999999998 999998776655443332110   


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                     .          ...+..++..+.++|.+||+.+|.+||++.++++
T Consensus       231 ---------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 ---------------R----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ---------------c----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                           0          0012457889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-37  Score=277.44  Aligned_cols=240  Identities=23%  Similarity=0.344  Sum_probs=181.8

Q ss_pred             eeeeecCceEEEEEEECC---CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           41 RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +.||+|+||.||+|.+..   .+..+|+|.+....     ....+|+.+++.++||||+++++++..    .+...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            468999999999998653   34579999874322     223468889999999999999886532    223467999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||+. ++|.+++...   ....+...+..++.||+.||+|||+. +++||||||+||+++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            9998 5888887643   23456777888999999999999988 999999999999999888 8999999998754322


Q ss_pred             CC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          192 EP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       192 ~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..     .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+....           
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-----------  219 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-----------  219 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            11     1123456789999998654 48999999999999999999 567787665544333322110           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                              .+         ..+..++..+.+++.+||..+|++||++.++++.
T Consensus       220 --------~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 --------RL---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             --------CC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                    00         0113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-37  Score=283.81  Aligned_cols=245  Identities=22%  Similarity=0.338  Sum_probs=191.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc----EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|+..+.||+|+||.||++.+..+|+    .+|+|.+.....     ...+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            4578999999999999999999887776    468887754432     23468899999999999999987632     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      . ..+++++|++ |+|.+.+...   ...+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~-~~kL~Dfg  154 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPN-HVKITDFG  154 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCC-ceEEcccc
Confidence            1 2458999998 5788777653   24588899999999999999999998 999999999999999887 79999999


Q ss_pred             ceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +++........   ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+. ..+.+....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~---  229 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGER---  229 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCC---
Confidence            99765432221   123346789999998544 48999999999999999997 9999987654332 222221000   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                    .+          .+...+..+.+++.+|+..+|++||+++++++.
T Consensus       230 --------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 --------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             --------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          00          113467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-37  Score=278.93  Aligned_cols=251  Identities=21%  Similarity=0.314  Sum_probs=191.2

Q ss_pred             eEeeeeeeecCceEEEEEEEC---CCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc-e
Q 017341           37 YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE-L  106 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~-~  106 (373)
                      |.+.+.||+|+||.||+|.+.   .+++.+|+|.+..+..      ...+|+++++.++||||+++++++......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678889999999999999864   3578999998865421      23478999999999999999987754332222 2


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~--~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..+++++|+. +++...+.....  ....++...++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCC-CEEECccc
Confidence            3468899988 577766643221  123478889999999999999999988 999999999999999887 79999999


Q ss_pred             ceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +++.......   .....+++.|++||.+... .++.++|+|||||++|+|++ |++||.+.+..+....+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-----  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            9876533221   1223446789999998544 47899999999999999999 899998776544433332210     


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                 ..            ..+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       233 -----------~~------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 -----------RL------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -----------cC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       00            0113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.1e-37  Score=275.56  Aligned_cols=246  Identities=19%  Similarity=0.269  Sum_probs=183.5

Q ss_pred             eeeeecCceEEEEEEECCC--CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLET--GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.||+|+||.||++.....  ...+++|.+....     ....+|+.+++.++||||+++++.+.     +....|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            3689999999999975433  2356677664332     23346888899999999999999873     3445789999


Q ss_pred             ccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC
Q 017341          114 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  192 (373)
Q Consensus       114 ~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~  192 (373)
                      |+. ++|.+.+..........++..++.++.||+.||.|||++ +++||||||+||+++.++ .++|+|||++.......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKED  153 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCc-cEEecccccccccCcch
Confidence            999 588888876543334567778889999999999999988 999999999999999888 79999999875432211


Q ss_pred             ---CcccccccccccccccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          193 ---PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       193 ---~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                         ......++..|+|||++...      ..++.++|+|||||++|+|++ |..||...+..+.+..+.......     
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  228 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK-----  228 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc-----
Confidence               12234678899999987421      235778999999999999997 678998777666655544321100     


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                 .       ....+...+++.+.+++..|+ .+|.+||+++++++
T Consensus       229 -----------~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -----------L-------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -----------c-------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                       0       001112346788999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=290.03  Aligned_cols=262  Identities=27%  Similarity=0.369  Sum_probs=192.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+++|.-...||+|+||.||+|.-. +|..||||++....    +.+.+|+.++..++|||+|++++++.....    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            3568888899999999999999964 45899999886543    346789999999999999999998843221    46


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      +||+||+. |+|.+.+......  ++++.....|+.+++.||+|||+...  |+||||||+|||+|++. +.||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            79999999 7998888764322  78999999999999999999998753  99999999999999998 8999999999


Q ss_pred             eeccC-CCCcccc-cccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHH-HhCCCCHH
Q 017341          186 KVLVK-GEPNISY-ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEIIK-VLGTPTRE  260 (373)
Q Consensus       186 ~~~~~-~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~--~~~~~~~i~~-~~~~~~~~  260 (373)
                      +.... ....... .||..|+|||++.. ...+.++||||||+++.||+||+.+.+...  ....+..+.. .+...   
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---  300 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---  300 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence            65543 2222233 89999999999965 458999999999999999999998876543  1111222211 11110   


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccC-CCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                             ...++--+......    ++. ..-..+..+..+|++.+|.+||+..++.+
T Consensus       301 -------~~~eiiD~~l~~~~----~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 -------KLREIVDPRLKEGE----YPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -------chhheeCCCccCCC----CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                   11111111110000    000 01122556778999999999999999743

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.5e-37  Score=273.59  Aligned_cols=234  Identities=21%  Similarity=0.225  Sum_probs=181.1

Q ss_pred             eeeeecCceEEEEEEECCCC----------cEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           41 RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +.||+|+||.||++.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            46899999999999998776          357888765433   234578999999999999999987743      22


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC------ceeEe
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QLKLC  180 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~------~ikl~  180 (373)
                      .++||||+.+ +|.+.+....   ..++...+..++.||+.||.|||++ ||+||||||+||+++.++.      .++|+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999995 7777776542   3688899999999999999999988 9999999999999987652      49999


Q ss_pred             eccceeeccCCCCcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          181 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       181 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |||++.....   .....++..|+|||.+.+. ..++.++|+|||||++|+|++ |..||...+..+........     
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-----  222 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-----  222 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-----
Confidence            9999876433   2234567789999998654 358999999999999999999 68888766532221111100     


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                               .    .            .+......+.++|.+||..+|.+|||+.++++
T Consensus       223 ---------~----~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ---------H----R------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---------C----C------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                     0    0            00112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.2e-37  Score=276.45  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=191.5

Q ss_pred             cceEeeeeeeecCceEEEEEEEC----CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..|++.+.||+|+||.||++...    .+++.+|+|.+.....     ...+|+++++.++|+||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            46888999999999999999864    3488999998865543     34579999999999999999887633   234


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+.+++|||++ ++|.+.+....   ..++...+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            55789999998 48888876542   3588999999999999999999988 999999999999999887 899999999


Q ss_pred             eeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCCH
Q 017341          185 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK-VLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~-~~~~~~~  259 (373)
                      +.........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.........  +.. ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence            8765422211    112345669999998654 5889999999999999999999998654321100  000 0000000


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ..+......  ....          ..+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKE--GERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHc--CCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000  0000          011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.4e-38  Score=298.89  Aligned_cols=244  Identities=24%  Similarity=0.346  Sum_probs=203.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEecccccc-----hHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRY-----KNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      +.+..+.||+|.||+||+++...     ....||||.++.+...     +++|++++..++|||||+++++....+    
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~----  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD----  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC----
Confidence            57778899999999999998642     3467999988765433     468999999999999999999984432    


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhc------CC----CCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKM------SQ----RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~------~~----~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                       -+|+|+|||. |+|.++|+.+...      +.    +++..+...++.||+.|+.||-++ .+|||||-..|+||.++.
T Consensus       563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccce
Confidence             3889999999 8999999876532      22    278889999999999999999988 999999999999999988


Q ss_pred             CceeEeeccceeeccCCCCccc---ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017341          175 HQLKLCDFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  250 (373)
Q Consensus       175 ~~ikl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i  250 (373)
                       .|||+|||+++.....+....   ..-...|||||.++-. .++++|||||+||+|||+++ |+-||.+.+..+.++.|
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             899999999987655544322   2335789999999644 59999999999999999998 99999999998888877


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                      .+..-                ..            -+.+.|.++.+|+..|++..|.+||++.|+
T Consensus       719 ~~g~l----------------L~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  719 RAGQL----------------LS------------CPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HcCCc----------------cc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            65310                01            126899999999999999999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-38  Score=252.55  Aligned_cols=221  Identities=23%  Similarity=0.392  Sum_probs=182.7

Q ss_pred             CCCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-----hHHHHHHHHh-CCCCCeeecceeeee
Q 017341           26 GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----KNRELQTMRL-LDHPNVVSLKHCFFS   99 (373)
Q Consensus        26 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~-l~h~~iv~~~~~~~~   99 (373)
                      +..+.....+....+..||+|+||.|-+.++..+|...|+|.+...-..     ..+|+++... ...|++|++++.++.
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            3444555666777888999999999999999999999999998543321     2245554433 368999999998744


Q ss_pred             cCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          100 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      .     .-++|.||.|..+|..+-++..+.+..++|..+..++..++.||.|||++..++|||+||+|||++.+| .+|+
T Consensus       117 e-----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKi  190 (282)
T KOG0984|consen  117 E-----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKI  190 (282)
T ss_pred             c-----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEE
Confidence            3     338899999999999888888888999999999999999999999999999999999999999999999 8999


Q ss_pred             eeccceeeccCCCCccccccccccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHH
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIK  252 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwslG~il~~lltG~~pf~~~-~~~~~~~~i~~  252 (373)
                      ||||.+..+.++-......|...|||||.+.   ....|+.++||||||+++.||.+++.||... ++.+++.++..
T Consensus       191 CDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  191 CDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9999998776665555567888999999984   2335899999999999999999999999764 56666666654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=285.90  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=196.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc---E-EEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE---A-VAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..+-.+.++||+|+||.||+|..+..+.   . ||+|....+.       ...-+|+++++.++|||||+++++......
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3356666999999999999999765422   3 8999876422       122379999999999999999997744332


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                           +++|||+|.| +|.++|+...   ..++..+...++.+.+.||+|||++ +++||||-..|+|++.++ .+||+|
T Consensus       236 -----l~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~-~vKISD  305 (474)
T KOG0194|consen  236 -----LMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKG-VVKISD  305 (474)
T ss_pred             -----cEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCC-eEEeCc
Confidence                 7899999995 8999998753   3688999999999999999999998 999999999999999877 689999


Q ss_pred             ccceeeccCCCCcc-cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          182 FGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       182 fg~a~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      ||+++......... ..--...|+|||.+... .|+.++||||+||++||+.+ |..||.+....+....|...      
T Consensus       306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~------  378 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN------  378 (474)
T ss_pred             cccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc------
Confidence            99987543111111 11235679999999654 69999999999999999998 89999999999888888542      


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                 .+++          ..+...+.++..++.+|+..+|++|||..++.+
T Consensus       379 -----------~~r~----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  379 -----------GYRM----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -----------CccC----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                       1111          122457889999999999999999999988854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.7e-36  Score=284.63  Aligned_cols=273  Identities=21%  Similarity=0.290  Sum_probs=182.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC----------------CCCcEEEEEEeccccc------------------chHHH
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL----------------ETGEAVAIKKVLQDKR------------------YKNRE   78 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~E   78 (373)
                      ..++|.+.++||+|+||.||++...                ..++.||||++..+..                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                2456799999854321                  11235


Q ss_pred             HHHHHhCCCCCe-----eecceeeeecCC---CCceeEEEEEeccc-ccHHHHHHHhhh--------------------c
Q 017341           79 LQTMRLLDHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYVP-ETVHRVIKHHYK--------------------M  129 (373)
Q Consensus        79 ~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~-g~l~~~l~~~~~--------------------~  129 (373)
                      +.++..++|.++     +++++++.....   ......++|+||++ ++|.+.+.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666667766554     555555432111   11234789999999 488877754210                    0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCccc--ccccccccccc
Q 017341          130 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAPE  207 (373)
Q Consensus       130 ~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE  207 (373)
                      ...++...++.++.|++.+|.|||+. +|+||||||+||+++.++ .+||+|||++...........  ..+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12345677889999999999999988 999999999999999888 899999999865433322222  23488999999


Q ss_pred             cccCCCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          208 LIFGATE-------------------Y--TAAIDIWSAGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       208 ~l~~~~~-------------------~--~~~~DiwslG~il~~lltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .+.....                   +  ....|+||+||++|+|++|.. ||.+.......   .+..... ...+.. 
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~~-~~~~r~-  455 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDND-LNRWRM-  455 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhccch-HHHHHh-
Confidence            9853211                   1  224799999999999999875 77543221110   0000000 000000 


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCC---CCCCCHHHHhcCCCccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP---NLRSTALEALIHPFFDE  323 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~R~t~~~ll~hp~~~~  323 (373)
                            +.     ...+.-......++.+++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       456 ------~~-----~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 ------YK-----GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ------hc-----ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                  00     0000001124678999999999999876   68999999999999954

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=297.49  Aligned_cols=247  Identities=20%  Similarity=0.345  Sum_probs=201.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCc-----EEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .+-+..+.||+|.||.||.|.......     .||+|.+.+...     .+.+|..+|+.++|||||+++++.+...   
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~---  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG---  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC---
Confidence            478899999999999999998764433     389998865432     2347999999999999999999886522   


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                        -.+|++|||. |+|..++++...   ....++......++.||++|+.||+++ ++|||||...|+|++... .+||+
T Consensus       769 --~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  769 --PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             --CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccC-cEEEc
Confidence              2679999999 589999987522   135588889999999999999999998 999999999999999987 89999


Q ss_pred             eccceeeccCCCCcccc---cccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 017341          181 DFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       181 Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |||+|+.+...+.....   .-...|||||.+.. ..++.++|||||||++||++| |..||.+.+..+.+.-+...-  
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            99999855444332211   22467999999965 469999999999999999998 999999999888777655531  


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                      +++          .+..++..+.+++..|++.+|++||+...+++
T Consensus       922 ----------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 ----------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ----------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                            111          12578999999999999999999999999886

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-35  Score=259.88  Aligned_cols=238  Identities=39%  Similarity=0.636  Sum_probs=191.3

Q ss_pred             CceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc-cHH
Q 017341           47 SFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVH  120 (373)
Q Consensus        47 ~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~  120 (373)
                      +||.||+|.+..+|+.+++|.+....     ....+|++.++.++|+|++++.+.+..     ....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            58999999999899999999986543     344589999999999999999988733     3457899999997 888


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCccccccc
Q 017341          121 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS  200 (373)
Q Consensus       121 ~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt  200 (373)
                      ..+...    ..++...+..++.+++.++.+||+. +++|+||+|+||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKKR----GRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            777643    3388899999999999999999998 999999999999999887 8999999999876544344456788


Q ss_pred             ccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCC
Q 017341          201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  280 (373)
Q Consensus       201 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (373)
                      ..|+|||.+.+. .++.++|+||||+++++|++|..||..........+.........                      
T Consensus       150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------  206 (244)
T smart00220      150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF----------------------  206 (244)
T ss_pred             cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence            899999998643 478899999999999999999999987443333333222100000                      


Q ss_pred             CccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          281 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                         ......++.++.+++.+||..+|++||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00001277899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=293.37  Aligned_cols=251  Identities=31%  Similarity=0.468  Sum_probs=192.6

Q ss_pred             ceEeeeeeeecCce-EEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           36 SYMAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        36 ~y~~~~~lg~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      -|.-.+++|.|+.| .||+|..  .|+.||||++..+.. ...+|+..|+.- +||||++++..     +.+..++||..
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIal  582 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIAL  582 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEe
Confidence            35556788999988 5699987  788999999866544 567999999987 59999998654     37788999999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CC-CceeEeeccceeec
Q 017341          113 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVL  188 (373)
Q Consensus       113 e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~-~~ikl~Dfg~a~~~  188 (373)
                      |.|..+|.+++...............+.++.|++.||++||+. +||||||||.||||+.   ++ ..++|+|||+++..
T Consensus       583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9999999999987411111112144677889999999999986 9999999999999976   33 37999999999988


Q ss_pred             cCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          189 VKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       189 ~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ..+...    ....||..|+|||++.... -+.++|||||||++|+.++ |.+||.+.-  +.-.+|+...         
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~---------  729 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN---------  729 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc---------
Confidence            655432    3457899999999997654 5779999999999999998 599996543  2223343321         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                           +.-..            ..+.-..++.+||.+|+..+|..||+|.++|.||+|-.
T Consensus       730 -----~~L~~------------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  730 -----YTLVH------------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             -----cceee------------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence                 00000            00111228999999999999999999999999999954

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=8.9e-37  Score=270.59  Aligned_cols=284  Identities=30%  Similarity=0.512  Sum_probs=216.7

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECC---CCcEEEEEEecc--cccchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQ--DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      .|.....|.++++||.|.|++||++.+..   ..+.||+|.+..  ....+..|+++|..+ .+.||+++..++     .
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----R  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence            44556789999999999999999999887   788999998853  335567899999988 589999999988     5


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      .+...++||||++. ...++..       .++...++.+++.++.||.++|.. |||||||||+|++.+...+.-.|+||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEec
Confidence            55558899999995 4444443       367888999999999999999988 99999999999999988878999999


Q ss_pred             cceeecc-----------------C--C------------CC--------------cccccccccccccccccCCCCCCC
Q 017341          183 GSAKVLV-----------------K--G------------EP--------------NISYICSRYYRAPELIFGATEYTA  217 (373)
Q Consensus       183 g~a~~~~-----------------~--~------------~~--------------~~~~~gt~~y~aPE~l~~~~~~~~  217 (373)
                      |+|....                 .  +            .+              .....||+.|+|||++...+.-++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9986110                 0  0            00              012358999999999988877899


Q ss_pred             chhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcCcC------------------ccccc---CC
Q 017341          218 AIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFK---FP  275 (373)
Q Consensus       218 ~~DiwslG~il~~lltG~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~---~~  275 (373)
                      ++||||.|+|+..+++++.|| ...++.+.+.++...+|.........+...                  |....   ..
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999886 456777778887777666544432222211                  11110   00


Q ss_pred             CcCC-CCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          276 QIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       276 ~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      +... ..+........+..+.+|+.+||..||.+|.||+++|+||||.....
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            0000 01222233445679999999999999999999999999999996544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=276.91  Aligned_cols=240  Identities=30%  Similarity=0.478  Sum_probs=193.7

Q ss_pred             ceEeeeeeeecCceEEEEEEECCC--C--cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLET--G--EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~--~--~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++.++||.|.||.||.|.....  |  --||||.-+.+.     ..+..|..+++.++||||++++++...    .. 
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e----~P-  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE----QP-  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec----cc-
Confidence            445667899999999999986432  2  358889776543     334479999999999999999998732    11 


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                       .|||||.++ |.|..++..+.   ..++......++.||+.||+|||+. ..|||||...|||+.+.. .|||+|||++
T Consensus       465 -~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~-CVKLaDFGLS  538 (974)
T KOG4257|consen  465 -MWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQ-CVKLADFGLS  538 (974)
T ss_pred             -eeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcc-eeeecccchh
Confidence             789999999 78998888763   6688999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCCcccccc--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          186 KVLVKGEPNISYIC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       186 ~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +............|  ..-|||||.+ +-+.++.+||||.|||.+||+++ |..||.+-...+.+-.+.+.-+.|     
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP-----  612 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP-----  612 (974)
T ss_pred             hhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-----
Confidence            98766554443344  4569999998 45568999999999999999986 999999876555444333321111     


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                                             .++++|+.+..|+.+|+.++|.+||+..++
T Consensus       613 -----------------------~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  613 -----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             -----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence                                   236899999999999999999999987665

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=273.06  Aligned_cols=241  Identities=21%  Similarity=0.366  Sum_probs=200.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      +..+..+||.|.||.||.+.+++-.-.||||.++.+..   .+.+|..+|+.++|||+|++++++..     +.-+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEE
Confidence            56788899999999999999999999999998876653   34579999999999999999998833     33378999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      |||. |+|++++++...  ...+.-.+..++.||..|+.||..+ ++|||||...|+|+.++. .||+.|||+++.+..+
T Consensus       343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD  418 (1157)
T ss_pred             ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence            9998 899999997643  3366667888899999999999987 999999999999999877 8999999999876433


Q ss_pred             CCcccccc---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          192 EPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       192 ~~~~~~~g---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                       ......|   ..-|.|||-+. ...++.++|||+|||++||+.| |..||++.+-.+.+..+.+.              
T Consensus       419 -TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------------  482 (1157)
T KOG4278|consen  419 -TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------------  482 (1157)
T ss_pred             -ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence             3333333   55699999984 4458999999999999999999 99999998876666555442              


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                          |++..          +..+++...+|+..|++|.|++||+..|+
T Consensus       483 ----yRM~~----------PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  483 ----YRMDG----------PEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ----ccccC----------CCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                22222          25789999999999999999999998876

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=267.05  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=200.7

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ...++++||+|.||.|.+|.- ..+..||+|.+..+.     ..+.+|+++|.+|+||||+.+.++.....     -+++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Picm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHH
Confidence            678899999999999999985 447999999986543     33457999999999999999999885422     2789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |+||++ |+|.+++..+....  +.......++.||+.|++||.+. ++|||||.+.|+|++.+. ++||+|||.++...
T Consensus       613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEF-TIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcc-cEEecCcccccccc
Confidence            999999 89999998764222  34455667999999999999987 999999999999999998 89999999998765


Q ss_pred             CCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          190 KGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       190 ~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      .++...   ..+-...|||||.+... .++.+||+|++|+++||+++  ...||...++.+...+....+..+.....  
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~--  765 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV--  765 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee--
Confidence            554432   23446789999999654 49999999999999999875  78999988887777766654433332211  


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                         ..-+.-++..+.+++.+|+..+-.+||+.+++-.
T Consensus       766 -------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  766 -------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                               1122468889999999999999999999999843

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=279.71  Aligned_cols=244  Identities=25%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCC---cEEEEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ...|.++||.|.||.||+++-+..|   ..||||.++.-     .+.+..|+.||-+++||||+++.++...     ..-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence            4678999999999999999988776   46999988643     3444579999999999999999998732     333


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +.||+|||+ |+|..+|+.+   ++.++..++..+++.|+.|+.||-+. |+|||||...|||++++- .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeeccce-EEEecccccee
Confidence            789999999 7999999877   36689999999999999999999976 999999999999999998 89999999999


Q ss_pred             eccCCCC-cccc-cc--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGEP-NISY-IC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~~-~~~~-~g--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ...++.. ..+. .|  ...|.|||.+.- +.++.+||+||+|++|||.++ |..||-+.+..+.+..|.+..+-|++  
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--  856 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--  856 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence            7754432 2222 23  467999999954 459999999999999999887 99999999999999988876544432  


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                .++|..+.+|+..|+++|-.+||...|+..+
T Consensus       857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                      5789999999999999999999999998764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=256.94  Aligned_cols=279  Identities=21%  Similarity=0.275  Sum_probs=204.0

Q ss_pred             cCCCCCCCCce-EEecccCCCCCCcccc-----ceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-chHHHHHH
Q 017341            9 VDGNGTEAGHI-IVTTIGGKNGQPKQTI-----SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQT   81 (373)
Q Consensus         9 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~   81 (373)
                      ..|+++...-+ .++++++.+|.|....     +.++.+.||+|.||.||+|++  -|+.||||++....+ .-.+|.++
T Consensus       179 ~~~~stl~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEI  256 (513)
T KOG2052|consen  179 LAGDSTLKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEI  256 (513)
T ss_pred             ccCCccHHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHH
Confidence            44555554444 5778888899986643     899999999999999999998  689999999975543 33466666


Q ss_pred             HH--hCCCCCeeecceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc---
Q 017341           82 MR--LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT---  155 (373)
Q Consensus        82 l~--~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---  155 (373)
                      .+  .|+|+||+.+++.-.... .....++||++|.+ |+|.++|.+     ..++......++..++.||++||..   
T Consensus       257 YqTvmLRHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~G  330 (513)
T KOG2052|consen  257 YQTVMLRHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVG  330 (513)
T ss_pred             HHHHHhccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhc
Confidence            65  579999999987653332 45667999999999 899999986     5588888999999999999999953   


Q ss_pred             ----CCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC-----CcccccccccccccccccCCCCC----C-CchhH
Q 017341          156 ----IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGATEY----T-AAIDI  221 (373)
Q Consensus       156 ----~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~----~-~~~Di  221 (373)
                          ..|.|||||..||||.+++ ...|+|+|+|.......     .....+||..|||||++......    + ..+||
T Consensus       331 TqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI  409 (513)
T KOG2052|consen  331 TQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI  409 (513)
T ss_pred             CCCCchhhccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHH
Confidence                3699999999999999999 89999999997765432     23467899999999999543221    1 25899


Q ss_pred             HHHHHHHHHHHhC----------CCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccc
Q 017341          222 WSAGCVLAELLLG----------QPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ  287 (373)
Q Consensus       222 wslG~il~~lltG----------~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (373)
                      ||||.++||++..          .+||.+..+.    +...+++.                  ..+++......|.+   
T Consensus       410 YafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC------------------v~~~RP~ipnrW~s---  468 (513)
T KOG2052|consen  410 YAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC------------------VQKLRPNIPNRWKS---  468 (513)
T ss_pred             HHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee------------------ecccCCCCCccccc---
Confidence            9999999999853          3777654221    11111111                  01111111112211   


Q ss_pred             CCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          288 KRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       288 ~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ...=..+-.+++.|+..+|.-|.||-.+.+
T Consensus       469 ~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  469 DPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            111234567899999999999999977754

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=273.09  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=206.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCC---cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ++.++.++||+|.||.|+++.++..+   -.||||.+..+..     .+.+|+.+|..|+|+|++++|++....      
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------  183 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------  183 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------
Confidence            47888899999999999999987533   3589998865542     345899999999999999999987531      


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      -+.||||++. |+|++.|...  ....+.......++.||+.|+.||.++ ++|||||...|+++-+.. .|||+|||+.
T Consensus       184 p~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllaspr-tVKI~DFGLm  259 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPR-TVKICDFGLM  259 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccc-eeeeecccce
Confidence            1568999999 7999888873  356788899999999999999999998 999999999999998866 8999999999


Q ss_pred             eeccCCCCcccccc----cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          186 KVLVKGEPNISYIC----SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       186 ~~~~~~~~~~~~~g----t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +.+..++......+    ...|.|||.+... .++.++|+|++||++|||++ |..||.|-...+++.+|-+...-    
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL----  334 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL----  334 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC----
Confidence            88766655443222    3459999999654 49999999999999999998 89999999998888877642111    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                    +          -++.++.++.++++.|+..+|.+|||..+|...-+..+.
T Consensus       335 --------------p----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  335 --------------P----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             --------------C----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence                          1          125689999999999999999999999998765555443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.3e-34  Score=300.92  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=183.1

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecc
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      .|...+.||+|+||.||+|.+..++..||+|++........+|++.++.++||||+++++++..     ....|+||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCC
Confidence            5667789999999999999998999999999987655555678999999999999999998843     33478999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH---ccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          116 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH---NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       116 ~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH---~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      + |+|.+.+.       .+++..+..++.||+.||+|||   +. +|+||||||+||+++.++ ..++. ||......  
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~--  833 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLC--  833 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCC-ceEEE-eccccccc--
Confidence            8 57877774       2678889999999999999999   55 999999999999999877 56664 55543221  


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                       ......+|+.|+|||++.+. .++.++||||+||++|||+||+.||...... ....+..+......         ...
T Consensus       834 -~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  902 (968)
T PLN00113        834 -TDTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC---------HLD  902 (968)
T ss_pred             -cCCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc---------chh
Confidence             11234678999999998654 5899999999999999999999999543211 11111111100000         000


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ....+.....   ...+.....++.+++.+|++.||++|||+.|+++.
T Consensus       903 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        903 MWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             heeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000000000   00011123467789999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=263.18  Aligned_cols=196  Identities=29%  Similarity=0.447  Sum_probs=173.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc------------hHHHHHHHHhCC---CCCeeecceee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------------KNRELQTMRLLD---HPNVVSLKHCF   97 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~E~~~l~~l~---h~~iv~~~~~~   97 (373)
                      ....|+..+.+|.|+||.|++|.++.+...|++|.+.+++..            .-.|+++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            344799999999999999999999999999999988665422            125999999997   99999999999


Q ss_pred             eecCCCCceeEEEEEeccc-c-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC
Q 017341           98 FSTTEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  175 (373)
Q Consensus        98 ~~~~~~~~~~~~lv~e~~~-g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  175 (373)
                           +++.|+||+||..+ | +|.+++...    .+++|..+..+++||+.|+++||+. ||||||||-+|+.++++| 
T Consensus       639 -----Eddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g-  707 (772)
T KOG1152|consen  639 -----EDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNG-  707 (772)
T ss_pred             -----ecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCC-
Confidence                 88888999999887 4 778887754    6799999999999999999999999 999999999999999999 


Q ss_pred             ceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017341          176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  240 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~  240 (373)
                      -+||+|||.+... .+.+...+.||..|.|||++.+....+...|||+||+++|.++....||..
T Consensus       708 ~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  708 FVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            8999999998643 455677899999999999998888788899999999999999999888853

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=262.96  Aligned_cols=255  Identities=27%  Similarity=0.383  Sum_probs=202.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ++|.....+|+|.||.||+++++.+++..|+|.++.+.    ..+.+|+-+++..+||||+.+++.|....     .+++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcEE
Confidence            58999999999999999999999999999999986543    44568999999999999999999884432     3889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      .||||+|+-++.+.+   ...++++.++.++++..+.+|+|||+. |=+|||||-.||+++..| .+|+.|||.+..+..
T Consensus        90 cMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~g-DvklaDfgvsaqita  164 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEG-DVKLADFGVSAQITA  164 (829)
T ss_pred             EEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccC-ceeecccCchhhhhh
Confidence            999999643333332   368899999999999999999999988 999999999999999988 799999998755432


Q ss_pred             C-CCccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 G-EPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~-~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      . ....++.|||+|||||+..  ....|...+|+|++|+...|+---.+|-........+..+.+..-+|+         
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp---------  235 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP---------  235 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC---------
Confidence            2 2234679999999999873  334589999999999999999877777655544444443333211111         


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                              ...       -....++.+.+|++.+|..+|.+|||++.+|.|||...
T Consensus       236 --------~lk-------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  236 --------TLK-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             --------ccc-------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                    000       11356788999999999999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=239.81  Aligned_cols=264  Identities=25%  Similarity=0.323  Sum_probs=185.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHh--CCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .....+..++|+|.||.||+|.-  +++.||||++.... .....|.++...  ++|+||++++.+-.... .+..-++|
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywL  285 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWL  285 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeE
Confidence            34688889999999999999986  66999999986443 344567666664  58999999876532222 23445889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc--------CCceeecCCCCcEEEcCCCCceeEee
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--------IGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      |++|.+ |+|.++|+.     ..++.....+++..+++||+|||+.        ..|+|||||..||||.+|+ +..|+|
T Consensus       286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaD  359 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIAD  359 (534)
T ss_pred             EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeec
Confidence            999998 899999986     4588999999999999999999963        3699999999999999999 899999


Q ss_pred             ccceeeccCCCCc---ccccccccccccccccCCCCCC-----CchhHHHHHHHHHHHHhCCCCCC-CC-CcHHHHHHHH
Q 017341          182 FGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYT-----AAIDIWSAGCVLAELLLGQPLFP-GE-SGVDQLVEII  251 (373)
Q Consensus       182 fg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwslG~il~~lltG~~pf~-~~-~~~~~~~~i~  251 (373)
                      ||+|.+...+...   ...+||..|||||++.+..++.     .+.||||+|.+++||++....+. +. .+.+...+ .
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe-~  438 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE-A  438 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh-H
Confidence            9999887655433   3468999999999997655544     36899999999999998654432 11 11111000 0


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  313 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  313 (373)
                      ..-..|+.+++....-.  ....|.++ ..|..   ..--.-+++.+..|+..||+-|+|+.
T Consensus       439 evG~hPt~e~mq~~VV~--kK~RP~~p-~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVR--KKQRPKIP-DAWRK---HAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HhcCCCCHHHHHHHHHh--hccCCCCh-hhhhc---CccHHHHHHHHHHHcCCchhhhhhhH
Confidence            11112232222111000  00001100 11111   11235688999999999999999984

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=256.40  Aligned_cols=246  Identities=24%  Similarity=0.393  Sum_probs=190.2

Q ss_pred             eEeeeeeeecCceEEEEEEEC----C---CCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           37 YMAERVVGHGSFGVVFQAKCL----E---TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~----~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+.+.||+|.||.|+++.-.    .   ....||+|......     .....|+++++.+ .|+||+.+.++...    
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----  373 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----  373 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence            356679999999999999743    1   14579999875443     2334799999988 59999999998733    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhh---hc-------CC--CCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHY---KM-------SQ--RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~-------~~--~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                       ...+++|+||+. |+|..++++..   ..       ..  .++......++.||+.|++||++. +++||||-..|||+
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLI  451 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEe
Confidence             445889999999 79999999876   11       11  288889999999999999999988 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCCccc--ccc--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEPNIS--YIC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  245 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~  245 (373)
                      ..+. .+||+|||+|+..........  ..+  ...|||||.+.. ..|+.++||||+|+++||+++ |..||.+.....
T Consensus       452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9887 899999999986544433321  122  345999999976 569999999999999999998 999999855222


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+.+.++.                 ..++.          .+..+++++.++++.|+..+|++||+..++..
T Consensus       530 ~l~~~l~~-----------------G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  530 ELLEFLKE-----------------GNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHhc-----------------CCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            22322221                 01111          12467999999999999999999999988864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=252.44  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=196.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+..++||+|+||+||++.+...|+    +||+|++....     ....+|+-+|..++|||+++++++.....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            56677899999999999999876665    57888765432     33447889999999999999999763321     


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                       +-||++|++ |.|+++++.+.   .++.......|..||++|+.|||.+ .++||||-..||||.+-. .+||+|||++
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~-hvkitdfgla  845 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPN-HVKITDFGLA  845 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCC-eEEEEecchh
Confidence             568999999 79999999864   6688888999999999999999998 999999999999999888 6999999999


Q ss_pred             eeccCCCCcccccc---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          186 KVLVKGEPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       186 ~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      +............+   .+.|||=|.+.. ..|+.++||||+||++||++| |..|+.+....++...+....+      
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------  918 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------  918 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------
Confidence            87755544333322   456999999854 559999999999999999998 9999999887665544433211      


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                  +          .-++..+.++..++.+||..|+..||+++++-.
T Consensus       919 ------------L----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  919 ------------L----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ------------C----------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                        0          122568899999999999999999999998854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.4e-30  Score=219.77  Aligned_cols=207  Identities=36%  Similarity=0.615  Sum_probs=175.6

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEeccc-
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-  116 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-  116 (373)
                      ||+|.+|.||++.+..+++.+++|.+.....     ...+|+..++.++|++++++++++.     .....+++||+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence            6899999999999988899999999876643     4678999999999999999998873     3355789999999 


Q ss_pred             ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC-CCCceeEeeccceeeccCCC-Cc
Q 017341          117 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  194 (373)
Q Consensus       117 g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~-~~~~ikl~Dfg~a~~~~~~~-~~  194 (373)
                      ++|...+....   ..++...++.++.+++.++.+||+. |++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            58887776532   4688899999999999999999988 9999999999999998 66 79999999987653332 12


Q ss_pred             ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 017341          195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  274 (373)
Q Consensus       195 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  274 (373)
                      ....+...|++||.+.....++.++|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3355788899999985543578999999999999999                                           


Q ss_pred             CCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017341          275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  319 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp  319 (373)
                                       ..+.+++.+|++.+|.+||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1567899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=224.76  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=187.2

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhC-CCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..+.|.|.+.||+|.||.+-+|+|+.++..+++|.+.....   .+.+|..---.| -|.||+.-+++-+.    ...++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceE
Confidence            35689999999999999999999999999999998876543   233555444444 48999998876543    33367


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE-cCCCCceeEeecccee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAK  186 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll-~~~~~~ikl~Dfg~a~  186 (373)
                      ++++||++ |+|...+..     ..+.|...+.++.|++.|+.|||++ ++||||||.+|||+ +.|..+|||||||.++
T Consensus        98 vF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeeccccc
Confidence            89999999 787666553     4578888999999999999999998 99999999999998 5555689999999986


Q ss_pred             eccCCCCcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~  261 (373)
                      .....  -...-.+..|-+||.....    -...+.+|+|.||+++|.++||++||+..... ..+.+..+-.+.     
T Consensus       172 k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r-----  244 (378)
T KOG1345|consen  172 KVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR-----  244 (378)
T ss_pred             ccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc-----
Confidence            43211  1112235668899987422    12467899999999999999999999854321 223333332111     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCcc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFD  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~~ll~hp~~~  322 (373)
                                 ..+..     ...| ..+++.+..+.++-|..+|.+|   -++..-.+.-|..
T Consensus       245 -----------k~~~~-----P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  245 -----------KNPAL-----PKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             -----------cCccC-----chhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence                       11111     1112 4578999999999999999999   5666666666664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4e-31  Score=269.85  Aligned_cols=207  Identities=19%  Similarity=0.225  Sum_probs=146.7

Q ss_pred             hCCC-CCeeecceeeeecC--CCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCcee
Q 017341           84 LLDH-PNVVSLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  160 (373)
Q Consensus        84 ~l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH  160 (373)
                      .++| +||+++.+.|-...  ......++.+||+++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ-GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            4455 57777777652211  1122346788999999999888642   35689999999999999999999988 9999


Q ss_pred             ecCCCCcEEEcCCC------------------CceeEeeccceeeccCCC-----------------Ccccccccccccc
Q 017341          161 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA  205 (373)
Q Consensus       161 ~Dlkp~NIll~~~~------------------~~ikl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~a  205 (373)
                      |||||+||||+..+                  ..+|++|||+++......                 ......||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996432                  156677777665321100                 0012357899999


Q ss_pred             cccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccc
Q 017341          206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  285 (373)
Q Consensus       206 PE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (373)
                      ||++.+. .++.++|||||||++|||++|.+|+....  .....+.... .+.         .                 
T Consensus       184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~---------~-----------------  233 (793)
T PLN00181        184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP---------Q-----------------  233 (793)
T ss_pred             hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh---------h-----------------
Confidence            9998765 48999999999999999999998875322  1111111110 000         0                 


Q ss_pred             ccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          286 FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      . ....+...+++.+||..+|.+||++.|+++||||....
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            0 01234567899999999999999999999999998753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.3e-29  Score=218.77  Aligned_cols=198  Identities=35%  Similarity=0.583  Sum_probs=165.2

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      |.+.+.||.|++|.||++.+..+++.+++|.+....     ....+|++.++.++|+|++++++.+.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            678899999999999999998889999999986542     34457999999999999999998773     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      +|++++ +|.+.+....   ..+++..+..++.+++.++.+||++ +++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~  150 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDG-LVKLADFGLARFIHR  150 (225)
T ss_pred             EeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeCceeeEecC
Confidence            999997 8887776532   1178899999999999999999988 999999999999999887 899999999887654


Q ss_pred             CC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcH
Q 017341          191 GE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGV  244 (373)
Q Consensus       191 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~-~~~~  244 (373)
                      ..  ......++..|++||.+.....++.++|+|+||+++++|++|+.||.. .+..
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            43  234456788899999984334577899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-29  Score=220.63  Aligned_cols=248  Identities=20%  Similarity=0.241  Sum_probs=194.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEecccccch-----HHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .+++....+-+|.||.||.|.+.+.     .+.+.+|.+......+     ..|...+.-+.|||++++.++...    +
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence            3788888999999999999976543     2446667665544333     257777778899999999887643    3


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKM----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~----~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      ....++++.+++ |+|..++......    .+.++..+...++.|++.|++|||++ |++|.||...|.++|..- .+||
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~L-qVkl  437 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQL-QVKL  437 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceehhhe-eEEe
Confidence            333567888888 7998888844321    23466778889999999999999998 999999999999999876 8999


Q ss_pred             eeccceeeccCCCCccc---ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017341          180 CDFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      +|=.+++.....+....   ......||+||.+.. ..|+.++|+||||+++|||+| |+.|+...++.+...-+.... 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-  515 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-  515 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-
Confidence            99999987766655432   223567999999965 459999999999999999998 999999998887766554421 


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       +.          ..+-++|.++..++..|+..+|++||+.+|+..
T Consensus       516 -----------------Rl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 -----------------RL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------ee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             11          122479999999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.5e-29  Score=208.57  Aligned_cols=167  Identities=22%  Similarity=0.199  Sum_probs=126.5

Q ss_pred             ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCccc
Q 017341          117 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS  196 (373)
Q Consensus       117 g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~  196 (373)
                      |+|.+.+..+   ...+++..++.++.||+.||.|||++ +      ||+||+++.++ .+++  ||.+......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            5777777654   35699999999999999999999987 6      99999999888 7888  9998765332    2


Q ss_pred             ccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017341          197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFP  275 (373)
Q Consensus       197 ~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            3689999999999654 48999999999999999999999997654432 222222211100000               


Q ss_pred             CcCCCCccccccCCCCh--hHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          276 QIKAHPWHKIFQKRMPP--EAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       276 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                         ..+    ....++.  ++.++|.+||..+|.+||++.++++|+|+..
T Consensus       128 ---~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 ---DRS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ---ccc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence               000    0012333  6999999999999999999999999999754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.8e-27  Score=201.16  Aligned_cols=228  Identities=22%  Similarity=0.299  Sum_probs=182.7

Q ss_pred             CCCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCC-CCCeeecceeeeecCC
Q 017341           26 GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTE  102 (373)
Q Consensus        26 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  102 (373)
                      +.++.......|+++++||+|+||.++.+++.-++++||||.-...  ......|....+.|. .+.|..++.+.     
T Consensus        19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----   93 (449)
T KOG1165|consen   19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----   93 (449)
T ss_pred             CCCCceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----
Confidence            4445555666999999999999999999999999999999976433  344567899999885 67888876433     


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC----CCcee
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLK  178 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~----~~~ik  178 (373)
                      +...+-.||+|.++.+|.+++.-.   +.+++..+++.++.|++.-++++|++ .+|+|||||+|+||..-    .+.|.
T Consensus        94 qeG~~NiLVidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen   94 QEGKYNILVIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             cccchhhhhhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEE
Confidence            556677899999999999998865   57799999999999999999999998 99999999999999543    34699


Q ss_pred             EeeccceeeccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHH
Q 017341          179 LCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQL  247 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~---~~~~~  247 (373)
                      ++|||+|+...+...        ..+..||..||+--...+.. -+..-|+=|||-++++.+.|..||+|-.   ..+.+
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY  248 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY  248 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence            999999987754432        23567999999988777765 6899999999999999999999999863   44445


Q ss_pred             HHHHHHhCCCCHHHHh
Q 017341          248 VEIIKVLGTPTREEIK  263 (373)
Q Consensus       248 ~~i~~~~~~~~~~~~~  263 (373)
                      ++|-..-...+.+.++
T Consensus       249 eKIGe~Kr~T~i~~Lc  264 (449)
T KOG1165|consen  249 EKIGETKRSTPIEVLC  264 (449)
T ss_pred             HHhccccccCCHHHHH
Confidence            5554444444444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-26  Score=191.75  Aligned_cols=221  Identities=24%  Similarity=0.302  Sum_probs=173.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc--hHHHHHHHHhCCC-CCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--KNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..+.|.++++||+|+||.+|++.+..+|+.||||.-++..+.  ...|..+.+.|++ ..|+.+..+.     .+..|-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccce
Confidence            356899999999999999999999999999999987665543  3578999999875 4455555544     4455667


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC--CCceeEeeccceee
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~ikl~Dfg~a~~  187 (373)
                      +||+.++.+|.+++.-.   +..++..++.-++-|++.-++|+|.+ +.+||||||+|+|..-+  .+.+.|+|||+|+.
T Consensus        88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhh
Confidence            99999999999888765   46789999999999999999999988 99999999999998543  33799999999987


Q ss_pred             ccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Q 017341          188 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGT  256 (373)
Q Consensus       188 ~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~---~~~~i~~~~~~  256 (373)
                      .-+...        .....||..|.+--...+.. -+...|+-|+|.++..+-.|..||++.....   .+.+|.+.-..
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            644322        23567899998876665443 5788999999999999999999999975443   34445444444


Q ss_pred             CCHHHHh
Q 017341          257 PTREEIK  263 (373)
Q Consensus       257 ~~~~~~~  263 (373)
                      .+.+.++
T Consensus       243 ~~ie~LC  249 (341)
T KOG1163|consen  243 TPIEVLC  249 (341)
T ss_pred             CCHHHHh
Confidence            4444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.9e-28  Score=237.18  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=191.1

Q ss_pred             ce-EeeeeeeecCceEEEEEEECCCCcEEEEEEeccc----ccc------hHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           36 SY-MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        36 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .| .....+|.|.+|.|+.+......+.++.|.+...    ...      ...|+-+-..+.|+|++.....++...   
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~---  394 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID---  394 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc---
Confidence            35 4567899999998888888777777777765421    100      123455556679999887766553322   


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                       .+. -.||||+++|...+...    ..+....+..++.|++.||.|+|+. ||.|||+||+|++++.+| .+||+|||.
T Consensus       395 -~~~-~~mE~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g-~lki~Dfg~  466 (601)
T KOG0590|consen  395 -GIL-QSMEYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENG-ILKIIDFGA  466 (601)
T ss_pred             -cch-hhhhcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCC-ceEEeecCc
Confidence             222 23999999777777653    4678888999999999999999988 999999999999999998 899999999


Q ss_pred             eeeccCCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +........     ....+|+..|+|||++.+........||||.|++++.|++|+.||......+....-..       
T Consensus       467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------  539 (601)
T KOG0590|consen  467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------  539 (601)
T ss_pred             ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-------
Confidence            876533322     23567899999999998777667789999999999999999999976543322210000       


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                            ...  ..   +....+  ..+...++.+.+.+|.+||++||.+|.|++++++.+||+.+.-+
T Consensus       540 ------~~~--~~---~~~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  540 ------YSD--QR---NIFEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ------ccc--cc---ccccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence                  000  00   000000  11224678899999999999999999999999999999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-25  Score=204.46  Aligned_cols=251  Identities=21%  Similarity=0.201  Sum_probs=190.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCC-cEEEEEEeccccc----chHHHHHHHHhCCC----CCeeecceeeeecCCCCce
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKR----YKNRELQTMRLLDH----PNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~----~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~  106 (373)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|.......    ....|..++..+..    +++..+++.+.    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            8999999999999999999987775 6789997754321    45679999988873    57777776552    2455


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC----CceeEeec
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCDF  182 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~----~~ikl~Df  182 (373)
                      +.|+||+.++.+|.++.....  .+.++..++..++.|++.+|.+||+. |++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999998876654  57899999999999999999999988 999999999999997653    47999999


Q ss_pred             ccee--eccCCC--------C-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 017341          183 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  251 (373)
Q Consensus       183 g~a~--~~~~~~--------~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~  251 (373)
                      |+++  ......        . .....||..|.++....+.. .+.+.|+||++.++.+|..|..||.+........++.
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  422111        1 12355999999999886654 7999999999999999999999997766443333333


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +......               ...         +....+.++.++...+-..+...+|....+...
T Consensus       251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2110000               000         112355677888887777888899988777554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.9e-27  Score=219.59  Aligned_cols=236  Identities=28%  Similarity=0.436  Sum_probs=190.1

Q ss_pred             eeeecCceEEEEEEE---CCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEEE
Q 017341           42 VVGHGSFGVVFQAKC---LETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|.|.||.|++++-   .+.|..+|+|...+..      .....|..++..++ ||.++++...|     +.+..++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            378999999988763   2457789999764321      22335788888887 99999998888     444457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      +++..| .+...+.    ....+.+..++.+...++.++.++|+. +|+|||+|++||+++.+| .+++.|||+++....
T Consensus        76 ld~~rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~G-hi~~tdfglske~v~  149 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhcccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccC-ccccCCchhhhHhHh
Confidence            999986 4433333    346688889999999999999999987 999999999999999999 699999999987654


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  270 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....   +||..|||||++.   ....++|+||+|+++++|+||..||.+    +...+|.+..                
T Consensus       150 ~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~----------------  203 (612)
T KOG0603|consen  150 EKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE----------------  203 (612)
T ss_pred             hhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc----------------
Confidence            4433   9999999999985   367899999999999999999999987    5555665521                


Q ss_pred             cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                       ..            ++..++.++.+++..++..+|..|..     +.++++|+||+.+++.
T Consensus       204 -~~------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  204 -LE------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             -cC------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence             11            22467889999999999999999975     4899999999998876

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=9.4e-26  Score=198.15  Aligned_cols=238  Identities=24%  Similarity=0.309  Sum_probs=147.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHH-------HhCC----------CCCeeecceee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLD----------HPNVVSLKHCF   97 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-------~~l~----------h~~iv~~~~~~   97 (373)
                      .+...++.||.|+++.||.+.|.+||+.+|+|.+........++++.+       ..+.          |-.++...+..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            378899999999999999999999999999998864443222222211       1111          11222222221


Q ss_pred             ee---------cCCCCce---eEEEEEecccccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHhHccCCceeec
Q 017341           98 FS---------TTEKDEL---YLNLVLEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRD  162 (373)
Q Consensus        98 ~~---------~~~~~~~---~~~lv~e~~~g~l~~~l~~~~~~~~~---~~~~~~~~i~~qil~~L~~LH~~~~ivH~D  162 (373)
                      ..         ..+....   ..+++|+-+.++|...+.........   +.......+..|++..+++||+. |++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEecc
Confidence            11         1111111   24789999998888776643332222   22222344558999999999998 999999


Q ss_pred             CCCCcEEEcCCCCceeEeeccceeeccCCCCcccccccccccccccccCC-------CCCCCchhHHHHHHHHHHHHhCC
Q 017341          163 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQ  235 (373)
Q Consensus       163 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwslG~il~~lltG~  235 (373)
                      |+|+|++++.+| .+.|+||+........  ......+..|.+||.....       ..++.+.|.|+||+++|.|++|+
T Consensus       171 i~~~nfll~~~G-~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDG-GVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS--EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCC-CEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            999999999998 7999999987654221  1113446779999987432       23788999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCC
Q 017341          236 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  309 (373)
Q Consensus       236 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  309 (373)
                      .||...........                               .+...  .++|+.+++||.++|+.||.+|
T Consensus       248 lPf~~~~~~~~~~~-------------------------------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW-------------------------------DFSRC--RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG-------------------------------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc-------------------------------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence            99976543210000                               11111  2689999999999999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.9e-25  Score=204.66  Aligned_cols=159  Identities=21%  Similarity=0.337  Sum_probs=121.1

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECC-CCcEEEEEEeccc---------ccchHHHHHHHHhCCCCCeeecceeeeec
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      +...++|.+.+.||+|+||+||+|.+.. +++.+|+|+....         .....+|+++++.++|+|++..+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3456689999999999999999999876 6788899986432         12346899999999999998532211   


Q ss_pred             CCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecC-CCCcEEEcCCCCcee
Q 017341          101 TEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLK  178 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dl-kp~NIll~~~~~~ik  178 (373)
                         +  ..|+||||+.| +|. .+.       ...   ...++.|++.+|.|||++ ||+|||| ||+|||++.++ .++
T Consensus        91 ---~--~~~LVmE~~~G~~L~-~~~-------~~~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~-~ik  152 (365)
T PRK09188         91 ---G--KDGLVRGWTEGVPLH-LAR-------PHG---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDG-EAA  152 (365)
T ss_pred             ---C--CcEEEEEccCCCCHH-HhC-------ccc---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCC-CEE
Confidence               1  26799999997 443 211       111   145788999999999998 9999999 99999998877 799


Q ss_pred             EeeccceeeccCCCCc---------cccccccccccccccc
Q 017341          179 LCDFGSAKVLVKGEPN---------ISYICSRYYRAPELIF  210 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~l~  210 (373)
                      |+|||+|+........         ....+++.|+|||.+.
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999999865433211         2345678899999984

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=8.8e-26  Score=220.53  Aligned_cols=226  Identities=28%  Similarity=0.487  Sum_probs=171.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ....+|..++.+..|+||.||.++|+.+.+.+|+| +.++.-...+   ++....+|++|                    
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee--------------------
Confidence            44558999999999999999999999999999994 5554432222   33333334333                    


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          112 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       112 ~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                           |+=...++.    -++++..        ++.+++|||+- ||+|||+||+|.+|+.-| .+|++|||+++.....
T Consensus       136 -----gDc~tllk~----~g~lPvd--------mvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKN----IGPLPVD--------MVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhccc----CCCCcch--------hhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhh
Confidence                 221122222    1334433        37789999987 999999999999999888 6999999998654221


Q ss_pred             CC----------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          192 EP----------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       192 ~~----------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      ..                ....+|||.|+|||++... .|+..+|||++|+|+|+.+-|..||.++++.+.+..++.-..
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            11                0134799999999999655 499999999999999999999999999999988887776321


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCccccCCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELRDP  327 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~~ll~hp~~~~~~~~  327 (373)
                      .                         |.+. +...+++++++|.++|+.+|..|.   .+-++.+|+||+.++|.
T Consensus       276 ~-------------------------wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  276 E-------------------------WPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             c-------------------------cccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            1                         1111 245789999999999999999996   57888899999999876

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.8e-23  Score=191.53  Aligned_cols=260  Identities=35%  Similarity=0.507  Sum_probs=195.4

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCC-CeeecceeeeecCCCCceeE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  108 (373)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.....       ...+|..++..+.|+ +++++.+.+     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            889999999999999999986   7789998754332       245788899999988 799999887     222336


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +++++++.+ ++...+...... ..++...+..++.|++.++.++|+. +++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            899999996 555444432111 2688999999999999999999988 9999999999999998774599999999875


Q ss_pred             ccCCC-------CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 017341          188 LVKGE-------PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG  255 (373)
Q Consensus       188 ~~~~~-------~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~---~~~~~~i~~~~~  255 (373)
                      .....       ......||..|+|||.+.+.  ..++...|+||+|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       23566899999999999763  4688999999999999999999999887764   333333333222


Q ss_pred             CC-CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          256 TP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       256 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .+ ...              +.      ...........+.+++.+++..+|..|.+..+...++|......
T Consensus       232 ~~~~~~--------------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         232 TPSLAS--------------PL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             Cccccc--------------cc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            11 000              00      00000112357899999999999999999999999877665433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7e-24  Score=187.41  Aligned_cols=195  Identities=24%  Similarity=0.374  Sum_probs=142.5

Q ss_pred             CCCCeeecceeeeecC----------------------CCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHH
Q 017341           86 DHPNVVSLKHCFFSTT----------------------EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY  143 (373)
Q Consensus        86 ~h~~iv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~  143 (373)
                      +|||||.+...|.+..                      -.....+|+||..+..+|..++-.     ...+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988874321                      123466899999999999888874     4567778888999


Q ss_pred             HHHHHHHHhHccCCceeecCCCCcEEEcC--CC-CceeEeeccceeeccCC-------CCcccccccccccccccccCCC
Q 017341          144 QICRALAYIHNTIGVCHRDIKPQNLLVNP--HT-HQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGAT  213 (373)
Q Consensus       144 qil~~L~~LH~~~~ivH~Dlkp~NIll~~--~~-~~ikl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~  213 (373)
                      |+++|+.|||.+ ||.|||+|.+||++.-  |+ ..+.|+|||++-....-       .......|.-.-||||+....+
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999998 9999999999999833  22 26899999998532210       1112345677899999985333


Q ss_pred             CC-----CCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccC
Q 017341          214 EY-----TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  288 (373)
Q Consensus       214 ~~-----~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (373)
                      ..     -.+.|.|+.|.+.||++....||.+......             +     ..+|.+-..|.         .++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~-----~r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------D-----TRTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-------------c-----hhhhhhhhCCC---------Ccc
Confidence            21     1278999999999999999999987321100             0     01122222232         336


Q ss_pred             CCChhHHHHHHhhcCcCCCCCCCHH
Q 017341          289 RMPPEAVDLVSRLLQYSPNLRSTAL  313 (373)
Q Consensus       289 ~~~~~~~~li~~~L~~dP~~R~t~~  313 (373)
                      .+++.+++++..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            7899999999999999999999863

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=6.4e-24  Score=207.98  Aligned_cols=241  Identities=29%  Similarity=0.419  Sum_probs=171.5

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-----hH---HHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----KN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +|...+.||++.|=+|.+|++. .|. |++|++.+....     ..   +|++ ....++||++.+..+.     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            7899999999999999999974 455 999998655422     12   2344 5566899999987765     34445


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .|||-+|+..+|.+-+..+    .-+...+.+-++.|++.||..+|.. ||+|||||.+|||+++=+ =+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeec-hhhhhcccccCC
Confidence            6788899888888777643    3356667788899999999999987 999999999999999866 689999976432


Q ss_pred             cc--CCCC-cc-ccc----ccccccccccccCCC----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 017341          188 LV--KGEP-NI-SYI----CSRYYRAPELIFGAT----------EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  248 (373)
Q Consensus       188 ~~--~~~~-~~-~~~----gt~~y~aPE~l~~~~----------~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~  248 (373)
                      ..  .+.+ .. .+.    .-.+|+|||.+....          ..+++-||||+||+++||++ |++||.-    .++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence            21  1111 11 111    234699999985311          15678999999999999998 8999942    1221


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...... ....+.+                       ...--+..++.+|..|++.||++|.+|++.|+.
T Consensus       246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111110 1111111                       001124478999999999999999999999976

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.4e-22  Score=170.93  Aligned_cols=134  Identities=16%  Similarity=0.220  Sum_probs=102.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------------c-----------------hHHHHHHHHhCCCCC
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------------Y-----------------KNRELQTMRLLDHPN   89 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------------~-----------------~~~E~~~l~~l~h~~   89 (373)
                      ...||+|++|.||+|.+. +|+.||+|++.....             .                 ..+|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 899999999854321             0                 123888999998877


Q ss_pred             eeecceeeeecCCCCceeEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-HccCCceeecCCCCc
Q 017341           90 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVCHRDIKPQN  167 (373)
Q Consensus        90 iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~L-H~~~~ivH~Dlkp~N  167 (373)
                      +.......     ...  .+|||||++|+ +...+..    ...+++..+..++.|++.+|.++ |+. ||+||||||+|
T Consensus        81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~N  148 (190)
T cd05147          81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYN  148 (190)
T ss_pred             CCCCcEEE-----ecC--CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHH
Confidence            64432221     111  36999999974 3222221    35688899999999999999999 677 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeec
Q 017341          168 LLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+++. + .++|+|||+|...
T Consensus       149 Ili~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEEC-C-cEEEEEccccccC
Confidence            99984 5 7999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.7e-22  Score=172.55  Aligned_cols=170  Identities=13%  Similarity=0.134  Sum_probs=124.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cc---------hHHHHHHHHhCCCCCeeecceeeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RY---------KNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      .++|++.++||.|+||.||++.+  ++..+|+|.+....    ..         .++|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            45899999999999999999765  46789999885321    11         35788899999999999998876542


Q ss_pred             CCC---CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341          101 TEK---DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus       101 ~~~---~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                      ...   .....+++|||++| +|.+..        .+++    ....+++.+|..||+. |++|||++|+||+++.++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC--
Confidence            211   12346899999998 554442        1233    2356999999999998 999999999999999776  


Q ss_pred             eeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH
Q 017341          177 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  232 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll  232 (373)
                      ++|+|||..........            -+.+.-...+..++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            99999998764421111            111222234678999999999877654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=9.3e-22  Score=164.44  Aligned_cols=181  Identities=17%  Similarity=0.127  Sum_probs=132.6

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc--------chHHHHHHHHhCC-CCCeeecceeeeecCCCCceeE
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+...|++|+||+||.+..  .+.+++.+.+.....        ...+|+++|+.|. |+++++++++.     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            4667899999999998775  678888776654432        3568999999995 47788887641     1    5


Q ss_pred             EEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecC-CCCcEEEcCCCCceeEeecccee
Q 017341          109 NLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       109 ~lv~e~~~g~-l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dl-kp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++|+|+.|. |.....          .. ...++.|++.+|.++|++ ||+|||| ||+||+++.++ .++|+|||++.
T Consensus        74 ~lvmeyI~G~~L~~~~~----------~~-~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~  140 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPP----------RG-DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDG-SPAVIDFQLAV  140 (218)
T ss_pred             EEEEeeecCccHHhhhh----------hh-hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence            7999999984 432211          11 134678999999999998 9999999 79999999887 79999999998


Q ss_pred             eccCCCCc--------------ccccccccccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 017341          187 VLVKGEPN--------------ISYICSRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGES  242 (373)
Q Consensus       187 ~~~~~~~~--------------~~~~gt~~y~aPE~l~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~  242 (373)
                      ........              ....+++.|++|+...-....+ ...++++.|+-+|.++|+..++-+++
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            54332211              0112477788887643222234 56799999999999999998875543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.4e-21  Score=164.06  Aligned_cols=134  Identities=16%  Similarity=0.246  Sum_probs=104.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccccc------------------------------chHHHHHHHHhCCCCC
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN   89 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~~   89 (373)
                      .+.||+|++|.||+|.+. +|+.||+|.+.....                              ...+|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999987 899999998864321                              0135788888898888


Q ss_pred             eeecceeeeecCCCCceeEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCCc
Q 017341           90 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQN  167 (373)
Q Consensus        90 iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~N  167 (373)
                      +.....+..     ..  .++||||++|. +......    ...++...+..++.|++.++.++|+ . ||+||||||+|
T Consensus        81 i~~p~~~~~-----~~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILL-----KK--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEe-----cC--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence            754433321     11  36999999974 3222121    2457788899999999999999998 7 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeec
Q 017341          168 LLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9998 56 7999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.9e-20  Score=186.54  Aligned_cols=193  Identities=25%  Similarity=0.391  Sum_probs=147.3

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCC---CCCeeecceeeeecCC
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD---HPNVVSLKHCFFSTTE  102 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~  102 (373)
                      -..+....|.|.+.+|.|+||.||+|.+.. |+.||+|+-....   -++  -.+++.+|+   -+-|..+..++..   
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI--~~q~~~RLk~~~~~~~~~~~~a~~~---  765 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI--CLQVMERLKPQMLPSIMHISSAHVF---  765 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee--hHHHHHhhchhhhcchHHHHHHHcc---
Confidence            344455689999999999999999999866 9999999754322   222  133444444   2344454444433   


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC------CCC
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP------HTH  175 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~------~~~  175 (373)
                      .+.  -++|++|.+ |+|++++.    .++.+++..+..++.|++..+..||.. +|||+||||+|+||..      +..
T Consensus       766 ~~~--S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  766 QNA--SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             CCc--ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCccc
Confidence            222  358999999 89998887    357789999999999999999999987 9999999999999932      223


Q ss_pred             ceeEeeccceeecc---CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 017341          176 QLKLCDFGSAKVLV---KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  235 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~  235 (373)
                      -++|+|||.+..+.   ++.......+|-.+-++|+..+. .++++.|.|.|+.+++-|+.|+
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence            59999999985442   22233455678899999999665 4999999999999999999996

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.2e-19  Score=154.53  Aligned_cols=135  Identities=18%  Similarity=0.240  Sum_probs=102.4

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHhC-----CCCCeeecceeeeecCCCCcee-
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTEKDELY-  107 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~-  107 (373)
                      .-.+.||+|++|.||.  ++.++.. +||++...    .....+|+.+++.+     +||||+++++++.+..  +..+ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence            3456899999999995  7777776 69987643    23456899999999     6799999999885532  2234 


Q ss_pred             EEEEEeccc---ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHhHccCCceeecCCCCcEEEcCCC---CceeEe
Q 017341          108 LNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL-AYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLC  180 (373)
Q Consensus       108 ~~lv~e~~~---g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L-~~LH~~~~ivH~Dlkp~NIll~~~~---~~ikl~  180 (373)
                      +.+||||++   ++|.+.+.+     ..+++.  ..++.|++.++ +|||++ +|+||||||+||+++..+   ..++|+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            447899955   588888864     235555  35678888888 999998 999999999999997432   269999


Q ss_pred             eccce
Q 017341          181 DFGSA  185 (373)
Q Consensus       181 Dfg~a  185 (373)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95443

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=1.5e-19  Score=157.69  Aligned_cols=138  Identities=14%  Similarity=0.151  Sum_probs=104.5

Q ss_pred             ceEeeeeeeecCceEEEEEE-ECCCCcEEEEEEeccccc----------------------------chHHHHHHHHhCC
Q 017341           36 SYMAERVVGHGSFGVVFQAK-CLETGEAVAIKKVLQDKR----------------------------YKNRELQTMRLLD   86 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~~----------------------------~~~~E~~~l~~l~   86 (373)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|.+.....                            ...+|+..++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999999 677999999998864321                            1246888998887


Q ss_pred             CCCeeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC-ceeecCC
Q 017341           87 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIK  164 (373)
Q Consensus        87 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~-ivH~Dlk  164 (373)
                      +. .+.+..++..   . .  .++||||++| ++......    ........+..++.||+.+|.+||++ | ++|||||
T Consensus       109 ~~-~i~~p~~~~~---~-~--~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dik  176 (237)
T smart00090      109 EA-GVPVPKPIAW---R-R--NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLS  176 (237)
T ss_pred             hc-CCCCCeeeEe---c-C--ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCC
Confidence            53 3333333311   1 1  3699999998 44332211    23455666788999999999999998 9 9999999


Q ss_pred             CCcEEEcCCCCceeEeeccceee
Q 017341          165 PQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       165 p~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 799999998864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-19  Score=153.38  Aligned_cols=240  Identities=16%  Similarity=0.228  Sum_probs=174.2

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecc------cccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +..+..+|.....|..|++++..  ..++.|++..      -.+.+..|.-.|+.+.||||+.+++..     .....+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence            55667789999999999999954  4456665432      134455788889999999999999887     4445588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceee-cCCCCcEEEcCCCCceeEeeccceee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR-DIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~-Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|..||+ |+|...+....  +-..+..++..++.+|+++++|||+.-.++-| -|....+++|++. +.+|+ .+-+++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-taris-mad~kf  339 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARIS-MADTKF  339 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhhee-ccccee
Confidence            9999999 78888876542  33466778899999999999999976444443 5788899999876 55553 222222


Q ss_pred             ccCCCCcccccccccccccccccCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEY--TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..   ........|.||+||.++..+..  -.++|+|||+++++||.|...||..-.+.+.--+|.-             
T Consensus       340 sf---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------------  403 (448)
T KOG0195|consen  340 SF---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------------  403 (448)
T ss_pred             ee---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------------
Confidence            11   11223457899999999755432  3479999999999999999999988765543222211             


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll  316 (373)
                                    .-+...+++.++.....|++-|+..||.+||....+.
T Consensus       404 --------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 --------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             --------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                          1112235578899999999999999999999877653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=7.5e-20  Score=167.99  Aligned_cols=179  Identities=31%  Similarity=0.499  Sum_probs=131.4

Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..|+||.|++|. .+|.+++.+.. .....+....+.++.|+..++.|   + +.+|+|+||.||++..+. .+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhhh
Confidence            446899999999 58888886543 34556677888999999999999   6 999999999999998887 89999999


Q ss_pred             ceeeccCCC-------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhC
Q 017341          184 SAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       184 ~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      +........       ......||..||+||.+.+. .|+.++||||||+|++|++.- ...|...   .....+     
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~-----  472 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDI-----  472 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh-----
Confidence            987665444       33466899999999999765 599999999999999999972 2222110   001000     


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                       +...     +...+..+ .+.-.+|+.+||...|.+||++.+.--|+|.
T Consensus       473 -----------------r~g~-----ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 -----------------RDGI-----IPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             -----------------hcCC-----CChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                             1011     11011111 2455689999999999999988777777764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=4.3e-18  Score=159.19  Aligned_cols=208  Identities=25%  Similarity=0.369  Sum_probs=149.8

Q ss_pred             HHhCCCCCeeecceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCc-e
Q 017341           82 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-C  159 (373)
Q Consensus        82 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~i-v  159 (373)
                      |+.+.|.|+.++.+..+..     ...++|.+||. |+|.+.+...   ...++.-....++++|+.||.|||+. .| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS-PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence            3568999999999988654     34789999999 7999998873   35677778889999999999999987 55 9


Q ss_pred             eecCCCCcEEEcCCCCceeEeeccceeeccCC---CCcccccccccccccccccCCCC------CCCchhHHHHHHHHHH
Q 017341          160 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAE  230 (373)
Q Consensus       160 H~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DiwslG~il~~  230 (373)
                      |+.++..|.++|..- .+||+|||+.......   .......-..-|.|||.+.....      .+.+.|+||+|++++|
T Consensus        72 hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999988 8999999998665321   11111123455999999965311      3667999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC
Q 017341          231 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  310 (373)
Q Consensus       231 lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  310 (373)
                      +++...||..........++...+..                 ......+|..... ...++++..++..|+..+|.+||
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~-----------------~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rP  212 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKK-----------------GGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRP  212 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHh-----------------cCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCc
Confidence            99999999774322211222221100                 0000001111111 14566899999999999999999


Q ss_pred             CHHHHhc
Q 017341          311 TALEALI  317 (373)
Q Consensus       311 t~~~ll~  317 (373)
                      +++++-.
T Consensus       213 s~~~i~~  219 (484)
T KOG1023|consen  213 SIEQIRS  219 (484)
T ss_pred             cHHHHHh
Confidence            9998854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=3.4e-19  Score=173.94  Aligned_cols=258  Identities=25%  Similarity=0.340  Sum_probs=191.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-CCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...|.+.+.||+|.++.|-.+.... +...+|.|.+....      .....|..+-+.+. |+|++++++..     .+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence            4579999999999999998887643 34456666554332      12234777777776 99999998876     555


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH-ccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      .+.+++++|..| ++...+..  ......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+..+++.|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCch
Confidence            667899999775 44433311  11114566678889999999999999 77 999999999999999877469999999


Q ss_pred             ceeeccC-CCCc---ccccc-cccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVK-GEPN---ISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~-~~~~---~~~~g-t~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      +|..... ....   ...+| ++.|+|||...+........|+||.|+++..|++|..|+..........          
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------  240 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------  240 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------
Confidence            9987655 2222   24577 9999999999776667889999999999999999999987654332110          


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                 .  .+.... ..........++....+++.+++..+|..|.+.+++..+||+..
T Consensus       241 -----------~--~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 -----------S--SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----------e--eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                       0  000000 11112223568899999999999999999999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.4e-17  Score=142.09  Aligned_cols=129  Identities=19%  Similarity=0.326  Sum_probs=100.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      +.||+|++|.||+|.+  .|..+++|......            ....+|+.++..+.|++++....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5789999999999987  67889999754321            1234688899999998877665544321     235


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +++|||++| +|.+.+...       .. ....++.+++.+|.++|+. |++|+|++|.||+++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            789999986 777666532       11 6778899999999999988 999999999999999 55 799999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=2.6e-17  Score=140.40  Aligned_cols=131  Identities=19%  Similarity=0.187  Sum_probs=98.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--------------------------cchHHHHHHHHhCCCCC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN   89 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~~   89 (373)
                      .|.+.+.||.|++|.||++.+. +|+.+|+|.+....                          ....+|..++..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888999999999999999874 79999999864322                          01245777888887764


Q ss_pred             --eeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCC
Q 017341           90 --VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  166 (373)
Q Consensus        90 --iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~  166 (373)
                        ++..++       .  ...+++|||++| ++.....          ......++.+++.++.++|+. |++|+||+|+
T Consensus        95 i~v~~~~~-------~--~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~  154 (198)
T cd05144          95 FPVPKPID-------W--NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEF  154 (198)
T ss_pred             CCCCceee-------c--CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCcc
Confidence              333321       1  124789999997 4433211          023567888999999999988 9999999999


Q ss_pred             cEEEcCCCCceeEeeccceeec
Q 017341          167 NLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ||+++.++ .++|+|||.+...
T Consensus       155 Nill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         155 NILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEcCCC-cEEEEECCccccC
Confidence            99999877 8999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=8.7e-17  Score=137.33  Aligned_cols=125  Identities=21%  Similarity=0.349  Sum_probs=93.9

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           42 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .||+|++|.||++..  +|..+++|......            ....+|+++++.+.|+++....-++..   .+  ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---~~--~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD---PD--NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE---CC--CCE
Confidence            479999999999985  67889999754321            122368999999988765444333322   11  256


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++|||++| ++.+.+....     .      .++.|++.+|.+||+. |++|+|++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 6666554321     0      6788999999999988 999999999999999 55 799999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=2.1e-16  Score=154.66  Aligned_cols=131  Identities=18%  Similarity=0.281  Sum_probs=98.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEec-cc-----------ccchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QD-----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..|...+.||+|+||.||++.+...  .+++|+.. +.           .....+|+++++.++|++++....+...   
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---  407 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD---  407 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence            3567789999999999999987443  34444321 11           0123479999999999998876554432   


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                        ....++||||++| +|.+.+.            ....++.|++.+|.+||+. |++||||||+||+++ ++ .++|+|
T Consensus       408 --~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl~-~~-~~~liD  470 (535)
T PRK09605        408 --PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIVR-DD-RLYLID  470 (535)
T ss_pred             --CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEEE-CC-cEEEEe
Confidence              1125699999986 7766654            2456788999999999998 999999999999994 45 799999


Q ss_pred             ccceee
Q 017341          182 FGSAKV  187 (373)
Q Consensus       182 fg~a~~  187 (373)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=3.5e-16  Score=132.19  Aligned_cols=130  Identities=21%  Similarity=0.240  Sum_probs=90.3

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEecccccch----------------------------HHHHHHHHhCCCCC--
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--   89 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~~--   89 (373)
                      .+.||+|++|.||+|.+. +|+.||+|.+.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999976 89999999875432111                            12444444443322  


Q ss_pred             eeecceeeeecCCCCceeEEEEEecccc-cHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCC
Q 017341           90 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQ  166 (373)
Q Consensus        90 iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~-~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~  166 (373)
                      +.+.+.+         ...+++|||+++ .+. ..+....     . ...++.++.+++.++.++|. . ||+|+||||+
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~  144 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREA-GLVHGDLSEY  144 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhcc-CcCcCCCChh
Confidence            2222221         114799999997 211 1222111     1 15577889999999999998 7 9999999999


Q ss_pred             cEEEcCCCCceeEeeccceeec
Q 017341          167 NLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ||+++ ++ .++|+|||.+...
T Consensus       145 Nili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         145 NILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             hEEEE-CC-cEEEEECcccccc
Confidence            99999 66 7999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=4.2e-15  Score=130.00  Aligned_cols=133  Identities=17%  Similarity=0.262  Sum_probs=96.6

Q ss_pred             eeee-ecCceEEEEEEECCCCcEEEEEEecccc-----------------cchHHHHHHHHhCCCCCe--eecceeeeec
Q 017341           41 RVVG-HGSFGVVFQAKCLETGEAVAIKKVLQDK-----------------RYKNRELQTMRLLDHPNV--VSLKHCFFST  100 (373)
Q Consensus        41 ~~lg-~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~~i--v~~~~~~~~~  100 (373)
                      ..|| .||.|+||.+..  .+..+++|.+....                 ....+|+.++..+.|+++  +..+.+....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 888999999986  47789999774211                 123469999999988775  4554443221


Q ss_pred             CCCCceeEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          101 TEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                      . ......++|||+++|  +|.+.+..     ..+++..    +.||+.+|.+||++ ||+|+||||+|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCC-CEE
Confidence            1 111123599999996  66666542     3455443    56899999999998 999999999999999877 799


Q ss_pred             Eeeccceee
Q 017341          179 LCDFGSAKV  187 (373)
Q Consensus       179 l~Dfg~a~~  187 (373)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=1.7e-15  Score=122.88  Aligned_cols=131  Identities=19%  Similarity=0.247  Sum_probs=100.7

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHhCCC--CCeeecceeeeecCCCCceeEEEEEec
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--YKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      +.+.||.|.++.||++...  +..+++|.......  ...+|..+++.+++  .++++++...     ......+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence            4578999999999999974  37899998765543  46689999999976  4788876654     222457899999


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc--CCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          115 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       115 ~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +.|.....          ++......++.+++.+|+.+|..  .+++|+|++|+||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            98742211          13445567788999999999974  1699999999999999866 899999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=7.6e-16  Score=144.34  Aligned_cols=249  Identities=25%  Similarity=0.269  Sum_probs=189.5

Q ss_pred             cceEeeeeeee--cCceEEEEEEE--CCCCcEEEEEEecc------cccchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGH--GSFGVVFQAKC--LETGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+.+.+.+|.  |.+|.||.+..  ..++..+|+|+-..      ......+|+...+.+ .|++.++....+     +
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence            36888899999  99999999998  88899999997322      223334677666666 489999976666     5


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~----~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      +...+++-+|+|+.++...-...   ..-++...++..+.+...    ||.++|+. +++|-|+||.||+...+....++
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeeccccchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeec
Confidence            66668899999997766554432   344788889999999999    99999998 99999999999999998338999


Q ss_pred             eeccceeeccCCCCcc-c-----ccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHH
Q 017341          180 CDFGSAKVLVKGEPNI-S-----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE--SGVDQLVEII  251 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~-~-----~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~--~~~~~~~~i~  251 (373)
                      +|||+...+..+.... .     ..+...|++||...+  .++...|++++|.++.+-.+|..++...  +...++.+..
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            9999988775554222 1     256778999999843  4799999999999999999987766544  2221111110


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                                    ....+-...+.++...+..|+..+|..|++++.+++|+++...
T Consensus       343 ------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 ------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                          0011113456777789999999999999999999999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.6e-15  Score=149.47  Aligned_cols=261  Identities=25%  Similarity=0.294  Sum_probs=190.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+.+.+.+-+-+|.++.++.+.-..+|...+.|......       +....+-.++....+|.++.....+     ...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence            4457888889999999999999877788777777543221       1222333334334556666554332     222


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .-.+++++|.++ ++...+.+-    .+.+.+.++.++..+..++++||+. .+.|+|++|.|++...++ ..+++|||.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~g-h~~l~~~~t  950 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDG-HRPLTDFGT  950 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccC-CcccCcccc
Confidence            336789999985 665555542    4566677888888999999999977 799999999999999988 699999983


Q ss_pred             eeeccC---------------------C-----------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH
Q 017341          185 AKVLVK---------------------G-----------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  232 (373)
Q Consensus       185 a~~~~~---------------------~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll  232 (373)
                      .....-                     .           .......+|+.|.+||.+.+.. ....+|+|++|+++++.+
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence            321100                     0           0012345799999999997765 688899999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH
Q 017341          233 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  312 (373)
Q Consensus       233 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  312 (373)
                      +|.+||...+..+...+|.....                         +|.. -+...+.++++++..+|..+|.+|..+
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~-------------------------~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDI-------------------------PWPE-GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCC-------------------------CCCC-CccccChhhhhhhhhhhccCchhccCc
Confidence            99999999998888777665311                         1111 114578899999999999999999988


Q ss_pred             H---HHhcCCCccccCCCCCCC
Q 017341          313 L---EALIHPFFDELRDPNTRL  331 (373)
Q Consensus       313 ~---~ll~hp~~~~~~~~~~~~  331 (373)
                      .   ++-.||||+..++.+...
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             ccccccccCCccCCCCcccccc
Confidence            7   889999999988765443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=1.8e-13  Score=129.82  Aligned_cols=180  Identities=23%  Similarity=0.315  Sum_probs=129.8

Q ss_pred             ceEeeeeeeecCceEEE-EEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           36 SYMAERVVGHGSFGVVF-QAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy-~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      -|.+ ...+-++.+ +| -+..+.++.++.+........    ...+-++.|+.++||||+++++.+     +....+|+
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl   86 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL   86 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence            4555 344444444 44 355677888899887755443    245678889999999999999988     44556899


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |+|.+.. |...+++.       ....+..-+.||+.||.|||+.++++|++|.-+.|+|+..| ..||++|.++.....
T Consensus        87 vTErV~P-l~~~lk~l-------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~  157 (690)
T KOG1243|consen   87 VTERVRP-LETVLKEL-------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASG  157 (690)
T ss_pred             Eeecccc-HHHHHHHh-------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEecccc
Confidence            9998863 44455543       25667778999999999999777999999999999999999 899999998865422


Q ss_pred             CCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 017341          191 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  234 (373)
Q Consensus       191 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG  234 (373)
                      ... .....---.|..|+.+...   .-..|.|-|||++++++.|
T Consensus       158 ~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  158 FNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            221 1111122336677655211   2457999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=1.4e-14  Score=125.96  Aligned_cols=212  Identities=20%  Similarity=0.237  Sum_probs=148.3

Q ss_pred             HHHHhCCCCCeeecceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC-C
Q 017341           80 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-G  157 (373)
Q Consensus        80 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-~  157 (373)
                      ..+-++.|.|+|+++.++-+...++.....+++||+. |++..+|++..+....+.......|+-||+.||.|||+.. -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            4455668999999999886666556666788999999 7899999887766777888889999999999999999752 6


Q ss_pred             ceeecCCCCcEEEcCCCCceeEeeccceeec--cCC---CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH
Q 017341          158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--VKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  232 (373)
Q Consensus       158 ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~--~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll  232 (373)
                      |+|+++..+.|++..+| -||+.--.-....  ...   .......+-+.|.|||.=. ....+.++|||++|....+|.
T Consensus       199 iihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHH
Confidence            99999999999999887 6776432111100  000   0111224567899998642 234677899999999999999


Q ss_pred             hCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC
Q 017341          233 LGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  311 (373)
Q Consensus       233 tG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  311 (373)
                      .|..- -.+.+....-..+.+.+                               + .--...-+++|.+||+-.|..||+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i-------------------------------~-~len~lqr~~i~kcl~~eP~~rp~  324 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVI-------------------------------I-GLENGLQRGSITKCLEGEPNGRPD  324 (458)
T ss_pred             HheeccCCCcceeehhhhhhhhe-------------------------------e-eccCccccCcCcccccCCCCCCcc
Confidence            87643 22222111111111100                               0 001123457899999999999999


Q ss_pred             HHHHhcCCCccccC
Q 017341          312 ALEALIHPFFDELR  325 (373)
Q Consensus       312 ~~~ll~hp~~~~~~  325 (373)
                      +.+++-||-+-++.
T Consensus       325 ar~llfHpllfeVh  338 (458)
T KOG1266|consen  325 ARLLLFHPLLFEVH  338 (458)
T ss_pred             hhhhhcCceeeecc
Confidence            99999999875543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.8e-12  Score=107.53  Aligned_cols=123  Identities=15%  Similarity=0.225  Sum_probs=88.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCee-ecceeeeecCCCCceeEEEEEecc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      .+.|+.|..+.||++..  .+..+++|......   ....+|+.+++.+.+..++ +++...     .+.  .++|||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            45788999999999986  47889999875443   2346899999988655443 333321     112  35899999


Q ss_pred             ccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCc-----eeecCCCCcEEEcCCCCceeEeecccee
Q 017341          116 PET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       116 ~g~-l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~i-----vH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|. +...         ..   ....++.+++.+|+.||+. ++     +|+|++|.||+++ ++ .++++||+.+.
T Consensus        74 ~G~~l~~~---------~~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELLTE---------DF---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccccc---------cc---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            973 2211         01   1123567899999999987 74     9999999999999 45 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=4e-12  Score=106.51  Aligned_cols=132  Identities=17%  Similarity=0.220  Sum_probs=92.7

Q ss_pred             eeeeeecCceEEEEEEECC------CCcEEEEEEeccc--------------cc------------ch----HHHHHHHH
Q 017341           40 ERVVGHGSFGVVFQAKCLE------TGEAVAIKKVLQD--------------KR------------YK----NRELQTMR   83 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~--------------~~------------~~----~~E~~~l~   83 (373)
                      ...||.|.-+.||.|....      .+..+|+|.....              .+            ..    ++|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3468999999999998643      3578999976311              00            00    16888888


Q ss_pred             hCCC--CCeeecceeeeecCCCCceeEEEEEeccccc-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-HccCCc
Q 017341           84 LLDH--PNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGV  158 (373)
Q Consensus        84 ~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~-~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~L-H~~~~i  158 (373)
                      ++..  -++++.+.+.     .    .+|||||++++ +. ..++     ...+++..+..+..+++.+|..| |+. |+
T Consensus        82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~-gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC-NL  146 (197)
T ss_pred             HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence            8753  4555554321     1    46899999863 21 1222     12345556677889999999998 777 99


Q ss_pred             eeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       159 vH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|+||++.||+++. + .+.|+|||.+...
T Consensus       147 VHGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            99999999999974 4 6999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.39  E-value=2.5e-11  Score=112.20  Aligned_cols=214  Identities=21%  Similarity=0.264  Sum_probs=155.5

Q ss_pred             ceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc--cHHH
Q 017341           48 FGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHR  121 (373)
Q Consensus        48 ~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g--~l~~  121 (373)
                      ..+.|++....+|..|++|++..+..    ..-.-+++++.+.|+|+|++.++|.... -++..+++|++|.++  +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence            35789999999999999999843321    2235688999999999999999987443 355668899999984  5655


Q ss_pred             HHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          122 VIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       122 ~l~~~~~-----------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      .-.....           .+...+|..+|.++.|+..||.++|+. |+..+-|.|.+|+++.+. +++|+..|..-....
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence            4433221           234478899999999999999999988 999999999999999887 799998887654432


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHH-HHHHHHHhCCCCHHHHhhcCcC
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQ-LVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      +.           .  |.+.    --.+-|.=.||.++..|.||..- +......+. +..|                  
T Consensus       446 d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------  490 (655)
T KOG3741|consen  446 DP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------  490 (655)
T ss_pred             CC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence            22           0  1121    13367999999999999999632 111111111 1111                  


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                        ...++.+++++|.-+...++++ .++.+++.|
T Consensus       491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                              1457888999999888888876 778777654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=3.9e-13  Score=129.16  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=92.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc--------------------------------------ch-
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------------------------------------YK-   75 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------------------------------------~~-   75 (373)
                      ..|.. +.||+|++|.||+|+.+.+|+.||||+......                                      .. 
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35776 789999999999999988899999998753310                                      00 


Q ss_pred             -----HHHHHHHHhC----CCCCeeecceeeeecCCCCceeEEEEEecccc-cHHHH--HHHhhhcCCCCCHHHHHHHHH
Q 017341           76 -----NRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV--IKHHYKMSQRMPLIYVKLYFY  143 (373)
Q Consensus        76 -----~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~--l~~~~~~~~~~~~~~~~~i~~  143 (373)
                           .+|...+.++    .+.+.+.+..++...    ....++||||+.| .+.+.  +.........+.+..+..++.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence                 1233333222    244445555554321    1225699999997 55443  221110011244455555666


Q ss_pred             HHHHHHHHhHccCCceeecCCCCcEEEcCCC---CceeEeeccceeeccC
Q 017341          144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVK  190 (373)
Q Consensus       144 qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~---~~ikl~Dfg~a~~~~~  190 (373)
                      |++       .. |++|+|++|.||+++.++   +.++++|||++.....
T Consensus       275 Qif-------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF-------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            655       35 999999999999998775   3699999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=4.1e-13  Score=127.93  Aligned_cols=157  Identities=22%  Similarity=0.331  Sum_probs=115.0

Q ss_pred             HHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCc-c---------cccccccccccccccCCC
Q 017341          144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-I---------SYICSRYYRAPELIFGAT  213 (373)
Q Consensus       144 qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~-~---------~~~gt~~y~aPE~l~~~~  213 (373)
                      ++..|+.|+|.+.++||+.|.|++|.++.++ .+||+.|+.+......... .         ...-...|.|||++.. .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999988999999999999999988 8999999987544331111 0         1123557999999976 4


Q ss_pred             CCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCCh
Q 017341          214 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP  292 (373)
Q Consensus       214 ~~~~~~DiwslG~il~~ll-tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ..+.++|++|+||++|.+. .|+..+...........-....+.                         -...+..++++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCcH
Confidence            4788999999999999998 566666555332222211111000                         00112257999


Q ss_pred             hHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          293 EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       293 ~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ++++=+.++|..++.-||++..++..|||++..-.
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~  274 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK  274 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence            99999999999999999999999999999886443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=5.1e-12  Score=120.05  Aligned_cols=137  Identities=20%  Similarity=0.265  Sum_probs=89.1

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccccc-c-------------------------------------------h
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-Y-------------------------------------------K   75 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~-------------------------------------------~   75 (373)
                      .+.||+|+.|.||+|+. .+|+.||||+...... .                                           .
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            46799999999999986 4799999998743210 0                                           0


Q ss_pred             HHHHHHHHhC----CCCCeeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HH
Q 017341           76 NRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR-AL  149 (373)
Q Consensus        76 ~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~-~L  149 (373)
                      .+|...+..+    ++.+-+.+..++....    ...++||||++| ++.+......   ...+   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence            1233333333    3333444444442211    124699999997 5555443211   1122   2234445554 46


Q ss_pred             HHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       150 ~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ..+|.. |++|+|++|.||+++.++ .++++|||++....
T Consensus       271 ~ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            778887 999999999999999887 89999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=1.2e-12  Score=123.13  Aligned_cols=248  Identities=21%  Similarity=0.179  Sum_probs=172.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEEC-CCCcEEEEEEecccccch------HHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKRYK------NRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      -...+|..+..||.|.++.|+.+.-. .++..|++|...+.....      ..|+-+...+ .|.+++..+..|....  
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--  339 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--  339 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--
Confidence            34557889999999999999987754 678889999775443222      2455555555 5888888877764322  


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                         ..|+=.|||.+ ++....    .....+.+...+.+..|++.++.++|+. .++|+|++|+||++..++...++.||
T Consensus       340 ---~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  340 ---QGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             ---cccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhcccc
Confidence               24578899975 332222    1224467778889999999999999987 99999999999999887557899999


Q ss_pred             cceeeccCCCCccccccccccc-ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYR-APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+...+  .-..........++ .+|++.....+..+.|++|||..+.+.++|.+.-......   ..+...        
T Consensus       412 ~~~t~~--~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~--------  478 (524)
T KOG0601|consen  412 GCWTRL--AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG--------  478 (524)
T ss_pred             cccccc--ceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc--------
Confidence            988642  11122233344455 3666656666888999999999999999987443322111   011000        


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                 ..+.          .+..+..+..+.+.++..++..|+.+.++..|+=|..
T Consensus       479 -----------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  479 -----------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -----------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                       0000          0233467888899999999999999999998876654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=1.2e-10  Score=94.09  Aligned_cols=138  Identities=20%  Similarity=0.261  Sum_probs=96.7

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEec-ccc-----------cchHHHHHHHHhCCCC--CeeecceeeeecCCCC
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDK-----------RYKNRELQTMRLLDHP--NVVSLKHCFFSTTEKD  104 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~-----------~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~  104 (373)
                      ....+.+|+-+.|+++.+  .|+...||.=. +..           ....+|.+++..+.--  ..+.++  |.+.   .
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~---~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDT---Y   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEec---C
Confidence            456788999999999987  78888888532 211           2223688887766422  222222  2221   1


Q ss_pred             ceeEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCce--eEe
Q 017341          105 ELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLC  180 (373)
Q Consensus       105 ~~~~~lv~e~~~g--~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~i--kl~  180 (373)
                      .  -+|+|||++|  ++.+++.....  ..........++.+|-..+.-||.. +|+|+||..+||++.+++..+  .++
T Consensus        84 ~--~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lI  158 (229)
T KOG3087|consen   84 G--GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILI  158 (229)
T ss_pred             C--CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEE
Confidence            1  3589999998  77777776532  2222333367888999999999998 999999999999998887655  899


Q ss_pred             eccceeec
Q 017341          181 DFGSAKVL  188 (373)
Q Consensus       181 Dfg~a~~~  188 (373)
                      |||++...
T Consensus       159 dfgls~~s  166 (229)
T KOG3087|consen  159 DFGLSSVS  166 (229)
T ss_pred             eecchhcc
Confidence            99998643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.22  E-value=5.1e-10  Score=101.25  Aligned_cols=260  Identities=16%  Similarity=0.196  Sum_probs=155.0

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch-HHHHHHHH-hCCCCCeee-c---ceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVS-L---KHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~E~~~l~-~l~h~~iv~-~---~~~~~~~~~~~~~~~~l  110 (373)
                      ....+.||+|+-+.+|-.-.   -.-.+.|++....... .+-+..|. .-.||-+-. +   ....+- . .......+
T Consensus        13 i~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G-~-~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHG-G-RRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhC-C-CccceeEE
Confidence            34566899999999986542   2223456554433222 12222222 224554332 1   111111 1 22233778


Q ss_pred             EEecccc--cHHHHHHH--hhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          111 VLEYVPE--TVHRVIKH--HYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       111 v~e~~~g--~l~~~l~~--~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+.+.|  ....+..-  +...........+.+..+.++.+.+.||++ |.+-+|+.++|+|++.++ .|.|.|=..-.
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfq  165 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSDSFQ  165 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEccccee
Confidence            9999886  33333321  112234467788999999999999999998 999999999999999888 79998855443


Q ss_pred             eccCCCCcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHH-
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTRE-  260 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~~-  260 (373)
                      ...++......+|.++|.+||.-.-    .-.-+..+|.|.||+++++++.| ++||.|...         ....+.+. 
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p~E  236 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNPLE  236 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCcch
Confidence            3334444455678999999997531    11246689999999999999986 999987521         11111111 


Q ss_pred             -HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcC--CCCCCCHH
Q 017341          261 -EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS--PNLRSTAL  313 (373)
Q Consensus       261 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--P~~R~t~~  313 (373)
                       .+....-.|.....+.....+... -..-+++++..+..+|+...  +.-|||++
T Consensus       237 ~~Ia~g~f~ya~~~~~g~~p~P~~~-P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         237 TDIAHGRFAYASDQRRGLKPPPRSI-PLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hhhhcceeeechhccCCCCCCCCCC-ChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence             111111111111111111111111 11457899999999998754  45899874

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=7e-10  Score=90.09  Aligned_cols=124  Identities=15%  Similarity=0.316  Sum_probs=83.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEec-ccc-----------cchHHHHHHHHhCCC--CCeeecceeeeecCCCCce
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDK-----------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~-----------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+++|+-+.+|.+..  -|..+++|.=. +..           ....+|+.++..+.-  -+.+.++++.     .+. 
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~-   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDN-   73 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCC-
Confidence            3578899999999865  34456666422 211           112368888877643  3334444332     333 


Q ss_pred             eEEEEEecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~-~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                       ..|+|||++|.+.. .+...           ...++..+-..+.-||.. ||+|+||.++||++...  .+.++|||++
T Consensus        74 -~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~--~i~~IDfGLg  138 (204)
T COG3642          74 -GLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGG--RIYFIDFGLG  138 (204)
T ss_pred             -CEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCC--cEEEEECCcc
Confidence             34899999985443 55432           134566777888899988 99999999999999864  4999999998


Q ss_pred             ee
Q 017341          186 KV  187 (373)
Q Consensus       186 ~~  187 (373)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            64

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=3.8e-09  Score=93.57  Aligned_cols=139  Identities=12%  Similarity=0.077  Sum_probs=92.0

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc---------------cchHHHHHHHHhCCCCCeeec--ceeeeecCCCCc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSL--KHCFFSTTEKDE  105 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~  105 (373)
                      +-......|+++..  .|+.|.+|......               ....+|...+..+..-.|...  ..+.........
T Consensus        30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            33333344556543  56778888653221               124578888887743333333  323322222222


Q ss_pred             eeEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC------CCce
Q 017341          106 LYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH------THQL  177 (373)
Q Consensus       106 ~~~~lv~e~~~g--~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~------~~~i  177 (373)
                      ..-++|||++++  +|.+++....  ..+.+......++.+++..+.-||.. ||+|+|++++|||++.+      ...+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceE
Confidence            335689999997  6777765432  24456677788999999999999998 99999999999999852      2379


Q ss_pred             eEeecccee
Q 017341          178 KLCDFGSAK  186 (373)
Q Consensus       178 kl~Dfg~a~  186 (373)
                      .|+||+.+.
T Consensus       185 ~LIDl~r~~  193 (268)
T PRK15123        185 SVIDLHRAQ  193 (268)
T ss_pred             EEEECCccc
Confidence            999999874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=7.1e-10  Score=92.61  Aligned_cols=121  Identities=23%  Similarity=0.315  Sum_probs=75.6

Q ss_pred             EEEEEEECCCCcEEEEEEecccc--------------c----------------chHHHHHHHHhCCCC--Ceeecceee
Q 017341           50 VVFQAKCLETGEAVAIKKVLQDK--------------R----------------YKNRELQTMRLLDHP--NVVSLKHCF   97 (373)
Q Consensus        50 ~Vy~~~~~~~~~~vaiK~~~~~~--------------~----------------~~~~E~~~l~~l~h~--~iv~~~~~~   97 (373)
                      .||.|.. ..|+.+|+|......              +                ...+|.+.|..+..-  ++++.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888886 567899999763210              1                112699999999755  456654332


Q ss_pred             eecCCCCceeEEEEEeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-hHccCCceeecCCCCcEEEcCCC
Q 017341           98 FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY-IHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus        98 ~~~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~-LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                           .    .+|||||++  |.....+....     ++......++.+++..+.. +|.. ||+|+||++.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-
Confidence                 2    358999999  64333333321     1123355667788885555 5676 99999999999999965 


Q ss_pred             CceeEeeccceeec
Q 017341          175 HQLKLCDFGSAKVL  188 (373)
Q Consensus       175 ~~ikl~Dfg~a~~~  188 (373)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=1.1e-09  Score=94.89  Aligned_cols=139  Identities=16%  Similarity=0.175  Sum_probs=90.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCC--CeeecceeeeecCCCCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHP--NVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      +.|+.|..+.||++... +|+.+++|......     ....+|..+++.+.+.  ++++++.+...  .......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~--~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCED--PSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCC--CCccCCceEEEE
Confidence            56899999999999864 36889999875432     3456899999998753  34555443311  111123579999


Q ss_pred             ccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc--------------------------------------
Q 017341          114 YVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--------------------------------------  154 (373)
Q Consensus       114 ~~~g~-l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~--------------------------------------  154 (373)
                      |++|. +...+.     ...+++.....++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99973 322211     0224444444555555555555552                                      


Q ss_pred             -----------------cCCceeecCCCCcEEEcCC-CCceeEeeccceee
Q 017341          155 -----------------TIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  187 (373)
Q Consensus       155 -----------------~~~ivH~Dlkp~NIll~~~-~~~ikl~Dfg~a~~  187 (373)
                                       ...++|+|+.|.||+++.+ ++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1257999999999999973 22689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.99  E-value=1.5e-09  Score=93.34  Aligned_cols=130  Identities=18%  Similarity=0.183  Sum_probs=89.6

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecc----------c----------------ccchHHHHHHHHhCCCC--
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----------D----------------KRYKNRELQTMRLLDHP--   88 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----------~----------------~~~~~~E~~~l~~l~h~--   88 (373)
                      +.++..||-|.-|.||.|.+. .|.++|+|.=..          .                ....++|.++|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567789999999999999975 789999994210          0                01123799999988654  


Q ss_pred             CeeecceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcE
Q 017341           89 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  168 (373)
Q Consensus        89 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NI  168 (373)
                      .+++.++         ....++|||+++|-.+.-++        ++......++..|+.-+..+-.. |+||+|+++-||
T Consensus       172 ~VP~P~~---------~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIA---------WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNI  233 (304)
T ss_pred             CCCCccc---------cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc-CccccCCchheE
Confidence            5666533         12256999999983221111        12223334455555555555445 999999999999


Q ss_pred             EEcCCCCceeEeecccee
Q 017341          169 LVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       169 ll~~~~~~ikl~Dfg~a~  186 (373)
                      +++.+| .+.++||--+.
T Consensus       234 lV~~dg-~~~vIDwPQ~v  250 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAV  250 (304)
T ss_pred             EEecCC-CEEEEeCcccc
Confidence            999998 79999997664

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=8e-08  Score=80.89  Aligned_cols=138  Identities=12%  Similarity=0.109  Sum_probs=96.7

Q ss_pred             eecCceEEEEEEECCCCcEEEEEEecc----------cccchHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEE
Q 017341           44 GHGSFGVVFQAKCLETGEAVAIKKVLQ----------DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        44 g~G~~g~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      |.||.|.|++...  .|..+-+|.-..          ......+|+..++.+..-.  +++.. ++-.........-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5578888888765  344688886531          1233458999888885332  44443 2212222334556799


Q ss_pred             Eecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC-ceeEeeccceee
Q 017341          112 LEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  187 (373)
Q Consensus       112 ~e~~~g--~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~ikl~Dfg~a~~  187 (373)
                      +|-++|  +|.+.+.+..  -.+.+......++.+++.++.-||+. |+.|+|+.+.||+++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  7877765432  13456677788999999999999998 9999999999999986662 399999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=1.1e-07  Score=81.38  Aligned_cols=107  Identities=18%  Similarity=0.306  Sum_probs=77.0

Q ss_pred             hHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 017341           75 KNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  150 (373)
Q Consensus        75 ~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~  150 (373)
                      ..+|...+..|..-.  .++.+.+........ ...++|+|++++  +|.+.+....    ..+......++.+++..+.
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHH
Confidence            457888777764322  333333333322222 446799999986  6777776532    2556667888999999999


Q ss_pred             HhHccCCceeecCCCCcEEEcCCC--CceeEeeccceee
Q 017341          151 YIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  187 (373)
Q Consensus       151 ~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~a~~  187 (373)
                      -||+. ||+|+|++|.|||++.++  ..+.++||+.++.
T Consensus       133 ~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99998 999999999999998765  3599999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.79  E-value=1.5e-07  Score=79.54  Aligned_cols=136  Identities=15%  Similarity=0.209  Sum_probs=85.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchH-------------HHHHHHHhCCCCCeeecce---ee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLDHPNVVSLKH---CF   97 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------------~E~~~l~~l~h~~iv~~~~---~~   97 (373)
                      ..+|.+.+++-......|.+..-  +|+.+++|......+..+             +++..+..+....+....+   +.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45799999999988877777764  678999997754433222             2333333332222111111   11


Q ss_pred             eecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341           98 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus        98 ~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                      .-....-....+++|||++| .+.+..        .+++.    +...|..++.-||+. |++|+|..|.|++++.++  
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~~--  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNNG--  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHHc-CCccCCCCcCcEEEECCc--
Confidence            11111223345689999998 433221        12222    334677789999988 999999999999999654  


Q ss_pred             eeEeecccee
Q 017341          177 LKLCDFGSAK  186 (373)
Q Consensus       177 ikl~Dfg~a~  186 (373)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.59  E-value=6.4e-07  Score=90.94  Aligned_cols=204  Identities=21%  Similarity=0.306  Sum_probs=136.5

Q ss_pred             HHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc
Q 017341           77 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT  155 (373)
Q Consensus        77 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~  155 (373)
                      -|+..+..+.|+|++.++.+-+.....+ ....+..++|.+ ++...+.+    -...+...++.+..+++++|.++|+.
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            4677788889999999977654433222 223345667775 55555544    36688899999999999999999987


Q ss_pred             CCceeecCCCC---cEEEcCCCCceeEe--eccceeeccCCCCcccccccccccccccccCCC-CCCCchhHHHHHHHHH
Q 017341          156 IGVCHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLA  229 (373)
Q Consensus       156 ~~ivH~Dlkp~---NIll~~~~~~ikl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~  229 (373)
                       ...|.-|..+   +.-.+.++ .+.++  ||+.+..............+..+.+||...... ..+...|+|++|....
T Consensus       306 -~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  306 -SLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             -ccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence             6666655555   33344444 46666  888777665554444555667788888774322 1233479999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCC
Q 017341          230 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  309 (373)
Q Consensus       230 ~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  309 (373)
                      .+..|..+-....   ....+                                   .+........+++.+|+.-++++|
T Consensus       384 ~~~~~~~i~~~~~---~~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~~R  425 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA---VPVSL-----------------------------------LDVLSTSELLDALPKCLDEDSEER  425 (1351)
T ss_pred             hhhhcCccccccc---chhhh-----------------------------------hccccchhhhhhhhhhcchhhhhc
Confidence            9998764321110   00000                                   001112277889999999999999


Q ss_pred             CCHHHHhcCCCccccC
Q 017341          310 STALEALIHPFFDELR  325 (373)
Q Consensus       310 ~t~~~ll~hp~~~~~~  325 (373)
                      +++.+++.|||.+.-.
T Consensus       426 l~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  426 LSALELLTHPFLRFPT  441 (1351)
T ss_pred             cchhhhhhchhccccc
Confidence            9999999999987643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=8.5e-07  Score=75.89  Aligned_cols=132  Identities=16%  Similarity=0.191  Sum_probs=88.0

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEecccccc----------------------------hHHHHHHHHhCC--CCCee
Q 017341           42 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY----------------------------KNRELQTMRLLD--HPNVV   91 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~E~~~l~~l~--h~~iv   91 (373)
                      .|++|.-+.||+|.. .++..+|+|++......                            ..+|...|+++.  +-.++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677888889999985 56889999987432110                            014777777764  33444


Q ss_pred             ecceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc
Q 017341           92 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  171 (373)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~  171 (373)
                      +-+.+.     .    ..+|||+++...   ...-....-++....+..+..+++..+.-|-...++||+||+.-|||+.
T Consensus       134 ~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            443332     1    358999998430   0000001222333356777788888888887634999999999999999


Q ss_pred             CCCCceeEeeccceeec
Q 017341          172 PHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       172 ~~~~~ikl~Dfg~a~~~  188 (373)
                       ++ .+.|+|||-|...
T Consensus       202 -~~-~p~iID~~QaV~~  216 (268)
T COG1718         202 -DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             -CC-eEEEEECcccccc
Confidence             55 6999999988644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.55  E-value=1.4e-08  Score=96.50  Aligned_cols=245  Identities=18%  Similarity=0.163  Sum_probs=162.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCC-eeecceeeeecCCCCceeEEEEEe
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      .-|...+-+++++++.+++.+...+.... .+.+... ....-++++|.+++||| .+..++     ..+.+.+.++.|+
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMR  314 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhh
Confidence            35777788899999999999876665544 7766544 33445889999999999 333332     2256777899999


Q ss_pred             ccccc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          114 YVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       114 ~~~g~--l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      +++++  ....+..   ....+.+-+...+.+.-+++++++|+. -=+|+|    ||+..+ + ..+..||+....+...
T Consensus       315 i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  315 ICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-E-EVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhcCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-c-ccccccccCCcccCcc
Confidence            99854  1111110   112233344556667778899999965 558888    887775 3 5899999988766555


Q ss_pred             CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017341          192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  271 (373)
Q Consensus       192 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ....+..+|+.++|||+..... +....|.|++|.-..+|.-|-+|-.......      ..++..         +    
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~------~~~g~~---------p----  444 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL------PMIGNG---------P----  444 (829)
T ss_pred             cccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcccc------CCCCCC---------C----
Confidence            4566778999999999986554 8889999999988778887877765421000      000000         0    


Q ss_pred             ccCCCcC-CCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          272 FKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       272 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                       ..+... ...|...+       -.++-..|+...|..|+....++.|.+|.+-
T Consensus       445 -~s~~L~~~~aw~~~~-------~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  445 -NSPMLTDKSAWSPVF-------HRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             -CccccchhhhcCccc-------ccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence             000000 01121111       1157788999999999999999999998763

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=2.9e-07  Score=88.37  Aligned_cols=137  Identities=20%  Similarity=0.249  Sum_probs=82.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc-------------------------c-c------------------hH
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------------------R-Y------------------KN   76 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------------------~-~------------------~~   76 (373)
                      ..|+.++-|.||+|+-+ +|+.||||+....-                         + .                  ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57889999999999974 59999999763221                         0 0                  01


Q ss_pred             HHHHHHHhC----CCCCeeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 017341           77 RELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY  151 (373)
Q Consensus        77 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~  151 (373)
                      +|...+.++    ++..-+.+..++....++    -.++|||++| .+.+......   ...+...+...+.++..  ..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~--~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFL--RQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHH--HH
Confidence            244444333    334444555555322211    3589999998 4444432211   22332222222222211  11


Q ss_pred             hHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       152 LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +=.. |+.|.|..|.||+++.++ .+.+.|||......
T Consensus       281 ~~~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~  316 (517)
T COG0661         281 LLRD-GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD  316 (517)
T ss_pred             HHhc-CccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence            1124 999999999999999998 89999999987653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.40  E-value=4.1e-06  Score=72.97  Aligned_cols=78  Identities=18%  Similarity=0.197  Sum_probs=50.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEEEecc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +++++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4679999999999999744  58999987554  234557888888875332  34444322  1122333478999999


Q ss_pred             cc-cHHH
Q 017341          116 PE-TVHR  121 (373)
Q Consensus       116 ~g-~l~~  121 (373)
                      +| .+..
T Consensus        78 ~g~~~~~   84 (239)
T PF01636_consen   78 PGRPLDD   84 (239)
T ss_dssp             SSEEHHH
T ss_pred             ccccccc
Confidence            97 4444

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=7.1e-06  Score=71.17  Aligned_cols=69  Identities=16%  Similarity=0.096  Sum_probs=45.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEEEeccc
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVP  116 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~  116 (373)
                      ..||.|..+.||+.    .|..+++|......  ....+|.++++.+..-.  +++.+++.     .+....++|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            46899999999984    24568889765422  23568999998875332  34443332     22233578999999


Q ss_pred             cc
Q 017341          117 ET  118 (373)
Q Consensus       117 g~  118 (373)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=8.2e-06  Score=78.34  Aligned_cols=138  Identities=21%  Similarity=0.267  Sum_probs=82.3

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-----------------------------------h------H
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----------------------------------K------N   76 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------------------------------~------~   76 (373)
                      --.+.||..+.|.|++|+-+ +|+.||+|+-...-+.                                   .      .
T Consensus       164 f~~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~  242 (538)
T KOG1235|consen  164 FDEEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT  242 (538)
T ss_pred             cCcchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence            33468999999999999975 4999999975322100                                   0      0


Q ss_pred             HHHHHH----HhCCCCC---eeecceeeeecCCCCceeEEEEEecccc---cHHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 017341           77 RELQTM----RLLDHPN---VVSLKHCFFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQIC  146 (373)
Q Consensus        77 ~E~~~l----~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~g---~l~~~l~~~~~~~~~~~~~~~~~i~~qil  146 (373)
                      +|.+..    +.+.|-+   -|.+..++.+...    .-.|+||||+|   +-.+.+.+     ..++...+..-+.+..
T Consensus       243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~  313 (538)
T KOG1235|consen  243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAY  313 (538)
T ss_pred             HHHHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHH
Confidence            232222    2233444   2334444432211    14589999997   22344444     3344444433333332


Q ss_pred             HHHHHhHccCCceeecCCCCcEEEcC---CCCceeEeeccceeec
Q 017341          147 RALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  188 (373)
Q Consensus       147 ~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg~a~~~  188 (373)
                      .-.- ++ . |++|+|=.|.||+++.   .+..+.+-|||+....
T Consensus       314 ~~qI-f~-~-GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  314 LEQI-FK-T-GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHH-Hh-c-CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            2221 22 4 9999999999999984   2448999999998654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=5.8e-05  Score=66.42  Aligned_cols=68  Identities=19%  Similarity=0.163  Sum_probs=41.7

Q ss_pred             eeecCc-eEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEEEEecccc
Q 017341           43 VGHGSF-GVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  117 (373)
Q Consensus        43 lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g  117 (373)
                      |..|.+ +.||++..  .+..+.+|..... .....+|+.+++.+. +--+++++.+.     .....-++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCC
Confidence            334444 78999875  3467888876432 134568999988884 33344444433     111235689999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.03  E-value=3.2e-05  Score=62.81  Aligned_cols=129  Identities=17%  Similarity=0.280  Sum_probs=85.3

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      .-++.+.|++|.+|.||++.+  .|..+|+|+-..+.  ...+.|.++|..++-.++-.=...+ .   .    -++.||
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me   92 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRME   92 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhh
Confidence            456778999999999999997  56789999765543  4567899999988766554432211 1   1    235699


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCC-CCcEEEcCCCCceeEeeccceee
Q 017341          114 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK-PQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       114 ~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlk-p~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+.| .|......       .+    +.-+..++++---|- .+||-|+.|. |..+++-.++ .+.|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIG-------GD----RKHLLRVLEKAYKLD-RLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhc-------cc----HHHHHHHHHHHHHHH-HhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            9998 55433321       01    122334556533344 4599999996 5555554455 699999998863

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=0.00011  Score=76.14  Aligned_cols=78  Identities=21%  Similarity=0.222  Sum_probs=49.6

Q ss_pred             eeeeeeecCceEEEEEEECCCC--cEEEEEEeccc-----ccchHHHHHHHHhCC-CCCe--eecceeeeecCCCCceeE
Q 017341           39 AERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~  108 (373)
                      ..+.++.|.+..+|++.....+  ..+++|+....     .....+|..+++.+. |.++  ++++.+.  .........
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~--~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLC--TDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEe--cCCCcCCCc
Confidence            3567899999999998764332  46788875432     234568999999995 6654  4443322  111112335


Q ss_pred             EEEEeccccc
Q 017341          109 NLVLEYVPET  118 (373)
Q Consensus       109 ~lv~e~~~g~  118 (373)
                      |+||||++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            6899999874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.92  E-value=0.00022  Score=62.27  Aligned_cols=69  Identities=20%  Similarity=0.319  Sum_probs=43.5

Q ss_pred             eeeeeecCceEEEEEEECC-CCcEEEEEEeccccc---chHHHHHHHHhCCCCC-eeecceeeeecCCCCceeEEEEEec
Q 017341           40 ERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKR---YKNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      .+.|..|-...+|++.... .++.|++|.......   ..++|..+++.+.... .++++...     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            4567788888999997533 357889997643321   2247888888885333 33433221     11    279999


Q ss_pred             ccc
Q 017341          115 VPE  117 (373)
Q Consensus       115 ~~g  117 (373)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            886

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.86  E-value=2e-05  Score=74.09  Aligned_cols=173  Identities=21%  Similarity=0.248  Sum_probs=112.7

Q ss_pred             chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH
Q 017341           74 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  153 (373)
Q Consensus        74 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH  153 (373)
                      .+.....+++.+.|+|.....++...   .... ..+|||+++.++.+.+..+.     +..       .+++     - 
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~---~~~r-~IVV~e~~~~Sled~~~~~~-----l~~-------~s~~-----~-   85 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRG---KHER-VIVVMEHYTMSLEDILKTGN-----LKD-------ESLL-----A-   85 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecC---ccce-EEEEehhhccchHHHHHhcc-----cch-------hhhc-----c-
Confidence            34456888999999999998775422   1222 67899999999998887542     100       0111     1 


Q ss_pred             ccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 017341          154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  233 (373)
Q Consensus       154 ~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt  233 (373)
                       + ++.|-     |        .++.+| .+...               |  |-.      ..+++||||+|.++.++..
T Consensus        86 -~-~~~~~-----~--------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   86 -H-GVLHL-----N--------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             -c-cccee-----h--------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHH
Confidence             1 22221     1        244444 11100               0  111      1249999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH
Q 017341          234 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  313 (373)
Q Consensus       234 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  313 (373)
                      |...+......+....+.+....+.......+..                 .+...++.....+..+|+-..|..||...
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchh
Confidence            9999888887777777766544433322111100                 11235677888999999999999999999


Q ss_pred             HHhcCCCcccc
Q 017341          314 EALIHPFFDEL  324 (373)
Q Consensus       314 ~ll~hp~~~~~  324 (373)
                      ++.+++-|.++
T Consensus       190 ~~~k~~i~~ev  200 (725)
T KOG1093|consen  190 ELSKRCSFTEV  200 (725)
T ss_pred             HHhcCccHHHH
Confidence            99999999875

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.86  E-value=0.0001  Score=65.42  Aligned_cols=132  Identities=18%  Similarity=0.250  Sum_probs=72.4

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCe-eecceeeeecCCCCceeEEEEEecccc
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEYVPE  117 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~~~g  117 (373)
                      +..|-.+.+|++.  .+++.+++|.......    ...+|..+++.+....+ ++++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567777889887  3567888987543322    23578999998864333 2322211     1    1479999987


Q ss_pred             c-HH--------------HHHHHhhhc---CCCCCH-HHHHHHHHHH---------HHHHHHhHc-------cCCceeec
Q 017341          118 T-VH--------------RVIKHHYKM---SQRMPL-IYVKLYFYQI---------CRALAYIHN-------TIGVCHRD  162 (373)
Q Consensus       118 ~-l~--------------~~l~~~~~~---~~~~~~-~~~~~i~~qi---------l~~L~~LH~-------~~~ivH~D  162 (373)
                      . +.              +.+.+-...   ..+++. ..+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            2 21              111111111   111111 1112221111         111111211       12589999


Q ss_pred             CCCCcEEEcCCCCceeEeeccceee
Q 017341          163 IKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       163 lkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +.|.||+++.++  +.|+||..+..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999999765  78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.84  E-value=0.00028  Score=59.25  Aligned_cols=126  Identities=25%  Similarity=0.352  Sum_probs=86.0

Q ss_pred             cceEeeeeeeecCc-eEEEEEEECCCCcEEEEEEecc---c-----------c-----------cchHHHHHHH---HhC
Q 017341           35 ISYMAERVVGHGSF-GVVFQAKCLETGEAVAIKKVLQ---D-----------K-----------RYKNRELQTM---RLL   85 (373)
Q Consensus        35 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~---~-----------~-----------~~~~~E~~~l---~~l   85 (373)
                      ..++..+.||.|.- |.||+++-  .|+.||+|.+..   .           .           ..+..|.+..   +.+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 99999986  788999998311   0           0           0112355444   444


Q ss_pred             CCCCe--eecceeeeecCC-------------CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 017341           86 DHPNV--VSLKHCFFSTTE-------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  150 (373)
Q Consensus        86 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~  150 (373)
                      .+.++  |++++++....+             .......||.||+...-            .+...    -+.+|++-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHH
Confidence            55566  888887754421             11223467888877531            12222    2457888899


Q ss_pred             HhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       151 ~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+|.. ||+-+|+++.|..   +   =+|+|||.+
T Consensus       179 ~~~k~-gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL-GIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HHHHC-CeeeccCcccccc---C---CEEEecccC
Confidence            99977 9999999999974   2   389999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.81  E-value=0.00026  Score=59.80  Aligned_cols=123  Identities=20%  Similarity=0.327  Sum_probs=80.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEecccc--------------------cchHHHHHHHHhCC------CCCeeecc
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK   94 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~~   94 (373)
                      ..||+|+.-.||.--   ......||+.....                    +...+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            478999999998643   33447888876544                    23346776666665      78899998


Q ss_pred             eeeeecCCCCceeEEEEEeccc---c----cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341           95 HCFFSTTEKDELYLNLVLEYVP---E----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~lv~e~~~---g----~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                      +...+..+     ..+|+|.+.   |    +|.+++.+     +.+++ .+..   .+-....+|-++ +|+.+|++|.|
T Consensus        84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~-~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDH-HIVIRDLNPHN  148 (199)
T ss_pred             EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHc-CCeecCCCccc
Confidence            87744333     677888764   3    45555532     44555 3333   334455667777 99999999999


Q ss_pred             EEEcCCC--C-ceeEee
Q 017341          168 LLVNPHT--H-QLKLCD  181 (373)
Q Consensus       168 Ill~~~~--~-~ikl~D  181 (373)
                      |++....  . .+.|+|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            9995433  2 477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.76  E-value=0.00015  Score=65.73  Aligned_cols=137  Identities=17%  Similarity=0.240  Sum_probs=95.1

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------c-c-----------------------chHHHHHHHHhCCC
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------K-R-----------------------YKNRELQTMRLLDH   87 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~-~-----------------------~~~~E~~~l~~l~h   87 (373)
                      .+..+|..|.-+.||.|. ..+|..+|||++..+      . +                       -.++|++-|+++..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            455678889999999998 467888999987322      1 0                       01358888888876


Q ss_pred             CCeeecceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341           88 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus        88 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                      ..|+--.-+. ...      ..|||++++++-   +..-...+-.++...+..+-.|++.-+.-|-+.+++||.||+--|
T Consensus       226 aGIP~PePIl-Lk~------hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPIL-LKN------HVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCcee-eec------ceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            5543332222 111      358999998531   111111234577777888888888888888777799999999999


Q ss_pred             EEEcCCCCceeEeeccceee
Q 017341          168 LLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+-. | .+.|+|.+-+..
T Consensus       296 ~Lyhd-G-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYHD-G-KLYIIDVSQSVE  313 (520)
T ss_pred             heEEC-C-EEEEEEcccccc
Confidence            99984 5 699999887653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.75  E-value=0.00021  Score=62.46  Aligned_cols=29  Identities=34%  Similarity=0.441  Sum_probs=24.3

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++|+|+.|.||+++.++ ..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            589999999999998544 45699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.64  E-value=0.0011  Score=62.17  Aligned_cols=71  Identities=21%  Similarity=0.322  Sum_probs=46.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEecc-----------cccchHHHHHHHHhCC---CCCeeecceeeeecCCCCc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+.||.|....||++.+...++.++||.-..           .......|.+.|+.+.   ..++++++.+-     ++.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            4678999999999999854335899997431           1122345777777763   34566665532     222


Q ss_pred             eeEEEEEecccc
Q 017341          106 LYLNLVLEYVPE  117 (373)
Q Consensus       106 ~~~~lv~e~~~g  117 (373)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4589999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.63  E-value=0.00059  Score=62.25  Aligned_cols=143  Identities=15%  Similarity=0.086  Sum_probs=77.0

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCC--eeecceeeeecCC----CCceeEE
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE----KDELYLN  109 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~~  109 (373)
                      ...+.++.|....+|++.. . +..+++|.....  ......|.+++..|....  +++++.   +..+    ......+
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~---t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVK---SRDGRQLSTLAGKPA   99 (307)
T ss_pred             eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCcccc---CCCCCeehhcCCeEE
Confidence            3456677777788999874 3 345888976542  233446777777774322  333322   1111    1123467


Q ss_pred             EEEeccccc-H-----------HHHHHHhhhcCCCC--------CHHH-----HH----------HHHHHHHHHHHHhHc
Q 017341          110 LVLEYVPET-V-----------HRVIKHHYKMSQRM--------PLIY-----VK----------LYFYQICRALAYIHN  154 (373)
Q Consensus       110 lv~e~~~g~-l-----------~~~l~~~~~~~~~~--------~~~~-----~~----------~i~~qil~~L~~LH~  154 (373)
                      ++++|++|. +           ...+.+.......+        ....     ..          .....+...+.++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            899998862 1           11111111101111        0000     00          001112234444432


Q ss_pred             ------cCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          155 ------TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       155 ------~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                            ..++||+|+.+.||+++.++ .+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence                  23899999999999999876 56899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.61  E-value=5.1e-05  Score=67.55  Aligned_cols=128  Identities=17%  Similarity=0.228  Sum_probs=84.7

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEec----------ccc----------------cchHHHHHHHHhCC-CC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDK----------------RYKNRELQTMRLLD-HP   88 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~----------~~~----------------~~~~~E~~~l~~l~-h~   88 (373)
                      -|.++..||-|.-+.+|.+-+ ..|.+.++|.-.          ...                -...+|...|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367888999999999999986 568899999421          000                01125777777773 33


Q ss_pred             C-eeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCC
Q 017341           89 N-VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  166 (373)
Q Consensus        89 ~-iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~  166 (373)
                      . +++.++         ....++|||++.| .|.+. .+      -.+   +..+...+...+.-|..+ |+||+|+.-=
T Consensus       172 fpVPkpiD---------~~RH~Vvmelv~g~Pl~~v-~~------v~d---~~~ly~~lm~~Iv~la~~-GlIHgDFNEF  231 (465)
T KOG2268|consen  172 FPVPKPID---------HNRHCVVMELVDGYPLRQV-RH------VED---PPTLYDDLMGLIVRLANH-GLIHGDFNEF  231 (465)
T ss_pred             CCCCCccc---------ccceeeHHHhhcccceeee-ee------cCC---hHHHHHHHHHHHHHHHHc-Cceecccchh
Confidence            3 333322         2225789999987 43322 11      112   223344555556667777 9999999999


Q ss_pred             cEEEcCCCCceeEeeccce
Q 017341          167 NLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a  185 (373)
                      ||+++.++ .++++||--.
T Consensus       232 Nimv~dd~-~i~vIDFPQm  249 (465)
T KOG2268|consen  232 NIMVKDDD-KIVVIDFPQM  249 (465)
T ss_pred             eeEEecCC-CEEEeechHh
Confidence            99999877 7999999754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.61  E-value=0.00059  Score=61.84  Aligned_cols=141  Identities=13%  Similarity=0.052  Sum_probs=76.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEecc-cccchHHHHHHHHhCCCCC--eeecceeeeecCC----CCceeEEEEE
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE----KDELYLNLVL  112 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~~lv~  112 (373)
                      .+.+..|....+|++..  ++..+++|.... .......|+.++..+.+..  +++++..   ..+    ......++|+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~---~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIAD---RDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccC---CCCcEeeeeCCceEEEE
Confidence            55677777788999864  345789998753 2334557888888774332  3333221   110    1112357899


Q ss_pred             ecccccH------------HHHHHHhhhcCCCCC--------HHHHH------------HHHHHHHHHHHHhHc------
Q 017341          113 EYVPETV------------HRVIKHHYKMSQRMP--------LIYVK------------LYFYQICRALAYIHN------  154 (373)
Q Consensus       113 e~~~g~l------------~~~l~~~~~~~~~~~--------~~~~~------------~i~~qil~~L~~LH~------  154 (373)
                      ++++|..            .+.+.+.......+.        .....            .....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998621            111111111100000        00000            011112233344332      


Q ss_pred             cCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       155 ~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ..++||+|+.|.||+++.++ .+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            12799999999999999765 56899998774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.58  E-value=0.0016  Score=58.98  Aligned_cols=77  Identities=6%  Similarity=-0.004  Sum_probs=49.7

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecc--cccchHHHHHHHHhCCC---CCeeecceeeeecCCCCceeEEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDH---PNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      -.-.+.||.|..+.||+...  ++..+++|....  .......|...++.|..   ..+++++++....  .....-++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEE
Confidence            34456799999999999874  233577776543  12456789999998854   3455555433211  112335789


Q ss_pred             Eecccc
Q 017341          112 LEYVPE  117 (373)
Q Consensus       112 ~e~~~g  117 (373)
                      ||+++|
T Consensus        92 mE~i~G   97 (297)
T PRK10593         92 LERLRG   97 (297)
T ss_pred             EeccCC
Confidence            999986

>PRK05231 homoserine kinase; Provisional

Probab=97.58  E-value=0.0015  Score=59.99  Aligned_cols=29  Identities=31%  Similarity=0.327  Sum_probs=24.8

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            899999999999998554 45799999874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.47  E-value=2.3e-05  Score=82.01  Aligned_cols=213  Identities=17%  Similarity=0.029  Sum_probs=137.7

Q ss_pred             HHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC
Q 017341           78 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI  156 (373)
Q Consensus        78 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~  156 (373)
                      |.+.++...|+++...+.-...   ....-.+..++|+. |.+...+.+............+.....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4444555688888776543321   22222457889988 5788887766555555665555555555466666666543


Q ss_pred             C----ceeecCCCCcEEEcCCCCceeEeeccceeec-cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHH
Q 017341          157 G----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  231 (373)
Q Consensus       157 ~----ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~l  231 (373)
                      +    -+|++||+-|.++..+- ++++.++|+.+.. ..........+++.|++|++.. .-.++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence            3    48899999999999877 7999999999832 2223334567899999999874 34477789999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC
Q 017341          232 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  311 (373)
Q Consensus       232 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  311 (373)
                      ..|..+|.     ..++.+.++.           -.+-..++.+            ...|.++......+|-+.-..||.
T Consensus      1434 s~~n~~fi-----~flq~~Lkgi-----------idn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKGI-----------IDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHH-----HHHHHHHcCc-----------cccccccccc------------ccCCCcccHHHHHHHHHHhhhcch
Confidence            99987773     2222222211           1111111111            223445555556666666778999


Q ss_pred             HHHHhcCCCccc
Q 017341          312 ALEALIHPFFDE  323 (373)
Q Consensus       312 ~~~ll~hp~~~~  323 (373)
                      -...+.-+.|..
T Consensus      1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred             hhhhcccccccc
Confidence            888888777743

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.40  E-value=0.00071  Score=56.79  Aligned_cols=96  Identities=22%  Similarity=0.204  Sum_probs=72.7

Q ss_pred             HHHHHHHhCCC-CCeeecceeeeecCCCCceeEEEEEecccc-cHHHH---HHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 017341           77 RELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV---IKHHYKMSQRMPLIYVKLYFYQICRALAY  151 (373)
Q Consensus        77 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~---l~~~~~~~~~~~~~~~~~i~~qil~~L~~  151 (373)
                      .|.-+++.+.+ +++++++++.     +    -.++.||.+. ++...   +.+    --..+......++.+++..+.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~   74 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEE   74 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHH
Confidence            57888888876 6899988765     2    2468999884 43321   111    1235778889999999999999


Q ss_pred             hHc---cCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          152 IHN---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       152 LH~---~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |++   . .+.-.|++|+|+-++.++ .+|++|...+..
T Consensus        75 l~~~~~~-~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   75 LDHGPLG-FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             HhcCCCC-cEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence            996   3 477799999999999887 799999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02236 choline kinase

Probab=97.30  E-value=0.0049  Score=57.14  Aligned_cols=31  Identities=26%  Similarity=0.645  Sum_probs=26.3

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++|+|+++.||+++.+.+.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986444799999988753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.27  E-value=0.0056  Score=55.86  Aligned_cols=29  Identities=28%  Similarity=0.582  Sum_probs=24.9

Q ss_pred             CCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       156 ~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            38899999999999987 4 58999998763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.24  E-value=0.0054  Score=55.73  Aligned_cols=29  Identities=34%  Similarity=0.550  Sum_probs=25.7

Q ss_pred             CceeecCCCCcEEEcCC----CCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPH----THQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~----~~~ikl~Dfg~a~  186 (373)
                      .+||+|+.|.||+++.+    + .+.++||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence            68999999999999975    5 79999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.11  E-value=0.0089  Score=55.07  Aligned_cols=30  Identities=27%  Similarity=0.435  Sum_probs=25.7

Q ss_pred             ceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       158 ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .+|+|+.+.||+++.+++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            699999999999976544799999998853

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.01  E-value=0.0024  Score=58.09  Aligned_cols=106  Identities=16%  Similarity=0.243  Sum_probs=72.2

Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      .+..|.|++|++-++++...        .....+++..++.+.+..+.-+..+...-|||+...||+++ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            45678899999988765422        12334567788888888888888777889999999999999 67 8999999


Q ss_pred             cceeeccCCCCcccccccccccccccccCCCCCCCchhHHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSA  224 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diwsl  224 (373)
                      .+++....+....    -...--|-.+.|.  -+.+-+||-+
T Consensus       366 klsRl~~~q~~is----y~rldhp~lF~G~--dd~QFeIYrl  401 (488)
T COG5072         366 KLSRLSYSQGIIS----YNRLDHPDLFNGV--DDYQFEIYRL  401 (488)
T ss_pred             eeeecccCCceee----ccccCchhhhcCc--cceeeeHHHH
Confidence            9998432222111    1112233334333  2667777765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.98  E-value=0.013  Score=54.04  Aligned_cols=69  Identities=23%  Similarity=0.250  Sum_probs=42.7

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeccc-----------ccchHHHHHHHHhCC--CC-CeeecceeeeecCCCCcee
Q 017341           42 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        42 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+|.|....||++.+...++.++||.-...           ..+..-|...|+...  -| ++++++.+      .... 
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e~-   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTEM-   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------cccc-
Confidence            478899999999997544467999964211           122235777777653  23 45555432      1122 


Q ss_pred             EEEEEecccc
Q 017341          108 LNLVLEYVPE  117 (373)
Q Consensus       108 ~~lv~e~~~g  117 (373)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            3489999963

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.89  E-value=0.015  Score=53.11  Aligned_cols=29  Identities=14%  Similarity=0.192  Sum_probs=26.3

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++||+|+.++|++++.++ .+.++||..++
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            799999999999999877 79999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.86  E-value=0.011  Score=55.07  Aligned_cols=71  Identities=17%  Similarity=0.198  Sum_probs=45.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccc----------ccchHHHHHHHHhCC--CC-CeeecceeeeecCCCCce
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  106 (373)
                      .+.||.|.-.-||++.+...++.++||.-...          ..+..-|.+.|+.+.  -| ++++++.+      ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence            66889999999999998444567999964211          122335777877663  23 56666442      1121


Q ss_pred             eEEEEEecccc
Q 017341          107 YLNLVLEYVPE  117 (373)
Q Consensus       107 ~~~lv~e~~~g  117 (373)
                       ..+|||+++.
T Consensus       108 -~~~vMEdL~~  117 (409)
T PRK12396        108 -NCCVMEDLSD  117 (409)
T ss_pred             -hhHHHHhCcc
Confidence             3479999863

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.57  E-value=0.039  Score=49.42  Aligned_cols=31  Identities=29%  Similarity=0.517  Sum_probs=25.4

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++|+|++|.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999997552356999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.55  E-value=0.034  Score=50.44  Aligned_cols=30  Identities=27%  Similarity=0.513  Sum_probs=26.9

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++|+|+.+.|++++.++ .+-+.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999888 599999999865

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.53  E-value=0.04  Score=51.73  Aligned_cols=70  Identities=19%  Similarity=0.241  Sum_probs=45.4

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEecc-----------cccchHHHHHHHHhCC---CCCeeecceeeeecCCCC
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+.||.|....||++.+  .+..++||.-..           +......|...|+.+.   ..++++++.+.     ++
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            467789999999999987  345689996541           1222335677776654   24666665543     22


Q ss_pred             ceeEEEEEecccc
Q 017341          105 ELYLNLVLEYVPE  117 (373)
Q Consensus       105 ~~~~~lv~e~~~g  117 (373)
                      .  .+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            2  3578999976

>PTZ00384 choline kinase; Provisional

Probab=96.43  E-value=0.061  Score=50.49  Aligned_cols=28  Identities=29%  Similarity=0.355  Sum_probs=24.0

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ..||.|+-+.||+.+.+  .+.++||..|.
T Consensus       228 VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        228 LFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeccCCcccEEecCC--CEEEEEecccc
Confidence            67999999999998754  49999998874

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.18  E-value=0.033  Score=50.03  Aligned_cols=73  Identities=15%  Similarity=0.162  Sum_probs=42.8

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHhCC---CCCeeecceeeeecCCCCceeEEEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      .+-.+.++.|.-..+|++.  .+++.+.+|.-... ......|..-|+.|.   --.+++++.+...   .+.  -++||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~---~~~--~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY---DDD--AFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE----SSC--CEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee---cCC--ceEEE
Confidence            4556678889999999987  57888999976533 334567888888884   3345565554422   122  36899


Q ss_pred             eccc
Q 017341          113 EYVP  116 (373)
Q Consensus       113 e~~~  116 (373)
                      ||++
T Consensus        92 e~l~   95 (288)
T PF03881_consen   92 EFLE   95 (288)
T ss_dssp             E---
T ss_pred             Eeec
Confidence            9986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.37  E-value=0.33  Score=44.62  Aligned_cols=27  Identities=26%  Similarity=0.351  Sum_probs=23.2

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++||+|+.+.||+++ +  .+.|+||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            789999999999995 3  37899999774

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.29  E-value=0.039  Score=46.95  Aligned_cols=84  Identities=17%  Similarity=0.194  Sum_probs=54.7

Q ss_pred             HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH-c
Q 017341           76 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-N  154 (373)
Q Consensus        76 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-~  154 (373)
                      ..+.+++.++.  .|+++.      + .+...+.+|.|+|..--            -.+..    ++.-=+.+|.-.| +
T Consensus       106 ~nky~v~Armh--GilrL~------N-Dn~~~yGvIlE~Cy~~~------------i~~~N----~i~agi~~L~~fH~~  160 (308)
T PF07387_consen  106 FNKYRVFARMH--GILRLK------N-DNNYKYGVILERCYKIK------------INFSN----FITAGIKDLMDFHSE  160 (308)
T ss_pred             hhhhhHHHHhh--heeEee------c-CCCceeEEEEeeccCcc------------cchhH----HHHHhHHHHHHhhcc
Confidence            45666665542  244443      2 24455789999997420            01111    1111256788889 4


Q ss_pred             cCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       155 ~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      +.+.+|+|-.|+|||-|..| .+||.|-+.-
T Consensus       161 ~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L  190 (308)
T PF07387_consen  161 NQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL  190 (308)
T ss_pred             CCCeecCCCChhheeecCCC-CEEecChhhh
Confidence            44899999999999999999 8999997753

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.17  E-value=0.047  Score=46.72  Aligned_cols=30  Identities=40%  Similarity=0.717  Sum_probs=20.1

Q ss_pred             CceeecCCCCcEEE-cCCCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll-~~~~~~ikl~Dfg~a~~  187 (373)
                      -++|+|+.|.||++ +.++ .++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            58999999999999 5555 899999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.98  E-value=0.043  Score=45.74  Aligned_cols=29  Identities=28%  Similarity=0.350  Sum_probs=24.7

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      -.+|+|+.|.||+++.++  ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            359999999999998655  88999998853

>PTZ00296 choline kinase; Provisional

Probab=93.87  E-value=1.7  Score=41.70  Aligned_cols=28  Identities=29%  Similarity=0.565  Sum_probs=23.8

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .++|+|+-+.||+.+.+  .++|+||..|.
T Consensus       285 VfCHNDl~~~NiL~~~~--~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK--CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC--CEEEEeecccc
Confidence            57999999999988744  49999998874

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.62  E-value=0.11  Score=46.22  Aligned_cols=46  Identities=30%  Similarity=0.478  Sum_probs=33.7

Q ss_pred             HHHHHHHHHHHhHcc-CCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          141 YFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       141 i~~qil~~L~~LH~~-~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .+..+-.++.-.+.. .-+||+|+.|+|++.+..+ .++|+||..|..
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            344444555555522 2389999999999999867 799999998854

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=93.36  E-value=0.094  Score=49.75  Aligned_cols=30  Identities=17%  Similarity=0.302  Sum_probs=24.1

Q ss_pred             ceeecCCCCcEEEcCCCC----ceeEeeccceee
Q 017341          158 VCHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  187 (373)
Q Consensus       158 ivH~Dlkp~NIll~~~~~----~ikl~Dfg~a~~  187 (373)
                      ++|+||...|||.+.++.    -..|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            699999999999988653    457889877654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	373
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-142
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-142
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-142
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-142
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-142
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-141
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-141
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-141
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-140
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-140
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-140
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-140
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-139
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-139
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-138
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-138
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-138
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-138
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-137
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-137
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-136
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-133
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-95
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-90
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-45
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-45
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-45
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-44
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-44
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-44
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-44
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-44
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-44
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-44
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-44
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-44
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-43
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-43
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-43
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-43
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-43
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-43
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-43
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-43
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-43
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-43
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-43
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-43
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-43
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-43
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-43
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-43
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-43
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-43
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-43
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-43
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-43
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-43
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-43
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-43
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-43
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-43
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-43
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-43
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-43
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-43
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-43
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-43
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-43
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-43
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-42
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-42
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-42
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-42
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-42
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-42
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-42
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-42
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-42
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-42
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-42
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-42
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-42
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-42
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-42
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-42
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-42
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-42
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-42
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-42
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-41
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-41
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-40
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-40
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-40
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-40
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-39
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-39
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-39
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-39
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-39
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-39
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-39
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-39
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-39
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-39
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-39
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-39
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-39
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-39
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-39
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-39
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-39
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-39
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-39
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-39
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-39
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-39
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-39
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-39
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-39
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-39
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-38
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-38
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-38
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-38
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-38
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-38
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-38
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-38
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-38
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-38
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-38
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-38
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-38
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-38
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-38
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-38
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-38
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-38
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-38
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-37
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-37
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-37
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-36
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-36
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-36
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-35
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-34
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-34
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-33
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-33
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-33
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-33
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-33
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-33
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-33
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-32
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-32
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-32
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-32
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-32
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-32
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-32
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-32
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-32
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-32
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-32
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-32
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-32
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-32
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-32
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-32
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-32
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-32
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-32
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-31
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-31
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-31
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-31
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-31
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-31
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-31
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-31
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-31
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-31
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-31
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-31
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-30
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-30
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-30
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-30
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-29
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-29
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-29
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		6e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-28
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-27
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-27
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-27
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-27
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-27
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-27
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-27
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-27
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-26
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-24
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-24
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-21
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-21
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-21
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-21
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-21
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-20
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-20
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-20
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-20
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-20
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-20
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-20
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-20
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-20
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-20
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-20
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-20
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-20
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-20
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-20
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-20
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-19
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-19
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-18
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-17
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-16
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-16
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-16
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-16
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-16
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-16
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-16
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-16
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-16
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-16
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-16
3soa_A	444	Full-Length Human Camkii Length = 444		7e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-15
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-15
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-12
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		8e-12
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		9e-12
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		6e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  500 bits (1288), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 380
Query: 369 A 369
           A
Sbjct: 381 A 381

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  499 bits (1286), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 390
Query: 369 A 369
           A
Sbjct: 391 A 391

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  499 bits (1286), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 386
Query: 369 A 369
           A
Sbjct: 387 A 387

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  499 bits (1286), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 388
Query: 369 A 369
           A
Sbjct: 389 A 389

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  499 bits (1286), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 431
Query: 369 A 369
           A
Sbjct: 432 A 432

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 365
Query: 369 A 369
           A
Sbjct: 366 A 366

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  497 bits (1280), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 240/351 (68%), Positives = 286/351 (81%), Gaps = 4/351 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 11  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 69
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 129
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 130 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 248
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 249 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 308
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 369
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 309 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 358

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  496 bits (1278), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 386
Query: 369 A 369
           A
Sbjct: 387 A 387

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 364
Query: 369 A 369
           A
Sbjct: 365 A 365

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 364
Query: 369 A 369
           A
Sbjct: 365 A 365

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 371
Query: 369 A 369
           A
Sbjct: 372 A 372

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  494 bits (1273), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 360
Query: 369 A 369
           A
Sbjct: 361 A 361

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  492 bits (1266), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 238/347 (68%), Positives = 284/347 (81%), Gaps = 4/347 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  489 bits (1260), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 238/349 (68%), Positives = 284/349 (81%), Gaps = 4/349 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 367
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQ 351

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  489 bits (1259), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/347 (68%), Positives = 283/347 (81%), Gaps = 4/347 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  489 bits (1258), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/347 (68%), Positives = 283/347 (81%), Gaps = 4/347 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 7   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 65
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 66  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 125
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 126 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 184
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 244
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 245 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 304
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 305 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 350

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  489 bits (1258), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/347 (68%), Positives = 283/347 (81%), Gaps = 4/347 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 10  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 68
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 128
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 129 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 187
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 247
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 248 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 307
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 308 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 353

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  486 bits (1252), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/349 (67%), Positives = 282/349 (80%), Gaps = 6/349 (1%)
Query: 21  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 77
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           YICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 236/347 (68%), Positives = 282/347 (81%), Gaps = 4/347 (1%)
Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ EK D +YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  485 bits (1249), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 237/351 (67%), Positives = 282/351 (80%), Gaps = 6/351 (1%)
Query: 21  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 77
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           YICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 367
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  479 bits (1234), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 234/349 (67%), Positives = 279/349 (79%), Gaps = 6/349 (1%)
Query: 21  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 77
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVP TV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  472 bits (1214), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 227/356 (63%), Positives = 285/356 (80%), Gaps = 5/356 (1%)
Query: 19  IIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE 78
           I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 79  LQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 137
           LQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R  +H+ K+ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
           +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           ICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
           +RE+IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+SRLL+Y+P+ R TA+EAL 
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 318 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 373
           HPFFDELR    R+PNGR LPPLFN+   EL   P D++ +L+P+HA  +    G+
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELSVRP-DLISRLVPQHAEAELLSRGI 376

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  344 bits (882), Expect = 6e-95,   Method: Compositional matrix adjust.
 Identities = 166/377 (44%), Positives = 247/377 (65%), Gaps = 43/377 (11%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 88
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 89  NVVSLKHCFFSTTEKD---------------------------------ELYLNLVLEYV 115
           N++ L   F++T +++                                   YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 116 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 175
           P+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179
Query: 176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
            LKLCDFGSAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 236 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV 295
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 296 DLVSRLLQYSPNLRSTALEALIHPFFDELRDP-------NTRLPNG--RFLPPLFNFKPH 346
           DL+ ++L+Y P+LR    EA+ HPFFD LR+        N+  P+G  + +P LFNF P+
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 347 ELKGVPVDMLVKLIPEH 363
           EL  +P ++L +++P++
Sbjct: 360 ELSIIPGNVLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  327 bits (838), Expect = 7e-90,   Method: Compositional matrix adjust.
 Identities = 162/339 (47%), Positives = 228/339 (67%), Gaps = 10/339 (2%)
Query: 32  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LLDHP 88
           K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 89  NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           N+V L+  F++  E+D  ++YLN+V+EYVP+T+HR  +++Y+     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 147 RALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
           R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 266 NPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 322
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    EAL HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 323 ELRDPNTRLPNGRFLP-PLFNFKPHELKGVPVDMLVKLI 360
           EL DP T+LPN + LP  LF F P+E++ +      KL+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 112/345 (32%), Positives = 189/345 (54%), Gaps = 29/345 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 90
            +  + ++G G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YIC 199
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 258
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 259 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 316 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           L HP+     DPN   P G  +PP F    H  + +    L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 112/345 (32%), Positives = 190/345 (55%), Gaps = 29/345 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 90
            +  + ++G G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYIC 199
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 258
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 259 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 316 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           L HP+     DPN   P G  +PP F    H  + +    L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 104/305 (34%), Positives = 176/305 (57%), Gaps = 22/305 (7%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 91
           Y   + +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            ++    ++T +    + +V + +   +++++K     SQ++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 207
           IH+   V HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 265
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 266 --NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
               NY +   P      W K+F K    +A+DL+ R+L ++PN R T  EAL HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 324 LRDPN 328
             DP 
Sbjct: 336 YYDPT 340

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 188/345 (54%), Gaps = 29/345 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 90
            +  + ++G G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YIC 199
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 258
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 259 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 316 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           L HP+     DPN   P G  +PP F    H  + +    L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 114/319 (35%), Positives = 176/319 (55%), Gaps = 36/319 (11%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 79
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIY 137
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 198 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 255 GTPTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNL 308
           GTP       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN 
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 281
Query: 309 RSTALEALIHPFFDELRDP 327
           R +A  AL HPFF ++  P
Sbjct: 282 RISAKAALAHPFFQDVTKP 300

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/303 (35%), Positives = 169/303 (55%), Gaps = 26/303 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y     VG G++GVV++AK  + G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 266
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
            P + +  F   +  PW  I       E +DL+S +L + PN R +A +A+ HP+F +L 
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL- 307
Query: 326 DPN 328
           DP 
Sbjct: 308 DPQ 310

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 114/319 (35%), Positives = 176/319 (55%), Gaps = 36/319 (11%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 79
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 80  QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIY 137
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 198 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 255 GTPTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNL 308
           GTP       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN 
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 281
Query: 309 RSTALEALIHPFFDELRDP 327
           R +A  AL HPFF ++  P
Sbjct: 282 RISAKAALAHPFFQDVTKP 300

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 108/297 (36%), Positives = 168/297 (56%), Gaps = 26/297 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           VG G++GVV++AK  + G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVAHCHQH- 138
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
           +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
             F   +  PW  I       E +DL+S +L + PN R +A +A+ HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 110/300 (36%), Positives = 170/300 (56%), Gaps = 32/300 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +   +++LYL  V E+V + + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 272 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 112/302 (37%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E VH+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 326 DP 327
            P
Sbjct: 291 KP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 326 DP 327
            P
Sbjct: 294 KP 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 326 DP 327
            P
Sbjct: 293 KP 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 326 DP 327
            P
Sbjct: 295 KP 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 242 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 326 DP 327
            P
Sbjct: 296 KP 297

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 326 DP 327
            P
Sbjct: 291 KP 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 326 DP 327
            P
Sbjct: 291 KP 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 326 DP 327
            P
Sbjct: 295 KP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 326 DP 327
            P
Sbjct: 294 KP 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 326 DP 327
            P
Sbjct: 293 KP 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 326 DP 327
            P
Sbjct: 291 KP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 326 DP 327
            P
Sbjct: 295 KP 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 326 DP 327
            P
Sbjct: 291 KP 292

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 167/302 (55%), Gaps = 22/302 (7%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 96  CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 209
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 177 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294
Query: 270 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  AL HPF  +  D
Sbjct: 295 VRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353
Query: 327 PN 328
           P+
Sbjct: 354 PD 355

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 326 DP 327
            P
Sbjct: 293 KP 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 242 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 326 DP 327
            P
Sbjct: 296 KP 297

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 167/302 (55%), Gaps = 22/302 (7%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 96  CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 209
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 270 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  AL HPF  +  D
Sbjct: 296 VRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354
Query: 327 PN 328
           P+
Sbjct: 355 PD 356

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + L++ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 323 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 326 DP 327
            P
Sbjct: 294 KP 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 326 DP 327
            P
Sbjct: 293 KP 294

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 110/298 (36%), Positives = 168/298 (56%), Gaps = 36/298 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF +
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 169/302 (55%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 326 DP 327
            P
Sbjct: 292 KP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 169/302 (55%), Gaps = 36/302 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 154
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 211
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 269
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 270 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 326 DP 327
            P
Sbjct: 291 KP 292

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/302 (33%), Positives = 172/302 (56%), Gaps = 28/302 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + LV   +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 327 PN 328
           P+
Sbjct: 339 PS 340

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 168/300 (56%), Gaps = 32/300 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 124
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 272 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 242 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 169/300 (56%), Gaps = 32/300 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 123
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 272 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 168/300 (56%), Gaps = 32/300 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 272 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 169/300 (56%), Gaps = 32/300 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 271
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 272 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 319 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 323 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 269 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 327 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 366

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 319 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/302 (32%), Positives = 173/302 (57%), Gaps = 28/302 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 327 PN 328
           P+
Sbjct: 339 PS 340

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 321 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 360

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 319 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/339 (30%), Positives = 179/339 (52%), Gaps = 57/339 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTM-RLLDHPN 89
           Y   + +G G++G+V+++    TGE VA+KK+        D +   RE+  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +V+L +   +  ++D   + LV +Y+   +H VI+ +      +  ++ +   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAVIRANI-----LEPVHKQYVVYQLIKVI 122
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------------------- 190
            Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V                    
Sbjct: 123 KYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 191 --GEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 247
              +P ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 248 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFQKRMPP-- 292
             II V+  P+ E+++ +   + +     +K                W  +  K  P   
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 293 ---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
              EA+DL+ +LLQ++PN R +A +AL HPF     +PN
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 317 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 266 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 324 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 363

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 267 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 325 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 364

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 258 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 316 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 355

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 323 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 189/345 (54%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+  +  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 321 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 360

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 110/345 (31%), Positives = 190/345 (55%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 323 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 187/344 (54%), Gaps = 32/344 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNP 267
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                  P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+  +  DP
Sbjct: 263 RNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321
Query: 328 NTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           +    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 322 S----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 360

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 165/304 (54%), Gaps = 23/304 (7%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 89
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 90  VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V+ L   F   +     Y   LV+ ++   + +++   +   +      ++   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQYLVYQMLKG 156
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 207
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 157 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 211
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N 
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 268 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
              +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL HPFF+  
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330
Query: 325 RDPN 328
           RDP 
Sbjct: 331 RDPE 334

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 91
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            +     + T +    + +V + +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKY 143
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 204
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 265 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 321 FDELRDPN 328
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 189/345 (54%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 317 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 356

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 108/301 (35%), Positives = 160/301 (53%), Gaps = 31/301 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 93
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              F   +      ++LV +++   +  +IK +   S  +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 210
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QHW-ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 268
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 269 YTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
           Y  FK FP I   P H IF      + +DL+  L  ++P  R TA +AL   +F     P
Sbjct: 246 YVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301
Query: 328 N 328
Sbjct: 302 T 302

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 171/299 (57%), Gaps = 22/299 (7%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 213
           V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 269
            YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
                P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  DP+
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 171/299 (57%), Gaps = 22/299 (7%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 213
           V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 269
            YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
                P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  DP+
Sbjct: 269 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 103/304 (33%), Positives = 165/304 (54%), Gaps = 23/304 (7%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 89
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 90  VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V+ L   F   +     Y   LV+ ++   + +++   +   +   L+Y      Q+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY------QMLKG 138
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 207
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 139 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 268 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
              +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL HPFF+  
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 325 RDPN 328
           RDP 
Sbjct: 313 RDPE 316

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 188/345 (54%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 319 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 102/297 (34%), Positives = 160/297 (53%), Gaps = 20/297 (6%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 94
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 95  HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
             F  +T+ +D   + LV   +   ++ ++K     SQ +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKYIH 148
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 272
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 273 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
               P +       IF +   P A+DL+ R+L    + R +A EAL H +F +  DP
Sbjct: 265 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 110/345 (31%), Positives = 187/345 (54%), Gaps = 34/345 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 210
           V HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 266
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 327 PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 370
           P+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 319 PS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 162/296 (54%), Gaps = 34/296 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 267
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 164/310 (52%), Gaps = 21/310 (6%)
Query: 22  TTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYK 75
             +G +N   +    Y    +VG GS+G+V + +  +TG  VAIKK L+       K+  
Sbjct: 12  VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
            RE++ ++ L H N+V+L        +K   YL  V E+V    H ++         +  
Sbjct: 72  MREIKLLKQLRHENLVNLLEV---CKKKKRWYL--VFEFVD---HTILDDLELFPNGLDY 123
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPN 194
             V+ Y +QI   + + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE  
Sbjct: 124 QVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY 181
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              + +R+YRAPEL+ G  +Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  L
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241
Query: 255 GT--PTREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           G   P  +E+   NP +   + P+IK   P  + + K +    +DL  + L   P+ R  
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPF 300
Query: 312 ALEALIHPFF 321
             E L H FF
Sbjct: 301 CAELLHHDFF 310

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 162/296 (54%), Gaps = 34/296 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 267
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 162/296 (54%), Gaps = 34/296 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 267
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 20/298 (6%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 94
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 95  HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
             F  +T+ +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 148
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 272
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 273 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
               P +       IF +   P A+DL+ R+L    + R +A EAL H +F +  DP 
Sbjct: 265 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 164/297 (55%), Gaps = 27/297 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 96
           +G GS+GVVF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNT 155
           F     + +  L+LV EY   TV     H     QR +P   VK   +Q  +A+ + H  
Sbjct: 71  F-----RRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
               HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G 
Sbjct: 122 -NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGD 177
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYT 270
           T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  ++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 271 EFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
             K P  +   P    F     P A+ L+   L   P  R T  + L HP+F+ +R+
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYP-ALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 96  CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F   T  +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 270
           Y   +DIWS GC++AELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
               PQ+    +  +F     P AVDL+ ++L    + R TA EAL HP+F +  DP+
Sbjct: 289 N-SLPQMPKRNFADVFIG-ANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPD 344

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 101/297 (34%), Positives = 158/297 (53%), Gaps = 20/297 (6%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 94
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 95  HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
             F  +T+ +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 140
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +  G+ HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 141 SA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 196
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 272
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 273 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
               P +       IF +   P A+DL+ R+L    + R +A EAL H +F +  DP
Sbjct: 257 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 312

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNA 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 154/295 (52%), Gaps = 22/295 (7%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 96
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 97  FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
           F      D+     LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQMLKGLRYIH-A 146
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
            G+ HRD+KP NL VN    +LK+ DFG A+           + +R+YRAPE+I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 271
           T  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +      NY +
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
              P+++   +  I      P AV+L+ ++L      R TA EAL HP+F+ L D
Sbjct: 264 -GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 166/308 (53%), Gaps = 23/308 (7%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
           +Y+    +G G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLA 114
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 265
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
           N  +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A+ HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 326 DPNTRLPN 333
           +   +LP+
Sbjct: 290 ERIHKLPD 297

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K     SQ++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 99  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 151
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 152 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 207
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 267
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 268 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 278 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 277 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 269 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 220
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 281 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 269 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 87  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 139
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 140 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 195
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 255
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 256 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 278 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 204
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 277 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNW 220
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 281 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 254
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 255 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 254
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 255 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 88  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 140
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 141 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 196
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 256
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 257 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 193
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 158/301 (52%), Gaps = 34/301 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 214 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 273 KFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
           K P  K +P +           ++     DL+  LL+ +P  R +A EAL HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 327 P 327
           P
Sbjct: 292 P 292

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 157/301 (52%), Gaps = 34/301 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 214 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 273 KFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
           K P  K +P +           ++     DL+  LL+ +P  R +A EAL HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 327 P 327
           P
Sbjct: 292 P 292

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K       ++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYI 137
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNW 217
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 278 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 96  CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 268
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 104/315 (33%), Positives = 167/315 (53%), Gaps = 48/315 (15%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVV- 91
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 92  ----------SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 139
                      L     S TE + +Y+  V EY+   +  V+       ++ PL+  + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVL-------EQGPLLEEHAR 123
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 197
           L+ YQ+ R L YIH+   V HRD+KP NL +N     LK+ DFG A+++   +P+ S+  
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKG 179
Query: 198 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VE 249
                + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+   +E
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSP 306
            I V+    R+E+  + P Y      +      HK   + +P    EAVD + ++L +SP
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEP-----HKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 307 NLRSTALEALIHPFF 321
             R TA EAL HP+ 
Sbjct: 295 MDRLTAEEALSHPYM 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 159/298 (53%), Gaps = 28/298 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 97
           +G+G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNT 155
            +  +     L LV E++   + + +         + + L  VK + +Q+ + LA+ H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATE 214
             + HRD+KPQNLL+N    QLKL DFG A+   +      S + + +YRAP+++ G+  
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-K 273
           Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP     + + P+ T+  K
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKLPK 241
Query: 274 F-PQIKAHPWHKIFQKRMP-------PEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           + P I+  P   + Q   P          +D +  LLQ +P++R +A +AL HP+F E
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 159/312 (50%), Gaps = 30/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN---------RELQTMRL 84
           Y  +R +  GS+G V  A     G  VAIK+V   + D R  N         R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 85  LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 139
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 260 EEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 316 LIHPFFDELRDP 327
           L HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 159/312 (50%), Gaps = 30/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN---------RELQTMRL 84
           Y  +R +  GS+G V  A     G  VAIK+V   + D R  N         R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 85  LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 139
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 260 EEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 316 LIHPFFDELRDP 327
           L HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 106/327 (32%), Positives = 165/327 (50%), Gaps = 21/327 (6%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 83
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 84  -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
            P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A  A
Sbjct: 237 LPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 316 LIHPFFDELRDPNTRLPNGRFLPPLFN 342
           L HP+F +L      L +   LPP  N
Sbjct: 295 LSHPYFQDLERCKENLDS--HLPPSQN 319

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 101/309 (32%), Positives = 159/309 (51%), Gaps = 19/309 (6%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 83
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 84  -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
            P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A  A
Sbjct: 237 LPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 316 LIHPFFDEL 324
           L HP+F +L
Sbjct: 295 LSHPYFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 157/306 (51%), Gaps = 19/306 (6%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 83
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 84  -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
            P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A  A
Sbjct: 237 LPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 316 LIHPFF 321
           L HP+F
Sbjct: 295 LSHPYF 300

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 99/318 (31%), Positives = 164/318 (51%), Gaps = 41/318 (12%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 91  VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQ 144
           + L + F    S  E  ++Y+  V+E +   + +VI+    H +MS            YQ
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS---------YLLYQ 134
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 204
           +   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYR
Sbjct: 135 MLVGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K 
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 265 MNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRS 310
           + P    Y E + P+   + + K+F   + P           +A DL+S++L    + R 
Sbjct: 252 LQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 311 TALEALIHPFFDELRDPN 328
           +  EAL HP+ +   DP+
Sbjct: 311 SVDEALQHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 313 DDALQHPYINVWYDP 327

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 159/311 (51%), Gaps = 29/311 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 139
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y A +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 268 -NYTEF--KFPQIKAH--------PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
            NY E   K+P IK          P      K    +A DL+S++L   P+ R +  EAL
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 317 IHPFFDELRDP 327
            HP+     DP
Sbjct: 317 RHPYITVWYDP 327

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 99/318 (31%), Positives = 164/318 (51%), Gaps = 41/318 (12%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 91  VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQ 144
           + L + F    S  E  ++Y+  V+E +   + +VI+    H +MS            YQ
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS---------YLLYQ 134
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 204
           +   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYR
Sbjct: 135 MLCGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K 
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 265 MNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRS 310
           + P    Y E + P+   + + K+F   + P           +A DL+S++L    + R 
Sbjct: 252 LQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 311 TALEALIHPFFDELRDPN 328
           +  EAL HP+ +   DP+
Sbjct: 311 SVDEALQHPYINVWYDPS 328

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 129
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 306 DDALQHPYINVWYDP 320

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 313 DDALQHPYINVWYDP 327

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 161/312 (51%), Gaps = 41/312 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 96
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N++ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 97  FF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQICRALA 150
           F    S  E  ++Y+  V+E +   + +VI+    H +MS            YQ+   + 
Sbjct: 92  FTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS---------YLLYQMLVGIK 140
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 267
           G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEAL 316
            Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EAL
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 317 IHPFFDELRDPN 328
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 161/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 316 LIHPFFDELRDP 327
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 155/294 (52%), Gaps = 28/294 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                      L+L+ EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 IHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151
Query: 157 GVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 209
              HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 267
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +   P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           ++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A  AL HP+F
Sbjct: 270 DWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/299 (30%), Positives = 152/299 (50%), Gaps = 25/299 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVSL 93
            Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                    +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
            ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 214 EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMN 266
            Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ ++
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LD 266
Query: 267 PNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 267 PRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 99/318 (31%), Positives = 163/318 (51%), Gaps = 41/318 (12%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQ 144
           + L + F    S  E  ++Y+  V+E +   + +VI+    H +MS            YQ
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS---------YLLYQ 134
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 204
           +   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYR
Sbjct: 135 MLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K 
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 265 MNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRS 310
           + P    Y E + P+   + + K+F   + P           +A DL+S++L    + R 
Sbjct: 252 LQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 311 TALEALIHPFFDELRDPN 328
           +  EAL HP+ +   DP+
Sbjct: 311 SVDEALQHPYINVWYDPS 328

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 161/312 (51%), Gaps = 41/312 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 96
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 97  FF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQICRALA 150
           F    S  E  ++Y+  V+E +   + +VI+    H +MS            YQ+   + 
Sbjct: 92  FTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS---------YLLYQMLVGIK 140
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 267
           G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEAL 316
            Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EAL
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 317 IHPFFDELRDPN 328
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 255 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 313
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 314 DDALQHPYINVWYDP 328

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 313 DDALQHPYINVWYDP 327

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 129
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 306 DDALQHPYINVWYDP 320

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 313 DDALQHPYINVWYDP 327

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 177
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 316 LIHPFFDELRDP 327
           L HP+ +   DP
Sbjct: 354 LQHPYINVWYDP 365

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 255 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 313
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 314 DDALQHPYINVWYDP 328

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 135
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 136 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 194 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 253 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 311
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 312 DDALQHPYINVWYDP 326

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 130
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 248 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 313 LEALIHPFFDELRDP 327
            +AL HP+ +   DP
Sbjct: 307 DDALQHPYINVWYDP 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 133
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 316 LIHPFFDELRDP 327
           L HP+ +   DP
Sbjct: 310 LQHPYINVWYDP 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 177
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 316 LIHPFFDELRDP 327
           L HP+ +   DP
Sbjct: 354 LQHPYINVWYDP 365

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 161/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 159/312 (50%), Gaps = 31/312 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 137
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + P      + ++F   + P           +A DL+S++L   P+ R +  EA
Sbjct: 255 RNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 316 LIHPFFDELRDP 327
           L HP+     DP
Sbjct: 314 LRHPYITVWYDP 325

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 96/316 (30%), Positives = 161/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 138
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+        + ++ +RYYRAP
Sbjct: 139 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAP 196
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 197 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 256 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 314
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 315 DEALQHPYINVWYDPS 330

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 140
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 258 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 316 LIHPFFDELRDPN 328
           L HP+ +   DP+
Sbjct: 317 LQHPYINVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 160/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 157
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 270
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 271 AYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 330
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 331 LEAMTHPYFQQVR 343

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 158/307 (51%), Gaps = 31/307 (10%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 316 LIHPFFD 322
           L HP+ +
Sbjct: 316 LQHPYIN 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 138
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 251
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 252 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 311
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 312 LEAMTHPYFQQVR 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 87
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 250
Query: 267 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 312
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 313 LEALIHPFFDELR 325
           LEA+ HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 133
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 251 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 316 LIHPFFDELRDPN 328
           L HP+ +   DP+
Sbjct: 310 LQHPYINVWYDPS 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 144
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 145 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 267
            G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 268 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 315
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 262 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 316 LIHPFFDELRDPN 328
           L HP+ +   DP+
Sbjct: 321 LQHPYINVWYDPS 333

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 96/316 (30%), Positives = 159/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISV 312
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 150/300 (50%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N+L++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 106/355 (29%), Positives = 171/355 (48%), Gaps = 77/355 (21%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 89
           +Y+ + ++G GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 90  VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L          + DELY+  VLE     + ++ K    +++     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNI----------- 195
              +IH + G+ HRD+KP N L+N     +K+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 196 -----------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQ-------- 235
                      S++ +R+YRAPELI     YT +IDIWS GC+ AELL + Q        
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 236 --PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFP 275
             PLFPG                 +S  DQL  I  ++GTPT +++K +N P   ++   
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY--- 315
Query: 276 QIKAHPWHK---IFQK--RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
            IK  P  K   + QK   +  + ++L+  +L+++PN R T  +AL HP+  ++R
Sbjct: 316 -IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 107/359 (29%), Positives = 161/359 (44%), Gaps = 79/359 (22%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 90
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 91  VSLKHCFF-STTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V +         EK DELY+  VLE       ++ +    +++    +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------------ 196
           + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S            
Sbjct: 169 VKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 197 ----------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-------- 232
                           ++ +R+YRAPELI     YT AID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 233 ---LGQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNY 269
                 PLFPG S                      DQL  I  +LGTP+ E+I+ +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVD---LVSRLLQYSPNLRSTALEALIHPFFDELR 325
            + ++ +I          +R P  + D   L+ R+L ++PN R T  E L HPFF E+R
Sbjct: 347 AK-RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/316 (30%), Positives = 159/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP    +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P   NY E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/333 (28%), Positives = 167/333 (50%), Gaps = 53/333 (15%)
Query: 31  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 87
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 88  -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 201
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 262 IKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA--------- 294
            K ++ +     F   K +P +                  +  + R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 295 ------VDLVSRLLQYSPNLRSTALEALIHPFF 321
                 +D + + L++ P +R T  +AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/333 (28%), Positives = 167/333 (50%), Gaps = 53/333 (15%)
Query: 31  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 87
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 88  -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 201
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 262 IKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA--------- 294
            K ++ +     F   K +P +                  +  + R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 295 ------VDLVSRLLQYSPNLRSTALEALIHPFF 321
                 +D + + L++ P +R T  +AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/316 (29%), Positives = 159/316 (50%), Gaps = 37/316 (11%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 91  VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 146
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 267 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 312
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 313 LEALIHPFFDELRDPN 328
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLRQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 321 F 321
           F
Sbjct: 324 F 324

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 103/360 (28%), Positives = 161/360 (44%), Gaps = 78/360 (21%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 89
           +Y  + ++G GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 90  VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L          + DELY+  VLE     + ++ K    ++++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------------ 195
              +IH + G+ HRD+KP N L+N     +K+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 196 ---------------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ----- 235
                          S++ +R+YRAPELI     YT +IDIWS GC+ AELL        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 236 ------PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPN---- 268
                 PLFPG                 +S  DQL  I  V+GTP  E++KC+       
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
           Y +  FP        K +   +  E +DL+  +L+++   R T  +AL HP+  ++R  N
Sbjct: 320 YIKL-FPTRDGIDLSKKYSS-ISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKEN 377

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 151
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 270
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 271 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 321 F 321
           F
Sbjct: 324 F 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 93
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 94  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 144
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 145 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 264 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 321 F 321
           F
Sbjct: 324 F 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 321 F 321
           F
Sbjct: 324 F 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 321 F 321
           F
Sbjct: 324 F 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 145
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 263
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 264 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 321 F 321
           F
Sbjct: 323 F 323

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 264
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 265 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 321 F 321
           F
Sbjct: 324 F 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 27/300 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 91
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 145
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 212 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 265
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 266 NPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 265 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 169
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 164
Query: 170 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 229
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 230 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 280
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 281 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            W           + PEA+DL+ +LL+Y    R TA EA+ HP+F
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 169
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 169
Query: 170 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 229
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 230 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 280
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 281 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            W           + PEA+DL+ +LL+Y    R TA EA+ HP+F
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 164/333 (49%), Gaps = 53/333 (15%)
Query: 31  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 87
           P   ++Y  E  +V+G G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 88  -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 201
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 262 IKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA--------- 294
            K ++ +     F   K +P +                  +  + R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 295 ------VDLVSRLLQYSPNLRSTALEALIHPFF 321
                 +D + + L++ P +R T  +AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 16/288 (5%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVSL 93
           +G G++G V++A+   +G  VA+K V      +   + T+R           +HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                ++    E+ + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
               + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++  +T
Sbjct: 130 ANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGA 245
Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 FPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 16/288 (5%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVSL 93
           +G G++G V++A+   +G  VA+K V      +   + T+R           +HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                ++    E+ + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
               + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++  +T
Sbjct: 130 ANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGA 245
Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 FPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 104/351 (29%), Positives = 160/351 (45%), Gaps = 61/351 (17%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 87  HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 137
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 139
Query: 138 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------- 295
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 257 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 314
Query: 296 -----------------DLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 329
                            DL+ R+L Y P  R     AL H FF +  D  T
Sbjct: 315 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 16/288 (5%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVSL 93
           +G G++G V++A+   +G  VA+K V      +   + T+R           +HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                ++    E+ + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
               + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++  +T
Sbjct: 130 ANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGA 245
Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 FPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 140/284 (49%), Gaps = 42/284 (14%)
Query: 77  RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQ 131
           RE+  +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 132 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL 188
           ++P   VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 189 ---VKGEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF------ 238
              +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 239 ---PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFKFPQ---------IKAHPWH 283
                    DQL  I  V+G P     E+IK M  + T  K  +         IK    H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 284 KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
           K+   +   +A  L+ +LL   P  R T+ +A+  P+F  L DP
Sbjct: 303 KV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 27/295 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLD--- 86
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           HPNVV L     ++    E+ + LV E+V + +   +         +P   +K    Q  
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFL 130
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
           R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAP
Sbjct: 131 RGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 189 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 246
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +     FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 87  HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 137
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 138 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------- 295
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 296 -----------------DLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                            DL+ R+L Y P  R     AL H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 87  HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 137
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 138 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------- 295
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 296 -----------------DLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                            DL+ R+L Y P  R     AL H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 148/304 (48%), Gaps = 38/304 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 97  FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 206
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 267 PNYTEF----KFPQIKAHPWHKIFQKRM-----PPEAVDLVSRLLQYSPNLRSTALEALI 317
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + +AL 
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 318 HPFF 321
           H FF
Sbjct: 313 HDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 97  FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 206
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + +AL H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 148/304 (48%), Gaps = 38/304 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 97  FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 139
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 206
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 253
Query: 267 PNYTEF----KFPQIKAHPWHKIFQKRM-----PPEAVDLVSRLLQYSPNLRSTALEALI 317
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + +AL 
Sbjct: 254 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 318 HPFF 321
           H FF
Sbjct: 312 HDFF 315

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 148/304 (48%), Gaps = 38/304 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 97  FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKASIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 206
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 267 PNYTEF----KFPQIKAHPWHKIFQKRM-----PPEAVDLVSRLLQYSPNLRSTALEALI 317
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + +AL 
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 318 HPFF 321
           H FF
Sbjct: 313 HDFF 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 89
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 161
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 266 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 89
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 160
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 265 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 89
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 89
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 143
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 248 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 102/358 (28%), Positives = 162/358 (45%), Gaps = 51/358 (14%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 88
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 89  N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 134
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 189
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 243
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 244 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRM 290
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 291 PPEAVDLVSRLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 341
             E  D +S +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 102/358 (28%), Positives = 162/358 (45%), Gaps = 51/358 (14%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 88
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 89  N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 134
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 189
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 243
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 244 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRM 290
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 291 PPEAVDLVSRLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 341
             E  D +S +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 131/295 (44%), Gaps = 49/295 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 89
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           +  L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
              YT F+ PQ     W     K++   A DL+ + L Y P+ R +A +AL H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 88
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 206
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 92
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   F   T+   +YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 71  LYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 121
Query: 152 IHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            H  + V HRD+KP+N L   +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 122 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G   Y    D WSAG ++  LL G P F   +  + +++I +  GT             
Sbjct: 181 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT------------- 223
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
             F FP+     W  +      P+A  L+ RLL  SP  R T+L+AL H +F++
Sbjct: 224 --FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 92
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   F   T+   +YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 88  LYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 138
Query: 152 IHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            H  + V HRD+KP+N L   +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 139 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G   Y    D WSAG ++  LL G P F   +  + +++I +  GT             
Sbjct: 198 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT------------- 240
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
             F FP+     W  +      P+A  L+ RLL  SP  R T+L+AL H +F++
Sbjct: 241 --FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 280
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 281 HPWLQD 286

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 49/308 (15%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 94
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 155 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
             PQ     W  I       +A DL+ ++L + P+LR TA + L HP+   ++  ++  P
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 333 NGRFLPPL 340
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 273
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 274 HPWLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 148/327 (45%), Gaps = 54/327 (16%)
Query: 42  VVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 98
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 99  STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                +      ++ +V E +  + +  IK +  +  R+   +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 155 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 193
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
           + + + +R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 254 LG---------TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV------DLV 298
           LG         T  R+       ++ E            K  ++ M  + V      DL+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 299 SRLLQYSPNLRSTALEALIHPFFDELR 325
            ++L+Y P  R T  EAL HPFFD L+
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 207
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 250
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 251 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 294
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 295 FESVTWEN 302

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 94
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 155 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
             PQ     W  I       +A DL+ ++L + P+LR TA + L HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 94
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 155 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
             PQ     W  I       +A DL+ ++L + P+LR TA + L HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 146/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 146
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 203
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 246
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 247 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 290
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 291 FESVTWEN 298

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 143/302 (47%), Gaps = 46/302 (15%)
Query: 28  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMR 83
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLY 141
            L HPN++ LK  F + TE     ++LVLE V   E   R+++  Y  S+R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGY-YSERDAADAVK-- 155
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNISYIC 199
             QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
               Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------F 260
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           R  + C      E+ F      PW       +   A DLV +L+   P  R T  +AL H
Sbjct: 261 RRILNC------EYYF----ISPWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 319 PF 320
           P+
Sbjct: 307 PW 308

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 146/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
             CF    + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 103 YFCF---QDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 154
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 155 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 211
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 212 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 254
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 255 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 298
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 299 FESVTWEN 306

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 147/327 (44%), Gaps = 54/327 (16%)
Query: 42  VVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 98
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 99  STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                +      ++ +V E +  + +  IK +  +  R+   +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 155 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 193
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
           + + +  R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 254 LG---------TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV------DLV 298
           LG         T  R+       ++ E            K  ++ M  + V      DL+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 299 SRLLQYSPNLRSTALEALIHPFFDELR 325
            ++L+Y P  R T  EAL HPFFD L+
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 88
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 88
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L   Y       ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGL--SYAKNGC--LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 206
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSASKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 88
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL- 204
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 88
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSAXKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL------------- 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 317
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 367
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 368 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 413
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 414 HPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 83
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 200
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 201 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 353
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 354 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 399
Query: 318 HPFFDE 323
           HP+  +
Sbjct: 400 HPWLQD 405

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL------------- 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 207
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 250
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 251 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 294
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 295 FESVTWEN 302

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F  +T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  D    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 74  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 125
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 126 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 182
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 183 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 225
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 226 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 270 FESVTWEN 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 73  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 124
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 125 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 181
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 182 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 224
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 225 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 268
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 269 FESVTWEN 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 80  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 131
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 132 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 188
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 189 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 231
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 232 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 275
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 276 FESVTWEN 283

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 75  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 126
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 127 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 183
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 184 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 226
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 227 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 270
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 271 FESVTWEN 278

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 146
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 203
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 246
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 247 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 290
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 291 FESVTWEN 298

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 76  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 127
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 128 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 184
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 185 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 227
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 228 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 271
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 272 FESVTWEN 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 97
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEY 215
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
             A DIWS GC + E+  G+P F                        +   P    FK  
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 239
Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             K HP      + M  EA   + +  +  P+ R+ A + L+  F 
Sbjct: 240 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 49/305 (16%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 98
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 99  STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 157 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--AT 213
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            YT   D+WS G +   LL G   F GE+  + L              +K  + N  +  
Sbjct: 335 YYT---DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSA 379
Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--NTRL 331
           F  I               +  D + +LL   PN R T  +AL HP+      P  ++++
Sbjct: 380 FSGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 332 PNGRF 336
           P+ R+
Sbjct: 427 PSSRY 431

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 97
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 128
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEY 215
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
             A DIWS GC + E+  G+P F                        +   P    FK  
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 225
Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             K HP      + M  EA   + +  +  P+ R+ A + L+  F 
Sbjct: 226 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 49/305 (16%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 98
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 99  STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 157 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--AT 213
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            YT   D+WS G +   LL G   F GE+  + L              +K  + N  +  
Sbjct: 229 YYT---DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSA 273
Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--NTRL 331
           F  I               +  D + +LL   PN R T  +AL HP+      P  ++++
Sbjct: 274 FSGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 320
Query: 332 PNGRF 336
           P+ R+
Sbjct: 321 PSSRY 325

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 46/298 (15%)
Query: 32  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDH 87
           ++T  +M   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            N+V+L+  + STT     YL + L    E   R+++      +   L+       Q+  
Sbjct: 66  ENIVTLEDIYESTTH---YYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS 117
Query: 148 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSR-YYR 204
           A+ Y+H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 322
               Y EF+ P          F   +   A D +  LL+  PN R T  +AL HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 90/308 (29%), Positives = 144/308 (46%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF     A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 320
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 99/346 (28%), Positives = 146/346 (42%), Gaps = 90/346 (26%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 86
           Y  +  +G GS+GVV  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYV------------------------------- 115
           HPN+  L   +     +DE Y+ LV+E                                 
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 116 -PETVHRVIK---HHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 167
            PE     I    H ++ S    QR  LI       QI  AL Y+HN  G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLI--SNIMRQIFSALHYLHNQ-GICHRDIKPEN 198
Query: 168 LLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE-YTAAID 220
            L + + + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 221 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 280
            WSAG +L  LL+G   FPG +  D + +++        +++   NPNY           
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN---------- 301
Query: 281 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                    + P A DL+S LL  + + R  A+ AL HP+  +  D
Sbjct: 302 --------VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 149/319 (46%), Gaps = 51/319 (15%)
Query: 35  ISYMAERV--VGHGSFGVVF--QAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLD 86
           +S M +RV  +G G++G V   + K      A+ I +        N     E+  ++LLD
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLE-YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           HPN++ L + FF    +D+    LV+E Y    +   I H  K ++    + +K    Q+
Sbjct: 95  HPNIMKL-YDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK----QV 145
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYY 203
              + Y+H    + HRD+KP+NLL+        +K+ DFG + V    +     + + YY
Sbjct: 146 LSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI++          K
Sbjct: 205 IAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------K 248
Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                YT F  P+     W     K +   A DL+ ++LQ+    R +A +AL HP+  E
Sbjct: 249 VEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297
Query: 324 LRDPNTRLPNGRFLPPLFN 342
           +    ++  +G  LP L N
Sbjct: 298 M---CSKKESGIELPSLAN 313

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 25  GGKN-GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 77
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 78  -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 134
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 192
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 193 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 239
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 179 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 25  GGKN-GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 77
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 78  -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 134
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 192
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 121 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 179
Query: 193 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 239
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 180 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 138/313 (44%), Gaps = 46/313 (14%)
Query: 18  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKR 73
           H IVT    K G      +     ++G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 74  YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQ 131
               E+  M  LDH N++ L   F S  +     + LV+EYV   E   R+I   Y +++
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 132 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVK 190
              ++++K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 250
            E       +  + APE++      +   D+WS G +   LL G   F G++  + L  I
Sbjct: 242 REKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 310
           +        EE                        FQ  +  EA + +S+LL    + R 
Sbjct: 301 LACRWDLEDEE------------------------FQD-ISEEAKEFISKLLIKEKSWRI 335
Query: 311 TALEALIHPFFDE 323
           +A EAL HP+  +
Sbjct: 336 SASEALKHPWLSD 348

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 144/308 (46%), Gaps = 64/308 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 101 ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 152
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 210
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 153 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 209
Query: 211 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 266
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 210 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 252
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 320
               E+ FP                P+A DLV +L  L  +  L    +E       HPF
Sbjct: 253 ----EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 296
Query: 321 FDELRDPN 328
           F+ +   N
Sbjct: 297 FESVTWEN 304

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 49/298 (16%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 171
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 214 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 267
Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 329
            + P +++  W + F+        + V   LQ  P  R T+   L H F    R P  
Sbjct: 268 NESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 141/297 (47%), Gaps = 46/297 (15%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 91
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            +   F     +D   + +V+E     E + R++    +  + +   YV     Q+  AL
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNAL 137
Query: 150 AYIHNTIGVCHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
           AY H+   V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y AP
Sbjct: 138 AYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+     + T   DIWSAG V+  LL G   F G S    L E+        +++     
Sbjct: 196 EVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKE 241
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           PNY       ++  P        + P+AVDL+ ++L   P  R +A + L H +F +
Sbjct: 242 PNYA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 64/295 (21%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNISYICSRYYRA 205
           H+   V HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 214 E--YTAAIDIWSAGCVLAELLLGQP 236
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++ + R T  E L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 137/325 (42%), Gaps = 59/325 (18%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           +G G++GVV + + + +G+ +A+K++   +   N + Q   L+D    +    C F+ T 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 103 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 158
              L+    + + +E +  ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGATEY 215
            HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I        Y
Sbjct: 176 IHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
           +   DIWS G  + EL + +  FP +S            GTP ++               
Sbjct: 235 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LK 268
Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 335
           Q+   P  ++   +   E VD  S+ L+ +   R T  E + HPF               
Sbjct: 269 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF--------------- 313
Query: 336 FLPPLFNFKPHELKGVPVDMLVKLI 360
                  F  HE KG  V   VKLI
Sbjct: 314 -------FTLHESKGTDVASFVKLI 331

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++ + R T  E L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 137/297 (46%), Gaps = 47/297 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 140 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 189
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEY 215
           GV HRDIK  ++L+  H  ++KL DFG    + K  P     + + Y+ APELI     Y
Sbjct: 190 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 247
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 288
Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P + +P
Sbjct: 289 RLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 143/312 (45%), Gaps = 51/312 (16%)
Query: 29  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 81
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 122 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 224 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 321 FDELRDPNTRLP 332
             +   P + +P
Sbjct: 273 LAKAGPPASIVP 284

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 143/312 (45%), Gaps = 51/312 (16%)
Query: 29  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 81
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 126 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 227
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 228 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 276
Query: 321 FDELRDPNTRLP 332
             +   P + +P
Sbjct: 277 LAKAGPPASIVP 288

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 137/322 (42%), Gaps = 50/322 (15%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 82
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 201
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 322 DELRDPNTRLPNGRF-LPPLFN 342
                P  RLP     +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 143/312 (45%), Gaps = 51/312 (16%)
Query: 29  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 81
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 27  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 81
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 82  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 132
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 133 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 190
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 191 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 234
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 235 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 283
Query: 321 FDELRDPNTRLP 332
             +   P + +P
Sbjct: 284 LAKAGPPASIVP 295

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 143/312 (45%), Gaps = 51/312 (16%)
Query: 29  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 81
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 25  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 79
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 80  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 130
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 131 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 188
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 189 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 232
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 233 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 281
Query: 321 FDELRDPNTRLP 332
             +   P + +P
Sbjct: 282 LAKAGPPASIVP 293

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 140/326 (42%), Gaps = 61/326 (18%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           +G G++GVV + + + +G+ +A+K++   +   N + Q   L+D    +    C F+ T 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 103 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 158
              L+    + + +E +  ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 214
            HRD+KP N+L+N    Q+K+CDFG +  LV     +I   C + Y APE I        
Sbjct: 132 IHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQKG 189
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y+   DIWS G  + EL + +  FP +S            GTP ++              
Sbjct: 190 YSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------L 223
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG 334
            Q+   P  ++   +   E VD  S+ L+ +   R T  E + HPF              
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF-------------- 269
Query: 335 RFLPPLFNFKPHELKGVPVDMLVKLI 360
                   F  HE KG  V   VKLI
Sbjct: 270 --------FTLHESKGTDVASFVKLI 287

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 82
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 201
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 322 DELRDPNTRLPNGRF-LPPLFN 342
                P  RLP     +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E  E  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIET-EKTLYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 123
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 137/297 (46%), Gaps = 47/297 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 217 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 266
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEY 215
           GV HRDIK  ++L+  H  ++KL DFG    + K  P     + + Y+ APELI     Y
Sbjct: 267 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 324
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 365
Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P + +P
Sbjct: 366 RLKN--LHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 82
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 201
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 322 DELRDPNTRLPNGRF-LPPLFN 342
                P  RLP     +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 82
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 132
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 201
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 228 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 280
Query: 322 DELRDPNTRLPNGRF-LPPLFN 342
                P  RLP     +PP F+
Sbjct: 281 TSGYAP-MRLPTSCLTVPPRFS 301

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 25  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------- 76
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 77  RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMP 134
           RE+Q ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVE 109
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
            +  +  F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE  
Sbjct: 110 EMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFL 167
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
            +   S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 128/302 (42%), Gaps = 59/302 (19%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----------------E 78
           SY   R +G G++G V   K        AIK + + +  K R                 E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 79  LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLI 136
           +  ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I  H K  +     
Sbjct: 97  ISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAAN 150
Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN 194
            +K    QI   + Y+H    + HRDIKP+N+L+        +K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                         Y +F       + W     K +  EA +L+  +L Y  N R TA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 315 AL 316
           AL
Sbjct: 299 AL 300

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 25  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------- 76
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 77  RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMP 134
           RE+Q ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVE 109
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
            +  +  F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE  
Sbjct: 110 EMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFL 167
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
                S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 168 RDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------R 77
           G + QP    +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 135
           E++ M++L+HPN+V L    F   E  E  L L++EY    E    ++ H      RM  
Sbjct: 61  EVRIMKILNHPNIVKL----FEVIET-EKTLYLIMEYASGGEVFDYLVAHG-----RMKE 110
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              +  F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    
Sbjct: 111 KEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLD 168
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           ++  S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV+EY    E    ++ H +   +       +  F QI
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGWMKEKE-----ARAKFRQI 115
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 116 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 135/314 (42%), Gaps = 51/314 (16%)
Query: 23  TIGGKNGQPKQTISYMAERV---------VGHGSFGVVFQAKCLETGEAVAIK----KVL 69
           ++  +NG+   +    AE +         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 70  QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 128
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R+++  + 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL--CDFGSAK 186
             +    +       Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +K
Sbjct: 118 TEKDASTL-----IRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 246
           +  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+    
Sbjct: 172 MEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 306
             +I+K                  EF  P      W  I        A D +  L++  P
Sbjct: 231 FEQILKA---------------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKDP 265
Query: 307 NLRSTALEALIHPF 320
           N R T  +A  HP+
Sbjct: 266 NKRYTCEQAARHPW 279

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 92/337 (27%), Positives = 158/337 (46%), Gaps = 75/337 (22%)
Query: 25  GGKNGQPKQTIS-----------YMAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDK 72
           GGK G+  +  +            ++E+++G+GS G VVFQ      G  VA+K++L D 
Sbjct: 12  GGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID- 68
Query: 73  RYKNRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYL-----NLVLEYVPETVHRVI 123
            + +  L  ++LL    DHPNV+     + S T    LY+     NL L+ + E+ + V 
Sbjct: 69  -FCDIALMEIKLLTESDDHPNVI---RYYCSETTDRFLYIALELCNLNLQDLVESKN-VS 123
Query: 124 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-------- 175
             + K+ +    I +     QI   +A++H ++ + HRD+KPQN+LV+  +         
Sbjct: 124 DENLKLQKEYNPISL---LRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTG 179
Query: 176 ----QLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE--YTAAIDIWSA 224
               ++ + DFG  K L  G+            +  +RAPEL+  +T+   T +IDI+S 
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSM 239
Query: 225 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 284
           GCV    +L +   P      +   II+  G  + +E+KC++                  
Sbjct: 240 GCVFY-YILSKGKHPFGDKYSRESNIIR--GIFSLDEMKCLH------------------ 278
Query: 285 IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              + +  EA DL+S+++ + P  R TA++ L HP F
Sbjct: 279 --DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 92/337 (27%), Positives = 158/337 (46%), Gaps = 75/337 (22%)
Query: 25  GGKNGQPKQTIS-----------YMAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDK 72
           GGK G+  +  +            ++E+++G+GS G VVFQ      G  VA+K++L D 
Sbjct: 12  GGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID- 68
Query: 73  RYKNRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYL-----NLVLEYVPETVHRVI 123
            + +  L  ++LL    DHPNV+     + S T    LY+     NL L+ + E+ + V 
Sbjct: 69  -FCDIALMEIKLLTESDDHPNVI---RYYCSETTDRFLYIALELCNLNLQDLVESKN-VS 123
Query: 124 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-------- 175
             + K+ +    I +     QI   +A++H ++ + HRD+KPQN+LV+  +         
Sbjct: 124 DENLKLQKEYNPISL---LRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTG 179
Query: 176 ----QLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE--YTAAIDIWSA 224
               ++ + DFG  K L  G+            +  +RAPEL+  +T+   T +IDI+S 
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSM 239
Query: 225 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 284
           GCV    +L +   P      +   II+  G  + +E+KC++                  
Sbjct: 240 GCVFY-YILSKGKHPFGDKYSRESNIIR--GIFSLDEMKCLH------------------ 278
Query: 285 IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              + +  EA DL+S+++ + P  R TA++ L HP F
Sbjct: 279 --DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEA-VAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHC 96
           +G G+FGVV   +C+E     V + K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 97  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 155 TIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
              + H DIKP+N++        +K+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
                 D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDA 273
Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD-ELRDPNTRLP 332
           F  +              PEA D +  LLQ  P  R T  +AL HP+   +  +  +R+P
Sbjct: 274 FSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
Query: 333 NGRF 336
           + R+
Sbjct: 321 SSRY 324

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 33  QTISYMAERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMR 83
           Q +S   +RV  +G G++G V   K   TG   AIK + +              E+  ++
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
            LDHPN++ L   F    +K   YL + +    E    +I     + Q+   +   +   
Sbjct: 77  QLDHPNIMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMK 128
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 201
           Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + 
Sbjct: 129 QVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 187
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           YY APE++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +
Sbjct: 188 YYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGK 238
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                P++T+                  +  EA  LV  +L Y P+ R +A EAL HP+
Sbjct: 239 FSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 50/297 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKNRELQTMRLLDHPNVV 91
           YM    +G G FG+V   +C+ET       A  +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L   F S  E     L ++ E++   +   R+    +++++R  + YV    +Q+C AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
            ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +      + A D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 269 YT--EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           YT  E  F +I               EA+D V RLL      R TA EAL HP+  +
Sbjct: 220 YTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 143/322 (44%), Gaps = 71/322 (22%)
Query: 29  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 81
           G P++   Y+A  + +G GS G+V  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
           MR   H NVV +   + S    DEL++  V+E++       I  H +M++      +   
Sbjct: 96  MRDYHHDNVVDM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
              + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P    +   
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +                      
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPY---------------------- 241
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL--VSRLLQ--------YSPNLRS 310
                      F  P ++A    +  +  +PP   DL  VS +L+          P+ R+
Sbjct: 242 -----------FNEPPLQA---MRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRA 287
Query: 311 TALEALIHPFFDELRDPNTRLP 332
           TA E L HPF      P+  +P
Sbjct: 288 TAQELLGHPFLKLAGPPSCIVP 309

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 89
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           ++ L   F    +K   YL + +    E    +I     + Q+   +   +   Q+    
Sbjct: 66  IMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGT 117
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
            Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE
Sbjct: 118 TYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +     P
Sbjct: 177 VL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFDPP 227
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++T+                  +  EA  LV  +L Y P+ R +A EAL HP+
Sbjct: 228 DWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 89
           Y+    +G GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           ++ L     + T+     + +V+EY    +   I    +M++       + +F QI  A+
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVEKKRMTEDEG----RRFFQQIICAI 121
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            Y H    + HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E  E  L L++EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIET-EKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQI 123
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 40  ERV--VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 90
           ER+  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V     F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 127
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           AY+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE +
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQ 235
            G T Y+   DIWS G  L EL +G+
Sbjct: 186 QG-THYSVQSDIWSMGLSLVELAVGR 210

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 20/216 (9%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DH 87
            ++  +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           P +  +  C F T E     L  V+EY+       + +H +   +  L     Y  +I  
Sbjct: 78  PFLTHM-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAP 206
            L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y AP
Sbjct: 130 GLQFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           E++ G  +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 58/300 (19%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 88
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH---HYKMSQRMPLIYVKLYFY 143
           +++ L     + ++     + +V+EYV   E    + K+     K S+R+        F 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQ 123
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 203
           QI   + Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y
Sbjct: 124 QILSGVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNY 181
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            APE+I G       +DIWS+G +L  LL G   F  +               PT  +  
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKI 228
Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           C    YT    PQ             + P  + L+  +LQ  P  R+T  +   H +F +
Sbjct: 229 CDGIFYT----PQY------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 132/295 (44%), Gaps = 43/295 (14%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH 87
           QP++    + +  +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           P+VV     +F  T+     L +V+EY    +V  +I+   K      +  +        
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQSTL 135
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRA 205
           + L Y+H    + HRDIK  N+L+N   H  KL DFG A  L       +  I + ++ A
Sbjct: 136 KGLEYLHFMRKI-HRDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE+I     Y    DIWS G    E+  G+P +        +  +  +   PT       
Sbjct: 194 PEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT------- 239
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           NP  T F+ P++    W   F         D V + L  SP  R+TA + L HPF
Sbjct: 240 NPPPT-FRKPEL----WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++     
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 134/281 (47%), Gaps = 40/281 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 93
           R +G GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            + F     +DE  + +V++ +   +   +++H + +       VKL+  ++  AL Y+ 
Sbjct: 81  WYSF-----QDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-- 211
           N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+     
Sbjct: 133 NQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TREEI- 262
              Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E + 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEMVS 249
Query: 263 ---KCMNPN----YTEF----KFPQIKAHPWHKIFQKRMPP 292
              K + PN    +++      FP +    W  +FQKR+ P
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 91
           Y    V+G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 152 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------E 234
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            EF  P      W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 235 YEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 128/289 (44%), Gaps = 46/289 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           +G G+F VV +   +  G+  A K +       +D +   RE +  RLL HPN+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S +E+   YL   L    E    ++   Y                QI  A+ + H  +
Sbjct: 89  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEAVLHCHQ-M 140
Query: 157 GVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGA 212
           GV HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 198
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y   +D+W+ G +L  LL+G P F  E    +L + IK                   +
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 241
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            FP  +   W  +      PEA DL++++L  +P+ R TA EAL HP+ 
Sbjct: 242 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           +  C F T E     L  V+EY+       + +H +   +  L     Y  +I   L ++
Sbjct: 84  M-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 211
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G
Sbjct: 136 HSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
             +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 147/317 (46%), Gaps = 68/317 (21%)
Query: 38  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 92
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 147
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 74  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 195
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ + 
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 196 SYIC-----SRYYRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQPLFPGESGV 244
                    +  +RAPEL+  +         T +IDI+S GCV    +L +   P     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 245 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 304
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 305 SPNLRSTALEALIHPFF 321
            P  R TA++ L HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 92
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 89  L-FCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 211
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I  
Sbjct: 141 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQ 197
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
              Y  A+D W+ G +L E+L G   F  E+  D L E I
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAI 236

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 142/303 (46%), Gaps = 39/303 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 150 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 206
Query: 215 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           Y+   DIWS G  L E+ +G+ P+ P ++   +L+   +V G       +   P     K
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 274 FPQIKAHPWHKIFQ------KRMPP---------EAVDLVSRLLQYSPNLRSTALEALIH 318
           F  + + P   IF+         PP         E  D V++ L  +P  R+   + ++H
Sbjct: 267 F-GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 319 PFF 321
            F 
Sbjct: 326 AFI 328

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 91
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 149
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 208
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 257
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 215 YTAAIDIWSAGCVLAELLLGQ 235
           Y+   DIWS G  L E+ +G+
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGR 262

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 91
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 149
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 91  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 208
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 257
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 91
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 149
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 208
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 257
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 215 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQ 246
           Y+   DIWS G  L E+ +G+ P+ P ++  D 
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++     
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 90
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 91  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 142 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 198
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
           Y+   DIWS G  L E+ +G+      SG   + E++
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 146/317 (46%), Gaps = 68/317 (21%)
Query: 38  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 92
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 147
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 74  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 195
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 196 SYIC-----SRYYRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQPLFPGESGV 244
                    +  +RAPEL+  +         T +IDI+S GCV    +L +   P     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 245 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 304
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 305 SPNLRSTALEALIHPFF 321
            P  R TA++ L HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 158 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 217 AAIDIWSAGCVLAELLLG 234
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 134
Query: 158 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 217 AAIDIWSAGCVLAELLLG 234
              D+WS G  L  +L+G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++     
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FGV    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            T     +L +++EY    E   R+       + R      + +F Q+   ++Y H ++ 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH-SMQ 136
Query: 158 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
           +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 217 AAI-DIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
             I D+WS G  L  +L+G  P    E   D    I ++L                ++  
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSI 241
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           P             R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 242 PD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 139/319 (43%), Gaps = 48/319 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 59  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 116
Query: 100 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
               D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL ++H  
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN 174
Query: 156 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 197
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 175 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 231
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 255
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 232 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 290
Query: 256 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHK-IFQKRMPP-EAVDLVSRLL 302
                  TR++          + N ++ ++ +    P    + Q  +   +  DL+ R+L
Sbjct: 291 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 350
Query: 303 QYSPNLRSTALEALIHPFF 321
           ++ P  R T  EAL+HPFF
Sbjct: 351 EFDPAQRITLAEALLHPFF 369

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 215 YTAAIDIWSAGCVLAELLLGQ 235
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 215 YTAAIDIWSAGCVLAELLLGQ 235
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 139/319 (43%), Gaps = 48/319 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 100 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
               D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL ++H  
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN 151
Query: 156 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 197
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 152 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 255
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 209 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 267
Query: 256 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHK-IFQKRMPP-EAVDLVSRLL 302
                  TR++          + N ++ ++ +    P    + Q  +   +  DL+ R+L
Sbjct: 268 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 327
Query: 303 QYSPNLRSTALEALIHPFF 321
           ++ P  R T  EAL+HPFF
Sbjct: 328 EFDPAQRITLAEALLHPFF 346

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 139/319 (43%), Gaps = 48/319 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 100 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
               D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL ++H  
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 156 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 197
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 143 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 255
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 200 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 256 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHK-IFQKRMPP-EAVDLVSRLL 302
                  TR++          + N ++ ++ +    P    + Q  +   +  DL+ R+L
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318
Query: 303 QYSPNLRSTALEALIHPFF 321
           ++ P  R T  EAL+HPFF
Sbjct: 319 EFDPAQRITLAEALLHPFF 337

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 127/291 (43%), Gaps = 42/291 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 91
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 152 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            E++F    +  W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 233 AEYEF---DSPYWDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 58/310 (18%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 80  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
           T +   +D+W AG +  E L+G P F   S  +    I+ V                 + 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           KFP              +   + DL+S+LL+Y P  R      + HP+       N+R  
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR-- 271
Query: 333 NGRFLPPLFN 342
             R LPP++ 
Sbjct: 272 --RVLPPVYQ 279

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 91
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 152 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------E 234
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            EF  P      W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 235 YEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 58/310 (18%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 81  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
           T +   +D+W AG +  E L+G P F   S  +    I+ V                 + 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           KFP              +   + DL+S+LL+Y P  R      + HP+       N+R  
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR-- 272
Query: 333 NGRFLPPLFN 342
             R LPP++ 
Sbjct: 273 --RVLPPVYQ 280

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++     
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 132/326 (40%), Gaps = 61/326 (18%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           +G G++GVV + + + +G+  A+K++   +   N + Q   L D         C F+ T 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI---RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 103 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 158
              L+    + +  E    ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 214
            HRD+KP N+L+N    Q+K CDFG +  LV     +I   C + Y APE I        
Sbjct: 159 IHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQKG 216
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           Y+   DIWS G    EL + +  FP +S            GTP ++              
Sbjct: 217 YSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------------L 250
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG 334
            Q+   P  ++   +   E VD  S+ L+ +   R T  E   HPF              
Sbjct: 251 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPF-------------- 296
Query: 335 RFLPPLFNFKPHELKGVPVDMLVKLI 360
                   F  HE KG  V   VKLI
Sbjct: 297 --------FTLHESKGTDVASFVKLI 314

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 130/298 (43%), Gaps = 46/298 (15%)
Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 87
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PN+V L     S +E+   YL   L    E    ++   Y                QI  
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE 114
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYY 203
           ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y
Sbjct: 115 SVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGY 172
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK           
Sbjct: 173 LSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA---------- 220
Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                   + FP   +  W  +      PEA DL++++L  +P  R TA EAL HP+ 
Sbjct: 221 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 134/298 (44%), Gaps = 58/298 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 93
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              F     +D   + ++++Y+       +    + SQR P    K Y  ++C AL Y+H
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGE---LFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSR-YYRAPELIFG 211
           +   + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C    Y APE++  
Sbjct: 124 SK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV-S 176
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y  +ID WS G ++ E+L G   F   + +    +I+                   E
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----------------E 219
Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-----QYSPNLRSTALEALIHPFFDEL 324
            +FP                 +  DL+SRL+     Q   NL++   +   HP+F E+
Sbjct: 220 LRFPPF------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 215 YTAAIDIWSAGCVLAELLLGQ 235
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 215 YTAAIDIWSAGCVLAELLLGQ 235
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 91
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 152 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------E 234
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            EF  P          +   +   A D +  L++  P  R T  +AL HP+
Sbjct: 235 YEFDSP----------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 201
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 87
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 146
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 202
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------- 220
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                    + FP   +  W  +      PEA DL++++L  +P  R TA EAL HP+ 
Sbjct: 221 -------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 48/303 (15%)
Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 92
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           LK  +      D  Y+ +V E +   E + ++++  +   +    +      + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKTVE 130
Query: 151 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 204
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE +     Y AA DIWS G +L  +L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF---F 321
                   KF  +    W+ +        A DLVS++L   P+ R TA   L HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 322 DEL 324
           D+L
Sbjct: 285 DQL 287

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 24/220 (10%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++     
Sbjct: 18  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + 
Sbjct: 78  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHA 129
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +  
Sbjct: 130 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLC 185
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 95
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            +    +   +YL   L    E + ++++  +  S+R          + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKF-FSERE----ASFVLHTIGKTVEYLHSQ 140
Query: 156 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 209
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 210 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
                Y    DIWS G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
               KF  +    W+ + +      A DLVS++L   P+ R TA + L HP+  +
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 95
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            +    +   +YL   L    E + ++++  +   +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV-----LHTIGKTVEYLHSQ 140
Query: 156 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 209
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 210 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
                Y    DIWS G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
               KF  +    W+ + +      A DLVS++L   P+ R TA + L HP+
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQT 81
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
            R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFY 147
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 202
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    R +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
              + ++ P +V L+  F     KD   L +VLEY P      +  H +   R    + +
Sbjct: 94  RIQQAVNFPFLVKLEFSF-----KDNSNLYMVLEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQT 81
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
            R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFY 147
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 202
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++     
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 29  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 75
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 134
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
           +  +       C+AL + H   G+ HRD+KP N+L++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNS 172
Query: 195 I----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           +    + I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQT 81
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 141
            R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFXEPHARFY 147
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 202
Query: 202 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 115/250 (46%), Gaps = 36/250 (14%)
Query: 23  TIGGKNGQPK-----QTISY-----MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK 72
           ++GG +G+ +     QT+          RV+  G F  V++A+ + +G   A+K++L ++
Sbjct: 6   SLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 73  RYKNR----ELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY 127
             KNR    E+  M+ L  HPN+V          E+ +      L        ++++   
Sbjct: 66  EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 128 KMSQRMPLI--YVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPHTHQLKLCDFGS 184
           KM  R PL    V   FYQ CRA+ ++H     + HRD+K +NLL++ +   +KLCDFGS
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGS 184
Query: 185 AKVLVKGEPNISYICSR--------------YYRAPELI--FGATEYTAAIDIWSAGCVL 228
           A   +   P+ S+   R               YR PE+I  +         DIW+ GC+L
Sbjct: 185 ATT-ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 229 AELLLGQPLF 238
             L   Q  F
Sbjct: 244 YLLCFRQHPF 253

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           +    E     L +++E++       I    ++++      +      + +ALAY+H   
Sbjct: 111 YLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHAQ- 160
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 215
           GV HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
              +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           ++K    HK+      P   D + R+L   P  R+TA E L HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++     
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFXEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 30  QPKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ----- 80
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++     
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 81  --TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHA 143
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           + Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXL 198
Query: 199 CSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
           C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 46/288 (15%)
Query: 43  VGHGSFGVVFQ-AKCLETGEAVAI-----KKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           +G G+F VV +  K L   E  A+     K   +D +   RE +  RLL HPN+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 77
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
             S +E+   YL   L    E    ++   Y                QI  A+ + H  +
Sbjct: 78  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEAVLHCHQ-M 129
Query: 157 GVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGA 212
           GV HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 187
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y   +D+W+ G +L  LL+G P F  E    +L + IK                   +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 230
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            FP  +   W  +      PEA DL++++L  +P+ R TA EAL HP+
Sbjct: 231 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 87
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           PN+V L    F   E ++  L LV EY    E    ++ H      R      +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVXEYASGGEVFDYLVAHG-----RXKEKEARAKFRQI 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 61/300 (20%)
Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 89
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAP 206
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K          K   
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNL 240
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
           P Y                    +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 241 PPY--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 141/299 (47%), Gaps = 53/299 (17%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 94
           ++G GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 95  HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYI 152
           + F     +D  Y+ LVLE      ++R +K+  K  S+       + + +QI   + Y+
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN----EARHFMHQIITGMLYL 128
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFG 211
           H+  G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I  
Sbjct: 129 HSH-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IAT 185
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
            + +    D+WS GC+   LL+G+P F  ++  + L +++                   +
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LAD 228
Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR 330
           ++ P              +  EA DL+ +LL+ +P  R +    L HPF    R+ +T+
Sbjct: 229 YEMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 114 RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 165
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 166 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 220
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 93
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 151
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 308 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 253
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 254 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 292
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 93
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 151
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 307 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 363
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 253
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423
Query: 254 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 292
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 424 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 132/315 (41%), Gaps = 50/315 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 95
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 214
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 333
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 334 GRFLPPLFNFKPHEL 348
              +PP F+  P  L
Sbjct: 284 CLTIPPXFSIAPSSL 298

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 29  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 75
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 134
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 195 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 39/237 (16%)
Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---------------- 177
           P+  V+   +Q+C+A+ ++H+   + H D+KP+N+L     ++L                
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 178 --KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
             ++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  +G 
Sbjct: 194 AVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGF 250
Query: 236 PLFPGESGVDQLVEIIKVLG-TPTREEIKC------------MNPNYTEFKFPQIKAHPW 282
            LF      + L  + ++LG  P+R   K              + N +  ++ +    P 
Sbjct: 251 TLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPL 310
Query: 283 HKIFQKRMPP--EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD--PNTRLPNGR 335
            +          +  DL+  +L+Y P  R T  EAL HPFF  LR   PN    + R
Sbjct: 311 RRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 89
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAP 206
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +         C    Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K          K   
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNL 240
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
           P Y                    +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 241 PPY--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 158 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
           VCHRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 217 AAIDIWSAGCVLAELLLG 234
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 137
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 140/304 (46%), Gaps = 55/304 (18%)
Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIK-----KVLQDKRYKNRELQTMRLLDH----P 88
           +V+G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +V+L + F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  A
Sbjct: 120 FLVTLHYAFQTETK-----LHLILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAP 206
           L ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y AP
Sbjct: 172 LEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 207 ELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           +++ G  + +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K  
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSE 282
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 320
            P      +PQ             M   A DL+ RLL   P  R       A E   H F
Sbjct: 283 PP------YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
Query: 321 FDEL 324
           F ++
Sbjct: 325 FQKI 328

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 93
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 151
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 308 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 253
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 254 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 292
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 93
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 151
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 308 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 253
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 254 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 292
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 132/315 (41%), Gaps = 50/315 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 95
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 214
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 333
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 334 GRFLPPLFNFKPHEL 348
              +PP F+  P  L
Sbjct: 284 CLTIPPRFSIAPSSL 298

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 29  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 75
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 134
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 195 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 41  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 92
           R +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
            K   +S   ++   L L++E++P    R  ++  K  +R+  I +  Y  QIC+ + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRA 205
             T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 -GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE +   ++++ A D+WS G VL EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 132/315 (41%), Gaps = 50/315 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 95
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 88  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 214
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 141 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 231
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 333
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 232 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 287
Query: 334 GRFLPPLFNFKPHEL 348
              +PP F+  P  L
Sbjct: 288 CLTIPPRFSIAPSSL 302

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 29  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 75
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
           I V       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 196 S----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           +     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 138
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 38  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLD-HPNVVSLK 94
           + ++ +G GSF +  +    ++ +A A+K ++  +   N  +E+  ++L + HPN+V L 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F      D+L+  LV+E +   E   R+ K  +        I  KL       A++++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL-----VSAVSHM 122
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 209
           H+ +GV HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL+
Sbjct: 123 HD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMN 266
                Y  + D+WS G +L  +L GQ  F            VEI+K +            
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK---------- 230
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 309
               +F F   +   W  + Q     EA DL+  LL   PN R
Sbjct: 231 ---GDFSF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 162
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 128/297 (43%), Gaps = 46/297 (15%)
Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 87
           T  Y     +G G+F VV +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            N+V L     S +E+   YL   L    E    ++   Y                QI  
Sbjct: 63  SNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE 114
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYY 203
           A+ + H  +GV HRD+KP+NLL+        +KL DFG A + V+G+      +  +  Y
Sbjct: 115 AVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGY 172
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK           
Sbjct: 173 LSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA---------- 220
Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                   + FP   +  W  +      PEA +L++++L  +P  R TA EAL HP+
Sbjct: 221 ------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 74
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 75  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T 
Sbjct: 126 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-TH 182
Query: 215 YTAAIDIWSAGCVLAELLLGQ 235
           Y+   DIWS G  L E+ +G+
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGR 203

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 48/303 (15%)
Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 92
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           LK  +      D  Y+ +V E     E + ++++  +   +    +      + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV-----LFTITKTVE 130
Query: 151 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 204
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE +     Y AA DIWS G +L   L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF---F 321
                   KF  +    W+ +        A DLVS+ L   P+ R TA   L HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHW 284
Query: 322 DEL 324
           D+L
Sbjct: 285 DQL 287

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 137
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 136
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 137
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 20/224 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y+  + +G GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V  +  F    E   LY+  V++Y    +   R+      + Q   ++    +F QIC A
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLA 137
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPE 207
           L ++H+   + HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            I     Y    DIW+ GCVL EL   +  F   S  + +++II
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 129
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 135
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 29  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 75
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 134
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 136 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 189
Query: 195 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 134
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 130
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 29  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 75
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 76  NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H          
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
           I V       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 196 S----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           +     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 200
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 91
           +V+G GSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 149
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 208
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 257
           +     ++ + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 95  HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              +S   ++   L L++EY+P  ++   ++ H   ++R+  I +  Y  QIC+ + Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQAH---AERIDHIKLLQYTSQICKGMEYL- 133
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAP 206
            T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ AP
Sbjct: 134 GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAP 189
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E +   ++++ A D+WS G VL EL 
Sbjct: 190 ESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 31  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 80
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 81  -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
             ++ ++ P +V L+  F     KD   L +V+EYV       +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHAR 144
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 200 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 88
            Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  A
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLA 186
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNI-SYICSRYYRAP 206
           L  IH ++G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 207 ELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
           E++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 131/315 (41%), Gaps = 50/315 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 95
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 108 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 214
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 161 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 251
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 333
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 252 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 307
Query: 334 GRFLPPLFNFKPHEL 348
              +PP F+  P  L
Sbjct: 308 CLTIPPRFSIAPSSL 322

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 158 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
           VCHRD+K +N L++     +LK+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 217 AAIDIWSAGCVLAELLLG 234
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 131/315 (41%), Gaps = 50/315 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 95
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 106 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 214
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 159 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 249
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 333
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 250 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 305
Query: 334 GRFLPPLFNFKPHEL 348
              +PP F+  P  L
Sbjct: 306 CLTIPPRFSIAPSSL 320

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 88
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 198
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 199 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 88
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 180
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 198
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 181 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 234
Query: 199 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 235 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 88
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 198
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 199 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 209
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 29/240 (12%)
Query: 12  NGTEAGHIIVTTIGGKNGQPK-QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ 70
           +G + G++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 71  DKRYKNRELQTMRLLDHPNVVSLKH-------CFFSTTEKDELYLNLVLEYVPETVHRVI 123
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 124 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 183
           K   +M   +P   +      I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFG 170
Query: 184 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFP 239
            +  LV  +          Y APE I        +Y    D+WS G  L EL  GQ  FP
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 92
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 251
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 252 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 292
                     L    +E + C+     +  F  I+ HP      W  + QK++ P
Sbjct: 255 VKAASVLKSFLNKDPKERLGCL----PQTGFADIQGHPFFRNVDWDMMEQKQVVP 305

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 92
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 251
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 252 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 292
                     L    +E + C    + +  F  I+ HP      W  + QK++ P
Sbjct: 240 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP 290

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 92
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 251
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 252 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 292
                     L    +E + C    + +  F  I+ HP      W  + QK++ P
Sbjct: 244 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP 294

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 95/329 (28%), Positives = 146/329 (44%), Gaps = 53/329 (16%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 82
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLY 141
             ++   VVSL + + +   KD L L L L    +       H Y M Q   P      Y
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFY 291
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + + 
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y APE++     YT + D W+ GC+L E++ GQ  F       Q  + IK      REE
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REE 396
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 316
           ++ +           +K  P  + + +R  P+A  L S+LL   P  R      +A E  
Sbjct: 397 VERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443
Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKP 345
            HP F +L     RL  G   PP   FKP
Sbjct: 444 EHPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 94
           V+G GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           H  F T ++    L  V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISIGLFFLHK 138
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 213
             G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I    
Sbjct: 139 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AYQ 195
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 95
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                 E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI   + + H+
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QILDGIKHAHD 129
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 210
            + + HRDIKPQN+L++ +   LK+ DFG AK L   E +++     + +  Y +PE   
Sbjct: 130 -MRIVHRDIKPQNILIDSN-KTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAK 185
Query: 211 G-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           G AT+     DI+S G VL E+L+G+P F GE+ V
Sbjct: 186 GEATD--ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 58/295 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 92
           RV+G GS+  V   +  +T    A++ V ++    + ++  ++          +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFG 211
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++ G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 251
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 252 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 292
                     L    +E + C    + +  F  I+ HP      W  + QK++ P
Sbjct: 287 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 93/357 (26%), Positives = 149/357 (41%), Gaps = 77/357 (21%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKC-LETG--EAVAIKKVLQDKR--YKNRELQTMRLL 85
           P+ +  +  E  +G G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 86  D-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
               NV+ +K+CF     +   ++ + + Y+       I +     +      V+ Y   
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPYLEHESFLDILNSLSFQE------VREYMLN 125
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----------VLVKGEP- 193
           + +AL  IH   G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 194 ------NISYIC-SRY-----------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
                 N   IC SR            +RAPE++      T AID+WSAG +   LL G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 236 -PLFPGESGVDQLVEIIKVLGTPTREEIK-----------------------CMNPNYTE 271
            P +     +  L +I+ + G  +RE I+                       C      +
Sbjct: 245 YPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302
Query: 272 FKFPQ----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
              P+    I+ H  +      +P EA DL+ +LL  +P  R TA EAL+HPFF ++
Sbjct: 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 132
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 207
           T    HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +   ++++ A D+WS G VL EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 95/329 (28%), Positives = 146/329 (44%), Gaps = 53/329 (16%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 82
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLY 141
             ++   VVSL + + +   KD L L L L    +       H Y M Q   P      Y
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFY 291
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + + 
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y APE++     YT + D W+ GC+L E++ GQ  F       Q  + IK      REE
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REE 396
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 316
           ++ +           +K  P  + + +R  P+A  L S+LL   P  R      +A E  
Sbjct: 397 VERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443
Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKP 345
            HP F +L     RL  G   PP   FKP
Sbjct: 444 EHPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 130/312 (41%), Gaps = 50/312 (16%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 95
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 82  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 214
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 135 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 225
Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 333
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 226 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 281
Query: 334 GRFLPPLFNFKP 345
              +PP F+  P
Sbjct: 282 CLTIPPRFSIAP 293

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 37/214 (17%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           V+G G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 98  FSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                KD+  LN + EY+   T+  +IK     Y  SQR+       +   I   +AY+H
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS------FAKDIASGMAYLH 125
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEP-------------NISYI 198
            ++ + HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
            + Y+ APE+I G + Y   +D++S G VL E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 209
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 209
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 120 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 216
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 253

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/325 (23%), Positives = 143/325 (44%), Gaps = 41/325 (12%)
Query: 21  VTTIGGKNGQPKQTISYMAERV-----VGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKR 73
           + + G     P+Q   + AE +     +G G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 74  YKNRELQ----TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK- 128
            + + L      MR  D P +V      F   +       + +E +  +  +  K+ Y  
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSV 117
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
           +   +P   +        +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQL 176
Query: 189 VKGEPNISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGV- 244
           V           R Y APE I  +     Y    D+WS G  L EL  G+  +P  + V 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 245 DQLVEIIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFQK 288
           DQL +++K  G P   +  E +  +P++  F             K+ ++  HP+  ++++
Sbjct: 237 DQLTQVVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 289 RMPPEAVDLVSRLLQYSPNLRSTAL 313
           R   E    V ++L   P   S+ +
Sbjct: 295 RA-VEVACYVCKILDQMPATPSSPM 318

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 209
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 180
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 227
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 228 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 209
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 209
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 209
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 182
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 229
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 230 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 209
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 181
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 228
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 229 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 213
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 214 TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 265
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 209
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 323
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 370
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 371 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 209
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 320
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 367
Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 321
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 368 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 99
           +G G+FGV    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAH-AMQ 135
Query: 158 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
           V HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++       
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 217 AAIDIWSAGCVLAELLLG 234
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 136/303 (44%), Gaps = 47/303 (15%)
Query: 31  PKQTISYMAERVVG---HGSFGVVFQAKCLE-TGEAVAIKKVLQDKRYKNRELQTMR-LL 85
           PK  I      VV    H + G  F  K +E T E ++ +++ + +    RE   +R + 
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
            HP++++L   + S++     ++ LV + + +  +   +     +S++      +     
Sbjct: 158 GHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEK----ETRSIMRS 208
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 204
           +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y 
Sbjct: 209 LLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 205 APELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I         
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------- 317
Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                M   Y +F  P+     W             DL+SRLLQ  P  R TA +AL HP
Sbjct: 318 -----MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQALQHP 361
Query: 320 FFD 322
           FF+
Sbjct: 362 FFE 364

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  + 
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SK 234
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLF 238
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G++G V  A    T EAVA+K V   +         +E+    +L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVK--- 69
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 108 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 213
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 139/299 (46%), Gaps = 47/299 (15%)
Query: 35  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 92
           IS+  + V+GHG+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
                +  TEKD  +  + +E    T+   ++   K    + L  + L   Q    LA++
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLGLEPITL-LQQTTSGLAHL 134
Query: 153 HNTIGVCHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNISYIC----SRYYR 204
           H ++ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  + 
Sbjct: 135 H-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 205 APELIFGATEY--TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           APE++    +   T  +DI+SAGCV    ++ +   P    + +   I+  LG  +   +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS---L 247
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            C++P                   +K     A +L+ +++   P  R +A   L HPFF
Sbjct: 248 DCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 94  EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 146 -SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 199
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 233
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 95
           + +G G+ G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 210
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 207
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 177
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 217
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SK 213
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLF 238
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SK 213
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLF 238
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 207
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 19  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 78  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 129
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 212
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
           T Y    DIWS G  L E+   +P                    P  E    +NP     
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 224
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           K    K+ P   +   +   E  D +   L  +P  R +A + L HPF   +
Sbjct: 225 KIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 274

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 125/306 (40%), Gaps = 40/306 (13%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQIC 146
           VS    + S   KDEL+L + L     +V  +IKH     +    +     +     ++ 
Sbjct: 76  VSY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICS 200
             L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
             + APE++     Y    DIWS G    EL  G    P        V ++ +   P   
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP--- 244
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                         P ++     K   K+       ++S  LQ  P  R TA E L H F
Sbjct: 245 --------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290
Query: 321 FDELRD 326
           F + ++
Sbjct: 291 FQKAKN 296

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 133/308 (43%), Gaps = 60/308 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F+     D   + L+LEY P  E    + K      QR   I       ++  AL Y
Sbjct: 89  YNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI-----MEELADALMY 138
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
            H    V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CHGK-KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              +   +D+W  G +  ELL+G P F   S  +    I+KV                 +
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-----------------D 237
Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 331
            KFP              +P  A DL+S+LL+++P+ R    +   HP+         R 
Sbjct: 238 LKFPA------------SVPTGAQDLISKLLRHNPSERLPLAQVSAHPW--------VRA 277
Query: 332 PNGRFLPP 339
            + R LPP
Sbjct: 278 NSRRVLPP 285

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 27  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 86  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 137
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 212
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
           T Y    DIWS G  L E+   +P                    P  E    +NP     
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 232
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           K    K+ P   +   +   E  D +   L  +P  R +A + L HPF   +
Sbjct: 233 KIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 102 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 154 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 207
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 46/306 (15%)
Query: 38  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 92
           +   ++G G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   F     +D+    LV E +   ++   I+     ++R     V+     +  AL +
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR----DVAAALDF 126
Query: 152 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNISYIC-SR 201
           +H T G+ HRD+KP+N+L         +K+CDF  GS   L         P ++  C S 
Sbjct: 127 LH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 202 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 254
            Y APE++      AT Y    D+WS G VL  +L G P F G  G D      E+ +V 
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                E I+       +++FP      W  I       EA DL+S+LL      R +A +
Sbjct: 246 QNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRLSAAQ 292
Query: 315 ALIHPF 320
            L HP+
Sbjct: 293 VLQHPW 298

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 40/305 (13%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQIC 146
           VS    + S   KDEL+L + L     +V  +IKH     +    +     +     ++ 
Sbjct: 71  VSY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICS 200
             L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +
Sbjct: 127 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
             + APE++     Y    DIWS G    EL  G    P        V ++ +   P   
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSL 242
Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           E    +    +          + K F+K        ++S  LQ  P  R TA E L H F
Sbjct: 243 ETGVQDKEMLK---------KYGKSFRK--------MISLCLQKDPEKRPTAAELLRHKF 285
Query: 321 FDELR 325
           F + +
Sbjct: 286 FQKAK 290

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 58/303 (19%)
Query: 34  TISYMAERVVGHGSFGVV-----------FQAKCLETGEAVAIKKVLQDKRYKNRELQTM 82
           T  Y     +G G+F VV           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 141
           RLL HPN+V L     S +E+   YL   L    E    ++ + +Y  +     I+    
Sbjct: 85  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH---- 137
Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISY 197
             QI  ++ +IH    + HRD+KP+NLL+        +KL DFG A + V+GE      +
Sbjct: 138 --QILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGF 193
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
             +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK     
Sbjct: 194 AGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA---- 247
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                         + FP   +  W  +      PEA +L++++L  +P  R TA +AL 
Sbjct: 248 ------------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITADQALK 287
Query: 318 HPF 320
           HP+
Sbjct: 288 HPW 290

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 32/223 (14%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKN--RELQTMRLLDHPNVV 91
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L+          E  L LV+E+     ++RV+       +R+P   +  +  QI R + 
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 151 YIHN--TIGVCHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
           Y+H+   + + HRD+K  N+L+       +     LK+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAY 178
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
            + APE+I  A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 38/311 (12%)
Query: 37  YMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQDKRYKN------RELQTMRLLDHP 88
           Y+   ++G GS+G V +    ET    AV I K  + +R  N      +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           NV+ L    ++  EK ++Y+  V+EY    +  ++       +R P+     YF Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 205
           L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 206 PELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV--------LGT 256
           PE+  G   ++   +DIWSAG  L  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 257 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
           P  + +K M    P    F   QI+ H W   F+K+ PP    +    +  SP+ +    
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPPAEAPVP---IPPSPDTKDRWR 291
Query: 314 EALIHPFFDEL 324
              + P+ ++L
Sbjct: 292 SMTVVPYLEDL 302

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ ++  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 207
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------------ 216
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 207
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVV--SLKHCF- 97
           +V+G GSFG V  A+  +  E     KVLQ K    ++ +   ++   NV+  ++KH F 
Sbjct: 44  KVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFL 101
Query: 98  ----FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
               FS    D+LY   VL+Y+   E  + + +    +  R      + Y  +I  AL Y
Sbjct: 102 VGLHFSFQTADKLYF--VLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALGY 154
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIF 210
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE + 
Sbjct: 155 LH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLF 238
               Y   +D W  G VL E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 94
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 207
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 128/304 (42%), Gaps = 47/304 (15%)
Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----- 82
           N   K + +Y  +  +G G+F VV +     TG   A K ++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREAR 80
Query: 83  --RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVK 139
             R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I   
Sbjct: 81  ICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 135
Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 197
               QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +
Sbjct: 136 ----QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
             +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK     
Sbjct: 191 AGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA---- 244
Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                         + +P   +  W  +      PEA  L+  +L  +P  R TA +AL 
Sbjct: 245 ------------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALK 284
Query: 318 HPFF 321
            P+ 
Sbjct: 285 VPWI 288

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 60/302 (19%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 92
           V+G G+F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP------ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           L   + S        L +V E++       E V R     +  S+ +   Y++    QI 
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMR----QIL 140
Query: 147 RALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSR 201
            AL Y H+   + HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTP 197
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + +
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 248
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            K MNP              W  I +      A DLV R+L   P  R T  EAL HP+ 
Sbjct: 249 YK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 322 DE 323
            E
Sbjct: 291 KE 292

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 92
           Y+  + +G G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 93  L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L  +C      K E +L L   +   T+   I+        +    +      ICR L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNISYI-------CSR 201
           IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +       C+ 
Sbjct: 150 IHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 202 YYRAPELIFGATEYTA---AIDIWSAGCVLAELLLGQ 235
            YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 128/318 (40%), Gaps = 76/318 (23%)
Query: 36  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 83
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 84  ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 130
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 130
Query: 131 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 190
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 131 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 191 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           GE   S   +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
            L  I              M+ NY +F  P+     W             DLVSR L   
Sbjct: 237 MLRMI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQ 271
Query: 306 PNLRSTALEALIHPFFDE 323
           P  R TA EAL HPFF +
Sbjct: 272 PQKRYTAEEALAHPFFQQ 289

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 234
Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      E + P+        IF+        D ++R L      R +A E L H 
Sbjct: 235 -----------ELQNPE----KLSAIFR--------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 320 FF 321
           F 
Sbjct: 272 FL 273

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 234
Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      E + P+        IF+        D ++R L+     R +A E L H 
Sbjct: 235 -----------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 320 FF 321
           F 
Sbjct: 272 FL 273

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 99
           ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 100 ----TTEKDELY-----LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
               T+ K+        L + +E+  + T+ + I+   +  +++  +     F QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGV 135
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE I
Sbjct: 136 DYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 210 FGATEYTAAIDIWSAGCVLAELL 232
             + +Y   +D+++ G +LAELL
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 132/302 (43%), Gaps = 53/302 (17%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 234
Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      E + P+        IF+        D ++R L      R +A E L H 
Sbjct: 235 -----------ELQNPE----KLSAIFR--------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 320 FF 321
           F 
Sbjct: 272 FL 273

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 123 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 228
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 229 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 270
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 271 SINWQD--VVQKKLLPP---FKPQ 289

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 99
           ++G G FG VF+AK    G+   I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 100 ---TTEKDELYLNLVLEYVPETVHRVIKHHYK---------------------MSQRMPL 135
               T  D L  +   +Y PE      +   K                       +++  
Sbjct: 79  YDPETSDDSLESS---DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
           +     F QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L       
Sbjct: 136 VLALELFEQITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
               +  Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 194 RSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 235
Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      E + P+        IF+        D ++R L+     R +A E + H 
Sbjct: 236 -----------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 320 FF 321
           F 
Sbjct: 273 FL 274

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 212
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-S 212
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLF 238
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 127/318 (39%), Gaps = 76/318 (23%)
Query: 36  SYMAERVVGHGSFGVVFQA----KCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 83
           +Y  + ++G G   VV +      C E   AV I  V     +   E+Q +R        
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 84  ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 130
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 117
Query: 131 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 190
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 118 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 163
Query: 191 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 223
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
            L  I              M+ NY +F  P+   +               DLVSR L   
Sbjct: 224 MLRMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQ 258
Query: 306 PNLRSTALEALIHPFFDE 323
           P  R TA EAL HPFF +
Sbjct: 259 PQKRYTAEEALAHPFFQQ 276

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 76/318 (23%)
Query: 36  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 83
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 84  ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 130
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 130
Query: 131 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 190
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 131 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 191 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
            L  I              M+ NY +F  P+     W             DLVSR L   
Sbjct: 237 MLRMI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQ 271
Query: 306 PNLRSTALEALIHPFFDE 323
           P  R TA EAL HPFF +
Sbjct: 272 PQKRYTAEEALAHPFFQQ 289

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 121 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 226
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 227 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 268
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 269 SINWQD--VVQKKLLPP---FKPQ 287

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 97
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-- 155
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 72  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 181
Query: 216 TAAIDIWSAGCVLAELL 232
           +   D++S G +L E++
Sbjct: 182 SEKCDVFSWGIILWEVI 198

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 97
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-- 155
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 71  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 180
Query: 216 TAAIDIWSAGCVLAELL 232
           +   D++S G +L E++
Sbjct: 181 SEKCDVFSWGIILWEVI 197

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 90
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 207
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 323 ELRDPNTRLPNGRFLPPLFNFKPH 346
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 32  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 84
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 143
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 201
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK         
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA-------- 221
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     + +P  +   W  +      PEA  L+  +L  +P  R TA +AL  P+
Sbjct: 222 --------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 32  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 84
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 143
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 61  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 111
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 201
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 112 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 170
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK         
Sbjct: 171 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA-------- 220
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     + +P  +   W  +      PEA  L+  +L  +P  R TA +AL  P+
Sbjct: 221 --------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 263

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 32  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 84
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 143
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 201
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK         
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA-------- 221
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     + +P  +   W  +      PEA  L+  +L  +P  R TA +AL  P+
Sbjct: 222 --------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 53/302 (17%)
Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 84
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 145 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 199
           +CR    AL ++H+   V HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 235
Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      E + P+        IF+        D ++R L+     R +A E + H 
Sbjct: 236 -----------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 320 FF 321
           F 
Sbjct: 273 FL 274

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 125/309 (40%), Gaps = 57/309 (18%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 93
           +V+G G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              F     +DE YL LV+EY       ++    K  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 211
             +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 212 ATEYTAAI------DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
                         D W+ G    E+  GQ  F  +S  +   +I+              
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------------- 283
Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL---RSTALEALIHPFF- 321
                       K H    +  + +P EA D + RLL   P     R  A +   HPFF 
Sbjct: 284 ----------HYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
Query: 322 ----DELRD 326
               D LRD
Sbjct: 333 GLDWDGLRD 341

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 144/336 (42%), Gaps = 60/336 (17%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +++  R +G G+FG V   + ++  +  A+K V   K+Y         +L       + +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 96  CFFSTTEKDELYLN---LVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 151
                     +Y +   L+ E +  +++ +I +++Y       +  +KLY  +I +AL Y
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNY 152
Query: 152 IHNTIGVCHRDIKPQNLLVN-PHTHQ-----------------------LKLCDFGSAKV 187
           +   + + H D+KP+N+L++ P+  +                       +KL DFG A  
Sbjct: 153 LRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 247
             K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF     ++ L
Sbjct: 212 --KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 248 VEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ-----------IKAHPWHKIF 286
             +  ++           T T    K +N +  +  +P+            K  P +KI 
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327
Query: 287 QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 322
           +  +     D +  +LQ  P LR +  E L H F +
Sbjct: 328 KHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 94  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 147
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 148 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 205
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 247 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 258
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 274 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 246 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 94
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 95  HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 195
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 196 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 252 KVLGTPTRE 260
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 94
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 95  HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 195
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 196 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 252 KVLGTPTRE 260
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 41  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +  K C     EK    L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYY 203
           Y+H+   + HR++  +N+L++ +   +K+ DFG AK + +G       E   S +   ++
Sbjct: 132 YLHSQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FW 186
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELL 232
            APE +     Y A+ D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 107 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 160
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 161 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 218
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 278
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 279 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 253
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 254 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 274 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
             +  +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 41  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           R +G G FG V    +      TGE VA+K +  D   ++R     E+  +R L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
             K C     +     L LV+EYVP    R     Y     + L  + L+  QIC  +AY
Sbjct: 97  KYKGC---CEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAY 149
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYR 204
           +H    + HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   ++ 
Sbjct: 150 LHAQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWY 204
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE +     Y A+ D+WS G  L ELL
Sbjct: 205 APECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 133
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 207
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 134 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +     ++   D+WS G VL EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
             +  +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 132
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 207
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +     ++   D+WS G VL EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +     +   L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 129
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 207
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 130 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +     ++   D+WS G VL EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 85
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 86  DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 136
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 137 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
             +  +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 132 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 191 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 243
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 244 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 288
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 289 QSTKVPQTPLHTSRVL 304

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 131 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 190 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 242
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 243 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 287
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 288 QSTKVPQTPLHTSRVL 303

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 176 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 235 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 287
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 288 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 332
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 333 QSTKVPQTPLHTSRVL 348

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 43  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 94
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 207
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 146 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            +     ++   D+WS G VL EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 34/306 (11%)
Query: 38  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 96
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 97  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           + +     +  L +V+E +   E   R+     +  Q             I  A+ Y+H 
Sbjct: 94  YENLYAGRKCLL-IVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH- 148
Query: 155 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           +I + HRD+KP+NLL         LKL DFG AK         +   + YY APE + G 
Sbjct: 149 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGP 207
Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            +Y  + D+WS G ++  LL G P F    G      +    G  TR  +        ++
Sbjct: 208 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------GQY 254
Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-FDELRDPNTRL 331
           +FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+     + P T L
Sbjct: 255 EFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306
Query: 332 PNGRFL 337
              R L
Sbjct: 307 HTSRVL 312

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 236 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 281 QSTKVPQTPLHTSRVL 296

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 125 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 184 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 236
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 237 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 281
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 282 QSTKVPQTPLHTSRVL 297

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 238 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 283 QSTKVPQTPLHTSRVL 298

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 229 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 281
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 282 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 327 QSTKVPQTPLHTSRVL 342

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 130 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 189 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 241
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 242 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 286
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 287 QSTKVPQTPLHTSRVL 302

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 238 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 283 QSTKVPQTPLHTSRVL 298

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 41  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +  K C     EK    L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYY 203
           Y+H    + HR++  +N+L++ +   +K+ DFG AK + +G       E   S +   ++
Sbjct: 132 YLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FW 186
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELL 232
            APE +     Y A+ D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 194
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 195 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 249
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 309
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 310 STALEALIHPFFDELRDPNT 329
            +A + L HP+       NT
Sbjct: 288 LSAAQVLQHPWVQGCAPENT 307

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 94
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           H  F T ++    L  V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 213
             G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 140 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 41  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 149
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 139
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 205
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 198 PECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 41  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 149
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 127
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 205
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 128 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 186 PECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 142/327 (43%), Gaps = 46/327 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 100
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 101 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 138 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 210
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 297
Query: 271 E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDP 327
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ L   
Sbjct: 298 ERFQFP---SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 348
Query: 328 NTRLPNGRFLPPLFNFKPHELKGVPVD 354
           N R     ++P + +  P +     VD
Sbjct: 349 NIRNLEAPYIPDVSS--PSDTSNFDVD 373

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 142/327 (43%), Gaps = 46/327 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 100
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 101 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 154 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 210
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 313
Query: 271 E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDP 327
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ L   
Sbjct: 314 ERFQFP---SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 364
Query: 328 NTRLPNGRFLPPLFNFKPHELKGVPVD 354
           N R     ++P + +  P +     VD
Sbjct: 365 NIRNLEAPYIPDVSS--PSDTSNFDVD 389

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 89/367 (24%), Positives = 144/367 (39%), Gaps = 90/367 (24%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 88
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 89  N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 144
           N   VV L   F   +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQ 138
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLV---------------------------------- 170
           + + L Y+H    + H DIKP+N+L+                                  
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 171 --------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
                         N    ++K+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 255
Query: 217 AAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYT 270
              DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I  +   Y+
Sbjct: 256 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYS 313
Query: 271 EFKFPQ-------IKAHPWHKI--------FQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
           +  F +        K  PW           + +       D +  +L+  P  R+TA E 
Sbjct: 314 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 373
Query: 316 LIHPFFD 322
           L HP+ +
Sbjct: 374 LRHPWLN 380

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 89/367 (24%), Positives = 144/367 (39%), Gaps = 90/367 (24%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 88
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 89  N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 144
           N   VV L   F   +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQ 154
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLV---------------------------------- 170
           + + L Y+H    + H DIKP+N+L+                                  
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 171 --------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
                         N    ++K+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 271
Query: 217 AAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYT 270
              DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I  +   Y+
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYS 329
Query: 271 EFKFPQ-------IKAHPWHKI--------FQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
           +  F +        K  PW           + +       D +  +L+  P  R+TA E 
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 316 LIHPFFD 322
           L HP+ +
Sbjct: 390 LRHPWLN 396

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 91/365 (24%), Positives = 147/365 (40%), Gaps = 88/365 (24%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 88
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 89  N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 144
           N   VV L    F  +  + +++ +V E +   + + +IK +Y   Q +P+  VK    Q
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLGHHLLKWIIKSNY---QGLPVRCVKSIIRQ 148
Query: 145 ICRALAYIHNTIGVCHRDIKPQN------------------------------------- 167
           + + L Y+H+   + H DIKP+N                                     
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 168 ---LLVNP------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA 218
              LLVNP         ++K+ D G+A  + K       I +R YR+ E++ GA  Y+  
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTP 265
Query: 219 IDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            DIWS  C+  EL  G  LF   SG       D +  II++LG+  R     ++  Y+  
Sbjct: 266 ADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRH--FALSGKYSRE 323
Query: 273 KFPQ-------IKAHPW---HKIFQKRMPP-----EAVDLVSRLLQYSPNLRSTALEALI 317
            F +        K  PW     + +K   P     +  D +  +L+  P  R++A E L 
Sbjct: 324 FFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLR 383
Query: 318 HPFFD 322
           HP+ +
Sbjct: 384 HPWLN 388

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK             + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 236 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 281 QSTKVPQTPLHTSRVL 296

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/328 (23%), Positives = 127/328 (38%), Gaps = 69/328 (21%)
Query: 26  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------- 76
           G +G   Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 77  ---------------------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV 115
                                +E+  ++ LDHPNVV L        E D LY+  V E V
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYM--VFELV 120
Query: 116 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 175
            +     +     +S+       + YF  + + + Y+H    + HRDIKP NLLV    H
Sbjct: 121 NQGPVMEVPTLKPLSEDQ----ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGH 175
Query: 176 QLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELL 232
            +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  L   +
Sbjct: 176 -IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 233 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 292
            GQ  F                     E I C++         +IK+       Q  +  
Sbjct: 235 FGQCPF-------------------MDERIMCLHS--------KIKSQALEFPDQPDIAE 267
Query: 293 EAVDLVSRLLQYSPNLRSTALEALIHPF 320
           +  DL++R+L  +P  R    E  +HP+
Sbjct: 268 DLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 138/302 (45%), Gaps = 26/302 (8%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 87  HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 136
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 137 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 254
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 255 GTPTREEIK-CMNPNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 312
            +  +  I+ C+    ++   F +I+ HPW +     +P E  ++    L   P+ ++ A
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAA 289
Query: 313 LE 314
           LE
Sbjct: 290 LE 291

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 87  HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 136
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 113
Query: 137 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 114 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 254
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 255 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 52/303 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 123 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F GE+  + L  I              +N 
Sbjct: 182 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVNY 228
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
           ++ E  F                   A D + RLL   P  R T  ++L H +   +R  
Sbjct: 229 DFDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
Query: 328 NTR 330
           N R
Sbjct: 276 NVR 278

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 94
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           H  F T   D LY   V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 408 HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 213
             G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 461 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 517
Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 87  HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 136
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 137 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 254
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 255 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 87  HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 136
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 137 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 254
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 255 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 214
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 215 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEIKCMNPN 268
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR--------- 265
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                        W   F+        D + + L+ + + R T  + L HPF
Sbjct: 266 -------------WSSNFK--------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 214
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 215 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEIKCMNPN 268
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR--------- 265
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                        W   F+        D + + L+ + + R T  + L HPF
Sbjct: 266 -------------WSSNFK--------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 97  ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 145
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 263
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 237
Query: 264 CMNPNYTEF-KFPQIKAHPW 282
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 97  ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 145
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 263
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 264 CMNPNYTEF-KFPQIKAHPW 282
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/315 (25%), Positives = 141/315 (44%), Gaps = 68/315 (21%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 93
           +G G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 94  KHCFF--STTEK-----DELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
            + +   +TTEK      ++YL + ++    E +   +     + +R   + + + F QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI-FLQI 127
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY- 197
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 198 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 252
                + ++ Y +PE I G + Y+  +DI+S G +L EL     L+P  + ++++  +  
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTD 239
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 312
           V                   KFP         +F ++ P E V +V  +L  SP  R  A
Sbjct: 240 V----------------RNLKFP--------PLFTQKYPCEYV-MVQDMLSPSPMERPEA 274
Query: 313 LEALIHPFFDELRDP 327
           +  + +  F++L  P
Sbjct: 275 INIIENAVFEDLDFP 289

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 67
Query: 97  ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 145
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 68  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 122
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 123 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 180
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 263
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 240
Query: 264 CMNPNYTEF-KFPQIKAHPW 282
           C+    ++   F +I+ HPW
Sbjct: 241 CLALRPSDRPTFEEIQNHPW 260

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 24  KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 87  HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 136
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 83  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 136
Query: 137 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 137 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 194
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
            +  +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 130/305 (42%), Gaps = 61/305 (20%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 92
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP------ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           L   + S        L +V E++       E V R     +  S+ +   Y++    QI 
Sbjct: 93  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMR----QIL 142
Query: 147 RALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSR 201
            AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + 
Sbjct: 143 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 199
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + +
Sbjct: 200 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 250
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            K MNP              W  I +      A DLV R+L   P  R T  EAL HP+ 
Sbjct: 251 YK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWL 292
Query: 322 DELRD 326
            E RD
Sbjct: 293 KE-RD 296

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQT-MRLLDHPNVVSLKH 95
           +GHGS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            +    E   LYL   L         + +H       +P   V  Y      ALA++H+ 
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 207
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 177 -GLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 247
           L+ G+  Y  A D++S G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 22/260 (8%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 97  ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 145
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 263
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + +    +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 237
Query: 264 CMNPNYTEF-KFPQIKAHPW 282
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 128/302 (42%), Gaps = 60/302 (19%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 92
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP------ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           L   + S        L +V E++       E V R     +  S+ +   Y++    QI 
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMR----QIL 140
Query: 147 RALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSR 201
            AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 197
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + +
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 248
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            K MNP              W  I +      A DLV R+L   P  R T  EAL HP+ 
Sbjct: 249 YK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 322 DE 323
            E
Sbjct: 291 KE 292

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR   
Sbjct: 229 YVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR--- 278
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 322
             +     EF  P+     W ++ +     E   L+  LL+  P  R T  E   HP+  
Sbjct: 279 --IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPWIX 326
Query: 323 E-LRDPNTRLPNGRFL 337
           +  + P T L   R L
Sbjct: 327 QSTKVPQTPLHTSRVL 342

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 41  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 90
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 73  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSR 201
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G       E   S +   
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--- 178
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 179 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 41  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 90
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 74  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSR 201
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G       E   S +   
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--- 179
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 180 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 137/330 (41%), Gaps = 52/330 (15%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 93
           +V+G G+FG V   K     +  A+K + + +  K  E    R         D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            + F     +D+  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 140 HYAF-----QDDNNLYLVMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI-- 209
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 193 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 210 --FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
              G   Y    D WS G  + E+L G+  F  ES V+   +I+                
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------------- 294
Query: 268 NYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDEL 324
           N+ E F+FP              +   A DL+ RL+      L    +E    HPFF  +
Sbjct: 295 NHKERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345
Query: 325 RDPNTRLPNGRFLPPLFNFKPHELKGVPVD 354
              N R     ++P + +  P +     VD
Sbjct: 346 DWDNIRNCEAPYIPEVSS--PTDTSNFDVD 373

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 145
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 216
           + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 217 AAIDIWSAGCVLAELLLGQP 236
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 137/305 (44%), Gaps = 54/305 (17%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 97
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 98  FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 146
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 210
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 211 ----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
                AT Y    D+WS G    E+  G P       +  L  I +             N
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------N 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
           P       P++K+  W K FQ          +   L  + + R    + + HPF   +RD
Sbjct: 250 P------APRLKSKKWSKKFQS--------FIESCLVKNHSQRPATEQLMKHPF---IRD 292
Query: 327 -PNTR 330
            PN R
Sbjct: 293 QPNER 297

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 59  TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-E 117
             + ++IK    D  +KN ELQ +  + +   ++   C    T  DE+Y+  + EY+  +
Sbjct: 77  NNDKISIKSKYDD--FKN-ELQIITDIKNEYCLT---CEGIITNYDEVYI--IYEYMEND 128
Query: 118 TVHRVIKHHYKMSQR----MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH 173
           ++ +  ++ + + +     +P+  +K     +  + +YIHN   +CHRD+KP N+L++ +
Sbjct: 129 SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188
Query: 174 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA-IDIWSAGCVLAELL 232
             ++KL DFG ++ +V  +   S   +  +  PE     + Y  A +DIWS G  L  + 
Sbjct: 189 G-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
Query: 233 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR--- 289
                F  +     LVE+   + T   E             +P  + H  + +  K+   
Sbjct: 247 YNVVPFSLKIS---LVELFNNIRTKNIE-------------YPLDRNHFLYPLTNKKSTC 290
Query: 290 ----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
               +  E +D +   L+ +P  R T+ +AL H +   L D N
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW---LADTN 330

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 75  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 214
             + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 180
Query: 215 YTAAIDIWSAGCVLAELLLGQP 236
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 161
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 190
Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 215
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 249
Query: 216 TAAIDIWSAGCVLAELLLG 234
            A +DIWS+ C++  +L G
Sbjct: 250 DAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 119
Query: 103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 161
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 174
Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 215
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 233
Query: 216 TAAIDIWSAGCVLAELLLG 234
            A +DIWS+ C++  +L G
Sbjct: 234 DAKVDIWSSCCMMLHMLNG 252

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 27/200 (13%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 194
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 195 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 249
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 309
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 310 STALEALIHPFFDELRDPNT 329
            +A + L HP+       NT
Sbjct: 288 LSAAQVLQHPWVQGCAPENT 307

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 23/270 (8%)
Query: 27  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 86
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 87  HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 135
              VV LK                E+ + ++ L+LE +   + +   I     + + +  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILERMEPVQDLFDFITERGALQEEL-- 115
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 116 --ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 254
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 255 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 282
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 54/292 (18%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 97
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 214
           + HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 215 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEIKCMNPN 268
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR--------- 265
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                        W   F+        D + + L+ + + R T  + L HPF
Sbjct: 266 -------------WSSNFK--------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 125/303 (41%), Gaps = 52/303 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 143
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 144 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F GE+  + L  I              +N 
Sbjct: 203 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVNY 249
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
           ++ E  F                   A D + RLL   P  R    ++L H +   +R  
Sbjct: 250 DFDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRR 296
Query: 328 NTR 330
           N R
Sbjct: 297 NVR 299

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 90  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 214
             + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 215 YTAAIDIWSAGCVLAELLLGQP 236
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 84
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 143
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 144 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI 198
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFV 177
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 75  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 214
             + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 180
Query: 215 YTAAIDIWSAGCVLAELLLGQP 236
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           +G GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 133
Query: 103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 161
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 188
Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 215
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 247
Query: 216 TAAIDIWSAGCVLAELLLG 234
            A +DIWS+ C++  +L G
Sbjct: 248 DAKVDIWSSCCMMLHMLNG 266

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 161
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 209
Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 215
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 216 TAAIDIWSAGCVLAELLLG 234
            A +D+WS+ C++  +L G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 256
           R    + APE IF    Y+   D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             RE ++   P Y+  +  QI    WH+  ++R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD---------- 86
           Y    ++G G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 87  ---------HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 137
                    HP V+ L   F    E  E ++ LVLE  P     +  +   ++++ PL  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDLFDY---ITEKGPLGE 138
Query: 138 --VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              + +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
            +  +R Y  PE I     +     +WS G +L +++ G 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 136/314 (43%), Gaps = 42/314 (13%)
Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM 82
            G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  +
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 83  RL-------LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRM 133
            L       ++H N++ +   F     +++ +  LV+E       +   I  H ++ +  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-- 129
Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
           PL      F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+ 
Sbjct: 130 PL--ASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKL 185
Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVD------- 245
             ++  +  Y APE++ G       +++WS G  L  L+  + P    E  V+       
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY 245
Query: 246 ----QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ---IKAHPWHKIFQKRMPPEAVDLV 298
               +L+ ++  L  P  E    +    T+    Q   +  + W ++F+   P   V   
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
Query: 299 SRLLQYSPNLRSTA 312
           + L   + +L   A
Sbjct: 306 ASLEMGNRSLSDVA 319

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 159 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 216
Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 256
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 276
Query: 257 PTREEIK-CMNPNYTEF-KFPQIKAHPW 282
             +  I+ C+    ++   F +I+ HPW
Sbjct: 277 ECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 84
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 143
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 144 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI 198
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 84
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 143
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 144 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI 198
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 44/249 (17%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 94
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 95  HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
             +          T  K +  L +  EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 195
            AL+YIH+  G+ HR++KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 196 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNIL 238
Query: 252 KVLGTPTRE 260
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 234
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 235 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 155
             +T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTK-----LWIIMEYLGGG------SALDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 214
             + HRDIK  N+L++     +KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 215 YTAAIDIWSAGCVLAELLLGQP 236
           Y    DIWS G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 102
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 161
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 190
Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 215
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 216 TAAIDIWSAGCVLAELLLG 234
            A +D+WS+ C++  +L G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 614
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 615 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 233
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 233
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 234
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 235 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 81  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 132
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 133 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 188 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 239
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 240 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 73  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 124
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 125 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 179
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 180 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 231
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 232 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 104 L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 155
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 156 ESKRFV-HRDIAARNVLVSSN-DCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 210
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 211 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 262
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 263 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 300

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 78  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 130 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 184
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 185 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 236
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 237 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 274

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 79  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 130
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 131 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 185
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 186 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 237
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 238 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 201
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 137 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 193
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G        + +    +  
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRR 244
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           I+       ++ FP  +   W ++ +     +A  L+  LL+  P  R T  + + HP+ 
Sbjct: 245 IR-----LGQYGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWI 291
Query: 322 DE-LRDPNTRLPNGRFL 337
           ++ +  P T L   R L
Sbjct: 292 NQSMVVPQTPLHTARVL 308

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 234
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 235 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 201
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 118 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 174
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G        + +    +  
Sbjct: 175 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRR 225
Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           I+       ++ FP  +   W ++ +     +A  L+  LL+  P  R T  + + HP+ 
Sbjct: 226 IR-----LGQYGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWI 272
Query: 322 DE-LRDPNTRLPNGRFL 337
           ++ +  P T L   R L
Sbjct: 273 NQSMVVPQTPLHTARVL 289

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 91
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 148 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 204
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +S   +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 205 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 242
            P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 41  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 207
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 614
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 323
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 615 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F GE+  + L              I  +N 
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNY 235
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           ++ E  F                   A D + RLL   P  R    ++L H +
Sbjct: 236 DFDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 28/226 (12%)
Query: 29  GQPKQTIS---YMAERVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE---- 78
           G P+  I+    +  R++G G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 79  -LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 137
               M+ LDHP++V L        E++  ++ + L    E  H + ++       + ++ 
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLT 126
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
           + LY  QIC+A+AY+  +I   HRDI  +N+LV      +KL DFG ++  ++ E     
Sbjct: 127 LVLYSLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKA 183
Query: 198 ICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLF 238
             +R    + +PE I     +T A D+W     + E+L    QP F
Sbjct: 184 SVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-T 155
            F         L++V EY+       + H     +++         Y + + + Y+HN  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 209
             + HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + APE++
Sbjct: 158 PPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEVL 211
Query: 210 FGATEYTAAIDIWSAGCVLAEL-LLGQP 236
                   + D++S G +L EL  L QP
Sbjct: 212 RDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ERV+G G FG V   +    G+   AVAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+             + +V+E++    +   ++ H     +  +I +      I   + 
Sbjct: 108 HLEGVVTRGKP-----VMIVIEFMENGALDAFLRKH---DGQFTVIQLVGMLRGIAAGMR 159
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + A
Sbjct: 160 YLAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTA 216
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G V+ E++
Sbjct: 217 PEAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   +K   K   +  +I +      I   + 
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMK 138
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 139 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 195
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G V+ E++
Sbjct: 196 PEAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 41  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 92
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 129
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 209
             +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +PE I
Sbjct: 130 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 186
Query: 210 FGATEYTAAIDIWSAGCVLAELLL--GQPLF 238
                +T A D+W     + E+L    QP F
Sbjct: 187 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 41  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 92
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 74  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 125
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 209
             +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +PE I
Sbjct: 126 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 182
Query: 210 FGATEYTAAIDIWSAGCVLAELLL--GQPLF 238
                +T A D+W     + E+L    QP F
Sbjct: 183 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 126/302 (41%), Gaps = 64/302 (21%)
Query: 41  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 92
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L         ++ ++  +++E       R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--------VKGEPNISYICSRYYR 204
            +   V HRDI  +N+LV+ +   +KL DFG ++ +         KG+  I ++      
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM------ 179
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
           APE I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E  
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL 231
Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFF 321
            M PN                      PP    L+++   Y P+ R   T L+A +    
Sbjct: 232 PMPPN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270
Query: 322 DE 323
           +E
Sbjct: 271 EE 272

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 96
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-T 155
            F         L++V EY+       + H     +++         Y + + + Y+HN  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 209
             + HR++K  NLLV+   + +K+CDFG +++        +++ S+       + APE++
Sbjct: 158 PPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEVL 211
Query: 210 FGATEYTAAIDIWSAGCVLAEL-LLGQP 236
                   + D++S G +L EL  L QP
Sbjct: 212 RDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 38  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 90
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           ++L   + +T+E     + L+LEY    E     +    +M     +I +     QI   
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILEG 143
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
           + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         + +  Y AP
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E I      T A D+W+ G +   LL     F GE   +  + I +V            N
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------N 249
Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
            +Y+E  F  +                A D +  LL  +P  R TA   L H +  +
Sbjct: 250 VDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 91
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   + + T+     + L+ E V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 151 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 91
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 148 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 204
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +    +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYL 182
Query: 205 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 242
            P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 57/296 (19%)
Query: 43  VGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNRE--LQTMRLLDH-------- 87
           +G G+FG V +A         T   VA+K + +   +      +  +++L H        
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 88  -----------PNVVSLKHCFFSTTEKDELYL----NLVLEYVPETVHRVIKHHYKMSQR 132
                      P +V ++ C F        YL    N  + Y PE +++           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDF--------- 144
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKV-----LQDKRYKNRELQTM 82
           P + +   ++RV+G G FGVV+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           R L+HPNV++L            + L       P   H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ R + Y+     V HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 202 YYRAPELIFGATE------YTAAIDIWSAGCVLAELL 232
           + R P + + A E      +T   D+WS G +L ELL
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 92
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 152 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     ++ + + F  +    A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 149
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 150 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 206
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 207 PEAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 159
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 160 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 216
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 217 PEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 132
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 133 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 189
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 190 PEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           HP++V + +    T    +    +V+EYV     +  K      Q++P+     Y  +I 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEIL 192
Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSR 201
            AL+Y+H +IG+ + D+KP+N+++     QLKL D G+   +     + G P        
Sbjct: 193 PALSYLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
            ++APE++   T  T A DI++ G  LA L L  P   G   VD L E   VL T
Sbjct: 243 -FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYKN----------RELQTMRLLDHP 88
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 144
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 145 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 199
           I   + Y+ N    + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 200 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 238
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 91
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           + +   V HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I    ++T+A D+WS G V+ E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 97
           +G GSFG VF+     T + VAIK +       +     +E+  +   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
              ++     L +++EY+       +       +      +     +I + L Y+H+   
Sbjct: 91  LKGSK-----LWIIMEYLGGGSALDLLRAGPFDE----FQIATMLKEILKGLDYLHSEKK 141
Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 216
           + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 142 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 198
Query: 217 AAIDIWSAGCVLAELLLGQP 236
           +  DIWS G    EL  G+P
Sbjct: 199 SKADIWSLGITAIELAKGEP 218

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 133
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I    ++T+A D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 252
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 304
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 305 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 43  VGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNRE--LQTMRLL----DHPNVV 91
           +G G+FG V +A         T   VA+K + +   +      +  +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 92  SLKHCFFSTTEKDELYLNLVLE---------YVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +L         K    L +++E         Y+    +  + +       + L ++  Y 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 202
           +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 203 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 258
              + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRL 260
Query: 259 REEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 254
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 306
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 307 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           PE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  + 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL 273
Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTA 312
             P        Q+    WHK   +R    + V ++  L++   +LR+TA
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 247
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 299
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYKN----------RELQTMRLLDHP 88
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 144
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 145 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 199
           I   + Y+ N    + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 200 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 238
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 91
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I    ++T+A D+WS G V+ E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 92
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 152 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     ++ + + F       A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 245
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 297
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 298 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 91
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I    ++T+A D+WS G V+ E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 92
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 152 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     ++ + + F  +    A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 190 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 256
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 248 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 299
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 92
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 152 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     ++ + + F  +    A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 204
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 256
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 193 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 248
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 92
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 152 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     ++ + + F       A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 92
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 152 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                     ++ + + F       A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 91
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 146
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 207 ELI-FGATEYTAAIDIWSAGCVLAELL 232
           E I FG  +YT   D+WS G  + EL+
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 91
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 128
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 207 ELI-FGATEYTAAIDIWSAGCVLAELL 232
           E I FG  +YT   D+WS G  + EL+
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/345 (21%), Positives = 131/345 (37%), Gaps = 56/345 (16%)
Query: 42  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 93
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F +    +EL++             +  H       + + Y+      + +AL YIH
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 154 NTIGVCHRDIKPQNLLVNPH--------THQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-------------- 251
             L      Y A  DI+S G    EL  G   F        L+E +              
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 252 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 249 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS----PHFHHFVEQC 301
Query: 302 LQYSPNLRSTALEALIHPFFDEL-RDPNTRLPN-GRFLPPLFNFK 344
           LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+
Sbjct: 302 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 80
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 137
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 196
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 312
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 313 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 340
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 80
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 137
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 196
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 312
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 313 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 340
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/345 (21%), Positives = 131/345 (37%), Gaps = 56/345 (16%)
Query: 42  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 93
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F +    +EL++             +  H       + + Y+      + +AL YIH
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 154 NTIGVCHRDIKPQNLLVNPH--------THQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-------------- 251
             L      Y A  DI+S G    EL  G   F        L+E +              
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 252 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS----PHFHHFVEQC 317
Query: 302 LQYSPNLRSTALEALIHPFFDEL-RDPNTRLPN-GRFLPPLFNFK 344
           LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+
Sbjct: 318 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 80
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 137
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 196
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 312
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 313 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 340
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 80
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 137
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 196
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 312
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 313 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 340
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L     S T      + LV + +P        H +K +    L+    +  QI + + Y
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 155
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 208
           +     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E 
Sbjct: 156 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 209 IFGATEYTAAIDIWSAGCVLAELL 232
           I    ++T   D+WS G  + EL+
Sbjct: 214 IH-YRKFTHQSDVWSYGVTIWELM 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L     S T      + LV + +P        H +K +    L+    +  QI + + Y
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 132
Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 208
           +     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E 
Sbjct: 133 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 209 IFGATEYTAAIDIWSAGCVLAELLL--GQP 236
           I    ++T   D+WS G  + EL+   G+P
Sbjct: 191 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYKN----------RELQTMRLLDHP 88
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 144
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 145 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 199
           I   + Y+ N    + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 200 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 238
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 154
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF- 210
              + HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 127 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 211 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 36/289 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 205
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTA 222
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           PE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  + 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL 273
Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTA 312
             P        Q+    WHK   +R    + V ++  L++   +LR+TA
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGXLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+ DFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 256
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXR 258
Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 303
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 106 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 154
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 155 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 213 LESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC--- 96
           +G G FG V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 97  ---FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              F+  TE    Y NL L+Y+ E   + +         + L+Y+     QI  A+ Y+ 
Sbjct: 79  EPPFYIITEF-MTYGNL-LDYLRECNRQEV-------SAVVLLYMAT---QISSAMEYLE 126
Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 210
                 HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 127 KK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL- 182
Query: 211 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 240
              +++   D+W+ G +L E+   G   +PG
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 135
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 136 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 194 LESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 139
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 140 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 198 LESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 149
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 204
           Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 150 YLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE I    ++T+A D+WS G V+ E++
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 154
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 210
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 211 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 123
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 124 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 163
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 164 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 222 LESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 47/196 (23%)
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 202
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK    GE          
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE---------- 173
Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
                      +Y  + D+WS G ++  LL G P F    G    + I   + T  R   
Sbjct: 174 -----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIR--- 215
Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 321
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 216 ------MGQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261
Query: 322 DELRDPNTRLPNGRFL 337
              + P T L   R L
Sbjct: 262 QSTKVPQTPLHTSRVL 277

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 95
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPN+V    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 154
            + ST  K +  + LV E       +     +K+ +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTV-KGKKCIVLVTELXTSGTLKTYLKRFKVXK---IKVLRSWCRQILKGLQFLHTR 148
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
           T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 215 YTAAIDIWSAG-CVL 228
           Y  ++D+++ G C L
Sbjct: 206 YDESVDVYAFGXCXL 220

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 41/243 (16%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIK-KVLQDKRYKNR------ELQ 80
           P++ + +   +V+G G+FG V  A      +TG ++ +  K+L++K   +       EL+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 81  TM-RLLDHPNVVSLKHCFFSTTEKDELYLNL-------VLEYVPETVHRVIKHH--YKMS 130
            M +L  H N+V+L     + T    +YL         +L Y+     +  +    Y+  
Sbjct: 101 MMTQLGSHENIVNL---LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 131 QRMP-------LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
           +R+        L +  L  + YQ+ + + ++     V HRD+  +N+LV  H   +K+CD
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKICD 215
Query: 182 FGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPL 237
           FG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  LG   
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP 274
Query: 238 FPG 240
           +PG
Sbjct: 275 YPG 277

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 154
             +ST  +    L +V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 210
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 211 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI   
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAEG 126
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 127 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 185 LESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 89
           ++V+G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           ++ L+             + ++ EY+      + K   +      ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYR 204
            Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE I    ++T+A D+WS G V+ E++
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 32  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHP 88
           ++ I+ + E  +G G FGVV   K  +    VA+K + +    ++   +E QTM  L HP
Sbjct: 7   REEITLLKE--LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            +V     F+    K E  + +V EY+    +   ++ H K  +   L+ +    Y +C 
Sbjct: 64  KLVK----FYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM---CYDVCE 115
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YR 204
            +A++ +   + HRD+  +N LV+     +K+ DFG  + ++  +  +S + +++   + 
Sbjct: 116 GMAFLESHQFI-HRDLAARNCLVDRDL-CVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWS 172
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE +F   +Y++  D+W+ G ++ E+ 
Sbjct: 173 APE-VFHYFKYSSKSDVWAFGILMWEVF 199

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 92
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 93  --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
             L  C  ST +       LV + +P     ++ H  +   R+    +  +  QI + ++
Sbjct: 83  RLLGICLTSTVQ-------LVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 207
           Y+ + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 134 YLED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 208 LIFGATEYTAAIDIWSAGCVLAELL 232
            I     +T   D+WS G  + EL+
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 89
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 147
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 142
Query: 148 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 203
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 35  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 85
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 124
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 201
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 202 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
               + APE I    ++T+A D WS G V+ E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 89
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 147
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 150
Query: 148 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 203
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 238
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 94
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 152
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 209
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQP 236
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 96
           +G G FGVV++     T  AV     + D      K+  ++E++ M    H N+V L   
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL--L 96
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYIHN 154
            FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++H 
Sbjct: 97  GFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG 211
              + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G
Sbjct: 152 NHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG 209
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQP 236
             E T   DI+S G VL E++ G P
Sbjct: 210 --EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 96
           +G G FGVV++     T  AV     + D      K+  ++E++ M    H N+V L   
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL--L 90
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYIHN 154
            FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++H 
Sbjct: 91  GFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG 211
              + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G
Sbjct: 146 NHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG 203
Query: 212 ATEYTAAIDIWSAGCVLAELLLGQP 236
             E T   DI+S G VL E++ G P
Sbjct: 204 --EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 88  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 206
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL 232
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 91
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 92  SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 205
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 206 PELIFGATEYTAAIDIWSAGCVLAELL 232
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 81/264 (30%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 93
           +G G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 94  KHCFFST------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV--------- 138
            + +  T       E DE++L       P +    +       +RM              
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 139 ---KLYFY---QICR-------------------------------ALAYIHNTIGVCHR 161
              K+Y Y   Q+CR                               A+ ++H+  G+ HR
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHR 188
Query: 162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAPEL 208
           D+KP N+        +K+ DFG    + + E       P  +Y      + ++ Y +PE 
Sbjct: 189 DLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 209 IFGATEYTAAIDIWSAGCVLAELL 232
           I G   Y+  +DI+S G +L ELL
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 38  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVS 92
           M    +G GSFG V++ K      AV I KV+     Q + ++N E+  +R   H N++ 
Sbjct: 39  MLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL- 95
Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
               F     KD L   +V ++   +   + KH +    +  +  +     Q  + + Y+
Sbjct: 96  ---LFMGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELI 209
           H    + HRD+K  N+ ++     +K+ DFG A V  +  G   +     S  + APE+I
Sbjct: 149 HAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 210 F--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
                  ++   D++S G VL EL+ G+  +   +  DQ++ ++
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHCFF 98
           V   G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N++      F
Sbjct: 31  VKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQ-----F 83
Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC-------RALAY 151
              EK    +++ L  +          H K S    L    + + ++C       R LAY
Sbjct: 84  IGAEKRGTSVDVDLWLIT-------AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 152 IHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP---NISY 197
           +H  I          + HRDIK +N+L+    + L  C  DFG A     G+        
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 198 ICSRYYRAPELIFGATEYTAA----IDIWSAGCVLAEL 231
           + +R Y APE++ GA  +       ID+++ G VL EL
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 123
Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 204
           Y+ + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 124 YLAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL 232
           APE I    ++T+A D+WS G V+ E++
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMR-LLDHPN 89
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 90  VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
           +V+L              ++C +         LN +    P  +       +   +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
             +  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 223
Query: 196 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 60/244 (24%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYK-----NRELQ 80
           P+  I Y+  R +G G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 81  TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 128
            M   D+PN+V L          C    + +  + +E   ++    V    H  +    +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 129 MSQRMP--------LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 180
           +S   P        L   +    Q+   +AY+     V HRD+  +N LV      +K+ 
Sbjct: 163 VSSPGPPPLSCAEQLCIAR----QVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIA 216
Query: 181 DFGSAKVLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVL 228
           DFG ++ +   +         YY+A            PE IF    YT   D+W+ G VL
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVL 266
Query: 229 AELL 232
            E+ 
Sbjct: 267 WEIF 270

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L +  V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L +  V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 35  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 85
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 75  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 126
Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 201
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 202 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
               + APE I    ++T+A D WS G V+ E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 126 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMR-LLDHPN 89
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 90  VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
           +V+L              ++C +     D L        V ET       +  +S R  L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYG----DLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
            +      Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 168 HFSS----QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 196 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMR-LLDHPN 89
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFY- 143
           +V+L     + T    + +  + EY     +   + R  +         PL    L  + 
Sbjct: 104 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 144 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 202
            Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R 
Sbjct: 159 SQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 203 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 217 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMR-LLDHPN 89
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 90  VVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFY- 143
           +V+L     + T    + +  + EY     +   + R  +         PL    L  + 
Sbjct: 112 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 144 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 202
            Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R 
Sbjct: 167 SQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 203 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 225 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 44  GHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 95
           G G FGVV++     T   VA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK--LYFYQICRALAYIH 153
             FS+   D   L LV  Y P            +  R+  +     L ++  C+      
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG---------SLLDRLSCLDGTPPLSWHXRCKIAQGAA 134
Query: 154 NTIGV------CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYR 204
           N I         HRDIK  N+L++      K+ DFG A+   K    +     + +  Y 
Sbjct: 135 NGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYX 193
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQP 236
           APE + G  E T   DI+S G VL E++ G P
Sbjct: 194 APEALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMR-LLDHPN 89
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 90  VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 135
           +V+L              ++C +          + VLE  P          + ++     
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA---------FAIANSTAS 162
Query: 136 IYVKLYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
               L+F  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 220
Query: 195 ISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 221 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
             +ST  +    L +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 144 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L +  V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 95
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 212
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 213 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 159 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 216
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 217 AAIDIWSAGCVLAELLLGQPLFPGE 241
              DI++  CVL E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 158 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 211
            C  HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 212 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 242
              Y++  D+WS G +L E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 97
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 158 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 214
            C  HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 215 -----YTAAIDIWSAGCVLAELL-LGQPLFPGES 242
                Y++  D+WS G +L E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 303
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 304 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 334
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 43  VGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 99
           VG G +G V++   L  GE+VA+K      +   ++  E+    LL H N++        
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM- 72
Query: 100 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--- 156
           T+      L L+  Y     H  +    +     P + ++L     C  LA++H  I   
Sbjct: 73  TSRNSSTQLWLITHYHE---HGSLYDFLQRQTLEPHLALRLAVSAAC-GLAHLHVEIFGT 128
Query: 157 ----GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPE 207
                + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 208 LI--------FGATEYTAAIDIWSAGCVLAEL 231
           ++        F + ++T   DIW+ G VL E+
Sbjct: 188 VLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 42/209 (20%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 224
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
           Q++  I  L          ++PN+ E +FP I               +  D++   L+  
Sbjct: 225 QIINQISKLHA-------IIDPNH-EIEFPDIPEK------------DLQDVLKCCLKRD 264
Query: 306 PNLRSTALEALIHPFFDELRDPNTRLPNG 334
           P  R +  E L HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 303
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 259
Query: 304 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 334
             P  R +  E L HP+      P  ++  G
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 42/209 (20%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 240
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
           Q++  I  L          ++PN+ E +FP I               +  D++   L+  
Sbjct: 241 QIINQISKLHA-------IIDPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 306 PNLRSTALEALIHPFFDELRDPNTRLPNG 334
           P  R +  E L HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 36/286 (12%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 85  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 137
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    +  + 
Sbjct: 138 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKTG 195
Query: 202 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 255
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 196 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 250
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 303
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 304 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 334
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMR-LLDHPN 89
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 90  VVSL--------------KHC-------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 128
           +V+L              ++C       F     +  L  +L     PE + +      +
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK------E 150
Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             + + L  +  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ +
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDI 208
Query: 189 VKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           +     I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 42/209 (20%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 220
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
           Q++  I  L          ++PN+ E +FP I               +  D++   L+  
Sbjct: 221 QIINQISKLHA-------IIDPNH-EIEFPDIPEK------------DLQDVLKCCLKRD 260
Query: 306 PNLRSTALEALIHPFFDELRDPNTRLPNG 334
           P  R +  E L HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 42/209 (20%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
           Q++  I  L          ++PN+ E +FP I      K  Q        D++   L+  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIP----EKDLQ--------DVLKCCLKRD 308
Query: 306 PNLRSTALEALIHPFFDELRDPNTRLPNG 334
           P  R +  E L HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 104 KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 156
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 157 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 210
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 211 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 269
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 270 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 309

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 84  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 136
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 137 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 190
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 191 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 249
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 250 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 77
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 78  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 130
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 131 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 184
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 185 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 243
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 244 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 283

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 104
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 105 KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 157
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 158 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 211
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 212 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 270
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 271 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 310

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 139 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 192
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 251
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 129/307 (42%), Gaps = 55/307 (17%)
Query: 41  RVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           R +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E   M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP---LIYVKLYFYQICR 147
           V L     S  +   + + L+     ++  R ++   + +   P   L  +     +I  
Sbjct: 83  VRLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYR 204
            +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +        +    + 
Sbjct: 142 GMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
           APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +            
Sbjct: 200 APESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV------------ 245
Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL------I 317
            M+  Y +         P         P    DL+    Q++PN+R T LE +      +
Sbjct: 246 -MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 290
Query: 318 HPFFDEL 324
           HP F E+
Sbjct: 291 HPSFPEV 297

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 87  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 139
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ ++  E +  +  + 
Sbjct: 140 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKTG 197
Query: 202 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 255
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 198 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 252
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 253 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 83  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 135
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 136 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 189
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 248
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 249 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 288

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 189
Query: 205 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 190 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 85  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 137
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 138 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 191
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 192 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 250
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 183
Query: 205 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 81  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 133
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 134 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 187
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 246
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 247 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 286

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 179
Query: 205 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 180 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 139 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 192
Query: 202 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 251
Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 179
Query: 205 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 180 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 183
Query: 205 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 30  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL----QTMRLL 85
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
                +     F    E D  Y  LV++ +  ++  +       S+++ L  V +   Q+
Sbjct: 60  QGGTGIPNVRWF--GVEGD--YNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
Query: 146 CRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAK 186
              + ++H+     HRDIKP N L+      +Q+ + DFG AK
Sbjct: 113 INRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 195
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 196 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 240
Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
           Q++  I  L          ++PN+ E +FP I               +  D++   L+  
Sbjct: 241 QIINQISKLHA-------IIDPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 306 PNLRSTALEALIHPFFDELRDPNTRLPNG 334
           P  R +  E L HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYR 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +      R     + 
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 192 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 139 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 202 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 255
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 197 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 251
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 90
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 91  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 143
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 144 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 201
Query: 202 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 255
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 202 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 256
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 257 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 296

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 78
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 79  LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 141 GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 193
Query: 139 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDS 249
Query: 198 ICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 250
           + ++      + + A E      +T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 310 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 350

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 43  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 92
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 148
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYR 204
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +      R     + 
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 252
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 87  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 139
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 140 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 197
Query: 202 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 255
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 198 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 252
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 253 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 44/290 (15%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 78
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 79  LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 139 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +
Sbjct: 135 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 192
Query: 198 ICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 251
             +       + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++
Sbjct: 193 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                   +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 --------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 82
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 84  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 136
Query: 143 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 137 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 194
Query: 202 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 255
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 195 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 249
Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 250 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 201 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 40  ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 91
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 139
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 80  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 140 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 195
           L+F   + R + Y+     + HRD+  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 135 LHFAADVARGMDYLSQKQFI-HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 190
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 191 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 40  ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 91
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 139
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 90  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 140 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 195
           L+F   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 145 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 200
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 201 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 130/316 (41%), Gaps = 73/316 (23%)
Query: 41  RVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           R +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E   M+     +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP---LIYVKLYFYQICR 147
           V L     S  +   + + L+     ++  R ++   + +   P   L  +     +I  
Sbjct: 84  VRLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            +AY+ N     HR++  +N +V  H   +K+ DFG  + + +         + YYR   
Sbjct: 143 GMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYYRKGG 191
Query: 205 ---------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 254
                    APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +   
Sbjct: 192 KGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV--- 246
Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                     M+  Y +         P         P    DL+    Q++PN+R T LE
Sbjct: 247 ----------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLE 282
Query: 315 AL------IHPFFDEL 324
            +      +HP F E+
Sbjct: 283 IVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 130/316 (41%), Gaps = 73/316 (23%)
Query: 41  RVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           R +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E   M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP---LIYVKLYFYQICR 147
           V L     S  +   + + L+     ++  R ++   + +   P   L  +     +I  
Sbjct: 83  VRLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            +AY+ N     HR++  +N +V  H   +K+ DFG  + + +         + YYR   
Sbjct: 142 GMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYYRKGG 190
Query: 205 ---------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 254
                    APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +   
Sbjct: 191 KGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV--- 245
Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                     M+  Y +         P         P    DL+    Q++PN+R T LE
Sbjct: 246 ----------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 315 AL------IHPFFDEL 324
            +      +HP F E+
Sbjct: 282 IVNLLKDDLHPSFPEV 297

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 41/211 (19%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKK----VLQDKRYKNRELQTMRLLDHPNVVSL-KHC 96
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 152
                E++E+ L  + +Y+    +  +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYME---NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 201
           H T  + HRD+K  N+L++ +    K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTELGQTHLXXVVKG--TLGYIDPE 211
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 24/182 (13%)
Query: 25  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKN 76
           G    + + T  +     +G G FG VF  KC++   G   AIK+  +      D++   
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 58
Query: 77  RELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMP 134
           RE+    +L  H +VV     +FS   +D+  L +  EY    ++   I  +Y++     
Sbjct: 59  REVYAHAVLGQHSHVVR----YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFK 113
Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVL 188
              +K    Q+ R L YIH ++ + H DIKP N+ +      N  + +    D+ S KV+
Sbjct: 114 EAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 189 VK 190
            K
Sbjct: 173 FK 174

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 41/211 (19%)
Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKK----VLQDKRYKNRELQTMRLLDHPNVVSL-KHC 96
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 152
                E++E+ L  + +Y+    +  +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYME---NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 201
           H T  + HRD+K  N+L++ +    K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTELDQTHLXXVVKG--TLGYIDPE 211
Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 43  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 93
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 17  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 94  KHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              +FS   +D+  L +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 74  ---YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 153 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 190
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 43  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 93
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 15  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 71
Query: 94  KHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              +FS   +D+  L +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 72  ---YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 153 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 190
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 128 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 43  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 93
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 17  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 94  KHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              +FS   +D+  L +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 74  ---YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 153 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 190
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           Y   R +G GSFG ++    + +GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSI 70
Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
            +   E D  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH+  
Sbjct: 71  KWCGAEGD--YNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK- 124
Query: 157 GVCHRDIKPQNLL--VNPHTHQLKLCDFGSAK 186
              HRD+KP N L  +    + + + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 40  ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 91
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 139
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 87  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 140 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 195
           L+F   + R + Y+     + HR++  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 142 LHFAADVARGMDYLSQKQFI-HRNLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 197
Query: 196 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 232
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 198 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	373
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-99
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-92
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-91
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-89
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-89
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-88
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-88
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-87
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-86
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-86
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-79
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-62
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-60
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-60
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-60
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-60
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-59
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-59
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-59
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-58
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-58
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-57
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-57
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-57
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-56
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-56
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-56
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-56
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-56
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-55
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-55
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-54
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-54
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-54
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-54
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-54
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-53
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-53
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-53
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-53
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-53
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-53
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-53
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-52
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-52
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-52
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-52
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-52
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-52
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-51
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-51
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-51
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-51
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-51
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-50
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-50
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-50
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-50
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-50
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-50
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-50
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-49
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-49
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-49
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-49
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-48
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-47
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-47
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-46
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-46
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-46
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-45
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-44
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-44
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-44
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-42
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-41
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-41
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-41
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-41
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-40
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-40
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-38
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-38
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-37
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-37
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-37
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-36
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-36
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-35
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-35
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-35
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-35
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-34
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-34
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-34
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-34
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-33
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-32
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-32
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  627 bits (1619), Expect = 0.0
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)

Query: 10  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 69
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query: 70  QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 128
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query: 309 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 368
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 386

Query: 369 A 369
           A
Sbjct: 387 A 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  622 bits (1606), Expect = 0.0
 Identities = 228/372 (61%), Positives = 289/372 (77%), Gaps = 5/372 (1%)

Query: 3   EMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEA 62
            +    ++        I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ E 
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE- 66

Query: 63  VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHR 121
           VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R
Sbjct: 67  VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126

Query: 122 VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 181
             +H+ K+ Q MP++ +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL D
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLID 185

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGE
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
           SG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+SRL
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL 305

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP 361
           L+Y+P+ R TA+EAL HPFFDELR    R+PNGR LPPLFN+   EL  V  D++ +L+P
Sbjct: 306 LEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVP 364

Query: 362 EHARKQCAFLGL 373
           +HA  +    G+
Sbjct: 365 QHAEAELLSRGI 376

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  595 bits (1537), Expect = 0.0
 Identities = 162/358 (45%), Positives = 231/358 (64%), Gaps = 12/358 (3%)

Query: 17  GHIIVTTIGGKNGQP--KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY 74
           G ++         +   K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 75  KNRELQTMRLL---DHPNVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKM 129
           +NRELQ M+ L    HPN+V L+  F++  E+   ++YLN+V+EYVP+T+HR  +++Y+ 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 130 SQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
               P I +K++ +Q+ R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
              EPN++YICSRYYRAPELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYS 305
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 306 PNLRSTALEALIHPFFDELRDPNTRLPNGRFLPP-LFNFKPHELKGVPVDMLVKLIPE 362
           P  R    EAL HP+FDEL DP T+LPN + LP  LF F P+E++ +      KL+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  577 bits (1489), Expect = 0.0
 Identities = 167/382 (43%), Positives = 247/382 (64%), Gaps = 43/382 (11%)

Query: 29  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 88
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 89  NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYV 115
           N++ L   F++T ++                                    YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 116 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 175
           P+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179

Query: 176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 235
            LKLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 236 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV 295
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 296 DLVSRLLQYSPNLRSTALEALIHPFFDELRDP-------NTRLPNG--RFLPPLFNFKPH 346
           DL+ ++L+Y P+LR    EA+ HPFFD LR+        N+  P+G  + +P LFNF P+
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 347 ELKGVPVDMLVKLIPEHARKQC 368
           EL  +P ++L +++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  296 bits (761), Expect = 2e-99
 Identities = 95/315 (30%), Positives = 155/315 (49%), Gaps = 34/315 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 90
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 91  VSLKHCF-----------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 139
           V +                S TE + +Y+  V EY+   +  V++        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 196
           L+ YQ+ R L YIH +  V HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 197 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
             + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 256 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
               E+ + +      +          P  ++    +  EAVD + ++L +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 314 EALIHPFFDELRDPN 328
           EAL HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  294 bits (754), Expect = 2e-98
 Identities = 102/296 (34%), Positives = 157/296 (53%), Gaps = 21/296 (7%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G GS+GVVF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
           F     K  L+L  V EY   TV   +    +  + +P   VK   +Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 215
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 273
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 274 FPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
            P  +   P    F   +   A+ L+   L   P  R T  + L HP+F+ +R+  
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  293 bits (752), Expect = 1e-97
 Identities = 110/348 (31%), Positives = 181/348 (52%), Gaps = 37/348 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 89
           +  + ++G G++GVV  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 90  VVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++++ +     + ++  E+Y+  + E +   +HRVI      +Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 196
           A+  +H    V HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           ++ +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 257 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 312
           P  +       +P   E+    P   A P  K+F + + P+ +DL+ R+L + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 313 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
            EAL HP+     DPN         P  F F  H  + +    L KLI
Sbjct: 301 KEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  291 bits (747), Expect = 7e-97
 Identities = 93/315 (29%), Positives = 154/315 (48%), Gaps = 34/315 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------------RELQT 81
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 82  MRLLDHPNVVSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IY 137
           +    HPN++ L+  F  F      +LYL  V E +   + +VI       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 258 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
             E++    +P   +Y       + A  W  +      P A+DL++++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 314 EALIHPFFDELRDPN 328
           +AL HP+F+ L DP 
Sbjct: 313 QALRHPYFESLFDPL 327

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  289 bits (743), Expect = 1e-96
 Identities = 98/295 (33%), Positives = 155/295 (52%), Gaps = 21/295 (7%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           VG GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                +K   YL  V E+V  T+   ++        +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 215
            + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 273
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 274 FPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
            P+IK   P  + +  ++    +DL  + L   P+ R    E L H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  289 bits (741), Expect = 7e-96
 Identities = 106/338 (31%), Positives = 182/338 (53%), Gaps = 29/338 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 91
           Y     +G G++G+V  A        VAIKK+         +   RE++ +    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 92  SLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            +     + T +   ++Y+  V + +   +++++K     +Q +   ++  + YQI R L
Sbjct: 89  GINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRA 205
            YIH +  V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRA
Sbjct: 142 KYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259

Query: 266 -NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 322
            N     +    P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

Query: 323 ELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           +  DP+   P        F F   EL  +P + L +LI
Sbjct: 319 QYYDPS-DEPI---AEAPFKF-DMELDDLPKEKLKELI 351

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  288 bits (738), Expect = 7e-96
 Identities = 89/304 (29%), Positives = 148/304 (48%), Gaps = 25/304 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 93
           Y   R +G G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 94  KHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
                    +       V E+V  T   ++        Q +    ++ Y Y+I +AL Y 
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 146

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
           H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+   
Sbjct: 147 H-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 213 TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNY 269
             Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +   K      
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 270 TEFK--FPQIKAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
             F     +     W +      Q  + PEA+D + +LL+Y    R TA EA+ HP+F  
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325

Query: 324 LRDP 327
           +   
Sbjct: 326 VVKD 329

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  286 bits (735), Expect = 2e-95
 Identities = 101/329 (30%), Positives = 171/329 (51%), Gaps = 36/329 (10%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLD 86
           +Y+    +G G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           H N+V+L         +  L L  V EY+ + + + +         + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLL 110

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYY 203
           R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 260
           R P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            I      +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A+ HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 321 FDELRDPNTRLPNGRFLPPLFNFKPHELK 349
           F  L +   +LP+      +F  K  +L+
Sbjct: 285 FLSLGERIHKLPD---TTSIFALKEIQLQ 310

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  283 bits (727), Expect = 5e-94
 Identities = 106/300 (35%), Positives = 154/300 (51%), Gaps = 31/300 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 93
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
              F     K  + L  V +++   +  +IK     S  +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 210
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 267
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
           +Y    F      P H IF      + +DL+  L  ++P  R TA +AL   +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  282 bits (724), Expect = 3e-93
 Identities = 99/305 (32%), Positives = 160/305 (52%), Gaps = 26/305 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 91  VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           + L   F    +  +  + YL  V+ ++   + +++K      +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 206
            L YIH   G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 265
           E+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 266 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           +     +    P+++   +  I      P AV+L+ ++L      R TA EAL HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 324 LRDPN 328
           L D  
Sbjct: 314 LHDTE 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  281 bits (722), Expect = 4e-93
 Identities = 105/337 (31%), Positives = 170/337 (50%), Gaps = 32/337 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y++   VG G++G V  A    +GE VAIKK+          +   REL  ++ + H NV
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 91  VSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           + L   F   +      + YL  V+ ++   + +++        +     ++   YQ+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 206
            L YIH+  GV HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAP 192

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 265
           E+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ + 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252

Query: 266 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
           +     +    PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

Query: 324 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
            RDP             F+    E + + VD   + I
Sbjct: 312 FRDPE-EETE---AQQPFDD-SLEHEKLTVDEWKQHI 343

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  277 bits (712), Expect = 3e-92
 Identities = 102/294 (34%), Positives = 165/294 (56%), Gaps = 27/294 (9%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                 +  L L  V E++ + + +V+         +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 270
           +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           +  F   +  PW  I       E +DL+S +L + PN R +A +A+ HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  277 bits (711), Expect = 7e-92
 Identities = 89/298 (29%), Positives = 155/298 (52%), Gaps = 30/298 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                    L+L  + EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151

Query: 157 GVCHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 209
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 266
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A  AL HP+F   
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  277 bits (710), Expect = 3e-91
 Identities = 102/307 (33%), Positives = 163/307 (53%), Gaps = 30/307 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 88
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 89  NVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           NV+ L   F      +   ++YL  V   +   ++ ++K      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYR 204
            R L YIH+   + HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 265 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 322 DELRDPN 328
            +  DP+
Sbjct: 316 AQYHDPD 322

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  274 bits (702), Expect = 5e-91
 Identities = 100/294 (34%), Positives = 159/294 (54%), Gaps = 28/294 (9%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                 K  L L  V E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 270
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           +  F   +  PW     K +    +DL+S++L+  PN R TA +AL H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  273 bits (699), Expect = 3e-89
 Identities = 102/373 (27%), Positives = 182/373 (48%), Gaps = 65/373 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---QD----KR-YKNRELQTMRLL-DH 87
           Y   + +G G++G+V+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            N+V+L +   +  ++D +YL  V +Y+   +H VI+     +  +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 196
            + Y+H + G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 197 -----------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 246 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMP----------- 291
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 292 ----PEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHE 347
                EA+DL+ +LLQ++PN R +A +AL HPF     +PN           +     ++
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPIND 354

Query: 348 LKGVPVDMLVKLI 360
                +D    L+
Sbjct: 355 NVKHSIDDYRNLV 367

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  269 bits (690), Expect = 3e-89
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 28/298 (9%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 96
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                   +L L  V E+  + + +        +  +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 213
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 214 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 269
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
             +            +   ++     DL+  LL+ +P  R +A EAL HP+F +   P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  270 bits (692), Expect = 4e-89
 Identities = 93/306 (30%), Positives = 157/306 (51%), Gaps = 36/306 (11%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 93
           +G+G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH--YKMSQRMPLIYVKLYFYQICRALAY 151
                    +++L L  V E++   + + +         + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 208
            H    + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 265
           + G+  Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 266 NPNYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            P Y      Q       ++ Q      +    +D +  LLQ +P++R +A +AL HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 322 DELRDP 327
            E    
Sbjct: 298 AEYYHH 303

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  274 bits (701), Expect = 1e-88
 Identities = 99/348 (28%), Positives = 168/348 (48%), Gaps = 41/348 (11%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 88
           Y   + +G G+ G+V  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 89  NVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           N++SL + F    +  E  ++YL  V+E +   + +VI+        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
              + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 266 NPNYTEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPNLRSTA 312
            P    +    P+     + K+F            K    +A DL+S++L   P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 313 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
            +AL HP+ +   DP          P +++ +  + +   ++   +LI
Sbjct: 351 DDALQHPYINVWYDPAEVEA---PPPQIYDKQ-LDEREHTIEEWKELI 394

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  270 bits (691), Expect = 2e-88
 Identities = 95/346 (27%), Positives = 162/346 (46%), Gaps = 37/346 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+          +   REL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 91  VSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           + L + F    S  E  ++Y+  V+E +   + +VI+        +    +    YQ+  
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQ------MELDHERMSYLLYQMLC 138

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
            + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P
Sbjct: 197 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 268 NYTEF--KFPQIKAHPWHKIFQKRMP-----------PEAVDLVSRLLQYSPNLRSTALE 314
               +    P+   + + K+F   +             +A DL+S++L    + R +  E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 315 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           AL HP+ +   DP+          P       + +   ++   +LI
Sbjct: 316 ALQHPYINVWYDPS-EAEAPPPKIPDKQL---DEREHTIEEWKELI 357

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  272 bits (698), Expect = 3e-88
 Identities = 108/396 (27%), Positives = 164/396 (41%), Gaps = 87/396 (21%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 88
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 89  NVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           +VV +         +  DELY  +VLE       ++ +        +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLL 166

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 196
             + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 197 ------------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL----- 233
                             ++ +R+YRAPELI     YT AID+WS GC+ AELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 234 ------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM-N 266
                   PLFPG S                      DQL  I  +LGTP+ E+I+ +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 267 PNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
            +   +   FP+ +     + F      +A+ L+ R+L ++PN R T  E L HPFF E+
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

Query: 325 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 360
           R       N            ++   +    L    
Sbjct: 404 RIAE-VETN---ATEKVRLPFNDWMNMDEPQLRYAF 435

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  270 bits (692), Expect = 1e-87
 Identities = 101/388 (26%), Positives = 163/388 (42%), Gaps = 79/388 (20%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQD-KR-YKNRELQTMRLLDHP 88
           Y+ + ++G GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 89  NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            ++ L             ELY+  VLE     + ++ K    +++     ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTE----EHIKTILYNLL 139

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 196
               +IH   G+ HRD+KP N L+N     +K+CDFG A+ +   +              
Sbjct: 140 LGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 197 -------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-------- 235
                        ++ +R+YRAPELI     YT +IDIWS GC+ AELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 236 ---PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 272
              PLFPG S                   DQL  I  ++GTPT +++K +  P   ++  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
            FP  K     + +   +  + ++L+  +L+++PN R T  +AL HP+  ++R       
Sbjct: 318 LFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK-LEN 375

Query: 333 NGRFLPPLFNFKPHELKGVPVDMLVKLI 360
              F          +   +    L  + 
Sbjct: 376 ---FSTKKIILPFDDWMVLSETQLRYIF 400

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  265 bits (680), Expect = 7e-87
 Identities = 90/325 (27%), Positives = 146/325 (44%), Gaps = 28/325 (8%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 94
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 95  -HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                S   + +  + LV ++     H +      +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 208
               + HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 265
           + G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 266 NPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
              Y + +  + +        +     P A+DL+ +LL   P  R  + +AL H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 325 RDPNTRLPNGRFLPPLFNFKPHELK 349
            DP       + +         E  
Sbjct: 318 -DPMPSDL--KGMLSTHLTSMFEYL 339

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  263 bits (674), Expect = 1e-86
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 90
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLD 134

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 207
           ++H    + HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 268 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                    FP     P   +    M      L+  +L ++P+ R +A  AL H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 325 RDPN 328
            + N
Sbjct: 304 -EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  262 bits (671), Expect = 8e-86
 Identities = 97/324 (29%), Positives = 153/324 (47%), Gaps = 37/324 (11%)

Query: 43  VGHGSFGVVFQAK-CLETGEAVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 91
           +G G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L      +    E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDF 135

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 208
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 269 YTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
                   F    A P  K     +     DL+ + L ++P  R +A  AL HP+F +L 
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

Query: 326 DPNTRLPNGRFLPPLFNFKP-HEL 348
                L        L   +   EL
Sbjct: 305 RCKENLD-----SHLPPSQNTSEL 323

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  248 bits (636), Expect = 1e-79
 Identities = 96/343 (27%), Positives = 154/343 (44%), Gaps = 46/343 (13%)

Query: 43  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 98
           VG G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 99  STTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALAYIH 153
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 154 NTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 204
               V HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQLVEIIKVLG 255
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 256 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 306
            P  +         E   +  ++    +       + +  + +   +A  L+ +LL   P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 307 NLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 349
             R T+ +A+  P+F E  DP        F      +   E  
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSD--VFAGCQIPYPKREFL 361

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  205 bits (524), Expect = 1e-62
 Identities = 91/330 (27%), Positives = 150/330 (45%), Gaps = 57/330 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 87
           Y   +V+G GSFG V +A   +  + VA+K V  +KR+      E++ +  L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 88  PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
            NV+ +   F         + N   +  E +   ++ +IK +    Q   L  V+ + + 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHS 208

Query: 145 ICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 203
           I + L  +H    + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
           RAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P+++ + 
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 264 -----------CMNPNYTEFKF---------------PQIKAHPWHKIFQKRMPPEA--- 294
                         P Y                     +++  P  + +   +       
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 295 -VDLVSRLLQYSPNLRSTALEALIHPFFDE 323
            +D + + L++ P +R T  +AL HP+   
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  197 bits (502), Expect = 1e-60
 Identities = 67/319 (21%), Positives = 118/319 (36%), Gaps = 60/319 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 89
           Y   + +G G    VFQ    E  +  AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 90  -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 205
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 206 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 252

Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 253 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 290

Query: 316 LIHPFFDELRDPNTRLPNG 334
           L HP+      P  ++  G
Sbjct: 291 LAHPYVQIQTHPVNQMAKG 309

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  198 bits (506), Expect = 2e-60
 Identities = 94/339 (27%), Positives = 149/339 (43%), Gaps = 62/339 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 87
           Y  + ++G GSFG V +A      E VAIK +   K + N    E++ + L+        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 88  PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
             +V LK  F         + N   LV E +   ++ ++++     + + L   + +  Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165

Query: 145 ICRALAYIH-NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 202
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+     G+    YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG P    +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 263 K-----------CMNPNYTEFKFPQIKAH---PWHKIFQ-----KRMPPEA--------- 294
                         +  +   K    K     P  +        +   P           
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 295 -------VDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                   DL+ R+L Y P  R     AL H FF +  D
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  196 bits (500), Expect = 2e-60
 Identities = 69/301 (22%), Positives = 108/301 (35%), Gaps = 65/301 (21%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHP 88
           S+     +GHGS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
             V L+  +    E   LY  L  E    ++ +  +        +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLA 169

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           LA++H+  G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLHSQ-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +     Y  A D++S G  + E+     L  G                            
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHG---------------------------- 257

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPP--------EAVDLVSRLLQYSPNLRSTALEALIHPF 320
                        W ++ Q  +PP        E   ++  +L+  P LR+TA   L  P 
Sbjct: 258 ----------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307

Query: 321 F 321
            
Sbjct: 308 L 308

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  196 bits (499), Expect = 6e-60
 Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 60/319 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 89
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 90  -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 205
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 206 PELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 316 LIHPFFDELRDPNTRLPNG 334
           L HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  196 bits (499), Expect = 1e-59
 Identities = 84/336 (25%), Positives = 143/336 (42%), Gaps = 42/336 (12%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 88
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 89  NVVSLKHC-----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
           + +   H       F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 138

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNISYI 198
           Q+   L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 252
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 253 VLGTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVS 299
           +LG      +          N         ++K  P   +  ++         E  D +S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 300 RLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 335
            +LQ  P  R+ A   + HP+  +           R
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 351

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  196 bits (499), Expect = 2e-59
 Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 60/319 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 89
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 90  -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 205
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 206 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 255
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280

Query: 256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 315
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 318

Query: 316 LIHPFFDELRDPNTRLPNG 334
           L HP+      P  ++  G
Sbjct: 319 LAHPYVQIQTHPVNQMAKG 337

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  192 bits (490), Expect = 6e-59
 Identities = 70/314 (22%), Positives = 107/314 (34%), Gaps = 48/314 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 92
           Y+  + +G G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 93  LKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L          K E +  L+L +    T+   I+        +    +      ICR L 
Sbjct: 91  LVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----------EPNISYICS 200
            IH   G  HRD+KP N+L+     Q  L D GS                 +   +  C+
Sbjct: 149 AIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 201 RYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
             YRAPEL             D+WS GCVL  ++ G+  +         V +  V     
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQN--- 262

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                       +   PQ            R       L++ ++   P+ R      L  
Sbjct: 263 ------------QLSIPQ----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300

Query: 319 PFFDELRDPNTRLP 332
               +   P     
Sbjct: 301 LEALQPPAPGQHTT 314

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  194 bits (496), Expect = 1e-58
 Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 51/301 (16%)

Query: 35  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 92
           IS+  + V+GHG+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 151
                   TEKD  +  + +E    T+   + +  +      P+  ++    Q    LA+
Sbjct: 83  YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 152 IHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNISY---IC-SRYY 203
           +H+ + + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 204 RAPELIFGATE--YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 260
            APE++    +   T  +DI+SAGCV   ++  G   F                G   + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           +   +               P            A +L+ +++   P  R +A   L HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 321 F 321
           F
Sbjct: 287 F 287

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  192 bits (490), Expect = 2e-58
 Identities = 77/338 (22%), Positives = 141/338 (41%), Gaps = 66/338 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 88
           ++  R +G G+FG V   + ++  +  A+K V   K+Y      E   ++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 89  NVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           N+V     F        +Y +   L+ E +  +++ +I  +        +  +KLY  +I
Sbjct: 97  NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVN------------------------PHTHQLKLCD 181
            +AL Y+   + + H D+KP+N+L++                          +  +KL D
Sbjct: 147 LKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 241
           FG A    K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF   
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 242 SGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 292
             ++ L  +  ++    +  +         K +N +  +  +P+  +        K+  P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 293 EA--------VDLVSRLLQYSPNLRSTALEALIHPFFD 322
                      D +  +LQ  P LR +  E L H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  190 bits (484), Expect = 1e-57
 Identities = 79/345 (22%), Positives = 131/345 (37%), Gaps = 60/345 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 86
           Y     +G G+FG V +      G   VA+K +    +Y+     E+  ++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 87  HPNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
               V +   F         +     +  E + +     +K +    Q  PL +V+   Y
Sbjct: 81  KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHVRHMAY 130

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDFGSA 185
           Q+C AL ++H    + H D+KP+N+L                         +++ DFGSA
Sbjct: 131 QLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
                 E + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 246 QLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKAHPWHKIFQKRMPPEA-- 294
            LV + K+LG      I               + E            K  +  M  ++  
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306

Query: 295 ----VDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 335
                DL+ R+L++ P  R T  EAL+HPFF  L          R
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  189 bits (482), Expect = 2e-57
 Identities = 82/337 (24%), Positives = 136/337 (40%), Gaps = 60/337 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 86
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q +  L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 87  HPNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
               V +   F         +     +V E +  + +  IK +        L +++   Y
Sbjct: 76  TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDFGSA 185
           QIC+++ ++H+   + H D+KP+N+L                         +K+ DFGSA
Sbjct: 126 QICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
                 E + + + +R+YRAPE+I     ++   D+WS GC+L E  LG  +FP     +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

Query: 246 QLVEIIKVLGTPTREEI-KCMNPNY-TEFKFPQIKAHPWHKIFQKRMPP----------- 292
            L  + ++LG   +  I K     Y    +    +     +   +   P           
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301

Query: 293 --EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                DL+ ++L+Y P  R T  EAL HPFFD L+  
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  186 bits (474), Expect = 5e-57
 Identities = 73/299 (24%), Positives = 115/299 (38%), Gaps = 45/299 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V          ++    L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 150 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 204
              H        V HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           +PE +     Y    DIWS GC+L EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                 E KF +I               E  ++++R+L      R +  E L +P   E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  189 bits (483), Expect = 1e-56
 Identities = 76/314 (24%), Positives = 137/314 (43%), Gaps = 60/314 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 94
            ++E+++G+GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQICRALAY 151
                 +E  + +L + LE     +  +++      + + L           QI   +A+
Sbjct: 76  C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGE----PNI 195
           +H+ + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 196 SYIC-SRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 247
           +    +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F  +    + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 248 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 307
             II+                   F   ++K      +       EA DL+S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 308 LRSTALEALIHPFF 321
            R TA++ L HP F
Sbjct: 286 KRPTAMKVLRHPLF 299

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  190 bits (485), Expect = 2e-56
 Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 50/317 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 90
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 147
           + L   F     +D+    LV+E     E    +I    +  ++        +   Q+  
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKF--NEV----DAAVIIKQVLS 147

Query: 148 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY A
Sbjct: 148 GVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+         +++  
Sbjct: 207 PEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEKG 252

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
              +            W  +        A DL+ ++LQ+    R +A +AL HP+  E+ 
Sbjct: 253 KYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299

Query: 326 DPNTRLPNGRFLPPLFN 342
                      L     
Sbjct: 300 SKKESGIELPSLANAIE 316

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  187 bits (476), Expect = 2e-56
 Identities = 48/333 (14%), Positives = 92/333 (27%), Gaps = 57/333 (17%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHP 88
                  +  G   VVF  + +E  E  A+K                +        L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 89  NVVSLKHCFFSTTEKDELYLN---------------------LVLEYVP---ETVHRVIK 124
           +    +         D + +                      L++       E +   + 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 125 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS 184
             Y       ++ + +   Q+ R  A + +  G+ H    P NL + P    L L D  +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVSA 240

Query: 185 AKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 243
              +  G    +      Y   E +      +T A++ W  G  +  +      F   + 
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 303
             +       L  P  +                             +P     L+ R L 
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338

Query: 304 YSPNLRSTALEALIHPFFDELRD-PNTRLPNGR 335
           +    R   LEA+  P F +L++  ++ L  G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  185 bits (472), Expect = 3e-56
 Identities = 55/302 (18%), Positives = 108/302 (35%), Gaps = 23/302 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 91
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L      TT      L  ++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 150 AYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 207 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           ++   A        +Y A +D+WS G        G   F    G  +  E++  + T   
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                                P      + +      +++ +L+          +     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

Query: 320 FF 321
             
Sbjct: 305 SD 306

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  190 bits (484), Expect = 4e-56
 Identities = 78/317 (24%), Positives = 132/317 (41%), Gaps = 50/317 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 90
           Y    ++G GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 147
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEH----DAARIIKQVFS 132

Query: 148 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WSAG +L  LL G P F G++  +   +I+        + ++  
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVETG 237

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
              +            W  I       +A DL+ ++L + P+LR TA + L HP+  +  
Sbjct: 238 KYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

Query: 326 DPNTRLPNGRFLPPLFN 342
                + +   L     
Sbjct: 285 SETPTISDLPSLESAMT 301

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  189 bits (483), Expect = 5e-56
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 51/297 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHPN 89
           Y  +RV+G GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQIC 146
           ++ L   F     +D+ Y  LV E     E    +I    +  S+            Q+ 
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRF--SEV----DAARIIRQVL 136

Query: 147 RALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYR 204
             + Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY 
Sbjct: 137 SGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE++ G   Y    D+WS G +L  LL G P F G +  +   +I+        ++++ 
Sbjct: 196 APEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEK 241

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
               +            W K+        A DL+ ++L Y P++R +A +AL H + 
Sbjct: 242 GKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  182 bits (465), Expect = 3e-55
 Identities = 72/312 (23%), Positives = 118/312 (37%), Gaps = 59/312 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 93
           +    V+G G+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 94  KHCF--------FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
              +          T  K +  L + +EY    T++ +I       QR         F Q
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 201
           I  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK + +    +         
Sbjct: 125 ILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 202 ------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 249
                        Y A E++ G   Y   ID++S G +  E++   P   G       V 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236

Query: 250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 309
           I+K L +                +FP     P    F          ++  L+ + PN R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275

Query: 310 STALEALIHPFF 321
             A   L   + 
Sbjct: 276 PGARTLLNSGWL 287

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  187 bits (476), Expect = 6e-55
 Identities = 79/307 (25%), Positives = 127/307 (41%), Gaps = 61/307 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------------REL 79
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 80  QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLI 136
             ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I    +   +     
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKF--DEC---- 146

Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPN 194
                  QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K    
Sbjct: 147 DAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 195 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +II   
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII--- 256

Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                ++++     +          + W  I       EA +L+  +L Y  N R TA E
Sbjct: 257 -----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEE 298

Query: 315 ALIHPFF 321
           AL   + 
Sbjct: 299 ALNSRWI 305

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  180 bits (460), Expect = 1e-54
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 42/300 (14%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
            V+G G++G+V+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHN 154
            +  +  +  ++ + +E VP  ++  +++  +  +      I    Y  QI   L Y+H+
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 213
              + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I    
Sbjct: 141 N-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 214 E-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y  A DIWS GC + E+  G+P F       +L E    +                 F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 332
           K    K HP      + M  EA   + +  +  P+ R+ A + L+  F           P
Sbjct: 237 KVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  181 bits (461), Expect = 1e-54
 Identities = 81/302 (26%), Positives = 122/302 (40%), Gaps = 60/302 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 89
           +  E+ +G G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V+     F    E +EL   +VLE      + R+IKH  K  + +P   V  YF Q+C A
Sbjct: 94  VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYIC 199
           L ++H+   V HRDIKP N+ +   T  +KL D G  +           + G P      
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 258
             YY +PE I     Y    DIWS GC+L E+   Q  F G+   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                       +  +P +               E   LV+  +   P  R         
Sbjct: 252 ------------QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 319 PF 320
             
Sbjct: 292 AK 293

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  181 bits (461), Expect = 4e-54
 Identities = 76/313 (24%), Positives = 121/313 (38%), Gaps = 47/313 (15%)

Query: 18  HIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQ 70
           H       G      Q++  Y+  + +G GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 71  DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM 129
           ++    RE+  +  + HPN+V  +  F    E   LY  +V++Y     + + I      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINAQKG- 119

Query: 130 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 189
                   +  +F QIC AL ++H+   + HRDIK QN+ +      ++L DFG A+VL 
Sbjct: 120 -VLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 190 KGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
                      + YY +PE+      Y    DIW+ GCVL EL   +  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
             I             ++ +Y                       +   LVS+L + +P  
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267

Query: 309 RSTALEALIHPFF 321
           R +    L   F 
Sbjct: 268 RPSVNSILEKGFI 280

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  179 bits (456), Expect = 4e-54
 Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 66/332 (19%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 83
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 142
            L H +VV     F      D +++  VLE     ++  + K      + +     + Y 
Sbjct: 71  SLAHQHVVGFHGFFED---NDFVFV--VLELCRRRSLLELHKRR----KALTEPEARYYL 121

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 193
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 122 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179

Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
           N        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K 
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230

Query: 254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
                            E+  P              + P A  L+ ++LQ  P  R T  
Sbjct: 231 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 261

Query: 314 EALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 345
           E L   FF     P         +PP F+  P
Sbjct: 262 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  178 bits (454), Expect = 6e-54
 Identities = 86/306 (28%), Positives = 133/306 (43%), Gaps = 50/306 (16%)

Query: 29  GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM 82
           G  K  I+  Y  E  +G GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 139
           + LDHPN++ L   F     +D   + LV+E     E   RV+    +   +        
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVF--RES----DAA 109

Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 197
                +  A+AY H  + V HRD+KP+N L    +    LKL DFG A     G+   + 
Sbjct: 110 RIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           + + YY +P+++ G   Y    D WSAG ++  LL G P F   +  + +++I +     
Sbjct: 169 VGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG---- 222

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                         F FP      W  +      P+A  L+ RLL  SP  R T+L+AL 
Sbjct: 223 -------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALE 261

Query: 318 HPFFDE 323
           H +F++
Sbjct: 262 HEWFEK 267

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  178 bits (454), Expect = 6e-54
 Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 50/297 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 96
           +    ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 97  FFSTTEKDEL-----------YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           +       E             L + +E+  + T+ + I+   +  +++  +     F Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQ 130

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 204
           I + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           +PE I    +Y   +D+++ G +LAELL                ++              
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                               I       +   L+ +LL   P  R    E L     
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  176 bits (450), Expect = 2e-53
 Identities = 74/320 (23%), Positives = 138/320 (43%), Gaps = 66/320 (20%)

Query: 29  GQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQ 80
               + I  +    ++G GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 139
               L HP+++ L + F      + +Y  LVLE      ++R +K+  K          +
Sbjct: 64  IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVK---PFSENEAR 115

Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------ 192
            + +QI   + Y+H+  G+ HRD+   NLL+  +   +K+ DFG + ++ +  E      
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173

Query: 193 --PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 250
             PN        Y +PE+    + +    D+WS GC+   LL+G+P F  ++  + L ++
Sbjct: 174 GTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

Query: 251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 310
           +                   +++ P      +       +  EA DL+ +LL+ +P  R 
Sbjct: 225 VLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRL 255

Query: 311 TALEALIHPFFDELRDPNTR 330
           +    L HPF        ++
Sbjct: 256 SLSSVLDHPFMSRNSSTKSK 275

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  178 bits (454), Expect = 3e-53
 Identities = 87/348 (25%), Positives = 137/348 (39%), Gaps = 84/348 (24%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---------QDKRYKNRELQTMRLLDH 87
           Y  +  +G GS+GVV  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL----- 140
           PN+  L   +     +DE Y+ LV+E       + ++       + +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 141 ------------------------------YFYQICRALAYIHNTIGVCHRDIKPQN-LL 169
                                            QI  AL Y+HN  G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201

Query: 170 VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTAAIDIWS 223
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 224 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 283
           AG +L  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 284 KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 331
            +      P A DL+S LL  + + R  A+ AL HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  178 bits (453), Expect = 3e-53
 Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 66/332 (19%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 83
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 142
            L H +VV     F      D +++  VLE     ++  + K      + +     + Y 
Sbjct: 97  SLAHQHVVGFHGFFED---NDFVFV--VLELCRRRSLLELHKRR----KALTEPEARYYL 147

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 193
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
           N        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K 
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256

Query: 254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
                            E+  P              + P A  L+ ++LQ  P  R T  
Sbjct: 257 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 287

Query: 314 EALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 345
           E L   FF     P         +PP F+  P
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 319

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  179 bits (457), Expect = 3e-53
 Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 44/316 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 92
           Y     +G G+FGVV +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L   F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L 
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 151 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                     D+W+ G +   LL G   F GE  ++ L  + +                 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPN 328
            +++F       +  +      PEA D +  LLQ  P  R T  +AL HP+   +  +  
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316

Query: 329 TRLPNGRFLPPLFNFK 344
           +R+P+ R+       K
Sbjct: 317 SRIPSSRYNKIRQKIK 332

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  177 bits (450), Expect = 4e-53
 Identities = 67/318 (21%), Positives = 120/318 (37%), Gaps = 60/318 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 91
           +   + +G G FGVVF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 92  SLKHCFF-------STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 143
              + +              ++YL + ++    E +   +       +          F 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 201
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 202 -----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 250
                       Y +PE I G   Y+  +DI+S G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 310
           ++                    KFP +              P    +V  +L  SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 311 TALEALIHPFFDELRDPN 328
            A+  + +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  180 bits (459), Expect = 4e-53
 Identities = 81/306 (26%), Positives = 141/306 (46%), Gaps = 56/306 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------------RELQTMRL 84
           Y+  + +G G+ G V  A   +T + VAI+ + + K                 E++ ++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 142
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEAT----CKLYF 245

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 199
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 200 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                        ++ F       W ++       +A+DLV +LL   P  R T  EAL 
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399

Query: 318 HPFFDE 323
           HP+  +
Sbjct: 400 HPWLQD 405

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  176 bits (448), Expect = 6e-53
 Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 52/320 (16%)

Query: 18  HIIVTTIGGKNGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQ 70
           H    + G +N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 71  DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYK 128
                  E++ ++ LDHPN++ +   F     +D   + +V+E     E + R++    +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 129 M---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG 183
               S+     YV     Q+  ALAY H+   V H+D+KP+N+L    +    +K+ DFG
Sbjct: 118 GKALSEG----YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFG 172

Query: 184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 243
            A++    E + +   +  Y APE+     + T   DIWSAG V+  LL G   F G S 
Sbjct: 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230

Query: 244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 303
            +   +                     E  +               + P+AVDL+ ++L 
Sbjct: 231 EEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLT 264

Query: 304 YSPNLRSTALEALIHPFFDE 323
             P  R +A + L H +F +
Sbjct: 265 KDPERRPSAAQVLHHEWFKQ 284

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  182 bits (463), Expect = 1e-52
 Identities = 82/317 (25%), Positives = 136/317 (42%), Gaps = 45/317 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 92
           Y     +G G+FGVV +     TG   A K V      DK    +E+QTM +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L 
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 151 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF--DELRDP 327
            +  F  I               +  D + +LL   PN R T  +AL HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 328 NTRLPNGRFLPPLFNFK 344
           ++++P+ R+     + K
Sbjct: 423 DSQIPSSRYTKIRDSIK 439

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  178 bits (452), Expect = 2e-52
 Identities = 61/313 (19%), Positives = 116/313 (37%), Gaps = 32/313 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 91
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L      TT      L  ++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 150 AYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 207 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 257
           ++   A        +Y A +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
           +               +      P      + +      +++ +L+          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 318 HPFFDELRDPNTR 330
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  175 bits (447), Expect = 2e-52
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 44/290 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 93
           YM    +G G FG+V +     + +      +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              F     +    L ++ E++   +   R+    +++++R  + YV     Q+C AL +
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 152 IHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 209
           +H+   + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                 + A D+WS G ++  LL G   F  E+  +Q  +II        E I      +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
            E  F +I               EA+D V RLL      R TA EAL HP
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  176 bits (448), Expect = 3e-52
 Identities = 63/328 (19%), Positives = 126/328 (38%), Gaps = 52/328 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN----------------REL 79
           R +  G F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 80  QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMP 134
           Q +  + +   ++      +    DE+Y+  + EY+      +            +  +P
Sbjct: 95  QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 135 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 194
           +  +K     +  + +YIHN   +CHRD+KP N+L++ +   +KL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 195 ISYIC-SRYYRAPELIFGATEY-TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 252
           I     +  +  PE     + Y  A +DIWS G  L  +      F  +  + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 312
                  + I+   P      F     +         +  E +D +   L+ +P  R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 313 LEALIHPFF-----DELRDPNTRLPNGR 335
            +AL H +      ++LR+ +  L   R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  173 bits (441), Expect = 6e-52
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 50/298 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y    ++G GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 147
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEHD----AARIIKQVFS 132

Query: 148 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
            + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G   Y    D+WSAG +L  LL G P F G++  D L  +               
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------- 236

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                ++ F       W  I       +A DL+ ++L + P+LR TA + L HP+  +
Sbjct: 237 ----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  174 bits (444), Expect = 6e-52
 Identities = 81/304 (26%), Positives = 139/304 (45%), Gaps = 56/304 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN--------RELQTMRL 84
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 142
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 72  LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEA----TCKLYF 120

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 199
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 178

Query: 200 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I   G  
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 235

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                        ++ F       W ++       +A+DLV +LL   P  R T  EAL 
Sbjct: 236 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 274

Query: 318 HPFF 321
           HP+ 
Sbjct: 275 HPWL 278

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  173 bits (440), Expect = 7e-52
 Identities = 79/309 (25%), Positives = 125/309 (40%), Gaps = 66/309 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              F      D   + L+LEY P       + K       +        Y  ++  AL+Y
Sbjct: 75  YGYF-----HDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSY 124

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 204
            H+   V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 125 CHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YL 174

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
            PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V           
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 222

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                 EF FP      +       +   A DL+SRLL+++P+ R    E L HP+    
Sbjct: 223 ------EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

Query: 325 RDPNTRLPN 333
               +   N
Sbjct: 265 SSKPSNCQN 273

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  172 bits (439), Expect = 1e-51
 Identities = 56/327 (17%), Positives = 100/327 (30%), Gaps = 90/327 (27%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHPN 89
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           VV     +    E D + +    EY    ++   I  +Y++        +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPH------------------THQLKLCDFGSAKVL-- 188
           L YIH+   + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 189 ---VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
               +G+          + A E++     +    DI++    +      +PL        
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----- 233

Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLV 298
                                               WH+I Q R+P        E  +L+
Sbjct: 234 ---------------------------------GDQWHEIRQGRLPRIPQVLSQEFTELL 260

Query: 299 SRLLQYSPNLRSTALEALIHPFFDELR 325
             ++   P  R +A+  + H       
Sbjct: 261 KVMIHPDPERRPSAMALVKHSVLLSAS 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  174 bits (442), Expect = 2e-51
 Identities = 65/315 (20%), Positives = 119/315 (37%), Gaps = 48/315 (15%)

Query: 15  EAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK 72
             G ++   +   + + ++ +     +  VG GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 73  RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ 131
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ ++IK    + +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149

Query: 132 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 191
                    Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 150 D----RALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 192 EPNISYICSR------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
               S +          + APE++ G     A +DIWS+ C++  +L G   +       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
             ++I      P                  +I              P     +   L+  
Sbjct: 264 LCLKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKE 297

Query: 306 PNLRSTALEALIHPF 320
           P  R++A+E      
Sbjct: 298 PVHRASAMELRRKVG 312

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  171 bits (437), Expect = 3e-51
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 50/305 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 92
           ++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRAL 149
           L+  +         Y  LV++ V   E   R++ +  Y  +++       L   Q+  A+
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVY--TEKDA----SLVIQQVLSAV 119

Query: 150 AYIHNTIGVCHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 206
            Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y AP
Sbjct: 120 KYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAP 176

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E +     Y+ A+D WS G +   LL G P F  E+      +I +              
Sbjct: 177 E-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------- 222

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                ++F    +  W  I        A D +  LL+  PN R T  +AL HP+ D    
Sbjct: 223 ----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270

Query: 327 PNTRL 331
            +  +
Sbjct: 271 LHRDI 275

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  174 bits (442), Expect = 6e-51
 Identities = 82/320 (25%), Positives = 132/320 (41%), Gaps = 37/320 (11%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 95
            +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EASEIMKSIGEAIQYL 177

Query: 153 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE + 
Sbjct: 178 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           G  +Y  + D+WS G ++  LL G P F    G+     +           I+       
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MG 282

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-PNT 329
           +++FP      W ++       E   L+  LL+  P  R T  E + HP+  +    P T
Sbjct: 283 QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334

Query: 330 RLPNGRFLPPLFNFKPHELK 349
            L   R L      +  ++K
Sbjct: 335 PLHTSRVL-KEDKERWEDVK 353

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  179 bits (456), Expect = 6e-51
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 22/337 (6%)

Query: 25  GGKNGQPKQTIS---YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----- 76
           GG       T +   +  +  +G G FG V +    +TGE VAIK+  Q+   KN     
Sbjct: 1   GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60

Query: 77  RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN-LVLEYVP--ETVHRVIKHHYKMSQRM 133
            E+Q M+ L+HPNVVS +       +     L  L +EY    +    + +        +
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGL 118

Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKG 191
               ++     I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +G
Sbjct: 119 KEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

Query: 192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
           E    ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    +
Sbjct: 178 ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

Query: 252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
           +     + E I   +      KF  +   P H         +    +  +L +    R T
Sbjct: 237 R---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGT 291

Query: 312 ALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 348
             +      F  L    +                + +
Sbjct: 292 DPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPV 328

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  170 bits (434), Expect = 6e-51
 Identities = 62/297 (20%), Positives = 118/297 (39%), Gaps = 56/297 (18%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 95
            +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH- 153
            + ST +  +  + LV E +   T+   +K      + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 206
            T  + HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E+     +Y  ++D+++ G  + E+   +  +       Q+                   
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                ++       P    F K   PE  +++   ++ + + R +  + L H FF E
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  171 bits (435), Expect = 2e-50
 Identities = 80/317 (25%), Positives = 133/317 (41%), Gaps = 47/317 (14%)

Query: 14  TEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR 73
           T   H IV  +   + Q      Y  +  +G GS+ V  +     T    A+K + + KR
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 74  YKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKM 129
               E++ + R   HPN+++LK  +      D  Y+ +V E +   E + ++++   +  
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFF-- 113

Query: 130 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAK 186
           S+R          + I + + Y+H   GV HRD+KP N+L    + +   +++CDFG AK
Sbjct: 114 SERE----ASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 187 VLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
            L      +   C +  + APE +     Y AA DIWS G +L  +L G   F       
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227

Query: 246 QLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 304
               + ++  G               +F         W+ +        A DLVS++L  
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264

Query: 305 SPNLRSTALEALIHPFF 321
            P+ R TA   L HP+ 
Sbjct: 265 DPHQRLTAALVLRHPWI 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  171 bits (435), Expect = 2e-50
 Identities = 74/314 (23%), Positives = 130/314 (41%), Gaps = 39/314 (12%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 98
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P++V +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 99  STTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
                 +  L +++E +   E   R+  +     ++R            I  A+ ++H+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHS- 146

Query: 156 IGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 212
             + HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE + G 
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            +Y  + D+WS G ++  LL G P F   +G      + +         I+       ++
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-----QY 250

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPNTRL 331
            FP      W ++       +A  L+  LL+  P  R T  + + HP+    +  P T L
Sbjct: 251 GFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

Query: 332 PNGRFLPPLFNFKP 345
              R L    +   
Sbjct: 303 HTARVLQEDKDHWD 316

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  172 bits (437), Expect = 2e-50
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 43/303 (14%)

Query: 24  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNREL 79
           +  K G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 80  QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY 137
             M  LDH N++ L   F     + +  + LV+EYV   E   R+I   Y +++   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 138 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNIS 196
           +K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
              +  + APE +      +   D+WS G +   LL G   F G++  + L  I+     
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--- 303

Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
                          +         +  I       EA + +S+LL    + R +A EAL
Sbjct: 304 --------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEAL 341

Query: 317 IHP 319
            HP
Sbjct: 342 KHP 344

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  168 bits (429), Expect = 3e-50
 Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 56/311 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 86
           Y     +G G F +V + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 143
           HPN+++L   F     +++  + L+LE V   E    +  K     ++         +  
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESL--TEDE----ATQFLK 115

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 199
           QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G      I  
Sbjct: 116 QILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFG 173

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           +  + APE I          D+WS G +   LL G   F GE+  + L  I  V      
Sbjct: 174 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------ 226

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                       + F       +           A D + RLL   P  R T  ++L H 
Sbjct: 227 -----------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEHS 267

Query: 320 FFDELRDPNTR 330
           +   +R  N R
Sbjct: 268 WIKAIRRRNVR 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  168 bits (429), Expect = 3e-50
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 66/297 (22%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 93
           R +G G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F     +  +Y  L+LE+ P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFHD---RKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 204
            H    V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 130 CHER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
            PE+I G   +   +D+W AG +  E L+G P F   S  +    I+ V           
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                 + KFP     P+       +   + DL+S+LL+Y P  R      + HP+ 
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  170 bits (433), Expect = 4e-50
 Identities = 82/325 (25%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 87
           Y    V+G G F VV +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY----VKLY 141
           P++V L   +       +  L +V E++   +    ++K           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 199
             QI  AL Y H+   + HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 200 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
            + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                       ++K        W  I        A DLV R+L   P  R T  EAL H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 319 PFFDELRDPNTRLPNGRFLPPLFNF 343
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  169 bits (430), Expect = 6e-50
 Identities = 73/310 (23%), Positives = 137/310 (44%), Gaps = 40/310 (12%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 94
            + ++ +G GSF +  +    ++ +A A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 151
             F      D+L+  LV+E +   E   R+  K H+  S+            ++  A+++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHF--SETE----ASYIMRKLVSAVSH 121

Query: 152 IHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 208
           +H+ +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE 
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE- 179

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +     Y  + D+WS G +L  +L GQ  F            ++++     ++IK     
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG--- 231

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-P 327
             +F F       W  +       EA DL+  LL   PN R        + +  +     
Sbjct: 232 --DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281

Query: 328 NTRLPNGRFL 337
           +  L     L
Sbjct: 282 SNPLMTPDIL 291

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  172 bits (438), Expect = 7e-50
 Identities = 79/319 (24%), Positives = 127/319 (39%), Gaps = 50/319 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y     +G G+F VV +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 147
           V L          +E +  L+ + V   E    ++   +Y  S+            QI  
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYY--SEAD----ASHCIQQILE 121

Query: 148 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYR 204
           A+ + H  +GV HR++KP+NLL  +      +KL DFG A  +   +        +  Y 
Sbjct: 122 AVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           +PE +     Y   +D+W+ G +L  LL+G P F  E       +I              
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------ 227

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                  + FP   +  W  +      PEA DL++++L  +P+ R TA EAL HP+    
Sbjct: 228 -----GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274

Query: 325 RDPNTRLPNGRFLPPLFNF 343
               + +     +  L  F
Sbjct: 275 STVASCMHRQETVDCLKKF 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  169 bits (431), Expect = 1e-49
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 49/318 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 147
           V L         ++E +  LV + V   E    ++    Y  S+            QI  
Sbjct: 91  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 139

Query: 148 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +
Sbjct: 140 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 198

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE +     Y+  +DIW+ G +L  LL+G P F  E       +I               
Sbjct: 199 PE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 245

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
                 + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P+     
Sbjct: 246 -----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 292

Query: 326 DPNTRLPNGRFLPPLFNF 343
              + +     +  L  F
Sbjct: 293 RVASAIHRQDTVDCLKKF 310

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  169 bits (429), Expect = 1e-49
 Identities = 76/342 (22%), Positives = 126/342 (36%), Gaps = 60/342 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 91
               RV+  G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 92  SLKHCFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
                     E        +L L+ E     +   +K   +    +    V   FYQ CR
Sbjct: 90  QFCSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCR 147

Query: 148 ALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EP 193
           A+ ++H     + HRD+K +NLL++     +KLCDFGSA  +                E 
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 194 NISYICSRYYRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
            I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F   +         
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--------- 257

Query: 252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
                    +++ +N  Y+                          L+  +LQ +P  R +
Sbjct: 258 ---------KLRIVNGKYSIPPHD-------------TQYTVFHSLIRAMLQVNPEERLS 295

Query: 312 ALEALIHPF-FDELRDPNTRLPNGRFLPPLFNFKPHELKGVP 352
             E +         R+ N + P    L     +    L   P
Sbjct: 296 IAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  166 bits (424), Expect = 2e-49
 Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 51/297 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 147
           V L         ++E +  LV + V   E    ++ +  Y  S+            QI  
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 116

Query: 148 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 204
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E        +  Y 
Sbjct: 117 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYL 174

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                  + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  167 bits (425), Expect = 3e-49
 Identities = 73/325 (22%), Positives = 117/325 (36%), Gaps = 57/325 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 86
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 143
           H NV++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 199
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------ 233

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                       + F       +           A D + +LL      R T  EAL HP
Sbjct: 234 -----------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 320 FFDELRDPNTRLPNGRFLPPLFNFK 344
           +     D    +     +  L NF+
Sbjct: 275 WITP-VDNQQAMVRRESVVNLENFR 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  168 bits (427), Expect = 3e-49
 Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 48/302 (15%)

Query: 28  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMR 83
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 140
            L HPN++ LK  F     +    ++LVLE V   E   R+++  +Y  S+R        
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYY--SERD----AAD 152

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYI 198
              QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K++      +  +
Sbjct: 153 AVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTV 210

Query: 199 C-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           C +  Y APE I     Y   +D+WS G +   LL G   F  E G   +   I      
Sbjct: 211 CGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----- 264

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                 C      E+ F    +  W ++        A DLV +L+   P  R T  +AL 
Sbjct: 265 -----NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQ 305

Query: 318 HP 319
           HP
Sbjct: 306 HP 307

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (425), Expect = 3e-49
 Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 54/317 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 86
           Y     +G G F VV + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           HPNV++L   +     +++  + L+LE V   E    + +    +++         +  Q
Sbjct: 73  HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKES-LTEEE----ATEFLKQ 122

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 200
           I   + Y+H+ + + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +
Sbjct: 123 ILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 180

Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
             + APE I          D+WS G +   LL G   F G++  + L  +  V       
Sbjct: 181 PEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------- 232

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                      ++F       +           A D + RLL   P  R T  ++L HP+
Sbjct: 233 ----------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

Query: 321 FDELRDPNTRLPNGRFL 337
                           +
Sbjct: 275 IKPKDTQQALSRKASAV 291

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  167 bits (425), Expect = 8e-49
 Identities = 74/325 (22%), Positives = 119/325 (36%), Gaps = 57/325 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 86
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 143
           HPN+++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 199
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------ 233

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                       + F       + +         A D + +LL      R T  EAL HP
Sbjct: 234 -----------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 320 FFDELRDPNTRLPNGRFLPPLFNFK 344
           +     D    +     +  L NFK
Sbjct: 275 WITP-VDTQQAMVRRESVVNLENFK 298

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  164 bits (417), Expect = 3e-48
 Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 62/317 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK------------KVLQDKRYK-NRELQTMR 83
           Y  + ++G G   VV +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 84  LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 139
            +  HPN++ LK  +     +   +  LV + +   E    + +      S++      +
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEK----ETR 127

Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
                +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C
Sbjct: 128 KIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVC 184

Query: 200 -SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 253
            +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 313
                             ++F    +  W             DLVSR L   P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 314 EALIHPFFDELRDPNTR 330
           EAL HPFF +      R
Sbjct: 280 EALAHPFFQQYVVEEVR 296

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  162 bits (412), Expect = 8e-47
 Identities = 59/378 (15%), Positives = 115/378 (30%), Gaps = 92/378 (24%)

Query: 1   MQEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAE--------RVVGHGSFGVVF 52
           + +            A   +V+T     GQP +  S + E         V+G        
Sbjct: 31  IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL 90

Query: 53  QAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-------------------- 85
           +A   ETGE+  +      +R  +        E+  +RLL                    
Sbjct: 91  EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150

Query: 86  -----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 140
                    ++ ++            +L   ++   +T   V+  H    + +       
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
              Q+ R LA +H+  G+ H  ++P +++++     + L  F      V+    +    S
Sbjct: 211 LTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VFLTGFEHL---VRDGARVVSSVS 265

Query: 201 RYYRAPELI----------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 250
           R +  PEL              T  T + D W+ G V+  +         ++ +      
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG----- 320

Query: 251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNL 308
                                             IF+  K +P     L+   L+Y    
Sbjct: 321 ------------------------------GSEWIFRSCKNIPQPVRALLEGFLRYPKED 350

Query: 309 RSTALEALIHPFFDELRD 326
           R   L+A+  P +++LR 
Sbjct: 351 RLLPLQAMETPEYEQLRT 368

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  160 bits (408), Expect = 9e-47
 Identities = 82/323 (25%), Positives = 130/323 (40%), Gaps = 51/323 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 94
           E V+G G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 95  HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICRALAY 151
             F     ++E    LV E +     +  + K  H+  ++        +    +  AL +
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHF--NEL----EASVVVQDVASALDF 126

Query: 152 IHNTIGVCHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------PNISYIC-SR 201
           +HN  G+ HRD+KP+N+L  +P     +K+CDF     +           P +   C S 
Sbjct: 127 LHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 202 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
            Y APE++      A+ Y    D+WS G +L  LL G P F G  G D   +  +     
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 258 TR---EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                E I+       +++FP      W  I        A DL+S+LL      R +A +
Sbjct: 246 QNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSAAQ 292

Query: 315 ALIHPFFDELRDPNTRLPNGRFL 337
            L HP+      P   LP    L
Sbjct: 293 VLQHPWVQG-CAPENTLPTPMVL 314

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  161 bits (410), Expect = 1e-46
 Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 61/307 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----------KVLQDKRYK-NRELQTMRL 84
           Y  + V+G G   VV +     TG   A+K           + L++ R    RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 85  L-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 140
           +  HP++++L   +     +   ++ LV + +   E    + +      S++      + 
Sbjct: 156 VAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEK----ETRS 204

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 199
               +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C 
Sbjct: 205 IMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCG 261

Query: 200 SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
           +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++  
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG- 320

Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                           +++F    +  W             DL+SRLLQ  P  R TA +
Sbjct: 321 ----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAEQ 356

Query: 315 ALIHPFF 321
           AL HPFF
Sbjct: 357 ALQHPFF 363

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  160 bits (407), Expect = 2e-46
 Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 50/308 (16%)

Query: 38  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 90
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 147
           ++L   +     ++   + L+LEY    E     + +    +S+      V     QI  
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142

Query: 148 ALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 204
            + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           APE I      T A D+W+ G +   LL     F GE   +  + I +V           
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----------- 248

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                    +       +  +        A D +  LL  +P  R TA   L H +  + 
Sbjct: 249 ------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294

Query: 325 RDPNTRLP 332
              N   P
Sbjct: 295 DFENLFHP 302

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  158 bits (403), Expect = 3e-46
 Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 62/320 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN---RELQTMRLLDHP 88
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
           NV+ L    ++  ++  +Y  +V+EY      E +  V +       R P+     YF Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SR 201
           +   L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 202 YYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            ++ PE+  G   ++   +DIWSAG  L  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
            I         +  P                P   DL+  +L+Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 321 FDELRDPNTRLPNGRFLPPL 340
           F        + P      P+
Sbjct: 267 F------RKKHPPAEAPVPI 280

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  158 bits (402), Expect = 5e-46
 Identities = 76/320 (23%), Positives = 123/320 (38%), Gaps = 58/320 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 95
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 96  CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 152
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----ASEIMKSIGEAIQYL 133

Query: 153 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK                        
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE------------------- 173

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
              +Y  + D+WS G ++  LL G P F    G+     +           I+       
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MG 217

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-PNT 329
           +++FP      W ++       E   L+  LL+  P  R T  E + HP+  +    P T
Sbjct: 218 QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269

Query: 330 RLPNGRFLPPLFNFKPHELK 349
            L   R L      +  ++K
Sbjct: 270 PLHTSRVL-KEDKERWEDVK 288

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  159 bits (404), Expect = 9e-46
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 91
           Y   + +G G+FGV    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
             K    +      L   +++EY    E   R+         R      + +F Q+   +
Sbjct: 80  RFKEVILT---PTHLA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           +Y H+ + +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 209 IFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +    EY     D+WS G  L  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
              ++  P             R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  159 bits (403), Expect = 3e-45
 Identities = 62/407 (15%), Positives = 119/407 (29%), Gaps = 92/407 (22%)

Query: 1   MQEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAER--------VVGHGSFGVVF 52
           + +            A   +V+T     GQP +  S + ER        V+G        
Sbjct: 36  IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL 95

Query: 53  QAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-------------------- 85
           +A   ETGE+  +      +R  +        E+  +RLL                    
Sbjct: 96  EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155

Query: 86  -----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 140
                    ++ ++            +L   ++   +T   V+  H    + +       
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 215

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
              Q+ R LA +H+  G+ H  ++P +++++     + L  F        G   +S I  
Sbjct: 216 LTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGR 271

Query: 201 RY----YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 252
            +      A  ++       T  T A D W+ G  +  +         ++ +        
Sbjct: 272 GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----- 326

Query: 253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRS 310
                                           IF+  K +P     L+   L+Y    R 
Sbjct: 327 ------------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRL 356

Query: 311 TALEALIHPFFDELRD---PNTRLPNGRFLPPLFNFKPHELKGVPVD 354
             L+A+  P +++LR        L      P      P      P +
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDE 403

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  153 bits (389), Expect = 2e-44
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 206
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 207 ELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           EL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                          PW K     +    + L+ ++L  +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (394), Expect = 2e-44
 Identities = 74/330 (22%), Positives = 132/330 (40%), Gaps = 34/330 (10%)

Query: 23  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--R 77
           T   K G+ K    +     +G G+ GVVF+     +G  +A K +   ++        R
Sbjct: 22  TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLI 136
           ELQ +   + P +V     F+S  E     +++ +E++   ++ +V     K + R+P  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQV----LKKAGRIPEQ 131

Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
            +      + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189

Query: 197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
           ++ +R Y +PE + G   Y+   DIWS G  L E+ +G+   P     +  +     +  
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---------------KRMPPEAVDLVSRL 301
              E                + + P   IF+                    E  D V++ 
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 302 LQYSPNLRSTALEALIHPFFDELRDPNTRL 331
           L  +P  R+   + ++H F           
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  153 bits (390), Expect = 3e-44
 Identities = 77/332 (23%), Positives = 124/332 (37%), Gaps = 73/332 (21%)

Query: 25  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--- 76
            G +G   Q   Y  +  +G GS+GVV  A         A+K     K+++   +     
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 77  ----------------------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY 114
                                 +E+  ++ LDHPNVV L         +D LY+  V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119

Query: 115 VP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP 172
           V     V  V        + +     + YF  + + + Y+H    + HRDIKP NLLV  
Sbjct: 120 VNQGP-VMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG- 171

Query: 173 HTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-AAIDIWSAGCVLA 229
               +K+ DFG +      +  +S    +  + APE +      ++  A+D+W+ G  L 
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 230 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR 289
             + GQ  F  E  +  L   IK                    +FP     P        
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD---QPD------- 264

Query: 290 MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
           +  +  DL++R+L  +P  R    E  +HP+ 
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  153 bits (389), Expect = 6e-44
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 206
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 207 ELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           EL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                          PW K     +    + L+ ++L  +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  149 bits (377), Expect = 3e-42
 Identities = 70/321 (21%), Positives = 118/321 (36%), Gaps = 67/321 (20%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 86
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 87  H--PNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 141
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 200
           F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 201 RYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
           R Y  PE I     Y      +WS G +L +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                      +  F             +R+  E   L+   L   P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 320 FFDELRDPNTRLP-NGRFLPP 339
           +  ++  P      +   L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  147 bits (374), Expect = 4e-42
 Identities = 81/307 (26%), Positives = 130/307 (42%), Gaps = 52/307 (16%)

Query: 25  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------R 77
           G K+    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 135
           E+Q ++L  HP+++ L     +     + +  +V+EYV   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-----GRVEE 110

Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
           +  +  F QI  A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 196 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              C S  Y APE+I G       +DIWS G +L  LL G   F  E         +  L
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL 219

Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                ++I+        F  P      +       +      L+  +LQ  P  R+T  +
Sbjct: 220 ----FKKIR-----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258

Query: 315 ALIHPFF 321
              H +F
Sbjct: 259 IREHEWF 265

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  148 bits (375), Expect = 9e-42
 Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 57/308 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 88
           Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           N+V L       TEK    L L++EY    E    ++ H      RM     +  F QI 
Sbjct: 75  NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 205
            A+ Y H    + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 206 PELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           PEL  G  +Y    +D+WS G +L  L+ G   F G++ + +L E +             
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                 +++ P      +       M  +  +L+ R L  +P  R T  + +   + +  
Sbjct: 228 ----RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271

Query: 325 RDPNTRLP 332
            + +   P
Sbjct: 272 HEEDELKP 279

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  146 bits (371), Expect = 1e-41
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 41/299 (13%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKH 95
            +G G++GVV + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
             F   +     + + +E +  ++ +  K      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---A 212
           + V HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y+   DIWS G  + EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 331
             PQ+ A  +          E VD  S+ L+ +   R T  E + HPFF       T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  146 bits (371), Expect = 2e-41
 Identities = 77/308 (25%), Positives = 122/308 (39%), Gaps = 72/308 (23%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 93
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              F     +D+  L   L Y    E     +  + +          + Y  +I  AL Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------YICSRY 202
           +H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
             +PEL+        + D+W+ GC++ +L+ G P F   +    + + I           
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245

Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP------NLRSTALEAL 316
                   E+ FP            ++  P+A DLV +LL                    
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 317 IHPFFDEL 324
            HPFF+ +
Sbjct: 288 AHPFFESV 295

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  145 bits (368), Expect = 7e-41
 Identities = 77/323 (23%), Positives = 122/323 (37%), Gaps = 68/323 (21%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 86
           Y    ++G G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 87  ----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---IKHHYKMSQRMPLIYVK 139
               HP V+ L   +F T  ++   L  VLE  P     +   I     + +       +
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLER-PLPAQDLFDYITEKGPLGEGP----SR 142

Query: 140 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
            +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS  +L       +   
Sbjct: 143 CFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD 199

Query: 200 -SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
            +R Y  PE I    +Y A    +WS G +L +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                        E  FP              + P+   L+ R L   P+ R +  E L+
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 318 HPFFDELRDPNTRLPNGRFLPPL 340
            P+     +     P+     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  144 bits (365), Expect = 3e-40
 Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 51/294 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 89
           Y+    +G GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           ++ L     +     ++   +V+EY   E    +++      +RM     + +F QI  A
Sbjct: 71  IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 207
           + Y H    + HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +I G       +D+WS G VL  +L+G+  F  E  +  L + +                
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
               +  P      +       + P A  L+ R++   P  R T  E    P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  144 bits (366), Expect = 2e-39
 Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 53/307 (17%)

Query: 26  GKNGQPKQTI-SYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--R 77
            +    +  I  Y+    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 78  ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 135
           E+Q ++L  HP+++ L     +     +++  +V+EYV   E    + K+      R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVIST---PSDIF--MVMEYVSGGELFDYICKN-----GRLDE 115

Query: 136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 195
              +  F QI   + Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 196 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
              C S  Y APE+I G       +DIWS+G +L  LL G   F  +  V  L + I   
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-- 229

Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
                            F  P      +       + P  + L+  +LQ  P  R+T  +
Sbjct: 230 --------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKD 263

Query: 315 ALIHPFF 321
              H +F
Sbjct: 264 IREHEWF 270

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  142 bits (359), Expect = 3e-39
 Identities = 37/315 (11%), Positives = 91/315 (28%), Gaps = 64/315 (20%)

Query: 36  SYMAERVVGHGSFGVVFQAKC-----LETGEAVAIK----KVLQDKRYKNRELQTMRLLD 86
                 ++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
               +           ++   L  V E       ++ +  +     + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----------LKLCDFGSA---KVLVKG 191
           +   +  +H+   + H DIKP N ++     +          L L D G +   K+  KG
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 192 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
               +   +  ++  E++     +   ID +     +  +L G  +     G        
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290

Query: 252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 311
                    + + +                W++ F              +L         
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLP 325

Query: 312 ALEALIHPFFDELRD 326
           +L+ L        + 
Sbjct: 326 SLDLLRQKLKKVFQQ 340

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  146 bits (371), Expect = 4e-39
 Identities = 77/345 (22%), Positives = 131/345 (37%), Gaps = 71/345 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 89
           R++G G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           +V + + F +    D+L    +L+ +   +     + +H           ++ Y  +I  
Sbjct: 254 IVCMSYAFHT---PDKLSF--ILDLMNGGD-----LHYHLSQHGVFSEADMRFYAAEIIL 303

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
            L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++     Y ++ D +S GC+L +LL G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF- 321
                                   PE   L+  LLQ   N R       A E    PFF 
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 322 ----DELRD--------PNTRLPNGRFLPPLFNFKPHELKGVPVD 354
                 +          P     N      + +F   + KG+ + 
Sbjct: 455 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLL 499

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  140 bits (354), Expect = 8e-39
 Identities = 66/301 (21%), Positives = 113/301 (37%), Gaps = 46/301 (15%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 95
            +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
            F + T+     + + +E +     ++ K   +M   +P   +      I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FG 211
            GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 270
             +Y    D+WS G  L EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR 330
               P +  H            +    V   L      R    + L H F          
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 331 L 331
           +
Sbjct: 297 V 297

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  141 bits (358), Expect = 9e-39
 Identities = 79/321 (24%), Positives = 139/321 (43%), Gaps = 61/321 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 93
           R +G GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F     +DE  + +V++ +   +     +++H + +       VKL+  ++  AL Y
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGD-----LRYHLQQNVHFKEETVKLFICELVMALDY 130

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 210
           + N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQN-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 211 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP 267
                Y+ A+D WS G    ELL G+  +   S     ++V   +               
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDELRD 326
             T   +P                 E V L+ +LL+ +P+ R S   +    P+     D
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---ND 277

Query: 327 PN-TRLPNGRFLPPLFNFKPH 346
            N   +   R +P    F P+
Sbjct: 278 INWDAVFQKRLIPG---FIPN 295

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  139 bits (352), Expect = 2e-38
 Identities = 70/358 (19%), Positives = 121/358 (33%), Gaps = 103/358 (28%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +   + +G G FGVVF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------------- 138
              + +  T  +        +    E+    +     M      I               
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 139 -------KLY--------------------------------FYQICRALAYIHNTIGVC 159
                   LY                                F QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLM 186

Query: 160 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNISYICSRYYRAP 206
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E I G   Y+  +DI+S G +L ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                 KFP         +F ++ P E   +V  +L  SP  R  A + + +  F+ L
Sbjct: 288 ----NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIFENL 332

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  139 bits (352), Expect = 2e-38
 Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 39/300 (13%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 95
            +G G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 96  CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHN 154
             F   +       + +E +  +  +  K+ Y +    +P   +        +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
            + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 215 ---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y    D+WS G  L EL  G+  +P  + V   +  + V G P              
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 331
              PQ+      + F     P  ++ V+  L    + R    E L HPF     +    +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  139 bits (351), Expect = 3e-38
 Identities = 69/308 (22%), Positives = 120/308 (38%), Gaps = 66/308 (21%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-------RELQTMRL 84
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 85  LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 141
           ++H N++ +    F    +      LV+E      +    + +H      R+        
Sbjct: 86  VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH-----PRLDEPLASYI 135

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 200
           F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 201 RYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 259
             Y APE++ G   Y    +++WS G  L  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
                          P              +  E + LVS LLQ  P  R+T  + +  P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 320 FFDELRDP 327
           +  +  + 
Sbjct: 277 WVTQPVNL 284

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  140 bits (353), Expect = 4e-38
 Identities = 62/320 (19%), Positives = 114/320 (35%), Gaps = 44/320 (13%)

Query: 37  YMAERVVGHG--SFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHP 88
           Y    V+G G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           N+V  +  F +    +EL+  +V  ++   +   +I  H+     M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLK 139

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNISYIC 199
           AL YIH+  G  HR +K  ++L++    ++ L    S         +  V  +     + 
Sbjct: 140 ALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 200 SRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQP----------LF-------PGE 241
              + +PE++      Y A  DI+S G    EL  G            L        P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 242 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 301
                +      +          ++ + T               + +   P     V + 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 302 LQYSPNLRSTALEALIHPFF 321
           LQ +P+ R +A   L H FF
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  140 bits (355), Expect = 5e-38
 Identities = 88/366 (24%), Positives = 146/366 (39%), Gaps = 70/366 (19%)

Query: 1   MQEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLET 59
               E     G+ ++        +     + + T++ +   +++G G+FG V   K   T
Sbjct: 113 QAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT 172

Query: 60  GEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 109
           G   A+K      ++           NR LQ  R   HP + +LK+ F +    D L   
Sbjct: 173 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYSFQT---HDRLCF- 225

Query: 110 LVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 167
            V+EY    E     +  H    +       + Y  +I  AL Y+H+   V +RD+K +N
Sbjct: 226 -VMEYANGGE-----LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279

Query: 168 LLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGC 226
           L+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  A+D W  G 
Sbjct: 280 LMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGV 337

Query: 227 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 286
           V+ E++ G+  F  +   ++L E+I                   E +FP           
Sbjct: 338 VMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP----------- 369

Query: 287 QKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDPN-TRLPNGRFLPPL 340
            + + PEA  L+S LL+  P  R       A E + H FF          +   +  PP 
Sbjct: 370 -RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVYEKKLSPP- 424

Query: 341 FNFKPH 346
             FKP 
Sbjct: 425 --FKPQ 428

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  139 bits (353), Expect = 6e-38
 Identities = 83/337 (24%), Positives = 124/337 (36%), Gaps = 85/337 (25%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 93
           +V+G G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              F     +DE YL LV+EY    + +        K  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 203
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 204 RAPELI------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
            +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALE 314
                  ++        P            + +P EA D + RLL   P  R     A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324

Query: 315 ALIHPFF-----DELRDPNTRLPNGRFLPPLFNFKPH 346
              HPFF     D LR           +PP   F P 
Sbjct: 325 FRTHPFFFGLDWDGLR---------DSVPP---FTPD 349

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  141 bits (357), Expect = 1e-37
 Identities = 86/325 (26%), Positives = 139/325 (42%), Gaps = 65/325 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 92
           RV+G G FG V   +   TG+  A K  L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPET-----VHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           L + + +   KD L L  VL  +        ++ + +  +  ++         Y  +IC 
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKFHIYHMGQAGFPEAR------AVFYAAEICC 297

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 207
            L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE
Sbjct: 298 GLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++     YT + D W+ GC+L E++ GQ  F       +  E+ ++        +K +  
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPE 406

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
            Y+E                    P+A  L S+LL   P  R      +A E   HP F 
Sbjct: 407 EYSER-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF- 448

Query: 323 ELRDPN-TRLPNGRFLPPLFNFKPH 346
             +  N  RL  G   PP   FKP 
Sbjct: 449 --KKLNFKRLGAGMLEPP---FKPD 468

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  140 bits (354), Expect = 2e-37
 Identities = 74/326 (22%), Positives = 125/326 (38%), Gaps = 56/326 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 92
           RV+G G FG VF  +   TG+  A K  L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L + F +   K +L L  V+  +   +  +  I +  + +          Y  QI   L 
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 209
           ++H    + +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G  EY  ++D ++ G  L E++  +  F       +  E+         + +      Y
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTY 412

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDEL 324
            +                    P + D    LLQ  P  R      +      HP F   
Sbjct: 413 PDK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF--- 452

Query: 325 RDPN-TRLPNGRFLPPLFNFKPHELK 349
           RD +  +L  G  L P F      + 
Sbjct: 453 RDISWRQLEAGM-LTPPFVPDSRTVY 477

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  138 bits (349), Expect = 3e-37
 Identities = 82/361 (22%), Positives = 138/361 (38%), Gaps = 69/361 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 93
           +V+G G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F     +D+  L LV++Y    + +        K   R+P    + Y  ++  A+  
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 209
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 210 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
                G   Y    D WS G  + E+L G+  F  ES + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN-LRSTALEAL-IHPFF-- 321
           N     F+FP              +   A DL+ RL+    + L    +E    HPFF  
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

Query: 322 ---DELRDPNTRLPNGRFLPPL------FNFKPHELKGVPVDMLV-KLIPEHARKQCAFL 371
              D +R  N   P   ++P +       NF   +      + +        +     F+
Sbjct: 345 IDWDNIR--NCEAP---YIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFV 399

Query: 372 G 372
           G
Sbjct: 400 G 400

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  133 bits (337), Expect = 1e-36
 Identities = 81/311 (26%), Positives = 126/311 (40%), Gaps = 46/311 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR--- 147
           S    F     KDEL+  LV++ +   +V  +IKH     +    +  +     I R   
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 148 -ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR---- 201
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 202 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                  N        P ++     K   K+       ++S  LQ  P  R TA E L H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 319 PFFDELRDPNT 329
            FF + ++   
Sbjct: 289 KFFQKAKNKEF 299

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  134 bits (339), Expect = 2e-36
 Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 64/322 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 93
           +++G G+FG V   +   TG   A+K      ++      +   E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           K+ F  T ++  L    V+EY    E     +  H    +       + Y  +I  AL Y
Sbjct: 71  KYAF-QTHDR--LCF--VMEYANGGE-----LFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 210
           +H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++ 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
              +Y  A+D W  G V+ E++ G+  F  +   ++L E+I                   
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 325
           E +FP            + + PEA  L++ LL+  P  R     S A E + H FF    
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---L 265

Query: 326 DPN-TRLPNGRFLPPLFNFKPH 346
             N   +   + LPP   FKP 
Sbjct: 266 SINWQDVVQKKLLPP---FKPQ 284

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  134 bits (338), Expect = 6e-36
 Identities = 79/364 (21%), Positives = 137/364 (37%), Gaps = 84/364 (23%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLL-----DHP 88
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 89  N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
           N   VV L   F  +      ++ +V E +   + + I       Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLV----------------------------------- 170
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 171 -------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 217
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 218 AIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 264
             DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVSRLLQYSPNLRSTALEALIH 318
                      ++K     ++  ++            D +  +L+  P  R+TA E L H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 319 PFFD 322
           P+ +
Sbjct: 393 PWLN 396

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  132 bits (333), Expect = 1e-35
 Identities = 78/327 (23%), Positives = 132/327 (40%), Gaps = 77/327 (23%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +  F     KD   L +V+EYV   E     +  H +   R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 205
           +H+ + + +RD+KP+NLL++   + +++ DFG AK +        G P           A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +   
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG- 253

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPF 320
                + +FP                 +  DL+  LLQ        NL++   +   H +
Sbjct: 254 -----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

Query: 321 FDELRDPN-TRLPNGRFLPPLFNFKPH 346
           F      +   +   +   P   F P 
Sbjct: 297 FATT---DWIAIYQRKVEAP---FIPK 317

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  130 bits (329), Expect = 3e-35
 Identities = 80/335 (23%), Positives = 140/335 (41%), Gaps = 78/335 (23%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 93
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
              F     +D   + ++++Y+   E     +    + SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGE-----LFSLLRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 205
           +H+   + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++     Y  +ID WS G ++ E+L G   F   +   +  E I              
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL------------- 216

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPF 320
                E +FP                 +  DL+SRL+         NL++   +   HP+
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

Query: 321 FDELRDPN-TRLPNGRFLPPLFNFKPHELKGVPVD 354
           F E+      +L +     P   ++P  ++    D
Sbjct: 262 FKEV---VWEKLLSRNIETP---YEPP-IQQGQGD 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  129 bits (327), Expect = 4e-35
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 97
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 98  FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 154
                     + LV+EY    +++ V+ H  +        +   +  Q  + +AY+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
              + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 249
           Y+   D++S G +L E++  +  F    G    + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  129 bits (327), Expect = 7e-35
 Identities = 80/324 (24%), Positives = 134/324 (41%), Gaps = 66/324 (20%)

Query: 41  RVVGHGSFGVVFQAK---CLETGEAVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 91
           +V+G GSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L + F  T  K  LYL  +L+++   +     +              VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGD-----LFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 208
            ++H+ +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +     +T + D WS G ++ E+L G   F G+    + + +I                 
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDE 323
             +   PQ             + PEA  L+  L + +P  R         E   H FF  
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF-- 285

Query: 324 LRDPN-TRLPNGRFLPPLFNFKPH 346
               +  +L      PP   FKP 
Sbjct: 286 -STIDWNKLYRREIHPP---FKPA 305

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  129 bits (327), Expect = 7e-35
 Identities = 88/327 (26%), Positives = 136/327 (41%), Gaps = 70/327 (21%)

Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIK---KVLQDKRYKNRELQTM---RLL---DHP 88
           RV+G G +G VFQ + +    TG+  A+K   K +  +  K+    T     +L    HP
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-HTKAERNILEEVKHP 81

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            +V L + F  T  K  LYL  +LEY+   E     +    +            Y  +I 
Sbjct: 82  FIVDLIYAF-QTGGK--LYL--ILEYLSGGE-----LFMQLEREGIFMEDTACFYLAEIS 131

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 205
            AL ++H   G+ +RD+KP+N+++N   H +KL DFG  K  +         C    Y A
Sbjct: 132 MALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++   + +  A+D WS G ++ ++L G P F GE+   + ++ I              
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL------------- 234

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 320
                +   P              +  EA DL+ +LL+ +   R       A E   HPF
Sbjct: 235 ---KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

Query: 321 FDELRDPN-TRLPNGRFLPPLFNFKPH 346
           F   R  N   L   +  PP   FKP 
Sbjct: 280 F---RHINWEELLARKVEPP---FKPL 300

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  131 bits (331), Expect = 8e-35
 Identities = 80/330 (24%), Positives = 127/330 (38%), Gaps = 75/330 (22%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 93
           +V+G G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 94  KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            + F     +D+ YL +V+EY+P  + V+ +  +       +P  + + Y  ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDA 183

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 203
           IH+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI     
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 204 RAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            +PE++    G   Y    D WS G  L E+L+G   F  +S    LV            
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALI 317
             K MN       FP              +  EA +L+   L     +R   +   E   
Sbjct: 284 --KIMNHK-NSLTFPD---DND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329

Query: 318 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 346
           H FF                + P     P 
Sbjct: 330 HLFFKND---QWAWETLRDTVAP---VVPD 353

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  129 bits (326), Expect = 2e-34
 Identities = 86/326 (26%), Positives = 138/326 (42%), Gaps = 70/326 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 90
           RV+G GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
             L  C F T ++  L+   V+E+V   +     +  H + S+R      + Y  +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGD-----LMFHIQKSRRFDEARARFYAAEIISA 136

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 207
           L ++H+  G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++     Y  A+D W+ G +L E+L G   F  E+  D L E I                
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL--------------- 237

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEALIHPFF 321
              E  +P              +  +A  ++   +  +P +R            L HPFF
Sbjct: 238 -NDEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

Query: 322 DELRDPN-TRLPNGRFLPPLFNFKPH 346
              ++ +  +L + +  PP   F+P 
Sbjct: 285 ---KEIDWAQLNHRQIEPP---FRPR 304

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  129 bits (327), Expect = 2e-34
 Identities = 83/323 (25%), Positives = 128/323 (39%), Gaps = 66/323 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 91
           +V+G GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L    F T +K  LY   VL+Y+   E     + +H +  +       + Y  +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGE-----LFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 208
            Y+H+ + + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +     Y   +D W  G VL E+L G P F   +   ++ + I                 
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR----STALEALIHPFFDEL 324
               +                +   A  L+  LLQ     R       +E   H FF   
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF--- 297

Query: 325 RDPN-TRLPNGRFLPPLFNFKPH 346
              N   L N +  PP   F P+
Sbjct: 298 SLINWDDLINKKITPP---FNPN 317

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  129 bits (326), Expect = 2e-34
 Identities = 82/325 (25%), Positives = 126/325 (38%), Gaps = 69/325 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 90
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
             L  C F T ++  LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 133

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 207
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 234

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                 +P            K M  EAV +   L+   P  R         +   H FF 
Sbjct: 235 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 280

Query: 323 ELRDPN-TRLPNGRFLPPLFNFKPH 346
             R  +  +L      PP   +KP 
Sbjct: 281 --RYIDWEKLERKEIQPP---YKPK 300

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  128 bits (324), Expect = 2e-34
 Identities = 85/323 (26%), Positives = 139/323 (43%), Gaps = 69/323 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 88
           +++G GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            +  +   F  T E   L+   V+EY+   +     + +H +   +  L     Y  +I 
Sbjct: 79  FLTHMFCTF-QTKEN--LFF--VMEYLNGGD-----LMYHIQSCHKFDLSRATFYAAEII 128

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 205
             L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G  +Y  ++D WS G +L E+L+GQ  F G+   ++L   I+             
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------------- 231

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFDEL 324
                   +P            + +  EA DL+ +L    P  R      +  HP F   
Sbjct: 232 ---MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF--- 273

Query: 325 RDPN-TRLPNGRFLPPLFNFKPH 346
           R+ N   L      PP   F+P 
Sbjct: 274 REINWEELERKEIDPP---FRPK 293

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  127 bits (320), Expect = 8e-34
 Identities = 76/302 (25%), Positives = 131/302 (43%), Gaps = 49/302 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 89
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            +  + C+     +   +  LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 210 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES 270

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                  P +++  W + F+        + V   LQ  P  R T+   L H F    R P
Sbjct: 271 -------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315

Query: 328 NT 329
             
Sbjct: 316 TV 317

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  127 bits (320), Expect = 1e-33
 Identities = 88/329 (26%), Positives = 143/329 (43%), Gaps = 66/329 (20%)

Query: 41  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNREL--QTM---RLL----DHP 88
           +V+G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            +V+L + F  T  K  L+L  +L+Y+   E     +  H    +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF-QTETK--LHL--ILDYINGGE-----LFTHLSQRERFTEHEVQIYVGEIV 169

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYR 204
            AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 205 APELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
           AP+++ G    +  A+D WS G ++ ELL G   F  +   +   EI           I 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279

Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 318
                 +E  +PQ             M   A DL+ RLL   P  R       A E   H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322

Query: 319 PFFDELRDPN-TRLPNGRFLPPLFNFKPH 346
            FF   +  N   L   +   P   FKP 
Sbjct: 323 LFF---QKINWDDLAAKKVPAP---FKPV 345

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  124 bits (313), Expect = 3e-33
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 32/225 (14%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHP 88
           E+ +G G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 146
           N+V L                +V+E+VP   ++  +    + +   + L  +      I 
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM----LDIA 132

Query: 147 RALAYIHN-TIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYICSR 201
             + Y+ N    + HRD++  N+ +           K+ DFG ++           + + 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNF 190

Query: 202 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 245
            + APE I    E YT   D +S   +L  +L G+  F   S   
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  125 bits (317), Expect = 3e-33
 Identities = 75/328 (22%), Positives = 135/328 (41%), Gaps = 65/328 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 88
           RV+G GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 120

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 205
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +   
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEALIHP 319
                   F  I          + +  +A  ++   L   P  R      +   +   HP
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277

Query: 320 FFDELRDPN-TRLPNGRFLPPLFNFKPH 346
           FF   R+ +   +   + +PP   FKP+
Sbjct: 278 FF---RNVDWDMMEQKQVVPP---FKPN 299

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (312), Expect = 6e-33
 Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +     +G GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
                +   T+     L +++EY+   +   +++        +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 209
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
             +  Y +  DIWS G    EL  G+P       +  L  I K    PT E         
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG-------- 241

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 329
                       + K  +        + V   L   P+ R TA E L H F        +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 330 RL 331
            L
Sbjct: 283 YL 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (310), Expect = 1e-32
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 47/300 (15%)

Query: 28  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR 83
            G PK+   Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 142
              +PN+V+    +      DEL+  +V+EY+   ++  V+         M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTET-----CMDEGQIAAVC 122

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 201
            +  +AL ++H+   V HRDIK  N+L+      +KL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP  + 
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238

Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                                  IF+        D ++R L+     R +A E L H F 
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (309), Expect = 2e-32
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYK---NRELQTMRLLDHP 88
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           +VV +        E D     + +  +    +  +++    ++    +  V+    QI  
Sbjct: 95  HVVPI----HDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVR----QIGS 145

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYY 203
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            APE    +   T   DI++  CVL E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (318), Expect = 4e-32
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP 88
           Y  +  + HG  G ++ A      G  V +K  L               E Q +  + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139

Query: 89  NVVSLKHCFFSTTEKDELYLN-LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           ++V +   F   T++    +  +V+EYV  +++ R         Q++P+     Y  +I 
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSR 201
            AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +     + G P        
Sbjct: 193 PALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTP-------- 241

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 242
            ++APE++      T A DI++ G  LA L L  P   G  
Sbjct: 242 GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (305), Expect = 4e-32
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 30/222 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDH 87
           Y     +G G    V+ A+       VAIK  +           KR++ RE+     L H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFE-REVHNSSQLSH 70

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            N+VS+        E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI 
Sbjct: 71  QNIVSM----IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QIL 121

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 202
             + + H+   + HRDIKPQN+L++     LK+ DFG AK L   E +++     + +  
Sbjct: 122 DGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQ 177

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
           Y +PE   G        DI+S G VL E+L+G+P F GE+ V
Sbjct: 178 YFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  123 bits (311), Expect = 5e-32
 Identities = 74/328 (22%), Positives = 135/328 (41%), Gaps = 65/328 (19%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 88
           RV+G GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 163

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 205
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +   
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEALIHP 319
                   F  I          + +  +A  ++   L   P  R      +   +   HP
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320

Query: 320 FFDELRDPN-TRLPNGRFLPPLFNFKPH 346
           FF   R+ +   +   + +PP   FKP+
Sbjct: 321 FF---RNVDWDMMEQKQVVPP---FKPN 342

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (306), Expect = 6e-32
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNR---ELQTMRLLDHP 88
           Y    ++G G    V  A+ L     VA+K VL     +D  +  R   E Q    L+HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHP 72

Query: 89  NVVSLKHCFFSTTEKDELYLN---LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
            +V++    + T E +        +V+EYV   T+  ++     M+ +  +  +      
Sbjct: 73  AIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA----D 124

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICS 200
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 201 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 244
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  126 bits (317), Expect = 6e-32
 Identities = 82/325 (25%), Positives = 126/325 (38%), Gaps = 69/325 (21%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 90
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
             L  CF +    D LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 405 TQLHSCFQT---MDRLYF--VMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 454

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 207
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 555

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 322
                 +P            K M  EAV +   L+   P  R         +   H FF 
Sbjct: 556 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 601

Query: 323 ELRDPN-TRLPNGRFLPPLFNFKPH 346
             R  +  +L      PP   +KP 
Sbjct: 602 --RYIDWEKLERKEIQPP---YKPK 621

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 9e-32
 Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 45/291 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 92
             +   +G GS G+V  A+   +G  VA+K +     Q +     E+  MR   H NVV 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           +   +      +EL+  +++E++    +  ++        R+    +      + +ALAY
Sbjct: 107 MYKSYLV---GEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 210
           +H   GV HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I 
Sbjct: 157 LHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
             + Y   +DIWS G ++ E++ G+P +  +S V  +  +      P  +          
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------- 263

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                   +H    + +        D + R+L   P  R+TA E L HPF 
Sbjct: 264 --------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (304), Expect = 1e-31
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 41/297 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 94
           +     +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 95  HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
             +F  T+     L +V+EY    +V  +I+     ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 212
                 HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 FM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
             Y    DIWS G    E+  G+P +     +  +  I      PT  +           
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK----------- 247

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 329
                    W   F         D V + L  SP  R+TA + L HPF    +  + 
Sbjct: 248 ------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (303), Expect = 1e-31
 Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 46/303 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 92
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           L   ++   +     L +++E+ P   V  ++    +    +    +++   Q+  AL +
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNF 132

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 210
           +H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++ 
Sbjct: 133 LHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 211 GAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
             T     Y    DIWS G  L E+   +P     + +  L++I K    PT        
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT----- 244

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
                          W   F+        D +   L  +P  R +A + L HPF   +  
Sbjct: 245 ------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

Query: 327 PNT 329
              
Sbjct: 285 NKA 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (303), Expect = 1e-31
 Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 42/307 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 92
           +    +VG+G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 93  LKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
               F        +  L LV+E+    +V  +IK+       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLS 143

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 209
           ++H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 210 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
           NP       P++K+  W K FQ          +   L  + + R    + + HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 326 DPNTRLP 332
           +      
Sbjct: 295 NERQVRI 301

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (299), Expect = 2e-31
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 91
           E ++G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 92  SLK-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQICRA 148
           +L+  C     ++  L L  V+E+     ++RV+          +          QI R 
Sbjct: 70  ALRGVC----LKEPNLCL--VMEFARGGPLNRVLSGKRIPPDILVNWAV------QIARG 117

Query: 149 LAYIH--NTIGVCHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNISYIC 199
           + Y+H    + + HRD+K  N+L+             LK+ DFG A+   +    +S   
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG 176

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 240
           +  + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (294), Expect = 3e-30
 Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 46/312 (14%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 95
             V+G G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAYIH 153
                 +   L    + EY+   T+  +IK    M  + P    ++ F   I   +AY+H
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWS-QRVSFAKDIASGMAYLH 125

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------------ 201
           + + + HRD+   N LV      + + DFG A+++V  +     + S             
Sbjct: 126 S-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 202 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
              Y+ APE+I G   Y   +D++S G VL E++      P          +        
Sbjct: 184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--L 240

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----L 313
                   P      F  I         +KR  P  V L   L     +L         L
Sbjct: 241 DRYC----PPNCPPSFFPITVRCCDLDPEKR--PSFVKLEHWLETLRMHLAGHLPLGPQL 294

Query: 314 EALIHPFFDELR 325
           E L   F++  R
Sbjct: 295 EQLDRGFWETYR 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  116 bits (293), Expect = 4e-30
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 93
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
                + T+   L   +V EY+   +++R++ H     +++         Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 153 HN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 210
           HN    + HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPG 240
                    D++S G +L EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 4e-30
 Identities = 44/216 (20%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 95
            + +G G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 153
               T    +LYL  + +Y    +++  +K         + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 154 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 201
             I        + HRD+K +N+LV  +     + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 202 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 232
            Y  PE++  +      +     D++S G +L E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (289), Expect = 1e-29
 Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 95
              VG G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 153
              S     +L+L  +  Y    +++  ++         + +         I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI------VLSIASGLAHLH 122

Query: 154 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 201
             I        + HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 202 YYRAPELI-----FGATEYTAAIDIWSAGCVLAELL 232
            Y APE++         +    +DIW+ G VL E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  112 bits (282), Expect = 6e-29
 Identities = 28/211 (13%), Positives = 74/211 (35%), Gaps = 22/211 (10%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 93
              +     G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
                        +  L+  ++P  +++ V+  H   +  +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 153 HN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           H     +    +  ++++++      ++                  + +  + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQK 182

Query: 212 --ATEYTAAIDIWSAGCVLAELLLGQPLFPG 240
                   + D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (281), Expect = 3e-28
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 95
           +  +G G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 96  CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 153
                    +L+L  V +Y    ++   +  +   +   + L             LA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156

Query: 154 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 201
             I        + HRD+K +N+LV  +     + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 202 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 232
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  109 bits (275), Expect = 9e-28
 Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 26/224 (11%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 93
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 94  KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F   +   +L +  V ++    +++  +        +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 209
           H    + HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 H-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 210 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 251
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (273), Expect = 2e-27
 Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 39/255 (15%)

Query: 34  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 90
           ++      V   G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 91  VS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICR 147
           +  +      T+   +L+L  +  +  + ++   +K +    ++   +         + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132

Query: 148 ALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
            LAY+H  I          + HRDIK +N+L+  +     + DFG A      E   S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAG 188

Query: 199 CSRY------YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 248
            +        Y APE++ GA     +    ID+++ G VL EL        G      L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 249 EIIKVLGTPTREEIK 263
              ++   P+ E+++
Sbjct: 249 FEEEIGQHPSLEDMQ 263

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  107 bits (268), Expect = 1e-26
 Identities = 41/228 (17%), Positives = 85/228 (37%), Gaps = 47/228 (20%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 93
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 94  K-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI---KHHYKMSQRMPLIYVKLYFYQICRA 148
              C         L   ++       T++ V+   K    +++   +        +I + 
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIA------QEIVKG 142

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------ 202
           + Y+H   G+ H+D+K +N+  +     + + DFG     + G         +       
Sbjct: 143 MGYLH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFS--ISGVLQAGRREDKLRIQNGW 197

Query: 203 --YRAPELIFGATE--------YTAAIDIWSAGCVLAELLLGQPLFPG 240
             + APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (259), Expect = 3e-25
 Identities = 53/253 (20%), Positives = 98/253 (38%), Gaps = 37/253 (14%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 96
             ++G G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 97  FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 155
               T    +   LV+EY P  ++ + +  H         +      + + R LAY+H  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130

Query: 156 I--------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY----- 202
           +         + HRD+  +N+LV        + DFG +  L                   
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 203 ----YRAPELIFGA------TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVD-QLVEI 250
               Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 251 IKVLGTPTREEIK 263
            +V   PT E+++
Sbjct: 250 TEVGNHPTFEDMQ 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 37/313 (11%), Positives = 69/313 (22%), Gaps = 76/313 (24%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNR---ELQTMRLLDHPN 89
           Y      G       +QA        VA+  V                    +  +D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V  +              L +V E++   ++  V             +        +  A
Sbjct: 93  VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
               H   GV      P  + V+     + L                             
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
                      DI   G  L  LL+ +   P       L    +        E   ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
                                +P +   + +R +Q    +RS +         + ++   
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSASTLL------NLMQQAT 264

Query: 329 TRLPNGRFLPPLF 341
                   L P+ 
Sbjct: 265 AVADRTEVLGPID 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
             L            +   L+ + +P    +  V +H       +   Y+  +  QI + 
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKG 129

Query: 149 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 204
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 205 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)

Query: 40  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            + +G G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V  K             L L++EY+P       + KH  ++     L Y      QIC+ 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKG 126

Query: 149 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 204
           + Y+     I   HRD+  +N+LV  + +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 205 ----------APELIFGATEYTAAIDIWSAGCVLAELL 232
                     APE +   ++++ A D+WS G VL EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)

Query: 40  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            R +G G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +  K C     +     L LV+EYVP      ++  Y     + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLR-DYLPRHSIGLAQLLLFAQQICEGMA 148

Query: 151 YIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 204
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 205 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 250
                   APE +     +  A D+WS G  L ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 49/233 (21%), Positives = 88/233 (37%), Gaps = 40/233 (17%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
            R++G G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 91  VSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQIC 146
             L      S  +       ++L ++    +H  +           L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 204
             + Y+ ++    HRD+  +N ++      + + DFG ++ +  G+         YYR  
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 205 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                     A E L      YT   D+W+ G  + E++  GQ  + G    +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 44/217 (20%)

Query: 40  ERVVGHGSFGVVFQAKCL----ETGEAVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 91
            + +G G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
             K             L L++EY+P       + KH  ++     L Y      QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKGM 158

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 205 ---------APELIFGATEYTAAIDIWSAGCVLAELL 232
                    APE +   ++++ A D+WS G VL EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 40  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            R +G G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V  K      TE     + L++E++P  ++   +  +     ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGM 139

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 205 ---------APELIFGATEYTAAIDIWSAGCVLAELL 232
                    APE +  +  +  A D+WS G  L ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 43/234 (18%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
            +++G G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQICR 147
           + L       + +      ++L ++    +H  + +    +    +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 148 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
            + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         YYR 
Sbjct: 159 GMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYRQ 205

Query: 205 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                      A E L      YT+  D+W+ G  + E+   G   +PG    +
Sbjct: 206 GRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.1 bits (211), Expect = 9e-19
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 46/218 (21%)

Query: 40  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
              +G G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           V  +   +    +  L   LV+EY+P       + +H  ++     L+Y      QIC+ 
Sbjct: 87  VKYRGVSYGPGRQS-LR--LVMEYLPSGCLRDFLQRHRARLDASRLLLYS----SQICKG 139

Query: 149 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 204
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   +         YY   
Sbjct: 140 MEYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVR 187

Query: 205 ----------APELIFGATEYTAAIDIWSAGCVLAELL 232
                     APE +     ++   D+WS G VL EL 
Sbjct: 188 EPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 55/224 (24%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 94
           + ++GHG FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 95  HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMS--QRMPLIYVKLYFYQIC- 146
            C     E++E+ L  + +Y+        ++        MS  QR+          +IC 
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICI 146

Query: 147 ---RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 202
              R L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +   
Sbjct: 147 GAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVK 202

Query: 203 ----YRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQP 236
               Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 203 GTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 152
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 206
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
           E +     ++   D+W+ G +L E+   G   +PG     
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 45/228 (19%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 94
              +G G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 95  H--CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 151
              C    T+K  +Y  +V+E V            +       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------- 204
           + +     HRD+  +N LV    + LK+ DFG ++    G          Y         
Sbjct: 229 LES-KCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 205 -----APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                APE L +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 47/232 (20%)

Query: 38  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 89
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +V +        E +     LV+E         +  + + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 205 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                    APE + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 45/235 (19%), Positives = 78/235 (33%), Gaps = 50/235 (21%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN----RELQTMRLLDHP 88
              +G G+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 89  NVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQIC 146
           ++V     C       DE    LV E+V       +  + K ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 147 RALAYI--HNTIGVCHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNISY 197
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 198 ICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                 +       PE I        A D WS G  L E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 81.5 bits (202), Expect = 8e-18
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 152
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 206
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 207 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
           E L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 82.6 bits (203), Expect = 8e-18
 Identities = 50/330 (15%), Positives = 90/330 (27%), Gaps = 74/330 (22%)

Query: 43  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRE--------------------LQT 81
           +G G FG VFQ         VAIK + ++     N                      L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY---------------------VPETVH 120
                    + L            L L     Y                     V E   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 121 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 180
             I      ++   L   K   +Q+  +LA    ++   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 181 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 240
              + K                     L     +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 241 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIFQ--KRMP 291
           +   D   +I +++           +P       +Y   K  +             K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 292 PEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            +  +    +L +     S+A + L     
Sbjct: 310 RKIQEFHRTMLNF-----SSATDLLCQHSL 334

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 48/236 (20%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
             L            +   L+ + +P   +   ++ H      +   Y+  +  QI + +
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y    
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178

Query: 205 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
                   A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 37/220 (16%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 97
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 153
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 207
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 208 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
            L     +++   D+WS G +L E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 31/224 (13%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYIHN 154
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 208
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 299 -MNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352

Query: 209 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
                 +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 152
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 206
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 37/215 (17%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 97
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 153
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 207
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 208 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
            L     +++   D+WS G +L E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 38/231 (16%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
            +V+G G FG V +   +  GE+    V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V L            L   LV +Y+P  ++   ++ H      +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +     +   
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 205 ---APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
              A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 38  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V L        + + L   LV+E      +H+ +       + +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGM 449

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 205 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 56/252 (22%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 88
            + +G G+FG V +A        +    VA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPL 135
           N+V+L       T        ++ EY                 +             + L
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 136 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
               L    YQ+ + +A++  +    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 194 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                    Y             APE IF    YT   D+WS G  L EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 241 ESGVDQLVEIIK 252
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           E+ +G G FG V+ A   +  + VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 152
             +   K+ +Y  ++ E++       +    K  +       KL  +  QI   +A+I  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 204
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 205 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
              APE + FG   +T   D+WS G +L E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 38  MAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V L        + + L   LV+E      +H+ +    +      +       +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAE---LLHQVSMGM 123

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 205 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 49/242 (20%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTM 82
           P + +   ++RV+G G FGVV+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 83  RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 142
           R L+HPNV++L         +   +  ++L Y+    H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC---HGDLLQFIRSPQRNPTVKDLISF 129

Query: 143 -YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 199
             Q+ R + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E       
Sbjct: 130 GLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------- 178

Query: 200 SRYYR--------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 243
             YY               A E L      +T   D+WS G +L ELL  G P +     
Sbjct: 179 --YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

Query: 244 VD 245
            D
Sbjct: 235 FD 236

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 51/229 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 95
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 96  CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           C     E+  +   LV E++         R  +  +       L+        +C  +AY
Sbjct: 72  C----LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAET---LLG---MCLDVCEGMAY 119

Query: 152 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 204
           +     I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y       
Sbjct: 120 LEEACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTK 166

Query: 205 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                 +PE   F    Y++  D+WS G ++ E+   G+  +   S  +
Sbjct: 167 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 78.4 bits (194), Expect = 8e-17
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 51/229 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 95
            + +G G FGVV   K     + VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 96  CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           C    +++  +Y  +V EY+         R      + SQ   L+      Y +C  +A+
Sbjct: 72  C----SKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQ---LLE---MCYDVCEGMAF 119

Query: 152 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 204
           +  H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y       
Sbjct: 120 LESHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTK 166

Query: 205 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                 APE   +   +Y++  D+W+ G ++ E+  LG+  +   +  +
Sbjct: 167 FPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.8 bits (195), Expect = 8e-17
 Identities = 56/261 (21%), Positives = 102/261 (39%), Gaps = 63/261 (24%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQT 81
            ++ I     R +G G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 82  MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMS 130
           +  L H ++V          + D L   +V EY+                 ++       
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 131 QRMPLIYVKLYF--YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 186
            +  L   ++     QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181

Query: 187 VLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL- 232
            +   +         YYR             PE +++   ++T   D+WS G +L E+  
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230

Query: 233 LG-QPLFPGESGVDQLVEIIK 252
            G QP +   S   +++E I 
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 52/243 (21%), Positives = 95/243 (39%), Gaps = 50/243 (20%)

Query: 41  RVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 90
           R +G GSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFY 143
           V L       ++       +++E +            R    +  +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 203
           +I   +AY+ N     HRD+  +N +V      +K+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYL-NANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 204 R------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 249
           R            +PE L  G   +T   D+WS G VL E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 250 IIK 252
            + 
Sbjct: 252 FVM 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 53/249 (21%)

Query: 41  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 89
           + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPLI 136
           VV+L      T     L   +++E+               E V   +         + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 137 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
           ++  Y +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 197 YICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 243
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 244 VDQLVEIIK 252
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
              +G G FG V+        + VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 152
            ++   ++ +Y  ++ EY+    +  +    K    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 204
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 205 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 249
              APE + +G   +T   D+WS G +L E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
            R++G G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            L        E++  +  +++E  P           K+  K+     L+    Y  QIC+
Sbjct: 77  KL----IGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLT---LVL---YSLQICK 124

Query: 148 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
           A+AY+   N +   HRDI  +N+LV      +KL DFG ++ +   +         YY+ 
Sbjct: 125 AMAYLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKA 171

Query: 205 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                     +PE + F    +T A D+W     + E+L  G+  F      D
Sbjct: 172 SVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 55/236 (23%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 91
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 145
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
            + + Y+ +     HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 138 AKGMKYLAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 205 -------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                        A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 56/239 (23%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            L         ++ ++  +++E        +  +V K    ++    LI    Y YQ+  
Sbjct: 455 KL----IGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLAS---LIL---YAYQLST 502

Query: 148 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 503 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 549

Query: 205 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 249
                     APE + F    +T+A D+W  G  + E+L  G   F G     V   +E
Sbjct: 550 SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKN-------RELQTMRLLDHPN 89
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           ++ L    +       +   +V E  P    + R+ KH         L  +  Y  Q+  
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAE 132

Query: 148 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
            + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y  
Sbjct: 133 GMGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVM 180

Query: 205 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 249
                      APE L      ++ A D W  G  L E+   GQ  + G +G      ++
Sbjct: 181 QEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
            L         ++ ++  +++E        +  +V K+   ++    LI    Y YQ+  
Sbjct: 80  KL----IGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLAS---LIL---YAYQLST 127

Query: 148 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 128 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 174

Query: 205 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                     APE + F    +T+A D+W  G  + E+L  G   F G    D
Sbjct: 175 SKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 92  SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L+       T+   +   +V EY+   ++   ++ H      + L+        I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGM 160

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 204
            Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL              Y      
Sbjct: 161 KYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211

Query: 205 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                 +PE + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 212 IPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 55/249 (22%), Positives = 96/249 (38%), Gaps = 56/249 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQTMRLLDHPNV 90
           +  +G G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQRMPLIYVKL 140
           V         TE   L   +V EY+                 +    +     PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 141 YF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
                Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 199 CSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGESG 243
              YYR             PE +++   ++T   D+WS G VL E+   G QP +   S 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265

Query: 244 VDQLVEIIK 252
             + ++ I 
Sbjct: 266 NTEAIDCIT 274

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 49/232 (21%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 91
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 92  SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            L+       T        +V EY+   ++   ++ H      M L+        +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGM 164

Query: 150 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 204
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 205 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                    APE + F    +++A D+WS G V+ E+L  G+  +   +  D
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.1 bits (188), Expect = 8e-16
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 95
            + +G G FGVV   K     + VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 96  CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           C    T++  ++  ++ EY+         R ++H ++  Q   L+        +C A+ Y
Sbjct: 88  C----TKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQ---LLE---MCKDVCEAMEY 135

Query: 152 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 204
           +     +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y       
Sbjct: 136 LESKQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSK 182

Query: 205 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                  PE L++   ++++  DIW+ G ++ E+  LG+  +   +  +
Sbjct: 183 FPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 47/223 (21%), Positives = 87/223 (39%), Gaps = 43/223 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 93
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            +       ++ L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH
Sbjct: 72  YYFG-----QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 154 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 204
               + +RDIKP N L+    + + + + + DFG  K          Y          YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173

Query: 205 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 235
             + + G   Y  +I            D+ + G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 50/222 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 94
           + ++G G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 95  -HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKM--SQRMPLIYVKLYFYQIC 146
             C        E  L  V  Y+        +    +    +   +R           +I 
Sbjct: 94  GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIA 137

Query: 147 ----RALAYIHNTIGVC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 200
               R LAY+H+       HRD+K  N+L++    +  + DFG AK++   +   +++ +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTT 193

Query: 201 RY-----YRAPE-LIFG-ATEYTAAIDIWSAGCVLAELLLGQ 235
                  + APE L  G ++E T   D++  G +L EL+ GQ
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 91
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 145
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 204
            + + ++  +    HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 202 AKGMKFL-ASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 205 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                     A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 68/268 (25%)

Query: 31  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 80
           P+  I Y+  R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-------------------ETVHR 121
            M   D+PN+V L            + L  + EY+                         
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 122 VIKHHYKMSQRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 179
             +         PL   +      Q+   +AY+ +     HRD+  +N LV  +   +K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 180 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGC 226
            DFG ++ +   +         YY+             PE + +    YT   D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 227 VLAELL-LG-QPLFPGESGVDQLVEIIK 252
           VL E+   G QP + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 64/258 (24%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 89
            + +G G FG V +A             VA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVK--- 139
           V+ L       ++   L   L++EY             R +   Y  S            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 140 ----------LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
                     + F +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 189 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG- 234
            + +          Y             A E +F    YT   D+WS G +L E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 235 QPLFPGESGVDQLVEIIK 252
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 89
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 143
           +V        + +    +  +++E +      +  R  +   + SQ   L  + L     
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 147

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 201
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 148 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 202 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 247
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 248 VEIIK 252
           +E + 
Sbjct: 255 LEFVT 259

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 89
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 143
           +V        + +    +  ++LE +      +  R  +   + SQ   L  + L     
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 188

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 201
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 189 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 202 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 247
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 248 VEIIK 252
           +E + 
Sbjct: 296 LEFVT 300

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 48/232 (20%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 90
           ++V+G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 91  VSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 148
           + L+       ++   +   ++ EY+    +  +    +       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 149 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 204
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL              Y   
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTS 208

Query: 205 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
                    APE + +    +T+A D+WS G V+ E++  G+  +   S  +
Sbjct: 209 GGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 45/223 (20%), Positives = 81/223 (36%), Gaps = 43/223 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 93
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            +           Y  +VLE +  ++  +        +   L  V +   Q+   + Y+H
Sbjct: 71  YYFG-----PCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 154 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 204
           +   + +RD+KP+N L+    N     + + DF  AK          YI         YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 205 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 235
             + + G   Y  +I            D+ + G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.8 bits (182), Expect = 5e-15
 Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 58/251 (23%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 89
              +G   FG V++         E  +AVAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYV 138
           VV L       T+   L   ++  Y                  V       + +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 139 KLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
                  QI   + Y+ ++  V H+D+  +N+LV      +K+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 197 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGE 241
                YY+            APE +++G  +++   DIWS G VL E+   G QP + G 
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGY 234

Query: 242 SGVDQLVEIIK 252
           S    +VE+I+
Sbjct: 235 S-NQDVVEMIR 244

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 93
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           + C       +  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH
Sbjct: 71  RWCG-----AEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 154 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 206
           +     HRD+KP N L+      + + + DFG AK          Y  +R      YR  
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172

Query: 207 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 235
           + + G   Y A+I            D+ S G VL    LG 
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 63/258 (24%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 88
            +V+G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP-----------------ETVHRVIKHHYKMSQ 131
           N+V+L       T    +YL  + EY                   + +    +   +  +
Sbjct: 110 NIVNLLGA---CTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 132 RMPLIYVK--LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
            + ++  +  L F YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 189 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLG 234
           +             Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 235 QPLFPGESGVDQLVEIIK 252
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 54/249 (21%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTM-RLLDHP 88
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP---------ETVHRVIKHHYKMSQRMPLIYVK 139
           N+V+L       T    +   ++ EY                +                 
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 140 L-YF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 197
           L +F  Q+ + +A++  +    HRD+  +N+L+    H  K+ DFG A+ ++        
Sbjct: 166 LLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS----- 218

Query: 198 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGESG 243
                Y             APE IF    YT   D+WS G +L E+  LG  P +PG   
Sbjct: 219 ----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272

Query: 244 VDQLVEIIK 252
             +  +++K
Sbjct: 273 NSKFYKLVK 281

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 57/252 (22%)

Query: 40  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 86
            + +G G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPL 135
           H N+++L       T+   LY  +++EY                     ++   +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 136 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
               L    YQ+ R + Y+  +    HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 194 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                   YY+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 241 ESGVDQLVEIIK 252
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 93
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +         +  Y  LV++ +  ++  +       S+++ L  V +   Q+   + ++H
Sbjct: 69  RWFG-----VEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 154 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 206
           +     HRDIKP N L+      +Q+ + DFG AK          Y  +       YR  
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170

Query: 207 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 235
           + + G   Y A++            D+ S G VL   L G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 40  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 86
            + +G G FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRM 133
           H N+++L       T+   LY  +++EY              P  +      +    ++M
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
               +    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 194 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 241 ESGVDQLVEIIK 252
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 57/252 (22%)

Query: 40  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 86
            + +G G+FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-----------TVHRVIKHHYKMSQRMPL 135
           H N+++L       T+   LY  +++EY  +                  +         +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 136 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
            +  L    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 194 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 241 ESGVDQLVEIIK 252
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 40/250 (16%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 16  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK 75
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 76  N---RELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVPET 118
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 119 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQL 177
           + ++   +    +      V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKISGQNGTFKKST----VLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 178 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWSAG 225
            L D+G +        +  Y         +   G  E+  ++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 226 CVLAELLLGQ 235
             +   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 46/218 (21%)

Query: 42  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 93
            +G G FGVV++   +     VA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 94  K-HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----R 147
                   ++ D+L L  V  Y+P  ++         +    PL +      +I      
Sbjct: 96  LGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRC--KIAQGAAN 144

Query: 148 ALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 201
            + ++H      HRDIK  N+L+           K+ DFG A+   K     + + SR  
Sbjct: 145 GINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIV 196

Query: 202 --Y-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 236
               Y APE + G  E T   DI+S G VL E++ G P
Sbjct: 197 GTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 60/238 (25%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEA--VAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 91
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYVKL 140
           +L         +  LYL   +EY P             +          S    L   +L
Sbjct: 90  NLLGA---CEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 141 -YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 196
            +F   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 197 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 240
                 Y             A E L +    YT   D+WS G +L E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 38/252 (15%), Positives = 80/252 (31%), Gaps = 50/252 (19%)

Query: 16  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG--------EAVAIKK 67
            G ++    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 68  VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTEKDELYLNLVLEYVP 116
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 117 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 175
            ++   +    K    +    V     ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198

Query: 176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 223
           Q+ L  +G A        +++Y             G  E+  ++            D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253

Query: 224 AGCVLAELLLGQ 235
            G  + + L G 
Sbjct: 254 LGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 43/252 (17%), Positives = 77/252 (30%), Gaps = 50/252 (19%)

Query: 16  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQ 70
            G II                +     +G G FG ++ A     + + +     +K    
Sbjct: 25  VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75

Query: 71  DKRYKNRELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVP 116
           D      EL+  +    P  +                        +  + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 117 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 175
             + ++ + + K   R     V     +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 223
           Q+ L D+G A        + +Y             G  E+  +I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 224 AGCVLAELLLGQ 235
            G  + + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 25/123 (20%)

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 202
           +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K            
Sbjct: 200 FQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP---------D 248

Query: 203 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 249
           Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++   
Sbjct: 249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 250 IIK 252
            +K
Sbjct: 308 RLK 310

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 27/147 (18%), Positives = 52/147 (35%), Gaps = 23/147 (15%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HP 88
            + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           NVV+L      T     L   +++E+        +  +   S+R   +  K    +  + 
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEFCK---FGNLSTYL-RSKRNEFVPYKTKGARFRQG 138

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTH 175
             Y+         D+K +   +     
Sbjct: 139 KDYVGA----IPVDLKRRLDSITSSQS 161

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 52/388 (13%), Positives = 97/388 (25%), Gaps = 130/388 (33%)

Query: 66  KKVLQDKRYK------NRELQTMRLLD-------------------------------HP 88
           K +L  +         +    T+RL                                   
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM----PLIYVKLY--- 141
              S+    +   ++D LY N    +    V R ++ + K+ Q +    P   V +    
Sbjct: 103 RQPSMMTRMYI-EQRDRLY-NDNQVFAKYNVSR-LQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 142 -------FYQICRALAYIHN--------TIGVCHRD---IKPQNLLVNPHTHQLKLCDFG 183
                     +C +               +  C+     ++    L+    +Q+   ++ 
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQID-PNWT 214

Query: 184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI----DIWSAGCVLAELLLGQPLFP 239
           S         NI             +  +  Y   +    ++ +A    A        F 
Sbjct: 215 S---RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FN 263

Query: 240 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLV 298
                       K+L T TR          T+F       H         + P E   L+
Sbjct: 264 LSC---------KILLT-TR------FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 299 SRLLQYSPN-LRSTALEALIHPFF-----DELRDPNTRLPNGRFLPP----------LFN 342
            + L   P  L    L    +P       + +RD      N + +            L  
Sbjct: 308 LKYLDCRPQDLPREVLT--TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 343 FKPHELKGV-------PVDMLVKLIPEH 363
            +P E + +       P       IP  
Sbjct: 366 LEPAEYRKMFDRLSVFPPS--AH-IPTI 390

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 7e-04
 Identities = 24/139 (17%), Positives = 44/139 (31%), Gaps = 30/139 (21%)

Query: 78  ELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-- 132
           +L    L++     + +S+   +     K E    L         HR I  HY + +   
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL---------HRSIVDHYNIPKTFD 460

Query: 133 ---MPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
              +   Y+  YFY     + + H   I    R    + + ++    + K+    +A   
Sbjct: 461 SDDLIPPYLDQYFYSH---IGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516

Query: 189 VKGEPNI--------SYIC 199
                N          YIC
Sbjct: 517 SGSILNTLQQLKFYKPYIC 535

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	373
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.46
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.33
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.14
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.98
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.5
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.36
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.31
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.29
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.1
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.18
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.4

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-64  Score=449.97  Aligned_cols=250  Identities=30%  Similarity=0.467  Sum_probs=204.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|.+.+..       ....+|+++++.++||||+++++++     .+..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence            468999999999999999999999999999999986432       2345899999999999999999998     4455


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+|||||+|+|.+.+.+.    .++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            68999999999999888753    6799999999999999999999998 999999999999999988 79999999998


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .........+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+..            
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------  228 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------  228 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence            76655555678999999999999877656789999999999999999999999988777776665521            


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                           ..            ++..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus       229 -----~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -----YT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -----CC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -----CC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                 01            23468999999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-64  Score=454.23  Aligned_cols=254  Identities=32%  Similarity=0.545  Sum_probs=222.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+..       ....+|+++++.++|||||+++++|     ++..
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            457999999999999999999999999999999986431       2345899999999999999999998     5556


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|||||||+| +|.+.+.+.    +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g-~vKl~DFGla  179 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTA  179 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence            68999999995 899988764    6799999999999999999999998 999999999999999988 7999999999


Q ss_pred             eeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          186 KVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       186 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +......   ...+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.+|.+.         
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------  249 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------  249 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence            8764332   23467899999999999765 4899999999999999999999999999988888887763         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCccccCCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE------ALIHPFFDELRDPN  328 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~------ll~hp~~~~~~~~~  328 (373)
                              .+.            ++..+|+++++||.+||+.||++|||++|      +++||||++++|..
T Consensus       250 --------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          250 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             --------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             --------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence                    111            23568999999999999999999999988      58999999998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-63  Score=463.97  Aligned_cols=318  Identities=34%  Similarity=0.613  Sum_probs=251.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecC-CCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~  106 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++|||||++++++.... ..+..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999999999999999986443      22347999999999999999999875432 13445


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|||||||+|+|.+.+..    .+++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus       133 ~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCC-CEEEeecceee
Confidence            6899999999998888864    46799999999999999999999998 999999999999999988 89999999997


Q ss_pred             eccCC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      .....     ....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..|....+.++...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65332     2234678999999999998777789999999999999999999999999999999999999999988765


Q ss_pred             HhhcCcCcc---cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCC
Q 017341          262 IKCMNPNYT---EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLP  338 (373)
Q Consensus       262 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~  338 (373)
                      +........   ...++.....+|...+ +.+++++++||.+||++||.+|||++|+|+||||+...++.....    ..
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~----~~  361 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD----CA  361 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC----CS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC----CC
Confidence            433221110   0123333334444444 568999999999999999999999999999999999877653321    22


Q ss_pred             CCCCCChhhcCCCCHHHHhhhchHH
Q 017341          339 PLFNFKPHELKGVPVDMLVKLIPEH  363 (373)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~  363 (373)
                      +.+++. .+....+.+.+++++.++
T Consensus       362 ~~~~~~-~~~~~~~~~~~k~~i~~e  385 (398)
T 4b99_A          362 PPFDFA-FDREALTRERIKEAIVAE  385 (398)
T ss_dssp             SCCCCH-HHHSCCCHHHHHHHHHHH
T ss_pred             CCCCCc-cchhhcCHHHHHHHHHHH
Confidence            223332 233445666666665544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.3e-63  Score=451.39  Aligned_cols=253  Identities=29%  Similarity=0.427  Sum_probs=217.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+++.++|||||+++++|.     +..++||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            4699999999999999999999999999999998543    234568999999999999999999984     3445899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |||||+| +|.+++.+     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999995 78877754     4699999999999999999999998 999999999999999998 79999999998765


Q ss_pred             CC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+........          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  290 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  290 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            44 334567899999999999654 589999999999999999999999999988887777765211000          


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                      .....+|+++++||.+||+.||++|||++|+|+||||+....
T Consensus       291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                            011468999999999999999999999999999999987544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.9e-63  Score=444.58  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=212.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||+||+|++.   .+++.||+|.+.+..      ....+|+++++.++|||||++++++     .+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~   97 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QT   97 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EE
Confidence            468999999999999999999974   468899999985432      2345799999999999999999998     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|||||||+ |+|.+.+.+.    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFG  171 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFG  171 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTS-CEEEESSE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCC-CEEecccc
Confidence            456899999999 5898888764    6799999999999999999999998 999999999999999998 79999999


Q ss_pred             ceeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+.+|.+..        
T Consensus       172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------  242 (304)
T 3ubd_A          172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------  242 (304)
T ss_dssp             EEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--------
Confidence            99865433 334567899999999999765 58999999999999999999999999999888888876521        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                               ..            ++..+|+++++||.+||+.||++|||     ++|+++||||+++++.
T Consensus       243 ---------~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          243 ---------LG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             ---------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------CC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence                     11            23568999999999999999999998     5899999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.9e-63  Score=451.78  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=211.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++....      ....+|+++++.++|||||++++++     .+...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence            468999999999999999999999999999999986542      2345899999999999999999998     44456


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|||||||+ |+|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-CEEEcccccce
Confidence            899999998 59999887542  35679999999999999999999998 999999999999999988 79999999998


Q ss_pred             eccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....... ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.+...          
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------  242 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----------  242 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----------
T ss_pred             eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------
Confidence            6543221 2356799999999999764 589999999999999999999999999998888888776310          


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                               +         ..+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       243 ---------~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          243 ---------P---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ---------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ---------C---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                     0         012468999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-61  Score=453.11  Aligned_cols=253  Identities=29%  Similarity=0.428  Sum_probs=218.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|..     ..++||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998543    2345689999999999999999999843     445899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |||||+| +|.+++..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+| .+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999995 78887753     5699999999999999999999998 999999999999999998 79999999998765


Q ss_pred             CC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|.......           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  366 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  366 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence            44 334567899999999999654 58999999999999999999999999998888877776521100           


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                     ......+|+++++||.+||+.||.+|||++|+|+||||+....
T Consensus       367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence                           0012468999999999999999999999999999999998543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3e-61  Score=431.35  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=208.9

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      |++.+.||+|+||.||+|.+..++..||+|++....      ....+|+++++.++|||||+++++|.... .+..++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            478889999999999999999999999999986432      23458999999999999999999885432 34566899


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcC-CCCceeEeecccee
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNP-HTHQLKLCDFGSAK  186 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~-~~~~ikl~Dfg~a~  186 (373)
                      |||||+ |+|.+.+.+.    ..+++..++.++.||+.||+|||++ |  |+||||||+|||++. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            999999 5899888764    6799999999999999999999988 8  999999999999985 55 89999999997


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .. ......+.+||+.|||||++.+  .|+.++|||||||++|+|+||++||.+.+....+.+.+.....          
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----------  247 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------  247 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----------
Confidence            53 3334456789999999999854  4899999999999999999999999887665554443321000          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                      ...++...++++++||.+||+.||++|||++|+|+||||++
T Consensus       248 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 ----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            01123567899999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-61  Score=440.77  Aligned_cols=256  Identities=26%  Similarity=0.393  Sum_probs=216.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEe
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  113 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  113 (373)
                      ...|++.++||+|+||.||+|+++.+|+.||||++..+. ...+|+.+++.++|||||++++++     .+..++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEEe
Confidence            457999999999999999999999999999999987643 345899999999999999999998     34456899999


Q ss_pred             ccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC
Q 017341          114 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  192 (373)
Q Consensus       114 ~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~  192 (373)
                      ||+ |+|.+++.+.    +++++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999 5999988764    6799999999999999999999998 999999999999999887569999999998764332


Q ss_pred             C------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          193 P------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       193 ~------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .      ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+...+|....  +.        
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~--------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP--------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG--------
T ss_pred             cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC--------
Confidence            1      1235799999999999765 58999999999999999999999999888777776665521  00        


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH-------------hcCCCccccCCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-------------LIHPFFDELRDP  327 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l-------------l~hp~~~~~~~~  327 (373)
                                      ...+++.+|+++.+||.+||+.||.+|||+.|+             |+|||+.+.+.|
T Consensus       275 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          275 ----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             ----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             ----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence                            011335789999999999999999999999997             689999887665

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-60  Score=447.49  Aligned_cols=333  Identities=50%  Similarity=0.982  Sum_probs=287.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCC---------
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---------  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---------  102 (373)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|++..+.....+|+.+++.++||||+++++++.....         
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            44568999999999999999999999999999999998877777899999999999999999999866433         


Q ss_pred             ------------------------CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCc
Q 017341          103 ------------------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV  158 (373)
Q Consensus       103 ------------------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~i  158 (373)
                                              .+..++++||||++++|.+.+.........+++..++.++.||+.||.|||++ ||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-cC
Confidence                                    34567899999999999999887766678899999999999999999999988 99


Q ss_pred             eeecCCCCcEEEcCCCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 017341          159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  238 (373)
Q Consensus       159 vH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf  238 (373)
                      +||||||+||+++.+.+.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            99999999999985444899999999987766666667789999999999977666899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          239 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       239 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+.+..+.+.++.+..+.++.+.+..+++.+....++......|...++...++++.+||.+||+.||.+|||+.|+|+|
T Consensus       243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            99999999999999999999999999999999999999988999999999999999999999999999999999999999


Q ss_pred             CCccccCC-------CCCCCCCC--CCCCCCCCCChhhcCCCCHHHHhhhchHHHH
Q 017341          319 PFFDELRD-------PNTRLPNG--RFLPPLFNFKPHELKGVPVDMLVKLIPEHAR  365 (373)
Q Consensus       319 p~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (373)
                      |||+.+++       +....+++  ..+|++++|.+.+++.++.+...+++|.+..
T Consensus       323 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          323 PFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             GGGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            99998755       33344444  5578899999999998899999999988754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.3e-60  Score=444.35  Aligned_cols=346  Identities=65%  Similarity=1.117  Sum_probs=303.8

Q ss_pred             CCceEEecccCCCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecce
Q 017341           16 AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH   95 (373)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   95 (373)
                      ...+......+..|. ....+|++.+.||+|+||.||+|++..+++ +|+|++..+.....+|+++++.++||||+++++
T Consensus        22 ~~~~~~~~~~~~~~~-~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~   99 (394)
T 4e7w_A           22 NKVIKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA   99 (394)
T ss_dssp             CCCEEEEEEESSSCC-EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEE
T ss_pred             CceEEEEecCCCCCC-cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEE
Confidence            344444444555444 345789999999999999999999977766 899988877777779999999999999999999


Q ss_pred             eeeecCC-CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc-CC
Q 017341           96 CFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PH  173 (373)
Q Consensus        96 ~~~~~~~-~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~-~~  173 (373)
                      ++..... .+..++++||||+++++...+.........+++..++.++.||+.||.|||++ ||+||||||+||+++ .+
T Consensus       100 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~  178 (394)
T 4e7w_A          100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPS  178 (394)
T ss_dssp             EEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTT
T ss_pred             EEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCC
Confidence            9876554 56777899999999998888877666678899999999999999999999998 999999999999999 56


Q ss_pred             CCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017341          174 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  253 (373)
Q Consensus       174 ~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~  253 (373)
                      + .+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++.+.
T Consensus       179 ~-~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~  257 (394)
T 4e7w_A          179 G-VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV  257 (394)
T ss_dssp             T-EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             C-cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            6 899999999988766666667889999999999977667999999999999999999999999999999999999999


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCC
Q 017341          254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPN  333 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~  333 (373)
                      .+.+..+.+..+++.+....++.....++...+...+++++.+||.+||+.||.+|||+.|+++||||++++++....+.
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  337 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPN  337 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTT
T ss_pred             hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCC
Confidence            99999999999999998889999888888888888899999999999999999999999999999999999998888888


Q ss_pred             CCCCCCCCCCChhhcCCCCHHHHhhhchHHHHh
Q 017341          334 GRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  366 (373)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (373)
                      ....+++++|...++.. ..+++.++++.+.+.
T Consensus       338 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  369 (394)
T 4e7w_A          338 GRELPPLFNWTKEELSV-RPDLISRLVPQHAEA  369 (394)
T ss_dssp             SSCCCCSCCCCHHHHHT-CGGGHHHHSCGGGCS
T ss_pred             CCCCCCcCCCCHHHhhc-CHHHHHhhccHhhhh
Confidence            78889999999877665 447888888877643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-59  Score=445.53  Aligned_cols=332  Identities=70%  Similarity=1.166  Sum_probs=291.7

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCC-CCceeE
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  108 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  108 (373)
                      ......+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||++++++++.... .+..++
T Consensus        49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3345568999999999999999999999999999999998777777799999999999999999998865432 456778


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||||+++++.+.+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||+++..
T Consensus       129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            89999999998888887666668899999999999999999999998 99999999999999977657899999999877


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ..........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++++.++.+..+.+..+++.
T Consensus       208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~  287 (420)
T 1j1b_A          208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  287 (420)
T ss_dssp             CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred             ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            66665667789999999999977656899999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL  348 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (373)
                      +..+.++.....+|...+...+++++.+||.+||++||.+|||+.|+++||||++++++....+.....+..++|...++
T Consensus       288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (420)
T 1j1b_A          288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL  367 (420)
T ss_dssp             CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHH
T ss_pred             hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHh
Confidence            99999999988999988888999999999999999999999999999999999999888777777777788888887666


Q ss_pred             CCCCHHHHhhhchHH
Q 017341          349 KGVPVDMLVKLIPEH  363 (373)
Q Consensus       349 ~~~~~~~~~~~~~~~  363 (373)
                      .. .......+.+.+
T Consensus       368 ~~-~~~~~~~~~~~~  381 (420)
T 1j1b_A          368 SS-NPPLATILIPPH  381 (420)
T ss_dssp             TT-CGGGHHHHSCTT
T ss_pred             cc-ChhHHHhhCCHh
Confidence            54 333333333333

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-59  Score=433.87  Aligned_cols=282  Identities=28%  Similarity=0.483  Sum_probs=217.1

Q ss_pred             CccccceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEeccccc--chHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKR--YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  104 (373)
                      |...++|++.+.||+|+||+||+|+++   .+++.||+|.+.....  ...+|+++++.+ +||||++++++|     .+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EE
Confidence            455678999999999999999999875   4678999998865443  345899999988 699999999998     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..++|+|||||+ |+|.+.+       +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            456899999998 5787766       3489999999999999999999998 999999999999999874589999999


Q ss_pred             ceeeccCCC-----------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 017341          184 SAKVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  234 (373)
Q Consensus       184 ~a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG  234 (373)
                      +|+......                             ...+.+||+.|+|||++.+...|+.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997653321                             112457999999999998777799999999999999999999


Q ss_pred             CCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-------c--------------ccccCCCc----CCCCccccccC
Q 017341          235 QPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNPN-------Y--------------TEFKFPQI----KAHPWHKIFQK  288 (373)
Q Consensus       235 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~~  288 (373)
                      ++|| .+.++.+++..|.+..+.+...........       .              .....|..    ...........
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            9998 455677888888887775443322111000       0              00000000    00000111225


Q ss_pred             CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          289 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       289 ~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .+|++++|||++||++||++|+|++|+|+||||+++.
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            6899999999999999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-58  Score=451.71  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=214.7

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHH---HHHHHHhCCCCCeeecceeeee
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFS   99 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~   99 (373)
                      .+...++|++.++||+|+||.||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|  
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--  261 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--  261 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--
Confidence            4556789999999999999999999999999999999985432       11123   35666777999999999998  


Q ss_pred             cCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          100 TTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                         .+..++|||||||. |+|...+.+.    +.+++..++.+++||+.||.|||++ ||+||||||+|||++.+| .+|
T Consensus       262 ---~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G-~vK  332 (689)
T 3v5w_A          262 ---HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVR  332 (689)
T ss_dssp             ---ECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTS-CEE
T ss_pred             ---EECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCC-CEE
Confidence               55566999999999 5898888764    6799999999999999999999998 999999999999999998 799


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLG  255 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~---~~~i~~~~~  255 (373)
                      |+|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|+|++|++||.+.+..+.   ...+...  
T Consensus       333 L~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--  409 (689)
T 3v5w_A          333 ISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--  409 (689)
T ss_dssp             ECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--
T ss_pred             ecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--
Confidence            9999999876443 345679999999999996555699999999999999999999999987543222   2222221  


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                                     .            ..++..+|+++++||.+||+.||.+|++     ++|+++||||++++|.
T Consensus       410 ---------------~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          410 ---------------A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             ---------------C------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             ---------------C------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence                           0            0133578999999999999999999998     7999999999999874

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.2e-59  Score=418.68  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=195.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC-------
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-------  102 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------  102 (373)
                      .+|++.+.||+|+||.||+|+++.+|+.||+|++....     ....+|+++++.++|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999999999999999986433     234579999999999999999999865432       


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      ....++|+|||||. |+|.+.+..... ....+...++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCC-cEEEcc
Confidence            23456899999998 588888875422 12345667889999999999999998 999999999999999988 899999


Q ss_pred             ccceeeccCCCC-------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017341          182 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  248 (373)
Q Consensus       182 fg~a~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~  248 (373)
                      ||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987643321             1235799999999999764 59999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      .+........+..                         ....++.+.+||.+||+.||.+|||++|+|+||||++++++.
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            2222211111110                         023567889999999999999999999999999999987664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6e-57  Score=441.32  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=223.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|.+....    ....+|+++|+.++||||++++++|     .+..++|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            358999999999999999999999999999999986543    2345799999999999999999998     4556689


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-CCceeEeeccceee
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~ikl~Dfg~a~~  187 (373)
                      ||||||+| +|.+.+...   ...+++..++.+++||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999984 888877543   35699999999999999999999998 99999999999999865 23799999999998


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ..........+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|.+.......        
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  377 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  377 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS--------
T ss_pred             ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc--------
Confidence            7666556677899999999999765 5899999999999999999999999999988888877653211110        


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                       .....+|+++++||.+||+.||.+|||++|+|+||||+...++.
T Consensus       378 -----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          378 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                             11246899999999999999999999999999999999876653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.2e-56  Score=400.72  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=208.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|.+.+.||+|+||.||+|++.     .++..||||++....    +...+|+++++.++|||||++++++.     +
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----e
Confidence            357999999999999999999875     368899999986443    23458999999999999999999884     3


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHY---------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~---------~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                      ...+|||||||+ |+|.+++....         .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCC
Confidence            344889999999 69999997643         1235699999999999999999999998 999999999999999988


Q ss_pred             CceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017341          175 HQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  250 (373)
Q Consensus       175 ~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i  250 (373)
                       .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+....+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             8999999999765433322   234689999999999765 49999999999999999998 99999999888777776


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .+....                            ..+..+|+++.+||.+||+.||++|||++++  ++|++++.
T Consensus       244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            653110                            0225689999999999999999999999999  56787654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.8e-54  Score=400.08  Aligned_cols=316  Identities=48%  Similarity=0.913  Sum_probs=252.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHhCCCCCeeecceeeeecCC--CCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFSTTE--KDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++..+....   .++++.++.++||||+++++++.....  ....+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            3568999999999999999999999999999999886554333   356666778899999999999866443  44566


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH--ccCCceeecCCCCcEEEcC-CCCceeEeeccc
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--NTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGS  184 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--~~~~ivH~Dlkp~NIll~~-~~~~ikl~Dfg~  184 (373)
                      +++||||+++++...+.........+++..++.++.||+.||.|||  ++ ||+||||||+||+++. ++ .+||+|||+
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~  178 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADG-TLKLCDFGS  178 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTT-EEEECCCTT
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCC-cEEEeeCCC
Confidence            8899999999988888876666778999999999999999999999  88 9999999999999997 55 899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.+..+.+..+.+..
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            98776555556678899999999997666689999999999999999999999999999999999999999999998887


Q ss_pred             cCcCcccccCCCcCCCCccccccC---CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCC-CC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLP-PL  340 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~-~~  340 (373)
                      ..+.............+|...+..   ..++++.+||.+||+.||.+|||+.|+|+||||+++.++....+.....+ .+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~  338 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDL  338 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGG
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHH
Confidence            776665555555445555544432   36789999999999999999999999999999999988766555544333 44


Q ss_pred             CCCChhhcCC
Q 017341          341 FNFKPHELKG  350 (373)
Q Consensus       341 ~~~~~~~~~~  350 (373)
                      .++.+.+...
T Consensus       339 ~~~~~~~~~~  348 (360)
T 3e3p_A          339 FRFLPNEIEV  348 (360)
T ss_dssp             GCCCHHHHHH
T ss_pred             HHcCchHHHH
Confidence            4455444433

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-54  Score=395.46  Aligned_cols=249  Identities=22%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|.+.++||+|+||.||+|++.     .+++.||||++....    ..+.+|+++++.++|||||++++++.     +
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----E  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            357999999999999999999864     468899999986443    23458999999999999999999883     3


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  172 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~-----------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~  172 (373)
                      ...+|||||||+ |+|.+++.....           ...++++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECC
Confidence            445889999999 599998875431           234689999999999999999999998 9999999999999999


Q ss_pred             CCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 017341          173 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  248 (373)
Q Consensus       173 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~  248 (373)
                      ++ .+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+...
T Consensus       194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TT-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            88 899999999986543322   2345789999999999654 58999999999999999999 999999988887777


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+.+....                            ..+..+|+++.+|+.+||+.||++|||++|++++
T Consensus       272 ~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            66553110                            1225689999999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-53  Score=400.89  Aligned_cols=286  Identities=34%  Similarity=0.666  Sum_probs=224.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.+. ||||+++++++..   .+..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCCC
Confidence            468999999999999999999999999999999885432      22347999999997 9999999998854   3334


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+|||||+++|...+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAEC-HVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence            5889999999999888864     4689999999999999999999998 999999999999999988 89999999997


Q ss_pred             eccCC----------------------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 017341          187 VLVKG----------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  244 (373)
Q Consensus       187 ~~~~~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~  244 (373)
                      .....                      ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                      11234579999999999977667999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccC------CCcCCCCccccc------------cCCCChhHHHHHHhhcCcCC
Q 017341          245 DQLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSP  306 (373)
Q Consensus       245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP  306 (373)
                      +++..+...++.|..+.+......+.....      .......+...+            ...+++++.+||.+||++||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            999999999999998876544332211000      000000111111            12678999999999999999


Q ss_pred             CCCCCHHHHhcCCCccccCCCCC
Q 017341          307 NLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       307 ~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .+|||++|+|+||||+.+.+++.
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTCCGGG
T ss_pred             ccCCCHHHHhCCHHHHHhcCCcc
Confidence            99999999999999998877643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-53  Score=384.88  Aligned_cols=281  Identities=34%  Similarity=0.561  Sum_probs=228.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.     +...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            57999999999999999999999999999999986433      22347999999999999999999884     34458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||||+++++...+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            899999999888877654   36799999999999999999999998 999999999999999988 8999999999866


Q ss_pred             cCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            433 2234567899999999997766689999999999999999987655 77778888889999988888776544322


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      ........+............+.+++++.+||.+||+.||++|||++|+|+||||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            11111112222222222223356899999999999999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-53  Score=410.01  Aligned_cols=321  Identities=32%  Similarity=0.523  Sum_probs=236.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.....+....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999999999999999986432      23457999999999999999999886554444566


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+||||++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            899999999999888864    36799999999999999999999998 999999999999999988 899999999976


Q ss_pred             ccCCC----------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh------
Q 017341          188 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------  233 (373)
Q Consensus       188 ~~~~~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt------  233 (373)
                      .....                            .....+||+.|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            53221                            12345789999999987666679999999999999999998      


Q ss_pred             -----CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCcCCCCcccc
Q 017341          234 -----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKI  285 (373)
Q Consensus       234 -----G~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  285 (373)
                           |+++|.+.+                    ..+++..+.+.++.+..+.+.........   ..++......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 788887765                    35778889999999998876544321100   01222222333333


Q ss_pred             ccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhcCCCCHHHHhhhchHHHH
Q 017341          286 FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR  365 (373)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (373)
                      + +..++++.+||.+||.+||.+|||++|+|+||||++++++........  +....|  .+....+.+.+...+.++.+
T Consensus       366 ~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~--~~~~~~--~~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          366 F-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATE--KVRLPF--NDWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             S-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSS--CCCCSS--CTTSCCCHHHHHHHHHHHHT
T ss_pred             C-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCC--CCCCCc--cccccCCHHHHHHHHHHHHH
Confidence            3 467999999999999999999999999999999999987643322111  111112  23345666777776665544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-54  Score=411.38  Aligned_cols=286  Identities=31%  Similarity=0.553  Sum_probs=228.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... ++.
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3568999999999999999999999999999999986432      233479999999999999999998854332 234


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|+||||+++++.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~-~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCCC
T ss_pred             CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCC-CEEEEEEEee
Confidence            5678999999998877664      3589999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++.++.+.++.+..+.+...
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            876555555667899999999999765 5899999999999999999999999999999999999999999988776544


Q ss_pred             CcCcccc--cCCCcCCCCccccccCC-----------CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 NPNYTEF--KFPQIKAHPWHKIFQKR-----------MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      .+....+  ..+......+...++..           .++++.+||.+||++||.+|||++|+|+||||+.+.++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            3221111  11111111222222111           15679999999999999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-54  Score=388.71  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=197.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..++++.+.||+|+||+||+|++.   ..||||.+....      ..+.+|+.+++.++|||||++++++.    ++  .
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~----~~--~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT----KD--N  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----SS--S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----CC--e
Confidence            357899999999999999999864   359999875332      23457999999999999999998752    12  2


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|||||||+ |+|.+.+...   ..++++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            689999999 5898888643   36799999999999999999999998 999999999999999988 89999999997


Q ss_pred             eccCCC---CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ......   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+.......+......     
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-----  255 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-----  255 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-----
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-----
Confidence            653322   23356899999999999643  34899999999999999999999999988777666655542111     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                  .|..      ...+.++|+++.+||.+||+.||++|||+.|++++
T Consensus       256 ------------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          256 ------------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ------------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ------------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        1110      11235789999999999999999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-54  Score=391.82  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=205.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..++++.+.||+|+||.||+|...     .+++.||||.+....     ..+.+|+.+++.++|||||++++++.     
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----   99 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----   99 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----
Confidence            357899999999999999999853     467899999986432     23458999999999999999999883     


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      +...++||||||+ |+|.+++.....            ....+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl  178 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEE
Confidence            3334789999999 699999875421            134689999999999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  246 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~  246 (373)
                      +.++ .+||+|||+|+......   ......||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9988 89999999998654332   22346789999999999765 59999999999999999998 8999999888777


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ...+.+....+                            .+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       257 ~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66654321100                            225689999999999999999999999999865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-53  Score=388.58  Aligned_cols=283  Identities=35%  Similarity=0.661  Sum_probs=230.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|+||.||+|++. +|+.||+|++....      ....+|+.+++.++||||+++++++     .+.
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   91 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSE   91 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCS
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccC
Confidence            44679999999999999999999985 58999999986432      2235799999999999999999988     445


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .++++||||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        92 ~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a  166 (311)
T 3niz_A           92 RCLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLA  166 (311)
T ss_dssp             SCEEEEEECCSEEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCC-CEEEccCcCc
Confidence            568899999999988888754   35689999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +..... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+..
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            876433 2233457899999999997666689999999999999999999999999999999999999888877654433


Q ss_pred             cCc--CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          265 MNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ...  .+....+......++.. ..+.+++++.+||.+||++||.+|||++|+|+||||++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            221  11111122222223333 23568899999999999999999999999999999998753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1e-52  Score=400.35  Aligned_cols=321  Identities=30%  Similarity=0.501  Sum_probs=244.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            458999999999999999999999999999999986432      23458999999999999999999885543333356


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            889999999999888864    36699999999999999999999998 999999999999999988 899999999987


Q ss_pred             ccCCCC-----------------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-----------
Q 017341          188 LVKGEP-----------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-----------  233 (373)
Q Consensus       188 ~~~~~~-----------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-----------  233 (373)
                      ......                       ....+||+.|+|||++.....++.++|||||||++|+|++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            643321                       2456789999999997666679999999999999999998           


Q ss_pred             CCCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCcCCCCccccccCCCChh
Q 017341          234 GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPE  293 (373)
Q Consensus       234 G~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      |.++|.+.+                 ..+++..+...++.|..+.+.........   ...+.....++...+ +.++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence            556666654                 36788899999999998876554321100   011111222222223 468999


Q ss_pred             HHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhcCCCCHHHHhhhchHHHH
Q 017341          294 AVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR  365 (373)
Q Consensus       294 ~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (373)
                      +.+||.+||++||.+|||++|+|+||||++++++........  +....|.  +....+.+.+..++.++..
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~e~~  405 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTK--KIILPFD--DWMVLSETQLRYIFLKEVQ  405 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CC--CCCCSSC--TTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCC--CCCCChh--hcccCCHHHHHHHHHHHHH
Confidence            999999999999999999999999999999987654322111  1111122  2345667777776666554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-52  Score=385.30  Aligned_cols=257  Identities=27%  Similarity=0.441  Sum_probs=220.6

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+++++.++||||+++++++     ..
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~   85 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ET   85 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EE
Confidence            344678999999999999999999999999999999986542      2234799999999999999999988     34


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||++ ++|.+.+...    .++++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG  159 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADM-NIKIADFG  159 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCC-CEEEeecc
Confidence            455889999997 5888888764    6699999999999999999999998 999999999999999988 89999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....         
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  230 (328)
T 3fe3_A          160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------  230 (328)
T ss_dssp             CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             CceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence            99876555555667899999999999776645689999999999999999999999988777776665521         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                              +.            ++..+++++.+||.+||+.||.+|||++|+++||||+...+.
T Consensus       231 --------~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          231 --------YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             --------CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                    11            123578999999999999999999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-53  Score=388.33  Aligned_cols=288  Identities=33%  Similarity=0.628  Sum_probs=230.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....     ...+|+.+++.++||||+++++++.     +...++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence            579999999999999999999999999999998854322     2347999999999999999999883     344588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999999888764   35689999999999999999999998 999999999999999988 89999999997553


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc-
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  267 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  267 (373)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+..+.+....+..... 
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 223457899999999997766789999999999999999999999999999999999999988887765433211 


Q ss_pred             -CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCC
Q 017341          268 -NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPN  333 (373)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~  333 (373)
                       .+..+.++......... ....+++++.+||.+||+.||.+|||++|+|+||||.++.......+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence             11112222222222222 225689999999999999999999999999999999998765544444

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=393.47  Aligned_cols=255  Identities=28%  Similarity=0.469  Sum_probs=212.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence            34568999999999999999999999999999999986432       2234788899887 799999999988     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+|||||.| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g-~ikL~DF  168 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADF  168 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCC-CEEEccc
Confidence            45568999999985 888887654    6699999999999999999999998 999999999999999988 7999999


Q ss_pred             cceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+...++....       
T Consensus       169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  240 (353)
T 3txo_A          169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------  240 (353)
T ss_dssp             TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            99975432 2334466899999999999654 48999999999999999999999999998888888776521       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDELRDP  327 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~ll~hp~~~~~~~~  327 (373)
                                .            .++..+++++.+||++||+.||.+||++      +++++||||+++++.
T Consensus       241 ----------~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          241 ----------V------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             ----------C------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                      1            1224588999999999999999999999      899999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-52  Score=385.44  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=216.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|.+.+..       ....+|..+++.++||||+++++++     .+..
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            468999999999999999999999999999999986431       2345799999999999999999988     4445


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+|+||||++| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            68999999985 888777653    5789999999999999999999998 999999999999999988 7999999999


Q ss_pred             eeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+...           
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  220 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------  220 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence            76432 3334567899999999999654 5899999999999999999999999988877766666542           


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                            ...            ++..+++++.+||.+||+.||.+||     +++++++||||+.+++.
T Consensus       221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence                  011            2346899999999999999999999     99999999999987653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-52  Score=386.84  Aligned_cols=286  Identities=35%  Similarity=0.621  Sum_probs=229.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... .+..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999999999999999985432      223479999999999999999998854321 1224


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+||||++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCC-CEEEEeeeccc
Confidence            4689999998899888764     5689999999999999999999998 999999999999999988 89999999998


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.++.+.+....
T Consensus       177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            6532  23456789999999999775669999999999999999999999999999999999999999999887665433


Q ss_pred             cCccc---ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          267 PNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       267 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .....   ...+......+...+ ...++++.+||.+||+.||.+|||++++|+||||+.+.++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            21100   012233333343333 578999999999999999999999999999999999877643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.7e-52  Score=385.90  Aligned_cols=317  Identities=32%  Similarity=0.619  Sum_probs=248.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+++++.++||||+++++++..........+
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            458999999999999999999999999999999986432     233479999999999999999998865544445568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+||||++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus       106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCC-CEEEEeCcceEec
Confidence            89999999999888864     5699999999999999999999998 999999999999999988 7999999999865


Q ss_pred             cCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          189 VKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       189 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      .....    .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            43322    23457899999999987666689999999999999999999999999999999999999999998877654


Q ss_pred             cCcCc---ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCC
Q 017341          265 MNPNY---TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLF  341 (373)
Q Consensus       265 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~  341 (373)
                      .....   .....+.....++...+ +.+++++.+||.+||+.||.+|||++|+|+||||+...++....    .....+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~  333 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  333 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence            32110   00112222222333322 56899999999999999999999999999999999876543321    111222


Q ss_pred             CCChhhcCCCCHHHHhhhchHH
Q 017341          342 NFKPHELKGVPVDMLVKLIPEH  363 (373)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~  363 (373)
                      .+. .++..++.+.+.+++.++
T Consensus       334 ~~~-~~~~~~~~~~~~~~~~~e  354 (364)
T 3qyz_A          334 KFD-MELDDLPKEKLKELIFEE  354 (364)
T ss_dssp             CCC------CCHHHHHHHHHHH
T ss_pred             Ccc-cccccCCHHHHHHHHHHH
Confidence            222 345566667777666544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-52  Score=392.43  Aligned_cols=261  Identities=25%  Similarity=0.461  Sum_probs=211.5

Q ss_pred             CCCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceee
Q 017341           26 GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCF   97 (373)
Q Consensus        26 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~   97 (373)
                      +.........+|++.+.||+|+||.||+|+++.+++.||+|++.+..       ....+|..+++.+ +||||+++++++
T Consensus        43 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           43 GKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             ------CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             cccccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            34444456679999999999999999999999999999999986532       2245788888776 899999999988


Q ss_pred             eecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341           98 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus        98 ~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                           .+...+|+|||||.| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .
T Consensus       123 -----~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~  191 (396)
T 4dc2_A          123 -----QTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-H  191 (396)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-C
T ss_pred             -----EECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCC-C
Confidence                 445568999999985 888777754    5699999999999999999999998 999999999999999998 7


Q ss_pred             eeEeeccceeecc-CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH--------H-H
Q 017341          177 LKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV--------D-Q  246 (373)
Q Consensus       177 ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~--------~-~  246 (373)
                      +||+|||+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||......        + .
T Consensus       192 ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~  270 (396)
T 4dc2_A          192 IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  270 (396)
T ss_dssp             EEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred             EEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence            9999999997632 33445567899999999999664 5899999999999999999999999754221        1 1


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPF  320 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~ll~hp~  320 (373)
                      ...+...                 ..            .++..+++++.+||++||+.||.+||++      +|+++|||
T Consensus       271 ~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          271 FQVILEK-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             HHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             HHHHhcc-----------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence            2222221                 00            1335689999999999999999999995      89999999


Q ss_pred             ccccCCC
Q 017341          321 FDELRDP  327 (373)
Q Consensus       321 ~~~~~~~  327 (373)
                      |+++++.
T Consensus       322 f~~i~w~  328 (396)
T 4dc2_A          322 FRNVDWD  328 (396)
T ss_dssp             TTTCCHH
T ss_pred             ccCCCHH
Confidence            9998763

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-53  Score=389.73  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEecccc-----cchHHHHHHHHhCCC-CCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDH-PNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~  103 (373)
                      ++|++.+.||+|+||.||+|.+..+     ++.||+|.+....     +...+|+.+++.++| ||||++++++..    
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~----  139 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----  139 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC----
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe----
Confidence            4899999999999999999998654     3689999886543     234579999999976 899999998743    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      ....+|||||||+ |+|.+++......            ...+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl  218 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILL  218 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccceee
Confidence            2234789999999 5999999865431            24588999999999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  246 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~  246 (373)
                      +.++ .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus       219 ~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9988 8999999999866444322   345789999999999765 59999999999999999998 9999998775555


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +.+++..-..+                           ..+..+++++.++|.+||+.||++|||++++++|
T Consensus       297 ~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            55444321100                           1224689999999999999999999999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-52  Score=377.52  Aligned_cols=277  Identities=35%  Similarity=0.663  Sum_probs=221.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|++....      ....+|+.+++.++||||+++++++.     +...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence            5799999999999999999998 679999999985432      23357999999999999999999884     33458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      ++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            899999999998888753   35689999999999999999999998 999999999999999888 8999999998765


Q ss_pred             cCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 017341          189 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  266 (373)
Q Consensus       189 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  266 (373)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++.+..+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            322 223345789999999999766668999999999999999999999999999999999998887776654332111 


Q ss_pred             -cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          267 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                       +.+. -.++.....++.. +...+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       231 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYD-PNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCC-TTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccc-cccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             1110 0111111222222 335689999999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-52  Score=381.17  Aligned_cols=285  Identities=29%  Similarity=0.522  Sum_probs=230.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhC---CCCCeeecceeeeec
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLL---DHPNVVSLKHCFFST  100 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~  100 (373)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|.+....         ....+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4568999999999999999999999999999999986322         2344677777766   499999999998776


Q ss_pred             CCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          101 TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                      ......+++++|||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-TVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTS-CEEEC
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEEe
Confidence            555566789999999999998887642  23489999999999999999999998 999999999999999888 89999


Q ss_pred             eccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          181 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       181 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      |||++.............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+...++.+..+.+...
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999866555555667899999999999765 48999999999999999999999999999999999999988877765


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      .+..... .....++.....+... ..+.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       242 ~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          242 DWPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TSCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            4332111 1111122222222222 235789999999999999999999999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.5e-52  Score=386.05  Aligned_cols=258  Identities=25%  Similarity=0.385  Sum_probs=220.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|.+....          ....+|+.+++.++||||+++++++    
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----   84 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----   84 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence            34568999999999999999999999999999999986532          2245899999999999999999988    


Q ss_pred             CCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---ce
Q 017341          102 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QL  177 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~i  177 (373)
                       .+...+|+||||+. |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+
T Consensus        85 -~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           85 -ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCE
T ss_pred             -EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCE
Confidence             44556899999997 588887754    35799999999999999999999998 9999999999999987663   69


Q ss_pred             eEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          178 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       178 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus       159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~  237 (361)
T 2yab_A          159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF  237 (361)
T ss_dssp             EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             EEEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            99999999877665555667899999999999654 58999999999999999999999999988887777766532221


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      ...                         +...+++++++||.+||..||.+|||++|+++||||+...
T Consensus       238 ~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          238 DEE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             CHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             Cch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            111                         2246899999999999999999999999999999998654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.6e-52  Score=381.77  Aligned_cols=288  Identities=32%  Similarity=0.577  Sum_probs=217.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++||||+++++++     .+...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            458999999999999999999999999999999986432     2345899999999999999999988     444568


Q ss_pred             EEEEecccccHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          109 NLVLEYVPETVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~--~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      |+||||++++|.+.+......  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~  156 (317)
T 2pmi_A           79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLAR  156 (317)
T ss_dssp             EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCSSCE
T ss_pred             EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCC-CEEECcCccce
Confidence            899999999999988765422  24589999999999999999999998 999999999999999988 89999999998


Q ss_pred             eccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            76433 22345678999999999976556899999999999999999999999999999999999988887765433221


Q ss_pred             C--cCcccccCCCcCCCCc----cccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          266 N--PNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       266 ~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .  +.+.. ..+......+    .......++.++.+||.+||+.||.+|||++|+|+||||++...+..
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          237 TKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             GGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             hhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence            1  11100 0000000001    11122468899999999999999999999999999999999876543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-52  Score=381.75  Aligned_cols=252  Identities=26%  Similarity=0.470  Sum_probs=217.3

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+|++.+.||+|+||.||+|++..+|+.||+|.+.+..       ....+|..+++.++||||+++++++     .+.
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~   78 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA   78 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeC
Confidence            3568999999999999999999999999999999986431       2334799999999999999999988     445


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+|+||||+.| +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~Dfg~  152 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGF  152 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCC-CEEEeecCc
Confidence            568999999985 888888753    5689999999999999999999988 999999999999999988 799999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ++....  .....+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+...++....          
T Consensus       153 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  219 (318)
T 1fot_A          153 AKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------  219 (318)
T ss_dssp             CEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC----------
T ss_pred             ceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            986532  34466899999999999654 58999999999999999999999999988877777776521          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                             ..            ++..+++++.++|.+||+.||.+|+     +++++++||||+++.+.
T Consensus       220 -------~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          220 -------LR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             -------CC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             -------CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                   11            2246889999999999999999999     99999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-52  Score=386.42  Aligned_cols=254  Identities=27%  Similarity=0.477  Sum_probs=215.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|.+.+..       .....|..+++.+ +||||+++++++     .
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence            44578999999999999999999999999999999986432       2234688888876 999999999988     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+||||+. |+|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DF  162 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADF  162 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCC-CEEEeEC
Confidence            4556899999997 5888888754    5689999999999999999999998 999999999999999988 7999999


Q ss_pred             cceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+....+....       
T Consensus       163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  234 (345)
T 1xjd_A          163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------  234 (345)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             hhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-------
Confidence            99976432 2334567899999999999664 48999999999999999999999999988877777665420       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCccccCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFFDELRD  326 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-~ll~hp~~~~~~~  326 (373)
                           +                 .++..+++++.+||.+||+.||.+||++. ++++||||+++++
T Consensus       235 -----~-----------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          235 -----P-----------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             -----C-----------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             -----C-----------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                 0                 12245889999999999999999999998 9999999999865

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-52  Score=383.92  Aligned_cols=285  Identities=30%  Similarity=0.584  Sum_probs=226.4

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++.     +
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  104 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----H  104 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----E
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----c
Confidence            345679999999999999999999999999999999985432      22358999999999999999999884     3


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC----CceeEe
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLC  180 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~----~~ikl~  180 (373)
                      ...+++||||++++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++    ..+||+
T Consensus       105 ~~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAENDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEEC
Confidence            4458899999999999888754    5689999999999999999999998 999999999999995332    259999


Q ss_pred             eccceeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          181 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       181 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      |||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD  259 (329)
T ss_dssp             CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence            99999765322 22334578999999999977666899999999999999999999999999999999999998887776


Q ss_pred             HHHhhcC--cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          260 EEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       260 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ..+....  +.+. ..++......+...+...+++++.+||.+||+.||.+|||++|+|+||||++.++
T Consensus       260 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          260 TTWPGVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TTSTTGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            5433211  1111 1223333333344444558899999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.6e-52  Score=386.74  Aligned_cols=317  Identities=32%  Similarity=0.540  Sum_probs=233.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3468999999999999999999999999999999985432      233479999999999999999998854321 123


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|++||+++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC----
T ss_pred             CeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCC-CEEEeecccc
Confidence            44789999998888877753     5699999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +....  ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.+..+.+...
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          180 RHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            76432  2345688999999999977567899999999999999999999999999999999999999999988776544


Q ss_pred             CcCccc---ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCC
Q 017341          266 NPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN  342 (373)
Q Consensus       266 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~  342 (373)
                      ......   ...+..+..++...+ ...++++.+||.+||+.||.+|||++++|+||||+...++......     +.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~-----~~~~  331 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-----DPYD  331 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCC-----CCCC
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCC-----CCCC
Confidence            321100   012222233333333 4689999999999999999999999999999999998776543211     1122


Q ss_pred             CChhhcCCCCHHHHhhhchHHHH
Q 017341          343 FKPHELKGVPVDMLVKLIPEHAR  365 (373)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~  365 (373)
                      +. .+......+.+++++.++..
T Consensus       332 ~~-~~~~~~~~~~~~~~~~~e~~  353 (367)
T 2fst_X          332 QS-LESRDLLIDEWKSLTYDEVI  353 (367)
T ss_dssp             GG-GSSCCCCHHHHHHHHHHHHH
T ss_pred             cc-hhhccCCHHHHHHHHHHHHH
Confidence            21 23335566777776665544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-51  Score=391.53  Aligned_cols=273  Identities=25%  Similarity=0.413  Sum_probs=225.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.++||+|+||.||+|+++.+++.||+|++.+.       .....+|..++..++||||+++++++     .+.
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  146 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD  146 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence            346899999999999999999999999999999998542       22356899999999999999999988     445


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+|+|||||. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g-~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCC-CEEEcchhh
Confidence            56899999997 5888888753   36799999999999999999999998 999999999999999988 799999999


Q ss_pred             eeeccCCCCc--cccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          185 AKVLVKGEPN--ISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       185 a~~~~~~~~~--~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ++........  ...+||+.|+|||++.    +...++.++|||||||++|+|++|++||.+.+..+...++.....   
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---  298 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---  298 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc---
Confidence            9766443332  2467999999999986    234589999999999999999999999999988888887764210   


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCCCCCCCCCCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPNTRLPNGRF  336 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~~~~~~~~~~~  336 (373)
                                  .+.+|.         ....+++++++||++||+.+|.+  |++++|+++||||+++++...+....++
T Consensus       299 ------------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~  357 (437)
T 4aw2_A          299 ------------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPY  357 (437)
T ss_dssp             ------------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSC
T ss_pred             ------------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCC
Confidence                        011111         11358999999999999999988  9999999999999999887654333344


Q ss_pred             CCC
Q 017341          337 LPP  339 (373)
Q Consensus       337 ~~~  339 (373)
                      .|.
T Consensus       358 ~P~  360 (437)
T 4aw2_A          358 IPE  360 (437)
T ss_dssp             CCC
T ss_pred             CCc
Confidence            443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-51  Score=381.69  Aligned_cols=285  Identities=34%  Similarity=0.600  Sum_probs=228.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....         ....+|+.+++.++||||+++++++     .
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   82 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G   82 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence            3568999999999999999999999999999999885321         2345799999999999999999988     3


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      +...+++||||++++|...+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        83 ~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  157 (346)
T 1ua2_A           83 HKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFG  157 (346)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCG
T ss_pred             eCCceEEEEEcCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCC-CEEEEecc
Confidence            44457899999999988777643   35688899999999999999999998 999999999999999988 89999999


Q ss_pred             ceeeccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+..+.+
T Consensus       158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            997653332 2345678999999999976666899999999999999999999999999999999999998888876654


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ...........+...+..++... ...++.++.+||.+||+.||.+|||++|+|+||||+....+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             hhhccCcccccccccCCCChHHh-hccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            43222111112222222222222 256889999999999999999999999999999999866554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-51  Score=379.70  Aligned_cols=256  Identities=25%  Similarity=0.461  Sum_probs=211.1

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  101 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  101 (373)
                      .+....+|++.+.||+|+||.||+|+++.+++.||+|.+.+..       ....+|..+++.+ +||||+++++++    
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~----   79 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF----   79 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE----
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE----
Confidence            3455679999999999999999999999999999999986542       1234688898887 899999999988    


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                       .+...+|+||||+.| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        80 -~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~  152 (345)
T 3a8x_A           80 -QTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLT  152 (345)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEEC
T ss_pred             -EeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEE
Confidence             444568999999985 888887654    5699999999999999999999998 999999999999999988 79999


Q ss_pred             eccceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHH
Q 017341          181 DFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEI  250 (373)
Q Consensus       181 Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---------~~~~~~i  250 (373)
                      |||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.....         ......+
T Consensus       153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i  231 (345)
T 3a8x_A          153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  231 (345)
T ss_dssp             CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred             eccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence            9999976432 3334567899999999999654 589999999999999999999999975321         1112222


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCcccc
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDEL  324 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~ll~hp~~~~~  324 (373)
                      ...                 ..            .++..++.++.+||.+||+.||.+||++      +++++||||+++
T Consensus       232 ~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          232 LEK-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HcC-----------------CC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            210                 00            1235689999999999999999999995      899999999988


Q ss_pred             CC
Q 017341          325 RD  326 (373)
Q Consensus       325 ~~  326 (373)
                      ++
T Consensus       283 ~w  284 (345)
T 3a8x_A          283 DW  284 (345)
T ss_dssp             CH
T ss_pred             CH
Confidence            75

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.3e-52  Score=386.26  Aligned_cols=321  Identities=29%  Similarity=0.499  Sum_probs=232.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... .+.
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            3568999999999999999999999999999999986432      223479999999999999999998854321 223


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+|+||||++++|.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus       103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a  174 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLA  174 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCCCC-
T ss_pred             cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEEEeecc
Confidence            4688999999999887774      4589999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+.++.+..+
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            866544444566899999999999764 5899999999999999999999999999999999999988888877655433


Q ss_pred             CcCcccc--cCCCcCCCCcccccc-----------CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCC
Q 017341          266 NPNYTEF--KFPQIKAHPWHKIFQ-----------KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP  332 (373)
Q Consensus       266 ~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~  332 (373)
                      .+....+  ..+......+...++           ...++++.+||.+||+.||.+|||++|+|+||||+...++.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~  333 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA  333 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence            2211100  001111111111110           112578999999999999999999999999999998665432211


Q ss_pred             CCCCCCCCCCCChhhcCCCCHHHHhhhchHHHHh
Q 017341          333 NGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  366 (373)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (373)
                      .   .|..... ..+......+.++++++...++
T Consensus       334 ~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  363 (371)
T 2xrw_A          334 P---PPKIPDK-QLDEREHTIEEWKELIYKEVMD  363 (371)
T ss_dssp             C---CCCCCTT-TTCCCCCCHHHHHHHHHHHHHH
T ss_pred             C---CCCCCCh-hhccccCcHHHHHHHHHHHHHH
Confidence            1   1111111 1223345667777777665543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-51  Score=381.60  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=218.5

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....++|++.+.||+|+||.||+|++..+|+.||+|.+.+..       ....+|+.+++.++||||+++++++     .
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----K  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----E
Confidence            345679999999999999999999999999999999985432       2344799999999999999999988     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+||||+. |+|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DF  185 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDF  185 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCC
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCC-CEEEccc
Confidence            4556899999997 5888888764    5699999999999999999999998 999999999999999988 7999999


Q ss_pred             cceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      |+++....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....        
T Consensus       186 g~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  254 (350)
T 1rdq_E          186 GFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------  254 (350)
T ss_dssp             TTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             ccceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            99986533  33456899999999999654 58999999999999999999999999988877777766521        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                               .            .++..+++++.++|.+||+.||.+||+     ++++++||||+.+++
T Consensus       255 ---------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          255 ---------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ---------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ---------C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                     0            122468999999999999999999998     999999999998765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-51  Score=387.03  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=218.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|.+.+.       .....+|..+++.++||||+++++++     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            456899999999999999999999999999999998542       23355899999999999999999988     455


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .++|+|||||+ |+|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCC-CEEEeccce
Confidence            56899999997 588887754     4589999999999999999999998 999999999999999988 799999999


Q ss_pred             eeeccCCCC--cccccccccccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEP--NISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~---~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      ++.......  ....+||+.|+|||++.+...   ++.++|||||||++|+|++|++||.+.+..+...++......   
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  291 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  291 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence            987644321  235689999999999965432   788999999999999999999999999888888887653100   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~ll~hp~~~~~~~~~  328 (373)
                                  ..+|.          ...+|+++++||.+||+.+|.+  |++++|+++||||+++++.+
T Consensus       292 ------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          292 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             ------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             ------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence                        01111          1358999999999999999988  99999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=369.89  Aligned_cols=284  Identities=35%  Similarity=0.608  Sum_probs=222.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....      ...+|+.+++.++||||+++++++.     +...
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence            3689999999999999999999999999999998865432      2347999999999999999999883     3445


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +++||||+++++...+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  151 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCC-CEEEeeCCCchh
Confidence            8899999997544444332   36699999999999999999999998 999999999999999888 899999999987


Q ss_pred             ccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc-
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-  265 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-  265 (373)
                      ..... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+..+.......... 
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence            54332 2345678999999999977667899999999999999999999999999999999988888877766543221 


Q ss_pred             -CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          266 -NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                       ...+.....+............+.+++++.+||.+||+.||.+|||++|+++||||+++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence             11122222222221111112224689999999999999999999999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-52  Score=385.12  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=216.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ....+|++.+.||+|+||.||+|+++.+|+.||+|.+.+..       ....+|..++..+ +||||+++++++     .
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   91 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q   91 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----E
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----E
Confidence            44568999999999999999999999999999999986432       2234688888877 799999999988     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+||||+.| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DF  165 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADF  165 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCC-cEEEEeC
Confidence            45568999999985 888888754    5699999999999999999999998 999999999999999988 7999999


Q ss_pred             cceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....       
T Consensus       166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  237 (353)
T 2i0e_A          166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------  237 (353)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             CcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-------
Confidence            99976432 2334567899999999999654 58999999999999999999999999988887777776520       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  327 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~~  327 (373)
                                ..            ++..+++++.+||.+||+.||.+||+     ++++++||||+.+++.
T Consensus       238 ----------~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          238 ----------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             ----------CC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             ----------CC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                      11            23468999999999999999999994     6999999999988763

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-52  Score=385.41  Aligned_cols=252  Identities=28%  Similarity=0.453  Sum_probs=212.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+.+++.++||||+++++++.     .
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence            3467899999999999999999999999999999988532       124568999999999999999999883     3


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+++||||++|+|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNL-NVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTC-CEEECCSSC
T ss_pred             CCEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCC-CEEEEEecc
Confidence            4458899999999998888764    5699999999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........               
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------  219 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------  219 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------
Confidence            98765555556678999999999997665457899999999999999999999976543211100               


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                             ..       .....++..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       220 -------i~-------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 -------VN-------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -------CC-------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -------HH-------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                   00       0001133568999999999999999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-51  Score=377.55  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=217.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.++||||+++++++.     +...+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEEE
Confidence            468999999999999999999999999999999886443   23457999999999999999999883     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC--CCCceeEeeccceee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~--~~~~ikl~Dfg~a~~  187 (373)
                      |||||+| +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.  ++ .+||+|||++..
T Consensus        79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence            9999985 888777542   35699999999999999999999998 9999999999999987  45 899999999987


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...........      
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  226 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------  226 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred             CCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------
Confidence            7555555567899999999999654 479999999999999999999999999988888777776432222211      


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                         ...+|.++.+||.+||..||.+|||++|+|+||||+..
T Consensus       227 -------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 -------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                               14689999999999999999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-51  Score=383.51  Aligned_cols=271  Identities=28%  Similarity=0.444  Sum_probs=222.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+|++.+.||+|+||.||+|+++.+|+.||+|++.+.       .....+|..++..++||||+++++++     .+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            456899999999999999999999999999999998542       23356899999999999999999988     445


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .++|+||||+. |+|.+.+.+.   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g-~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCG-HIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCC-CEEEeechh
Confidence            56899999997 5898888764   35799999999999999999999998 999999999999999988 799999999


Q ss_pred             eeeccCCCC--cccccccccccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          185 AKVLVKGEP--NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       185 a~~~~~~~~--~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      ++.......  ....+||+.|+|||++..      ...++.++|||||||++|+|++|++||.+.+..+...++......
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            987644332  234589999999999962      235899999999999999999999999999888887777642100


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCccccCCCCCCCCC
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFDELRDPNTRLPN  333 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~~ll~hp~~~~~~~~~~~~~~  333 (373)
                                     ..+|.         ++..+|+++++||++||+ +|.+|   ++++|+++||||+++++...+...
T Consensus       289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~  343 (412)
T 2vd5_A          289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSV  343 (412)
T ss_dssp             ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSC
T ss_pred             ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcC
Confidence                           01110         124689999999999999 99998   599999999999999876554333


Q ss_pred             CCCCC
Q 017341          334 GRFLP  338 (373)
Q Consensus       334 ~~~~~  338 (373)
                      +++.|
T Consensus       344 ~p~~p  348 (412)
T 2vd5_A          344 PPFTP  348 (412)
T ss_dssp             CSCCC
T ss_pred             CCCCC
Confidence            33333

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-51  Score=382.85  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=212.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHH-HHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....+|++.+.||+|+||.||+|+++.+++.||+|.+.+...       ...+|..+ ++.++||||+++++++     .
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence            455689999999999999999999999999999999865432       12234444 4667999999999988     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+||||+.| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~ikL~DF  183 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDF  183 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEeeC
Confidence            45568999999985 888887753    5689999999999999999999998 999999999999999988 7999999


Q ss_pred             cceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+...++....       
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  255 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------  255 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------
T ss_pred             ccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------
Confidence            99976432 3344567899999999999654 58999999999999999999999999988887777776520       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRDP  327 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~ll~hp~~~~~~~~  327 (373)
                                .            .++..++.++.+||.+||+.||.+||++    +++++||||+.+++.
T Consensus       256 ----------~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          256 ----------L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             ----------C------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------c------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence                      0            1235689999999999999999999987    699999999998763

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-50  Score=377.78  Aligned_cols=313  Identities=33%  Similarity=0.576  Sum_probs=239.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC-Cce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  106 (373)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            458999999999999999999999999999999986532      2334799999999999999999988543321 122


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+||||+.++|.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       121 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECSTTCC-
T ss_pred             eEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCC-CEEEEecCccc
Confidence            348999999998876653      4599999999999999999999998 999999999999999988 79999999997


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+......
T Consensus       193 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             ccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            542  233456789999999999765668999999999999999999999999999999999999999888877654432


Q ss_pred             cCcccc---cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCC
Q 017341          267 PNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNF  343 (373)
Q Consensus       267 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~  343 (373)
                      ......   ..+......+.. ..+.+++++.+||.+||+.||.+|||++|+|+||||+.+.++............    
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~----  345 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD----  345 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC----
T ss_pred             hhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc----
Confidence            211000   111111222222 225689999999999999999999999999999999988776443222211111    


Q ss_pred             ChhhcCCCCHHHHhhhchH
Q 017341          344 KPHELKGVPVDMLVKLIPE  362 (373)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~  362 (373)
                       ..+......+.+...+.+
T Consensus       346 -~~~~~~~~~~~~~~~~~~  363 (371)
T 4exu_A          346 -SLEHEKLTVDEWKQHIYK  363 (371)
T ss_dssp             -TTSSCCCCHHHHHHHHHH
T ss_pred             -chhhcccchHHHHHHHHH
Confidence             122334556666665554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-50  Score=374.56  Aligned_cols=292  Identities=34%  Similarity=0.647  Sum_probs=230.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+.....     ...+|+.+++.++||||+++++++......+..
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            345689999999999999999999999999999999854322     234799999999999999999877543333445


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ..++||||+.++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        88 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~  160 (353)
T 2b9h_A           88 EVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLAR  160 (353)
T ss_dssp             CEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCC-cEEEEeccccc
Confidence            6889999999999888764     5689999999999999999999998 999999999999999888 79999999997


Q ss_pred             eccCCCC-----------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          187 VLVKGEP-----------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       187 ~~~~~~~-----------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      .......           .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            6543211           12346899999999986656689999999999999999999999999998888888888777


Q ss_pred             CCCHHHH-hhcCc-Cccc--ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCC
Q 017341          256 TPTREEI-KCMNP-NYTE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL  331 (373)
Q Consensus       256 ~~~~~~~-~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~  331 (373)
                      .+..... .+... ....  ...+.....++.. ..+.+++++.+||.+||+.||++|||++++++||||+...++....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  319 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP  319 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc
Confidence            6653211 00000 0000  0111111122222 2246899999999999999999999999999999999988776543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.5e-51  Score=376.57  Aligned_cols=259  Identities=29%  Similarity=0.386  Sum_probs=213.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+...         .....+|+.+++.++||||+++++++.     +
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            45899999999999999999999999999999988532         233468999999999999999999883     3


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--ceeEee
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCD  181 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ikl~D  181 (373)
                      ...+|+|||||. ++|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+||+|
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEec
Confidence            445889999999 588888877655566799999999999999999999998 9999999999999986552  499999


Q ss_pred             ccceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          182 FGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       182 fg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. .+....+..........
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence            999987654332 3356799999999999654 48999999999999999999999998753 34444444321111111


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                               ....+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                                     1145789999999999999999999999999999998743

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.8e-50  Score=366.26  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=214.2

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++++..     ...+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEE
Confidence            4568999999999999999999999999999999985432    234579999999999999999998843     3347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||||+. ++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~  165 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            89999997 588888764     4589999999999999999999998 999999999999999988 899999999876


Q ss_pred             ccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........        
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------  236 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------  236 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------
T ss_pred             cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            64433 23456799999999999765 489999999999999999999999998887776666554311100        


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                        ..+..++..+.+||.+||+.||.+|||++|+++||||+...
T Consensus       237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 ------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             ------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                              01245789999999999999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.3e-51  Score=380.20  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=214.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            45579999999999999999999999999999999885432       2345799999999999999999988     44


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||+.| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCC-CEEEeccc
Confidence            4568999999975 88777764    36799999999999999999999998 999999999999999988 79999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCC
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~---~~~i~~~~~~~~  258 (373)
                      ++............+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||...+....   ...+...     
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----  235 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----  235 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence            99877666666678899999999999642  3488999999999999999999999986543222   2222110     


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCccccCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEALIHPFFDELRD  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~~ll~hp~~~~~~~  326 (373)
                                              ...++..+++++.+||.+||+.||.+||+ ++++++||||+++++
T Consensus       236 ------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 ------------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             ------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                                    00123568999999999999999999998 899999999998865

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-50  Score=377.19  Aligned_cols=288  Identities=31%  Similarity=0.598  Sum_probs=228.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------------cchHHHHHHHHhCCCCCeeecceeee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFF   98 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~   98 (373)
                      .++|++.+.||+|+||.||+|.+.. |+.||+|++....               ....+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4689999999999999999999854 9999999885421               23458999999999999999999987


Q ss_pred             ecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341           99 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus        99 ~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                      ........++|+||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNN-DIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEE
T ss_pred             eccCCCcceEEEEEccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCC-CEE
Confidence            7665666778999999999998888743   35699999999999999999999998 999999999999999888 799


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+.
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999997655555555678899999999997656689999999999999999999999999999999999999998888


Q ss_pred             HHHHhhcCcC----cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          259 REEIKCMNPN----YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       259 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      .+........    +............+.. ..+..++.+.+||.+||+.||.+|||++++++||||+.+.++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            7654322110    0001111112222222 2356789999999999999999999999999999999986653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=371.05  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=217.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....          ....+|+.+++.++||||+++++++     
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   83 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   83 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            3458999999999999999999999999999999886432          2345899999999999999999988     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---cee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  178 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~ik  178 (373)
                      .+...+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+|
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEE
Confidence            34455889999997 588888754    36699999999999999999999998 9999999999999987652   699


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            9999999877555555567899999999999654 589999999999999999999999999888777776655322211


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      ..                         ....++..+.+||.+||+.||.+|||++++|+||||+...
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            11                         1246789999999999999999999999999999998653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-50  Score=384.51  Aligned_cols=280  Identities=32%  Similarity=0.543  Sum_probs=227.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhC------CCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLL------DHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+.....   ...+|+.+++.+      +|+||+++++++.     .
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-----~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-----F  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----E
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----c
Confidence            4589999999999999999999999999999999865432   334688888776      5779999999883     3


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC-ceeEeecc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~ikl~Dfg  183 (373)
                      ...+|+||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++. .+||+|||
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            44588999999999999888653  34589999999999999999999998 9999999999999998872 29999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      +++...  .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+.
T Consensus       248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            997643  3344568999999999997654 8999999999999999999999999999999999999999999887654


Q ss_pred             hcCcC--------cccc----------------------cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH
Q 017341          264 CMNPN--------YTEF----------------------KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  313 (373)
Q Consensus       264 ~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  313 (373)
                      .....        +..+                      .........|...+....++++.+||.+||++||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            32110        0000                      00001122333344455688999999999999999999999


Q ss_pred             HHhcCCCcccc
Q 017341          314 EALIHPFFDEL  324 (373)
Q Consensus       314 ~ll~hp~~~~~  324 (373)
                      |+|+||||+..
T Consensus       405 e~L~Hpw~~~~  415 (429)
T 3kvw_A          405 QALRHPWLRRR  415 (429)
T ss_dssp             HHHTSTTTC--
T ss_pred             HHhCChhhccC
Confidence            99999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-50  Score=374.86  Aligned_cols=291  Identities=29%  Similarity=0.488  Sum_probs=227.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC---
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTE---  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  102 (373)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++.....      ...+|+.+++.++||||+++++++.....   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            346799999999999999999999999999999998854322      23479999999999999999998855321   


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      .....+|+||||+++++...+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Df  168 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADF  168 (351)
T ss_dssp             ---CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCC
T ss_pred             cCCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-CEEEccc
Confidence            124468899999999988888654   35699999999999999999999998 999999999999999988 8999999


Q ss_pred             cceeeccCC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |+++.....     .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999765422     222345789999999999766668999999999999999999999999999999999998887777


Q ss_pred             CHHHHhhcCc--CcccccCCCcCCCCccccc-cCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          258 TREEIKCMNP--NYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       258 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ....+.....  .+................+ ....++++.+||.+||+.||.+|||++|+|+||||+....+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            6554322110  0000011100000000000 00137789999999999999999999999999999875443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=384.87  Aligned_cols=256  Identities=29%  Similarity=0.391  Sum_probs=213.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.+|+|.+....      ....+|+.+++.++||||+++++++     .+..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence            4568999999999999999999999999999999986543      2345899999999999999999988     4555


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC--CCceeEeecc
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~ikl~Dfg  183 (373)
                      .+|+|||||.| +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.+  ++.+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            68899999985 888877753    6699999999999999999999998 99999999999999852  2379999999


Q ss_pred             ceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.........   
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---  234 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS---  234 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc---
Confidence            9976544332 2456899999999999654 5899999999999999999999999998888777777653211110   


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                            .....+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       235 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          235 ----------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                  0114689999999999999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-50  Score=377.61  Aligned_cols=255  Identities=29%  Similarity=0.409  Sum_probs=215.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++     .+..+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            458999999999999999999999999999999986543      2345799999999999999999988     44556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccc
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  184 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~  184 (373)
                      .|+||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            8899999985 88777754    35689999999999999999999998 999999999999998654  2599999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.........     
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----  251 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-----  251 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred             ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence            9876555445567899999999999654 5899999999999999999999999998877777666553111100     


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                          .....+++++.+||.+||+.||.+|||++++|+||||+..
T Consensus       252 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          252 --------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             --------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             --------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                0113578999999999999999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.4e-51  Score=368.90  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=206.9

Q ss_pred             CCCCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------------------------cchH
Q 017341           27 KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------------------RYKN   76 (373)
Q Consensus        27 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~   76 (373)
                      ..+.....++|++.+.||+|+||.||+|.+..+++.||+|.+....                              ....
T Consensus         5 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A            5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             -----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHH
T ss_pred             cCCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            3455566789999999999999999999999999999999985432                              2345


Q ss_pred             HHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc
Q 017341           77 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT  155 (373)
Q Consensus        77 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~  155 (373)
                      +|+.+++.++||||+++++++..   ....++|+||||+++ +|.+.+     ....+++..++.++.||+.||.|||++
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~  156 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ  156 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            79999999999999999998743   234568899999985 554432     235799999999999999999999998


Q ss_pred             CCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC-cccccccccccccccccCCCC--CCCchhHHHHHHHHHHHH
Q 017341          156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELL  232 (373)
Q Consensus       156 ~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwslG~il~~ll  232 (373)
                       ||+||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|+
T Consensus       157 -~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          157 -KIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             -TEECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             -CeeccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence             999999999999999888 899999999987644322 234578999999999865432  377899999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH
Q 017341          233 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  312 (373)
Q Consensus       233 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  312 (373)
                      +|+.||.+.+.......+....                 ..++          ....+++++.+||.+||+.||.+|||+
T Consensus       235 ~g~~pf~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~  287 (298)
T 2zv2_A          235 FGQCPFMDERIMCLHSKIKSQA-----------------LEFP----------DQPDIAEDLKDLITRMLDKNPESRIVV  287 (298)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-----------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HCCCCCCCccHHHHHHHHhccc-----------------CCCC----------CccccCHHHHHHHHHHhhcChhhCCCH
Confidence            9999998877655544443310                 0111          114688999999999999999999999


Q ss_pred             HHHhcCCCccc
Q 017341          313 LEALIHPFFDE  323 (373)
Q Consensus       313 ~~ll~hp~~~~  323 (373)
                      +|+++||||++
T Consensus       288 ~e~l~hp~~~~  298 (298)
T 2zv2_A          288 PEIKLHPWVTR  298 (298)
T ss_dssp             HHHTTCHHHHC
T ss_pred             HHHhcCccccC
Confidence            99999999963

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.5e-49  Score=363.19  Aligned_cols=294  Identities=33%  Similarity=0.556  Sum_probs=235.2

Q ss_pred             CCCCccccceEeeeeeeecCceEEEEEEEC-CCCcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceee
Q 017341           28 NGQPKQTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCF   97 (373)
Q Consensus        28 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~   97 (373)
                      .|.....++|++.+.||+|+||.||+|.+. .+|+.||+|.+....      ....+|+.+++.+   +||||+++++++
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             -CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             ccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            345566689999999999999999999995 678999999885322      2344777777766   899999999988


Q ss_pred             eecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCce
Q 017341           98 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  177 (373)
Q Consensus        98 ~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~i  177 (373)
                      ..........+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~-~~  159 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QI  159 (326)
T ss_dssp             EEEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CE
T ss_pred             eecccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCC-CE
Confidence            644444667789999999999998887643  24589999999999999999999998 999999999999999888 89


Q ss_pred             eEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          178 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       178 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.+
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999999765443334456789999999999654 48999999999999999999999999999999999999888877


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ....+...... ....+......+ ...+...++..+.+||.+||+.||.+|||++++++||||++++...
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          239 GEEDWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CGGGSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             CcccCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            76544321110 001111111111 2223467899999999999999999999999999999999987643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.1e-50  Score=374.38  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=200.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...++|++.+.||+|+||.||++++..+++.||+|++....   ....+|+.+++.++||||+++++++.     +...+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL   91 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence            44568999999999999999999999999999999986543   33458999999999999999999884     34458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC-ceeEeecccee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAK  186 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~ikl~Dfg~a~  186 (373)
                      |+||||+. ++|.+.+...    .++++..++.++.||+.||.|||++ ||+||||||+||+++.++. .+||+|||+++
T Consensus        92 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            89999997 5888887654    5699999999999999999999998 9999999999999987652 49999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.+.+...         
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------  237 (361)
T 3uc3_A          167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---------  237 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT---------
T ss_pred             cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC---------
Confidence            55444444567899999999999766544455999999999999999999998865544333333321100         


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                          ....+          ....+++++.+||.+||+.||.+|||++|+++||||...
T Consensus       238 ----~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          238 ----KYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ----CCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ----CCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                00111          113578999999999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-50  Score=359.59  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=209.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..++|.+.+.||+|+||.||+|.+..++..+|+|.+....     ....+|+++++.++||||+++++++     .+...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            3458999999999999999999999999999999986543     3345899999999999999999988     44455


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CCCceeEeecc
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFG  183 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg  183 (373)
                      +++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence            8899999985 89988887666668899999999999999999999998 9999999999999953   34 79999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.....        
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------  242 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--------  242 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--------
Confidence            9976655544556789999999999843  589999999999999999999999998876665544433110        


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                          .+.              .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       243 ----~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 ----NYA--------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ----CCC--------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ----ccc--------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                000              011347899999999999999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2e-50  Score=372.65  Aligned_cols=258  Identities=28%  Similarity=0.433  Sum_probs=212.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|.+........+|++++..+ +||||+++++++     .+..++|+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~l   93 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYV   93 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEE
Confidence            345689999999999999999999999999999999987777778899999887 799999999988     45556899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---ceeEeecccee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKLCDFGSAK  186 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~ikl~Dfg~a~  186 (373)
                      |||||.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||++..+.+   .+||+|||++.
T Consensus        94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999985 88887764    35699999999999999999999998 9999999999999854322   49999999998


Q ss_pred             eccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHH
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.   +..+....+....        
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--------  239 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--------  239 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC--------
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC--------
Confidence            66443 233456789999999999654 3788999999999999999999999864   2333333333210        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                               +.++        ......+++++.+||.+||..||.+|||++++++||||..+.
T Consensus       240 ---------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          240 ---------FSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             ---------CCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             ---------cccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                     0000        012246899999999999999999999999999999997753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-49  Score=357.73  Aligned_cols=260  Identities=28%  Similarity=0.396  Sum_probs=217.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++     .+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            3568999999999999999999999999999999986543      2334799999999999999999988     4445


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeecc
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg  183 (373)
                      ..++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            57899999985 887777654    5689999999999999999999998 999999999999998665  249999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      .+.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  228 (284)
T 3kk8_A          154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----  228 (284)
T ss_dssp             TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred             eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence            99876555555567899999999999654 4899999999999999999999999998877776666553211110    


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                           .....+++++.+||.+||+.||++|||++|+++||||+..+...
T Consensus       229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          229 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             ---------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence                                 01135789999999999999999999999999999998866543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=380.39  Aligned_cols=291  Identities=31%  Similarity=0.520  Sum_probs=213.2

Q ss_pred             ccceEe-eeeeeecCceEEEEEEEC--CCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMA-ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+.|.+ +++||+|+||.||+|+++  .+++.||+|.+....  ....+|+.+++.++||||+++++++..   .....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeE
Confidence            346887 558999999999999966  578999999986543  345589999999999999999998865   334468


Q ss_pred             EEEEecccccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE----cCCCCceeE
Q 017341          109 NLVLEYVPETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKL  179 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~-----~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll----~~~~~~ikl  179 (373)
                      |+||||++++|.+.+......     ...+++..++.++.||+.||.|||++ ||+||||||+|||+    +.++ .+||
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kl  173 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKI  173 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTT-CEEE
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCC-cEEE
Confidence            899999999998888755432     22489999999999999999999998 99999999999999    5555 8999


Q ss_pred             eeccceeeccCC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHH
Q 017341          180 CDFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQ  246 (373)
Q Consensus       180 ~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---------~~~  246 (373)
                      +|||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.         .+.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999765432    1223467899999999997766689999999999999999999999987654         478


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcC---------cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          247 LVEIIKVLGTPTREEIKCMNPN---------YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      +..+...++.+....+......         +....+.......+........++.+.+||.+||++||.+|||++|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            8889998888876544322100         0000000000000001111234789999999999999999999999999


Q ss_pred             CCCccccCCCCC
Q 017341          318 HPFFDELRDPNT  329 (373)
Q Consensus       318 hp~~~~~~~~~~  329 (373)
                      ||||++...+..
T Consensus       334 hp~f~~~~~~~~  345 (405)
T 3rgf_A          334 DPYFLEDPLPTS  345 (405)
T ss_dssp             SGGGTSSSCCCS
T ss_pred             ChhhccCCCCcc
Confidence            999998665543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-50  Score=368.97  Aligned_cols=283  Identities=33%  Similarity=0.598  Sum_probs=227.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++.....      ...+|+.+++.++||||+++++++.     +.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            346699999999999999999999999999999998854432      2347999999999999999999883     44


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+++||||+++++...+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCC-cEEEEeCCCc
Confidence            458899999998655555432   35699999999999999999999998 999999999999999888 8999999999


Q ss_pred             eeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ...... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+....+...+.....
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            765332 2234567899999999997665689999999999999999999999999999999999988888777654322


Q ss_pred             --cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          265 --MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       265 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                        ..+.+.....+............+.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence              233334444444433333333345789999999999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.9e-51  Score=393.59  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=215.4

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|.+.+.||+|+||.||+|+++.+|+.||+|++.+..       ....+|..+++.++||||+++++++     .+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            45578999999999999999999999999999999985432       2234799999999999999999988     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||+. |+|...+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g-~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDG-NVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCC-CEEEeecc
Confidence            456899999998 588888876544456799999999999999999999998 999999999999999988 79999999


Q ss_pred             ceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~----~~~~~~i~~~~~~~~  258 (373)
                      +++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.    .+....+...     
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----  408 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----  408 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence            9987654433 2345899999999999664 589999999999999999999999987643    2333333321     


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                                  .            ..++..+++++.+||.+||+.||.+||+     ++++++||||+.+++
T Consensus       409 ------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 ------------A------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ------------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ------------c------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                        0            0123568999999999999999999995     589999999998765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-49  Score=374.55  Aligned_cols=286  Identities=22%  Similarity=0.357  Sum_probs=211.3

Q ss_pred             ccccceEeeeeeeec--CceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|++.+.||+|  +||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----   97 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----   97 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence            446689999999999  99999999999999999999986543      233469999999999999999999843    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                       ...+|+|||||. ++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEccc
Confidence             345889999998 58888887642  35689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCC--------CCcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017341          183 GSAKVLVKG--------EPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  253 (373)
Q Consensus       183 g~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~  253 (373)
                      |.+......        .......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            987654221        112234789999999999753 45899999999999999999999999988776665554432


Q ss_pred             hCCCCHH-------HHhhc------CcCc----c-cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          254 LGTPTRE-------EIKCM------NPNY----T-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       254 ~~~~~~~-------~~~~~------~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                      .......       .+...      ....    . ....+.. .......++..+++++.+||.+||+.||.+|||++|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN-GDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCccccccccccccccccccccccccccccccccCcccccc-CCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            1110000       00000      0000    0 0000000 0001112345689999999999999999999999999


Q ss_pred             hcCCCccccCCC
Q 017341          316 LIHPFFDELRDP  327 (373)
Q Consensus       316 l~hp~~~~~~~~  327 (373)
                      |+||||+.+...
T Consensus       332 l~hp~f~~~~~~  343 (389)
T 3gni_B          332 LNHSFFKQIKRR  343 (389)
T ss_dssp             TTSGGGGGC---
T ss_pred             hcCHHHHHHhhc
Confidence            999999998654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-50  Score=392.73  Aligned_cols=260  Identities=28%  Similarity=0.426  Sum_probs=214.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            45678999999999999999999999999999999985431       2235799999999999999999988     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||+. |+|...+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g-~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHG-HIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCC-CeEEEecc
Confidence            456899999997 58888776532  24599999999999999999999998 999999999999999988 79999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      +++...........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+...+..       
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-------  403 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-------  403 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------
T ss_pred             cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------
Confidence            99877655555567899999999999654 4899999999999999999999999886432211122111000       


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                       .                 ...++..+++++.+||.+||+.||.+||     +++|+++||||+.+++
T Consensus       404 -~-----------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          404 -V-----------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             -C-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             -c-----------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence             0                 0012356899999999999999999999     8999999999998765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.1e-51  Score=371.05  Aligned_cols=257  Identities=20%  Similarity=0.210  Sum_probs=188.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-h--HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-K--NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++...... .  +.|+..+..++|||||++++++.... .....+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            5799999999999999999997  6899999998654322 2  24555566789999999999886533 223457899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc-------CCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------IGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-------~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ||||+ |+|.+.+..     .++++..+..++.|++.||+|||++       .+|+||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            99999 699988864     4688999999999999999999964       2899999999999999998 89999999


Q ss_pred             ceeeccCCCCc-----ccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-------
Q 017341          184 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-------  246 (373)
Q Consensus       184 ~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~-------  246 (373)
                      +|+........     ...+||+.|||||++.+..     .++.++|||||||++|||+||.+||......+.       
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876443322     2457999999999996532     256789999999999999999887754322110       


Q ss_pred             ----HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 ----LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                          ...+.+...          ...    ..|..+..    ......+..+.+|+.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~----------~~~----~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVC----------EQK----LRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHT----------TSC----CCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHh----------ccc----CCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                011111000          000    00000000    0001234578899999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-49  Score=370.85  Aligned_cols=279  Identities=26%  Similarity=0.440  Sum_probs=221.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCC-----CCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|++.+.||+|+||.||+|++..+++.||+|.+....   ....+|+.+++.+.     ||||+++++++..    
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~----  107 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY----  107 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE----
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE----
Confidence            34568999999999999999999999999999999986432   23346899999986     9999999998843    


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC-----------
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-----------  172 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~-----------  172 (373)
                       ..++|+||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.           
T Consensus       108 -~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          108 -YDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             -TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             -CCeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchh
Confidence             34588999999889999988653  24589999999999999999999998 9999999999999975           


Q ss_pred             --------------CCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 017341          173 --------------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  238 (373)
Q Consensus       173 --------------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf  238 (373)
                                    ++ .+||+|||++....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus       184 ~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          184 RVTDGKKIQIYRTKST-GIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             CTTTCCEEEEEEESCC-CEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCCC-CEEEEeccCceecC--CCCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCC
Confidence                          45 79999999998643  233456889999999999765 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc-cc--------cCCCcCCC--------CccccccCCCChhHHHHHHhh
Q 017341          239 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYT-EF--------KFPQIKAH--------PWHKIFQKRMPPEAVDLVSRL  301 (373)
Q Consensus       239 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~  301 (373)
                      .+.+..+.+..+....+..+...+........ .+        ..+.....        .....+....++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            99999999988888877777655433221100 00        00000000        000001122457888999999


Q ss_pred             cCcCCCCCCCHHHHhcCCCcc
Q 017341          302 LQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       302 L~~dP~~R~t~~~ll~hp~~~  322 (373)
                      |+.||.+|||++|+|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.2e-50  Score=401.66  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=217.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|++.+..       .....|..++..+ +||+|+++++++     .+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            4568999999999999999999999999999999986431       2234688888877 799999999988     55


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||+.| +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCC-cEEEeecc
Confidence            5568999999984 888888754    5699999999999999999999998 999999999999999998 79999999


Q ss_pred             ceeeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +++.... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..|....        
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------  558 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  558 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9986432 3344567899999999999654 58999999999999999999999999998888777776420        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRDP  327 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~ll~hp~~~~~~~~  327 (373)
                               .            .++..+++++.+||.+||+.||.+|+++     +|+++||||+.+++.
T Consensus       559 ---------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          559 ---------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             ---------C------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             ---------C------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence                     1            1335689999999999999999999997     999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-49  Score=365.45  Aligned_cols=254  Identities=28%  Similarity=0.459  Sum_probs=208.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeec
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      ....+|++.+.||+|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.++||||+++++++.  
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--   91 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--   91 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--
Confidence            44568999999999999999999985   689999999986432        22347999999999999999999883  


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                         ....+|+||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl  162 (327)
T 3a62_A           92 ---TGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQG-HVKL  162 (327)
T ss_dssp             ---CSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTS-CEEE
T ss_pred             ---cCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCC-cEEE
Confidence               3445889999998 5888887654    5689999999999999999999998 999999999999999888 8999


Q ss_pred             eeccceeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          180 CDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       180 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      +|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+..    
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----  237 (327)
T 3a62_A          163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK----  237 (327)
T ss_dssp             CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred             EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence            999998754322 223456799999999999654 48999999999999999999999999988877777766521    


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                                   ..            ++..+++++.+||.+||+.||.+||     +++++++||||+.+.+
T Consensus       238 -------------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          238 -------------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             -------------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             -------------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                         01            2246789999999999999999999     8999999999998765

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-50  Score=385.18  Aligned_cols=253  Identities=29%  Similarity=0.452  Sum_probs=217.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|.+.+.||+|+||.||+|++..+|+.||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----ST   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence            45678999999999999999999999999999999985432       2345899999999999999999988     33


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+|+||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~-~vkL~DFG  161 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFG  161 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCC-CeEEEecc
Confidence            445889999997 588877753    36799999999999999999999998 999999999999999888 79999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+......++....         
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------  232 (476)
T 2y94_A          162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------  232 (476)
T ss_dssp             SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---------
T ss_pred             chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------
Confidence            99877655555677899999999999766545789999999999999999999999888777766665421         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                              +.            .+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       233 --------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 --------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             --------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             --------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                    00            124578999999999999999999999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.5e-49  Score=362.61  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=217.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....          ....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   84 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----   84 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence            3468999999999999999999999999999999986432          2245899999999999999999988     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---cee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  178 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~ik  178 (373)
                      .+...+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEE
Confidence            34455889999997 588888864    35689999999999999999999998 9999999999999987763   599


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            9999999877655555567799999999999654 589999999999999999999999999887777666654321111


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .                         .+...+++.+.+||.+||+.||.+|||++++++||||+...+
T Consensus       239 ~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          239 E-------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             H-------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             h-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            1                         122468899999999999999999999999999999987653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=366.59  Aligned_cols=285  Identities=35%  Similarity=0.630  Sum_probs=226.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC-Cce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  106 (373)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            458999999999999999999999999999999986532      2234799999999999999999988543211 112


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .+|+||||+.++|.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTC-CEEECSTTCTT
T ss_pred             eEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCC-cEEEeeccccc
Confidence            358999999998765542      4589999999999999999999998 999999999999999888 89999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+......
T Consensus       175 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCC--CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            542  223456789999999999765668999999999999999999999999999999999999988888776554332


Q ss_pred             cCccc---ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 017341          267 PNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  329 (373)
Q Consensus       267 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~  329 (373)
                      .....   ...+......+.. ....+++++.+||.+||+.||.+|||++++++||||+...++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  317 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  317 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence            21100   0111111122222 22468999999999999999999999999999999998876543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-50  Score=374.42  Aligned_cols=257  Identities=27%  Similarity=0.407  Sum_probs=215.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.+|+|.+....    ....+|+.+++.++||||+++++++     .+...++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence            468999999999999999999999999999999886542    2345799999999999999999988     4445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-CCceeEeeccceee
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~ikl~Dfg~a~~  187 (373)
                      +||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+ .+.+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999985 887776542   34689999999999999999999998 99999999999999753 23799999999987


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......           
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  268 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----------  268 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            6555545566899999999999654 4899999999999999999999999998877777666542110           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                            ++        ......+++++.+||.+||+.||.+|||++++|+||||+...
T Consensus       269 ------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          269 ------FD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ------CC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ------CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                  00        001146899999999999999999999999999999998743

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.8e-50  Score=383.60  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++.     +
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~  219 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----T  219 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----E
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----e
Confidence            44578999999999999999999999999999999986431       22346888899999999999999883     3


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ...+|+||||+++ +|...+...    ..+++..++.++.||+.||+|||+ + ||+||||||+|||++.++ .+||+||
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~-~~kl~DF  293 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDF  293 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSS-CEEECCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCC-CEEEccC
Confidence            4458899999985 887777653    578999999999999999999997 7 999999999999999988 8999999


Q ss_pred             cceeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....       
T Consensus       294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  365 (446)
T 4ejn_A          294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------  365 (446)
T ss_dssp             CCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             CCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------
Confidence            999754322 233456899999999999654 58999999999999999999999999988777766665421       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                                ..            ++..+++++.+||.+||+.||.+||     |++|+++||||+++.+.
T Consensus       366 ----------~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          366 ----------IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ----------CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                      11            2346889999999999999999999     99999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-49  Score=354.56  Aligned_cols=255  Identities=31%  Similarity=0.461  Sum_probs=217.3

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++....    ....+|+++++.++||||+++++++     .+....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence            3568999999999999999999999999999999986432    3345899999999999999999988     444558


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE---cCCCCceeEeeccc
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGS  184 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~ikl~Dfg~  184 (373)
                      ++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .++|+|||+
T Consensus        82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~  155 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDS-PLKLIDFGL  155 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCC-cEEEEeccc
Confidence            899999985 888777653    5689999999999999999999998 99999999999999   6566 799999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+............  
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  231 (277)
T 3f3z_A          156 AARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--  231 (277)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--
T ss_pred             ceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--
Confidence            987765555566789999999999854  3899999999999999999999999998887777776653222222111  


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                             ..+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       232 -----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          232 -----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             -----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                   35789999999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.2e-50  Score=365.75  Aligned_cols=256  Identities=27%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     .+...
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence            3568999999999999999999999999999999885432     3456899999999999999999987     44556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .|+|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~Dfg~a~  153 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLAT  153 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCC-CEEEEEeeccc
Confidence            8899999985 77666543    35699999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          187 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       187 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ......   ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+...............      
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  227 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------  227 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT------
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc------
Confidence            653222   22356789999999999766545789999999999999999999998766543322222210000      


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                .     .     ....+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       228 ----------~-----~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          228 ----------L-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             ----------S-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ----------C-----C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                      0     0     0135789999999999999999999999999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-49  Score=383.83  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=217.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----------------cchHHHHHHHHhCCCCCeeecce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------------RYKNRELQTMRLLDHPNVVSLKH   95 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~   95 (373)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+....                 ....+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3568999999999999999999999999999999986432                 22357999999999999999999


Q ss_pred             eeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC
Q 017341           96 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus        96 ~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                      ++     .+..++|+|||||.| +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTT
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCC
Confidence            98     455568999999985 888887654    5699999999999999999999998 999999999999998775


Q ss_pred             C--ceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017341          175 H--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       175 ~--~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~  252 (373)
                      .  .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            3  599999999987765555566789999999999853  489999999999999999999999999988888777766


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .........                         ...+|+++++||.+||+.||.+|||++|+|+||||+....
T Consensus       262 ~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          262 GKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            322221111                         1468999999999999999999999999999999988654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-49  Score=359.74  Aligned_cols=260  Identities=26%  Similarity=0.385  Sum_probs=199.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc------hHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+......      ..++...++.++||||+++++++..     .
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~   78 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----E   78 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----c
Confidence            3457899999999999999999999999999999998654221      1234445777899999999998843     3


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ...++||||++++|.+.+.........+++..++.++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus        79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T 3fme_A           79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGIS  157 (290)
T ss_dssp             SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred             CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence            347899999999998888876666788999999999999999999999755999999999999999888 8999999999


Q ss_pred             eeccCCCCcccccccccccccccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHH
Q 017341          186 KVLVKGEPNISYICSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~  261 (373)
                      .............||+.|+|||++   .....++.++|||||||++|+|++|+.||.... ..............     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  232 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-----
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-----
Confidence            876555445556799999999997   234458899999999999999999999998743 33333333321000     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                            ......+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                                  00113578999999999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-49  Score=384.51  Aligned_cols=257  Identities=28%  Similarity=0.465  Sum_probs=214.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++     .+..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            345899999999999999999999999999999998432      23345899999999999999999988     4455


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeecc
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg  183 (373)
                      .+|+|||||.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++..+  ..+||+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            68999999985 888877654    5699999999999999999999998 999999999999996432  269999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++.............||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+.+..+.........    
T Consensus       170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  243 (486)
T 3mwu_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----  243 (486)
T ss_dssp             CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----
T ss_pred             cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----
Confidence            9976655555556789999999999964  4899999999999999999999999999888877777653211110    


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                 +          ....+|+++++||.+||+.||.+|||+.++|+||||+....
T Consensus       244 -----------~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          244 -----------P----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             -----------G----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             -----------c----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                       0          11457899999999999999999999999999999998654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-49  Score=363.49  Aligned_cols=284  Identities=30%  Similarity=0.519  Sum_probs=219.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++ ||||+++++++..   ....+.+
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~  109 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  109 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceE
Confidence            34568999999999999999999999999999999986433 44568999999997 9999999998743   2345578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+.+ +|...+.       .+++..++.++.||+.||.|||++ ||+||||||+||+++.++..+||+|||+++..
T Consensus       110 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999995 6655542       388999999999999999999998 99999999999999977768999999999877


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHH-hhcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEI-KCMN  266 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~~~~~~~~-~~~~  266 (373)
                      ..........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.. .+..+.+..+....+.+..... ....
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            6665556678999999999997656689999999999999999999999844 4555666666655543322111 1000


Q ss_pred             cCccc---ccCCCcCCCCcccc----ccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 PNYTE---FKFPQIKAHPWHKI----FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 ~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .....   ..........|...    ....+++++.+||.+||+.||.+|||++|+|+||||+++..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            00000   00000011111111    11347899999999999999999999999999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=360.48  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=198.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccch------HHHHHHH-HhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK------NRELQTM-RLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++|++.++||+|+||+||+|++..+|+.||+|++.......      .+|+..+ +..+||||+++++++     .+...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence            57999999999999999999999999999999875433221      2344344 344899999999988     34455


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999999998888765   36799999999999999999999998 999999999999999888 899999999987


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...   ...+...  ..          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~--~~----------  269 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG--YL----------  269 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT--CC----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc--CC----------
Confidence            655555556679999999999865  589999999999999999999777654322   1111110  00          


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                     ...++..+++++.+||.+||+.||.+|||++++++||||++
T Consensus       270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                           01123568999999999999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=365.91  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=197.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...++|++.+.||+|+||.||+|++..+++.||+|.+....  ....+|+.+++.++||||+++++++.     +...++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence            44568999999999999999999999999999999986542  34557999999999999999999883     344588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CCCceeEeeccce
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSA  185 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg~a  185 (373)
                      +||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||++
T Consensus       125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a  198 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDA-PLKIADFGLS  198 (349)
T ss_dssp             EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTC-CEEECCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCC-CEEEccCccc
Confidence            9999998 588877754    35689999999999999999999998 9999999999999975   55 7999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  264 (373)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...... ...+.....         
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---------  268 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---------  268 (349)
T ss_dssp             --------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC---------
T ss_pred             cccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC---------
Confidence            866444444566799999999999654 489999999999999999999999987766553 333332100         


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                              ..        .......++.++.+||.+||+.||++|||++++|+||||++..
T Consensus       269 --------~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          269 --------YF--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             --------CC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             --------cc--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                    00        0011246889999999999999999999999999999998743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-49  Score=382.86  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=213.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..+|++.+.||+|+||.||+|++..++..+|+|.+....      ....+|+.+++.++||||+++++++     .+...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            458999999999999999999999999999999986432      3345899999999999999999988     44556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccc
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  184 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~  184 (373)
                      +|+|||||.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++..+  ..+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999985 888877654    5689999999999999999999998 999999999999997643  2599999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+..........    
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  259 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----  259 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence            987765555566789999999999853  58999999999999999999999999998888777776532111110    


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                           ....+|+++.+||.+||+.||.+|||++++|+||||+...
T Consensus       260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                                 1146899999999999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.3e-50  Score=385.97  Aligned_cols=257  Identities=32%  Similarity=0.514  Sum_probs=217.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            34568999999999999999999999999999999985432       2345899999999999999999988     44


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc---CCCCceeEe
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLC  180 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~---~~~~~ikl~  180 (373)
                      ..++|+|||||. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++   .++ .+||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~-~~kl~  171 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDA-NIRII  171 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEEC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCC-cEEEE
Confidence            556899999998 488777764    36799999999999999999999998 999999999999995   445 79999


Q ss_pred             eccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          181 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       181 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      |||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+......  
T Consensus       172 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--  247 (484)
T 3nyv_A          172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--  247 (484)
T ss_dssp             CTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             eeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            9999987655555556789999999999965  489999999999999999999999999988887777765311111  


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                   .+          ....+|+++++||.+||+.||.+|||++++|+||||+....
T Consensus       248 -------------~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          248 -------------LP----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             -------------SG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             -------------Cc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                         00          11458999999999999999999999999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-48  Score=363.57  Aligned_cols=253  Identities=27%  Similarity=0.447  Sum_probs=214.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhC-CCCCeeecceeeeecC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  101 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  101 (373)
                      ++|.+.+.||+|++|.||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++    
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  169 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY----  169 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence            47999999999999999999999999999999886433            1234789999998 799999999987    


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                       ......|+||||+.| +|.+.+...    ..+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .++|+
T Consensus       170 -~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          170 -ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             -EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEEC
T ss_pred             -eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEE
Confidence             344568899999985 888888753    5689999999999999999999998 999999999999999888 89999


Q ss_pred             eccceeeccCCCCcccccccccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          181 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       181 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987765555566789999999999853     23478899999999999999999999998877776666655322


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      ......                         ...++.++.+||.+||+.||.+|||++++++||||+.
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            211111                         1357889999999999999999999999999999973

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-49  Score=360.68  Aligned_cols=287  Identities=31%  Similarity=0.521  Sum_probs=220.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecC--------
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT--------  101 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------  101 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999999999999999886443    23457999999999999999998763221        


Q ss_pred             -CCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEe
Q 017341          102 -EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  180 (373)
Q Consensus       102 -~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~  180 (373)
                       ..+...+|+||||++++|.+.+..     .++++..++.++.||+.||+|||++ ||+||||||+||+++.++..+||+
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEc
Confidence             123456889999999998887752     5689999999999999999999998 999999999999998555589999


Q ss_pred             eccceeeccCC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          181 DFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       181 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |||++......    .......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999765322    12234567999999999876566899999999999999999999999999998888888887766


Q ss_pred             CCHHHHhhcCcCcccc---cCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          257 PTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ...+...........+   ... ....++ ....+.++.++.+||.+||+.||.+|||++++++||||+....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMT-EPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTT-SCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CchhhhhhhhhcCccccccccc-CCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            6655433221111000   000 001111 112356899999999999999999999999999999999876653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.5e-49  Score=363.55  Aligned_cols=251  Identities=28%  Similarity=0.441  Sum_probs=212.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..|.+.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++..     ...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence            46999999999999999999999999999999986432       223579999999999999999998843     345


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++||||+.|++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            8899999999988888654   36799999999999999999999998 999999999999999888 899999999976


Q ss_pred             ccCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|++||.+.+....+..+......         
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---------  271 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------  271 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Confidence            432   235679999999999852  345899999999999999999999999988877766655542100         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                        ......+++.+.+||.+||+.||.+|||++++++||||....
T Consensus       272 ------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          272 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                              001145789999999999999999999999999999997643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=370.14  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=207.0

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      |...+.||+|+||.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++++     .+...+++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEE
Confidence            334678999999999999999999999999986532    3345899999999999999999988     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE--cCCCCceeEeeccceeecc
Q 017341          113 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       113 e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll--~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||++  +.++ .+||+|||+++...
T Consensus       166 E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence            99984 887777653   24589999999999999999999998 99999999999999  4444 89999999998775


Q ss_pred             CCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          190 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       190 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++.........          
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------  309 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED----------  309 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----------
T ss_pred             CccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----------
Confidence            55555566799999999998644 5899999999999999999999999999888888777763211110          


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                     .....+++++.+||.+||+.||.+|||++|+|+||||++.+
T Consensus       310 ---------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 ---------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ---------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ---------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                           01146899999999999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-48  Score=351.96  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=214.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|.+.+.||+|+||.||+|.+..+++.+|+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~   86 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----ED   86 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----cc
Confidence            34568999999999999999999999999999999886442       2234799999999999999999988     34


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg  160 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFG  160 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCC-CEEEEecc
Confidence            456889999998 5888777653    5789999999999999999999998 999999999999999888 79999999


Q ss_pred             ceeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ++...... .......||+.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+....+....+...         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------  230 (294)
T 2rku_A          161 LATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------  230 (294)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---------
T ss_pred             CceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc---------
Confidence            99765432 233456789999999999654 4899999999999999999999999988766655444321         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                              ..            .++..+++.+.++|.+||+.||++|||++++++||||+....+.
T Consensus       231 --------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          231 --------EY------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             --------cC------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence                    00            12246789999999999999999999999999999998865544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.7e-49  Score=352.45  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=212.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....          ....+|+.+++.++||||+++++++.     
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence            458999999999999999999999999999999886432          23458999999999999999999883     


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---ceeE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKL  179 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~ikl  179 (373)
                      +....++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             CCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEE
Confidence            3445889999997 5888888653    5689999999999999999999998 9999999999999987652   6999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +|||++.............+|+.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.........
T Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T 3bhy_A          154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE  232 (283)
T ss_dssp             CCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred             EecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence            999999876555444566789999999998654 5899999999999999999999999988877666655432111111


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                                               .....++..+.+||.+||+.||.+|||++++++||||+.++..
T Consensus       233 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          233 -------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             -------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                                     1124678999999999999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.5e-49  Score=360.43  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=187.9

Q ss_pred             cceEee---eeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAE---RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .+|.+.   +.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.+. ||||+++++++     .+....|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence            467776   78999999999999999999999999986543 34568999999997 99999999998     4455688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--ceeEeecccee
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAK  186 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ikl~Dfg~a~  186 (373)
                      +||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 888888753    6799999999999999999999998 9999999999999976542  69999999997


Q ss_pred             eccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 017341          187 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT  258 (373)
Q Consensus       187 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-------~~~~~i~~~~~~~~  258 (373)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..       +....+....    
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----  232 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----  232 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC----
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC----
Confidence            654332 23456789999999999654 5899999999999999999999999875432       2222221110    


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                   +.        +.......+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       233 -------------~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          233 -------------FS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             -------------CC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             -------------CC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence                         00        00011135899999999999999999999999999999998753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.2e-48  Score=351.35  Aligned_cols=260  Identities=26%  Similarity=0.373  Sum_probs=216.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------------cchHHHHHHHHhCC-CCCeeecceee
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCF   97 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~   97 (373)
                      ...++|++.+.||+|++|.||+|.+..+|+.||+|.+....             ....+|+.+++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34568999999999999999999999999999999985432             22347899999995 99999999988


Q ss_pred             eecCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341           98 FSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus        98 ~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                           .+....++||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~  162 (298)
T 1phk_A           94 -----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-N  162 (298)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-C
T ss_pred             -----ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCC-c
Confidence                 44556889999998 5898888754    5689999999999999999999998 999999999999999888 7


Q ss_pred             eeEeeccceeeccCCCCccccccccccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 017341          177 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  251 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~  251 (373)
                      +||+|||++.............+|+.|+|||++.     ....++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  242 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  242 (298)
T ss_dssp             EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence            9999999998766555555678999999999985     23457899999999999999999999999887776666655


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ........                         .....++..+.++|.+||+.||.+|||++++++||||++....
T Consensus       243 ~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          243 SGNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             HTCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cCCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            42111100                         0113578999999999999999999999999999999986543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-48  Score=349.65  Aligned_cols=253  Identities=30%  Similarity=0.481  Sum_probs=211.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence            35679999999999999999999999999999999885431       2345799999999999999999988     34


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ....++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCC-CEEEEecc
Confidence            4558899999994 888887654    5689999999999999999999988 999999999999999888 89999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++..... .......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+....         
T Consensus       155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------  223 (279)
T 3fdn_A          155 WSVHAPS-SRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------  223 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ccccCCc-ccccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------
Confidence            9864432 223456789999999999654 57899999999999999999999999888777666655421         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                              .            .++..+++++.+||.+||+.||.+|||++|+++||||+....
T Consensus       224 --------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          224 --------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             --------C------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                    0            122457899999999999999999999999999999988543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.1e-49  Score=369.19  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             cccceEee-eeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHH-HhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           33 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        33 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..++|.+. +.||.|+||.||+|.+..+|+.||+|.+.. .....+|+.++ +..+||||+++++++.... .+..++|+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            34578887 799999999999999999999999998854 34456788876 5568999999999874322 34567899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CCCceeEeecccee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAK  186 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg~a~  186 (373)
                      |||||.| +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||+++
T Consensus       137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~  212 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  212 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence            9999985 8988887532  24689999999999999999999998 9999999999999987   45 79999999998


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHH
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEI  262 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  262 (373)
                      ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...    ....+...         
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------  282 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------  282 (400)
T ss_dssp             ECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---------
T ss_pred             ccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---------
Confidence            7655444556788999999999954 458999999999999999999999998765322    22222221         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                              .+.++.        .....++.++.+||.+||+.||.+|||++++++||||...
T Consensus       283 --------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 --------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             --------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                    011110        0114589999999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=362.25  Aligned_cols=246  Identities=25%  Similarity=0.394  Sum_probs=208.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeec
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....            ....+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            3568999999999999999999999999999999986542            2345799999999999999999988   


Q ss_pred             CCCCceeEEEEEeccc-c-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          101 TEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                        .+...+++||||+. | +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+|
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  170 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDF-TIK  170 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCC-cEE
Confidence              44556889999986 4 78777764    35699999999999999999999998 999999999999999888 899


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||.......      .      
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~------  238 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------E------  238 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T------
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------h------
Confidence            9999999877666555667899999999999766545889999999999999999999996532100      0      


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                              .               ....+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       239 --------~---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 --------A---------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             --------T---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             --------h---------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                    0               000124578999999999999999999999999999999763

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.4e-48  Score=363.57  Aligned_cols=281  Identities=31%  Similarity=0.539  Sum_probs=217.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCC-CC-----CeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLD-HP-----NVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~  104 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+|+.+++.++ |+     +|+++.+++..     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence            5689999999999999999999999999999999865432   2346888888775 44     48888887743     


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeecCCCCcEEEcC--CCCceeEee
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNP--HTHQLKLCD  181 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~Dlkp~NIll~~--~~~~ikl~D  181 (373)
                      ...+|+||||++++|.+.+....  ...+++..++.++.||+.||.|||+ ..||+||||||+|||++.  ++ .+||+|
T Consensus       128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence            34588999999999999988653  2458999999999999999999994 239999999999999954  44 799999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ||+++...  .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++...
T Consensus       205 FG~a~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLG--QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETT--CCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceecc--cccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99998753  234456889999999999765 489999999999999999999999999999999999999988887765


Q ss_pred             HhhcCc-----------Ccccc-------cCCCcCCCCccccccC-----------------CCChhHHHHHHhhcCcCC
Q 017341          262 IKCMNP-----------NYTEF-------KFPQIKAHPWHKIFQK-----------------RMPPEAVDLVSRLLQYSP  306 (373)
Q Consensus       262 ~~~~~~-----------~~~~~-------~~~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~dP  306 (373)
                      +.....           .|...       .+.......+...+..                 ..++++.+||.+||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            432210           00000       0000000000000000                 001478999999999999


Q ss_pred             CCCCCHHHHhcCCCccccC
Q 017341          307 NLRSTALEALIHPFFDELR  325 (373)
Q Consensus       307 ~~R~t~~~ll~hp~~~~~~  325 (373)
                      ++|||++|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-49  Score=365.15  Aligned_cols=263  Identities=31%  Similarity=0.473  Sum_probs=211.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....         ....+|+.+++.++||||+++++++     .
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~   98 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----E   98 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----c
Confidence            3468999999999999999999999999999999885431         2345799999999999999999988     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhc------------------------------------CCCCCHHHHHHHHHHHH
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKM------------------------------------SQRMPLIYVKLYFYQIC  146 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~qil  146 (373)
                      +..++++|||||+ ++|.+.+......                                    ...+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            4556899999997 5888777421100                                    11245778899999999


Q ss_pred             HHHHHhHccCCceeecCCCCcEEEcCCCC-ceeEeeccceeeccCCC-----CcccccccccccccccccCC-CCCCCch
Q 017341          147 RALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGA-TEYTAAI  219 (373)
Q Consensus       147 ~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~~  219 (373)
                      .||.|||++ ||+||||||+||+++.++. .+||+|||++.......     ......||+.|+|||++.+. ..++.++
T Consensus       179 ~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          179 SALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            999999998 9999999999999986552 69999999998653321     12356789999999998642 4589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHH
Q 017341          220 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  299 (373)
Q Consensus       220 DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  299 (373)
                      |||||||++|+|++|+.||.+.+..+....+.........                         .....+++++.+||.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~  312 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLS  312 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHH
Confidence            9999999999999999999999888777776653211110                         011347899999999


Q ss_pred             hhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          300 RLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       300 ~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      +||+.||.+|||+.++|+||||+++.+
T Consensus       313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999999999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-48  Score=349.58  Aligned_cols=253  Identities=30%  Similarity=0.447  Sum_probs=204.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   82 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----ST   82 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ec
Confidence            45678999999999999999999999999999999885432       2345799999999999999999987     33


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg  156 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFG  156 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCC-CEEEeecc
Confidence            445889999998 5898888764    5689999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++.............+|+.|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+....         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------  227 (276)
T 2h6d_A          157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------  227 (276)
T ss_dssp             GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence            99766544444556789999999999765545789999999999999999999998877666555544310         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                              .            .++..++.++.++|.+||+.||.+|||++++++||||++.
T Consensus       228 --------~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 --------F------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------c------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                    0            0124578899999999999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.3e-48  Score=355.93  Aligned_cols=256  Identities=28%  Similarity=0.437  Sum_probs=215.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ....+|.+.+.||+|+||.||++.+..+++.+|+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  112 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----ED  112 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ec
Confidence            34568999999999999999999999999999999886432       2345799999999999999999988     34


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..++|+||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg  186 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFG  186 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCT
T ss_pred             CCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCC-CEEEeecc
Confidence            456889999999 4888777653    5689999999999999999999998 999999999999999888 79999999


Q ss_pred             ceeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          184 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       184 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+....        
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------  257 (335)
T 2owb_A          187 LATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------  257 (335)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------
T ss_pred             CceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--------
Confidence            99865432 233456789999999999654 48999999999999999999999999887666655554320        


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                               ..            ++..+++++.+||.+||+.||.+|||++++++||||.....+.
T Consensus       258 ---------~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          258 ---------YS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             ---------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ---------CC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence                     01            2245789999999999999999999999999999998865543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-48  Score=358.87  Aligned_cols=260  Identities=24%  Similarity=0.355  Sum_probs=210.7

Q ss_pred             ccceEee-eeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCC-CCCeeecceeeeecCCCCc
Q 017341           34 TISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  105 (373)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. ||||+++++++     .+.
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence            4478888 89999999999999999999999999886432      23457899999885 69999999988     445


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CCCceeEee
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCD  181 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~D  181 (373)
                      ..+++||||+.+ +|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~-~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLG-DIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBC-CEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCC-cEEEee
Confidence            558899999986 776665432  236689999999999999999999998 9999999999999987   55 799999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ||++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.........  
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  254 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--  254 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             CccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence            9999876555555567899999999999654 5899999999999999999999999998887777766653211111  


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                             .....+++.+.+||.+||+.||.+|||++++|+||||+.+++.+
T Consensus       255 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          255 -----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             -----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                                   01146889999999999999999999999999999999987653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.9e-49  Score=372.36  Aligned_cols=256  Identities=30%  Similarity=0.468  Sum_probs=199.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+....            ....+|+.+++.++||||+++++++    
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~----  209 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF----  209 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE----
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            458999999999999999999999999999999986432            1345899999999999999999986    


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--cee
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLK  178 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ik  178 (373)
                       .... +|+||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.  .+|
T Consensus       210 -~~~~-~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          210 -DAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             -ESSE-EEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             -ecCc-eEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEE
Confidence             2222 6799999985 77655543    46799999999999999999999998 9999999999999975441  599


Q ss_pred             EeeccceeeccCCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|++||.+......+.........
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987655444456789999999999853  345788999999999999999999999876544333333221111


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      ..                        .......+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus       363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            00                        001124689999999999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-47  Score=345.86  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=209.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .....|++.+.||+|+||.||+|.+..++..||+|.+....      ....+|+.+++.++||||+++++++.... .+.
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence            34457999999999999999999999999999999886432      22357999999999999999999875433 345


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEc-CCCCceeEee
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVN-PHTHQLKLCD  181 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~-~~~~~ikl~D  181 (373)
                      .++++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ |  |+||||||+||+++ .++ .+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~-~~kl~D  175 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGD  175 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTS-CEEECC
T ss_pred             ceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCC-CEEEee
Confidence            678999999975 898888754    5689999999999999999999988 8  99999999999998 555 899999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ||++.... ........||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+................     
T Consensus       176 fg~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  247 (290)
T 1t4h_A          176 LGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----  247 (290)
T ss_dssp             TTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----
T ss_pred             CCCccccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-----
Confidence            99986432 233345678999999998853  4899999999999999999999999886655544433221000     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                           ...++...++++.++|.+||+.||.+|||++++++||||++
T Consensus       248 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 ---------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                 01123467889999999999999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-48  Score=365.48  Aligned_cols=284  Identities=27%  Similarity=0.422  Sum_probs=220.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCC--------CCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            468999999999999999999999999999999986543   23457999998885        788999999875322 


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--------
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--------  174 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--------  174 (373)
                      .+..++|+||||+++++.+.+....  ...+++..++.++.||+.||.|||++.||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            2456789999999998888877542  356999999999999999999999754899999999999998764        


Q ss_pred             ----------------------------------------CceeEeeccceeeccCCCCcccccccccccccccccCCCC
Q 017341          175 ----------------------------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  214 (373)
Q Consensus       175 ----------------------------------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  214 (373)
                                                              ..+||+|||++.....  ......||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCC-
Confidence                                                    2699999999987533  234567899999999997654 


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCcCccccc----CCCcCC-CCcc
Q 017341          215 YTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIKA-HPWH  283 (373)
Q Consensus       215 ~~~~~DiwslG~il~~lltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~  283 (373)
                      ++.++|||||||++|+|++|+.||.+.+      ....+..+.+..+.++...+.........+.    ...... .++.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998765      4566777888888877665432211100000    000000 0000


Q ss_pred             --------ccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          284 --------KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       284 --------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                              ..++...+.++.+||.+||+.||.+|||++|+|+||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                    0011234567899999999999999999999999999974

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-48  Score=353.32  Aligned_cols=252  Identities=28%  Similarity=0.428  Sum_probs=210.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..|...+.||+|+||.||+|++..+|+.||+|.+....    ....+|+.+++.++||||+++++++..     ....++
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l  119 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWV  119 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence            46999999999999999999999999999999986433    224579999999999999999998844     334889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+.+ +|.+.+.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus       120 v~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          120 LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  192 (321)
T ss_dssp             EECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-cEEEeeeeeeeecc
Confidence            9999985 7777664     25689999999999999999999998 999999999999999888 89999999987664


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......           .
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------~  260 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-----------K  260 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-----------C
T ss_pred             cCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------C
Confidence            432 23456799999999999654 5899999999999999999999999988776666555432100           0


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      .               .....+++++.++|.+||+.||.+|||++++++||||....
T Consensus       261 ~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          261 L---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             C---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             c---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            0               01135788999999999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.8e-48  Score=353.89  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=199.5

Q ss_pred             cccceEee-eeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHh-CCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+.|++. +.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++. ++||||+++++++.     +..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~   84 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EED   84 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCC
Confidence            34589995 78999999999999999999999999986543    234579999988 47999999999884     334


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--ceeEeecc
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ikl~Dfg  183 (373)
                      .+|+||||+. ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.  .+||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            5889999998 5888888764    5689999999999999999999998 9999999999999987762  39999999


Q ss_pred             ceeeccCCC--------CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH------
Q 017341          184 SAKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD------  245 (373)
Q Consensus       184 ~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~------  245 (373)
                      ++.......        ......||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+....+      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            986543211        12234689999999998531    237889999999999999999999998764321      


Q ss_pred             ---------HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017341          246 ---------QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  316 (373)
Q Consensus       246 ---------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll  316 (373)
                               ....+.....                 .++        ......+++++.+||.+||+.||.+|||++|++
T Consensus       240 ~~~~~~~~~~~~~i~~~~~-----------------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKY-----------------EFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCC-----------------CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhccCc-----------------ccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                     1222222100                 000        001135789999999999999999999999999


Q ss_pred             cCCCccccCC
Q 017341          317 IHPFFDELRD  326 (373)
Q Consensus       317 ~hp~~~~~~~  326 (373)
                      +||||++...
T Consensus       295 ~hp~~~~~~~  304 (316)
T 2ac3_A          295 QHPWVQGCAP  304 (316)
T ss_dssp             HSTTCC----
T ss_pred             cChhhcCCCC
Confidence            9999998643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=348.88  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=187.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++     .+.
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence            4568999999999999999999999999999999985432       3345799999999999999999988     444


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+.++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~  158 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGL  158 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEEeecc
Confidence            568899999985 888877643   35689999999999999999999998 999999999999999888 799999999


Q ss_pred             eeeccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          185 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       185 a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      +...... .......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+..           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------  226 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------  226 (278)
T ss_dssp             CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence            9765432 223356789999999998654 478999999999999999999999987654332221110           


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                            ...            ..+..++.++.++|.+||+.||.+|||++++++||||....
T Consensus       227 ------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 ------ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ------SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ------ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                  000            12245789999999999999999999999999999998743

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=351.86  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=213.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+....        ....+|+.+++.++||||+++++++..   .+.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            468999999999999999999999999999999985432        334589999999999999999998753   334


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..+++||||+.+++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~-~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGG-TLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCC-cEEeeccccc
Confidence            4578999999988887776543  46799999999999999999999998 999999999999999888 8999999999


Q ss_pred             eeccCCC---CcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          186 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       186 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      .......   ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+....+.+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence            7654221   123456899999999986532 24779999999999999999999999887766655554310       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                                .            .++..+++.+.+||.+||..||.+|||++++++||||+....+.
T Consensus       230 ----------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 ----------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ----------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ----------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                      0            12246789999999999999999999999999999999866543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.5e-48  Score=346.31  Aligned_cols=252  Identities=28%  Similarity=0.461  Sum_probs=213.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence            34578999999999999999999999999999999885421       2345799999999999999999988     34


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg  159 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKG-ELKIADFG  159 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCC-CEEEeccc
Confidence            4568899999985 888888764    5689999999999999999999988 999999999999999888 79999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ++..... .......||+.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+....         
T Consensus       160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  228 (284)
T 2vgo_A          160 WSVHAPS-LRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------  228 (284)
T ss_dssp             TCEECSS-SCBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ccccCcc-cccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------
Confidence            9875533 233456789999999999654 48999999999999999999999999887766555544310         


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                              .            .++..++.++.++|.+||+.||.+|||++++++||||+...
T Consensus       229 --------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 --------L------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             --------c------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                    0            12246789999999999999999999999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.7e-48  Score=355.30  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=200.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC------
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE------  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  102 (373)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++....     ....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            468999999999999999999999999999999986432     234579999999999999999998755321      


Q ss_pred             ----------------------------------------------CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCH
Q 017341          103 ----------------------------------------------KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPL  135 (373)
Q Consensus       103 ----------------------------------------------~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~  135 (373)
                                                                    ....++++|||||.+ +|.+.+..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          223458999999985 88888875432 233566


Q ss_pred             HHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCC-------------Cccccccccc
Q 017341          136 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNISYICSRY  202 (373)
Q Consensus       136 ~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~-------------~~~~~~gt~~  202 (373)
                      ..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            67899999999999999998 999999999999999888 89999999998764432             1234568999


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCc
Q 017341          203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  282 (373)
Q Consensus       203 y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (373)
                      |+|||++.+. .++.++|||||||++|+|++|..|+..     ....+........+.                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc----------------------
Confidence            9999999764 489999999999999999998766521     111111111110000                      


Q ss_pred             cccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          283 HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                         .....++++.+||.+||+.||.+|||++|+++||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               012356788999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-47  Score=353.26  Aligned_cols=282  Identities=28%  Similarity=0.502  Sum_probs=219.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEE-CCCCcEEEEEEecccc---cchHHHHHHHHhCCCC------CeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKC-LETGEAVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|.+ ..+++.||+|.+....   ....+|+.+++.++|+      +++++++++     
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            346899999999999999999998 5688999999986543   2345788888888655      489998887     


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC----------
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----------  172 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~----------  172 (373)
                      ....++++||||++++|.+.+....  ..++++..++.++.||+.||+|||++ ||+||||||+||+++.          
T Consensus        87 ~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           87 EHHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             ccCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCc
Confidence            3344689999999889999887643  24688999999999999999999998 9999999999999987          


Q ss_pred             ---------CCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 017341          173 ---------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  243 (373)
Q Consensus       173 ---------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~  243 (373)
                               ++ .+||+|||++....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus       164 ~~~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          164 IKRDERTLINP-DIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             --CEEEEESCC-CEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccccCC-CceEeeCcccccCc--cccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                     44 69999999997643  233456789999999999654 489999999999999999999999999998


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcC-ccc---ccCCCc---------CCCCccc--cccCCCChhHHHHHHhhcCcCCCC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPN-YTE---FKFPQI---------KAHPWHK--IFQKRMPPEAVDLVSRLLQYSPNL  308 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~-~~~---~~~~~~---------~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~  308 (373)
                      .+....+....+..+...+...... +..   ......         ...+...  ......++++.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            8888888888777766544332110 000   000000         0000000  011224578999999999999999


Q ss_pred             CCCHHHHhcCCCccccCC
Q 017341          309 RSTALEALIHPFFDELRD  326 (373)
Q Consensus       309 R~t~~~ll~hp~~~~~~~  326 (373)
                      |||++|+++||||+.++.
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999998753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.6e-48  Score=350.08  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=211.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|.+....    ....+|+.+++.++||||+++++++     .+...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEE
Confidence            3458999999999999999999999999999999986532    2345899999999999999999987     344568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE---cCCCCceeEeeccc
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGS  184 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~ikl~Dfg~  184 (373)
                      ++||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .++|+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~  155 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENS-KIMITDFGL  155 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTC-CEEBCSCST
T ss_pred             EEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCC-CEEEccCCc
Confidence            89999998 5888887654    5689999999999999999999998 99999999999999   5555 799999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+.....       
T Consensus       156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------  226 (304)
T 2jam_A          156 SKMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF-------  226 (304)
T ss_dssp             TCCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC-------
T ss_pred             ceecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            865422 223445789999999999654 48999999999999999999999999888777666665421110       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                        ...+...+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          227 ------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                              011224688999999999999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.3e-48  Score=353.48  Aligned_cols=256  Identities=30%  Similarity=0.473  Sum_probs=205.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....            ....+|+.+++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            458999999999999999999999999999999885432            234589999999999999999988732  


Q ss_pred             CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--cee
Q 017341          102 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLK  178 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ik  178 (373)
                         .. +|+||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+|
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEE
Confidence               22 6899999985 88777653    36799999999999999999999998 9999999999999987652  499


Q ss_pred             EeeccceeeccCCCCccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017341          179 LCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||.+......+.........
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998764333333557899999999974  3445899999999999999999999999876544333322221110


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      ..                        .......++.++.+||.+||+.||.+|||++++++||||+..
T Consensus       238 ~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             cc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            00                        001124678999999999999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=357.54  Aligned_cols=277  Identities=19%  Similarity=0.298  Sum_probs=209.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+++++.++||||+++++++..   .+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~   83 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH   83 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCce
Confidence            3468999999999999999999999999999999986432     233589999999999999999998743   33345


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE----cCCCCceeEeec
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDF  182 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll----~~~~~~ikl~Df  182 (373)
                      +++||||+. ++|.+.+..... ...+++..++.++.||+.||.|||++ ||+||||||+||++    +.++ .+||+||
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~Df  160 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDF  160 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCE-EEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCc-eEEEccC
Confidence            789999998 588888876432 34489999999999999999999998 99999999999998    6655 7999999


Q ss_pred             cceeeccCCCCcccccccccccccccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEII  251 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~----~~~~~~i~  251 (373)
                      |+++............||+.|+|||++..       ...++.++|||||||++|+|++|+.||.....    .+...++.
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            99988766655566789999999999852       34589999999999999999999999976443    33344443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  319 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp  319 (373)
                      ..........+.......  +...  ...+....+...++..+.+||.+||+.||++|||++|+|+||
T Consensus       241 ~~~p~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGP--IDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHCCTTCCEEEECSTTCC--EEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCc--cccC--ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            321111100000000000  0000  000111112234567899999999999999999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.9e-48  Score=363.87  Aligned_cols=266  Identities=15%  Similarity=0.141  Sum_probs=190.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhC--CCCCeeecceeee------
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL--DHPNVVSLKHCFF------   98 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l--~h~~iv~~~~~~~------   98 (373)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++.....       ...+|+.+++.+  +||||++++..++      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3469999999999999999999999999999999876432       223564444444  6999888653332      


Q ss_pred             -ecCC--------C----CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHhHccCCce
Q 017341           99 -STTE--------K----DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------KLYFYQICRALAYIHNTIGVC  159 (373)
Q Consensus        99 -~~~~--------~----~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~------~~i~~qil~~L~~LH~~~~iv  159 (373)
                       ....        .    ....+|+|||||+++|.+++.....   .++....      ..++.||+.||+|||++ ||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK-GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCc
Confidence             1110        0    0145789999999999999987632   2334444      56679999999999998 999


Q ss_pred             eecCCCCcEEEcCCCCceeEeeccceeeccCCCCcccccccccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 017341          160 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLF  238 (373)
Q Consensus       160 H~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwslG~il~~lltG~~pf  238 (373)
                      ||||||+|||++.++ .+||+|||+++...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999988 89999999998652  22225567899999999964 135899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          239 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       239 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+.....                    ...+............+.......+++++.+||.+||+.||++|||++++|+|
T Consensus       294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            8764321                    00011111111111111111224789999999999999999999999999999


Q ss_pred             CCccccCC
Q 017341          319 PFFDELRD  326 (373)
Q Consensus       319 p~~~~~~~  326 (373)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.1e-47  Score=355.74  Aligned_cols=292  Identities=29%  Similarity=0.465  Sum_probs=221.0

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCC-----------CCCeeecc
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLK   94 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~   94 (373)
                      |.+...++|++.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+.+++.++           ||||++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            34445678999999999999999999999999999999986543   23457888888776           89999999


Q ss_pred             eeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC
Q 017341           95 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                      +++.... .+..+++++|||++++|.+.+....  ...+++..++.++.||+.||.|||++.||+||||||+||+++.++
T Consensus        93 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           93 DHFNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHhhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            9885432 3445789999999889999888643  355899999999999999999999744999999999999995322


Q ss_pred             -----CceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------c
Q 017341          175 -----HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------G  243 (373)
Q Consensus       175 -----~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~------~  243 (373)
                           ..+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+      .
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence                 2699999999976533  23455789999999999765 48999999999999999999999998764      4


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCccc-------ccCCCcCCCCcc------ccccCCCChhHHHHHHhhcCcCCCCCC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTE-------FKFPQIKAHPWH------KIFQKRMPPEAVDLVSRLLQYSPNLRS  310 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~  310 (373)
                      .+.+..+....+.++...+.........       .........+..      ..++...+.++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            5667778887777766543321100000       000000000000      012234567899999999999999999


Q ss_pred             CHHHHhcCCCccccCC
Q 017341          311 TALEALIHPFFDELRD  326 (373)
Q Consensus       311 t~~~ll~hp~~~~~~~  326 (373)
                      |++|+|+||||++...
T Consensus       327 t~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             CHHHHHTCGGGTTCTT
T ss_pred             CHHHHhhChhhhcccC
Confidence            9999999999998644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-48  Score=358.82  Aligned_cols=259  Identities=28%  Similarity=0.440  Sum_probs=207.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHhC-CCCCeeecceeeee
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFS   99 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~   99 (373)
                      ...++|++.+.||+|+||.||+|++.   .+++.||+|++....        ....+|+.+++.+ +||||+++++++. 
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-  129 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-  129 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe-
Confidence            44579999999999999999999984   589999999885422        2344799999999 6999999999883 


Q ss_pred             cCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          100 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                          ....+++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+|
T Consensus       130 ----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  199 (355)
T 1vzo_A          130 ----TETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVV  199 (355)
T ss_dssp             ----ETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEE
T ss_pred             ----eCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-cEE
Confidence                33458899999985 888888754    5689999999999999999999998 999999999999999888 899


Q ss_pred             EeeccceeeccCCC--CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          179 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       179 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      |+|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.+...
T Consensus       200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            99999998653322  22345789999999999652 3478999999999999999999999976543322222222110


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                              ...                 ..++..++..+.+||.+||..||.+||     |++++++||||+.+++
T Consensus       280 --------~~~-----------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          280 --------KSE-----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             --------HCC-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             --------ccC-----------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                    000                 012256889999999999999999999     9999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-47  Score=344.35  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=204.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+..+..+ +||||+++++++.     +
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----E   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----E
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----c
Confidence            34568999999999999999999999999999999986532      2234688888888 9999999999884     3


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC---------
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---------  174 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~---------  174 (373)
                      ...+++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccc
Confidence            3458899999985 99999987766667899999999999999999999998 999999999999998432         


Q ss_pred             ---------CceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017341          175 ---------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  245 (373)
Q Consensus       175 ---------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~  245 (373)
                               ..+||+|||.+......   ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     26999999999865432   2346899999999997655567899999999999999999988754422  


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                       ...+.+.                   ..+         .++..+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       237 -~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQG-------------------RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTT-------------------CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcC-------------------CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             2222211                   000         1235689999999999999999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-47  Score=346.05  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=212.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     .+...
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCe
Confidence            458999999999999999999999999999999985432      2345799999999999999999987     33445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccc
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  184 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~  184 (373)
                      +++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            889999997 5888777654    5689999999999999999999998 999999999999997654  2699999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............+|+.|+|||++.+  .++.++|+||||+++|+|++|+.||.+.+..+....+.......       
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  241 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF-------  241 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred             ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            876554444455678999999999854  38999999999999999999999999988776666555421100       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                              ..+          ....+++++.++|.+||+.||.+|||++++++||||++..+
T Consensus       242 --------~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          242 --------DLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------CSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------Cch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                    000          11357899999999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.6e-48  Score=344.96  Aligned_cols=255  Identities=27%  Similarity=0.356  Sum_probs=206.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     +....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence            468999999999999999999999999999999985432     23457999999999999999999873     34457


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||.+..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence            899999985 77666543    35689999999999999999999998 999999999999999888 799999999876


Q ss_pred             ccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          188 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       188 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      .....   ......||+.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+..............        
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------  226 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--------
Confidence            53221   2335578999999999976554577999999999999999999999876543322221111000        


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                              ..+          ....+++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus       227 --------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          227 --------YLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             --------TST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             --------ccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                    000          0135789999999999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.9e-47  Score=342.96  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=215.1

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      |...++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..   ..
T Consensus         2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~   78 (279)
T 2w5a_A            2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RT   78 (279)
T ss_dssp             -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GG
T ss_pred             CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CC
Confidence            345679999999999999999999999999999999986432      224579999999999999999997754   23


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC-----ceeecCCCCcEEEcCCCCcee
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~-----ivH~Dlkp~NIll~~~~~~ik  178 (373)
                      ...+++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ |     |+||||||+||+++.++ .+|
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~-~~k  156 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVK  156 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSS-CEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCC-CEE
Confidence            4458899999985 99999987765566799999999999999999999998 8     99999999999999888 899


Q ss_pred             EeeccceeeccCCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          179 LCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....  
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--  233 (279)
T 2w5a_A          157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--  233 (279)
T ss_dssp             ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred             EecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence            999999876533221 1245689999999999654 489999999999999999999999998876665555544210  


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                       +         .++..++.++.++|.+||+.||.+|||++++++|+|+.+-.
T Consensus       234 -----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 -----------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -----------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -----------------c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                             0         12246789999999999999999999999999999998743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.8e-48  Score=352.02  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..+..       ...+|+.+++.++||||+++++++.... ...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence            45689999999999999999999999999999999865421       2347888899999999999999875433 233


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .+.|+||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  162 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred             cccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence            45689999997 5888888754    5689999999999999999999998 999999999999999888 799999999


Q ss_pred             eeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +........    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+.. 
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-  240 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-  240 (311)
T ss_dssp             C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-
Confidence            976533221    2245689999999999765 4899999999999999999999999998877766665553211111 


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                              .....++.++.++|.+||+.||.+||++.+++.|+|++....
T Consensus       241 ------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          241 ------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                    112468999999999999999999999999999999986543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-49  Score=372.47  Aligned_cols=255  Identities=17%  Similarity=0.223  Sum_probs=195.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHH---HHHhCCCCCeeecce-------e
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQ---TMRLLDHPNVVSLKH-------C   96 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~---~l~~l~h~~iv~~~~-------~   96 (373)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.   +++.++||||+++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999986331       23347884   455558999999984       3


Q ss_pred             eeecC---------CCCce---eEEEEEecccccHHHHHHHhhhcCC---CCCHHHHHHHHHHHHHHHHHhHccCCceee
Q 017341           97 FFSTT---------EKDEL---YLNLVLEYVPETVHRVIKHHYKMSQ---RMPLIYVKLYFYQICRALAYIHNTIGVCHR  161 (373)
Q Consensus        97 ~~~~~---------~~~~~---~~~lv~e~~~g~l~~~l~~~~~~~~---~~~~~~~~~i~~qil~~L~~LH~~~~ivH~  161 (373)
                      +....         +.+..   ..|++|||++|+|.+.+........   .+++..++.++.||+.||+|||++ ||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            32211         11111   3789999999999999987543221   233477888999999999999998 99999


Q ss_pred             cCCCCcEEEcCCCCceeEeeccceeeccCCCCcccccccccccccccccCC----------CCCCCchhHHHHHHHHHHH
Q 017341          162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAEL  231 (373)
Q Consensus       162 Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~l  231 (373)
                      ||||+|||++.++ .+||+|||+++..  +.......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999888 8999999999863  223345567 999999999754          2489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC
Q 017341          232 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  311 (373)
Q Consensus       232 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  311 (373)
                      ++|+.||.+.+.......+.                                 .....+++++.+||.+||+.||.+|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            99999997654322111000                                 011468999999999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 017341          312 ALEALIHPFFDELRD  326 (373)
Q Consensus       312 ~~~ll~hp~~~~~~~  326 (373)
                      +.++++||||++++.
T Consensus       354 ~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          354 PLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHTSHHHHHHHH
T ss_pred             HHHHhhChHHHHHHH
Confidence            999999999988653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-47  Score=352.62  Aligned_cols=281  Identities=27%  Similarity=0.470  Sum_probs=218.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCC-cEEEEEEecccc---cchHHHHHHHHhCCCCC------eeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||.||+|.+..++ +.||+|.+....   ....+|+.+++.++|++      ++.+.+++     .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----N   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----E
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----e
Confidence            468999999999999999999998777 689999986532   23457889998887655      78887776     3


Q ss_pred             CceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE-------------
Q 017341          104 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-------------  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll-------------  170 (373)
                      ...++++||||+++++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||++             
T Consensus        93 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           93 FHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccc
Confidence            344588999999999888887642  25689999999999999999999998 99999999999999             


Q ss_pred             ------cCCCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 017341          171 ------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  244 (373)
Q Consensus       171 ------~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~  244 (373)
                            +.++ .+||+|||++....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus       170 ~~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNT-SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCC-CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCC-cEEEeecCcccccc--ccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  4455 79999999997643  233456799999999999654 4899999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccc----cCCCc---------CCCCccc--cccCCCChhHHHHHHhhcCcCCCCC
Q 017341          245 DQLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQI---------KAHPWHK--IFQKRMPPEAVDLVSRLLQYSPNLR  309 (373)
Q Consensus       245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~---------~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R  309 (373)
                      +....+.+..+..+...+.........+    ..+..         ...++..  ......+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            8888888888777665443221100000    00000         0000000  0011234589999999999999999


Q ss_pred             CCHHHHhcCCCccccCC
Q 017341          310 STALEALIHPFFDELRD  326 (373)
Q Consensus       310 ~t~~~ll~hp~~~~~~~  326 (373)
                      ||++|+|+||||+++++
T Consensus       326 pt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CCHHHHTTSGGGGGCCH
T ss_pred             cCHHHHhcChhhcCCCh
Confidence            99999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=353.29  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCC--CCeeecceeeeecCCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~  104 (373)
                      ...+|++.+.||+|+||.||++.+ .+++.||+|++....      ....+|+.+++.++|  |||+++++++     .+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~   80 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT   80 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----ee
Confidence            345899999999999999999997 568999999986432      223579999999987  9999999987     34


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..++|+|||+.+++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~-~~kl~DFG~  153 (343)
T 3dbq_A           81 DQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGI  153 (343)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TT-EEEECCCSS
T ss_pred             CCEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CC-cEEEeeccc
Confidence            4568999998888999988763    6789999999999999999999998 999999999999997 45 799999999


Q ss_pred             eeeccCCCC---cccccccccccccccccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH
Q 017341          185 AKVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEI  250 (373)
Q Consensus       185 a~~~~~~~~---~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i  250 (373)
                      ++.......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||.+.... .....+
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence            976543322   234579999999999853          245788999999999999999999999875432 222221


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ..   ..                        ....++...+.++.+||.+||+.||.+|||++++++||||+....
T Consensus       234 ~~---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          234 ID---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             HC---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             hc---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            11   00                        001123456789999999999999999999999999999986443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.3e-47  Score=358.54  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCC--CCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|++.+.||+|+||.||+|.+.. ++.||+|.+....      ....+|+.+++.++  ||||+++++++.     ..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~  128 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  128 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cC
Confidence            3469999999999999999999865 8999999986443      23357999999997  599999999873     34


Q ss_pred             eeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          106 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       106 ~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .++|+|||+.+++|.+++...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||++
T Consensus       129 ~~~~lv~E~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~-~~kl~DFG~a  201 (390)
T 2zmd_A          129 QYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIA  201 (390)
T ss_dssp             SEEEEEEECCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SS-CEEECCCSSS
T ss_pred             CEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CC-eEEEEecCcc
Confidence            458999997778999888753    5688999999999999999999998 999999999999996 45 7999999999


Q ss_pred             eeccCCCC---cccccccccccccccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q 017341          186 KVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEII  251 (373)
Q Consensus       186 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i~  251 (373)
                      +.......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|++||.+.... ..+..+.
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            76543321   2355799999999998641          35888999999999999999999999876433 2222222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ..              ..             ...++...+.++.+||.+||+.||.+|||++|+|+||||+....
T Consensus       282 ~~--------------~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 DP--------------NH-------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CT--------------TS-------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             Cc--------------cc-------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            10              00             00122345789999999999999999999999999999986544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.1e-47  Score=344.74  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=208.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|.+....    ....+|+.+++.++||||+++++++..     ...
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCe
Confidence            34568999999999999999999999999999999885432    234579999999999999999998843     345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++||||+++ +|...+...   ...+++..++.++.||+.||.|||++ |++||||||+||+++.++ .+||+|||++.
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  165 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSA  165 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTS-CEEECCCHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCC-CEEEEECCCCc
Confidence            8899999985 777776653   36699999999999999999999998 999999999999999888 79999999875


Q ss_pred             eccCC-CCccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ..... .......||+.|+|||++.    ....++.++|||||||++|+|++|..||...+.......+.......    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  241 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----  241 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----
Confidence            32211 1223457899999999984    34458899999999999999999999999888766665554421000    


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                            ...+..++.++.++|.+||+.||.+|||++++++||||+....
T Consensus       242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                                  0112457889999999999999999999999999999988653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=345.94  Aligned_cols=265  Identities=23%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhC-CCCCeeecceeeeecCC-C
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-K  103 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~  103 (373)
                      ......++|++.+.||+|+||.||+|.+..+|+.||+|.+....   ....+|+.+++.+ +||||+++++++..... .
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            34455678999999999999999999999999999999885432   3455899999998 79999999998865432 1


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ....+++||||+++ +|.+++....  ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~-~~kl~Df  173 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDF  173 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCC-CEEEeeC
Confidence            24568899999985 8988887643  35689999999999999999999998 999999999999999888 7999999


Q ss_pred             cceeeccCCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |++....... ......||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+.......+.....  
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--  251 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--  251 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--
Confidence            9987653322 2334578999999999852    34588999999999999999999999988876665554433100  


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                               .......++..+.+||.+||..||.+|||++++++||||++.
T Consensus       252 -------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 -------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             -------------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             -------------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                     001124678999999999999999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=342.84  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=207.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....  ....+|+.+++.++||||+++++++..     ...+++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEE
Confidence            458999999999999999999999999999999986543  334689999999999999999998843     3457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+++ +|.+.+...   ...+++..++.++.||+.||.|||+. |++|+||||+||+++.++ .+||+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence            999986 888887643   46799999999999999999999998 999999999999999888 799999999976543


Q ss_pred             CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      .. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.....           +.+
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~  245 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-----------PTF  245 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------CCC
T ss_pred             hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----------ccc
Confidence            32 23355789999999999654 489999999999999999999999988776555443332100           000


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                     ..+..++.++.+||.+||..||.+|||++++++||||+...
T Consensus       246 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          246 ---------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ---------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                           01235788999999999999999999999999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.5e-48  Score=349.55  Aligned_cols=269  Identities=27%  Similarity=0.391  Sum_probs=193.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence            44568999999999999999999998899999999875432     234478889999999999999998843     33


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYK----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~----~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      ..++||||++ ++|.+.+.....    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~d  164 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDG-SVQIAD  164 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCC-CEEEEe
Confidence            4789999997 588888875432    235589999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCC------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          182 FGSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       182 fg~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      ||++.......      ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.............
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            99986543221      123457899999999986544589999999999999999999999998776655544332110


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ...                   ............++.++.++|.+||+.||.+|||++++++||||+...+
T Consensus       245 ~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 PSL-------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCT-------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             Ccc-------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            000                   0000001122468899999999999999999999999999999988654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-47  Score=354.89  Aligned_cols=283  Identities=24%  Similarity=0.385  Sum_probs=209.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+..+.     ....+|+.+++.++||||+++++++..     ..
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  104 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG  104 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence            34568999999999999999999999999999999986542     234579999999999999999998843     34


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  179 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVS  179 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCC
T ss_pred             EEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCC
Confidence            58899999985 998888764    56899999999999999999999733899999999999999988 7999999998


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh-
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC-  264 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-  264 (373)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.............. 
T Consensus       180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          180 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             cccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            654322 23346789999999999654 589999999999999999999999988765554332211111100000000 


Q ss_pred             --cCcCcccccCCC------------cCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          265 --MNPNYTEFKFPQ------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       265 --~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                        ....+..+....            .............++.++.+||.+||+.||.+|||++++|+||||+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence              000000000000            00000011112357889999999999999999999999999999988654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-46  Score=341.04  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=204.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+.
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence            3568999999999999999999999999999999885432       2335799999999999999999987     445


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+|+||||++| +|.+.+...    .++++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  157 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNK-TLKIFDFGI  157 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCSS
T ss_pred             CeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEEeCCC
Confidence            568899999985 888888754    5689999999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          185 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       185 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +.......  ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+......+...... +.    
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~----  231 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PN----  231 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CC----
T ss_pred             ccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CC----
Confidence            87553322  12345789999999999765 489999999999999999999999998876665444432110 00    


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                         ........+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus       232 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 -------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                               01112356899999999999999999999777777776655443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-46  Score=340.37  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=210.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ...+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence            347999999999999999999999999999999986432     334579999999999999999998843     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+++ +|.+.+.     ..++++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~  168 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQ  168 (303)
T ss_dssp             EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCC-CEEEeeccccee
Confidence            899999985 7877764     25689999999999999999999998 999999999999999888 899999999976


Q ss_pred             ccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          188 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       188 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..... ......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+....            
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------  235 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN------------  235 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred             cCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC------------
Confidence            54432 23456789999999999654 48899999999999999999999998877665554443310            


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                      ...+...++..+.+||.+||+.||.+|||++++++||||...
T Consensus       236 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 ----------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ----------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ----------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                            001224688999999999999999999999999999999774

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.9e-47  Score=350.25  Aligned_cols=266  Identities=24%  Similarity=0.374  Sum_probs=186.5

Q ss_pred             ccccceEeee-eeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           32 KQTISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        32 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ...++|.+.+ .||+|+||.||+|.+..+|+.||+|.+........+....++.++||||+++++++.... .+..++++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence            4456899965 699999999999999999999999998765544444455677889999999999875432 33566889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccceee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~a~~  187 (373)
                      ||||+.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||++..
T Consensus       104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999985 8988887542  35699999999999999999999998 999999999999998643  2599999999976


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.............+..           
T Consensus       181 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (336)
T 3fhr_A          181 TTQ-NALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-----------  247 (336)
T ss_dssp             C-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred             ccc-cccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----------
Confidence            532 233456789999999998544 4788999999999999999999999876544332221111000           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                        .....+        ......+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       248 --~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 --GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             --cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence              000000        00114689999999999999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=344.02  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=191.8

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc------hHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .....+|++.+.||+|+||.||+|.+..+|+.||+|.+......      ..++..+++.++||||+++++++.     +
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~   95 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----T   95 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----c
Confidence            34567999999999999999999999999999999998654321      123445678889999999999884     3


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...+++||||+++.+..+....   ...+++..++.++.||+.||.|||++.||+|+||||+||+++.++ .+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~  171 (318)
T 2dyl_A           96 NTDVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGI  171 (318)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CCcEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCC
Confidence            4458899999976665555433   467999999999999999999999722999999999999999888 899999999


Q ss_pred             eeeccCCCCccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~  259 (373)
                      +.............+|+.|+|||++.    ....++.++|||||||++|+|++|+.||.... ..+....+......   
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  248 (318)
T 2dyl_A          172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP---  248 (318)
T ss_dssp             C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---
T ss_pred             chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---
Confidence            97665544445567899999999985    23457889999999999999999999998743 33444444331100   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                              .     .+          ....+++++.++|.+||+.||.+|||++++++||||+...
T Consensus       249 --------~-----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 --------L-----LP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             --------C-----CC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             --------C-----CC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                    0     00          1135789999999999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.6e-47  Score=347.44  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=206.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCC--CCCeeecceeeee
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFS   99 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~   99 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....          ....+|+.+++.++  |+||+++++++  
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--  117 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--  117 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE--
Confidence            34568999999999999999999999999999999986432          33457999999996  59999999988  


Q ss_pred             cCCCCceeEEEEEeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCce
Q 017341          100 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  177 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~i  177 (373)
                         .+...+++|||++.  ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.+.+.+
T Consensus       118 ---~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          118 ---ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             ---ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEE
T ss_pred             ---ecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCE
Confidence               33445889999997  6888888764    5689999999999999999999998 999999999999999443389


Q ss_pred             eEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          178 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       178 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||+|||++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+      .+...    
T Consensus       190 kL~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~----  258 (320)
T 3a99_A          190 KLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG----  258 (320)
T ss_dssp             EECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC----
T ss_pred             EEeeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc----
Confidence            9999999986543 233456789999999998765545788999999999999999999996532      11110    


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                   .            ..++..+++++.+||.+||+.||.+|||++++++||||++...
T Consensus       259 -------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 -------------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             -------------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -------------c------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                         0            0122568999999999999999999999999999999988644

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.7e-46  Score=336.92  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCC--------
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTE--------  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------  102 (373)
                      .++|++.+.||+|+||.||+|++..+|+.||+|.+....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            458999999999999999999999999999999986433   234579999999999999999998754321        


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      .....+|+||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCC-CEEEee
Confidence            345678999999984 999888753   34578889999999999999999998 999999999999999888 799999


Q ss_pred             ccceeeccCC---------------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-H
Q 017341          182 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-D  245 (373)
Q Consensus       182 fg~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~  245 (373)
                      ||++......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||...... .
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998755321               112345689999999999765568999999999999999998   55432221 2


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                      ....+...            .     ..        +...++...+..+.++|.+||+.||.+|||++++++||||+..
T Consensus       237 ~~~~~~~~------------~-----~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSV------------S-----IE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHST------------T-----CC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhcccc------------c-----cc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            22221110            0     00        0111334677889999999999999999999999999999763

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-46  Score=348.92  Aligned_cols=272  Identities=20%  Similarity=0.335  Sum_probs=208.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------------------cchHHHHHHHHhCCCCCe
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNV   90 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~~i   90 (373)
                      ...++|++.+.||+|+||.||+|.+  +|+.||+|.+....                     ....+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            3456899999999999999999998  89999999985331                     445689999999999999


Q ss_pred             eecceeeeecCCCCceeEEEEEecccc-cHHHH------HHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-cCCceeec
Q 017341           91 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV------IKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRD  162 (373)
Q Consensus        91 v~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~------l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~~ivH~D  162 (373)
                      +++++++.     +...+++||||+++ +|.+.      +...  ....+++..++.++.||+.||.|||+ + ||+|||
T Consensus       106 ~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~d  177 (348)
T 2pml_X          106 LTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRD  177 (348)
T ss_dssp             CCCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCC
T ss_pred             ceEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecC
Confidence            99999883     34468899999986 77665      3321  14679999999999999999999998 7 999999


Q ss_pred             CCCCcEEEcCCCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCC
Q 017341          163 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGE  241 (373)
Q Consensus       163 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DiwslG~il~~lltG~~pf~~~  241 (373)
                      |||+||+++.++ .+||+|||.+...... ......||+.|+|||++.+...++. ++|||||||++|+|++|+.||.+.
T Consensus       178 l~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          178 VKPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999888 8999999999865433 3345678999999999976534555 999999999999999999999987


Q ss_pred             Cc-HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          242 SG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       242 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                      +. .+....+.........        ....+. .... ..........+++++.+||.+||+.||.+|||++++++|||
T Consensus       256 ~~~~~~~~~i~~~~~~~~~--------~~~~~~-~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          256 ISLVELFNNIRTKNIEYPL--------DRNHFL-YPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             SCSHHHHHHHTSCCCCCCC--------SSSSST-TTTC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CcHHHHHHHHhccCcCCcc--------chhhhh-cccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            76 4444443321000000        000000 0000 00011122568999999999999999999999999999999


Q ss_pred             ccccC
Q 017341          321 FDELR  325 (373)
Q Consensus       321 ~~~~~  325 (373)
                      |++..
T Consensus       326 f~~~~  330 (348)
T 2pml_X          326 LADTN  330 (348)
T ss_dssp             GTTCC
T ss_pred             ccCCC
Confidence            98754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.7e-46  Score=341.67  Aligned_cols=250  Identities=19%  Similarity=0.198  Sum_probs=202.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|.+...  .....+|+.+++.+ +||||+++++++.     +..+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            3456899999999999999999999999999999988643  34467899999999 9999999999873     34458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc-----eeEeecc
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFG  183 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~-----ikl~Dfg  183 (373)
                      ++||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .     +||+|||
T Consensus        81 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg  155 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPG-NKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGG-GTCTTSEEECCCT
T ss_pred             EEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCC-CCCCceEEEEEcc
Confidence            899999988999988764   36799999999999999999999998 999999999999999877 5     9999999


Q ss_pred             ceeeccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Q 017341          184 SAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIK  252 (373)
Q Consensus       184 ~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~---~~~~i~~  252 (373)
                      +++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+   .+..+..
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9987544322        2356799999999999664 48999999999999999999999998854333   3333332


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .......+.                        .....+ ++.++|..||+.||.+||+++++++
T Consensus       235 ~~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 TKRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            211111111                        112344 9999999999999999999988865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.2e-46  Score=338.19  Aligned_cols=254  Identities=22%  Similarity=0.336  Sum_probs=197.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ....+|++.+.||+|+||.||+|++  +|+.||+|.+.....      ...+|+.+++.++||||+++++++     .+.
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            3456899999999999999999987  688999999865432      234799999999999999999988     334


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcCCCCceeEeec
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ..+++||||+.+ +|.+.+..... ...+++..++.++.||+.||+|||++ |  |+||||||+||+++.++ .+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~-~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY-TVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC-cEEECCC
Confidence            447899999985 88888875321 12489999999999999999999998 9  99999999999999888 8999999


Q ss_pred             cceeeccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          183 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       183 g~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      |+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......     
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  257 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-----  257 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             CCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Confidence            9997543322 23356789999999999654 4899999999999999999999999988776665554321100     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDE  323 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~--hp~~~~  323 (373)
                                            ..++..+++++.+||.+||+.||.+|||++++++  +++++.
T Consensus       258 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                  0123568999999999999999999999999987  555544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=334.86  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=200.5

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      |.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++++.     ....+++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEEE
Confidence            333449999999999999999999999999886543    23457999999999999999999883     334588999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCC
Q 017341          113 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  191 (373)
Q Consensus       113 e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~  191 (373)
                      ||++ ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+|+||||+||+++...+.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9997 58888887542 224567889999999999999999998 99999999999999973338999999999765432


Q ss_pred             C-CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          192 E-PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       192 ~-~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                      . ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..................             
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  243 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------  243 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence            2 23355789999999998543 23788999999999999999999999765443322111111000             


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                   ...++..+++++.++|.+||+.||.+|||++++++||||+....
T Consensus       244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                         00123568899999999999999999999999999999987543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-45  Score=332.10  Aligned_cols=252  Identities=19%  Similarity=0.228  Sum_probs=204.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+...  .....+|+.+++.+ +|+|++++++++     .+....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~   82 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV   82 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeE
Confidence            345899999999999999999999999999999988543  34567899999999 799999999877     3444588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC----ceeEeeccce
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH----QLKLCDFGSA  185 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~----~ikl~Dfg~a  185 (373)
                      +||||++++|.+.+...   ..++++..++.++.||+.||.|||++ ||+||||||+||+++.++.    .+||+|||++
T Consensus        83 lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           83 LVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            99999988999998764   35699999999999999999999988 9999999999999987661    3999999999


Q ss_pred             eeccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHh
Q 017341          186 KVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVL  254 (373)
Q Consensus       186 ~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---~~~~~~i~~~~  254 (373)
                      ........        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.   ......+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            87644322        2345789999999999654 489999999999999999999999988543   33333333321


Q ss_pred             CCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ..+....                        ....+++++.++|.+||+.||.+|||++++++.
T Consensus       238 ~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111111                        124688999999999999999999999999753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.2e-46  Score=342.09  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=186.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-----hHHHHH-HHHhCCCCCeeecceeeeecCCCCce
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----KNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+......     ..+|.. +++.++||||+++++++.     +..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence            346899999999999999999999999999999998654221     123444 667789999999999884     334


Q ss_pred             eEEEEEecccccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..++||||++++|.+.+..... ....+++..++.++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            5789999999998888775432 2567899999999999999999999744999999999999999888 8999999999


Q ss_pred             eeccCCCCccccccccccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      .............||+.|+|||++.   ....++.++|||||||++|+|++|+.||.+.+....  .+...         
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---------  242 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV---------  242 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC---------
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH---------
Confidence            7665444444557899999999983   233488999999999999999999999986532110  00000         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                             .....+     .+.......+++++.+||.+||+.||.+|||+.++++||||....
T Consensus       243 -------~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          243 -------VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                   000000     011112246889999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=335.92  Aligned_cols=249  Identities=25%  Similarity=0.468  Sum_probs=202.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+++++.++||||+++++++..     ...+
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   82 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRL   82 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCee
Confidence            3568999999999999999999999999999999885432    234579999999999999999998843     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+.+ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  157 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENK-NVVVADFGLARL  157 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCC-CEEEeeccccee
Confidence            899999985 888888763   36689999999999999999999998 999999999999999888 799999999976


Q ss_pred             ccCCCCc---------------ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-----H
Q 017341          188 LVKGEPN---------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-----L  247 (373)
Q Consensus       188 ~~~~~~~---------------~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~-----~  247 (373)
                      .......               ....||+.|+|||++.+. .++.++|||||||++|+|++|..||........     .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            5433221               145789999999999654 589999999999999999999999876432110     0


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          248 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      ....                               ....+..+++.+.++|.+||+.||++|||++++++  |++.++
T Consensus       237 ~~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          237 RGFL-------------------------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             HHHH-------------------------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             hccc-------------------------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            0000                               01123568899999999999999999999999987  666654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-45  Score=328.68  Aligned_cols=246  Identities=20%  Similarity=0.330  Sum_probs=203.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|++....   ....+|+.+++.++||||+++++++     .+...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence            4468999999999999999999986 57789999986543   3345899999999999999999988     3444588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+++ +|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999985 888887653   35689999999999999999999998 999999999999999888 8999999998754


Q ss_pred             cCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....  ......+|+.|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+..+....+......         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------  226 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred             cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------
Confidence            3221  12234567889999999654 48999999999999999999 99999988877666655432100         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                         ..+...++++.++|.+||+.||.+|||++++++|
T Consensus       227 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 -------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                               1124578999999999999999999999999976

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=346.64  Aligned_cols=255  Identities=19%  Similarity=0.229  Sum_probs=205.8

Q ss_pred             ccceEeeeeeeecCceEEEEEE-----ECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|++.+.||+|+||.||+|.     +..+++.||+|++....     ....+|+.+++.++||||+++++++.     
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----  144 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  144 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence            4689999999999999999999     45578899999985432     22447999999999999999999883     


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--Cce
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQL  177 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~i  177 (373)
                      +....++|||||. |+|.+++.....   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceE
Confidence            3344689999997 599999887642   224589999999999999999999998 999999999999998554  259


Q ss_pred             eEeeccceeeccCC---CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 017341          178 KLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  253 (373)
Q Consensus       178 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~  253 (373)
                      ||+|||+++.....   .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999754222   223345679999999999654 48999999999999999998 99999998877666655442


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      ...                            ..+..++..+.+||.+||+.||.+|||+++++++.++-.
T Consensus       303 ~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            100                            012467899999999999999999999999999987643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.2e-45  Score=342.85  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFST  100 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~  100 (373)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|.+.....     ...+|+.+++.+ +||||+++++++   
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            468999999999999999999974       3456899998865432     245799999999 899999999988   


Q ss_pred             CCCCceeEEEEEecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          101 TEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                        .+...+|+||||+.+ +|.+++.....            ....+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus       157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~N  233 (370)
T 2psq_A          157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARN  233 (370)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGG
T ss_pred             --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceeccccchhh
Confidence              334458899999985 99998886532            124588999999999999999999998 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      ||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       234 Ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          234 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999888 899999999986543322   2234568899999999764 48999999999999999999 9999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+....+.....                            ...+..++.++.++|.+||+.||.+|||+.+++++
T Consensus       312 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            665554433110                            01224688999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-45  Score=338.04  Aligned_cols=263  Identities=20%  Similarity=0.275  Sum_probs=191.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ...++|++.+.||+|+||.||+|.+..++.   .||+|.+....      ....+|+.+++.++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999877765   89999886432      234579999999999999999998854332


Q ss_pred             C-CceeEEEEEecccc-cHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCcee
Q 017341          103 K-DELYLNLVLEYVPE-TVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  178 (373)
Q Consensus       103 ~-~~~~~~lv~e~~~g-~l~~~l~~~~~~--~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ik  178 (373)
                      . .....++||||+.+ +|.+.+......  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+|
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~-~~k  177 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDM-TVC  177 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCC-CEE
Confidence            1 11234899999985 898888765422  22589999999999999999999998 999999999999999888 899


Q ss_pred             EeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 017341          179 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVL  254 (373)
Q Consensus       179 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~  254 (373)
                      |+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999976543322   1234567889999999654 48999999999999999999 999999988777666554421


Q ss_pred             CCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-------HHHHhcCCCccccC
Q 017341          255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-------ALEALIHPFFDELR  325 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~~ll~hp~~~~~~  325 (373)
                      ..                            ..+..+++++.+||.+||+.||.+|||       +++++.|||+....
T Consensus       257 ~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          257 RL----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CC----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            00                            112468899999999999999999999       78889999997743

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=336.94  Aligned_cols=248  Identities=22%  Similarity=0.323  Sum_probs=202.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....+|++.+.||+|+||.||+|.+..+++   .||+|.+....     ....+|+.+++.++||||+++++++     .
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            345689999999999999999999986655   49999986532     2345799999999999999999988     4


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCC-CEEECCC
Confidence            45558899999975 888888643   35699999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |+++........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  274 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP  274 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence            999876433221    123457789999999654 48999999999999999999 999999888777666654421111


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                  .+..+++++.++|.+||..||.+|||+.++++.
T Consensus       275 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 ----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                        124688999999999999999999999999863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.6e-45  Score=325.61  Aligned_cols=247  Identities=20%  Similarity=0.304  Sum_probs=204.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|.+....   ....+|+.+++.++||||+++++++     .+...+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPI   78 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCce
Confidence            34568999999999999999999875 57789999986543   3345899999999999999999987     444558


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  153 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDL-CVKVSDFGMTRY  153 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTC-CEEECCTTCEEE
T ss_pred             EEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCC-CEEEccCcccee
Confidence            89999997 5788888765   24589999999999999999999998 999999999999999888 899999999986


Q ss_pred             ccCCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          188 LVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       188 ~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      .......  ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+....+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  224 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------  224 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--------
Confidence            5433221  233457789999999654 48999999999999999999 99999988877666555432100        


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                          ..+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       225 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 --------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                0123568899999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.6e-46  Score=332.87  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=209.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecC-----------C
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-----------E  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~  102 (373)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+|+++++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            45899999999999999999999999999999999877778889999999999999999999874311           1


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      .....+++||||+++ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCC-CEEECc
Confidence            234568899999995 9999887643  35789999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          182 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       182 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ||++.............+|+.|+|||++.+. .++.++|+|||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            9999877655555566799999999999654 48999999999999999999998874211  11111100         


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                            ..++..++.++.++|.+||+.||.+|||+.++++|+|.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0012457889999999999999999999999999977543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=334.58  Aligned_cols=247  Identities=28%  Similarity=0.452  Sum_probs=198.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhC----CCCCeeecceeee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFF   98 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~~   98 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....          ....+|+.+++.+    +||||+++++++ 
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~-  107 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF-  107 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE-
Confidence            3568999999999999999999999999999999985432          2334799999988    899999999987 


Q ss_pred             ecCCCCceeEEEEEec-cc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc-CCCC
Q 017341           99 STTEKDELYLNLVLEY-VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTH  175 (373)
Q Consensus        99 ~~~~~~~~~~~lv~e~-~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~-~~~~  175 (373)
                          .+....++|||+ +. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++ .++ 
T Consensus       108 ----~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~-  177 (312)
T 2iwi_A          108 ----ETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRG-  177 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTT-
T ss_pred             ----ecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCC-
Confidence                334457899998 55 5898888764    5689999999999999999999998 999999999999999 555 


Q ss_pred             ceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          176 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       176 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      .+||+|||++...... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||....      .+...  
T Consensus       178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred             eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence            8999999999865433 34456789999999998665544568999999999999999999997532      11110  


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                     .            ..++..++.++.++|.+||+.||++|||++++++||||+....
T Consensus       249 ---------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ---------------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                           0            0122468899999999999999999999999999999987644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-45  Score=332.62  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=197.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCC--CCCeeecceeeeecCCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~  104 (373)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|.+....      ....+|+.+++.++  ||||+++++++.     +
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~   99 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T   99 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence            3458999999999999999999985 58999999986432      22357999999997  599999999873     3


Q ss_pred             ceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          105 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       105 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..++++|||+.+++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++. + .+||+|||+
T Consensus       100 ~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~-~~kL~Dfg~  172 (313)
T 3cek_A          100 DQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGI  172 (313)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSS
T ss_pred             CCEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-C-eEEEeeccc
Confidence            4468899998778999888753    5689999999999999999999998 9999999999999974 5 799999999


Q ss_pred             eeeccCCCC---cccccccccccccccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHH
Q 017341          185 AKVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEI  250 (373)
Q Consensus       185 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~-~~~~i  250 (373)
                      +........   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||....... ....+
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            876533221   2245689999999998541          357889999999999999999999998764332 22221


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ..   .           .             ....++...+.++.++|.+||+.||.+|||++++++||||+....
T Consensus       253 ~~---~-----------~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          253 ID---P-----------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             HC---T-----------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             Hh---c-----------c-------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            11   0           0             001122456789999999999999999999999999999987543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=351.07  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=192.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      .+|.+.+.||+|+||.||. ....+|+.||||++..+. ....+|+.+++.+ +||||+++++++     .+..++|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            4799999999999998763 344689999999986543 4457899999999 799999999887     4455689999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC---C-CceeEeeccceeec
Q 017341          113 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH---T-HQLKLCDFGSAKVL  188 (373)
Q Consensus       113 e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~---~-~~ikl~Dfg~a~~~  188 (373)
                      |||+|+|.+.+....   ...++..++.++.||+.||.|||++ ||+||||||+||+++.+   + ..+||+|||+++..
T Consensus        98 E~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999999999887542   3345555778999999999999998 99999999999999532   2 14789999999866


Q ss_pred             cCCC----CcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          189 VKGE----PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       189 ~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |.+||......... .+..   ...   
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~---~~~---  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLG---ACS---  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTT---CCC---
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhc---cCC---
Confidence            4332    2234579999999999964  3446889999999999999999 99999665433221 1110   000   


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                  .+..       ......+..+.+||.+||+.||.+|||++++++||||..+.
T Consensus       247 ------------~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          247 ------------LDCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             ------------CTTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ------------cccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                        0000       00012356789999999999999999999999999997643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.3e-45  Score=339.22  Aligned_cols=258  Identities=16%  Similarity=0.152  Sum_probs=198.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCC-----CcEEEEEEecccccchHHHH---------------HHHHhCCCCCeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKRYKNREL---------------QTMRLLDHPNVVSL   93 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~E~---------------~~l~~l~h~~iv~~   93 (373)
                      ..+|++.+.||+|+||.||+|.+..+     ++.||+|.+........+|+               ..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            44899999999999999999998764     58899999876554443343               34556679999999


Q ss_pred             ceeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc--
Q 017341           94 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN--  171 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~--  171 (373)
                      ++++.... .+..+.|+||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++  
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESS
T ss_pred             Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecC
Confidence            99876532 345678999999977999888764   36799999999999999999999998 999999999999998  


Q ss_pred             CCCCceeEeeccceeeccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 017341          172 PHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  243 (373)
Q Consensus       172 ~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~  243 (373)
                      .++ .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus       189 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          189 NPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             CTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            666 899999999976543221        1234599999999999655 489999999999999999999999986443


Q ss_pred             HHHHHHHHH-HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          244 VDQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       244 ~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ......... .........+...   +                ....++.++.++|..||+.||.+||+++++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~---~----------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKC---F----------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHH---S----------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHh---c----------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            333222222 1111111111100   0                01467899999999999999999999998875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.9e-44  Score=326.22  Aligned_cols=251  Identities=22%  Similarity=0.249  Sum_probs=201.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|.+....  ....+|+.+++.++|++++..+..+..    ...+.++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~l   82 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   82 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEE
Confidence            4568999999999999999999999999999999876443  345689999999999887777655432    3345789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc---CCCCceeEeeccceee
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~---~~~~~ikl~Dfg~a~~  187 (373)
                      ||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++   .++ .+||+|||++..
T Consensus        83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~  157 (296)
T 3uzp_A           83 VMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKK  157 (296)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred             EEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccc
Confidence            9999988999888754   35799999999999999999999998 999999999999994   555 899999999987


Q ss_pred             ccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCC
Q 017341          188 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGT  256 (373)
Q Consensus       188 ~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~---~~~~~~i~~~~~~  256 (373)
                      ......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.   .+....+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            644322        2355789999999999654 489999999999999999999999987432   2333333332111


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ....                        .....+|+++.++|.+||+.||.+|||++++++
T Consensus       237 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 TPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CchH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1111                        112467899999999999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.5e-45  Score=340.12  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             ccceEeeeeeeecCceEEEEEE-----ECCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.     +..+++.||+|.+....     ....+|+++++.+ +||||+++++++..   
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~---   97 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   97 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec---
Confidence            4689999999999999999999     55677999999986543     2245799999999 78999999998743   


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhc----------------------------------------------------
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKM----------------------------------------------------  129 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~----------------------------------------------------  129 (373)
                       ....+++|||||.+ +|.+.+......                                                    
T Consensus        98 -~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           98 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             -TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             -CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence             23347899999985 899888765321                                                    


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC---ccc
Q 017341          130 ----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NIS  196 (373)
Q Consensus       130 ----------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~  196 (373)
                                ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++........   ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                      12288999999999999999999998 999999999999999888 799999999976533322   224


Q ss_pred             ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017341          197 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  275 (373)
Q Consensus       197 ~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+...........+                  
T Consensus       255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  315 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------  315 (359)
T ss_dssp             CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred             cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence            5678999999999654 48999999999999999998 999999887655555444421110                  


Q ss_pred             CcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                               ..+..+++++.++|.+||+.||.+|||++++++|
T Consensus       316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                     1124578999999999999999999999999976

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-45  Score=340.94  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++||||+++++++     .+...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCC
Confidence            3468999999999999999999999999999999886432     2345799999999999999999988     33344


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+||||++ |+|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence            789999998 5898888764   24589999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          187 VLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       187 ~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ........   ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......      
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------  334 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------  334 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            64332111   122357789999999654 48999999999999999998 99999988766554444321100      


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                            ..+..+++++.++|.+||+.||.+|||++++++
T Consensus       335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  022457899999999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-44  Score=325.74  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=198.8

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----------cchHHHHHHHHhCCCCCeeecceeeeec
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....           ....+|+.+++.++||||+++++++   
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---   92 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---   92 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence            34568999999999999999999999999999999885322           2345799999999999999999987   


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcCCCC--
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTH--  175 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~--  175 (373)
                        .+..  ++||||+. ++|.+.+...   ...+++..++.++.|++.||.|||++ |  |+||||||+||+++.++.  
T Consensus        93 --~~~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           93 --HNPP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             --TTTT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTC
T ss_pred             --cCCC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCC
Confidence              3332  58999998 6888777653   35799999999999999999999998 9  999999999999987762  


Q ss_pred             --ceeEeeccceeeccCCCCcccccccccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHH
Q 017341          176 --QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ--LVEI  250 (373)
Q Consensus       176 --~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~--~~~i  250 (373)
                        .+||+|||+++...  .......||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+....  ...+
T Consensus       165 ~~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             SCCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             ceeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence              29999999997532  23445678999999999842 33468899999999999999999999987654433  2222


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ... +                          ....++..+++++.++|.+||+.||.+|||++++++
T Consensus       243 ~~~-~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          243 REE-G--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHS-C--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcc-C--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            110 0                          011123568999999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.2e-45  Score=326.57  Aligned_cols=247  Identities=19%  Similarity=0.284  Sum_probs=201.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ....+|++.+.||+|+||.||++.+. ++..||+|.+....   ....+|+.+++.++||||+++++++     .+...+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            44569999999999999999999875 67789999986543   3345899999999999999999988     444458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999997 5888888753   25699999999999999999999998 999999999999999888 899999999875


Q ss_pred             ccCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          188 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       188 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      .....  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence            43221  12234567889999999654 48999999999999999998 99999988877766665542111        


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                          ..+...++.+.++|.+||+.||.+|||++++++|
T Consensus       241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                1124578899999999999999999999999976

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-44  Score=325.42  Aligned_cols=251  Identities=22%  Similarity=0.253  Sum_probs=198.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+|+.+++.++|++++..+..+..    ...+.++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEE
Confidence            356899999999999999999999999999999976433  3456789999999999888777665533    3345789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE---cCCCCceeEeeccceee
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~ikl~Dfg~a~~  187 (373)
                      ||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .+||+|||++..
T Consensus        83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~  157 (296)
T 4hgt_A           83 VMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKK  157 (296)
T ss_dssp             EEECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred             EEEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCC-eEEEecCcccee
Confidence            9999988999888754   35699999999999999999999998 99999999999999   6666 899999999987


Q ss_pred             ccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 017341          188 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGT  256 (373)
Q Consensus       188 ~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~---~~~~~i~~~~~~  256 (373)
                      ......        .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..   .....+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            644322        2345789999999999655 4899999999999999999999999875432   223333221111


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ....                        .....+++++.++|.+||+.||++|||++++++
T Consensus       237 ~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 TPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1111                        112457899999999999999999999999976

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.6e-45  Score=332.39  Aligned_cols=250  Identities=20%  Similarity=0.335  Sum_probs=203.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+.+++.++||||+++++++     
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence            3568999999999999999999983     456899999886543     2334799999999999999999987     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKM--------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  161 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~--------------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~  161 (373)
                      .+...+++||||+. ++|.+.+......                    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~  174 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHR  174 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCccc
Confidence            33445789999998 5999988865431                    23488999999999999999999998 99999


Q ss_pred             cCCCCcEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 017341          162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  237 (373)
Q Consensus       162 Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~p  237 (373)
                      ||||+||+++.++ .+||+|||++........   .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999888 899999999986543322   2234568899999999654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          238 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       238 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      |.+.+.......+.....                            ...+..+++++.++|.+||+.||.+|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            998877665544432100                            0122468999999999999999999999999987


Q ss_pred             C
Q 017341          318 H  318 (373)
Q Consensus       318 h  318 (373)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            5

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=351.22  Aligned_cols=275  Identities=19%  Similarity=0.295  Sum_probs=203.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+++++.++||||+++++++..   .+..+.
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence            468999999999999999999999999999999986432     233489999999999999999998743   233457


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE----cCCCCceeEeecc
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG  183 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll----~~~~~~ikl~Dfg  183 (373)
                      ++|||||. ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+||||||+||++    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            89999998 58888876543 233489999999999999999999998 99999999999999    6555 79999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHH
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIK  252 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwslG~il~~lltG~~pf~~~~----~~~~~~~i~~  252 (373)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+...++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99876555444567799999999998531       346789999999999999999999997533    3344444443


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .........+......  .+...  ...+....+...++..+.++|.+||++||++|||+.+++++
T Consensus       242 ~~p~~~~~~~~~~~~~--~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          242 GKPSGAISGVQKAENG--PIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             SCCTTCCEEEECSTTC--CEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCCcccchhheeccCC--CcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            2111000000000000  00000  00011111223456788999999999999999999998543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.9e-45  Score=330.73  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=196.4

Q ss_pred             ccccceEeeeeeeecCceEEEEEE----ECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++..   .
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~   83 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---A   83 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---H
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence            345689999999999999999998    56789999999986543    234589999999999999999998743   2


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+++||||++ ++|.+.+....   ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  158 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDF  158 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCC-eEEEccC
Confidence            2334789999997 59998887642   4589999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          183 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       183 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |++........    .....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||......     .....+...
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~  232 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDK  232 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTC
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCcc
Confidence            99976543321    1234567889999999654 4899999999999999999999998653211     111111111


Q ss_pred             HHH------HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REE------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ...      .......             .....+..+++++.++|.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          233 QGQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CTHHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000      0000000             000123568899999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=338.09  Aligned_cols=250  Identities=21%  Similarity=0.323  Sum_probs=204.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCC-------CcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS   99 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~   99 (373)
                      ..++|.+.+.||+|+||.||+|.+..+       +..||+|++....     ....+|+++++.+ +||||+++++++  
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee--
Confidence            346899999999999999999997543       3579999986543     2244799999999 999999999988  


Q ss_pred             cCCCCceeEEEEEecccc-cHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCC
Q 017341          100 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  166 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~  166 (373)
                         .....+++||||+.+ +|.+.+......            ...+++..++.++.||+.||.|||++ ||+||||||+
T Consensus       145 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~  220 (382)
T 3tt0_A          145 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  220 (382)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGG
T ss_pred             ---ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcc
Confidence               334447899999985 999988875421            24589999999999999999999998 9999999999


Q ss_pred             cEEEcCCCCceeEeeccceeeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017341          167 NLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  242 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~  242 (373)
                      ||+++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       221 NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          221 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999888 89999999997654332   22344678899999999764 48999999999999999999 999999887


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          243 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       243 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ..+....+......                            ..+..+++++.+||.+||+.||++|||+++++++
T Consensus       299 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66655544432100                            1124688999999999999999999999999886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=337.01  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=205.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|++.     .+++.||+|.+....     ....+|+.+++.++||||+++++++     
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----  119 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----  119 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence            3568999999999999999999987     455899999986543     2345799999999999999999988     


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKM--------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  161 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~--------------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~  161 (373)
                      .+...+|+||||+.+ +|.+++......                    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~  198 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR  198 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            334457899999985 999988764211                    25689999999999999999999998 99999


Q ss_pred             cCCCCcEEEcCCCCceeEeeccceeeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 017341          162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  237 (373)
Q Consensus       162 Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~p  237 (373)
                      ||||+||+++.++ .+||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999888 89999999987543321   22345678999999998654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          238 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       238 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      |.+.+..+....+.....                            ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            998877666555443100                            0122468899999999999999999999999986


Q ss_pred             CCCcccc
Q 017341          318 HPFFDEL  324 (373)
Q Consensus       318 hp~~~~~  324 (373)
                      +  ++.+
T Consensus       329 ~--L~~~  333 (343)
T 1luf_A          329 I--LQRM  333 (343)
T ss_dssp             H--HHHT
T ss_pred             H--HHHH
Confidence            4  4444

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-44  Score=328.03  Aligned_cols=249  Identities=25%  Similarity=0.303  Sum_probs=191.6

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++..    
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----  105 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----  105 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----
Confidence            344678999999999999999999999999999999986442       234579999999999999999998843    


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                       ...+|+||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       106 -~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~-~~kl~Df  178 (309)
T 2h34_A          106 -DGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADD-FAYLVDF  178 (309)
T ss_dssp             -TTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSC
T ss_pred             -CCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCC-CEEEecC
Confidence             4458899999985 888888754    5689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          183 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       183 g~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      |++.......  ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.... ....... .    
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~-~----  251 (309)
T 2h34_A          179 GIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQA-I----  251 (309)
T ss_dssp             CC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSC-C----
T ss_pred             ccCccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccC-C----
Confidence            9987654332  12345789999999998654 589999999999999999999999987654422 2222210 0    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-CHHHHhc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TALEALI  317 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~~~ll~  317 (373)
                                          +........+++++.++|.+||+.||.+|| |++++++
T Consensus       252 --------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 --------------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             --------------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --------------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                001112357899999999999999999999 7877764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-45  Score=335.73  Aligned_cols=251  Identities=22%  Similarity=0.305  Sum_probs=203.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEE--EEEEeccc-----ccchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+.+++.+ +||||+++++++.     
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----   96 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----   96 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----
Confidence            44569999999999999999999998888865  99987542     23345799999999 8999999999883     


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      +..++|+||||++ ++|.+.+....            .....+++..++.++.||+.||.|||++ ||+||||||+||++
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILV  175 (327)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEE
T ss_pred             eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEE
Confidence            3445889999997 49998887643            2235799999999999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  249 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~  249 (373)
                      +.++ .+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....
T Consensus       176 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          176 GENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             CGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             cCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            9888 8999999999754333333445678899999998654 47999999999999999998 9999998876655444


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       250 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +....                            ....+..+++++.+||.+||+.||.+|||+++++++
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          254 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32210                            001124678999999999999999999999999876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=334.48  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=186.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCC-CCCeeecceeeeecCC---CCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTE---KDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~  106 (373)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            48999999999999999999999999999999885443    23357899999996 9999999998754322   4556


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      .++++|||+.|+|.+.+..... ...+++..++.++.||+.||.|||++ |  |+||||||+||+++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            6889999999999988876432 45699999999999999999999988 8  99999999999999888 899999999


Q ss_pred             eeeccCCCCc-------------cccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 017341          185 AKVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  249 (373)
Q Consensus       185 a~~~~~~~~~-------------~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~  249 (373)
                      +.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|+.||.+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9765432211             1446899999999983  234478899999999999999999999976543221110


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017341          250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  319 (373)
Q Consensus       250 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp  319 (373)
                      .                     ...          ......+..+.+||.+||+.||.+|||++++++|-
T Consensus       265 ~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          265 K---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ----------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             c---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            0                     000          01135678899999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-44  Score=322.49  Aligned_cols=242  Identities=27%  Similarity=0.446  Sum_probs=189.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .++|++.+.||+|+||.||+|.+  +++.+|+|.+....        ....+|+.+++.++||||+++++++     .+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            46899999999999999999998  48899999875432        2345799999999999999999988     344


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC---ceeecCCCCcEEEcC--------C
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG---VCHRDIKPQNLLVNP--------H  173 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~---ivH~Dlkp~NIll~~--------~  173 (373)
                      ...++||||+++ +|.+.+.     ...+++..++.++.||+.||.|||++ |   |+||||||+||+++.        +
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccC
Confidence            457899999985 7776663     36799999999999999999999998 8   899999999999986        4


Q ss_pred             CCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017341          174 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  253 (373)
Q Consensus       174 ~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~  253 (373)
                      + .+||+|||++...... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus       153 ~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          153 K-ILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             C-CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             c-ceEEccCCcccccccc-cccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            4 7999999999765333 23356789999999998654 4899999999999999999999999988766555444321


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          254 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .                           .....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       230 ~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 K---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             C---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            0                           0001225688999999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-44  Score=329.48  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=204.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      ..+|++.+.||+|+||.||+|.+     ..+++.||+|.+....     ....+|+.+++.+ +||||+++++++.    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   97 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence            45899999999999999999985     4578899999986543     2345799999999 9999999999883    


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~--------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                       +....++||||+++ +|.+.+.....              ....+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus        98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~N  175 (313)
T 1t46_A           98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARN  175 (313)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccce
Confidence             33447899999985 99998886532              123589999999999999999999998 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      |+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+...
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999888 8999999999765443321   234568899999998654 48999999999999999999 9999998876


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .............+                           ..+..++.++.++|.+||+.||.+|||+++++++
T Consensus       254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            66555554421110                           1124678999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.3e-45  Score=346.68  Aligned_cols=259  Identities=28%  Similarity=0.409  Sum_probs=191.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhC-CCCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ...|.+.+.||+|+||+||.+. ..+|+.||+|.+..+. ....+|+.+++.+ +||||+++++++     .+..++|+|
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            3468888999999999998754 4679999999886543 2345799999876 899999998887     445568999


Q ss_pred             EecccccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC------------Cc
Q 017341          112 LEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT------------HQ  176 (373)
Q Consensus       112 ~e~~~g~l~~~l~~~~~~~~~---~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~------------~~  176 (373)
                      ||||+|+|.+.+.........   .++..++.++.||+.||+|||++ ||+||||||+||+++.++            ..
T Consensus        88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceE
Confidence            999999999998764322111   12334677999999999999998 999999999999997532            27


Q ss_pred             eeEeeccceeeccCCCC-----cccccccccccccccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 017341          177 LKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  244 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~  244 (373)
                      +||+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |+.||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999987644322     124578999999999964      2458999999999999999999 99999766543


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          245 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      .  ..+.....                 ..+...     ...+..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       247 ~--~~i~~~~~-----------------~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 E--SNIIRGIF-----------------SLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H--HHHHHTCC-----------------CCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H--HHHhcCCC-----------------Cccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            3  23332110                 001000     0011235678999999999999999999999999999964

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-44  Score=331.43  Aligned_cols=260  Identities=22%  Similarity=0.268  Sum_probs=209.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|.+.....     ...+|+.+++.++||||+++++++    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   97 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----   97 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence            44568999999999999999999876     3578899998864432     234799999999999999999987    


Q ss_pred             CCCceeEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC
Q 017341          102 EKDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                       .+....++||||+. ++|.+.+......      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++
T Consensus        98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC
T ss_pred             -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCC
Confidence             33445789999998 4999888765421      24578999999999999999999998 999999999999999888


Q ss_pred             CceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017341          175 HQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  250 (373)
Q Consensus       175 ~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i  250 (373)
                       .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence             899999999875533321   1234568899999998654 48999999999999999999 89999988776655554


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC------CCcccc
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH------PFFDEL  324 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h------p~~~~~  324 (373)
                      .....                   +         ..+..++..+.++|.+||+.||.+|||+.++++|      |+|+++
T Consensus       254 ~~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          254 MEGGL-------------------L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HTTCC-------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HcCCc-------------------C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            43100                   0         0124688999999999999999999999999876      777665


Q ss_pred             CCC
Q 017341          325 RDP  327 (373)
Q Consensus       325 ~~~  327 (373)
                      ...
T Consensus       306 ~~~  308 (322)
T 1p4o_A          306 SFY  308 (322)
T ss_dssp             CST
T ss_pred             ccc
Confidence            543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-44  Score=326.54  Aligned_cols=248  Identities=20%  Similarity=0.314  Sum_probs=206.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.+..+..   ...+|+.+++.++||||+++++++     .+...+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            345689999999999999999999999999999999875542   345899999999999999999987     344458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      ++||||+. ++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence            89999999 58988887642  35689999999999999999999998 999999999999999888 899999999976


Q ss_pred             ccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          188 LVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       188 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ......  .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+.......+.....         
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------  230 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------  230 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred             ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------
Confidence            543322  1234568899999999654 48999999999999999999 9999998877665554433110         


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                         ...+..+++++.+||.+||..||.+|||++++++
T Consensus       231 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 -------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                               0122468899999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-44  Score=332.66  Aligned_cols=247  Identities=22%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcE----EEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ....+|++.+.||+|+||.||+|.+..+++.    +|+|.+....     ....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----   84 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-----   84 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----
Confidence            3456899999999999999999999888876    6777664322     3345899999999999999999976     


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      .+ ...++||||+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 ~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~D  158 (325)
T 3kex_A           85 PG-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVAD  158 (325)
T ss_dssp             CB-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSS-CEEECS
T ss_pred             cC-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCC-eEEECC
Confidence            22 23679999998 5888888653   24688889999999999999999998 999999999999999888 799999


Q ss_pred             ccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          182 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       182 fg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....  
T Consensus       159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--  235 (325)
T 3kex_A          159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--  235 (325)
T ss_dssp             CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB--
T ss_pred             CCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--
Confidence            999986543322   2344578899999999654 48999999999999999999 9999998776665544433100  


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                ...+..++.++.++|.+||+.||.+|||+.+++++
T Consensus       236 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 --------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             --------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             --------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      01123567889999999999999999999999886

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=333.70  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=202.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      ..+|.+.+.||+|+||.||+|.+     ..++..||+|.+....     ....+|+.+++.+ +||||+++++++.    
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----  119 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----  119 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe----
Confidence            46899999999999999999997     3466789999986432     2345899999999 8999999999883    


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeec
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKM-------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  162 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~-------------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~D  162 (373)
                       ....+++||||++ |+|.+.+......                   ...+++..++.++.||+.||.|||++ ||+|||
T Consensus       120 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~D  197 (344)
T 1rjb_A          120 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRD  197 (344)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETT
T ss_pred             -eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence             3344789999998 5999988764321                   13478999999999999999999998 999999


Q ss_pred             CCCCcEEEcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 017341          163 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  238 (373)
Q Consensus       163 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf  238 (373)
                      |||+||+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus       198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999888 8999999999765443322   234568899999998654 48999999999999999998 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          239 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       239 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+.........+......                           ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       276 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            988766655555442100                           01124578999999999999999999999999987


Q ss_pred             C
Q 017341          319 P  319 (373)
Q Consensus       319 p  319 (373)
                      .
T Consensus       329 l  329 (344)
T 1rjb_A          329 L  329 (344)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-45  Score=334.89  Aligned_cols=269  Identities=22%  Similarity=0.264  Sum_probs=197.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...+|++.+.||+|+||.||+|++.  ++.||+|++.....   ...+|+.+++.++||||+++++++.... .....++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            3568999999999999999999974  79999999865432   2345788899999999999999886533 2245578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC---------CceeecCCCCcEEEcCCCCceeE
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~---------~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      +||||+.+ +|.+++..     ..+++..++.++.||+.||.|||+..         ||+||||||+||+++.++ .+||
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL  172 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI  172 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence            99999985 99888864     45899999999999999999999642         999999999999999888 8999


Q ss_pred             eeccceeeccCCCC---cccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017341          180 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~  252 (373)
                      +|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999976644322   2345789999999999653    2355688999999999999999999987644222111111


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccc-cCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ....+....+......  ....+.     ....+ ....++++.+||.+||+.||++|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVH--KKKRPV-----LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTT--SCCCCC-----CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhc--ccCCCC-----ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1222222222110000  000000     00000 0123456999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-44  Score=325.47  Aligned_cols=249  Identities=18%  Similarity=0.234  Sum_probs=198.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCC-------cEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  101 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  101 (373)
                      ..++|.+.+.||+|+||.||+|.+..++       ..||+|.+....    ....+|+.+++.++||||+++++++.   
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   82 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---   82 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC---
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---
Confidence            4568999999999999999999998877       469999885433    23457999999999999999999883   


Q ss_pred             CCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc----
Q 017341          102 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----  176 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~----  176 (373)
                        +....++||||+. ++|.+.+....   ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .    
T Consensus        83 --~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~~~~  155 (289)
T 4fvq_A           83 --CGDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREE-DRKTG  155 (289)
T ss_dssp             --CTTCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECC-BGGGT
T ss_pred             --eCCCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCC-ccccc
Confidence              3334689999998 59998887642   4489999999999999999999998 999999999999998877 4    


Q ss_pred             ----eeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHH
Q 017341          177 ----LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEII  251 (373)
Q Consensus       177 ----ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~  251 (373)
                          +||+|||++...   .......+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+... .....
T Consensus       156 ~~~~~kl~Dfg~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~  231 (289)
T 4fvq_A          156 NPPFIKLSDPGISITV---LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFY  231 (289)
T ss_dssp             BCCEEEECCCCSCTTT---SCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHH
T ss_pred             ccceeeeccCcccccc---cCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHh
Confidence                999999998543   2223456899999999997645689999999999999999995 45555544333 22222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          252 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      ...                             ..++...++++.++|.+||+.||.+|||++++++|  ++.+-.
T Consensus       232 ~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~  275 (289)
T 4fvq_A          232 EDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT  275 (289)
T ss_dssp             HTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred             hcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence            210                             01123467889999999999999999999999986  445443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.7e-44  Score=327.08  Aligned_cols=256  Identities=19%  Similarity=0.268  Sum_probs=196.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECC---CCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ....+|.+.+.||+|+||.||+|.+..   ++..||+|.+....      ....+|+.+++.++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            445689999999999999999998765   55689999886442      224579999999999999999998865443


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~--~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      ......++||||+.+ +|.+.+....  .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kl  188 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDM-TVCV  188 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTS-CEEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEE
Confidence            333456899999985 8888886443  2345699999999999999999999998 999999999999999888 7999


Q ss_pred             eeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017341          180 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      +|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            99999876543321   2234568899999999654 58999999999999999999 9999998877766655543210


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                  ...+..+++++.++|.+||..||.+|||+++++++
T Consensus       268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        01224688999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-44  Score=331.90  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=195.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEE----EEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ....+|++.+.||+|+||.||+|++..+++.+    |+|.+....     ....+|+.+++.++||||+++++++..   
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---
Confidence            34568999999999999999999998887754    777664321     234579999999999999999998743   


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                        .. .++|++|+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        89 --~~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~D  160 (327)
T 3poz_A           89 --ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITD  160 (327)
T ss_dssp             --SS-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECC
T ss_pred             --CC-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCC-CEEEcc
Confidence              11 567889888 5888888764   36689999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          182 FGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       182 fg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||+++........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||.+.+..+....+...... 
T Consensus       161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-  238 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-  238 (327)
T ss_dssp             TTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred             CcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-
Confidence            9999765433322   233568899999999754 48999999999999999999 99999988766554443321100 


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                 ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 ---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                       0124578899999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=333.46  Aligned_cols=259  Identities=14%  Similarity=0.109  Sum_probs=194.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC---CCcEEEEEEecccccc---------------hHHHHHHHHhCCCCCeeecce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKH   95 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~   95 (373)
                      .++|++.+.||+|+||.||+|.+..   ++..+|+|.+......               ..+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4589999999999999999999987   7889999988654322               225677788889999999999


Q ss_pred             eeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC-
Q 017341           96 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT-  174 (373)
Q Consensus        96 ~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~-  174 (373)
                      ++.... .+..++|+||||++++|.+++...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ 
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSST
T ss_pred             cccccc-CCCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCC
Confidence            886533 345678999999977988887653    3789999999999999999999998 999999999999998664 


Q ss_pred             CceeEeeccceeeccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHH
Q 017341          175 HQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVD  245 (373)
Q Consensus       175 ~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~-~~~~  245 (373)
                      +.+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. ....
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence            2699999999976533211        1345789999999999765 4899999999999999999999999653 2222


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .............+..+....                   -...+++++.++|.+||+.||.+|||++++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWA-------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHS-------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHhhcccccHHHHhhc-------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            222222221111111111000                   002688999999999999999999999999863

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-44  Score=330.54  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=204.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc-----EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      ..+|++.+.||+|+||.||+|.+..+++     .||+|.+....     ....+|+.+++.+ +||||+++++++     
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----  119 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-----  119 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence            4589999999999999999999977664     79999886543     2345799999999 899999999988     


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  171 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~----------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~  171 (373)
                      .+...+++||||+++ +|.+.+......          ...+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT  198 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEEC
Confidence            333457899999985 999988865432          35689999999999999999999998 999999999999999


Q ss_pred             CCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 017341          172 PHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  247 (373)
Q Consensus       172 ~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~  247 (373)
                      .++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.......
T Consensus       199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            888 8999999999765433321   234568899999998654 48999999999999999998 99999987766655


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          248 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ..+......+                           ..+...++.+.++|.+||+.||.+|||+++++++
T Consensus       277 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          277 YKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            5555421110                           0124578899999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=328.84  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=202.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++++.... ......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            358999999999999999999999999999999885432    23457999999999999999999885432 3455688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~  184 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCSSCEES
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCC-CEEEEecCcchhc
Confidence            99999995 99999887665567899999999999999999999998 999999999999999888 7999999988654


Q ss_pred             cCCCCc----------ccccccccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhC
Q 017341          189 VKGEPN----------ISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLG  255 (373)
Q Consensus       189 ~~~~~~----------~~~~gt~~y~aPE~l~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~  255 (373)
                      ......          ....||+.|+|||++.+..  .++.++|||||||++|+|++|+.||...... .........  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence            221110          1235699999999985432  2688999999999999999999999532100 001111110  


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                     ....+          ....+++++.++|.+||+.||.+|||+++++++  ++.+.
T Consensus       263 ---------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~  305 (317)
T 2buj_A          263 ---------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQ  305 (317)
T ss_dssp             ---------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTC
T ss_pred             ---------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcC
Confidence                           00000          114578999999999999999999999999986  44443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.4e-44  Score=321.57  Aligned_cols=247  Identities=27%  Similarity=0.366  Sum_probs=192.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ...++|++.+.||+|+||.||+|.+..+   +..+|+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   86 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence            4456999999999999999999998654   4579999875432     23457999999999999999998762     


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      + ...++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        87 ~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Df  160 (281)
T 1mp8_A           87 E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDF  160 (281)
T ss_dssp             S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred             c-CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCC-CEEECcc
Confidence            1 136799999995 888888754   34689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          183 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       183 g~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      |+++.......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---  236 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  236 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---
Confidence            99976543322  2234567899999999654 48999999999999999997 99999988877666555432100   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                               .++..+++++.++|.+||+.||.+|||+.+++++
T Consensus       237 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     1225689999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-44  Score=324.83  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=194.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHh--CCCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++..... ...+|.+++..  ++||||+++++++.... .....+
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~   81 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL   81 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence            4457899999999999999999997  689999999865432 23456777766  79999999998865433 345568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------ccCCceeecCCCCcEEEcCCCCceeE
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--------~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      ++||||+++ +|.+.+.     ...+++..++.++.||+.||+|||        ++ ||+||||||+||+++.++ .+||
T Consensus        82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~-~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNG-QCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEE
T ss_pred             EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCC-CEEE
Confidence            899999985 8888884     356899999999999999999999        87 999999999999999888 8999


Q ss_pred             eeccceeeccCCCCc-----ccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhC----------CCCCC
Q 017341          180 CDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLG----------QPLFP  239 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltG----------~~pf~  239 (373)
                      +|||+++........     ....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999765443322     2347899999999996543     234689999999999999999          88886


Q ss_pred             CCCcH----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017341          240 GESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  315 (373)
Q Consensus       240 ~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l  315 (373)
                      .....    ...........                 ..+..+    ...+....++++.+||.+||+.||.+|||++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQ-----------------QRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSC-----------------CCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCCCCcchhhhhHHHhccC-----------------CCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            54321    22222111000                 000000    011123356789999999999999999999999


Q ss_pred             hc
Q 017341          316 LI  317 (373)
Q Consensus       316 l~  317 (373)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.1e-44  Score=321.14  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECC---CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ....++|++.+.||+|+||.||+|.+..   ++..||+|.+....     ....+|+.+++.++||||+++++++.    
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC----
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc----
Confidence            4456799999999999999999998653   34569999886542     23457999999999999999999862    


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                       +. ..++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        84 -~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  156 (281)
T 3cc6_A           84 -EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPE-CVKLGD  156 (281)
T ss_dssp             -SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETT-EEEECC
T ss_pred             -CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCC-cEEeCc
Confidence             22 2478999998 5888888764   35689999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          182 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       182 fg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ||++........  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......+ 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~-  234 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP-  234 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-
Confidence            999876533221  2234568899999999654 48999999999999999998 999998877766655544321100 


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                 .+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       235 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 ---------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                       124578999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.8e-44  Score=318.13  Aligned_cols=246  Identities=20%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|.+....   ....+|+.+++.++||||+++++++.     +...++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   79 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence            3468999999999999999999986 67889999986543   33458999999999999999999873     334478


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ |++||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~  154 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  154 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCC-CEEEccccccccc
Confidence            9999998 5888888754   35689999999999999999999998 999999999999999888 7999999998754


Q ss_pred             cCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....  ......+|+.|+|||++.+. .++.++|+||||+++|+|++ |+.||.+.+..+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------  223 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  223 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             ccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------
Confidence            3211  12234567889999999654 48999999999999999999 9999998877666655543210          


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                        ...+...+..+.++|.+||+.||.+|||+++++++
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              01124578899999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-45  Score=337.05  Aligned_cols=269  Identities=21%  Similarity=0.253  Sum_probs=202.2

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .....++|++.+.||+|+||.||+|.+ .+|+.||+|++....    ....+|+.+++.++||||+++++++     .+.
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  107 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DER  107 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCT
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCC
Confidence            344567999999999999999999996 478999999876443    2345799999999999999999987     334


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++||||+. ++|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  185 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF-VPKITDFGI  185 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCC-CEEEeeccc
Confidence            45789999998 488777754433344689999999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          185 AKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       185 a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      +.......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.........     . 
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~-  258 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----E-  258 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----H-
T ss_pred             ccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----h-
Confidence            97643222   12345689999999998654 48999999999999999999999998754332111110000     0 


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  319 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp  319 (373)
                       ......     ............+....+..+.+++.+||+.||++|||+.+++++.
T Consensus       259 -~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          259 -SHNNGQ-----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             -HHTTTC-----CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -cccccc-----HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence             000000     0111111111122234567899999999999999999999999763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.5e-44  Score=328.59  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=203.2

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEE----ECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeec
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFST  100 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~  100 (373)
                      +......+|++.+.||+|+||.||+|+    +..+++.||+|.+.....    ...+|+++++.++||||+++++++.. 
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   95 (327)
T 3lxl_A           17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG-   95 (327)
T ss_dssp             CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec-
Confidence            333445699999999999999999999    567899999999865432    24589999999999999999988753 


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                        .+...+++||||++ ++|.+.+....   ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus        96 --~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~-~~kl  168 (327)
T 3lxl_A           96 --PGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA-HVKI  168 (327)
T ss_dssp             --SSSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEE
T ss_pred             --CCCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCC-CEEE
Confidence              34556889999996 58988887643   4589999999999999999999998 999999999999999888 8999


Q ss_pred             eeccceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017341          180 CDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      +|||++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......... ......
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~  246 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERD  246 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccc
Confidence            99999987643332    2234578889999998654 47899999999999999999999987543221100 000000


Q ss_pred             CCCHHHH-hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          256 TPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       256 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+....+ ......             .....+..+++++.+||.+||+.||.+|||+++++++
T Consensus       247 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          247 VPALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CCHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000000 000000             0011235689999999999999999999999999654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.4e-44  Score=323.94  Aligned_cols=253  Identities=31%  Similarity=0.480  Sum_probs=191.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++..     
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----  103 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----  103 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence            34568999999999999999999999999999999986421       223479999999999999999998843     


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ |++||||||+||+++.++ .+||+|||
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~-~~kl~Dfg  181 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLG  181 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC-
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCC-CEEEEecc
Confidence            3358899999985 89988887666667799999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 017341          184 SAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  261 (373)
Q Consensus       184 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~  261 (373)
                      ++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..........       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  253 (310)
T 2wqm_A          182 LGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------  253 (310)
T ss_dssp             -----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-------
T ss_pred             ceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-------
Confidence            987653322 22345789999999998654 5899999999999999999999999765321 1111111110       


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                 .++.        .....++.++.++|.+||..||.+|||+++++++
T Consensus       254 -----------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          254 -----------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             -----------CSCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------cCCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                       0000        0114578999999999999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-44  Score=331.20  Aligned_cols=267  Identities=20%  Similarity=0.277  Sum_probs=202.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++....     ....+|+.+++.++||||+++++++.     +..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~  100 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPT  100 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSS
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-----cCC
Confidence            3456899999999999999999985 468999999886432     23468999999999999999999883     334


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC--CceeecCCCCcEEEcCCCCceeEeecc
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--GVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ..++||||+.+ +|.+.+.........+++..++.++.||+.||.|||++.  ||+||||||+||+++.++ .+||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  179 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFG  179 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCc
Confidence            46899999985 999988876555567999999999999999999999753  999999999999999888 89999999


Q ss_pred             ceeeccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCC
Q 017341          184 SAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE----SGVDQLVEIIKVLGTP  257 (373)
Q Consensus       184 ~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~----~~~~~~~~i~~~~~~~  257 (373)
                      ++........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...    ............    
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  254 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG----  254 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT----
T ss_pred             cccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH----
Confidence            9986543322  23445899999999996544 899999999999999999999999521    111111111110    


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  320 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~  320 (373)
                                ..................+....+..+.+++.+||+.||.+|||++++++|-.
T Consensus       255 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          255 ----------LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             ----------TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ----------HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                      00000111111111111122334578999999999999999999999998854

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.8e-44  Score=327.31  Aligned_cols=250  Identities=21%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC-------CCCcEEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS   99 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~   99 (373)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|.+....     ....+|+.+++.+ +||||+++++++  
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE--
Confidence            3569999999999999999999975       467889999886543     2235799999999 899999999987  


Q ss_pred             cCCCCceeEEEEEecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCC
Q 017341          100 TTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  166 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~  166 (373)
                         .+...+++||||+.+ +|.+++.....            ....+++..++.++.||+.||.|||++ ||+||||||+
T Consensus       111 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~  186 (334)
T 2pvf_A          111 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAAR  186 (334)
T ss_dssp             ---CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGG
T ss_pred             ---ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccc
Confidence               334457899999985 99988876432            123488999999999999999999998 9999999999


Q ss_pred             cEEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017341          167 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  242 (373)
Q Consensus       167 NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~  242 (373)
                      ||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       187 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          187 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999888 899999999986544322   2234568899999998654 48999999999999999999 999999887


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          243 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       243 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ..+....+......                            ..+..++.++.++|.+||+.||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76665554442100                            1124688999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-43  Score=315.84  Aligned_cols=246  Identities=14%  Similarity=0.200  Sum_probs=199.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|+||.||+|++  +++.+|+|.+....      ....+|+.+++.++||||+++++++..   .+.
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~   81 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPA   81 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCC
Confidence            3456899999999999999999998  48899999986542      234578899999999999999998743   222


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcCCCCceeEeec
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ..+++||||++ ++|.+.+....  ...+++..++.++.||+.||.|||++ |  |+||||||+||+++.++ .++|+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~-~~~l~~~  157 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM-TARISMA  157 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTS-CEEEEGG
T ss_pred             CCeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCc-ceeEEec
Confidence            45789999998 49998887532  23589999999999999999999988 9  99999999999999888 7999999


Q ss_pred             cceeeccCCCCcccccccccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      |++...    ......+|+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+......    
T Consensus       158 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----  229 (271)
T 3kmu_A          158 DVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR----  229 (271)
T ss_dssp             GSCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----
T ss_pred             cceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----
Confidence            887532    2234578999999999965432  233799999999999999999999988877766555442100    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                             ..++..+++++.++|.+||+.||.+|||++++++
T Consensus       230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 -----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   0123568999999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5e-45  Score=345.21  Aligned_cols=254  Identities=19%  Similarity=0.215  Sum_probs=192.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCC-CCeeecc---------ee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDH-PNVVSLK---------HC   96 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~~iv~~~---------~~   96 (373)
                      ..+|...+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++| +|...+.         +.
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            347999999999999999999999999999999886332       233578888888877 2221111         11


Q ss_pred             e------------eecCCCCceeEEEEEecccccHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceee
Q 017341           97 F------------FSTTEKDELYLNLVLEYVPETVHRVIKHHY---KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  161 (373)
Q Consensus        97 ~------------~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~---~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~  161 (373)
                      .            ..........++++|+++.++|.+++....   .....+++..+..++.||+.||+|||++ ||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            1            000001123367899999999988886432   2234467778889999999999999998 99999


Q ss_pred             cCCCCcEEEcCCCCceeEeeccceeeccCCCCccccccccccccccccc---------CCCCCCCchhHHHHHHHHHHHH
Q 017341          162 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTAAIDIWSAGCVLAELL  232 (373)
Q Consensus       162 Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DiwslG~il~~ll  232 (373)
                      ||||+|||++.++ .+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999998 7999999998765332  345567 9999999983         3334788999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCH
Q 017341          233 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  312 (373)
Q Consensus       233 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  312 (373)
                      +|+.||.+.+..+....+                       +.          ....+|+++.+||.+||+.||.+|||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999876532211100                       00          013578999999999999999999999


Q ss_pred             HHHhcCCCccccC
Q 017341          313 LEALIHPFFDELR  325 (373)
Q Consensus       313 ~~ll~hp~~~~~~  325 (373)
                      .++++||||+.+.
T Consensus       359 ~~~l~~~~~~~~~  371 (413)
T 3dzo_A          359 LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHTTSHHHHHHH
T ss_pred             HHHHhCHHHHHHH
Confidence            9999999998753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-43  Score=319.50  Aligned_cols=249  Identities=21%  Similarity=0.298  Sum_probs=189.5

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|+||.||++++.   ..+|+|.+....      ....+|+.+++.++||||++++++.     . .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~-~   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----T-A   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C-S
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----c-C
Confidence            44568999999999999999999863   359999886433      2245799999999999999998854     1 2


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  166 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDN-TVKIGDFGL  166 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC-
T ss_pred             CccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCC-CEEEcccee
Confidence            23679999998 5887777533   35689999999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCC---CCccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKG---EPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~---~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +......   .......||+.|+|||++.  ....++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence            8754321   1223457899999999985  2344788999999999999999999999988777666665543211100


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                             .......+++++.+||.+||+.||.+|||++++++
T Consensus       247 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 -----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             -----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   01122468899999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-43  Score=321.23  Aligned_cols=261  Identities=23%  Similarity=0.361  Sum_probs=196.8

Q ss_pred             ccceEeeeeeeecCceEEEEEE----ECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||.||+|+    +..+++.||+|.+....     ....+|+.+++.++||||+++++++..   .+
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence            3479999999999999999999    56789999999986432     334589999999999999999998754   22


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||+++ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCC-CEEECccc
Confidence            3457899999985 999888654   35699999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          184 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       184 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      ++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..|+....     ............
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccc
Confidence            9987644432    2245678889999998654 47899999999999999999998864321     111111111110


Q ss_pred             HH-HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EE-IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .. .........         .......+..+++++.+||.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            00 000000000         00001123568999999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=333.51  Aligned_cols=256  Identities=13%  Similarity=0.109  Sum_probs=197.7

Q ss_pred             cceEeeeeeeecCceEEEEEEECCC--------CcEEEEEEecccccchHHHHHHHHhCCCCCeeecc------------
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLET--------GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK------------   94 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~------------   94 (373)
                      ++|++.+.||+|+||.||+|++..+        ++.||+|.+... ....+|+++++.++||||++++            
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            5899999999999999999999874        889999988654 4567899999999999999843            


Q ss_pred             ---eeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc
Q 017341           95 ---HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  171 (373)
Q Consensus        95 ---~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~  171 (373)
                         +++.    .+..++|+||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus       121 ~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEE
T ss_pred             chhhccc----cCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEc
Confidence               3332    1245688999999779999988642  35699999999999999999999998 999999999999999


Q ss_pred             CCC-CceeEeeccceeeccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 017341          172 PHT-HQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  242 (373)
Q Consensus       172 ~~~-~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~  242 (373)
                      .++ ..+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            765 2699999999976533211        1334789999999999654 48999999999999999999999998764


Q ss_pred             -cHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          243 -GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       243 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                       ................        ..+..        .   ......+++++.+||.+||+.||.+|||++++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~--------~~~~~--------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKP--------GPFVG--------P---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TCHHHHHHHHHHHHHSC--------CCEEC--------T---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cCHHHHHHHHHhccCCh--------hhhhh--------h---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence             3333333322110000        00000        0   00113578999999999999999999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-43  Score=336.08  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ....+|++.+.||+|+||.||++.+  +|+.||+|.+..+.  ....+|+.+++.++||||+++++++...    ...+|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence            3456899999999999999999998  47899999987543  3345899999999999999999986432    22478


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +|||||. |+|.+.+....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence            9999998 59999988652  23478999999999999999999998 999999999999999888 8999999999854


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...  .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+....           
T Consensus       340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-----------  405 (450)
T 1k9a_A          340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-----------  405 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-----------
T ss_pred             ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            322  2234678899999999654 48999999999999999998 99999988776665554432100           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       406 -----------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 -----------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             122568999999999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.7e-44  Score=326.00  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|.+.....     ...+|+.+++.+ +||||+++++++..   
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---  102 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---  102 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec---
Confidence            46899999999999999999985     45778999999865432     334799999999 68999999998743   


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEE
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  169 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIl  169 (373)
                       ....+++||||+.+ +|.+.+......            ...+++..++.++.||+.||.|||++ ||+||||||+||+
T Consensus       103 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil  180 (316)
T 2xir_A          103 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  180 (316)
T ss_dssp             -TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             -CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEE
Confidence             23347899999985 899888764321            12278999999999999999999998 9999999999999


Q ss_pred             EcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017341          170 VNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  245 (373)
Q Consensus       170 l~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~  245 (373)
                      ++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.....
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99888 7999999999765433221   234678899999999654 48999999999999999998 999998876555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ............                           ..+..+++++.++|.+||+.||.+|||++++++|
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444433321000                           0124578999999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=327.06  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=194.1

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEE----EEEEeccc-----ccchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ....+|++.+.||+|+||.||+|.+..+++.+    |+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   88 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---   88 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---
Confidence            34568999999999999999999998888765    66655322     1234579999999999999999998743   


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                        .. .++|++|+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        89 --~~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kL~D  160 (327)
T 3lzb_A           89 --ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITD  160 (327)
T ss_dssp             --SS-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECC
T ss_pred             --CC-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCC-CEEEcc
Confidence              11 567888888 5888888764   35699999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          182 FGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       182 fg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      ||+++........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  238 (327)
T 3lzb_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-  238 (327)
T ss_dssp             TTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred             CcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999765333222   234567889999999754 48999999999999999999 99999988776655444332100 


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                 ..+..++.++.++|.+||+.||.+|||+.++++.
T Consensus       239 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          239 ---------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                       0124578899999999999999999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.4e-44  Score=318.90  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             CCCccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           29 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        29 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      +.....++|++.+.||+|+||.||++.+  +|+.||+|.+..+.  ....+|+.+++.++||||+++++++..    ...
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~   88 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG   88 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCC
Confidence            3445567999999999999999999987  58899999886543  334579999999999999999997643    223


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+++||||+++ +|.+.+.....  ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~  164 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLT  164 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC-
T ss_pred             ceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCC-cEEEeecccc
Confidence            47899999985 99988876532  2378899999999999999999998 999999999999999888 8999999998


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ......  .....+++.|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+....+....          
T Consensus       165 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------  231 (278)
T 1byg_A          165 KEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------  231 (278)
T ss_dssp             -------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------
T ss_pred             cccccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------
Confidence            754322  2344678899999999654 48999999999999999998 999998877655544432210          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        ....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       232 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                              00122468899999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.3e-44  Score=328.69  Aligned_cols=256  Identities=19%  Similarity=0.225  Sum_probs=201.0

Q ss_pred             cccceEeeeeeeecCceEEEEEE-----ECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|+     +..+++.||+|.+....     ....+|+.+++.++||||+++++++.    
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence            45699999999999999999999     55678899999985432     23347999999999999999999883    


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--Cc
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQ  176 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~  176 (373)
                       +....|+||||++ ++|.+++......   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..
T Consensus       104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          104 -QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             -CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcce
Confidence             3344789999996 5999988865321   24488999999999999999999998 999999999999998433  26


Q ss_pred             eeEeeccceeeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017341          177 LKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~  252 (373)
                      +||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999986543222   22345678999999998654 48999999999999999998 9999998876665554433


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      ....                            ..+..++..+.++|.+||+.||.+|||++++++|.|+-.
T Consensus       261 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          261 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            1100                            012468899999999999999999999999999988643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.3e-44  Score=334.35  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=190.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEEC---CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...+|.+.+.||+|+||.||+|++.   .++..||+|.+....     ....+|+.+++.++||||+++++++     .+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence            3458999999999999999999986   467789999886432     2345799999999999999999987     33


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg  192 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNL-VCKVSDFG  192 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCC-CEEECcCc
Confidence            445789999997 5998888753   35689999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      +++........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......  
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~--  269 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL--  269 (373)
T ss_dssp             ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            99765433211    122347789999999654 48999999999999999998 99999888776655544332100  


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                      +          .+..++..+.++|.+||+.||.+|||++++++
T Consensus       270 ----------------~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 ----------------P----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ----------------C----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------C----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                            0          12357889999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.5e-44  Score=345.52  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=203.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+..+.   ....+|+.+++.++||||+++++++     .+...+|+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEEE
Confidence            458999999999999999999999889999999986543   2345899999999999999999987     33344789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+. |+|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENH-LVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCC-cEEEeecccceecc
Confidence            999998 69999887642  35588999999999999999999998 999999999999999888 89999999998654


Q ss_pred             CCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  .....+++.|+|||++... .++.++|||||||++|+|++ |..||.+.+..+....+.....           
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  437 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-----------  437 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----------
T ss_pred             CCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            3221  1233457889999999654 48999999999999999999 9999998877665544432110           


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                       ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       438 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 -----------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                             0122468899999999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-43  Score=323.84  Aligned_cols=247  Identities=21%  Similarity=0.302  Sum_probs=195.0

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCC----cEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ...+|++.+.||+|+||.||+|.+..++    ..||+|.+.....     ...+|+.+++.++||||+++++++     .
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence            3458999999999999999999987553    4599999865322     234799999999999999999987     3


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCC-cEEECCC
Confidence            44458899999985 888888753   35689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+...... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-  269 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-  269 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-
Confidence            99976543221    1123457889999999654 48999999999999999999 99999888776655554432100 


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                 ..+..++..+.++|.+||+.||.+||++.+++++
T Consensus       270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       0124578999999999999999999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.4e-43  Score=318.68  Aligned_cols=245  Identities=25%  Similarity=0.350  Sum_probs=190.1

Q ss_pred             ccccceEee-eeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHH-HhCCCCCeeecceeeeecCCCCceeEE
Q 017341           32 KQTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        32 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|.+.. .....+|+.++ +.++||||+++++++.... .+..+++
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~   91 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL   91 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence            345678887 789999999999999999999999998854 34556788887 6679999999999874322 3456789


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CCCceeEeeccce
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSA  185 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg~a  185 (373)
                      +||||+.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCC-cEEEeccccc
Confidence            99999985 9998888642  34699999999999999999999998 9999999999999997   55 7999999998


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....                      ...++.++|||||||++|+|++|+.||.+.+.......+..             
T Consensus       168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------------  212 (299)
T 3m2w_A          168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------------  212 (299)
T ss_dssp             EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------------
T ss_pred             cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------------
Confidence            6431                      12367899999999999999999999977654321110000             


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                           .....   ...........+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       213 -----~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 -----RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             -----SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             -----HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                 00000   00011111146899999999999999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.3e-43  Score=317.53  Aligned_cols=244  Identities=21%  Similarity=0.276  Sum_probs=197.2

Q ss_pred             cccceEeee-eeeecCceEEEEEE--ECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           33 QTISYMAER-VVGHGSFGVVFQAK--CLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        33 ~~~~y~~~~-~lg~G~~g~Vy~~~--~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ...+|++.+ .||+|+||.||+|.  +..+++.||+|.+....      ....+|+.+++.++||||+++++++ .   .
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~---~   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E---A   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E---S
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C---C
Confidence            346899999 99999999999995  45678999999986542      2345799999999999999999987 2   1


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                        ..+++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        90 --~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~-~~kl~Df  161 (291)
T 1xbb_A           90 --ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDF  161 (291)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCC
T ss_pred             --CCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCC-cEEEccC
Confidence              12679999998 5888888753    5689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |++.........    ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--  238 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--  238 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999866443321    123457889999999654 47889999999999999999 9999998877665544432100  


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                                ..++..+++++.++|.+||+.||.+|||+.++++
T Consensus       239 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 --------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      0122468899999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.7e-43  Score=335.95  Aligned_cols=252  Identities=21%  Similarity=0.250  Sum_probs=199.9

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+|+++++.++|++.+..+..+.    ....+.+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~   79 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV   79 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence            4457899999999999999999999999999999987543  345678999999998865555544443    2334578


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE---cCCCCceeEeecccee
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAK  186 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~ikl~Dfg~a~  186 (373)
                      +||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++ .+||+|||+++
T Consensus        80 lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~  154 (483)
T 3sv0_A           80 LVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK  154 (483)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTT-CEEECCCTTCE
T ss_pred             EEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCC-eEEEEeCCcce
Confidence            99999988999988754   36799999999999999999999998 99999999999999   4566 89999999998


Q ss_pred             eccCCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhC
Q 017341          187 VLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLG  255 (373)
Q Consensus       187 ~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~---~~~~~i~~~~~  255 (373)
                      .......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....   +.+..+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            7654332        1256789999999999655 4899999999999999999999999886543   23333332211


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ....+.                        +...++.++.+||.+||+.||.+||+++++++
T Consensus       234 ~~~~~~------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 ATSIEA------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HSCHHH------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccHHH------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            111111                        11467899999999999999999999987743

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=318.59  Aligned_cols=247  Identities=26%  Similarity=0.315  Sum_probs=200.8

Q ss_pred             cccceEeee-eeeecCceEEEEEEEC--CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           33 QTISYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..++|.+.+ .||+|+||.||+|.+.  .++..||+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   81 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A   81 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----S
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----C
Confidence            446788887 9999999999999864  468889999986532     22447999999999999999999872     1


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      . .+++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        82 ~-~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg  155 (287)
T 1u59_A           82 E-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFG  155 (287)
T ss_dssp             S-SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCT
T ss_pred             C-CcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCC-CEEECccc
Confidence            1 27899999985 888877542   35689999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---  231 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---  231 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---
Confidence            9987643322    1233568899999999654 48999999999999999998 9999998877666555433100   


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  319 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp  319 (373)
                                               ..++..+++++.++|.+||..||.+|||+.+++++.
T Consensus       232 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          232 -------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             -------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                                     012356899999999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.4e-45  Score=360.48  Aligned_cols=285  Identities=25%  Similarity=0.324  Sum_probs=206.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecC-CCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++||||+++++++.... ......
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            468999999999999999999999999999999876432     22447999999999999999988763311 122445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC--ceeEeeccc
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGS  184 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~ikl~Dfg~  184 (373)
                      .|+|||||. ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            689999997 58888887532 223688999999999999999999998 9999999999999997662  389999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........   ............
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC------CCS
T ss_pred             ccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccchhhhh
Confidence            9877655555667899999999999654 589999999999999999999999987543221110   000000000000


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .........++.  ..+....+...+++.+.+||.+||.+||.+|||++++++||||+.+++
T Consensus       247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            000000111111  111112233456789999999999999999999999999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=318.21  Aligned_cols=245  Identities=28%  Similarity=0.401  Sum_probs=188.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ...+|++.+.||+|+||.||++.+  .++.||+|.+....  ....+|+.+++.++||||+++++++.     +.  .++
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l   76 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL   76 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence            346899999999999999999997  47899999986543  23458999999999999999988762     22  579


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc---cCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~---~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ||||+++ +|.+.+..... ...++...+..++.||+.||.|||+   + ||+||||||+||+++.++..+||+|||++.
T Consensus        77 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            9999984 88888875321 2347888999999999999999998   6 999999999999999887458999999987


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||................+.          
T Consensus       155 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------  221 (307)
T 2eva_A          155 DIQT--HMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT----------  221 (307)
T ss_dssp             ------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC----------
T ss_pred             cccc--ccccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC----------
Confidence            5432  22345689999999999654 5899999999999999999999999865432211111100000          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                      .......++..+.++|.+||+.||.+|||++++++
T Consensus       222 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 ----------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ----------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                            00122468899999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-43  Score=338.35  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=201.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|.+....   ....+|+.+++.++||||+++++++.      ...+|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccE
Confidence            3458999999999999999999985 46789999987543   23458999999999999999998762      12367


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+. |+|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            9999998 59999987543  23578889999999999999999998 999999999999999888 8999999999765


Q ss_pred             cCCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ....  ......+|+.|+|||++... .++.++|||||||++|+|++ |+.||.+.+..+....+......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------  405 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------  405 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred             CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3221  11233457889999999654 48999999999999999999 999999988777766665431111        


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                          .+..+++++.++|.+||+.||.+|||+++++.
T Consensus       406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                12468899999999999999999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-43  Score=317.79  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             CccccceEeeeeeeecCceEEEEEEECCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCC
Q 017341           31 PKQTISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        31 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  102 (373)
                      +....+|++.+.||+|+||.||+|.+..++   ..+|+|.+....     ....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   97 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR---   97 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC---
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc---
Confidence            344568999999999999999999975443   468999876432     223479999999999999999997542   


Q ss_pred             CCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEee
Q 017341          103 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                       .....++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        98 -~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~D  171 (298)
T 3f66_A           98 -SEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKF-TVKVAD  171 (298)
T ss_dssp             -SSSCCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECS
T ss_pred             -CCCceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCC-CEEECc
Confidence             23346799999986 898888653   35689999999999999999999998 999999999999999888 899999


Q ss_pred             ccceeeccCCC-----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017341          182 FGSAKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  255 (373)
Q Consensus       182 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~  255 (373)
                      ||++.......     ......+|+.|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+....+.....
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             ccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            99997553321     12234578899999999654 48999999999999999999 7788887776665555443210


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .                            ..+..++..+.++|.+||+.||.+|||++++++
T Consensus       251 ~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 L----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0                            112457889999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.5e-43  Score=314.02  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=199.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|.+....   ....+|+++++.++||||+++++++.     +. ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-CcE
Confidence            3468999999999999999999974 56789999986543   33458999999999999999998762     11 267


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||+. ++|.+.+....  ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            9999997 58888876432  23689999999999999999999998 999999999999999888 8999999999866


Q ss_pred             cCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          189 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       189 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      .....  .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....          
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence            43321  1234567889999999644 47899999999999999999 9999998877666555433110          


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        ...+..+++++.++|.+||+.||++|||++++++
T Consensus       229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              0122468899999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=314.12  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=197.3

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .....|.+.+.||+|+||.||+|.+..+++   .+|+|.+....     ....+|+.+++.++||||+++++++...   
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   94 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---   94 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---
Confidence            344578899999999999999999765554   79999886433     2234799999999999999999987432   


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                       ....+++|||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        95 -~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~-~~kl~Df  168 (298)
T 3pls_A           95 -EGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESF-TVKVADF  168 (298)
T ss_dssp             -SSCCEEEECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred             -CCCcEEEEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEeCcC
Confidence             223478999997 6888888653   36689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 017341          183 GSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  256 (373)
Q Consensus       183 g~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~  256 (373)
                      |+++.....     .......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL  247 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence            999754322     122345678999999999654 48999999999999999999 55666666655544444332100


Q ss_pred             CCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                  ..+..+++.+.++|.+||+.||.+|||++++++.
T Consensus       248 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          248 ----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                        0124578999999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.8e-43  Score=336.15  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|++.+.||+|+||.||+|.+.. +..||+|.+....   ....+|+.+++.++||||+++++++.     + ..+++
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~~i  255 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYI  255 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-CceEE
Confidence            4589999999999999999999864 4679999986543   33468999999999999999998762     2 23679


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+. |+|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCC-CEEECCCccceecC
Confidence            999998 59998887542  35689999999999999999999998 999999999999999888 89999999997654


Q ss_pred             CCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......          
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------  400 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------  400 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             CCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            3221  1234567889999998654 48999999999999999999 99999998877666655432110          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDE  323 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~--hp~~~~  323 (373)
                                        ..+..+++.+.++|.+||+.||.+|||++++++  ..++..
T Consensus       401 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                              012468899999999999999999999999986  344443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.3e-43  Score=319.84  Aligned_cols=258  Identities=22%  Similarity=0.271  Sum_probs=197.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..|...+.||+|+||.||+|.+  +++.+|+|++....        ....+|+.+++.++||||+++++++.     +..
T Consensus        31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~  103 (307)
T 2nru_A           31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGD  103 (307)
T ss_dssp             BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-----cCC
Confidence            3466679999999999999986  68899999885431        23457999999999999999999873     334


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ..++||||++ ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~~  180 (307)
T 2nru_A          104 DLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAF-TAKISDFGLA  180 (307)
T ss_dssp             SCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             ceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCC-cEEEeecccc
Confidence            4789999997 58888886543 245689999999999999999999998 999999999999999888 8999999998


Q ss_pred             eeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          186 KVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       186 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      ........   .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+............
T Consensus       181 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  258 (307)
T 2nru_A          181 RASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE  258 (307)
T ss_dssp             EECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH
T ss_pred             cccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh
Confidence            76543222   223568999999999854  3789999999999999999999999886654433333332211110000


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .......     +         ..+...+..+.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~-----~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          259 DYIDKKM-----N---------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHSCSSC-----S---------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhccccc-----c---------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000000     0         0112345789999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=327.11  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=189.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...|.+.+.||+|+||.||+|.+..++   ..+|+|.+....     ....+|+.+++.++||||+++++++..    ..
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~  163 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE  163 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CS
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CC
Confidence            447999999999999999999975432   468999875432     223478999999999999999997642    22


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ...++||||+.+ +|.+++...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DFG~  238 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGL  238 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCC-CEEEeeccc
Confidence            346799999985 898888653   35688899999999999999999998 999999999999999888 899999999


Q ss_pred             eeeccCCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          185 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       185 a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      ++.......     .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....   
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~---  314 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  314 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC---
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC---
Confidence            976533221     1234567899999999654 48999999999999999999 7889988776655544433110   


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                               ...+..++..+.++|.+||+.||.+|||+++++++
T Consensus       315 -------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     01124578999999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.7e-43  Score=315.22  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=193.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-CCc--EEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-TGE--AVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ..+|++.+.||+|+||.||+|.+.. +++  .||+|.+....       ....+|+.+++.++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            3589999999999999999998643 333  68999875431       233479999999999999999998742    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                       .. .++||||+. ++|.+.+....   ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+||
T Consensus        93 -~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           93 -PP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             -SS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -CC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCC-CEEEccc
Confidence             11 679999998 58988887652   5589999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+...... 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-  243 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-  243 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-
Confidence            999876443321    234567889999999654 47899999999999999999 99999988876666555431100 


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                      .          ..+..++.++.++|.+||..||.+|||+.++++  +++.+
T Consensus       244 ----------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          244 ----------------L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             ----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ----------------C----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                            0          012468899999999999999999999999997  35544

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.3e-43  Score=319.29  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=193.8

Q ss_pred             ccce-EeeeeeeecCceEEEEEE----ECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISY-MAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++| ++.+.||+|+||.||++.    +..+++.||+|.+..+.     ....+|+++++.++||||+++++++..   .
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~  105 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---A  105 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---T
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---C
Confidence            3455 999999999999998775    34578999999987543     224589999999999999999998854   2


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+++||||+++ +|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  178 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDR-LVKIGDF  178 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCG
T ss_pred             CCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCC-CEEECCc
Confidence            34568899999985 88887753     4589999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          183 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       183 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......     ........
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~  252 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQ  252 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCC
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccc
Confidence            99987644332    2234578889999999654 47899999999999999999999997542210     00000000


Q ss_pred             HH----HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 RE----EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ..    .+......            ......+..++.++.+||.+||+.||.+|||++++++
T Consensus       253 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          253 GQMTVLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            00    00000000            0001122568899999999999999999999999984

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=318.95  Aligned_cols=279  Identities=21%  Similarity=0.304  Sum_probs=193.0

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-hHHHHHH--HHhCCCCCeeecceeeeecCCCCceeE
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-KNRELQT--MRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++...... ...|.++  +..++||||+++++.+......+...+
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            4567999999999999999999987  7899999998644322 2234444  445899999999886655444566678


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC--------CceeecCCCCcEEEcCCCCceeE
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--------~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      ++|||||+ |+|.+++..     ...++..++.++.||+.||.|||++.        ||+||||||+|||++.++ .+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEE
Confidence            89999997 599888864     34588889999999999999999642        999999999999999888 8999


Q ss_pred             eeccceeeccCCC---------CcccccccccccccccccCC------CCCCCchhHHHHHHHHHHHHhCCCCC-CCCCc
Q 017341          180 CDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLLGQPLF-PGESG  243 (373)
Q Consensus       180 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwslG~il~~lltG~~pf-~~~~~  243 (373)
                      +|||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..|| .+...
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999998654321         12245689999999999652      23567899999999999999996655 33321


Q ss_pred             HHHHHHHHH-HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHh------
Q 017341          244 VDQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL------  316 (373)
Q Consensus       244 ~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll------  316 (373)
                      ......+.. ....+....+......  ....+..+.. +  ......++++.+||.+||+.||++|||++|++      
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFPEA-W--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCCTT-C--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcc--cccCCCCCcc-c--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            111111111 1111111111110000  0000000000 0  00012455799999999999999999999994      


Q ss_pred             cCCCccc
Q 017341          317 IHPFFDE  323 (373)
Q Consensus       317 ~hp~~~~  323 (373)
                      .++|-++
T Consensus       317 l~~~~~~  323 (336)
T 3g2f_A          317 MMIWERN  323 (336)
T ss_dssp             HHCCCC-
T ss_pred             HHHHHhc
Confidence            4566544

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=324.12  Aligned_cols=245  Identities=16%  Similarity=0.165  Sum_probs=191.1

Q ss_pred             ccceEeeeeeeecCceEEEEE-----EECCCCcEEEEEEecccc-cchHHHHHHHHhCC---CCCeeecceeeeecCCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  104 (373)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||+|.+.... ....+|..+++.+.   |+||+++++++..     
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-----  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-----  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-----
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-----
Confidence            458999999999999999999     467789999999986543 23457888888887   8999999998843     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC----------
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----------  172 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~----------  172 (373)
                      ....|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.          
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC-----
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCcccccc
Confidence            334789999998 699999886543 246699999999999999999999998 9999999999999987          


Q ss_pred             -CCCceeEeeccceeeccC---CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017341          173 -HTHQLKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  248 (373)
Q Consensus       173 -~~~~ikl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~  248 (373)
                       ++ .+||+|||+|+....   ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........  
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~--  293 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--  293 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence             66 899999999975432   22234567999999999997654 89999999999999999999999965422100  


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017341          249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  319 (373)
Q Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp  319 (373)
                                     ....     .++.           ...++.+.+++..||..+|.+|++..+.+.+.
T Consensus       294 ---------------~~~~-----~~~~-----------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          294 ---------------KPEG-----LFRR-----------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ---------------EECS-----CCTT-----------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ---------------eech-----hccc-----------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                           0000     0000           12466889999999999999997766555543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=317.66  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=188.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHhC--CCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-KNRELQTMRLL--DHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|+||.||+|++  +++.||+|.+...... ..+|.+++..+  +||||+++++++.... .....+++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence            35899999999999999999998  4899999998654322 23455555544  8999999999875532 22356889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC-------CceeecCCCCcEEEcCCCCceeEeec
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-------~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ||||+.+ +|.+.+..     ..+++..++.++.|++.||.|||++.       ||+||||||+||+++.++ .+||+||
T Consensus       113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            9999985 99888864     46899999999999999999999642       899999999999999888 8999999


Q ss_pred             cceeeccCCCCc-----ccccccccccccccccCCCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 017341          183 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAA------IDIWSAGCVLAELLLG----------QPLFPGE  241 (373)
Q Consensus       183 g~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~------~DiwslG~il~~lltG----------~~pf~~~  241 (373)
                      |++.........     ....||+.|+|||++.+.. .+..      +|||||||++|+|++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433221     2457899999999996543 3443      9999999999999999          6677553


Q ss_pred             CcH----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          242 SGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       242 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ...    ...........         ..+.     .+       .......+++++.++|.+||+.||.+|||++++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~---------~~~~-----~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKK---------LRPS-----FP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSC---------CCCC-----CC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhc---------cCcc-----cc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            221    11111111000         0000     00       00011245678999999999999999999999997


Q ss_pred             C
Q 017341          318 H  318 (373)
Q Consensus       318 h  318 (373)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=337.88  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|++.+.||+|+||.||+|.+.. +..||||++....   ....+|+.+++.++||||+++++++.     + ..+|+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccceE
Confidence            4589999999999999999999864 4679999986543   33568999999999999999998762     2 23689


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      ||||+.+ +|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCC-cEEEcccccceecC
Confidence            9999985 8998887542  35689999999999999999999998 999999999999999888 89999999997543


Q ss_pred             CCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  ......++..|+|||++... .++.++|||||||++|+|++ |+.||.+.+..+....+......          
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------  483 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------  483 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            211  11233467889999998654 48999999999999999999 99999998877666655432110          


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                        ..+..++.++.+||.+||+.||++|||++++++
T Consensus       484 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          484 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              012468899999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=315.42  Aligned_cols=259  Identities=25%  Similarity=0.416  Sum_probs=197.4

Q ss_pred             ccccceEeeeeeeecCceEEEEEE----ECCCCcEEEEEEeccccc----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      ....+|++.+.||+|+||.||+|+    +..+++.||+|.+.....    ...+|+.+++.++||||+++++++..   .
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---A  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---c
Confidence            345689999999999999999998    467899999999865432    34589999999999999999988743   2


Q ss_pred             CceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCC-cEEEecC
Confidence            23357899999985 999888764   25689999999999999999999998 999999999999999888 8999999


Q ss_pred             cceeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          183 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       183 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      |++........    .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.....     ...+..+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhcccc
Confidence            99987644332    1234567889999999654 478999999999999999999999864311     1111111111


Q ss_pred             HHH-----H-hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REE-----I-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      ...     + ......   ..          ...+..++.++.++|.+||+.||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNN---GR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHHHHHHHHHHHHTT---CC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHhhcC---CC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            000     0 000000   00          0112468899999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=315.98  Aligned_cols=252  Identities=18%  Similarity=0.248  Sum_probs=196.6

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|.+....      ....+|+.+++.++||||+++++++..     .
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----P  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----S
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence            445689999999999999999999853   49999885432      334579999999999999999998843     3


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++ ++ .+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~-~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NG-KVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CC-CEEEeecCC
Confidence            34889999998 5888777543   34689999999999999999999998 999999999999998 55 799999998


Q ss_pred             eeeccC------CCCcccccccccccccccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 017341          185 AKVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  250 (373)
Q Consensus       185 a~~~~~------~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i  250 (373)
                      +.....      ........||+.|+|||++.+        ...++.++|||||||++|+|++|+.||.+.+.......+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            765421      112234468999999999864        234788999999999999999999999988776655544


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                      .......                           .....++.++.++|.+||..||.+|||+.++++.  ++.+..
T Consensus       256 ~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~~  302 (319)
T 2y4i_B          256 GTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPK  302 (319)
T ss_dssp             HTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC--
T ss_pred             ccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHHH
Confidence            3321000                           0113578899999999999999999999999873  445443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6e-42  Score=339.81  Aligned_cols=240  Identities=22%  Similarity=0.296  Sum_probs=192.6

Q ss_pred             eEe-eeeeeecCceEEEEEEE--CCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           37 YMA-ERVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        37 y~~-~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +.+ .+.||+|+||.||+|.+  ..+++.||||++....      ....+|+++++.++||||+++++++.     +. .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-C
Confidence            444 34899999999999954  4667899999886432      23457999999999999999999772     22 2


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++|||||. |+|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            679999998 488888864    36689999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......     
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----  591 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----  591 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6543322    1233467889999999654 48999999999999999998 99999998877766655442110     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                             ..+..+++++.+||.+||+.||.+|||++++++
T Consensus       592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                   122468899999999999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=339.02  Aligned_cols=241  Identities=26%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             ceEeee-eeeecCceEEEEEEEC--CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           36 SYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ++.+.+ .||+|+||.||+|.+.  .++..||||.+....     ....+|+++++.++||||+++++++..     . .
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~-~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-A  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----S-S
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----C-C
Confidence            556666 8999999999999875  356779999986532     234589999999999999999998732     1 2


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++|||||.+ +|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-~vkL~DFGla~  484 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRH-YAKISDFGLSK  484 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred             eEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence            7899999985 888877543   35689999999999999999999998 999999999999999888 89999999997


Q ss_pred             eccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+....     
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----  558 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----  558 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-----
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            65332211    123456889999999654 58999999999999999998 99999998887766655442100     


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  316 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll  316 (373)
                                             .++..+++++.++|.+||..||.+|||+++++
T Consensus       559 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          559 -----------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                                   12246899999999999999999999999984

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.6e-42  Score=315.12  Aligned_cols=256  Identities=21%  Similarity=0.237  Sum_probs=193.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHh--CCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ++|++.+.||+|+||.||++.+  +|+.||+|.+.... ....+|.++++.  ++||||+++++++.... .....+++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            5899999999999999999998  58999999986543 234578888887  78999999999875432 222358899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------ccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--------~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      |||+.+ +|.+.+..     ..+++..++.++.||+.||.|||        +. ||+||||||+||+++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999995 99988864     46899999999999999999999        77 999999999999999888 8999999


Q ss_pred             cceeeccCCCC-----cccccccccccccccccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 017341          183 GSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLG----------QPLFPGES  242 (373)
Q Consensus       183 g~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwslG~il~~lltG----------~~pf~~~~  242 (373)
                      |++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976654432     234578999999999965432     23689999999999999999          78886643


Q ss_pred             cHH-HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          243 GVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       243 ~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ... ....+.......          .    ..+..+    ........+..+.++|.+||+.||++|||++++++|
T Consensus       272 ~~~~~~~~~~~~~~~~----------~----~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQ----------K----LRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTS----------C----CCCCCC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHH----------H----hCCCCc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            211 111111110000          0    000000    000112345689999999999999999999999976

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.4e-44  Score=329.89  Aligned_cols=248  Identities=18%  Similarity=0.177  Sum_probs=183.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCC---------CCCeee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVS   92 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~~iv~   92 (373)
                      .++|++.+.||+|+||.||+|++  +|+.||+|++....            ....+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46899999999999999999998  78999999986542            33468999998886         656555


Q ss_pred             ccee-----------------eeecC--------CCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 017341           93 LKHC-----------------FFSTT--------EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQIC  146 (373)
Q Consensus        93 ~~~~-----------------~~~~~--------~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil  146 (373)
                      +.++                 |....        ..+...+|+|||||.+ ++.+.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            5544                 32200        0124568999999974 4544442     25689999999999999


Q ss_pred             HHHHHhH-ccCCceeecCCCCcEEEcCCC-------------------CceeEeeccceeeccCCCCccccccccccccc
Q 017341          147 RALAYIH-NTIGVCHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAP  206 (373)
Q Consensus       147 ~~L~~LH-~~~~ivH~Dlkp~NIll~~~~-------------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  206 (373)
                      .||.||| ++ ||+||||||+|||++.++                   ..+||+|||+|+....    ....||+.|+||
T Consensus       172 ~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCS
T ss_pred             HHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccCh
Confidence            9999999 88 999999999999999775                   2699999999986542    245899999999


Q ss_pred             ccccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccc
Q 017341          207 ELIFGATEYTAAIDIWSAGCV-LAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  284 (373)
Q Consensus       207 E~l~~~~~~~~~~DiwslG~i-l~~lltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (373)
                      |++.+..  +.++||||||++ .+++++|..||.+..... ....+......                  +.   .. ..
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~---~~-~~  302 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF------------------KT---KC-NT  302 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC------------------SS---CC-CS
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc------------------Cc---cc-ch
Confidence            9997543  889999998777 778889999985421111 11122211000                  00   00 00


Q ss_pred             cccCCCChhHHHHHHhhcCcCCCCCCCHHHHh-cCCCcc
Q 017341          285 IFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFD  322 (373)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll-~hp~~~  322 (373)
                      .....+++++.+||.+||++|     |++|+| +||||+
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            112357889999999999977     999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-41  Score=336.10  Aligned_cols=246  Identities=27%  Similarity=0.371  Sum_probs=198.8

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...+|++.+.||+|+||.||+|.+..+   +..+|+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            345899999999999999999998654   4679999875432     23457999999999999999998762     1


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                       ..+|+||||+. |+|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~-~vkL~DFG  536 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFG  536 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCC-CEEEEecC
Confidence             12679999998 5898888754   34689999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeccCCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          184 SAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       184 ~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +++........  ....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......    
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            99765433221  234567899999999654 58999999999999999997 99999998877776666542110    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                              .++..+++.+.++|.+||..||.+|||+.++++.
T Consensus       612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                    0224688999999999999999999999999753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.1e-40  Score=296.34  Aligned_cols=224  Identities=15%  Similarity=0.060  Sum_probs=176.4

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++.     +
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~  102 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----T  102 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----E
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----E
Confidence            44578999999999999999999999999999999986543       23457999999999999999999884     3


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ....|+||||++| +|.+++.+     . .....+..++.||+.||.|||++ ||+||||||+||+++.++ .+||++++
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g-~~kl~~~~  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDG-DVVLAYPA  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTS-CEEECSCC
T ss_pred             CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCC-CEEEEecc
Confidence            3458899999985 88887742     2 35567888999999999999998 999999999999999888 79988543


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                                         |++        .++.++|||||||++|+|++|+.||.+.+..+.+....            
T Consensus       175 -------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------  215 (286)
T 3uqc_A          175 -------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------  215 (286)
T ss_dssp             -------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------
T ss_pred             -------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------
Confidence                               232        26889999999999999999999998765422110000            


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                               ... .........+...+++++.++|.+||+.||.+| |++++++.
T Consensus       216 ---------~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          216 ---------RDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             ---------BCT-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             ---------HHh-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence                     000 000011112335789999999999999999999 99999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-41  Score=341.60  Aligned_cols=241  Identities=24%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||++.+.. +|+.||+|.+....     ....+|+.+++.++||||+++++++......+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4689999999999999999999976 78999999885432     12347899999999999999999886655444555


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .|+||||++| +|.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+||+++.+  .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC--cEEEEecccch
Confidence            7899999985 6665443      3689999999999999999999998 99999999999999974  69999999998


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.....                     
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------  283 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------  283 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc---------------------
Confidence            65332   456799999999998653  4889999999999999999999886532100                     


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                             .+.  ..     .....++.+.++|.+||+.||.+||+..+++.|+|+.-
T Consensus       284 -------~~~--~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 -------LPE--DD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------CCT--TC-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------ccc--cc-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                   000  00     00124678999999999999999999999999999864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.3e-34  Score=278.44  Aligned_cols=177  Identities=17%  Similarity=0.087  Sum_probs=124.2

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEecccc--------------cchHHHHHHHHhC-CCCCeeecceeeeecCCCCcee
Q 017341           43 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        43 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+.|+.|.+..++..-.|+.+++|.+.++.              +...+|+++|+++ .|+||+++++++     +++..
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQS  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSSE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECCE
Confidence            556777777777766789999999986542              2244799999999 699999999998     66667


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|||||||+| +|.+.+.+.    +++++.   .++.||+.||+|||++ ||+||||||+|||++.+| .+||+|||+|+
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg-~vKL~DFGlAr  387 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQ-HARLIDFGSIV  387 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTS-CEEECCCTTEE
T ss_pred             EEEEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCC-CEEEeecccCe
Confidence            9999999996 888888753    556654   4789999999999998 999999999999999988 89999999998


Q ss_pred             eccCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 017341          187 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  235 (373)
Q Consensus       187 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~  235 (373)
                      ..... ....+.+||+.|+|||++.+  .+..++|+||+|+++++|.++.
T Consensus       388 ~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          388 TTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            65433 23446789999999999965  3677899999999988776654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.8e-27  Score=231.52  Aligned_cols=179  Identities=17%  Similarity=0.241  Sum_probs=133.7

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ...+.||+|+||.||++.  ..++.+++|+.....            ....+|+++++.++||||+++..+...   .+.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---~~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD---LDN  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE---TTT
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe---CCc
Confidence            456799999999999995  467889999864322            113589999999999999955444432   222


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                        .|+|||||+ ++|.+.+..            +..++.||+.+|.|||++ ||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999998 588877653            457899999999999998 9999999999999997   699999999


Q ss_pred             eeeccCCCC--------cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 017341          185 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFP  239 (373)
Q Consensus       185 a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltG~~pf~  239 (373)
                      ++.......        .....||+.|+|||++... ..|+..+|+||..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            987643221        1256789999999999541 237788999999998888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.5e-24  Score=193.99  Aligned_cols=138  Identities=16%  Similarity=0.199  Sum_probs=108.7

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------------------cchHHHHHHHHhCCCCCeeecc
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK   94 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~   94 (373)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|.+....                      ....+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            34449999999999999999 889999999885321                      12458999999999  5 6776


Q ss_pred             eeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC
Q 017341           95 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  173 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~  173 (373)
                      +++..      ...|+||||++| +|.+ +.          ......++.||+.||.|||++ ||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-C
Confidence            65421      235899999986 7655 21          122457899999999999988 999999999999999 7


Q ss_pred             CCceeEeeccceeeccCCCCccccccccccccccccc
Q 017341          174 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  210 (373)
Q Consensus       174 ~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~  210 (373)
                      + .+||+|||+|+.            +..++|||++.
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            7 899999999863            34578898873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=4.6e-21  Score=169.27  Aligned_cols=135  Identities=17%  Similarity=0.255  Sum_probs=102.9

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcE--EEEEEecccc----------------------------cchHHHHHHHHhC
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDK----------------------------RYKNRELQTMRLL   85 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l   85 (373)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||+|.+....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999998778999  9999864321                            1245799999999


Q ss_pred             CCCCeeecceeeeecCCCCceeEEEEEecccc------cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH-ccCCc
Q 017341           86 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGV  158 (373)
Q Consensus        86 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g------~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-~~~~i  158 (373)
                      .|+++... ..+..      ...++||||+++      .|.+....       .++..+..++.||+.+|.||| +. ||
T Consensus       128 ~~~~i~~p-~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~-gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA-EL  192 (258)
T ss_dssp             HHTTCCCC-CEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS-CE
T ss_pred             HhCCCCCC-eEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            88764222 11211      125799999953      45443221       224457789999999999999 88 99


Q ss_pred             eeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          159 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       159 vH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999997   5999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=5.7e-18  Score=155.65  Aligned_cols=132  Identities=14%  Similarity=0.187  Sum_probs=90.8

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc----------c----------------hHHHHHHHHhCCCCCe
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----------Y----------------KNRELQTMRLLDHPNV   90 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~----------------~~~E~~~l~~l~h~~i   90 (373)
                      |.+.+.||+|++|.||+|.+ .+|+.||||++.....          .                ..+|...|..+.+..+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            99999999999999999997 4799999998642210          0                0134444554433322


Q ss_pred             eecceeeeecCCCCceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEE
Q 017341           91 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  169 (373)
Q Consensus        91 v~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIl  169 (373)
                      . ....+..      ...+|||||++| ++.+.          .....+..++.||+.+|.+||++ |||||||||.|||
T Consensus       176 ~-vp~p~~~------~~~~LVME~i~G~~L~~l----------~~~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NIL  237 (397)
T 4gyi_A          176 P-VPEPIAQ------SRHTIVMSLVDALPMRQV----------SSVPDPASLYADLIALILRLAKH-GLIHGDFNEFNIL  237 (397)
T ss_dssp             S-CCCEEEE------ETTEEEEECCSCEEGGGC----------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEE
T ss_pred             C-CCeeeec------cCceEEEEecCCccHhhh----------cccHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEE
Confidence            1 1111100      113699999997 43221          11123456789999999999988 9999999999999


Q ss_pred             EcCCCC---------ceeEeeccceee
Q 017341          170 VNPHTH---------QLKLCDFGSAKV  187 (373)
Q Consensus       170 l~~~~~---------~ikl~Dfg~a~~  187 (373)
                      ++.++.         .+.|+||+-+..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            987652         288999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=3e-12  Score=112.85  Aligned_cols=135  Identities=15%  Similarity=0.107  Sum_probs=100.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecc----cccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..|++...++.|+.+.||++..  .+..+++|....    ......+|..+++.+. +..+++++++..     +....|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceE
Confidence            4699999999999999999975  468899998753    2345678999999885 566777776652     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc---------------------------------
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT---------------------------------  155 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---------------------------------  155 (373)
                      +|||+++| ++...+.         +......++.++..+|..||+.                                 
T Consensus        87 lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999998 5543310         1112346678899999999970                                 


Q ss_pred             -------------------------CCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          156 -------------------------IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       156 -------------------------~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                                               ..++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                     2589999999999998643 56799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.16  E-value=1.5e-10  Score=101.52  Aligned_cols=134  Identities=16%  Similarity=0.098  Sum_probs=90.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ..|.+....+.|..+.||++.. .+|..+++|..... .....+|..+++.+.+.+  +++++.+..     +....++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEE
Confidence            3567665555666799999964 56788999986543 234568999999886443  455655442     22336799


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccC----------------------------------
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI----------------------------------  156 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~----------------------------------  156 (373)
                      |||++| ++ . .       ....   ...++.++...|..||+..                                  
T Consensus        94 ~e~i~G~~l-~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           94 LGEVPGQDL-L-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EECCSSEET-T-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEecCCccc-C-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            999997 43 2 1       1111   1244566777777777531                                  


Q ss_pred             -----------------------CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          157 -----------------------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 -----------------------~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                                             .++|+|++|.||+++.++ .+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence                                   299999999999998654 566999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=2.5e-10  Score=105.26  Aligned_cols=140  Identities=15%  Similarity=0.188  Sum_probs=98.4

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEec--cc-----ccchHHHHHHHHhCCC--CCeeecceeeeecCCCCceeE
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ...+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+..  ..+++++.+....  ......
T Consensus        41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred             ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence            3466789999999999986  34678899765  22     2356689999999874  4466666544221  111345


Q ss_pred             EEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc--------------------------------
Q 017341          109 NLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--------------------------------  155 (373)
Q Consensus       109 ~lv~e~~~g~-l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------------------------------  155 (373)
                      |+||||++|. +.+.      ....++......++.+++.+|..||+.                                
T Consensus       117 ~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            7899999973 2110      123466777888899999999999961                                


Q ss_pred             -------------------------CCceeecCCCCcEEEcCCCC-ceeEeeccceee
Q 017341          156 -------------------------IGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  187 (373)
Q Consensus       156 -------------------------~~ivH~Dlkp~NIll~~~~~-~ikl~Dfg~a~~  187 (373)
                                               ..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     36999999999999997752 368999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=9e-11  Score=105.67  Aligned_cols=185  Identities=12%  Similarity=0.152  Sum_probs=111.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecC-CCCceeEEEEEeccc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELYLNLVLEYVP  116 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~~  116 (373)
                      .+.++.|....||++.     ..+++|.....  .....+|..+++.+.+..-+.+..++.... .......|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            3458999999999864     46899976433  234568999998874322222222222211 111223478999999


Q ss_pred             c-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc----------------------------------------
Q 017341          117 E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT----------------------------------------  155 (373)
Q Consensus       117 g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~----------------------------------------  155 (373)
                      | .+.....      ..++......++.|++..|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            8 4432221      2355666667777777777777741                                        


Q ss_pred             -----------------CCceeecCCCCcEEEcCC-CCceeEeeccceeeccCCCCcccccccccc---cccccc----c
Q 017341          156 -----------------IGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYY---RAPELI----F  210 (373)
Q Consensus       156 -----------------~~ivH~Dlkp~NIll~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y---~aPE~l----~  210 (373)
                                       ..++|+|++|.||+++.+ +..+.|+||+.+......   ........+   ..|+..    .
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHH
Confidence                             147999999999999974 436889999988653211   111001111   122211    0


Q ss_pred             CCC---------CCCCchhHHHHHHHHHHHHhCCCCC
Q 017341          211 GAT---------EYTAAIDIWSAGCVLAELLLGQPLF  238 (373)
Q Consensus       211 ~~~---------~~~~~~DiwslG~il~~lltG~~pf  238 (373)
                      ...         ....-.+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000         0122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=4.9e-07  Score=81.17  Aligned_cols=137  Identities=16%  Similarity=0.130  Sum_probs=80.4

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEEecccc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  117 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g  117 (373)
                      .+.++.|....||++     |..+++|.....  .....+|..+++.+.+..-+.+........ ......++||++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccCC
Confidence            445788888899988     567899975322  134568999999997532222222221111 122335699999997


Q ss_pred             -cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc------------------------------------------
Q 017341          118 -TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN------------------------------------------  154 (373)
Q Consensus       118 -~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~------------------------------------------  154 (373)
                       .+.....      ..++......+..++...|..||+                                          
T Consensus        98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence             4433111      112222233333333333333332                                          


Q ss_pred             -----------------cCCceeecCCCCcEEEcC---CCCceeEeeccceeec
Q 017341          155 -----------------TIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  188 (373)
Q Consensus       155 -----------------~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg~a~~~  188 (373)
                                       ...++|+|++|.||+++.   ++..+.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             125699999999999987   3534589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.46  E-value=1.8e-06  Score=75.79  Aligned_cols=131  Identities=15%  Similarity=0.134  Sum_probs=82.0

Q ss_pred             eeecCc-eEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhCCC-CCeeecceeeeecCCCCceeEEEEEecccc-c
Q 017341           43 VGHGSF-GVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-T  118 (373)
Q Consensus        43 lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~  118 (373)
                      +..|.. +.||+......+..+++|.-.... ....+|...|+.+.. --+.+++.+.     .+....++|||+++| +
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEeeCCcc
Confidence            344444 479998877777889999764332 334678999988752 2244444433     222346799999997 5


Q ss_pred             HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc-------------------------------------------
Q 017341          119 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------------------------------------------  155 (373)
Q Consensus       119 l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-------------------------------------------  155 (373)
                      +.+.....        ......+..++...|..||+.                                           
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            44433221        111223444555555555531                                           


Q ss_pred             --------------CCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          156 --------------IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       156 --------------~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                                    ..++|+|+.|.||+++.++ .+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                          0179999999999999655 567999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.33  E-value=2.8e-06  Score=77.18  Aligned_cols=30  Identities=23%  Similarity=0.458  Sum_probs=26.4

Q ss_pred             CCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          156 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       156 ~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ..++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            4899999999999998666 79999999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=9.6e-06  Score=74.26  Aligned_cols=79  Identities=10%  Similarity=0.067  Sum_probs=49.1

Q ss_pred             eEeeeee-eecCceEEEEEEEC--C----CCcEEEEEEecccc-------cchHHHHHHHHhCCC---CCeeecceeeee
Q 017341           37 YMAERVV-GHGSFGVVFQAKCL--E----TGEAVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFS   99 (373)
Q Consensus        37 y~~~~~l-g~G~~g~Vy~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~   99 (373)
                      ....+.| +.|....+|++...  .    ++..+++|......       ....+|..+++.+..   ..+.+++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445677 78888899988753  0    16678999764432       345689998888742   345555543311


Q ss_pred             cCCCCceeEEEEEecccc
Q 017341          100 TTEKDELYLNLVLEYVPE  117 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g  117 (373)
                        .......++|||+++|
T Consensus       102 --~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 --GDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --STTTSSCEEEEECCCC
T ss_pred             --CCccCCceEEEEecCC
Confidence              1111234689999986

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.14  E-value=1.4e-05  Score=74.34  Aligned_cols=72  Identities=18%  Similarity=0.177  Sum_probs=44.4

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----------cchHHHHHHHHhCCC--C-CeeecceeeeecCCCC
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDH--P-NVVSLKHCFFSTTEKD  104 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h--~-~iv~~~~~~~~~~~~~  104 (373)
                      ..+.+|.|..+.||++....+++.+++|......           .....|.++++.+..  + .+++++.+  .   .+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TE  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CC
Confidence            3567899999999999765567889999754221           123568888887742  2 23344322  1   22


Q ss_pred             ceeEEEEEecccc
Q 017341          105 ELYLNLVLEYVPE  117 (373)
Q Consensus       105 ~~~~~lv~e~~~g  117 (373)
                      .  .++|||+++|
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            2  3589999976

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.98  E-value=0.00012  Score=60.89  Aligned_cols=98  Identities=15%  Similarity=0.082  Sum_probs=64.3

Q ss_pred             cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCcccc
Q 017341          118 TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY  197 (373)
Q Consensus       118 ~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~  197 (373)
                      +|.++|..+   +.+++++++|.++.|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ ..+           .
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s-----------~   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AAD-----------D   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-ccc-----------c
Confidence            688888876   589999999999999999987762110212333457899999988 676553 111           0


Q ss_pred             cccccccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 017341          198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  233 (373)
Q Consensus       198 ~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt  233 (373)
                      .....+.|||...  ...+.+.=|+|||+++|.-+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1233466888763  235778899999999999885

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.73  E-value=0.00022  Score=63.48  Aligned_cols=65  Identities=15%  Similarity=0.094  Sum_probs=40.7

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCe-eecceeeeecCCCCceeEEEEEecc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEYV  115 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~~  115 (373)
                      .+.|+.|....+|++      ..+++|......   ....+|..+++.+....+ .+++...     .+..  ++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~~--~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PATG--VMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTTC--CEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCCC--EEEEeec
Confidence            678899999999998      458899775432   123578888877743222 3333221     2222  4799999


Q ss_pred             -cc
Q 017341          116 -PE  117 (373)
Q Consensus       116 -~g  117 (373)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             65

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.70  E-value=0.00085  Score=59.22  Aligned_cols=75  Identities=16%  Similarity=0.133  Sum_probs=50.0

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      ...-.+.+|.|..+.||++.. .+|+.|++|+.....    .....|...|+.|....-+.+..++...  .    -++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEE
Confidence            456678899999999999985 578999999764332    2346899999988532222222222111  1    2579


Q ss_pred             Eecccc
Q 017341          112 LEYVPE  117 (373)
Q Consensus       112 ~e~~~g  117 (373)
                      ||++.+
T Consensus        89 ~e~l~~   94 (288)
T 3f7w_A           89 MEWVDE   94 (288)
T ss_dssp             EECCCC
T ss_pred             EEeecc
Confidence            999873

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.53  E-value=0.00053  Score=61.52  Aligned_cols=144  Identities=13%  Similarity=0.052  Sum_probs=75.1

Q ss_pred             EeeeeeeecCceEEEEEEECCCCcEEEEEEecc--cccchHHHHHHHHhCCCCC--eeecceeeeecCC----CCceeEE
Q 017341           38 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE----KDELYLN  109 (373)
Q Consensus        38 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~~  109 (373)
                      .-.+.|+.|....+|++... +| .+++|....  .......|..+++.+....  +++++..   ..+    ......+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPA   99 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEE
Confidence            34566778888899999853 33 688998765  3344567888887774222  2333221   110    0112357


Q ss_pred             EEEeccccc-H-----------HHHHHHhhhcCCC--------CCHHHHHH---------------HHHHHHHHHHHhHc
Q 017341          110 LVLEYVPET-V-----------HRVIKHHYKMSQR--------MPLIYVKL---------------YFYQICRALAYIHN  154 (373)
Q Consensus       110 lv~e~~~g~-l-----------~~~l~~~~~~~~~--------~~~~~~~~---------------i~~qil~~L~~LH~  154 (373)
                      ++|++++|. +           ...+.+.......        .....-..               +-..+...+..+.+
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            899999862 1           1111111111001        01000000               00012333444442


Q ss_pred             ------cCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          155 ------TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       155 ------~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                            ..+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                  12799999999999998654 457999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.50  E-value=0.0015  Score=61.62  Aligned_cols=70  Identities=13%  Similarity=0.205  Sum_probs=44.9

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-c--hHHHHHHHHhCCCCCe-eecceeeeecCCCCceeEEEEEec
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-Y--KNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~--~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      -.+.|+.|-...+|++.....+..+++|....... .  ..+|..+++.|...++ ++++..+     .+    .+||+|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            34568888889999998754457899997643222 2  2589999998865444 4444433     22    249999


Q ss_pred             ccc
Q 017341          115 VPE  117 (373)
Q Consensus       115 ~~g  117 (373)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            975

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.39  E-value=0.00075  Score=63.08  Aligned_cols=76  Identities=12%  Similarity=-0.049  Sum_probs=45.0

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeeccceeeccCCCCcccccc--cccccccccccCCCC--CCCchhHHHHHHHHHHHH
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELL  232 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~--~~~~~DiwslG~il~~ll  232 (373)
                      .++|+|++|.||+++.++  +.++||+.+..............  ...|.+|+.......  -....++.++...+++..
T Consensus       233 ~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             EEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            899999999999998654  99999998865321111111111  234666665421110  111244456777777766


Q ss_pred             hC
Q 017341          233 LG  234 (373)
Q Consensus       233 tG  234 (373)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.39  E-value=0.00092  Score=62.66  Aligned_cols=70  Identities=17%  Similarity=0.230  Sum_probs=45.9

Q ss_pred             eeeeeeecCceEEEEEEECC-------CCcEEEEEEecc-cc-cchHHHHHHHHhCCCCCe-eecceeeeecCCCCceeE
Q 017341           39 AERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  108 (373)
                      -.+.|+.|....+|++....       ++..+++|+... .. ....+|..+++.+...++ ++++..+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            45578888889999998643       257899998744 22 334478888887753333 4444433     22    


Q ss_pred             EEEEecccc
Q 017341          109 NLVLEYVPE  117 (373)
Q Consensus       109 ~lv~e~~~g  117 (373)
                      .+|++|++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            268999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.36  E-value=0.0016  Score=58.70  Aligned_cols=30  Identities=40%  Similarity=0.591  Sum_probs=26.3

Q ss_pred             CceeecCCCCcEEEcCC----CCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNPH----THQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~----~~~ikl~Dfg~a~~  187 (373)
                      .++|+|+.+.||+++.+    + .+.|+||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~-~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLA-RVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGG-GEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCC-CeEEEeCCCcCc
Confidence            79999999999999864    4 689999998865

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.31  E-value=0.0011  Score=60.96  Aligned_cols=138  Identities=17%  Similarity=0.228  Sum_probs=75.9

Q ss_pred             eeeeecCceEEEEEEECC-------CCcEEEEEEeccc---ccchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017341           41 RVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQD---KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~---~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      +.|..|-...+|++....       +++.+++|..-..   .....+|..+++.+. +.-..+++..+     ++    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence            456777788899988642       3578999976331   222347888888774 22234444433     22    2


Q ss_pred             EEEecccc-cH--------------HHHHHHhhhcC----CCCC--HHHHHHHHHHHHH-------------------HH
Q 017341          110 LVLEYVPE-TV--------------HRVIKHHYKMS----QRMP--LIYVKLYFYQICR-------------------AL  149 (373)
Q Consensus       110 lv~e~~~g-~l--------------~~~l~~~~~~~----~~~~--~~~~~~i~~qil~-------------------~L  149 (373)
                      +||||++| .+              .+.|.+.....    ....  ..++..++.++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            79999986 21              12222211111    1121  2445555544422                   12


Q ss_pred             HHhH----c---cCCceeecCCCCcEEEcCC---CCceeEeeccceee
Q 017341          150 AYIH----N---TIGVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  187 (373)
Q Consensus       150 ~~LH----~---~~~ivH~Dlkp~NIll~~~---~~~ikl~Dfg~a~~  187 (373)
                      ..|.    .   ...++|+|+.+.||+++.+   .+.+.++||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2222    1   1268999999999999876   23799999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.29  E-value=0.0014  Score=58.60  Aligned_cols=72  Identities=15%  Similarity=0.052  Sum_probs=49.7

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhCC---CCCeeecceeeeecCCCCceeEEEEEec
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEY  114 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~  114 (373)
                      -.+.|+.|....+|++..  ++..+++|...... .....|...|+.|.   ...+++++...     ......++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCceEEEEEe
Confidence            356789999999999985  46788999765432 33567888888774   24455655543     122346799999


Q ss_pred             ccc
Q 017341          115 VPE  117 (373)
Q Consensus       115 ~~g  117 (373)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.19  E-value=0.0014  Score=60.12  Aligned_cols=69  Identities=12%  Similarity=0.108  Sum_probs=40.3

Q ss_pred             eeeeeecCceEEEEEEECC--------CCcEEEEEEecccccc---hHHHHHHHHhCCCCC-eeecceeeeecCCCCcee
Q 017341           40 ERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKRY---KNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~  107 (373)
                      .+.++.|....+|++....        .+..+++|........   ...|..+++.+.... .++++..+     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            4567778888999998643        1367899976543222   357888888775333 33444332     11   


Q ss_pred             EEEEEecccc
Q 017341          108 LNLVLEYVPE  117 (373)
Q Consensus       108 ~~lv~e~~~g  117 (373)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             479999986

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.10  E-value=0.0035  Score=56.25  Aligned_cols=73  Identities=14%  Similarity=0.004  Sum_probs=42.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHhCCCCC--eeecceeeeecCC--CCceeEEEEEe
Q 017341           41 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE--KDELYLNLVLE  113 (373)
Q Consensus        41 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e  113 (373)
                      ..++ |....||++.. .+|+.+++|.....   ......|..+++.+....  +++++..  ....  ......+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            3455 77788998864 35667999987532   234456888887774222  3333321  1000  01234578999


Q ss_pred             cccc
Q 017341          114 YVPE  117 (373)
Q Consensus       114 ~~~g  117 (373)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.00  E-value=0.0012  Score=59.89  Aligned_cols=30  Identities=27%  Similarity=0.546  Sum_probs=26.5

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      .++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            689999999999998766 699999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.18  E-value=0.05  Score=50.62  Aligned_cols=70  Identities=11%  Similarity=0.122  Sum_probs=43.7

Q ss_pred             eeeeeeecCceEEEEEEECCC-------CcEEEEEEeccccc---chHHHHHHHHhCC-CCCeeecceeeeecCCCCcee
Q 017341           39 AERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDKR---YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~---~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      -.+.+..|-...+|++.....       +..+++|.......   ...+|..+++.+. +.-.++++..+     .+   
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~---  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE---  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC---
Confidence            344566777889999986421       57899997643221   2257888888875 22234444322     21   


Q ss_pred             EEEEEecccc
Q 017341          108 LNLVLEYVPE  117 (373)
Q Consensus       108 ~~lv~e~~~g  117 (373)
                       ++||+|++|
T Consensus       146 -~~I~efI~G  154 (424)
T 3mes_A          146 -GRIEEFIDG  154 (424)
T ss_dssp             -EEEEECCCS
T ss_pred             -CEEEEEeCC
Confidence             478999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.40  E-value=0.39  Score=44.22  Aligned_cols=31  Identities=29%  Similarity=0.484  Sum_probs=24.8

Q ss_pred             CceeecCCCCcEEEcC-----CCCceeEeeccceee
Q 017341          157 GVCHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  187 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~-----~~~~ikl~Dfg~a~~  187 (373)
                      .++|+|+.+.||++..     +...+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3689999999999932     233799999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	373
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-126
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-66
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-66
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-65
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-65
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-65
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-64
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-63
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-60
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-60
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-59
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-58
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-56
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-54
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-53
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-52
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-50
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-50
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-43
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  365 bits (937), Expect = e-126
 Identities = 238/347 (68%), Positives = 284/347 (81%), Gaps = 4/347 (1%)

Query: 20  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 79
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 80  QTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 138
           Q MR LDH N+V L++ F+S+ E KDE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
           KLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 319 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 365
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 6e-74
 Identities = 106/342 (30%), Positives = 179/342 (52%), Gaps = 25/342 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 91
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            +     + T +    + LV   +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 207
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 265
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 266 -NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 325 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK 366
            DP+            F F   EL  +P + L +LI E   +
Sbjct: 302 YDPSDE----PIAEAPFKF-DMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 6e-71
 Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 31/305 (10%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
                F       E+ +   +E++       +    K + R+P   +      + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 270
            T Y+   DIWS G  L E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 271 EFKF--------------PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
              +                I   P  K+       E  D V++ L  +P  R+   + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 317 IHPFF 321
           +H F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 2e-70
 Identities = 99/304 (32%), Positives = 148/304 (48%), Gaps = 23/304 (7%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 91
             +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L   F     K  + L  V +++   +          S  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 210
           +H    + HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--N 328
              F      P H IF      + +DL+  L  ++P  R TA +AL   +F     P   
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 329 TRLP 332
            +LP
Sbjct: 293 CQLP 296

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 4e-67
 Identities = 103/307 (33%), Positives = 163/307 (53%), Gaps = 21/307 (6%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           +     +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L           E  L LV E++ + + + +         +PLI  K Y +Q+ + LA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLA 116

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 209
           + H+   V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 268
            G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
             +  FP+     + K+    +  +   L+S++L Y PN R +A  AL HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 329 TRLPNGR 335
             +P+ R
Sbjct: 293 --VPHLR 297

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  213 bits (543), Expect = 7e-67
 Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 41/309 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 92
           Y     +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L   F     +D+  + ++ E++      + +       +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF-----EDDNEMVMIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 153 HNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--NT 329
                             +  +  D + +LL   PN R T  +AL HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 330 RLPNGRFLP 338
           ++P+ R+  
Sbjct: 294 QIPSSRYTK 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-66
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y     +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 91  VSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           V+L     +      + +  + LV ++     H +      +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-----SYICSRY 202
            L YIH    + HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 263 KCMNPNYTEFKFPQIKAHP---WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 319
             ++      K   +K        ++      P A+DL+ +LL   P  R  + +AL H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 320 FFDELRDPN 328
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-66
 Identities = 98/335 (29%), Positives = 162/335 (48%), Gaps = 24/335 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 90
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           + L   F      +E     ++ ++         ++    Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 210
           YIH+   + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 211 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
               Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 271 EF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                   Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 328 NTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE 362
           +        +   ++    E + + +D    L  +
Sbjct: 311 DDEP-----VADPYDQ-SFESRDLLIDEWKSLTYD 339

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 1e-65
 Identities = 100/302 (33%), Positives = 157/302 (51%), Gaps = 20/302 (6%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 91  VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           + L   F    T  D     LV+ ++   + +++KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            YIH   G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 270 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 326
            +      P+++   +  I      P AV+L+ ++L      R TA EAL HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 327 PN 328
             
Sbjct: 310 TE 311

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  208 bits (530), Expect = 2e-65
 Identities = 90/300 (30%), Positives = 149/300 (49%), Gaps = 21/300 (7%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 94
           Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
                  +       LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 214
            +G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 215 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           Y  ++D+WS GC+LA ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 274 FPQI----KAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
           F  I        W +      Q  + PEA+D + +LL+Y    R TA EA+ HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 8e-65
 Identities = 96/299 (32%), Positives = 151/299 (50%), Gaps = 17/299 (5%)

Query: 37  YMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDKRYKN------RELQTMRLL---D 86
           Y     +G G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           HPNVV L      +    E  L LV E+V + +   +    +    +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
           R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
           E++   + Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
                  F    A P  K     +     DL+ + L ++P  R +A  AL HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-64
 Identities = 98/299 (32%), Positives = 151/299 (50%), Gaps = 18/299 (6%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y     +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L           +  L LV E+       + K+    +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 209
           + H+   V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 210 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           FGA  Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                +P   A         ++     DL+  LL+ +P  R +A EAL HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  204 bits (520), Expect = 2e-63
 Identities = 80/334 (23%), Positives = 127/334 (38%), Gaps = 44/334 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 92
           Y     +G G+FGVV +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           L   F     +D+  + L+LE++   E   R+    YKMS+      V  Y  Q C  L 
Sbjct: 91  LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----VINYMRQACEGLK 141

Query: 151 YIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE++
Sbjct: 142 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                     D+W+ G +   LL G   F GE  ++ L  + +       +         
Sbjct: 201 DR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------- 252

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPN 328
                               + PEA D +  LLQ  P  R T  +AL HP+   +  +  
Sbjct: 253 ------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294

Query: 329 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE 362
           +R+P+ R+       K            +  I  
Sbjct: 295 SRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIAN 328

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 8e-63
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 32/305 (10%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 98
            +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 99  STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
           +     +  L +V+E +    +   I+   +  Q             I  A+ Y+H+ I 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131

Query: 158 VCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 215
           + HRD+KP+NLL         LKL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
             + D+WS G ++  LL G P F    G+     +   +                +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPNTRLPNG 334
             +           +  E   L+  LL+  P  R T  E + HP+     + P T L   
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 335 RFLPP 339
           R L  
Sbjct: 290 RVLKE 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  198 bits (504), Expect = 5e-62
 Identities = 95/295 (32%), Positives = 155/295 (52%), Gaps = 20/295 (6%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           V L           +  L LV E++ + + +++         +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIA 114

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 209
           Y H+   V HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 268
            G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
             +  F   +  PW     K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-61
 Identities = 72/295 (24%), Positives = 117/295 (39%), Gaps = 44/295 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
                             L LEY             +    MP    + +F+Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 208
           +H  IG+ HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +     +   +D+WS G VL  +L G+  +   S   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                      +PW KI         + L+ ++L  +P+ R T  +     ++++
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-61
 Identities = 59/289 (20%), Positives = 119/289 (41%), Gaps = 40/289 (13%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 93
           +  +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
            +  + +T K +  + LV E +       +K + K  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 154 -NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 212
             T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 213 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 272
            +Y  ++D+++ G  + E+   +  +       Q+                         
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224

Query: 273 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
               + +      F K   PE  +++   ++ + + R +  + L H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 1e-61
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 49/305 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 89
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
            +  + C+       E    LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 210 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                       +    +          + V   LQ  P  R T+   L H F    R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 328 NTRLP 332
              + 
Sbjct: 277 TVIMD 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 3e-61
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 48/292 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 89
           +   R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           ++ L   F      D   + L+LEY P      +    +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
           +Y H+   V HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
            EF FP              +   A DL+SRLL+++P+ R    E L HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 6e-61
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 44/294 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 92
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L   F       E  L +++E+             ++ + +    +++   Q   AL Y+
Sbjct: 74  LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 211
           H+   + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 212 AT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
            T     Y    D+WS G  L E+   +P     + +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 321
                     K+ P       R      D + + L+ + + R T  + L HPF 
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-60
 Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 45/296 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 90
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           V         T      L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 150 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYR 204
              H        V HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           +PE +     Y    DIWS GC+L EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                 E KF +I               E  ++++R+L      R +  E L +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 4e-60
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 40/292 (13%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 93
           YM    +G G FG+V +     + +    K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
              F     +    L ++ E++    +   I      +  +    +  Y +Q+C AL ++
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFL 118

Query: 153 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 211
           H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+   
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
               + A D+WS G ++  LL G   F  E+    +  I+    T   E           
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                           K +  EA+D V RLL      R TA EAL HP+  +
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 8e-60
 Identities = 93/333 (27%), Positives = 160/333 (48%), Gaps = 32/333 (9%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 90
           Y   + +G G+ G+V  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 91  VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +SL + F    T ++   + LV+E +   + +VI+      +      +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLCGI 132

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            ++H+  G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 270 TEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
             +    P+     + K+F            K    +A DL+S++L   P  R +  +AL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 349
            HP+ +   DP          P +++ +  E +
Sbjct: 310 QHPYINVWYDPAEVEAP---PPQIYDKQLDERE 339

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 5e-59
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 43/301 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 92
           Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
               +      DEL++  V+EY+                 M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV--VMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 211
           H+   V HRDIK  N+L+      +KL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 212 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 271
              Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP             E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------E 235

Query: 272 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 331
            + P            +++     D ++R L      R +A E L H F    +  ++  
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

Query: 332 P 332
           P
Sbjct: 284 P 284

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  192 bits (487), Expect = 1e-58
 Identities = 93/349 (26%), Positives = 155/349 (44%), Gaps = 49/349 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 93
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 94  KH----------CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 143
                         F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISK 132

Query: 144 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNISYI 198
           Q+   L Y+H   G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 252
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 253 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FQKRMPPEAVDLVS 299
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 300 RLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 341
            +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  186 bits (472), Expect = 3e-57
 Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 56/307 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------------LQDKRYKNRELQTMR 83
           Y  + ++G G   VV +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 84  LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLY 141
            +  HPN++ LK  +     +   +  LV + +    +   +     +S++      +  
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE----TRKI 115

Query: 142 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 201
              +   +  +H    + HRD+KP+N+L++   + +KL DFG +  L  GE       + 
Sbjct: 116 MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 202 YYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 256
            Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------ 227

Query: 257 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
                   M+ NY +F  P+                   DLVSR L   P  R TA EAL
Sbjct: 228 --------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268

Query: 317 IHPFFDE 323
            HPFF +
Sbjct: 269 AHPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 3e-57
 Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 44/304 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           Y    V+G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           +L   +        LYL  +++ V    +   I      ++R          +Q+  A+ 
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASRLIFQVLDAVK 121

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 208
           Y+H+   + HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE+
Sbjct: 122 YLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 209 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 268
           +     Y+ A+D WS G +   LL G P F  E+      +I+K                
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------- 231

Query: 269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 328
                            +   +   A D +  L++  P  R T  +AL HP+       +
Sbjct: 232 -----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

Query: 329 TRLP 332
             + 
Sbjct: 275 KNIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 58/313 (18%)

Query: 30  QPKQTI--SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQ 80
           QP++     +   +++G GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 81  TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 140
            M  LDHP  V L   F    + ++LY    L Y     +  +  + +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRF 112

Query: 141 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SY 197
           Y  +I  AL Y+H    + HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 198 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 257
           + +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK+    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225

Query: 258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 317
                        E+ FP+            +  P+A DLV +LL      R    E   
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260

Query: 318 ------HPFFDEL 324
                 HPFF+ +
Sbjct: 261 YGPLKAHPFFESV 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-54
 Identities = 81/356 (22%), Positives = 140/356 (39%), Gaps = 62/356 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--------MRLLDHP 88
           ++  +++G GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
            +  +   F     + +  L  V+EY+       + +H +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 207
           L ++H+  G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 208 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           ++ G  +Y  ++D WS G +L E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDELRD 326
            Y  +                 +  EA DL+ +L    P  R     +   HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 327 PNTRLPNGRFLPP----------LFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 372
               L      PP            NF    L   P          ++  Q  F  
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRN 317

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-53
 Identities = 65/318 (20%), Positives = 120/318 (37%), Gaps = 50/318 (15%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD 86
           Y     +G G F VV + +   TG   A K + + +   +          RE+  ++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           HPNV++L   +     +++  + L+LE V       +       + +       +  QI 
Sbjct: 72  HPNVITLHEVY-----ENKTDVILILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 147 RALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 203
             + Y+H+   + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 204 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 263
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 323
                                 +       A D + RLL   P  R T  ++L HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 324 LRDPNTRLPNGRFLPPLF 341
                 +  +  +  P F
Sbjct: 277 K--DTQQALSSAWSHPQF 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 74/323 (22%), Positives = 136/323 (42%), Gaps = 62/323 (19%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 89
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           ++ +   F     +D   + ++++Y+       +    + SQR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 209
            Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 210 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 269
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF--- 321
            E +FP                 +  DL+SRL+    + R     +   +   HP+F   
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 322 --DELRDPNTRLPNGRFLPPLFN 342
             ++L   N   P   + PP+  
Sbjct: 264 VWEKLLSRNIETP---YEPPIQQ 283

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-52
 Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 56/303 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD 86
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 87  --HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
                V+ L   F            L+LE       + +         +     + +F+Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 204
           +  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
            PE I     +  +  +WS G +L +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
                                F++R+  E   L+   L   P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 325 RDP 327
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  175 bits (444), Expect = 4e-52
 Identities = 76/350 (21%), Positives = 130/350 (37%), Gaps = 73/350 (20%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 86
           +   R++G G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 145
            P +V + + F      D+L    +L+ +    +H  +  H   S+      ++ Y  +I
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEI 116

Query: 146 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 205
              L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y A
Sbjct: 117 ILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMA 173

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE++     Y ++ D +S GC+L +LL G   F      D+       L           
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------ 227

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPF 320
                                     PE   L+  LLQ   N R       A E    PF
Sbjct: 228 --------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

Query: 321 F-----DELRDPNTRLPNGRFLPPLF-----------NFKPHELKGVPVD 354
           F       +       P    +PP             +F   + KG+ + 
Sbjct: 268 FRSLDWQMVFLQKYPPP---LIPPRGEVNAADAFDIGSFDEEDTKGIKLL 314

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  168 bits (427), Expect = 1e-50
 Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 43/295 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 89
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 149
           +V++ +              +V+EYV       ++        M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 150 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRA 205
            + H   G+ HRD+KP N++++   + +K+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 206 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           PE   G     A  D++S GCVL E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
                                 + +  +   +V + L  +P  R      +    
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 7e-50
 Identities = 71/318 (22%), Positives = 121/318 (38%), Gaps = 56/318 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           +++G G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           K+ F      D L        +       +  H    +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           +   V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           +Y  A+D W  G V+ E++ G+  F  +        I+                   E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDPN 328
           FP            + + PEA  L++ LL+  P  R     S A E + H FF  +    
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269

Query: 329 TRLPNGRFLPPLFNFKPH 346
             +   + LPP   FKP 
Sbjct: 270 QDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 49/291 (16%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 93
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 94  KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
                         L +V ++    +++  +     +  +  +I +     Q  + + Y+
Sbjct: 70  MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 209
           H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I
Sbjct: 121 HAK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 210 FG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++                
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
               +  P +             P     L++  L+   + R    + L  
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 3e-46
 Identities = 54/302 (17%), Positives = 100/302 (33%), Gaps = 45/302 (14%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 94
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
               +    +  Y  +V+E +  ++          S++  L  V L   Q+   + YIH+
Sbjct: 69  RWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 155 TIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNI--------SYICSRYYR 204
                HRD+KP N L+        +   DFG AK       +         +   +  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 205 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 264
           +     G  E +   D+ S G VL    LG   + G     +  +  ++        I+ 
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF 321
           +   Y                     P E    ++       + +   S   +   + F 
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

Query: 322 DE 323
            +
Sbjct: 279 RQ 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-43
 Identities = 53/282 (18%), Positives = 101/282 (35%), Gaps = 45/282 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 98
           + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 99  STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
               +++  L +V EY+ + ++   ++   +    +    +  +   +C A+ Y+     
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-N 123

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 217
             HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++ 
Sbjct: 124 FVHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179

Query: 218 AIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 276
             D+WS G +L E+   G+  +P     D +  + K                  +   P 
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPD 223

Query: 277 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                         PP   +++         +R + L+    
Sbjct: 224 ------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 49/267 (18%), Positives = 98/267 (36%), Gaps = 24/267 (8%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 94
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     +   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 95  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 154
           + F      + L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH 
Sbjct: 67  YYFGQ----EGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 155 TIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRY 202
              + +RDIKP N L+      + + + + DFG  K                 +   +  
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           Y +     G  E +   D+ + G V    L G   + G        +  ++        +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKR 289
           + +   + E +F +   +  +  F   
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (381), Expect = 5e-43
 Identities = 63/313 (20%), Positives = 114/313 (36%), Gaps = 57/313 (18%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 93
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
           +  F   +    +                +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVM--------EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 213
           + + + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 214 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
            Y  A+D W+ G ++ E+  G P F  +  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPFFDELRDPN 328
                       F      +  DL+  LLQ        NL++   +   H +F      +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301

Query: 329 TRLPNGRFLPPLF 341
                 R +   F
Sbjct: 302 WIAIYQRKVEAPF 314

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-42
 Identities = 79/330 (23%), Positives = 138/330 (41%), Gaps = 60/330 (18%)

Query: 37  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKV--------LQDKRYKNRELQTMRLL 85
           +   +V+G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 86  DH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 144
              P +V+L + F     + E  L+L+L+Y+       +  H    +R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF-----QTETKLHLILDYIN---GGELFTHLSQRERFTEHEVQIYVGE 137

Query: 145 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SR 201
           I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 261
           Y     +  G + +  A+D WS G ++ ELL G   F  +   +   EI +         
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246

Query: 262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 316
                    + + P          + + M   A DL+ RLL   P  R       A E  
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290

Query: 317 IHPFFDELRDPNTRLPNGRFLPPLFNFKPH 346
            H FF ++   +  L   +   P   FKP 
Sbjct: 291 EHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-41
 Identities = 56/293 (19%), Positives = 101/293 (34%), Gaps = 47/293 (16%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 93
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 94  KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 153
                    ++ +Y  ++ EY+                ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIY--IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 154 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 211
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 212 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 270
              +T   D+WS G +L E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 271 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL--IHPFF 321
                      +  +     P E   L+    +  P  R T       +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 47/296 (15%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
                 ++ +Y+  V EY+ +          +  + + L  +     QI   +AY+   +
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 214
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 215 YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 273
           +T   D+WS G +L EL   G+  +PG    + L ++ +    P   E            
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239

Query: 274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--LEALIHPFFDELRDP 327
                            P    DL+ +  +  P  R T   L+A +  +F      
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-40
 Identities = 55/302 (18%), Positives = 108/302 (35%), Gaps = 37/302 (12%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 92
           + + +  +G G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 93  LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
                 +        L LV +Y    ++   +  +      + +  +          LA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115

Query: 152 IHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YIC 199
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 200 SRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 254
           ++ Y APE++  +      E     DI++ G V  E+     +  G     QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 314
             P+ EE++ +          +++ +  ++            ++      +   R TAL 
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 315 AL 316
             
Sbjct: 288 IK 289

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (355), Expect = 9e-40
 Identities = 63/309 (20%), Positives = 115/309 (37%), Gaps = 54/309 (17%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVL-----QDKRYKNRELQTMRLLDH 87
               E+V+G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 88  PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 147
           PNV+ L+      T+   +   ++ E++            +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 148 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------ 201
            + Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 202 YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 260
            + APE I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 320
           +                             P     L+    Q   N R    + +    
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287

Query: 321 FDELRDPNT 329
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-39
 Identities = 59/299 (19%), Positives = 105/299 (35%), Gaps = 53/299 (17%)

Query: 41  RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 90
             +G GSFGVV + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 150
           + L     +        + +V E  P     ++    K      L  +  Y  Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 151 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 207
           Y+ +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +     
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 208 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
                  ++ A D W  G  L E+   GQ  + G +G   L +I K      R E     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 325
                                   P +  +++ +   + P  R T +   +  F  E +
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-39
 Identities = 64/304 (21%), Positives = 117/304 (38%), Gaps = 53/304 (17%)

Query: 41  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
           +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            L     ++T      + L+ + +P     ++ +  +    +   Y+  +  QI + + Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 208
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 209 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           I     YT   D+WS G  + EL+  G   + G     ++  I++      +  I     
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI----- 237

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 327
                                    +   ++ +      + R    E +I  F    RDP
Sbjct: 238 ----------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274

Query: 328 NTRL 331
              L
Sbjct: 275 QRYL 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-39
 Identities = 49/283 (17%), Positives = 95/283 (33%), Gaps = 43/283 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 97
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
               E+  + L  V E++         +            +      +C  +AY+     
Sbjct: 70  ---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 215
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 216 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 275
           ++  D+WS G ++ E+     +        ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 276 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                 +     +        +++   +  P  R      L  
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 53/284 (18%), Positives = 106/284 (37%), Gaps = 45/284 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 97
           + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 98  FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 157
              T++  ++  ++ EY+         +  +M  R     +      +C A+ Y+ +   
Sbjct: 69  ---TKQRPIF--IITEYMANGCLL--NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-Q 120

Query: 158 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 215
             HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 216 TAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++  DIW+ G ++ E+  LG+  +   +  +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
           P +               +   ++        + R T    L +
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 7e-39
 Identities = 55/299 (18%), Positives = 105/299 (35%), Gaps = 56/299 (18%)

Query: 40  ERVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 91
           ++ +G G+FG V +      +  + VA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
            +        E +   L  V+E         +  + + ++ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 207
           +  +    HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 208 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 266
            I    ++++  D+WS G ++ E    GQ  + G  G +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230

Query: 267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFFD 322
                                   P E  DL++    Y    R         L + ++D
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-38
 Identities = 63/298 (21%), Positives = 107/298 (35%), Gaps = 54/298 (18%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVS 92
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 93  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 152
           L        + + L L  V+E          K      + +P+  V    +Q+   + Y+
Sbjct: 74  LIGVC----QAEALML--VMEMAGGGPLH--KFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 153 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 208
                  HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE 
Sbjct: 126 EEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 209 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 267
           I    ++++  D+WS G  + E L  GQ  +    G + +  I +        E      
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237

Query: 268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFD 322
                                  PPE   L+S    Y    R    T  + +   ++ 
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 54/290 (18%), Positives = 110/290 (37%), Gaps = 43/290 (14%)

Query: 40  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 96
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 97  FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 156
               T +   Y+    E++               Q +  + +     QI  A+ Y+    
Sbjct: 82  C---TREPPFYIIT--EFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 214
              HRD+  +N LV  + H +K+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 215 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 274
           ++   D+W+ G +L E+            + Q+ E+++                    + 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYRMER 237

Query: 275 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 324
           P            +  P +  +L+    Q++P+ R +  E  IH  F+ +
Sbjct: 238 P------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 70/314 (22%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKN-----RELQTM-RLLDHP 88
            +V+G G+FG V  A      +      VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------------- 128
           N+V+L       T    +Y  L+ EY     +   ++   +                   
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 129 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 188
               +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 189 VKGEPNISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 244
           +     +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 245 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 304
               ++I+               N  +   P                 E   ++     +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306

Query: 305 SPNLRSTALEALIH 318
               R +       
Sbjct: 307 DSRKRPSFPNLTSF 320

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 6e-37
 Identities = 53/304 (17%), Positives = 108/304 (35%), Gaps = 57/304 (18%)

Query: 40  ERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 91
             V+G G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 151
           SL         + E    +VL Y+     R        +    +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 152 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 206
           + +     HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           E +    ++T   D+WS G +L EL+  G P +P  +  D  V +++             
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHP 319
                              +  +  P    +++ +       +R +       + A+   
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 320 FFDE 323
           F  E
Sbjct: 295 FIGE 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 69/293 (23%), Positives = 104/293 (35%), Gaps = 50/293 (17%)

Query: 37  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHP 88
               R +G G FG V Q   +       AVAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 148
           ++V L           E  + +++E       R           + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 149 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 206
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 207 ELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 265
           E I     +T+A D+W  G  + E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                                    PP    L+++   Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-36
 Identities = 61/307 (19%), Positives = 109/307 (35%), Gaps = 65/307 (21%)

Query: 40  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKN-----RELQTM-RLLDHP 88
            + +G G+FG V +A        +    VA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 89  NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM--------------SQRM 133
           N+V+L       T      +  + EY     +   ++                      +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 134 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 193
            L  +  + YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 194 NISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 249
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 250 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 309
           +IK                             +  +  +  P E  D++       P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 310 STALEAL 316
            T  + +
Sbjct: 293 PTFKQIV 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 50/294 (17%)

Query: 36  SYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLD 86
               ++V+G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
           H N++ L+             + ++ EY+        K   +      ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC----SRY 202
             + Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 203 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 262
           + APE I      +A+ D+WS G V+ E++        E    ++++ I           
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 316
                              +        P     L+ +  Q     R    + +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 57/300 (19%), Positives = 107/300 (35%), Gaps = 56/300 (18%)

Query: 40  ERVVGHGSFGVVFQAKCLETGE--AVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 91
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 92  SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYV 138
           +L             YL L +EY P   +   ++    +            +  +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 139 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 198
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 199 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 258
               + A E +   + YT   D+WS G +L E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 318
                         + P                 E  DL+ +  +  P  R +  + L+ 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (315), Expect = 5e-34
 Identities = 58/311 (18%), Positives = 99/311 (31%), Gaps = 71/311 (22%)

Query: 41  RVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 90
           R +G G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 91  VSLKHCFFSTTEKDELYLNLVLEYVP---------------------ETVHRVIKHHYKM 129
           V              + L  + EY+                        +    +     
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 130 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 189
              +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 190 KGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 245
             +      +      +  PE IF    YT   D+W+ G VL E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 305
            +  +                          I A P      +  P E  +L+       
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282

Query: 306 PNLRSTALEAL 316
           P  R +     
Sbjct: 283 PADRPSFCSIH 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-33
 Identities = 58/310 (18%), Positives = 114/310 (36%), Gaps = 66/310 (21%)

Query: 37  YMAERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN-----RELQTM-R 83
            +  + +G G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 84  LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS------------ 130
           +  H N+++L           +  L +++EY  +  +   ++                  
Sbjct: 75  IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 131 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 190
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 191 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQ 246
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 306
           L +++K                      P                 E   ++       P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278

Query: 307 NLRSTALEAL 316
           + R T  + +
Sbjct: 279 SQRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 5e-32
 Identities = 57/310 (18%), Positives = 106/310 (34%), Gaps = 62/310 (20%)

Query: 37  YMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD------KRYKNRELQTMRLL 85
               + +G G+FG V +A         T   VA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 86  DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-------------SQR 132
            H NVV+L              L +++E+             +                 
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 133 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 192
           + L ++  Y +Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 193 PNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLV 248
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 249 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 308
             +K                 T  + P                PE    +       P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 309 RSTALEALIH 318
           R T  E + H
Sbjct: 281 RPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 7e-31
 Identities = 54/312 (17%), Positives = 110/312 (35%), Gaps = 63/312 (20%)

Query: 40  ERVVGHGSFGVVFQAKC-----LETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 89
            R +G GSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 90  VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLI------YVKLYF 142
           VV         ++       +++E +    +   ++         P++       +    
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 143 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--- 199
            +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 200 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 258
              + +PE +     +T   D+WS G VL E+  L +  + G S    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------ 312
                                           P    +L+    QY+P +R +       
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 313 LEALIHPFFDEL 324
           ++  + P F E+
Sbjct: 289 IKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 2e-19
 Identities = 30/204 (14%), Positives = 56/204 (27%), Gaps = 32/204 (15%)

Query: 41  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------------LQDKRYKNRELQTMRLLD 86
           +++G G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 87  HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 146
              +  L+               +++E              K   R+ +         I 
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 147 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 206
             +A  ++   + H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 207 ELIFGATEYTAAIDIWSAGCVLAE 230
              F    Y    DI SA   + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	373
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.44
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.95
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.3
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.63
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.44

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-64  Score=465.18  Aligned_cols=327  Identities=71%  Similarity=1.190  Sum_probs=287.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHhCCCCCeeecceeeeecCC-CCceeEEEEEe
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLE  113 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~e  113 (373)
                      .+|+..++||+|+||+||+|++..+|+.||||++..+.....+|+++++.++||||++++++|+.... .+..++|+|||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            37999999999999999999999999999999998887777899999999999999999999876443 46678899999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccCCCC
Q 017341          114 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  193 (373)
Q Consensus       114 ~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~  193 (373)
                      ||++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||+++.......
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999988888877666677899999999999999999999998 9999999999999998876899999999988766666


Q ss_pred             cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017341          194 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  273 (373)
Q Consensus       194 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      ..+..||+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+++.++.+..+.+..+.+....+.+....
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  258 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK  258 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence            67788999999999987777799999999999999999999999999999999999999999999999988888888888


Q ss_pred             CCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhcCCCCH
Q 017341          274 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPV  353 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (373)
                      ++.....++........++++.+||.+||++||.+|||++|+|+||||+++.+++.++++....+.+.+|...++..-+ 
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~-  337 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-  337 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCG-
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCc-
Confidence            8888888888888888999999999999999999999999999999999999988888887777888888877766533 


Q ss_pred             HHHhhhchHH
Q 017341          354 DMLVKLIPEH  363 (373)
Q Consensus       354 ~~~~~~~~~~  363 (373)
                      ..-...+|.+
T Consensus       338 ~~~~~~~p~~  347 (350)
T d1q5ka_         338 PLATILIPPH  347 (350)
T ss_dssp             GGHHHHSCTT
T ss_pred             cccccCCCcc
Confidence            3333344433

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-61  Score=424.23  Aligned_cols=248  Identities=31%  Similarity=0.503  Sum_probs=214.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|.+.+..       ....+|+++++.++||||+++++++     .+..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence            468999999999999999999999999999999885321       2345799999999999999999998     4455


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+|+|||||+ |+|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCC-CEeeccccee
Confidence            6899999999 5888888754    5699999999999999999999998 999999999999999988 7999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ..... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+..           
T Consensus       154 ~~~~~-~~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPS-SRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCC-CCCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCC-CcccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            76543 334567899999999999765 48999999999999999999999999988777776665420           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                            .            .+++.+|+++.+||.+||+.||.+|||++|+|+||||++
T Consensus       221 ------~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 ------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                  1            123468999999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-61  Score=427.67  Aligned_cols=253  Identities=27%  Similarity=0.355  Sum_probs=210.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|.+....     ....+|+.+++.++||||+++++++.     +...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence            468999999999999999999999999999999985432     34568999999999999999999984     34568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          109 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       109 ~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      |+|||||+| +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            899999985 88777643    36799999999999999999999998 999999999999999888 799999999987


Q ss_pred             ccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          188 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       188 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      .....   .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+...............       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------  225 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  225 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            54332   23456899999999999776655788999999999999999999998776544433333211000       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                         ......+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus       226 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                               0011458999999999999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=426.71  Aligned_cols=254  Identities=32%  Similarity=0.546  Sum_probs=215.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||||.+.+..       ....+|+++++.++||||+++++++     .+..
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence            357999999999999999999999999999999985321       2345899999999999999999988     4455


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+|+|||||+| +|.+.+...    +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~-~vkl~DFG~a  155 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTA  155 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCc-eEEecccccc
Confidence            68999999995 888877654    6799999999999999999999998 999999999999999988 7999999999


Q ss_pred             eeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          186 KVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       186 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +......   .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+.         
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------  225 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------  225 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT---------
T ss_pred             eecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC---------
Confidence            8764332   22356799999999999765 4899999999999999999999999998888777776542         


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCccccCCCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE------ALIHPFFDELRDPN  328 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~------ll~hp~~~~~~~~~  328 (373)
                              ...            ++..+++++++||++||+.||++|||++|      +++||||+++++..
T Consensus       226 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         226 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             --------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             --------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence                    011            23568999999999999999999999988      58899999987653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=429.38  Aligned_cols=278  Identities=35%  Similarity=0.615  Sum_probs=228.0

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           39 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        39 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++||||+++++++     .+..++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            4689999999999999999999999999885432         2345899999999999999999998     4445588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          110 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       110 lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      +|||||.+++...+..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCC-ccccccCccccccC
Confidence            9999999876555543   246789999999999999999999998 999999999999999988 89999999997654


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ... .....+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++.+|.+..+.+..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3345679999999999976667899999999999999999999999999999999999999988887655433222


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      .....+...+..++...+ +.+++++.+||++||+.||++|||++|+|+||||++...+
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            222222233333333333 4689999999999999999999999999999999876544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-60  Score=424.41  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=214.3

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++....    ....+|+.+++.++||||+++++++..     ..++|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            48999999999999999999999999999999986432    234589999999999999999999843     445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |||||+| +|.+++.+     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999995 77766543     4699999999999999999999998 999999999999999988 79999999998765


Q ss_pred             CCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          190 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ... .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.......           
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-----------  235 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-----------  235 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-----------
T ss_pred             cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence            433 34566799999999999764 58999999999999999999999999988887777766531100           


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                     ...+..+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       236 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                           0122468999999999999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=429.42  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=218.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.++.       ....+|+.+++.++||||+++++++     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            468999999999999999999999999999999986431       2345799999999999999999998     5556


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|+|||||+| +|...+...    ..+++..++.+++||+.||+|||++ ||+||||||+|||++.+| .+||+|||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g-~vkl~DFG~a  152 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCC-CEEEeecccc
Confidence            68999999995 787777654    6799999999999999999999998 999999999999999998 7999999999


Q ss_pred             eeccC-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +.... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+....          
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------  221 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC----------
Confidence            86544 3344567899999999999765 48999999999999999999999999998877777665520          


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                             .            .++..+|+++++||++||+.||.+|++     ++|+++||||+++++
T Consensus       222 -------~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         222 -------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -------C------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                   1            123578999999999999999999994     999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-60  Score=420.42  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=206.3

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|.+....      ....+|+++++.++||||+++++++..   .....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence            468999999999999999999999999999999986543      223579999999999999999998753   33445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC-----ceeecCCCCcEEEcCCCCceeEee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLCD  181 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~-----ivH~Dlkp~NIll~~~~~~ikl~D  181 (373)
                      +|+|||||+ |+|.+++.+.......+++..++.++.||+.||+|||++ |     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            789999998 599999887766678899999999999999999999986 5     99999999999999988 899999


Q ss_pred             ccceeeccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          182 FGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       182 fg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      ||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+...++....      
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------  230 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------  230 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------
Confidence            99998764433 23456899999999999654 58999999999999999999999999988877777665421      


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  321 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~  321 (373)
                                   .+         .++..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       231 -------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                         00         1224689999999999999999999999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-59  Score=421.13  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=219.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+..          ....+|+.+++.++||||+++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            467999999999999999999999999999999985431          2245899999999999999999998     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC---ceeE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKL  179 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~ikl  179 (373)
                      +..++|+|||||+ |+|.+.+.+.    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.   .+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEe
Confidence            5556899999998 5888888764    5799999999999999999999998 9999999999999987763   4999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +|||+|.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++.+.......
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            999999887666666677899999999999654 5899999999999999999999999999888887777653221111


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                                               ...+++|+++++||++||+.||.+|||++|+|+||||+..++
T Consensus       238 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         238 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             -------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence                                     122568999999999999999999999999999999998654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-59  Score=421.36  Aligned_cols=292  Identities=33%  Similarity=0.549  Sum_probs=237.0

Q ss_pred             CCccccceEeeeeeeecCceEEEEEEECCC-CcEEEEEEecccc------cchHHHHHHHHhC---CCCCeeecceeeee
Q 017341           30 QPKQTISYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFS   99 (373)
Q Consensus        30 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~   99 (373)
                      .....++|++.+.||+|+||+||+|++..+ ++.||||++..+.      ....+|+.+++.+   +||||+++++++..
T Consensus         2 ~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            445567999999999999999999999765 6779999985321      2334788877766   79999999999876


Q ss_pred             cCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          100 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       100 ~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                      .......+++++||||++++.......  ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~-~~kl  157 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKL  157 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEE
T ss_pred             cccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCC-Ceee
Confidence            655667789999999998766555433  246689999999999999999999998 999999999999999888 8999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +|||+++............||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.+..+.+..
T Consensus       158 ~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cchhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            999998866555555677899999999999664 5899999999999999999999999999999999999999988877


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      ..+....... ...+......+ ...+...+++++++||.+||++||++|||++|+|+||||++++.++
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         237 EDWPRDVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             GGSCTTCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             hcccccccch-hhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence            6543321111 11111111112 2224467899999999999999999999999999999999987543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-59  Score=414.03  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=207.8

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      -|+..+.||+|+||+||+|++..+++.||+|++....      ....+|+++++.++||||+++++++.... .+...+|
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~   88 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV   88 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEE
Confidence            3478889999999999999999999999999986432      22457999999999999999999886533 3456688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCC--ceeecCCCCcEEEcC-CCCceeEeeccce
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNP-HTHQLKLCDFGSA  185 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~--ivH~Dlkp~NIll~~-~~~~ikl~Dfg~a  185 (373)
                      +|||||++ +|.+.+.+.    ..+++..++.++.||+.||+|||++ +  |+||||||+|||++. ++ .+||+|||+|
T Consensus        89 ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla  162 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLA  162 (270)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTS-CEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCC-CEEEeecCcc
Confidence            99999985 888888764    5799999999999999999999988 8  999999999999975 55 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +.. .........||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.+.+.....         
T Consensus       163 ~~~-~~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~---------  230 (270)
T d1t4ha_         163 TLK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------  230 (270)
T ss_dssp             GGC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------
T ss_pred             eec-cCCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC---------
Confidence            753 2333456789999999999854  4899999999999999999999999877655544433321000         


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                       ...++...++++.+||.+||+.||++|||++|+|+||||+
T Consensus       231 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             0113356789999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=420.73  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=214.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      +.|++.+.||+|+||.||+|+++.+|+.||+|.+....    ....+|+++++.++||||+++++++.     +...+|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence            46999999999999999999999999999999986432    34468999999999999999999984     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |||||++ +|...+.+.   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 787776654   36799999999999999999999998 999999999999999988 89999999997653


Q ss_pred             CCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          190 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       190 ~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      ... ......||+.|+|||++..    ...|+.++|||||||++|+|++|++||.+.+..+.+.++.+.....       
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-------  234 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------  234 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            321 2235689999999999842    3447899999999999999999999999998888887776531000       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                         ...+..+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       235 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 -------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                               0112468999999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=421.62  Aligned_cols=283  Identities=35%  Similarity=0.643  Sum_probs=230.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++..+.      ....+|+++++.++||||+++++++.     +...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence            58999999999999999999999999999999985432      23457999999999999999999984     44458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      |+|||||.+++...+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccC-cceeccCCcceec
Confidence            9999999988777765442  46699999999999999999999998 999999999999999888 8999999999766


Q ss_pred             cCC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ... .......||+.|+|||++.....++.++|+|||||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            433 2334568999999999987777678999999999999999999999999999999999998888776554332111


Q ss_pred             Cc-ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          268 NY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      .. .....+......... ....+|+++++||++||+.||.+|||++|+|+||||+++..|
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            00 001112222222222 224688999999999999999999999999999999998655

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-60  Score=426.64  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=202.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      .+.|++.+.||+|+||+||+|+++.+|+.||+|.+....     ....+|+.+++.++||||+++++++     .+..++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            457999999999999999999999999999999986432     2345799999999999999999998     455568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcC---CCCceeEeeccc
Q 017341          109 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGS  184 (373)
Q Consensus       109 ~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~ikl~Dfg~  184 (373)
                      |+|||||+ |+|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+||++..   ++ .+||+|||+
T Consensus        83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~  156 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDS-KIMISDFGL  156 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEECCC--
T ss_pred             EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCc-eEEEeccce
Confidence            99999998 589888864    36799999999999999999999998 9999999999999953   45 799999999


Q ss_pred             eeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          185 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       185 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      |+...........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+.+......      
T Consensus       157 a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------  229 (307)
T d1a06a_         157 SKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------  229 (307)
T ss_dssp             ----------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC------
T ss_pred             eEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC------
Confidence            9876555555677899999999999664 589999999999999999999999999888877777665311110      


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                         ....+.+|+++.+||.+||+.||.+|||++|+++||||++
T Consensus       230 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 -------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                               1122568999999999999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-59  Score=430.19  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=221.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++....    ....+|+.+++.++||||+++++++.     +...+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            458999999999999999999999999999999986543    23457999999999999999999984     445589


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC-CCceeEeeccceee
Q 017341          110 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  187 (373)
Q Consensus       110 lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~ikl~Dfg~a~~  187 (373)
                      +|||||+ |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       100 ivmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            9999998 5888877543   35699999999999999999999998 99999999999999643 23799999999988


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++.........        
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  246 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  246 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------
T ss_pred             cccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            7666666678899999999999765 4899999999999999999999999999888888887764211111        


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                                       .....+|+++++||.+||+.||++|||++|+|+||||+....+
T Consensus       247 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             -----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                             1124689999999999999999999999999999999987654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-59  Score=424.06  Aligned_cols=251  Identities=26%  Similarity=0.468  Sum_probs=216.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++.++.       ....+|+.+++.++||||+++++++     .+..
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCC
Confidence            357999999999999999999999999999999985321       2345799999999999999999998     4455


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|+|||||.| ++...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g-~vkL~DFG~a  151 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFA  151 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             eeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCC-CEEEecCccc
Confidence            68999999996 66666554    36688999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          186 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       186 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      +....  ...+.+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+...++.+..           
T Consensus       152 ~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------  217 (316)
T d1fota_         152 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------  217 (316)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred             eEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------
Confidence            87633  34467899999999999654 48999999999999999999999999998888887776521           


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  327 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~~  327 (373)
                            .            .+++.+|+++.++|.+||..||.+|+     |++++++||||+++.+.
T Consensus       218 ------~------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         218 ------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ------C------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                  0            12356899999999999999999996     99999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-59  Score=428.42  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=218.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      .+.|++.+.||+|+||.||+|++..+|+.||+|.+....    ....+|+.+++.++||||++++++|     .+...+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            457999999999999999999999999999999986543    2345799999999999999999998     4455689


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc--CCCCceeEeecccee
Q 017341          110 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN--PHTHQLKLCDFGSAK  186 (373)
Q Consensus       110 lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~--~~~~~ikl~Dfg~a~  186 (373)
                      +|||||+| +|.+.+...   ..++++..++.++.||+.||+|||++ ||+||||||+|||++  .++ .+||+|||+|+
T Consensus       103 ivmE~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~  177 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKAS-SVKIIDFGLAT  177 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCC-CEEECCCTTCE
T ss_pred             EEEEcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCC-eEEEeecccce
Confidence            99999995 777665432   35699999999999999999999998 999999999999997  345 89999999999


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+....+.        
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  248 (352)
T d1koba_         178 KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------  248 (352)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred             ecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            87666666677899999999999654 589999999999999999999999999998888887776321111        


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                       ......+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       249 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                             11224689999999999999999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-59  Score=422.75  Aligned_cols=251  Identities=27%  Similarity=0.493  Sum_probs=213.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHH-HhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.++.       ....+|..++ +.++||||+++++++     .+..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            57999999999999999999999999999999986432       1223455555 478999999999998     4455


Q ss_pred             eEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      ++|+|||||++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCC-ceeccccchh
Confidence            68999999994 888888754    5689999999999999999999998 999999999999999888 8999999999


Q ss_pred             eeccCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 017341          186 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  264 (373)
Q Consensus       186 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  264 (373)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            8654333 33456899999999999765 5899999999999999999999999999888877776542  00       


Q ss_pred             cCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCccccCC
Q 017341          265 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFFDELRD  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-~ll~hp~~~~~~~  326 (373)
                                          .+++.+|+++.+||++||+.||.+|||++ ++++||||+++++
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                                12356899999999999999999999996 8999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-59  Score=419.29  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=211.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..|++.+.||+|+||.||+|++..+|+.||||.+.....       ...+|+++++.++|||||++++++..     ..+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            369999999999999999999999999999999865432       23479999999999999999999843     445


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|+|||||.+++...+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        90 ~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            8999999997655444332   36799999999999999999999998 999999999999999888 899999999976


Q ss_pred             ccCCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  265 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  265 (373)
                      ...   .....||+.|+|||++.+.  ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+....+        
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------  233 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  233 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            432   3456899999999998642  358999999999999999999999999988887777766531100        


Q ss_pred             CcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          266 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                         ..+..+|+++.+||.+||+.||.+|||++|+|+||||..-
T Consensus       234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                               0124578999999999999999999999999999999763

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.9e-58  Score=408.45  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=218.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-------------chHHHHHHHHhCC-CCCeeecceeeeec
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------------YKNRELQTMRLLD-HPNVVSLKHCFFST  100 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~E~~~l~~l~-h~~iv~~~~~~~~~  100 (373)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+...             ...+|+.+++.++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            589999999999999999999999999999999865421             2347999999997 99999999998   


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                        .+..++|||||||+ |+|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCC-CeEE
Confidence              45566899999998 5999988754    5799999999999999999999988 999999999999999888 8999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  254 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~  254 (373)
                      +|||+++............||+.|+|||++.+     ...++.++||||+||++|+|++|++||.+.+.......+.+..
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999988766656667789999999999852     3347889999999999999999999999998888777777631


Q ss_pred             CCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          255 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      ..+.                         .....++|+++++||++||+.||.+|||++|+|+||||++
T Consensus       232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            1110                         0011468999999999999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-59  Score=424.44  Aligned_cols=281  Identities=25%  Similarity=0.410  Sum_probs=209.4

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++..+.     ....+|+.+++.++||||++++++|.     +...
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence            4568999999999999999999999999999999986442     22357999999999999999999984     4455


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +|+|||||.| +|.+++.+.    ..+++..++.++.||+.||.|||++.||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~  153 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcc
Confidence            8999999995 888888754    56999999999999999999999632899999999999999988 89999999998


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCCCCHHHHhhc
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE-IIKVLGTPTREEIKCM  265 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~  265 (373)
                      ..... ...+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+.... +....+.+........
T Consensus       154 ~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         154 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             ccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            65432 23467899999999999765 499999999999999999999999988765433221 1111111110000000


Q ss_pred             Cc-----CcccccCCC---------cCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          266 NP-----NYTEFKFPQ---------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       266 ~~-----~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                      ..     .+.....+.         ....+........+|.++.+||.+||+.||.+|||++|+|+||||++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            00     000000000         0000001111134688999999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-58  Score=419.75  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=218.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++.+..       ....+|+++++.++||||+++++++     .+
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cc
Confidence            44579999999999999999999999999999999985321       2235799999999999999999988     44


Q ss_pred             ceeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      ...+++||||+.| ++...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g-~ikL~DFG  186 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             ccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCC-CEEeeece
Confidence            5568899999995 777777654    5799999999999999999999998 999999999999999988 89999999


Q ss_pred             ceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          184 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       184 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      +|+....  ......||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+....+.++.....        
T Consensus       187 ~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------  255 (350)
T d1rdqe_         187 FAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------  255 (350)
T ss_dssp             TCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             eeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--------
Confidence            9987643  34467899999999999765 489999999999999999999999999988887777765210        


Q ss_pred             hcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 017341          264 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  326 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~~~~~~~  326 (373)
                                           .++..+|+++.+||++||+.||.+|+     |++++++||||+++++
T Consensus       256 ---------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         256 ---------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ---------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                                 12256899999999999999999995     9999999999998765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=415.89  Aligned_cols=285  Identities=35%  Similarity=0.623  Sum_probs=228.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      ..+|++.+.||+|+||+||+|.++.+|+.||||++....      ....+|+++|+.++||||++++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999999999999999986432      123479999999999999999999855332 2344


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++|+|||||+.++...+.+     .++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhccccc-cccccccccee
Confidence            5789999998787776653     5699999999999999999999998 999999999999999998 89999999998


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ...  .......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..+....+.++.+.+....
T Consensus       170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         170 QAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             ECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            653  334567899999999999877778999999999999999999999999999999999999999888877654432


Q ss_pred             cCccc---ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 017341          267 PNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  328 (373)
Q Consensus       267 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~  328 (373)
                      .....   ...+......+...+ ..+++++.+||.+||++||.+|||++|+|+||||+++.++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             chhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence            21100   012222223333322 57899999999999999999999999999999999987654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.5e-58  Score=421.99  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=210.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchH---HHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKN---RELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+..       ....   +|+.+++.++||||+++++++     .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            468999999999999999999999999999999985321       1112   346667777899999999988     4


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      +...+|+|||||. |+|.+.+.+.    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g-~iKl~DF  151 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDL  151 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSS-CEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCC-cEEEeee
Confidence            4456889999999 5888888764    6689999999999999999999998 999999999999999988 7999999


Q ss_pred             cceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          183 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       183 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      |+|+..... ......||+.|+|||++.....|+.++|||||||++|+|+||+.||.+.+..+... +.+.....     
T Consensus       152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~-----  224 (364)
T d1omwa3         152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-----  224 (364)
T ss_dssp             TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSC-----
T ss_pred             ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccC-----
Confidence            999876443 34566899999999999765668999999999999999999999998865543322 22211000     


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~ll~hp~~~~~~~  326 (373)
                                          ...++..+|+++++||.+||+.||.+|||     |+|+++||||+++++
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                                01123568999999999999999999999     799999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-58  Score=416.60  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=219.9

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|.+.....   ...+|+++|+.++||||++++++|     .+..++|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            4689999999999999999999999999999999865442   345899999999999999999998     44456899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC-CceeEeeccceeec
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT-HQLKLCDFGSAKVL  188 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~-~~ikl~Dfg~a~~~  188 (373)
                      |||||+| +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ ..+||+|||+++..
T Consensus        79 vmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999995 888877643   34699999999999999999999998 999999999999998543 37999999999877


Q ss_pred             cCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017341          189 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  268 (373)
Q Consensus       189 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  268 (373)
                      ..........+|+.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+.+.+|.+........        
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  225 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--------  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred             ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh--------
Confidence            655555677899999999998654 48999999999999999999999999999888888887743222222        


Q ss_pred             cccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          269 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                                       ..+.+|+++++||.+||..||.+|||++|+|+||||++
T Consensus       226 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                             12468999999999999999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-57  Score=407.54  Aligned_cols=277  Identities=35%  Similarity=0.634  Sum_probs=223.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....      ....+|+.+++.++||||+++++++.     +....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence            58999999999999999999985 78999999986532      23458999999999999999999984     34448


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +++|+++.+++...+...   ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||.+...
T Consensus        76 ~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            899999998877776543   47799999999999999999999998 999999999999999988 8999999999765


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+++.++.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            4332 234557899999999998777789999999999999999999999999999999999999888877654332211


Q ss_pred             Ccc-cccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          268 NYT-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       268 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      .-. ..........++ ..+...+++++.+||++||++||++|||++|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            000 011111112222 2234678999999999999999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=410.38  Aligned_cols=317  Identities=33%  Similarity=0.616  Sum_probs=241.9

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+.+|++++.||+|+||+||+|+++.+|+.||||++.....     ...+|+.+|+.++||||+++++++.........+
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            34689999999999999999999999999999999864332     2347999999999999999999986554444556


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceee
Q 017341          108 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  187 (373)
Q Consensus       108 ~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~  187 (373)
                      +|++|++++|+|.+++..     .++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|..
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCC-CEEEcccCceee
Confidence            778887777899988864     4699999999999999999999998 999999999999999888 899999999976


Q ss_pred             ccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 017341          188 LVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  263 (373)
Q Consensus       188 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  263 (373)
                      ......    ....+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+...........+......
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            543322    3455789999999999766678999999999999999999999999999989988888888888766443


Q ss_pred             hcCcCc---ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCC
Q 017341          264 CMNPNY---TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPL  340 (373)
Q Consensus       264 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~  340 (373)
                      ......   .....+.....++...+ +.+++++++||.+||+.||.+|||++|+|+||||+....+...    ....+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~----~~~~~~  313 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE----PIAEAP  313 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS----CCCSSC
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC----ccccCc
Confidence            221100   00122222223333333 5689999999999999999999999999999999987665432    122233


Q ss_pred             CCCChhhcCCCCHHHHhhhchH
Q 017341          341 FNFKPHELKGVPVDMLVKLIPE  362 (373)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~  362 (373)
                      .++. .+....+.+.+++++.+
T Consensus       314 ~~~~-~~~~~~~~~~l~~l~~~  334 (345)
T d1pmea_         314 FKFD-MELDDLPKEKLKELIFE  334 (345)
T ss_dssp             C---------CCHHHHHHHHHH
T ss_pred             cCCC-hhhhhCCHHHHHHHHHH
Confidence            3343 45556677777766544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-57  Score=401.48  Aligned_cols=246  Identities=27%  Similarity=0.431  Sum_probs=206.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHhCC--CCCeeecceeeeecC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTT  101 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  101 (373)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++.++.          ....+|+.+++.++  ||||+++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            458999999999999999999999999999999986432          22458999999987  89999999998    


Q ss_pred             CCCceeEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeE
Q 017341          102 EKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  179 (373)
Q Consensus       102 ~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl  179 (373)
                       .+...+|+||||+.+  ++...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+++.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEE
Confidence             444558899999974  666666653    6799999999999999999999998 99999999999999976558999


Q ss_pred             eeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          180 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       180 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      +|||+|+... ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      ++.+.      
T Consensus       153 ~DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------  219 (273)
T d1xwsa_         153 IDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------  219 (273)
T ss_dssp             CCCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred             Cccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence            9999997653 3334567899999999999766656788999999999999999999997532      22221      


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  325 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~  325 (373)
                                 .            ..++..+|+++++||.+||+.||++|||++|+|+||||+++.
T Consensus       220 -----------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 -----------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -----------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -----------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                       0            013357899999999999999999999999999999998754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=412.30  Aligned_cols=264  Identities=26%  Similarity=0.360  Sum_probs=211.3

Q ss_pred             cccceEeee-eeeecCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHH-hCCCCCeeecceeeeecCCCCceeEEE
Q 017341           33 QTISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-LLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        33 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..++|.+.+ .||+|+||.||+|++..+|+.||||++.. .....+|+.++. ..+||||++++++|.... ....++|+
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i   86 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   86 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence            356899875 69999999999999999999999998854 445678998865 558999999999885422 34567899


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC--CceeEeeccceee
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  187 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~ikl~Dfg~a~~  187 (373)
                      |||||+ |+|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++  +.+||+|||+|+.
T Consensus        87 vmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeee
Confidence            999998 59999887532  35699999999999999999999998 999999999999998632  2699999999988


Q ss_pred             ccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          188 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       188 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...........||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+...+..           
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-----------  231 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----------  231 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-----------
T ss_pred             ccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-----------
Confidence            7666666778899999999999654 4899999999999999999999999887765554444332110           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                        ..+.+|.        .....+|+++.+||++||+.||++|||++|+|+||||++
T Consensus       232 --~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 --GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             --CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             --CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence              0111111        111358999999999999999999999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.6e-56  Score=405.66  Aligned_cols=281  Identities=30%  Similarity=0.534  Sum_probs=222.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .++|+++++||+|+||+||+|+++.+|+.||+|++.... ....+|+++|+.++ ||||++++++|..   ....++++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEE
Confidence            468999999999999999999999999999999986543 34568999999995 9999999998754   334558899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||.+ +|...       .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+++.+||+|||+|+....
T Consensus       111 ~e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999996 54322       35699999999999999999999998 9999999999999998776799999999988766


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcC---
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMN---  266 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~---  266 (373)
                      ........+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ..++...+...++.+.........   
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            6666778899999999999877778999999999999999999999997654 445566666666554433322111   


Q ss_pred             --cCcccccCCCcCCCCccc----cccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 017341          267 --PNYTEFKFPQIKAHPWHK----IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  326 (373)
Q Consensus       267 --~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~  326 (373)
                        +.+.. ..+......+..    .....+++++.+||++||++||.+|||++|+|+||||+++.+
T Consensus       263 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGG-TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccch-hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence              11100 001111111111    112357899999999999999999999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=394.35  Aligned_cols=283  Identities=34%  Similarity=0.563  Sum_probs=227.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  108 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||+||+|++..+|+.||||++..+.      ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            58999999999999999999999999999999985443      2235899999999999999999988     444558


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeec
Q 017341          109 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  188 (373)
Q Consensus       109 ~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~  188 (373)
                      +++++++.++....+...   ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||.++..
T Consensus        77 ~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            899999997655554433   46789999999999999999999998 999999999999999888 8999999999876


Q ss_pred             cCCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          189 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       189 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|+.| |.+.+..+....+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5443 233456788999999997766689999999999999999999877 56667777788888887777665443322


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ........+..............+++++.+||.+||+.||.+|||++|+|+||||++..+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            1111112222222222333446789999999999999999999999999999999986543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=404.94  Aligned_cols=314  Identities=32%  Similarity=0.555  Sum_probs=240.5

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+...      ...+|+++++.++||||+++++++..... ++..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4589999999999999999999999999999999865432      23579999999999999999998865433 2334


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++++++++++|+|.+++.     .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||.+.
T Consensus        97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~-~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccc-cccccccchhc
Confidence            455555555578888774     35699999999999999999999998 999999999999999988 89999999986


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ..  ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+......
T Consensus       170 ~~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CC--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             cc--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            54  3334567899999999998777778999999999999999999999999999999999999998888776543322


Q ss_pred             cCccc---ccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCC
Q 017341          267 PNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNF  343 (373)
Q Consensus       267 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~  343 (373)
                      .....   ...+......+...+ ..+++++++||.+||+.||.+|||++|+|+||||+++.++.....     ...+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~-----~~~~~~  321 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-----ADPYDQ  321 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCC-----CCCCCC
T ss_pred             chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCC-----CCCCCC
Confidence            11100   011222222222222 468999999999999999999999999999999999876543221     112222


Q ss_pred             ChhhcCCCCHHHHhhhchHH
Q 017341          344 KPHELKGVPVDMLVKLIPEH  363 (373)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~  363 (373)
                      . .+.+....+.++.++-++
T Consensus       322 ~-~~~~~~~~~~~k~~~~~e  340 (348)
T d2gfsa1         322 S-FESRDLLIDEWKSLTYDE  340 (348)
T ss_dssp             G-GGGCCCCHHHHHHHHHHH
T ss_pred             c-ccchhcCHHHHHHHHHHH
Confidence            2 344556667776655443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=400.85  Aligned_cols=287  Identities=29%  Similarity=0.482  Sum_probs=223.2

Q ss_pred             ccccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC---
Q 017341           32 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---  102 (373)
Q Consensus        32 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  102 (373)
                      ...++|++.+.||+|+||+||+|++..+|+.||||++..+.      ....+|+++|+.++||||+++++++.....   
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            45689999999999999999999999999999999885432      223589999999999999999998754321   


Q ss_pred             CCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeec
Q 017341          103 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       103 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      ....++|++||||.+++.......   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~-~~kl~df  161 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADF  161 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCC
T ss_pred             ccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCC-cEEeeec
Confidence            224458899999998766555433   46799999999999999999999998 999999999999999998 8999999


Q ss_pred             cceeeccCC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          183 GSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       183 g~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |+++.....     .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999765422     223346799999999999877678999999999999999999999999999999999999988887


Q ss_pred             CHHHHhhcCcCc--ccccCCCcCCCCccccc-cCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017341          258 TREEIKCMNPNY--TEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  323 (373)
Q Consensus       258 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~  323 (373)
                      ..+........-  ................+ ....++++.+||.+||++||++|||++|+|+||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            765433222110  01111111111111111 0124778999999999999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=405.18  Aligned_cols=285  Identities=32%  Similarity=0.542  Sum_probs=220.4

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCC-CCce
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  106 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  106 (373)
                      ..+|++.++||+|+||+||+|.++.+|+.||||++....      ....+|+.+++.++||||++++++|..... +...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999999999999999986442      224589999999999999999999854332 3457


Q ss_pred             eEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          107 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       107 ~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      ++|+|||||.+++.+.+.      ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+|++|||+++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~-~~kl~df~~~~  167 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCcccccccccc-ceeeechhhhh
Confidence            789999999998776653      5689999999999999999999998 999999999999999988 79999999988


Q ss_pred             eccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          187 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       187 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ............+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......++......+..+.+....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            76666666677899999999999765 58999999999999999999999999999999999999998888877654433


Q ss_pred             cCcccc--cCCCcCCC-----------CccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 017341          267 PNYTEF--KFPQIKAH-----------PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  327 (373)
Q Consensus       267 ~~~~~~--~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~~~~  327 (373)
                      ..+..+  ..+.....           +.........++++.+||++||++||++||||+|+|+||||+...++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            221110  00000000           01111112356789999999999999999999999999999986553

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.3e-54  Score=383.66  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=204.6

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|.+..+.       ....+|+++++.++||||+++++++.... ...
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence            3568999999999999999999999999999999986432       12457999999999999999999886533 344


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+|+|||||+| +|...+...    +++++..++.++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||.
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~-~~~l~d~~~  157 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  157 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTS-CEEECCCTT
T ss_pred             ceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccc-cceeehhhh
Confidence            568899999995 777766553    6799999999999999999999998 999999999999999888 799999998


Q ss_pred             eeeccCCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      +.......    ......||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+...++......+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--  234 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--  234 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--
Confidence            86543322    23356799999999999654 589999999999999999999999999888887777665311111  


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~  322 (373)
                                             ....+.+|+++.+||.+||+.||.+||+..+.+.|+|.+
T Consensus       235 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                   112357899999999999999999999544445566654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=387.41  Aligned_cols=268  Identities=27%  Similarity=0.440  Sum_probs=215.1

Q ss_pred             ecccCCCCCCccccceEeeeeeeecCceEEEEEEE---CCCCcEEEEEEecccc--------cchHHHHHHHHhCCC-CC
Q 017341           22 TTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKC---LETGEAVAIKKVLQDK--------RYKNRELQTMRLLDH-PN   89 (373)
Q Consensus        22 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h-~~   89 (373)
                      ...++.... ...++|++.+.||+|+||+||+|++   +.+|+.||+|.+.+..        ....+|+++++.++| ||
T Consensus        12 ~~~~~~~~~-~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pn   90 (322)
T d1vzoa_          12 ANLTGHAEK-VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF   90 (322)
T ss_dssp             EECSSCCCC-CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTT
T ss_pred             cccCCCCcc-cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCe
Confidence            334444333 2347899999999999999999997   4478999999885321        234589999999977 89


Q ss_pred             eeecceeeeecCCCCceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcE
Q 017341           90 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  168 (373)
Q Consensus        90 iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NI  168 (373)
                      |+++++++     .+...++++|||+. |+|...+...    ..+++..++.++.||+.||.|||+. ||+||||||+||
T Consensus        91 Iv~~~~~~-----~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Ni  160 (322)
T d1vzoa_          91 LVTLHYAF-----QTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENI  160 (322)
T ss_dssp             BCCEEEEE-----EETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGE
T ss_pred             EEEeeeee-----ccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccce
Confidence            99999988     44456889999999 4888887754    5678999999999999999999998 999999999999


Q ss_pred             EEcCCCCceeEeeccceeeccCCC--CcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017341          169 LVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  245 (373)
Q Consensus       169 ll~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~  245 (373)
                      +++.++ .+||+|||+++......  ......|++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus       161 ll~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~  239 (322)
T d1vzoa_         161 LLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN  239 (322)
T ss_dssp             EECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred             eecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999988 89999999998653322  234567899999999996543 47889999999999999999999998887666


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCC
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPF  320 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~ll~hp~  320 (373)
                      ....+.+......                         ..++..+|+++.+||.+||+.||.+||     |++|+++|||
T Consensus       240 ~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         240 SQAEISRRILKSE-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             CHHHHHHHHHHCC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             HHHHHHHhcccCC-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence            6555554311000                         012356899999999999999999999     5899999999


Q ss_pred             ccccCC
Q 017341          321 FDELRD  326 (373)
Q Consensus       321 ~~~~~~  326 (373)
                      |+++++
T Consensus       295 f~~i~~  300 (322)
T d1vzoa_         295 FQKINW  300 (322)
T ss_dssp             GTTCCH
T ss_pred             hcCCCH
Confidence            998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-53  Score=381.13  Aligned_cols=252  Identities=19%  Similarity=0.288  Sum_probs=203.7

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++..+..   ...+|+++++.++|||||++++++.     +...+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeEE
Confidence            3589999999999999999999999999999999865543   3458999999999999999999883     3344789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |||||+ |+|...+....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999999 58888876532  46789999999999999999999998 999999999999999988 89999999997654


Q ss_pred             CCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          190 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       190 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      .....  ....||+.|+|||++.+. .++.++|||||||++|||++|..||..........+++..-.            
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------  233 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  233 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------
Confidence            33222  234578999999999655 489999999999999999997666544444444444333100            


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  324 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~hp~~~~~  324 (373)
                                     ...++..+|+++.+||.+||+.||.+|||++++++  +|+.+
T Consensus       234 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 ---------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ---------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                           00123568999999999999999999999999965  45443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=376.40  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=198.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|+..   ..||||++....      ....+|+.+++.++||||++++++..    .  ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~----~--~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST----A--PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC----S--SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe----c--cE
Confidence            457999999999999999999853   359999985432      23447999999999999999988642    1  13


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++|||||+ |+|.+.+...   ..++++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            689999999 5888888643   35699999999999999999999998 999999999999999988 89999999997


Q ss_pred             eccCCC---CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ......   ......||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||.+.+.......+......++   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p---  229 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP---  229 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            654322   22355789999999999643  3478999999999999999999999999887766665554321110   


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                          .....+.++|+++.+||.+||+.||.+|||++|++++
T Consensus       230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                0111235689999999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=373.03  Aligned_cols=244  Identities=20%  Similarity=0.327  Sum_probs=194.1

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||+|+||.||+|++. +++.||||++..+.   ....+|+++++.++||||+++++++..     ...+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEE
Confidence            47999999999999999999985 57789999986543   234589999999999999999998843     3347899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+ |+|.+++...   ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||+++....
T Consensus        79 ~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCC-CeEecccchheeccC
Confidence            99998 5888877654   35688999999999999999999998 999999999999999988 899999999976644


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+....+......           
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-----------  221 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-----------  221 (263)
T ss_dssp             -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------
T ss_pred             CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence            3322  245689999999999655 48999999999999999999 67778777766666665542111           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                       ..+...++++.+||.+||+.||++|||++|+++|
T Consensus       222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             1124578999999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=385.13  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=203.4

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCc-----EEEEEEecccc-----cchHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ++|++.+.||+|+||+||+|++..+++     .||+|.+....     ....+|+.+++.+ +|||||++++++     .
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~  111 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T  111 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----e
Confidence            589999999999999999999876554     69999875432     2345799999888 899999999988     3


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecC
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK-------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI  163 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~-------------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dl  163 (373)
                      +...+|+|||||+ |+|.+.+.....                   ....+++..++.++.||+.||+|||++ ||+||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRDl  190 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDL  190 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTC
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccC
Confidence            4445889999998 599999875432                   124588999999999999999999998 9999999


Q ss_pred             CCCcEEEcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 017341          164 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  239 (373)
Q Consensus       164 kp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~  239 (373)
                      ||+||+++.++ .+||+|||+|+........   ....||+.|+|||++.+. .++.++|||||||++|||+| |++||.
T Consensus       191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999988 8999999999866544332   245679999999999654 48999999999999999998 899999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          240 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       240 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +.+..+.+.++++....+                           ..+..+|+++.+||.+||+.||++|||++|+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            987777776666531110                           1224689999999999999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-52  Score=377.57  Aligned_cols=246  Identities=24%  Similarity=0.337  Sum_probs=192.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..+|++.+.||+|+||.||+|+++.+++   .||+|.+....     +...+|+++++.++|||||++++++.     +.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence            4689999999999999999999987765   58899875432     23458999999999999999999883     33


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++|||||++ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CEEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCC-cEEECCccc
Confidence            347899999995 787776643   35689999999999999999999998 999999999999999988 899999999


Q ss_pred             eeeccCCCCc------ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017341          185 AKVLVKGEPN------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  257 (373)
Q Consensus       185 a~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~  257 (373)
                      |+........      ....||+.|+|||.+.+. .++.++|||||||++|||+| |++||.+.+..+....+.+....+
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9865433221      123578999999999654 58999999999999999998 899999988777666654321110


Q ss_pred             CHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          258 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                                  .+..+++++.+||.+||+.||++|||+.|++++
T Consensus       254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                        124689999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=369.12  Aligned_cols=244  Identities=20%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||+|+||+||+|+++ +++.||||++..+.   ....+|+.+++.++||||+++++++.     +...+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence            57999999999999999999984 78899999986543   33458999999999999999999883     33348899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||+. |++...+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 5777776554   35688999999999999999999998 999999999999999988 899999999976544


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ....  ....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------  220 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  220 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            3322  245689999999999754 48999999999999999998 89999999887777666542111           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                       ..+...++++.+||.+||+.||++|||++++++|
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             1224678999999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=374.43  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .+|++.+.||+|+||.||+|.++ ++..||||++..+..   ...+|+++++.++|||||++++++.    .+  .+++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~--~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT----QE--PIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC----SS--SCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec----cC--CeEEE
Confidence            58999999999999999999975 678899999865432   3458999999999999999998762    11  25799


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      ||||+ |+|.+.+....  ..++++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus        86 ~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeeccc-ceeeccccceEEccC
Confidence            99999 57877665432  24589999999999999999999998 999999999999999988 899999999987644


Q ss_pred             CCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 017341          191 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  267 (373)
Q Consensus       191 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  267 (373)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+....+......           
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-----------  229 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-----------  229 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred             CccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence            332  2345689999999999654 489999999999999999995 5666666665555554431100           


Q ss_pred             CcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 017341          268 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDE  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~--hp~~~~  323 (373)
                                       ..+..+++++.+||.+||+.||++|||++++++  |+||..
T Consensus       230 -----------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         230 -----------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                             122468999999999999999999999999988  788864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=373.72  Aligned_cols=250  Identities=25%  Similarity=0.329  Sum_probs=204.0

Q ss_pred             ccceEeeee-eeecCceEEEEEEECC--CCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           34 TISYMAERV-VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        34 ~~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .++|.+.+. ||+|+||.||+|.++.  ++..||||.+....     ....+|+++++.++|||||++++++..     +
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C
Confidence            357889885 9999999999998754  45579999986432     234579999999999999999997632     1


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                       .+|+|||||++ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -eEEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCC-ceeeccchh
Confidence             26799999995 888776533   35699999999999999999999998 999999999999999988 899999999


Q ss_pred             eeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      |+.......    .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....   
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---  231 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---  231 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---
T ss_pred             hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            987644332    2244689999999999654 48999999999999999998 99999998877766665432100   


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCccc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA---LIHPFFDE  323 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l---l~hp~~~~  323 (373)
                                               .+++.+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       232 -------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         232 -------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                     1235689999999999999999999999888   67888754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=372.95  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=197.0

Q ss_pred             eEee-eeeeecCceEEEEEEEC--CCCcEEEEEEecccc------cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           37 YMAE-RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        37 y~~~-~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      +.+. ++||+|+||.||+|.+.  .+++.||+|++..+.      ....+|+++++.++|||||++++++.     ++. 
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~~-   81 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AES-   81 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SSS-
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cCC-
Confidence            3443 47999999999999864  456789999985432      23457999999999999999999872     122 


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      .++|||||+ |+|.+++..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~-~~kl~DFGla~  155 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  155 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccC-cccccchhhhh
Confidence            579999998 588887765    36699999999999999999999998 999999999999999988 89999999998


Q ss_pred             eccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 017341          187 VLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  261 (373)
Q Consensus       187 ~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  261 (373)
                      ........    ....||+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+....+.+...      
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~------  228 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------  228 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred             hccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            76443322    234689999999999654 48999999999999999998 9999999887666555543110      


Q ss_pred             HhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCccc
Q 017341          262 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA---LIHPFFDE  323 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~l---l~hp~~~~  323 (373)
                                            ..++..+|+++.+||.+||+.||.+|||++++   |+|+|++-
T Consensus       229 ----------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         229 ----------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                                  01225689999999999999999999999998   56766543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=367.07  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=199.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|+||.||+|++..+ +.||||++..+.   ....+|+.+++.++|||||++++++.    .+.  +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~----~~~--~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS----EEP--IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC----SSS--CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe----cCC--eEE
Confidence            46899999999999999999998655 579999986543   33458999999999999999999762    122  579


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeecc
Q 017341          111 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  189 (373)
Q Consensus       111 v~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~  189 (373)
                      |||||.+ ++...+....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        89 v~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCC-cEEEcccchhhhcc
Confidence            9999994 7776665543  35699999999999999999999998 999999999999999988 89999999997653


Q ss_pred             CCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 017341          190 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  266 (373)
Q Consensus       190 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  266 (373)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|||++| ++||.+....+.+..+.+....+         
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---------  234 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------  234 (285)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred             CCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------
Confidence            3322  2345689999999999654 589999999999999999995 56666666666665554321111         


Q ss_pred             cCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccccC
Q 017341          267 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDELR  325 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~--hp~~~~~~  325 (373)
                                         .+..+++++.+||.+||+.||++|||++++++  ++||....
T Consensus       235 -------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         235 -------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                               22568999999999999999999999999987  88887753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=364.91  Aligned_cols=244  Identities=27%  Similarity=0.371  Sum_probs=191.8

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCce
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  106 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||.||+|++..++   ..||+|.+....     ....+|+.+++.++||||+++++++.     + .
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~-~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E-N   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-S
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-C
Confidence            58999999999999999999986543   568899875332     22457999999999999999999872     1 2


Q ss_pred             eEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccce
Q 017341          107 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  185 (373)
Q Consensus       107 ~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a  185 (373)
                      .+|+|||||+ |++...+...   ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||+|
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~-~~Kl~DfG~a  155 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFGLS  155 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred             eEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCC-cEEEccchhh
Confidence            3689999999 4777766543   36789999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeccCCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 017341          186 KVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  262 (373)
Q Consensus       186 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  262 (373)
                      +.......  .....||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+.+....      
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------  228 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------  228 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred             eeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            86543322  2345679999999999654 58999999999999999998 89999998888777766542100      


Q ss_pred             hhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          263 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                            .+++++|+++.+||.+||+.||.+|||++|+++|
T Consensus       229 ----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 ----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  1235789999999999999999999999999876

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=360.40  Aligned_cols=244  Identities=21%  Similarity=0.285  Sum_probs=188.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCC----cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..|++.++||+|+||.||+|.+..++    ..||||++....     ....+|+++++.++|||||++++++.     +.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence            46999999999999999999987655    479999985432     22357999999999999999999883     33


Q ss_pred             eeEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      ..+++|||||.+ ++...+...   ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  156 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFGL  156 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC
T ss_pred             CceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCC-eEEEcccch
Confidence            347899999996 666655543   36799999999999999999999998 999999999999999988 899999999


Q ss_pred             eeeccCCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCH
Q 017341          185 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTR  259 (373)
Q Consensus       185 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~  259 (373)
                      ++.......    .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+....+.....    
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----  231 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----  231 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC----
Confidence            986543322    1234679999999999654 589999999999999999995 455555555444444332110    


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                              ...+.+++.++.+||.+||+.||++|||+.|+++
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 ------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                    0122468899999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=368.16  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCc
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  105 (373)
                      .+|++.++||+|+||+||+|.+..+|+    .||+|++....     +...+|+.+++.++|||||++++++..     .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence            469999999999999999999988876    58888775322     234589999999999999999998743     1


Q ss_pred             eeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccc
Q 017341          106 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  184 (373)
Q Consensus       106 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~  184 (373)
                      . .+++|+++. ++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCC-CeEeecccc
Confidence            1 456777776 6888777654   46799999999999999999999998 999999999999999988 899999999


Q ss_pred             eeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 017341          185 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       185 a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  260 (373)
                      |+........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+....    
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred             ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9876443332   234679999999999765 48999999999999999998 89999988777665555442111    


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                              ..+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                    0224688999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=362.53  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=191.5

Q ss_pred             cceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  103 (373)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|.+.....     ...+|..++.++ .|+||+.+++++..    
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc----
Confidence            589999999999999999999754     457899998864322     223566666655 68999999877632    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEE
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  170 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~~------------~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll  170 (373)
                      ....+++|||||+ |+|.+++......            ...+++..+..++.||+.||+|||++ ||+||||||+|||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl  167 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILL  167 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeE
Confidence            2334789999999 6899998765421            24588999999999999999999998 99999999999999


Q ss_pred             cCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHH
Q 017341          171 NPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQ  246 (373)
Q Consensus       171 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~  246 (373)
                      +.++ .+||+|||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9888 899999999976543322   2345789999999999764 489999999999999999986 578988776666


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          247 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      +..++.....+                           ..+..+++++.+||.+||+.||.+|||++|+++|
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55554421110                           1224688999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=357.24  Aligned_cols=244  Identities=21%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  111 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  111 (373)
                      .++|++.+.||+|+||.||+|++  +|..||+|++..+.  +...+|+++++.++||||+++++++..    +...+|+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEEE
Confidence            45899999999999999999998  57899999986553  335589999999999999999997743    22336899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeeccceeeccC
Q 017341          112 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  190 (373)
Q Consensus       112 ~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~~~~~  190 (373)
                      |||++ |+|.+++....  ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred             EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCC-CEeecccccceecCC
Confidence            99998 58998887543  23488999999999999999999998 999999999999999988 799999999976432


Q ss_pred             CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017341          191 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  269 (373)
Q Consensus       191 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  269 (373)
                        ......+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+...              
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------------  218 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------  218 (262)
T ss_dssp             --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------------
T ss_pred             --CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence              23445789999999999765 58999999999999999998 7999988877776666543110              


Q ss_pred             ccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          270 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                    ..++..+++++.+||++||+.||.+|||+.+++++
T Consensus       219 --------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         219 --------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                          11235688999999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=357.32  Aligned_cols=244  Identities=24%  Similarity=0.339  Sum_probs=192.2

Q ss_pred             cceEeeeeeeecCceEEEEEEECC-CC--cEEEEEEecccc-------cchHHHHHHHHhCCCCCeeecceeeeecCCCC
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLE-TG--EAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  104 (373)
                      .+|++.+.||+|+||.||+|++.. ++  ..||||++..+.       +...+|+.+++.++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            579999999999999999998643 33  368999875431       234589999999999999999998832     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  183 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg  183 (373)
                      . .+++|||||+ |++.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhcccccc-ceeeccch
Confidence            2 2579999998 5777776654   35699999999999999999999998 999999999999999988 89999999


Q ss_pred             ceeeccCCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017341          184 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  258 (373)
Q Consensus       184 ~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~  258 (373)
                      +++........    ....+|..|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+...++.+....  
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~--  233 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--  233 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC--
Confidence            99876444332    234568899999999764 48999999999999999998 89999999888877776542100  


Q ss_pred             HHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          259 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                                     .          ..+..+|+++.+||.+||..||++|||++++++
T Consensus       234 ---------------~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 ---------------L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ---------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------C----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           0          122568999999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=363.03  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=203.5

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcE--EEEEEeccc-----ccchHHHHHHHHhC-CCCCeeecceeeeecCCCC
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  104 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  104 (373)
                      ..++|++.++||+|+||.||+|+++.+|..  ||||.+...     .....+|+++++.+ +||||+++++++..     
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----   82 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----   82 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----
Confidence            456899999999999999999999888864  677876432     23356899999998 79999999999843     


Q ss_pred             ceeEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEc
Q 017341          105 ELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  171 (373)
Q Consensus       105 ~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~  171 (373)
                      ...+++|||||+ |+|.+++....            .....+++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVG  161 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEc
Confidence            345889999999 58988886542            2346799999999999999999999998 999999999999999


Q ss_pred             CCCCceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHH
Q 017341          172 PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEI  250 (373)
Q Consensus       172 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~-~pf~~~~~~~~~~~i  250 (373)
                      .++ .+||+|||+++............||+.|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+....+
T Consensus       162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            988 8999999999865544444566789999999999654 4899999999999999999964 678887766655554


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          251 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      .+...                            ...+..+++++.+||.+||+.||++|||++++++|
T Consensus       240 ~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCC----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33100                            01224688999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=358.03  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=196.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCC-------cEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeec
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFST  100 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~  100 (373)
                      .++|++.+.||+|+||.||+|++..++       ..||+|++..+..     ...+|...+..+ +||||+++++++.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence            358999999999999999999986554       4799998865432     223577777777 7999999999883  


Q ss_pred             CCCCceeEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          101 TEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       101 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                         +...+++|||||. |+|.+.+.....            ....+++..+..++.||+.||+|||++ +|+||||||+|
T Consensus        90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~N  165 (299)
T d1fgka_          90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARN  165 (299)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccc
Confidence               3445889999999 589888875431            235689999999999999999999998 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      ||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .|+.++|||||||++|+|++ |.+||.+.+.
T Consensus       166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            9999998 899999999986644332   2345789999999999654 59999999999999999998 7999988777


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+....+.+.. .                           ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~i~~~~-~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEGH-R---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTTC-C---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCC-C---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            65554443210 0                           0123568999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-49  Score=357.86  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=201.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||+||+|+++     .+++.||||++..+.     ....+|+++++.++||||+++++++..    
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc----
Confidence            357999999999999999999975     356889999986442     234589999999999999999998843    


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeec
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHY--------------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  162 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~D  162 (373)
                       ...++++|||+. |+|.+.+....                    .....+++..+..++.||+.||+|||++ +|+|||
T Consensus        88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrD  165 (301)
T d1lufa_          88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRD  165 (301)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeE
Confidence             334789999998 68888886432                    1123488899999999999999999998 999999


Q ss_pred             CCCCcEEEcCCCCceeEeeccceeeccCCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 017341          163 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLF  238 (373)
Q Consensus       163 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~-~pf  238 (373)
                      |||+|||++.++ .+||+|||+|+......   ......+|+.|+|||.+.+. .++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999988 89999999997553332   22345788999999999754 5899999999999999999985 789


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          239 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       239 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+.+..+....+.....                   +         ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~e~~~~v~~~~~-------------------~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNI-------------------L---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTCC-------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC-------------------C---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88888777766543210                   0         122568999999999999999999999999964

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-49  Score=356.89  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=199.0

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCCCCeeecceeeeecCCCCceeEEEEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  112 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  112 (373)
                      ++|++.+.||+|+||.||+|++..+|+.||||.+..+  .....+|+++++.++|++++..+..+..    +....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEE
Confidence            4799999999999999999999999999999987543  3455689999999988776665544432    334578999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC--CCceeEeeccceeeccC
Q 017341          113 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVK  190 (373)
Q Consensus       113 e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~ikl~Dfg~a~~~~~  190 (373)
                      ||+++++...+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++..  +..++|+|||+|+....
T Consensus        83 e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999887776653   46799999999999999999999998 99999999999998643  23699999999987644


Q ss_pred             CCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCCH
Q 017341          191 GEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG---TPTR  259 (373)
Q Consensus       191 ~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~  259 (373)
                      ...        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.+...   .+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            322        2345799999999999765 489999999999999999999999988765544433322110   0000


Q ss_pred             HHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHH---HHhcCCCccc
Q 017341          260 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL---EALIHPFFDE  323 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---~ll~hp~~~~  323 (373)
                                              .....++|+++.+||.+||+.||++||+++   ++|+|+|.+.
T Consensus       238 ------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 ------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                                    112256899999999999999999999986   5577877644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-48  Score=362.24  Aligned_cols=286  Identities=29%  Similarity=0.454  Sum_probs=209.1

Q ss_pred             cccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHhCC-----------CCCeeecceeee
Q 017341           33 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFF   98 (373)
Q Consensus        33 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~   98 (373)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.++           |+||+++++++.
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            3457999999999999999999999999999999987653   23357888888774           578999998875


Q ss_pred             ecCCCCceeEEEEEeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCC-
Q 017341           99 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-  175 (373)
Q Consensus        99 ~~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-  175 (373)
                      ..   +..+.+++|.++.  ++.......  .....+++..++.++.||+.||+|||+..||+||||||+|||++.++. 
T Consensus        91 ~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          91 HK---GPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EE---ETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             ec---cccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            42   2223445555544  444433332  235678999999999999999999998449999999999999986652 


Q ss_pred             ----ceeEeeccceeeccCCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHH
Q 017341          176 ----QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVD  245 (373)
Q Consensus       176 ----~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~------~~~  245 (373)
                          .++++|||.+....  .......||+.|+|||++... .++.++|+||+||++++|++|+.||...+      ..+
T Consensus       166 ~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cccceeeEeecccccccc--cccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                39999999997653  334567899999999999765 48999999999999999999999997643      345


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCc-------ccccCCCcCCCCcc------ccccCCCChhHHHHHHhhcCcCCCCCCCH
Q 017341          246 QLVEIIKVLGTPTREEIKCMNPNY-------TEFKFPQIKAHPWH------KIFQKRMPPEAVDLVSRLLQYSPNLRSTA  312 (373)
Q Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~t~  312 (373)
                      .+......++.+..+.........       ...........++.      ..+....++++.+||.+||++||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            667777777877766543211100       00011111111110      11123356789999999999999999999


Q ss_pred             HHHhcCCCccccCC
Q 017341          313 LEALIHPFFDELRD  326 (373)
Q Consensus       313 ~~ll~hp~~~~~~~  326 (373)
                      +|+|+||||++...
T Consensus       323 ~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         323 GGLVNHPWLKDTLG  336 (362)
T ss_dssp             HHHHTCGGGTTCTT
T ss_pred             HHHhcCcccCCCCC
Confidence            99999999997543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=355.53  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=207.1

Q ss_pred             ccceEeeeeeeecCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHhCCCCCeeecceeeeecCCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEK  103 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||.||+|.+..     ++..||||++.....     ...+|+++++.++||||+++++++.     
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----
Confidence            3689999999999999999998752     357899999864332     2348999999999999999999883     


Q ss_pred             CceeEEEEEeccc-ccHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCc
Q 017341          104 DELYLNLVLEYVP-ETVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  176 (373)
Q Consensus       104 ~~~~~~lv~e~~~-g~l~~~l~~~~~------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  176 (373)
                      ....+++|||||. |+|.+++.....      ....++...+..++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC-C
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCc-e
Confidence            3334789999998 688888775432      123468889999999999999999998 999999999999999988 8


Q ss_pred             eeEeeccceeeccCCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHH
Q 017341          177 LKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       177 ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~i~~  252 (373)
                      +||+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999976543322   2234689999999999654 489999999999999999997 588988888777766654


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCcccc
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI------HPFFDEL  324 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~------hp~~~~~  324 (373)
                      ....                            ..+..+++.+.++|.+||+.||++|||++++++      +|+|+++
T Consensus       251 ~~~~----------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GGLL----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            2100                            012468899999999999999999999999987      6666653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=352.23  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             ccceEeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeccccc-----chHHHHHHHHhC-CCCCeeecceeeeecCC
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTE  102 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  102 (373)
                      ..+|++.+.||+|+||.||+|++.     .+++.||||++.....     ...+|+.+++.+ +||||+++++++.    
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~----   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe----
Confidence            368999999999999999999863     5678999999865432     234789999988 6999999999883    


Q ss_pred             CCceeEEEEEeccc-ccHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCc
Q 017341          103 KDELYLNLVLEYVP-ETVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  167 (373)
Q Consensus       103 ~~~~~~~lv~e~~~-g~l~~~l~~~~~--------------~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~N  167 (373)
                       +...+++|||||+ |+|...+.....              ....+++..+..++.||+.||+|||++ +++||||||+|
T Consensus        98 -~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~N  175 (311)
T d1t46a_          98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARN  175 (311)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeeccccccc
Confidence             3344789999998 588888875432              233589999999999999999999998 99999999999


Q ss_pred             EEEcCCCCceeEeeccceeeccCCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017341          168 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  243 (373)
Q Consensus       168 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~  243 (373)
                      |+++.++ .+||+|||.++........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999888 8999999999876443322   235789999999999654 58999999999999999998 7788888777


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          244 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+.+.++...-..+                           ..+...|+++.+||.+||+.||.+|||++++++
T Consensus       254 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67666665531111                           122457899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-47  Score=344.09  Aligned_cols=250  Identities=20%  Similarity=0.235  Sum_probs=200.6

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHhCCC-CCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      .++|++.+.||+|+||.||+|++..+|+.||+|.+...  .....+|++.++.++| +|++.+++++     ......++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEE
Confidence            35899999999999999999999999999999987543  3445789999999976 8999998877     34455789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCC----CCceeEeecccee
Q 017341          111 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAK  186 (373)
Q Consensus       111 v~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~----~~~ikl~Dfg~a~  186 (373)
                      ||||++++|.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+||+++.+    .+.+||+|||+|+
T Consensus        79 vme~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          79 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999999998887654   35799999999999999999999998 99999999999999742    2379999999998


Q ss_pred             eccCCC--------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhC
Q 017341          187 VLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLG  255 (373)
Q Consensus       187 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~---~~~i~~~~~  255 (373)
                      ......        ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....   ..++.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            764321        12345799999999999764 589999999999999999999999987644332   333332211


Q ss_pred             CCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017341          256 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~  317 (373)
                      .+....                        ..+++|+++.+++..|+..+|++||+.+.+.+
T Consensus       234 ~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         234 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111111                        12468899999999999999999999776643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=344.90  Aligned_cols=245  Identities=20%  Similarity=0.274  Sum_probs=189.7

Q ss_pred             ceEeeeeeeecCceEEEEEEECCCC---cEEEEEEecccc-----cchHHHHHHHHhCCCCCeeecceeeeecCCCCcee
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  107 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  107 (373)
                      .+...++||+|+||+||+|++..++   ..||||++....     ....+|++++++++||||+++++++...    +..
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~  103 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS  103 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCc
Confidence            3444789999999999999986543   368999885422     2345899999999999999999986432    334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          108 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       108 ~~lv~e~~~g-~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      +++|||||++ +|.+++...   ....++..+..++.|++.||.|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus       104 ~~lv~E~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~-~~kL~DFG~~~  178 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGLAR  178 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSSGGGC
T ss_pred             eEEEEEEeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCC-CEEEecccchh
Confidence            7899999995 777766543   35577888999999999999999988 999999999999999888 89999999998


Q ss_pred             eccCCCCc-----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHH
Q 017341          187 VLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTRE  260 (373)
Q Consensus       187 ~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~~~  260 (373)
                      ........     ....||+.|+|||.+.+. .++.++||||||+++|||+||..||.... ..+....+.+..      
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~------  251 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------  251 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC------
T ss_pred             hccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence            65433221     234689999999998654 48999999999999999999777765543 222233222210      


Q ss_pred             HHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          261 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                                            ....++.+++++.+||.+||+.||++|||+.|+++|
T Consensus       252 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ----------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  001224678999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=346.49  Aligned_cols=269  Identities=19%  Similarity=0.197  Sum_probs=189.2

Q ss_pred             ccceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccccc-h--HHHHHHHHhCCCCCeeecceeeeecCCCCceeEEE
Q 017341           34 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-K--NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  110 (373)
Q Consensus        34 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  110 (373)
                      ..+|.+.+.||+|+||.||+|++  +|+.||||++..+... .  +.|+..+..++||||+++++++.... .....+|+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence            35799999999999999999996  6899999998654432 2  23444556789999999999886543 34456889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcc-------CCceeecCCCCcEEEcCCCCceeEeec
Q 017341          111 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------IGVCHRDIKPQNLLVNPHTHQLKLCDF  182 (373)
Q Consensus       111 v~e~~~-g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-------~~ivH~Dlkp~NIll~~~~~~ikl~Df  182 (373)
                      |||||. |+|...+.+     .+++...+..++.|++.||+|||+.       .||+||||||+|||++.++ .+||+||
T Consensus        79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DF  152 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  152 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEec
Confidence            999998 589888864     4588999999999999999999962       3999999999999999988 8999999


Q ss_pred             cceeeccCCCC-----cccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017341          183 GSAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  252 (373)
Q Consensus       183 g~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~i~~  252 (373)
                      |+++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||.+||......+...... 
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-  231 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-  231 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-
Confidence            99987644332     23457899999999985432     14668999999999999999998875432211000000 


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCcCCCCccccccCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017341          253 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  318 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ll~h  318 (373)
                      ....+....+.....  .....|..+    ........+..+.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         232 VPSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            000001010000000  000000000    000011233568999999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=187.92  Aligned_cols=163  Identities=16%  Similarity=0.123  Sum_probs=115.3

Q ss_pred             eEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----------------------cchHHHHHHHHhCCCCCeeecc
Q 017341           37 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK   94 (373)
Q Consensus        37 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~   94 (373)
                      |.++++||+|+||.||+|.+. +|+.||||.+....                      ....+|...+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            578999999999999999984 78999999764211                      0112477888899999998876


Q ss_pred             eeeeecCCCCceeEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHccCCceeecCCCCcEEEcCCC
Q 017341           95 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  174 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~~ivH~Dlkp~NIll~~~~  174 (373)
                      ++.     .    .+++|||+++...          ..++...+..++.|++.+|.|||++ ||+||||||+|||++.+ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-
Confidence            542     2    2589999997421          2244455678899999999999998 99999999999999964 


Q ss_pred             CceeEeeccceeeccCCCCcccccc-cccccccccccCCCCCCCchhHHHHHH
Q 017341          175 HQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGC  226 (373)
Q Consensus       175 ~~ikl~Dfg~a~~~~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DiwslG~  226 (373)
                       .++|+|||.|......... .... +... -.+.+ . ..|+.++|+||+.-
T Consensus       140 -~~~liDFG~a~~~~~~~~~-~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~  187 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR-EILERDVRN-IITYF-S-RTYRTEKDINSAID  187 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH-HHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH-HHHHHHHHH-HHHHH-c-CCCCCcccHHHHHH
Confidence             4899999998764322111 0000 0000 01222 1 34788999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.44  E-value=7.2e-07  Score=75.91  Aligned_cols=77  Identities=17%  Similarity=0.100  Sum_probs=50.6

Q ss_pred             cceEeeeeeeecCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHhCC-CCCeeecceeeeecCCCCceeEE
Q 017341           35 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  109 (373)
Q Consensus        35 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  109 (373)
                      ..|++.+..+.++.+.||++.  ..++.+++|......    ....+|...++.+. +-.+.+++.+.     .+....+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceE
Confidence            467777776666667999986  356678888775432    23467888888774 33345554433     2234467


Q ss_pred             EEEeccccc
Q 017341          110 LVLEYVPET  118 (373)
Q Consensus       110 lv~e~~~g~  118 (373)
                      +||++++|.
T Consensus        87 lv~~~l~G~   95 (263)
T d1j7la_          87 LLMSEADGV   95 (263)
T ss_dssp             EEEECCSSE
T ss_pred             EEEEecccc
Confidence            999999973

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=1.5e-05  Score=67.07  Aligned_cols=64  Identities=16%  Similarity=0.128  Sum_probs=41.3

Q ss_pred             ceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHhCCCCC--eeecceeeeecCCCCceeEEEEEecccc
Q 017341           48 FGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPE  117 (373)
Q Consensus        48 ~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~g  117 (373)
                      .+.||++.. ..+..+++|...... .....|...++.+....  +++++.+.     .+....++||++++|
T Consensus        24 ~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          24 DAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG   90 (255)
T ss_dssp             SCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred             CCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeec
Confidence            468999875 567778999765433 34567888888774322  44444433     222346789999986

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.95  E-value=3.9e-05  Score=68.97  Aligned_cols=71  Identities=18%  Similarity=0.154  Sum_probs=42.8

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeccc-----------ccchHHHHHHHHhCC-C--CCeeecceeeeecCCCCc
Q 017341           40 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        40 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  105 (373)
                      .+.||.|....||++.+..+++.+++|.-...           ......|...|+.+. +  ..+++++.+  .   ++.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            45689999999999998777889999964211           112345888887663 2  234444322  1   222


Q ss_pred             eeEEEEEecccc
Q 017341          106 LYLNLVLEYVPE  117 (373)
Q Consensus       106 ~~~~lv~e~~~g  117 (373)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3579999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.30  E-value=0.00087  Score=59.89  Aligned_cols=72  Identities=17%  Similarity=0.171  Sum_probs=45.6

Q ss_pred             ceEeeeeeeecCceEEEEEEECC-------CCcEEEEEEecccccc--hHHHHHHHHhCC-CCCeeecceeeeecCCCCc
Q 017341           36 SYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDKRY--KNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  105 (373)
Q Consensus        36 ~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~--~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  105 (373)
                      ..++ +.|+.|-.-.+|++....       .++.|.++..-.....  ..+|..+++.+. +.-.++++.++     ++ 
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~-  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG-  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT-
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC-
Confidence            3444 568888888999998653       3456777766432222  347888888775 33344555544     22 


Q ss_pred             eeEEEEEecccc
Q 017341          106 LYLNLVLEYVPE  117 (373)
Q Consensus       106 ~~~~lv~e~~~g  117 (373)
                         ++|++|++|
T Consensus       117 ---g~I~efi~g  125 (395)
T d1nw1a_         117 ---GRLEEYIPS  125 (395)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---ceEEEEecc
Confidence               368999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.63  E-value=0.0065  Score=52.38  Aligned_cols=68  Identities=16%  Similarity=-0.017  Sum_probs=38.6

Q ss_pred             eEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHhCCCCCe--eecceeeeecCCCCceeEEEEEecccc
Q 017341           49 GVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVPE  117 (373)
Q Consensus        49 g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~g  117 (373)
                      -.||++.. ++|+.|++|.....   ...+..|...+..|....+  +.....--........+.+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            58999985 67889999987543   2335578888777742222  111110000000123446788998875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.44  E-value=0.0063  Score=52.09  Aligned_cols=29  Identities=31%  Similarity=0.291  Sum_probs=25.7

Q ss_pred             CceeecCCCCcEEEcCCCCceeEeecccee
Q 017341          157 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  186 (373)
Q Consensus       157 ~ivH~Dlkp~NIll~~~~~~ikl~Dfg~a~  186 (373)
                      |+||+|+.++||+++.+. ..-++||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             ccccCCcchhhhhccccc-ceeEecccccc
Confidence            799999999999999766 56899999875